Citrus Sinensis ID: 023808

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------
Protein Sequence
MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR
Secondary Structure (PSIPRED)
cEEEcccccccccEEEEEcccccEEEEEEEcccccHHHHccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEcccccHHHHHcccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccEEEcccccccccccccccccccccccccEEEEEEccc
Secondary Structure Prediction (SSPRO)
ccHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEccccccEEEEEEEEccccccHHHHHcccccccHHHHHHHEEEEEEHccccccccccccccHHHHHHHHHHHHccccHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccEEcccccccccccccccccccccccccccEEEEccc
Coil and Loop (DISEMBL)
mtlsnvrhpnlVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVphivhrdikasnilldqefnpkigdfglaklfpdnithittriagttgylapeyvlggqltmkadvYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHqeekplelvdpelgeyppneIIRYMKVAFFCTqaaasrrpQMNQVIKMLTKNIrlneeeltapglfqdsesssvgtsdkkssdstlqmssvpvtitqvtpr
Flexible Loop (DISEMBL)
mtlsnvrhpnlveLIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAasrrpqmnQVIKMLTKNIRLNEEELtapglfqdsesssvgtsdkkssdstlqmssvpvtitqvtpr
Low Complexity Region (SEG)
MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQdsesssvgtsdkkssdstLQMSSVPVTITQVTPR
Disordered region (IsUnstruct)
********PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS****MNQVIKMLTKNIR***********************************************
Disordered Region (DISOPRED)
MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR****ELT***L****************************TITQVTPR
Disordered Region (DISEMBL)
MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ*********************SSVPVTITQVTPR
Disordered Region (DISPRO)
MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAP***Q**********************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	277	2.2.26 [Sep-21-2011]
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.989	0.265	0.436	7e-68
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.981	0.263	0.446	3e-67
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.826	0.220	0.526	2e-66
C0LGN2	1020	Probable leucine-rich rep	no	no	0.895	0.243	0.493	7e-66
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.826	0.221	0.517	1e-65
C0LGG7	953	Probable LRR receptor-lik	no	no	0.801	0.232	0.537	2e-65
C0LGE0	1014	Probable LRR receptor-lik	no	no	0.833	0.227	0.523	1e-63
Q9ASQ6	1019	Probable LRR receptor-lik	no	no	0.924	0.251	0.478	2e-62
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.978	0.420	0.435	1e-59
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.974	0.397	0.450	1e-59

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  257 bits (656), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 123/282 (43%), Positives = 187/282 (66%), Gaps = 8/282 (2%)

Query: 1    MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            + +S V+H NLV+L GCC +G  R+LVYEY+ N SLD+ L G  +  + L+W  R +IC+
Sbjct: 739  VAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFG--EKTLHLDWSTRYEICL 796

Query: 61   GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            G+A+GL +LHEE    IVHRD+KASNILLD +  PK+ DFGLAKL+ D  THI+TR+AGT
Sbjct: 797  GVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGT 856

Query: 121  TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             GYLAPEY + G LT K DVY+FGV+ LE++SGR +         ++LLEWAW LH++ +
Sbjct: 857  IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGR 916

Query: 181  PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 240
             +EL+D +L E+   E  R + +A  CTQ + + RP M++V+ ML+ ++ +++   + PG
Sbjct: 917  EVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVT-SKPG 975

Query: 241  L-----FQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
                  F D+ +SS+     +++ ++   +S     ++++PR
Sbjct: 976  YLTDWRFDDTTASSISGFPLRNTQASESFTSFVAPRSEISPR 1017

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  254 bits (650), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 126/282 (44%), Positives = 184/282 (65%), Gaps = 10/282 (3%)

Query: 1    MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            + +S+V H NLV+L GCC +G  R+LVYEY+ N SLD+ L G     + L+W  R +IC+
Sbjct: 740  VAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICL 797

Query: 61   GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            G+A+GL +LHEE    IVHRD+KASNILLD    P+I DFGLAKL+ D  THI+TR+AGT
Sbjct: 798  GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGT 857

Query: 121  TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             GYLAPEY + G LT K DVY+FGV+ LE++SGR +      +  K+LLEWAW LH++ +
Sbjct: 858  IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSR 917

Query: 181  PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 240
             +EL+D +L ++   E  R + +A  CTQ + + RP M++V+ ML+ ++ + +   + PG
Sbjct: 918  DIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVT-SKPG 976

Query: 241  L-----FQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
                  F D+  SS+  S  +  D+T    S+    ++++PR
Sbjct: 977  YVSDWRFDDTTGSSL--SGFQIKDTTGYSMSLVAPGSEISPR 1016

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  253 bits (645), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 121/230 (52%), Positives = 161/230 (70%), Gaps = 1/230 (0%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S ++HPNLV+L GCC++G   +LVYEY+ENNSL R L G  K  + L+W  R+ IC+GI
Sbjct: 717 ISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGI 776

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           AKGLA+LHEE    IVHRDIKA+N+LLD   N KI DFGLAKL  D  THI+TRIAGT G
Sbjct: 777 AKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIG 836

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           Y+APEY + G LT KADVYSFGV+ LEI+SG+++      +   +LL+WA+ L ++   L
Sbjct: 837 YMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLL 896

Query: 183 ELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 231
           ELVDP+LG  +   E +R + +A  CT  + + RP M+ V+ ML   I++
Sbjct: 897 ELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKV 946

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1

 Score =  250 bits (639), Expect = 7e-66,   Method: Compositional matrix adjust.
 Identities = 123/249 (49%), Positives = 167/249 (67%), Gaps = 1/249 (0%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S ++HP+LV+L GCCV+G + +LVYEY+ENNSL R L G  +  I LNW  R  ICVGI
Sbjct: 720 ISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGI 779

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+GLA+LHEE    IVHRDIKA+N+LLD+E NPKI DFGLAKL  +  THI+TR+AGT G
Sbjct: 780 ARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYG 839

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           Y+APEY + G LT KADVYSFGV+ LEI+ G+++  +       +LL+W   L ++   L
Sbjct: 840 YMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLL 899

Query: 183 ELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           E+VDP LG +Y   E +  +++   CT  A   RP M+ V+ ML  +  +N E+L    +
Sbjct: 900 EVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLEASV 959

Query: 242 FQDSESSSV 250
             + +  SV
Sbjct: 960 NNEKDEESV 968

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  249 bits (637), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 119/230 (51%), Positives = 161/230 (70%), Gaps = 1/230 (0%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S ++HPNLV+L GCC++G   +LVYEY+ENNSL R L G  K  + L+W  R+ +C+GI
Sbjct: 715 ISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGI 774

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           AKGLA+LHEE    IVHRDIKA+N+LLD   N KI DFGLAKL  +  THI+TRIAGT G
Sbjct: 775 AKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIG 834

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           Y+APEY + G LT KADVYSFGV+ LEI+SG+++      +   +LL+WA+ L ++   L
Sbjct: 835 YMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLL 894

Query: 183 ELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 231
           ELVDP+LG  +   E +R + +A  CT  + + RP M+ V+ ML   I++
Sbjct: 895 ELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  249 bits (635), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 121/225 (53%), Positives = 161/225 (71%), Gaps = 3/225 (1%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + HPNLV+L GCCV+G + +LVYE+VENNSL R L G  +  ++L+W  R  IC+G+
Sbjct: 672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGV 731

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+GLA+LHEE    IVHRDIKA+N+LLD++ NPKI DFGLAKL  ++ THI+TRIAGT G
Sbjct: 732 ARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFG 791

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQEEKP 181
           Y+APEY + G LT KADVYSFG++ LEI+ GR S K    + N F L++W   L ++   
Sbjct: 792 YMAPEYAMRGHLTDKADVYSFGIVALEIVHGR-SNKIERSKNNTFYLIDWVEVLREKNNL 850

Query: 182 LELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           LELVDP LG EY   E +  +++A  CT +    RP M++V+KML
Sbjct: 851 LELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKML 895

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  243 bits (620), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 122/233 (52%), Positives = 161/233 (69%), Gaps = 2/233 (0%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN-IKLNWEKRSDICVG 61
           +S ++HPNLV+L GCCV+G + ILVYEY+ENN L R L G  +++ +KL+W  R  I +G
Sbjct: 726 ISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLG 785

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IAKGL FLHEE    IVHRDIKASN+LLD++ N KI DFGLAKL  D  THI+TRIAGT 
Sbjct: 786 IAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTI 845

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GY+APEY + G LT KADVYSFGV+ LEI+SG+++      +   +LL+WA+ L +    
Sbjct: 846 GYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSL 905

Query: 182 LELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
           LELVDP L  +Y   E +  + VA  CT A+ + RP M+QV+ ++     + E
Sbjct: 906 LELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQE 958

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3

 Score =  239 bits (610), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 125/261 (47%), Positives = 172/261 (65%), Gaps = 5/261 (1%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + HPNLV+L GCCV+  + +LVYEY+ENNSL   L G  + ++KL+W  R  ICVGI
Sbjct: 721 ISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFG--QNSLKLDWAARQKICVGI 778

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+GL FLH+     +VHRDIK +N+LLD + N KI DFGLA+L     THI+T++AGT G
Sbjct: 779 ARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIG 838

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           Y+APEY L GQLT KADVYSFGV+ +EI+SG+++ K      +  L+ WA  L Q    L
Sbjct: 839 YMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDIL 898

Query: 183 ELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           E+VD  L GE+  +E +R +KVA  CT ++ S RP M++ +KML   I +  + ++ PG+
Sbjct: 899 EIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEIT-QVMSDPGI 957

Query: 242 F-QDSESSSVGTSDKKSSDST 261
           +  D   S +   D  SS ST
Sbjct: 958 YGHDWSISKLRDIDTHSSSST 978

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  229 bits (585), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 122/280 (43%), Positives = 175/280 (62%), Gaps = 9/280 (3%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + ++ ++H NLV+L+G C++G  +ILVYE+V N SLD  L  +T   +KL+W +R  I  
Sbjct: 372 VVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDST-MKMKLDWTRRYKIIG 430

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAG 119
           GIA+G+ +LH++    I+HRD+KA NILLD + NPKI DFG+A++F  D    +T R+ G
Sbjct: 431 GIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVG 490

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQE 178
           T GY++PEY + GQ +MK+DVYSFGVLVLEIISG +NS      +    L+ + W+L   
Sbjct: 491 TYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSN 550

Query: 179 EKPLELVDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELT 237
             P ELVDP  G+ Y  +EI R + +A  C Q  A  RP M+ +++MLT ++ +   E  
Sbjct: 551 GSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSL-IALAEPR 609

Query: 238 APGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
            PG F  S+    G     S DS+   S    +IT+VTPR
Sbjct: 610 PPGFFFRSKQEQAG----PSIDSSTHCSVDEASITRVTPR 645

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  229 bits (584), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 128/284 (45%), Positives = 178/284 (62%), Gaps = 14/284 (4%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + L+ ++H NLV LIG C+QG  R+LVYE+++N SLD+ +    K  + L+W  R  +  
Sbjct: 403 LLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQL-LDWVVRYKMIG 461

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITH-ITTRI 117
           GIA+GL +LHE+    I+HRD+KASNILLDQE NPKI DFGLAKLF     +TH  T+RI
Sbjct: 462 GIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRI 521

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFLLEWAWQL 175
           AGT GY+APEY + GQ ++K DV+SFGVLV+EII+G+  N+G +   +  + LL W W+ 
Sbjct: 522 AGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRS 581

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            +E+  L ++DP L     NEI+R + +   C Q +A+ RP M  V  M      LN   
Sbjct: 582 WREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMATVSLM------LNSYS 635

Query: 236 LTAPGLFQDSE--SSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
            T P   + +    S V  S+  SS   LQMSS  VT+++ +PR
Sbjct: 636 FTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	277
356521337	367	PREDICTED: probable LRR receptor-like se	0.985	0.743	0.740	1e-119
356548747	367	PREDICTED: probable LRR receptor-like se	0.981	0.741	0.733	1e-118
297742896	441	unnamed protein product [Vitis vinifera]	0.978	0.614	0.746	1e-117
359496587	364	PREDICTED: probable LRR receptor-like se	0.978	0.744	0.746	1e-117
224078940	306	predicted protein [Populus trichocarpa]	0.877	0.794	0.786	1e-115
255555999	367	Serine/threonine-protein kinase PBS1, pu	0.996	0.752	0.716	1e-113
224125454	310	predicted protein [Populus trichocarpa]	0.873	0.780	0.764	1e-112
358346657	392	hypothetical protein MTR_084s0004 [Medic	0.989	0.698	0.712	1e-112
449457713	383	PREDICTED: probable leucine-rich repeat	0.996	0.720	0.647	1e-105
356557677	360	PREDICTED: probable LRR receptor-like se	0.963	0.741	0.682	1e-104

>gi|356521337|ref|XP_003529313.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Glycine max]

 Score =  435 bits (1118), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 205/277 (74%), Positives = 240/277 (86%), Gaps = 4/277 (1%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+SNV+HPNLVEL+GCCVQ   RILVYE+VENNSLDR LLG+  +NI+L+W KRS IC+G
Sbjct: 94  TISNVKHPNLVELVGCCVQEPNRILVYEFVENNSLDRALLGSRGSNIRLDWRKRSAICMG 153

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GLAFLHEE VPHIVHRDIKASNILLD++FNPKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 154 TARGLAFLHEEHVPHIVHRDIKASNILLDRDFNPKIGDFGLAKLFPDDITHISTRIAGTT 213

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY +GGQLTMKADVYSFGVL+LEIISG++S +  WG  NKFLLEWAWQL++E K 
Sbjct: 214 GYLAPEYAMGGQLTMKADVYSFGVLILEIISGKSSARTNWGGSNKFLLEWAWQLYEEGKL 273

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDP++ E+P  E+IRYMKVAFFCTQAAASRRP M+QV+ ML+KN+RLNE++LTAPGL
Sbjct: 274 LELVDPDMVEFPEKEVIRYMKVAFFCTQAAASRRPMMSQVVDMLSKNMRLNEKQLTAPGL 333

Query: 242 FQDSESSSVGTSDKKSSDST-LQMSSVPVTITQVTPR 277
           FQDS +SS     K S +ST  Q SS P +ITQ+ PR
Sbjct: 334 FQDSGASS---QKKSSFESTGYQFSSNPSSITQLAPR 367

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548747|ref|XP_003542761.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max]

 Score =  429 bits (1102), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 204/278 (73%), Positives = 239/278 (85%), Gaps = 6/278 (2%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+SNV+HPNLVEL+GCCVQ   RILVYEYVENNSLDR LLG   +NI+L+W KRS IC+G
Sbjct: 94  TISNVKHPNLVELVGCCVQEPNRILVYEYVENNSLDRALLGPRSSNIRLDWRKRSAICMG 153

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GLAFLHEELVPHIVHRDIKASNILLD++F PKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 154 TARGLAFLHEELVPHIVHRDIKASNILLDRDFKPKIGDFGLAKLFPDDITHISTRIAGTT 213

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY +GGQLTMKADVYSFGVL+LEIISG++S +  WG  NKFLLEWAW L++E K 
Sbjct: 214 GYLAPEYAMGGQLTMKADVYSFGVLILEIISGKSSARTNWGGSNKFLLEWAWNLYEEGKL 273

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDP++ E+P  E+IRYMKVAFFCTQAAASRRP M+QV+ ML+KN+RLNE++LTAPGL
Sbjct: 274 LELVDPDMVEFPEEEVIRYMKVAFFCTQAAASRRPMMSQVVDMLSKNMRLNEKQLTAPGL 333

Query: 242 FQDSESSSVGTSDKKSS--DSTLQMSSVPVTITQVTPR 277
           FQDS +S    S KKSS   ++ Q SS   +ITQ++PR
Sbjct: 334 FQDSGAS----SQKKSSFESTSYQFSSNSSSITQLSPR 367

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742896|emb|CBI35687.3| unnamed protein product [Vitis vinifera]

 Score =  426 bits (1095), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 206/276 (74%), Positives = 235/276 (85%), Gaps = 5/276 (1%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+SNVRHPNLVELIGCCV G  +ILVYEYVENNS+D+VLLG     I L+W KRS IC+G
Sbjct: 171 TISNVRHPNLVELIGCCVHGNNKILVYEYVENNSIDQVLLGH---KIILDWGKRSAICMG 227

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GLAFLHEELVPHIVHRDIKASNILL+++F+PKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 228 TARGLAFLHEELVPHIVHRDIKASNILLEKDFSPKIGDFGLAKLFPDDITHISTRIAGTT 287

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY LGGQLTMKADVYSFGVLVLEIISG+ S +A +G   KFLLEWAWQLH E + 
Sbjct: 288 GYLAPEYALGGQLTMKADVYSFGVLVLEIISGKTSSQANFGGSQKFLLEWAWQLHIEGRF 347

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDPEL E+P  E++RY KVAFFCTQAAASRRP M+QV+ ML++NIRLNE+ELTAPG 
Sbjct: 348 LELVDPELVEFPEEEVMRYAKVAFFCTQAAASRRPLMSQVVDMLSRNIRLNEKELTAPGY 407

Query: 242 FQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
           FQ S+  S   S   S  ++ QMSSVPVTIT+VTPR
Sbjct: 408 FQTSDDCSRKPSSTDS--ASYQMSSVPVTITEVTPR 441

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496587|ref|XP_003635271.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Vitis vinifera]

 Score =  426 bits (1095), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 206/276 (74%), Positives = 235/276 (85%), Gaps = 5/276 (1%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+SNVRHPNLVELIGCCV G  +ILVYEYVENNS+D+VLLG     I L+W KRS IC+G
Sbjct: 94  TISNVRHPNLVELIGCCVHGNNKILVYEYVENNSIDQVLLGH---KIILDWGKRSAICMG 150

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GLAFLHEELVPHIVHRDIKASNILL+++F+PKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 151 TARGLAFLHEELVPHIVHRDIKASNILLEKDFSPKIGDFGLAKLFPDDITHISTRIAGTT 210

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY LGGQLTMKADVYSFGVLVLEIISG+ S +A +G   KFLLEWAWQLH E + 
Sbjct: 211 GYLAPEYALGGQLTMKADVYSFGVLVLEIISGKTSSQANFGGSQKFLLEWAWQLHIEGRF 270

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDPEL E+P  E++RY KVAFFCTQAAASRRP M+QV+ ML++NIRLNE+ELTAPG 
Sbjct: 271 LELVDPELVEFPEEEVMRYAKVAFFCTQAAASRRPLMSQVVDMLSRNIRLNEKELTAPGY 330

Query: 242 FQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
           FQ S+  S   S   S  ++ QMSSVPVTIT+VTPR
Sbjct: 331 FQTSDDCSRKPSSTDS--ASYQMSSVPVTITEVTPR 364

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078940|ref|XP_002305688.1| predicted protein [Populus trichocarpa] gi|222848652|gb|EEE86199.1| predicted protein [Populus trichocarpa]

 Score =  419 bits (1077), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 191/243 (78%), Positives = 218/243 (89%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+SNVRHPNLVELIGCCVQG  RILVYEY+ENNSLDR LLG+   NI+L+W +RS IC+G
Sbjct: 64  TISNVRHPNLVELIGCCVQGANRILVYEYLENNSLDRALLGSRSTNIRLDWGRRSAICLG 123

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IA+GLAFLHEELVPHIVHRDIKASNILLD++ NPKIGDFGLAKLFP+NITHI+TRIAGTT
Sbjct: 124 IARGLAFLHEELVPHIVHRDIKASNILLDKDLNPKIGDFGLAKLFPENITHISTRIAGTT 183

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY LGGQLTMKADVYSFGVL+LEIISGRNS K  WG M K LLEWAWQLH+E +P
Sbjct: 184 GYLAPEYALGGQLTMKADVYSFGVLILEIISGRNSTKPSWGGMEKLLLEWAWQLHEEGRP 243

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDPE+GE+P  E+IRY+KVAFFCTQ+AA+RRP  +QV+ ML+K IRLN++ LTAPG 
Sbjct: 244 LELVDPEMGEFPEEEVIRYIKVAFFCTQSAANRRPLTSQVVDMLSKQIRLNDKLLTAPGF 303

Query: 242 FQD 244
           F+D
Sbjct: 304 FRD 306

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555999|ref|XP_002519034.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223541697|gb|EEF43245.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  415 bits (1067), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 200/279 (71%), Positives = 230/279 (82%), Gaps = 3/279 (1%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           TLS VRHPNLVELIGCCV G  RILVYEYVENNSL+R LLG+   N  L+W KRS IC G
Sbjct: 89  TLSRVRHPNLVELIGCCVLGANRILVYEYVENNSLERALLGSQNTNTTLDWGKRSAICFG 148

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IAKGLAFLHEELVPHIVHRDIKASN+LLD+E+NPKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 149 IAKGLAFLHEELVPHIVHRDIKASNVLLDKEYNPKIGDFGLAKLFPDDITHISTRIAGTT 208

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY +GG LTMKADVYSFG+L+LEIISGR+S K   G M K LLEWAW+L++  K 
Sbjct: 209 GYLAPEYAMGGPLTMKADVYSFGILILEIISGRSSSKPSCGGMEKLLLEWAWELYEGGKL 268

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDP+LGE+P  E+IR+MKVA FCTQ   SRRP M+QV++ML+KNIRLNE+ L+APG 
Sbjct: 269 LELVDPQLGEFPEEEVIRHMKVALFCTQEVGSRRPLMSQVVEMLSKNIRLNEKLLSAPGF 328

Query: 242 FQDSESSSVGTS--DKKSSDST-LQMSSVPVTITQVTPR 277
           F+D    S G S   K S+DST L  SS+P TIT++ PR
Sbjct: 329 FRDLSGLSGGPSVTKKSSTDSTGLHTSSIPGTITELAPR 367

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125454|ref|XP_002329809.1| predicted protein [Populus trichocarpa] gi|222870871|gb|EEF08002.1| predicted protein [Populus trichocarpa]

 Score =  410 bits (1053), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 185/242 (76%), Positives = 215/242 (88%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+S V+HPNLVELIGCC QG+ RILVYEYVENNSLDR LLG+   +IKL+W +RS IC+G
Sbjct: 69  TISKVKHPNLVELIGCCAQGSNRILVYEYVENNSLDRALLGSRSTDIKLDWGRRSAICLG 128

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IA+GL FLH+E+VPHIVHRDIKASNILLD++FNPKIGDFGLAKLFPDNITHI+TRIAGTT
Sbjct: 129 IARGLDFLHKEVVPHIVHRDIKASNILLDKDFNPKIGDFGLAKLFPDNITHISTRIAGTT 188

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY LGGQLTMKADVYSFGVL+LEI+SGR+S K  WG   K LLEWAWQLH+E K 
Sbjct: 189 GYLAPEYALGGQLTMKADVYSFGVLILEIVSGRSSAKPSWGGTQKLLLEWAWQLHEEGKH 248

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           LELVDPE+GE+P  E+IRY+KVAFFCTQ+AA+RRP M QV+ ML++ I+LN++ELTAPG 
Sbjct: 249 LELVDPEMGEFPEEEVIRYIKVAFFCTQSAANRRPIMTQVVDMLSRQIQLNDKELTAPGF 308

Query: 242 FQ 243
           FQ
Sbjct: 309 FQ 310

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358346657|ref|XP_003637382.1| hypothetical protein MTR_084s0004 [Medicago truncatula] gi|355503317|gb|AES84520.1| hypothetical protein MTR_084s0004 [Medicago truncatula]

 Score =  409 bits (1050), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 201/282 (71%), Positives = 234/282 (82%), Gaps = 8/282 (2%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+S+V+HPNLVEL+GCC Q   R LVYEYVENNSLDR LLG    NIKL+W KRS+IC G
Sbjct: 113 TISHVKHPNLVELVGCCAQEPNRTLVYEYVENNSLDRALLGNRSTNIKLDWGKRSNICTG 172

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GLAFLHEE VPHIVHRDIKASNILLD+ FNPKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 173 TARGLAFLHEEAVPHIVHRDIKASNILLDRHFNPKIGDFGLAKLFPDDITHISTRIAGTT 232

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW------AWQL 175
           GYLAPEY +GGQLTMKADVYSFGVL+LE+ISG++S +  WG  NKFLLEW      AWQL
Sbjct: 233 GYLAPEYAMGGQLTMKADVYSFGVLILEVISGQSSARTNWGGSNKFLLEWVRFQLPAWQL 292

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
           H+EE+ LELVDP++ E+P  E+IRYMKVAFFCTQAAASRRP M+QV+ ML+K IRLNE++
Sbjct: 293 HEEERLLELVDPDMVEFPKEEVIRYMKVAFFCTQAAASRRPSMSQVVDMLSKKIRLNEKQ 352

Query: 236 LTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
           +TAPG FQ S  SS+  S  +S  ++ Q SS PV+ TQVTPR
Sbjct: 353 ITAPGFFQTSGESSLKKSSFES--TSHQFSSAPVSFTQVTPR 392

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457713|ref|XP_004146592.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] gi|449488434|ref|XP_004158036.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus]

 Score =  385 bits (990), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 180/278 (64%), Positives = 224/278 (80%), Gaps = 2/278 (0%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+SN+RHPNLVELIGCC Q   RILVYEY+ENNSLD  LL   K ++ L+W KRS IC+G
Sbjct: 106 TISNIRHPNLVELIGCCSQKASRILVYEYLENNSLDHALLDPKKISVHLDWRKRSSICIG 165

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GL FLHEE VPHIVHRDIKASNILLD++FNPKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 166 TARGLQFLHEEAVPHIVHRDIKASNILLDKDFNPKIGDFGLAKLFPDDITHISTRIAGTT 225

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GYLAPEY LGGQLT+KADVYSFGVL+LE++SG+ S      +++  LL   W+L++E K 
Sbjct: 226 GYLAPEYALGGQLTLKADVYSFGVLILELVSGKRSSTVFGVEISILLLGRVWELYEEGKL 285

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 241
           L++VDP LG+YP  E++RYMKVA FCTQAAA+RRP M+QVI MLTKN +LNE+ LTAPG 
Sbjct: 286 LDIVDPRLGDYPQEEVLRYMKVALFCTQAAANRRPVMSQVIDMLTKNNKLNEKLLTAPGF 345

Query: 242 FQDSESSSVGTSDKKSSD--STLQMSSVPVTITQVTPR 277
           +    +S + +  KK+S+  S+ +MS   ++IT++TPR
Sbjct: 346 YGGLGTSDIPSVSKKTSNASSSNEMSFAGISITKITPR 383

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557677|ref|XP_003547141.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Glycine max]

 Score =  382 bits (982), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 189/277 (68%), Positives = 219/277 (79%), Gaps = 10/277 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           TLSNV HPNLVELIG C+QG  R LVYEYVEN SL+  LLG    N+KL+W KRS IC+G
Sbjct: 93  TLSNVEHPNLVELIGFCIQGPSRTLVYEYVENGSLNSALLGTRNENMKLDWRKRSAICLG 152

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            AKGLAFLHEEL P IVHRDIKASN+LLD++FNPKIGDFGLAKLFPD+ITHI+TRIAGTT
Sbjct: 153 TAKGLAFLHEELSPPIVHRDIKASNVLLDRDFNPKIGDFGLAKLFPDDITHISTRIAGTT 212

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM-WGQMNKFLLEWAWQLHQEEK 180
           GYLAPEY LGGQLT KAD+YSFGVL+LEIISGR+S +    G  +KFLLEWAWQL++E K
Sbjct: 213 GYLAPEYALGGQLTKKADIYSFGVLILEIISGRSSARRTNGGGSHKFLLEWAWQLYEERK 272

Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 240
            LE VD ++ E+P  E+IRYMKVA FCTQ+AA+RRP M QV+ ML+K I+LNE+ELTAPG
Sbjct: 273 LLEFVDQDMEEFPEEEVIRYMKVALFCTQSAANRRPLMIQVVDMLSKAIQLNEKELTAPG 332

Query: 241 LFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 277
            F +   SS   S+  SS          +TITQVTPR
Sbjct: 333 FFTNEGESSRNNSNPVSSF---------ITITQVTPR 360

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	277
TAIR|locus:2095334	393	AT3G09010 [Arabidopsis thalian	0.870	0.613	0.640	3.8e-85
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.862	0.612	0.528	1e-68
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.855	0.226	0.5	2.3e-63
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.841	0.244	0.521	1.1e-60
TAIR|locus:2205250	1032	AT1G56130 [Arabidopsis thalian	0.855	0.229	0.483	3.1e-60
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.826	0.221	0.517	1.1e-59
TAIR|locus:2019317	969	AT1G29730 [Arabidopsis thalian	0.848	0.242	0.481	8.5e-56
TAIR|locus:2019367	1078	AT1G29740 [Arabidopsis thalian	0.844	0.217	0.485	1.7e-55
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.974	0.397	0.429	7e-54
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.978	0.420	0.417	1e-52

TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)]

 Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
 Identities = 155/242 (64%), Positives = 195/242 (80%)

Query:     3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
             +SN+ HPNLV+LIGCC++G  RILVYEY+ENNSL  VLLG+    + L+W KR+ ICVG 
Sbjct:    94 ISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGT 153

Query:    63 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             A GLAFLHEE+ PH+VHRDIKASNILLD  F+PKIGDFGLAKLFPDN+TH++TR+AGT G
Sbjct:   154 ASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVG 213

Query:   123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
             YLAPEY L GQLT KADVYSFG+LVLE+ISG +S +A +G     L+EW W+L +E + L
Sbjct:   214 YLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLL 273

Query:   183 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT-KNIRLNEEELTAPGL 241
             E VDPEL ++P +E+ R++KVA FCTQAAA +RP M QV++ML  K + LNE+ LT PG+
Sbjct:   274 ECVDPELTKFPADEVTRFIKVALFCTQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGV 333

Query:   242 FQ 243
             ++
Sbjct:   334 YR 335

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
 Identities = 128/242 (52%), Positives = 181/242 (74%)

Query:     3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL--GATKANIKLNWEKRSDICV 60
             +S ++H NLV+L GCCV+G  RILVY ++ENNSLD+ LL  G T++ I+ +W  R++ICV
Sbjct:    89 ISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRSGIQFDWSSRANICV 148

Query:    61 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
             G+AKGLAFLHEE+ PHI+HRDIKASNILLD+  +PKI DFGLA+L P N+TH++TR+AGT
Sbjct:   149 GVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARLMPPNMTHVSTRVAGT 208

Query:   121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
              GYLAPEY + GQLT KAD+YSFGVL++EI+SGR++         ++LLE AW+L++  +
Sbjct:   209 IGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEYQYLLERAWELYERNE 268

Query:   181 PLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAP 239
              ++LVD  L G +   E  RY+K+   CTQ +   RP M+ V+++LT    ++ ++++ P
Sbjct:   269 LVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRLLTGEKDIDYKKISRP 328

Query:   240 GL 241
             GL
Sbjct:   329 GL 330

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 653 (234.9 bits), Expect = 2.3e-63, P = 2.3e-63
 Identities = 120/240 (50%), Positives = 169/240 (70%)

Query:     1 MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             + +S+V H NLV+L GCC +G  R+LVYEY+ N SLD+ L G    ++ L+W  R +IC+
Sbjct:   756 IAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG--DKSLHLDWSTRYEICL 813

Query:    61 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
             G+A+GL +LHEE    I+HRD+KASNILLD E  PK+ DFGLAKL+ D  THI+TR+AGT
Sbjct:   814 GVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGT 873

Query:   121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
              GYLAPEY + G LT K DVY+FGV+ LE++SGR +      +  K+LLEWAW LH++ +
Sbjct:   874 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNR 933

Query:   181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 240
              +EL+D EL EY   E+ R + +A  CTQ++ + RP M++V+ ML+ +  +N+   + PG
Sbjct:   934 DVELIDDELSEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVNDAT-SKPG 992

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 1.1e-60, P = 1.1e-60
 Identities = 123/236 (52%), Positives = 165/236 (69%)

Query:     3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
             +S + HPNLV+L GCCV+G + +LVYE+VENNSL R L G  +  ++L+W  R  IC+G+
Sbjct:   672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGV 731

Query:    63 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             A+GLA+LHEE    IVHRDIKA+N+LLD++ NPKI DFGLAKL  ++ THI+TRIAGT G
Sbjct:   732 ARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFG 791

Query:   123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQEEKP 181
             Y+APEY + G LT KADVYSFG++ LEI+ GR S K    + N F L++W   L ++   
Sbjct:   792 YMAPEYAMRGHLTDKADVYSFGIVALEIVHGR-SNKIERSKNNTFYLIDWVEVLREKNNL 850

Query:   182 LELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
             LELVDP LG EY   E +  +++A  CT +    RP M++V+KML     +  E+L
Sbjct:   851 LELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKL 906

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)]

 Score = 624 (224.7 bits), Expect = 3.1e-60, P = 3.1e-60
 Identities = 116/240 (48%), Positives = 165/240 (68%)

Query:     1 MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             + +S+V H NLV+L GCC +G  R+LVYEY+ N SLD+ L G     + L+W  R +IC+
Sbjct:   740 VAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICL 797

Query:    61 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
             G+A+GL +LHEE    IVHRD+KASNILLD    P+I DFGLAKL+ D  THI+TR+AGT
Sbjct:   798 GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGT 857

Query:   121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
              GYLAPEY + G LT K DVY+FGV+ LE++SGR +      +  K+LLEWAW LH++ +
Sbjct:   858 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSR 917

Query:   181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 240
              +EL+D +L ++   E  R + +A  CTQ + + RP M++V+ ML+ ++ + +   + PG
Sbjct:   918 DIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVT-SKPG 976

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 619 (223.0 bits), Expect = 1.1e-59, P = 1.1e-59
 Identities = 119/230 (51%), Positives = 161/230 (70%)

Query:     3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
             +S ++HPNLV+L GCC++G   +LVYEY+ENNSL R L G  K  + L+W  R+ +C+GI
Sbjct:   715 ISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGI 774

Query:    63 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             AKGLA+LHEE    IVHRDIKA+N+LLD   N KI DFGLAKL  +  THI+TRIAGT G
Sbjct:   775 AKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIG 834

Query:   123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
             Y+APEY + G LT KADVYSFGV+ LEI+SG+++      +   +LL+WA+ L ++   L
Sbjct:   835 YMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLL 894

Query:   183 ELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 231
             ELVDP+LG  +   E +R + +A  CT  + + RP M+ V+ ML   I++
Sbjct:   895 ELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 8.5e-56, P = 8.5e-56
 Identities = 115/239 (48%), Positives = 165/239 (69%)

Query:     6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
             ++HPNLV+L GCCV+  + +LVYEY+ENN L   L  A ++ +KL W  R  IC+GIA+G
Sbjct:   691 LQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALF-AGRSCLKLEWGTRHKICLGIARG 749

Query:    66 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
             LAFLHE+    I+HRDIK +N+LLD++ N KI DFGLA+L  DN +HITTR+AGT GY+A
Sbjct:   750 LAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAGTIGYMA 809

Query:   126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK-AMWGQMNKFLLEWAWQLHQEEKPLEL 184
             PEY + G LT KADVYSFGV+ +EI+SG+++ K     +    LL+WA+ L ++    E+
Sbjct:   810 PEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLDWAFVLQKKGDIAEI 869

Query:   185 VDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 242
             +DP L G +   E  R +KV+  C   +++ RP M+QV+KML     + E+ ++ PG++
Sbjct:   870 LDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEI-EQIISDPGVY 927

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)]

 Score = 581 (209.6 bits), Expect = 1.7e-55, P = 1.7e-55
 Identities = 116/239 (48%), Positives = 166/239 (69%)

Query:     6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
             ++HPNLV+L GCCV+ T+ +LVYEY+ENN L   L G  ++ +KL+W  R  IC+GIA+G
Sbjct:   728 LQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFG--RSGLKLDWRTRHKICLGIARG 785

Query:    66 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
             LAFLHE+    I+HRDIK +NILLD++ N KI DFGLA+L  D+ +HITTR+AGT GY+A
Sbjct:   786 LAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMA 845

Query:   126 PEYVLGGQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 184
             PEY + G LT KADVYSFGV+ +EI+SG+ N+      +    LL+WA+ L ++    E+
Sbjct:   846 PEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEI 905

Query:   185 VDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 242
             +DP+L G +   E  R +KV+  C+  + + RP M++V+KML     + EE ++ PG +
Sbjct:   906 LDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEI-EEIISDPGAY 963

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 7.0e-54, P = 7.0e-54
 Identities = 122/284 (42%), Positives = 172/284 (60%)

Query:     1 MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             + L+ ++H NLV LIG C+QG  R+LVYE+++N SLD+ +    K  + L+W  R  +  
Sbjct:   403 LLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQL-LDWVVRYKMIG 461

Query:    61 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITH-ITTRI 117
             GIA+GL +LHE+    I+HRD+KASNILLDQE NPKI DFGLAKLF     +TH  T+RI
Sbjct:   462 GIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRI 521

Query:   118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFLLEWAWQL 175
             AGT GY+APEY + GQ ++K DV+SFGVLV+EII+G+  N+G +   +  + LL W W+ 
Sbjct:   522 AGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRS 581

Query:   176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
              +E+  L ++DP L     NEI+R + +   C Q +A+ RP M       T ++ LN   
Sbjct:   582 WREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTM------ATVSLMLNSYS 635

Query:   236 LTAPGLFQXXXXXXXXX--XXXXXXXXXLQMSSVPVTITQVTPR 277
              T P   +                    LQMSS  VT+++ +PR
Sbjct:   636 FTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 1.0e-52, P = 1.0e-52
 Identities = 117/280 (41%), Positives = 169/280 (60%)

Query:     1 MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             + ++ ++H NLV+L+G C++G  +ILVYE+V N SLD  L  +T   +KL+W +R  I  
Sbjct:   372 VVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTM-KMKLDWTRRYKIIG 430

Query:    61 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAG 119
             GIA+G+ +LH++    I+HRD+KA NILLD + NPKI DFG+A++F  D    +T R+ G
Sbjct:   431 GIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVG 490

Query:   120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQE 178
             T GY++PEY + GQ +MK+DVYSFGVLVLEIISG +NS      +    L+ + W+L   
Sbjct:   491 TYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSN 550

Query:   179 EKPLELVDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELT 237
               P ELVDP  G+ Y  +EI R + +A  C Q  A  RP M+ +++MLT ++ +   E  
Sbjct:   551 GSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSL-IALAEPR 609

Query:   238 APGLFQXXXXXXXXXXXXXXXXXXLQMSSVPVTITQVTPR 277
              PG F                   +  +S    IT+VTPR
Sbjct:   610 PPGFFFRSKQEQAGPSIDSSTHCSVDEAS----ITRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	277
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (346), Expect = 1e-39
 Identities = 60/182 (32%), Positives = 91/182 (50%), Gaps = 21/182 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L  + HPN+V+L G         LV EY E  SL  +L    +   KL+ ++   I + 
Sbjct: 44  ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQ 100

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGT 120
           I +GL +LH      I+HRD+K  NILLD      K+ DFGL+KL   +   +   I GT
Sbjct: 101 ILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGT 156

Query: 121 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 179
             Y+APE +LG G  + K+D++S GV++ E+   ++            L+    Q   E+
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKD------------LIRKMLQKDPEK 204

Query: 180 KP 181
           +P
Sbjct: 205 RP 206

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  136 bits (346), Expect = 4e-39
 Identities = 53/152 (34%), Positives = 82/152 (53%), Gaps = 9/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN+V L        +  LV EY E   L  +L    K   +L+ ++       I
Sbjct: 51  LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQI 106

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L +LH +    IVHRD+K  NILLD++ + K+ DFGLA+   D    +TT + GT  
Sbjct: 107 LSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPE 161

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE +LG       D++S GV++ E+++G+
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  134 bits (340), Expect = 3e-38
 Identities = 58/153 (37%), Positives = 81/153 (52%), Gaps = 9/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V LI          LV EY E   L   L         L+ ++   I + I
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQI 107

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GL +LH      I+HRD+K  NILLD+    KI DFGLAK    + + +TT   GT  
Sbjct: 108 LRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPW 163

Query: 123 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           Y+APE +LGG     K DV+S GV++ E+++G+
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  133 bits (338), Expect = 6e-38
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 28/227 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + HPN+V+L+G C +     +V EY+E   L   L        KL+        + I
Sbjct: 55  MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQI 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+ +L  +   + +HRD+ A N L+ +    KI DFGL++   D       R  G   
Sbjct: 112 ARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKL 165

Query: 123 ---YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQE 178
              ++APE +  G+ T K+DV+SFGVL+ EI +    G+  +  M N+ +LE+    ++ 
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLEYLKNGYRL 222

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            +P            P E+   M     C       RP  ++++++L
Sbjct: 223 PQP---------PNCPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  132 bits (335), Expect = 2e-37
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 29/228 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + HPN+V+L+G C +    ++V EY+    L   L        +L+        + I
Sbjct: 55  MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQI 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTR---IA 118
           A+G+ +L  +   + +HRD+ A N L+ +    KI DFGL++ L+ D+   +      I 
Sbjct: 113 ARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQ 177
               ++APE +  G+ T K+DV+SFGVL+ EI +    G+  +  M N  +LE+  + ++
Sbjct: 170 ----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTL---GEEPYPGMSNAEVLEYLKKGYR 222

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
             KP            P E+ + M     C       RP  ++++++L
Sbjct: 223 LPKP---------PNCPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 3e-37
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 33/235 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK-----LNWEKRSD 57
           +  + HPN+V L+G C +     LV EY+E   L   L  +           L+ +    
Sbjct: 50  MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
             + IAKG+ +L  +     VHRD+ A N L+ ++   KI DFGL++   D+  +     
Sbjct: 110 FAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-- 164

Query: 118 AGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEW 171
             T G     ++APE +  G  T K+DV+SFGVL+ EI +    G   +  + N+ +LE+
Sbjct: 165 --TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL---GATPYPGLSNEEVLEY 219

Query: 172 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
             + ++  KP         EY P+E+   M     C Q     RP  +++++ L 
Sbjct: 220 LRKGYRLPKP---------EYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  127 bits (322), Expect = 1e-35
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 31/230 (13%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + HPN+V L+G C QG    +V EY+    L   L    K   KL  +    + + 
Sbjct: 54  IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQ 110

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IAKG+ +L  +   + VHRD+ A N L+ +    KI DFGL++     I           
Sbjct: 111 IAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGG 163

Query: 122 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQL 175
           G L     APE +  G+ T K+DV+SFGVL+ EI +    G+  +  M+   +LE     
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLELLEDG 220

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           ++  +P         E  P+E+   M     C       RP  +++++ L
Sbjct: 221 YRLPRP---------ENCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  120 bits (304), Expect = 7e-33
 Identities = 57/158 (36%), Positives = 82/158 (51%), Gaps = 16/158 (10%)

Query: 3   LSNVRHPNLVELIGCCVQ-GTRRILVY-EYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           LS+++HPN+V   G         + ++ EYV   SL  +L    K   KL  E    I  
Sbjct: 53  LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLP-E--PVIRK 105

Query: 61  ---GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR- 116
               I +GLA+LH      IVHRDIK +NIL+D +   K+ DFG AK   D  T   T  
Sbjct: 106 YTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           + GT  ++APE + G +    AD++S G  V+E+ +G+
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (285), Expect = 3e-30
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L   +HPN+V+  G  ++     +V E+    SL  +L      N  L   + + +C  
Sbjct: 50  ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKE 106

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +LH      I+HRDIKA+NILL  +   K+ DFGL+     + T     + GT 
Sbjct: 107 LLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTP 161

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
            ++APE + G     KAD++S G+  +E+  G+ 
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (268), Expect = 1e-27
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 4/152 (2%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+++      +  +  +V EY +   L + +    K       E+  D  V +
Sbjct: 53  LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L +LH      I+HRDIK  NI L      K+GDFG++K+    +    T + GT  
Sbjct: 113 CLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPY 168

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           YL+PE         K+D++S G ++ E+ + +
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (278), Expect = 2e-27
 Identities = 68/231 (29%), Positives = 118/231 (51%), Gaps = 17/231 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPN+V+LIG C       L++EY+E  +L  VL         L+WE+R  I +GI
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGI 789

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           AK L FLH    P +V  ++    I++D +  P +      +L    +    T+   ++ 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSA 843

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           Y+APE      +T K+D+Y FG++++E+++G++   A +G ++  ++EWA   + +    
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLD 902

Query: 183 ELVDPELGEYPP---NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
             +DP +        NEI+  M +A  CT    + RP  N V+K L    R
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 6e-27
 Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 12/154 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           LS + HP +V+L     Q   ++ LV EY     L   L        + + E+R+     
Sbjct: 47  LSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFS-EERARFYAA 100

Query: 62  -IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I   L +LH      I++RD+K  NILLD + + K+ DFGLAK      +   T   GT
Sbjct: 101 EIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGT 156

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YLAPE +LG       D +S GVL+ E+++G+
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 4e-25
 Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 8/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N++HPN+V+ IG         ++ EY EN SL +++    K          +     +
Sbjct: 53  LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQV 108

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+LHE+    ++HRDIKA+NIL  ++   K+ DFG+A    D  +     + GT  
Sbjct: 109 LQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPY 164

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           ++APE +     +  +D++S G  V+E+++G 
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  101 bits (251), Expect = 1e-24
 Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 19/283 (6%)

Query: 2   TLSNVRHP-NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            L+++ HP N+V+L           LV EYV+  SL+  LL        L+  +   I  
Sbjct: 50  ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILA 108

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITH-----IT 114
            I   L +LH +    I+HRDIK  NILLD++    K+ DFGLAKL PD  +      + 
Sbjct: 109 QILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165

Query: 115 TRIAGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLE 170
           +   GT GY+APE +LG  L   +  +D++S G+ + E+++G    +           L+
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225

Query: 171 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
              +L         + P   E         +K            R   +  +        
Sbjct: 226 IILELPTPSLASP-LSPSNPELISKAASDLLKK---LLAKDPKNRLSSSSDLSHDLLAHL 281

Query: 231 LNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQ 273
             +E   +  L  D  +    +           ++S+ ++ + 
Sbjct: 282 KLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSD 324

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.5 bits (246), Expect = 1e-24
 Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 10/156 (6%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  +RH  LV+L   C +     +V EY+   SL   L       ++L   +  D+   
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQ 111

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAG 119
           IA+G+A+L      + +HRD+ A NIL+ +    KI DFGLA+L  D+        +   
Sbjct: 112 IAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP- 167

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
              + APE    G+ T+K+DV+SFG+L+ EI++ GR
Sbjct: 168 -IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.0 bits (245), Expect = 3e-24
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 9/154 (5%)

Query: 2   TLSNVRHPNLVELIGC-CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           TL +   P +V+  G    +G   I V EY++  SL  +L    K   K+     + I  
Sbjct: 52  TLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL----KKVGKIPEPVLAYIAR 106

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KGL +LH +   HI+HRDIK SN+L++ +   KI DFG++K+  + +    T + GT
Sbjct: 107 QILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GT 163

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             Y++PE + G   +  AD++S G+ +LE   G+
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 3e-23
 Identities = 48/155 (30%), Positives = 86/155 (55%), Gaps = 10/155 (6%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            ++ +RHPNLV+L+G  +QG    +V EY+   SL   L   ++    +   ++    + 
Sbjct: 53  VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALD 110

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + +G+ +L E+   + VHRD+ A N+L+ ++   K+ DFGLAK    +    + ++    
Sbjct: 111 VCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--V 163

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRN 155
            + APE +   + + K+DV+SFG+L+ EI S GR 
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.0 bits (237), Expect = 5e-23
 Identities = 43/157 (27%), Positives = 84/157 (53%), Gaps = 19/157 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +HPN+V+     + G    +V EY++  SL  ++   T+  +++N  + + +C  +
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREV 125

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR------ 116
            +GL +LH +   +++HRDIK+ NILL ++ + K+ DFG A         +T        
Sbjct: 126 LQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNS 175

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           + GT  ++APE +       K D++S G++ +E+  G
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.8 bits (231), Expect = 2e-22
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 43/229 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           L  ++HPNLV+  G  V   +  +  EY    +L+ +L      +         +  +  
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILD---------EHVIRV 103

Query: 62  ----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
               + +GLA+LH      IVHRDIK +NI LD     K+GDFG A    +N T +   +
Sbjct: 104 YTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160

Query: 118 AGTTG---YLAPEYVLGGQLTMK---ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW 171
               G   Y+APE + GG+       AD++S G +VLE+ +G+      W +++    E+
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP----WSELDN---EF 213

Query: 172 A--WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF--CTQAAASRRP 216
              + +    KP           P +  +      F   C ++   +RP
Sbjct: 214 QIMFHVGAGHKP---------PIPDSLQLSPEGKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 2e-22
 Identities = 47/153 (30%), Positives = 82/153 (53%), Gaps = 6/153 (3%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RHP L++L   C       +V E ++  SL   L G     +KL   +  D+   +
Sbjct: 55  MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQV 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L  +   + +HRD+ A N+L+ +    K+ DFGLA++  ++I            
Sbjct: 113 ASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
           + APE  L  + ++K+DV+SFG+L+ EI++ GR
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.0 bits (229), Expect = 4e-22
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 8/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L     P +V   G         +  EY++  SLD++L         +       I V +
Sbjct: 53  LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAV 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL +LHE+    I+HRD+K SNIL++     K+ DFG++    ++   +     GT+ 
Sbjct: 110 LKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSS 164

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE + G   ++K+D++S G+ ++E+ +GR
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 2e-21
 Identities = 60/155 (38%), Positives = 87/155 (56%), Gaps = 11/155 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HP LV L     Q    I + EY+EN SL   L   T   IKL   K  D+   I
Sbjct: 55  MKQLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQI 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
           A+G+AF+  +   + +HRD++A+NIL+ +    KI DFGLA+L  DN    T R      
Sbjct: 112 AEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN--EYTAREGAKFP 166

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
             + APE +  G  T+K+DV+SFG+L+ EI++ GR
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 90.2 bits (224), Expect = 3e-21
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 23/177 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL----------LGATKANIKLNW 52
           L+N +H N+V+  G C +G   I+V+EY+E+  L++ L                  +L  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
            +   I V IA G+ +L  +   H VHRD+   N L+  +   KIGDFG+++   D  T 
Sbjct: 122 SQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTT 175

Query: 113 ITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              R+ G T     ++ PE ++  + T ++DV+SFGV++ EI +    GK  W  ++
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT---YGKQPWYGLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 4e-21
 Identities = 48/155 (30%), Positives = 80/155 (51%), Gaps = 10/155 (6%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
            L  + H N+V+  G C +   R   L+ EY+ + SL R  L   +  I  N ++     
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQI--NLKRLLLFS 115

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I KG+ +L  +     +HRD+ A NIL++ E   KI DFGLAK+ P++  +   +  G
Sbjct: 116 SQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 120 TTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            +   + APE +   + +  +DV+SFGV + E+ +
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.4 bits (222), Expect = 7e-21
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 10/150 (6%)

Query: 8   HPNLVELIGCCV---QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
            P +V+  G  +     +  I + EY E  SLD +     K   ++  +    I   + K
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL++LH      I+HRDIK SNILL ++   K+ DFG++      +  +     GT+ Y+
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTSFYM 170

Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           APE + G   ++ +DV+S G+ +LE+   R
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 7e-21
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 20/157 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL---LGATKANIKLNWEKRSDIC 59
           +++V HP++V L+G C+  ++  L+ + +    L   +        +   LNW      C
Sbjct: 63  MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------C 115

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP--DNITHITTRI 117
           V IAKG+++L E+    +VHRD+ A N+L+    + KI DFGLAKL    +   H     
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--- 169

Query: 118 AGTT--GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            G     ++A E +L    T K+DV+S+GV V E+++
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 9e-21
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 16/160 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           L  ++H N+V+ +G  +      +  EYV   S+  +L   GA +  +  N+ ++     
Sbjct: 60  LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ----- 114

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-- 118
            I KGL +LH      I+HRDIK +NIL+D +   KI DFG++K    N     T  A  
Sbjct: 115 -ILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 119 ---GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
              G+  ++APE V     T KAD++S G LV+E+++G++
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 2e-20
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 18/160 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVEN--NSL-DRVLLGATKANIKLNWEKRSD 57
           L  +RHPN+V L        +    +V+EY+++    L D   +  T++ IK        
Sbjct: 52  LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC------- 104

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTR 116
               + +GL +LH      I+HRDIK SNIL++ +   K+ DFGLA+ +   N    T R
Sbjct: 105 YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161

Query: 117 IAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 155
           +  T  Y  PE +LG  +   + D++S G ++ E+  G+ 
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.9 bits (219), Expect = 2e-20
 Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 9/154 (5%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L  ++HPN+V+L+       +  LV+EY + + L +  L      +  N  K   I   
Sbjct: 51  LLKELKHPNIVKLLDVIHTERKLYLVFEYCDMD-L-KKYLDKRPGPLSPNLIKS--IMYQ 106

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + +GLA+ H      I+HRD+K  NIL++++   K+ DFGLA+ F   +   T  +  T 
Sbjct: 107 LLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TL 162

Query: 122 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
            Y APE +LG +  +   D++S G +  E+I+G+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 7e-20
 Identities = 52/158 (32%), Positives = 83/158 (52%), Gaps = 19/158 (12%)

Query: 3   LSNVRH---PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           LS +R    PN+ +  G  ++G R  ++ EY E  S+ R L+ A     K        I 
Sbjct: 53  LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKY-------IS 104

Query: 60  VGIAK---GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
           V I +    L ++H+     ++HRDIKA+NIL+    N K+ DFG+A L   N +  +T 
Sbjct: 105 VIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST- 160

Query: 117 IAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISG 153
             GT  ++APE +  G+    KAD++S G+ + E+ +G
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.1 bits (213), Expect = 8e-20
 Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 12/159 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +SN  HPN+V+L+G C+    + ++ E +E   L   L  A         L  ++  DIC
Sbjct: 53  MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAK-LFPDNITHI 113
           + +AKG  +L +    H +HRD+ A N L+ ++        KIGDFGLA+ ++  +    
Sbjct: 113 LDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                    ++APE +L G+ T ++DV+SFGVL+ EI++
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 85.9 bits (213), Expect = 8e-20
 Identities = 44/151 (29%), Positives = 81/151 (53%), Gaps = 6/151 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L  +RH +L+ L   C  G    ++ E +E  SL   L       + +      D+   
Sbjct: 55  ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV--ASLIDMACQ 112

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+A+L E+   + +HRD+ A NIL+ ++   K+ DFGLA+L  +++ ++++      
Sbjct: 113 VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPY 168

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE    G  + K+DV+SFG+L+ E+ +
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.8 bits (213), Expect = 8e-20
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 7/152 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L     P +V+  G   + T   +V EY    S+   ++  T  N  L  E+ + I    
Sbjct: 52  LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKIT--NKTLTEEEIAAILYQT 108

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL +LH       +HRDIKA NILL++E   K+ DFG++    D +    T I GT  
Sbjct: 109 LKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPF 164

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           ++APE +       KAD++S G+  +E+  G+
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.4 bits (209), Expect = 2e-19
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 18/164 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           LS ++HPN+V+ +G   +     +  E V   SL ++L   G+    +   + ++     
Sbjct: 56  LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ----- 110

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I  GL +LH+    + VHRDIK +NIL+D     K+ DFG+AK   +          G+
Sbjct: 111 -ILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGS 164

Query: 121 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 163
             ++APE +   G   + AD++S G  VLE+     +GK  W Q
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA----TGKPPWSQ 204

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 9/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +   R P +V   G  +      +  E+++  SLDR+     K    +  E    I V +
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAV 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GL +L+      I+HRDIK SNIL++     K+ DFG++    + I  I     GT+ 
Sbjct: 113 VEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTST 167

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y++PE + GG+ T+K+DV+S G+ ++E+  G+
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 20/160 (12%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI------KLNWEKR 55
            L  +RH N+V L     +  R  LV+EYVE   L+  LL A+   +         W+  
Sbjct: 53  VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQ-- 108

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 + + +A+ H     +I+HRDIK  NIL+ +    K+ DFG A+          T
Sbjct: 109 ------LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159

Query: 116 RIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
               T  Y APE ++G     K  DV++ G ++ E++ G 
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.7 bits (204), Expect = 2e-18
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 38/240 (15%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG------------ATKANIKL 50
           L+N++H ++V+  G C  G   I+V+EY+++  L++ L                +A  +L
Sbjct: 61  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 51  NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
              +   I   IA G+ +L  +   H VHRD+   N L+      KIGDFG+++   D  
Sbjct: 121 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVY 174

Query: 111 THITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-N 165
           +    R+ G T     ++ PE ++  + T ++DV+SFGV++ EI +    GK  W Q+ N
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLSN 231

Query: 166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
             ++E   Q    E+P            P E+   M     C Q    +R  + ++ K+L
Sbjct: 232 TEVIECITQGRVLERP---------RVCPKEVYDIM---LGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 39/235 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL---------DRVLLGATKANIKLNWE 53
           L+N++H ++V+  G CV+G   I+V+EY+++  L         D VL+       +L   
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
           +   I   IA G+ +L  +   H VHRD+   N L+ +    KIGDFG+++   D  +  
Sbjct: 121 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTD 174

Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFL 168
             R+ G T     ++ PE ++  + T ++DV+S GV++ EI +    GK  W Q+ N  +
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT---YGKQPWYQLSNNEV 231

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
           +E   Q    ++P            P E+   M     C Q    R P M   IK
Sbjct: 232 IECITQGRVLQRPRTC---------PKEVYDLM---LGCWQ----REPHMRLNIK 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 3e-18
 Identities = 49/150 (32%), Positives = 81/150 (54%), Gaps = 15/150 (10%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    +++ EY+EN SLD+ L    + + K    +   +  GIA G+ 
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMK 120

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----IAGTTG 122
           +L E    + VHRD+ A NIL++     K+ DFGL++   D+    TT+     I  T  
Sbjct: 121 YLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT-- 175

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             APE +   + T  +DV+SFG+++ E++S
Sbjct: 176 --APEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 6e-18
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 40/241 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H N+V+  GCC +   +   L+ EYV   SL   L    K  + L     + + +
Sbjct: 60  LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNL-----AQLLL 111

Query: 61  ---GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
               I +G+A+LH +   H +HRD+ A N+LLD +   KIGDFGLAK  P+   +   R 
Sbjct: 112 FAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168

Query: 118 AGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQM 164
            G +   + A E +   + +  +DV+SFGV + E+++  +S ++             GQM
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228

Query: 165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 224
               L     +   E+ + L  P   +  P E+   MK    C +  A  RP    +I +
Sbjct: 229 TVVRL-----IELLERGMRLPCP---KNCPQEVYILMKN---CWETEAKFRPTFRSLIPI 277

Query: 225 L 225
           L
Sbjct: 278 L 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.9 bits (200), Expect = 8e-18
 Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 46/240 (19%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA-----TKANIKLNWEKRSDI--- 58
           +H N++ L+G C Q     +V EY  + +L R  L A       A+          +   
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNL-RDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 59  -----CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +A+G+ FL  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHI 185

Query: 114 TTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMN 165
                 T G L     APE +     T ++DV+SFGVL+ EI +   S   G  +  ++ 
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELF 244

Query: 166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           K L E     ++ EKP              E+   M+    C     S+RP   Q+++ L
Sbjct: 245 KLLKEG----YRMEKPQ---------NCTQELYHLMRD---CWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 8e-18
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 35/234 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLN 51
           L+ ++H ++V   G C +G   ++V+EY+ +  L+R L            G   A  +L 
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNI 110
             +   I   IA G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  + 
Sbjct: 121 LGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177

Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLL 169
             +  R      ++ PE +L  + T ++D++SFGV++ EI +    GK  W Q+ N   +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT---YGKQPWYQLSNTEAI 234

Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
           E   Q  + E+P            P E+   M       Q    R PQ   VIK
Sbjct: 235 ECITQGRELERPRTC---------PPEVYAIM-------QGCWQREPQQRMVIK 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 80.7 bits (200), Expect = 8e-18
 Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 28/168 (16%)

Query: 7   RHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
            HP +++L     Q    +  V EY  N  L    L   +    L+ +        I   
Sbjct: 60  GHPGIIKLY-YTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA------- 118
           L +LH +    I+HRD+K  NILLD++ + KI DFG AK+   N +  + +         
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 119 ------------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                       GT  Y++PE +        +D+++ G ++ ++++G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 9e-18
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 19/161 (11%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRR---ILVYEYVEN---NSLDRVLLGATKANIKLNWEK 54
             L N+RHPN+VEL    V G       LV EY E    + LD +    +++ +K     
Sbjct: 58  TLLLNLRHPNIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC---- 112

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              + + + +GL +LHE     I+HRD+K SN+LL  +   KI DFGLA+ +      +T
Sbjct: 113 ---LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
            ++  T  Y APE +LG      A D+++ G ++ E+++ +
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 51/162 (31%), Positives = 70/162 (43%), Gaps = 33/162 (20%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL-------DRVLLGATK---ANIKLN 51
           L ++RHP LV L G   Q    + LV EYV    L        R      +   A + L 
Sbjct: 55  LQSIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL- 112

Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 111
                         L +LH      IV+RD+K  N+LLD +   KI DFG AK       
Sbjct: 113 -------------ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154

Query: 112 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             T  + GT  YLAPE +L        D ++ G+L+ E+++G
Sbjct: 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.9 bits (197), Expect = 1e-17
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 13/154 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           L N++H  +V+  GC        +  EY+   S+   L   GA    +   + ++     
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ----- 112

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIA 118
            I +G+ +LH      IVHRDIK +NIL D   N K+GDFG +K      +  T    + 
Sbjct: 113 -ILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           GT  +++PE + G     KADV+S G  V+E+++
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 79.1 bits (195), Expect = 2e-17
 Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN--WEKRSDICV 60
           L+ +    ++      +   +  +V EY EN  L ++L       +  +  W       +
Sbjct: 53  LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFI 108

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I  GLA LH +    I+HRDIK+ N+ LD   N KIGD G+AKL  DN T+    I GT
Sbjct: 109 QILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGT 164

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YL+PE         K+DV++ GV++ E  +G+
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 79.6 bits (196), Expect = 2e-17
 Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 14/156 (8%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL---DRVLLGATKANIKLNWEKRSD 57
           + + ++ H  +V L+G C  G    LV +     SL    R    +      LNW     
Sbjct: 61  LAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----- 114

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTR 116
            CV IAKG+ +L E     +VHR++ A NILL  +   +I DFG+A L +PD+  +  + 
Sbjct: 115 -CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 ++A E +L G+ T ++DV+S+GV V E++S
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.3 bits (196), Expect = 3e-17
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSD 57
            L   +HP +V+L+     G+  +LV EY+ +  L  VL        +A +K        
Sbjct: 52  ALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS------- 103

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
               + KG+A++H      I+HRD+K +N+L+  +   KI DFGLA+LF +    + +  
Sbjct: 104 YMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160

Query: 118 AGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 154
             T  Y APE + G +      D+++ G +  E+++G 
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.8 bits (194), Expect = 3e-17
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 30/202 (14%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           M LS   HP LV+L G C + +   LV+E++E+  L    L A +   K + E    +C+
Sbjct: 54  MKLS---HPKLVQLYGVCTERSPICLVFEFMEHGCLSD-YLRAQRG--KFSQETLLGMCL 107

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            + +G+A+L    V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T     
Sbjct: 108 DVCEGMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP 164

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR---------------NSGKAMW--- 161
             + +PE     + + K+DV+SFGVL+ E+ S G+               N+G  ++   
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224

Query: 162 --GQMNKFLLEWAWQLHQEEKP 181
              Q    L++  W+   E++P
Sbjct: 225 LASQSVYELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 4e-17
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)

Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
            + HPNLV+L G C +     +V EY+ N  L    L   K   KL  E   D+C  + +
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL-LNYLRERKG--KLGTEWLLDMCSDVCE 111

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
            + +L        +HRD+ A N L+ ++   K+ DFGLA+   D+    +        + 
Sbjct: 112 AMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168

Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISG 153
            PE     + + K+DV+SFGVL+ E+ S 
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 5e-17
 Identities = 56/152 (36%), Positives = 77/152 (50%), Gaps = 17/152 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN +E  GC ++     LV EY   ++ D  +L   K    L   + + IC G 
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKK--PLQEVEIAAICHGA 124

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTT 121
            +GLA+LH       +HRDIKA NILL +    K+ DFG A L  P N         GT 
Sbjct: 125 LQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTP 175

Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEI 150
            ++APE +L    GQ   K DV+S G+  +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 6e-17
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 16/156 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG---ATKANIKLNWEKRSDI 58
            ++ + HP +V LIG C +G   +LV E      L + L        +++K     +   
Sbjct: 49  VMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ--- 103

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              +A G+A+L  +   H VHRD+ A N+LL      KI DFG+++       +     A
Sbjct: 104 ---VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157

Query: 119 GT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G     + APE +  G+ + K+DV+S+GV + E  S
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.9 bits (192), Expect = 7e-17
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 6/152 (3%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L++V HPN++      + G +  +V EY     L + +    K    +  ++   I + +
Sbjct: 53  LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GL  LHE+    I+HRD+K++NILL      KIGD G++K+   N+    T+I GT  
Sbjct: 113 LRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQI-GTPH 166

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE   G   + K+D++S G L+ E+ +  
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.7 bits (192), Expect = 7e-17
 Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 7/94 (7%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I   L +LH +    I+HRDIK  NILLD++ +  I DF +A     +   +TT  +GT 
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTP 163

Query: 122 GYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           GY+APE VL  Q    A D +S GV   E + G+
Sbjct: 164 GYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 77.4 bits (190), Expect = 9e-17
 Identities = 52/153 (33%), Positives = 81/153 (52%), Gaps = 7/153 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 55  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQI 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 112 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 168

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
           + APE  L G+ T+K+DV+SFG+L+ E+ + GR
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.2 bits (193), Expect = 9e-17
 Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 14/151 (9%)

Query: 7   RHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +HP L +L   C Q   R+  V EYV  N  D  L+   + + + +  +       I  G
Sbjct: 54  KHPFLTQLH-SCFQTKDRLFFVMEYV--NGGD--LMFHIQRSGRFDEPRARFYAAEIVLG 108

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTR-IAGTTGY 123
           L FLHE     I++RD+K  N+LLD E + KI DFG+ K   + I   +TT    GT  Y
Sbjct: 109 LQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDY 162

Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           +APE +         D ++ GVL+ E+++G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.5 bits (191), Expect = 9e-17
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 16/170 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           TL ++ H N+V+ +G         +  EYV   S+   L    +   +   +        
Sbjct: 61  TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQ 116

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAG 119
           + +GLA+LH +    I+HRD+KA N+L+D +   KI DFG++K   D+I        + G
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQG 172

Query: 120 TTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF 167
           +  ++APE +       + K D++S G +VLE+ +GR      W      
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP----WSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 1e-16
 Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+     IV+RD+K  N+LLD   N +I D GLA              AGT 
Sbjct: 104 IICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTP 158

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GY+APE + G       D ++ G  + E+I+GR
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 23/160 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L  + HPN+++L+          LV+E+++ +    +     G  ++ IK          
Sbjct: 52  LKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK-------SYL 104

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH-ITT 115
             + +GLAF H      I+HRD+K  N+L++ E   K+ DFGLA+ F       TH + T
Sbjct: 105 YQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT 161

Query: 116 RIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR 154
           R      Y APE +LG    +   D++S G +  E++S R
Sbjct: 162 RW-----YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 77.5 bits (191), Expect = 1e-16
 Identities = 52/161 (32%), Positives = 70/161 (43%), Gaps = 18/161 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-LGATKAN--IKLNWEKRSDIC 59
           +S   H N+V LIG   +   R ++ E +    L   L     +      L  +      
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITT 115
             +AKG  +L E    H +HRDI A N LL  +  P    KI DFG+A+   D       
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR---DIYRASYY 175

Query: 116 RIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           R  G       ++ PE  L G  T K DV+SFGVL+ EI S
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 20/163 (12%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVL--LGATKANIKLNWEKRSD 57
             LS  + P +V+L     QG + + LV EY+    L  +L  +G+      L+ +    
Sbjct: 45  DILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS------LDEDVARI 97

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-------LFPDNI 110
               I   L +LH      I+HRD+K  NIL+D   + K+ DFGL+K       +  ++ 
Sbjct: 98  YIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154

Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
                RI GT  Y+APE +LG   +   D +S G ++ E + G
Sbjct: 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 1e-16
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 7/153 (4%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L    HPN+V+LIG CVQ     +V E V   SL   L    K  + +   K   + + 
Sbjct: 45  ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVK--KLLQMSLD 101

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
            A G+ +L  +   + +HRD+ A N L+ +    KI DFG+++     I  ++  +    
Sbjct: 102 AAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             + APE +  G+ T ++DV+S+G+L+ E  S 
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 11/152 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS  R P + +  G  ++G++  ++ EY    S LD +  G      KL+    + I   
Sbjct: 53  LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILRE 106

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +  GL +LHEE     +HRDIKA+NILL +E + K+ DFG++      ++   T   GT 
Sbjct: 107 VLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTP 162

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            ++APE +       KAD++S G+  +E+  G
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.0 bits (190), Expect = 1e-16
 Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 14/160 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV- 60
            +S   HPN+V+     V G    LV  Y+   SL  ++    K++        + I   
Sbjct: 52  AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM----KSSYPRGGLDEAIIATV 107

Query: 61  --GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTR- 116
              + KGL +LH      I HRDIKA NILL ++ + KI DFG+ A L          R 
Sbjct: 108 LKEVLKGLEYLHSN--GQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 117 -IAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 154
              GT  ++APE +        KAD++SFG+  +E+ +G 
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 3e-16
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 9/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     +     ++ EY+   SL   L   +    K+   K  D    I
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQI 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
           A+G+A++  +   + +HRD++A+N+L+ +    KI DFGLA++  DN    T R      
Sbjct: 113 AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN--EYTAREGAKFP 167

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.1 bits (187), Expect = 3e-16
 Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 22/224 (9%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + A
Sbjct: 121 YLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWEMSNQDVIKAIEEGYRLPAPMDC- 234

Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
                   P  + + M     C Q   + RP+  Q++ +L K I
Sbjct: 235 --------PAALHQLM---LDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 25/161 (15%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEY--------VENNSLDRVLLGATKANIKLNWEK 54
           L  ++HPN++ L+      +   LV+E+        +++ S+  VL   T A+IK ++  
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VL---TPADIK-SYML 109

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                    +GL +LH      I+HRD+K +N+L+  +   K+ DFGLA+ F      +T
Sbjct: 110 M------TLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160

Query: 115 TRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
            ++  T  Y APE + G     +  D++S G +  E++   
Sbjct: 161 HQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.3 bits (188), Expect = 3e-16
 Identities = 53/159 (33%), Positives = 82/159 (51%), Gaps = 18/159 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEK----R 55
            L +++H N+V+  G C    RR   LV EY+   SL   L    K   +L+  K     
Sbjct: 58  ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYA 114

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
           S IC    KG+ +L  +     VHRD+   NIL++ E   KIGDFGL K+ P +  +   
Sbjct: 115 SQIC----KGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167

Query: 116 RIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           R  G +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 52/157 (33%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--- 58
           T ++ RHP LV L  C         V EY     L          +  +  E R+     
Sbjct: 55  TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL------MMHIHTDVFSEPRAVFYAA 108

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTR 116
           CV +  GL +LHE     IV+RD+K  N+LLD E   KI DFGL K   + +     T+ 
Sbjct: 109 CVVL--GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST 160

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             GT  +LAPE +     T   D +  GVL+ E++ G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.0 bits (187), Expect = 4e-16
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 22/168 (13%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL------------GATKANI 48
             +S+++HPN+V L+G C +     +++EY+ +  L   L+            G      
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 49  KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 108
            L+      I + IA G+ +L      H VHRD+ A N L+ +    KI DFGL++   D
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---D 173

Query: 109 NITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             +    R+   +     ++ PE +L G+ T ++D++SFGV++ EI S
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.2 bits (187), Expect = 5e-16
 Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 18/162 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI-CVG 61
           +S +++PN++ L+G CV      ++ EY+EN  L++ L   ++  I+  +   ++I  V 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVS 127

Query: 62  ----------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNI 110
                     IA G+ +L      + VHRD+   N L+   +  KI DFG+++ L+  + 
Sbjct: 128 IANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             I  R      ++A E +L G+ T  +DV++FGV + E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.4 bits (186), Expect = 5e-16
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 5/156 (3%)

Query: 3   LSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  ++HPN+V      +        +V EY E   L +++    K    +  E    I  
Sbjct: 53  LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112

Query: 61  GIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            +   L   H    P   ++HRD+K +NI LD   N K+GDFGLAK+   + +   T   
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YV 171

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y++PE +       K+D++S G L+ E+ +  
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 9e-16
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 20/161 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDI 58
           LS  +HPN+V L        +  ++ E+ +  +LD ++L    G T+  I+        +
Sbjct: 56  LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------V 108

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C  + + L FLH   V   +HRD+KA NILL  + + K+ DFG++      +    T I 
Sbjct: 109 CRQMLEALNFLHSHKV---IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI- 164

Query: 119 GTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGR 154
           GT  ++APE V            KAD++S G+ ++E+    
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 74.7 bits (183), Expect = 9e-16
 Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 15/166 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +  +RH  LV+L    V     I +V EY+   SL   L       +KL      D+   
Sbjct: 55  MKKLRHDKLVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQ 110

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           +A G+A++      + +HRD++++NIL+      KI DFGLA+L  DN    T R     
Sbjct: 111 VAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN--EYTARQGAKF 165

Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE  L G+ T+K+DV+SFG+L+ E+++    G+  +  MN
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT---KGRVPYPGMN 208

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 9e-16
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 15/151 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN ++  GC ++     LV EY   ++ D  LL   K    L   + + +  G 
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAVTHGA 124

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+LH     +++HRD+KA NILL +    K+GDFG A     +I        GT  
Sbjct: 125 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPY 176

Query: 123 YLAPEYVLG---GQLTMKADVYSFGVLVLEI 150
           ++APE +L    GQ   K DV+S G+  +E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 19/158 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVG 61
           L +V HPN+V+            ++ E+++  SL+            +  E+  +D+   
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQ 176

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  G+A+LH     HIVHRDIK SN+L++   N KI DFG++++    +    + + GT 
Sbjct: 177 ILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTI 232

Query: 122 GYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE +      G       D++S GV +LE   GR
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 42/158 (26%), Positives = 81/158 (51%), Gaps = 15/158 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           ++ + HP+++ ++G   + +   L  E++   S+  +L   GA K  + +N+        
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY------TE 110

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNIT---HITTR 116
            + +GL++LHE     I+HRD+K +N+L+D      +I DFG A       T       +
Sbjct: 111 QLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           + GT  ++APE + G Q     DV+S G +++E+ + +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 44/149 (29%), Positives = 82/149 (55%), Gaps = 15/149 (10%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ + K L+
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALS 129

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IAGTTGYL 124
           FLH + V   +HRDIK+ +ILL  +   K+ DFG    F   ++    R   + GT  ++
Sbjct: 130 FLHAQGV---IHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWM 182

Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISG 153
           APE +       + D++S G++V+E++ G
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 9/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RH NLV LI    +  R  LV+E+V++  LD +     K    L+  +       I
Sbjct: 54  LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQI 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +G+ F H     +I+HRDIK  NIL+ Q    K+ DFG A+        + T    T  
Sbjct: 110 LRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRW 165

Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 153
           Y APE ++G     +A D+++ G LV E+++G
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 2e-15
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 50/237 (21%)

Query: 9   PNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWEKRS 56
            ++V L+G    G   ++V E +    L   L            LG       +      
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM---- 124

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
                IA G+A+L  +     VHRD+ A N ++ ++   KIGDFG+ +   D       R
Sbjct: 125 --AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYR 176

Query: 117 IAGT----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 172
             G       ++APE +  G  T K+DV+SFGV++ E+ +               L E  
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQP 221

Query: 173 WQLHQEEKPLELVDP----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +Q    E+ L+ V      +L E  P++++  M++   C Q     RP   +++  L
Sbjct: 222 YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.6 bits (180), Expect = 2e-15
 Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 10/169 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV L    V      +V E++   SL   L       +KL   +  D+   I
Sbjct: 55  MKKLRHDKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQI 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + +HRD++A+NIL+      KI DFGLA+L  DN             
Sbjct: 112 ADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK 168

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW-GQMNKFLLE 170
           + APE  L G+ T+K+DV+SFG+L+ E+++    G+  + G +N+ +LE
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVT---KGRVPYPGMVNREVLE 214

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 29/228 (12%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           H N+V L+G C  G   +++ EY     L   L    K    L  E        +AKG+A
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GTT----G 122
           FL  +   + +HRD+ A N+LL      KI DFGLA+    +I + +  +  G       
Sbjct: 156 FLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARLPVK 208

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           ++APE +     T ++DV+S+G+L+ EI S G N    M   ++    +   + ++  +P
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--PVDSKFYKLIKEGYRMAQP 266

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
                    E+ P EI   MK    C  A   +RP   Q+++++ K +
Sbjct: 267 ---------EHAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 11/158 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS------ 56
           LS +  PN+  L+G C       ++ EY+EN  L++ L         L    +S      
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 57  -DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHIT 114
             +   IA G+ +L E L  + VHRD+   N L+ + +  KI DFG+++ L+  +   + 
Sbjct: 133 LYMATQIASGMRYL-ESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            R      ++A E VL G+ T K+DV++FGV + EI++
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 11/163 (6%)

Query: 31  VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 90
           V + SLD+         + +  +    I V I K L +LH +L   ++HRD+K SN+L++
Sbjct: 81  VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLIN 138

Query: 91  QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVL 146
           +    K+ DFG++    D++    T  AG   Y+APE +          +K+DV+S G+ 
Sbjct: 139 RNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGIT 196

Query: 147 VLEIISGR---NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 186
           ++E+ +GR   +S K  + Q+ + + E + QL  E+   E  D
Sbjct: 197 MIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 4e-15
 Identities = 56/186 (30%), Positives = 94/186 (50%), Gaps = 8/186 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV+L     +    I+  E++   SL    L + + + K    K  D    I
Sbjct: 55  MKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD-FLKSDEGS-KQPLPKLIDFSAQI 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ +    + +HRD++A+NIL+      KI DFGLA++  DN             
Sbjct: 112 AEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK- 180
           + APE +  G  T+K+DV+SFG+L++EI++ GR     M        LE  +++ + E  
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 228

Query: 181 PLELVD 186
           P EL +
Sbjct: 229 PEELYN 234

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 6   VRHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           + HPN+V L+         +  V+EYV   +L R +L A  A   L   +   + + +  
Sbjct: 35  LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL-REVLAADGA---LPAGETGRLMLQVLD 90

Query: 65  GLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPD----NITHIT--T 115
            LA  H +    IVHRD+K  NI++       + K+ DFG+  L P     ++  +T  T
Sbjct: 91  ALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            + GT  Y APE + G  +T  +D+Y++G++ LE ++G+
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.4 bits (177), Expect = 6e-15
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILV--YEYVENNSLDRVL--LGATKANIKLNWEKRSDI 58
           L N++H  +V+  GC      + L    EY+   S+   L   GA   ++   + ++   
Sbjct: 58  LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--- 114

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              I +G+++LH  +   IVHRDIK +NIL D   N K+GDFG +K     I    T I 
Sbjct: 115 ---ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIR 167

Query: 119 GTTG---YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             TG   +++PE + G     KADV+S G  V+E+++ +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 6e-15
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 15/157 (9%)

Query: 8   HPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           HPN+    G  ++           LV E     S+  ++ G  K   +L  E  + I   
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
             +GLA+LHE     ++HRDIK  NILL +    K+ DFG++      +    T I GT 
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTP 177

Query: 122 GYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISG 153
            ++APE +   +        ++DV+S G+  +E+  G
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.4 bits (178), Expect = 7e-15
 Identities = 40/100 (40%), Positives = 59/100 (59%), Gaps = 7/100 (7%)

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           I V   K L +L EEL   I+HRD+K SNILLD+  N K+ DFG++    D+I    TR 
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRD 167

Query: 118 AGTTGYLAPEYVLGGQLT---MKADVYSFGVLVLEIISGR 154
           AG   Y+APE +         +++DV+S G+ + E+ +G+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 7e-15
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 10/158 (6%)

Query: 3   LSNVRHPNLVELIGCCVQ-GTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L N+ H N+V+  G C + G   I L+ E++ + SL   L    +   K+N +++    V
Sbjct: 60  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAV 116

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IA 118
            I KG+ +L        VHRD+ A N+L++ E   KIGDFGL K    +  + T +  + 
Sbjct: 117 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 156
               + APE ++  +  + +DV+SFGV + E+++  +S
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 8e-15
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             L   RHPN+V   G  ++  +  +V EY    SL  +          L+  + + +C 
Sbjct: 52  SMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCR 108

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
              KGLA+LHE      +HRDIK +NILL ++ + K+ DFG++      I    + I GT
Sbjct: 109 ETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GT 164

Query: 121 TGYLAPEYV---LGGQLTMKADVYSFGVLVLE 149
             ++APE       G    K D+++ G+  +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.9 bits (177), Expect = 8e-15
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 7/98 (7%)

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTR 116
               +     +LH      I++RD+K  N+LLD     K+ DFG AK L     T     
Sbjct: 98  YIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--- 151

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             GT  Y+APE +L        D +S G+L+ E+++GR
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    ++ E+++  +L  ++     +  +LN E+ + +C  +
Sbjct: 72  MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESV 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L +LH + V   +HRDIK+ +ILL  +   K+ DFG       ++      + GT  
Sbjct: 127 LQALCYLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPY 182

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 39/233 (16%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL----LGATKANIKLNWEKRSDICVG 61
           + H NL+ L G  V     ++V E     SL   L    LG    +   ++       V 
Sbjct: 53  LDHENLIRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQ 105

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----- 116
           IA G+ +L  +     +HRD+ A NILL  +   KIGDFGL +  P N  H         
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 117 -IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
             A    + APE +     +  +DV+ FGV + E+ +        +G+     L  +  L
Sbjct: 163 PFA----WCAPESLRTRTFSHASDVWMFGVTLWEMFT--------YGEEPWAGLSGSQIL 210

Query: 176 HQEEKPLE-LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
            + +K  E L  P   E  P +I   M     C     + RP    + + L +
Sbjct: 211 KKIDKEGERLERP---EACPQDIYNVMLQ---CWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN +E  GC ++     LV EY   ++ D  LL   K    L   + + I  G 
Sbjct: 75  LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAITHGA 130

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+LH     +++HRDIKA NILL +    K+ DFG A     + +       GT  
Sbjct: 131 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPY 182

Query: 123 YLAPEYVLG---GQLTMKADVYSFGVLVLEI 150
           ++APE +L    GQ   K DV+S G+  +E+
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 17/157 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVL--LGATKANIKLNWEKRSDI 58
           L N+RH  +V+  GC      + L    EY+   S+   L   GA   N+   + ++   
Sbjct: 58  LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ--- 114

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              I +G+++LH  +   IVHRDIK +NIL D   N K+GDFG +K     I    T I 
Sbjct: 115 ---ILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIK 167

Query: 119 GTTG---YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             TG   +++PE + G     KADV+S    V+E+++
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 53/151 (35%), Positives = 77/151 (50%), Gaps = 15/151 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN +E  GC ++     LV EY   ++ D  LL   K    L   + + I  G 
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAITHGA 134

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+LH     +++HRDIKA NILL +    K+ DFG A     +I        GT  
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA-----SIASPANSFVGTPY 186

Query: 123 YLAPEYVLG---GQLTMKADVYSFGVLVLEI 150
           ++APE +L    GQ   K DV+S G+  +E+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 54/225 (24%), Positives = 109/225 (48%), Gaps = 24/225 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           ++ + H NLV L+G  +     I V E +   +L   L   T+    ++  +     + +
Sbjct: 53  MTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDV 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+ +L  +    +VHRD+ A NIL+ ++   K+ DFGLA++    +    +++     
Sbjct: 110 AEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLP--VK 162

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           + APE +   + + K+DV+S+GVL+ E+ S    G+A + +M+  L E    + +  +  
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFS---YGRAPYPKMS--LKEVKECVEKGYR-- 215

Query: 183 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
             ++P  G      ++  M     C +    +RP  +++ + L K
Sbjct: 216 --MEPPEGCPADVYVL--MTS---CWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 42/126 (33%), Positives = 73/126 (57%), Gaps = 9/126 (7%)

Query: 29  EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 88
           E+++  SLD+VL  A +  I  N   +  I V   +GL +L E+    I+HRD+K SNIL
Sbjct: 79  EHMDGGSLDQVLKKAGR--IPENILGKISIAV--LRGLTYLREKH--KIMHRDVKPSNIL 132

Query: 89  LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 148
           ++     K+ DFG++    D++ +      GT  Y++PE + G   T+++D++S G+ ++
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189

Query: 149 EIISGR 154
           E+  GR
Sbjct: 190 EMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 39/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 125

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            K L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPY 181

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           +HPN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQAL 128

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++A
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAG 119
           I  GL FLH++    I++RD+K  N+LLD++ + KI DFG+ K    N+      +   G
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCG 158

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           T  Y+APE + G +     D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.7 bits (173), Expect = 3e-14
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 19/166 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL---------------LGATKAN 47
           LS ++ PN++ L+G CV      ++ EY+EN  L++ L               +      
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LF 106
             +++     + + IA G+ +L      + VHRD+   N L+ +    KI DFG+++ L+
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             +   I  R      ++A E +L G+ T  +DV++FGV + EI+ 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.9 bits (174), Expect = 3e-14
 Identities = 38/102 (37%), Positives = 60/102 (58%), Gaps = 10/102 (9%)

Query: 58  ICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
           + V I K L +L E+   H ++HRD+K SNILLD   N K+ DFG++    D+     TR
Sbjct: 119 MTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173

Query: 117 IAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGR 154
            AG   Y+APE +       +  ++ADV+S G+ ++E+ +G+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 20/156 (12%)

Query: 8   HPNLVELIGCCV---QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           HPN+V+L+   V   +  + I LV+EY+E + L  V+    +ANI  +  KR  I   + 
Sbjct: 66  HPNIVKLLN--VIKAENDKDIYLVFEYMETD-LHAVI----RANILEDVHKRY-IMYQLL 117

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----PDNITHITTRIAG 119
           K L ++H     +++HRD+K SNILL+ +   K+ DFGLA+       +    + T    
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 120 TTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           T  Y APE +LG     K  D++S G ++ E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.9 bits (173), Expect = 4e-14
 Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HP LV L  C    +R   V EYV    L    +   +   KL  E        I+  L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 125
           +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           PE + G       D ++ GVL+ E+++GR+
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 4e-14
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 8/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V L+       +  LV+E+++   LD      +     L+          +
Sbjct: 52  LKELNHPNIVRLLDVVHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +G+A+ H      ++HRD+K  N+L+D+E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 109 LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLW 164

Query: 123 YLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           Y APE +LG  Q +   D++S G +  E+++ R
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 8/96 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           I  GL FLH +    I++RD+K  N++LD++ + KI DFG+ K  +F DN     +   G
Sbjct: 105 IVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCG 158

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           T  Y+APE + G + T   D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.2 bits (172), Expect = 4e-14
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 22/162 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK------LNWEKRS 56
              + H N+V L+G C +     ++ EY +   L + L  ATK+  +      L+ +++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKV 120

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK------LFPDNI 110
            +C  IA G+  L        VHRD+ A N L+  +   K+    L+K       +    
Sbjct: 121 ALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177

Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             I  R      +LAPE V     + K+DV+SFGVL+ E+ +
Sbjct: 178 ALIPLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.4 bits (172), Expect = 4e-14
 Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 48/251 (19%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI-------- 58
           +H N++ L+G C Q     ++ EY    +L   L    +A      E   DI        
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQM 134

Query: 59  -------CV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
                  C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    ++
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DV 187

Query: 111 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 245

Query: 166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           + L +   + H+ +KP             NE+   M+    C  A  S RP   Q+++ L
Sbjct: 246 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAIPSHRPTFKQLVEDL 293

Query: 226 TKNIRL--NEE 234
            + + L  NEE
Sbjct: 294 DRILTLTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 70.4 bits (172), Expect = 5e-14
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 24/159 (15%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEK 54
           +++V +P++  L+G C+  T +++        + +YV  +  D +      +   LNW  
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNI-----GSQYLLNW-- 114

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHI 113
               CV IAKG+ +L E     +VHRD+ A N+L+    + KI DFGLAKL   D   + 
Sbjct: 115 ----CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                    ++A E +L    T ++DV+S+GV V E+++
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.9 bits (171), Expect = 5e-14
 Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +   ++N      +   I
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVNAVVLLYMATQI 113

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT- 121
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +     T  AG   
Sbjct: 114 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKF 167

Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEI 150
              + APE +   + ++K+DV++FGVL+ EI
Sbjct: 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 10/96 (10%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTR-IA 118
           IA GL FLH +    I++RD+K  N++LD E + KI DFG+ K  +F       TTR   
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 70.4 bits (172), Expect = 5e-14
 Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           +P LV L  C    +R  LV EYV    L    +   +   KL  E        I   L 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALN 110

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 125
           FLHE     I++RD+K  N+LLD + + K+ D+G+ K  L P + T   +   GT  Y+A
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIA 164

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           PE + G +     D ++ GVL+ E+++GR+
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 6e-14
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDI 58
            L  ++HPNLV LI    +  +  LV+EY ++   N L++   G  +  IK        I
Sbjct: 53  MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KI 105

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
                + + F H+    + +HRD+K  NIL+ ++   K+ DFG A++        T  +A
Sbjct: 106 IWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162

Query: 119 GTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMW 161
            T  Y APE ++G  Q     DV++ G +  E++    +G+ +W
Sbjct: 163 -TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL----TGQPLW 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 69.9 bits (171), Expect = 6e-14
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 22/164 (13%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVL----------LGATKANIKLNWEKRSD 57
           HPN+V+L+G C  G    L++EY+    L+  L          L  + ++ +        
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 58  IC--------VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPD 108
           +           +A G+A+L E      VHRD+   N L+ +    KI DFGL+  ++  
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 109 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +    +   A    ++ PE +   + T ++DV+++GV++ EI S
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 45/171 (26%), Positives = 83/171 (48%), Gaps = 24/171 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKL 50
           L  V HP++++L G C Q    +L+ EY +  SL   L                + +  L
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 51  NWEKRSDICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 102
           +      + +G        I++G+ +L E     +VHRD+ A N+L+ +    KI DFGL
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGL 173

Query: 103 AK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           ++ ++ ++     ++      ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.5 bits (170), Expect = 8e-14
 Identities = 59/231 (25%), Positives = 110/231 (47%), Gaps = 34/231 (14%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-----GI 62
           HPN++ L G   +    +++ E++EN +LD  L        + N  + + I +     GI
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGALDSFL--------RQNDGQFTVIQLVGMLRGI 115

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGT 120
           A G+ +L E    + VHRD+ A NIL++     K+ DFGL++   D+ +    T+ + G 
Sbjct: 116 AAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
               + APE +   + T  +DV+S+G+++ E++S     +  W   N+ ++    Q ++ 
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVINAIEQDYRL 230

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
             P++          P  + + M     C Q   + RP+  Q++  L K I
Sbjct: 231 PPPMDC---------PTALHQLM---LDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 8e-14
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 6/97 (6%)

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           I V + KGL +L       I+HRD+K SN+L++     K+ DFG++      +  I    
Sbjct: 100 IAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY 153

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            GT  Y+APE + G Q  + +DV+S G+  +E+  GR
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.1 bits (169), Expect = 8e-14
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)

Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S ++H N+V+ +G   +     +  E V   SL   LL +    +K N +        I 
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQIL 118

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTG 122
           +GL +LH+     IVHRDIK  N+L++      KI DFG +K     I   T    GT  
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQ 174

Query: 123 YLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGR 154
           Y+APE +  G       AD++S G  ++E+ +G+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK------------LNWEK 54
           +H N++ L+G C Q     ++ EY    +L   L       ++            L+++ 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 194

Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 252

Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 253 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 300

Query: 230 RLNEEE 235
            L   +
Sbjct: 301 ALTSNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 22/222 (9%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           H N++ L G   +    +++ EY+EN +LD+ L      + + +  +   +  GIA G+ 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMK 121

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITHITTRIAGTTGYLA 125
           +L +    + VHRD+ A NIL++     K+ DFGL+++  D+   T+ T+       + A
Sbjct: 122 YLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+SFG+++ E++S     +  W   N  +++      +   P++  
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS--FGERPYWDMSNHEVMKAINDGFRLPAPMDC- 235

Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
                   P+ + + M     C Q   +RRP+   ++ +L K
Sbjct: 236 --------PSAVYQLM---LQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 43/152 (28%), Positives = 80/152 (52%), Gaps = 9/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L     P +V   G         +  E+++  SLD+VL    K   ++  E    + + +
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAV 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  
Sbjct: 113 LRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRS 167

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + +  H N+V++    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 73  MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSV 127

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L++LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 128 LRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPY 183

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E+I G
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 41/158 (25%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR----SDI 58
           +S ++ PN++ L+  C+      ++ EY+EN  L++ L            +      S +
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 59  C---VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHIT 114
                 IA G+ +L      + VHRD+   N L+ + +  KI DFG+++ L+  +   I 
Sbjct: 133 IFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            R      +++ E +L G+ T  +DV++FGV + EI++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 30/225 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P +    G  ++GT+  ++ EY+   S LD +  G       L     + I   
Sbjct: 56  LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILRE 109

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I KGL +LH E     +HRDIKA+N+LL ++ + K+ DFG+A    D      T + GT 
Sbjct: 110 ILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTP 165

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-----------------RNSGKAMWGQM 164
            ++APE +       KAD++S G+  +E+  G                 +NS   + GQ 
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY 225

Query: 165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 209
           +K   E+      ++        EL ++    I RY K   F T+
Sbjct: 226 SKPFKEFVEACLNKDPRFRPTAKELLKH--KFITRYTKKTSFLTE 268

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAG 119
           I  GL FLH +    IV+RD+K  NILLD + + KI DFG+ K   +N+     T    G
Sbjct: 105 IICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCG 158

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           T  Y+APE +LG +     D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 8/151 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN++E     ++    ++V EY    +L   +    + N  L+ +      V I
Sbjct: 53  LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQI 110

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTT 121
              L  +H +L   I+HRD+K  NILLD+     KIGDFG++K+        T  + GT 
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTP 165

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            Y++PE   G     K+D+++ G ++ E+ S
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.0 bits (168), Expect = 1e-13
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + +  +++PN+V  +   + G    +V EY+   SL  V+        ++     + +C 
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-----AAVCR 122

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAG 119
              + L FLH      ++HRDIK+ N+LL  + + K+ DFG  A++ P+     T  + G
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  ++APE V       K D++S G++ +E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 11/153 (7%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--C 59
            +    HP++V+LIG   +    I V E      L R  L   K ++ L     S I   
Sbjct: 60  IMRQFDHPHIVKLIGVITENPVWI-VMELAPLGEL-RSYLQVNKYSLDL----ASLILYS 113

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D   +  ++   
Sbjct: 114 YQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL 170

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              ++APE +   + T  +DV+ FGV + EI+ 
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD-RVLLGATKANIKLNWEKRSDICVG 61
           L  ++HPN+V L    +Q +R  L++E++   S+D +  L +      ++ E        
Sbjct: 53  LKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQ 109

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I +G+ F H      ++HRD+K  N+L+D +   K+ DFGLA+ F   +   T  +  T 
Sbjct: 110 ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TL 165

Query: 122 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
            Y APE +LG    +   D++S G +  E+ + +
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 6/151 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + H  LV+L G C +     +V EY+ N  L   L    K   +    +  ++C  
Sbjct: 52  VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKD 108

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + +G+A+L  +     +HRD+ A N L+D +   K+ DFGL++   D+    +       
Sbjct: 109 VCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            +  PE +L  + + K+DV++FGVL+ E+ S
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 8/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++ +  L + +  +  + I L   K       +
Sbjct: 53  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIK--SYLFQL 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H   V   +HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 110 LQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 165

Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 17/158 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-----LGATKANIKLNWEKRSD 57
           +  ++H N+V L        + +LV+EY++ + L + +      GA   N   ++  +  
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQ-- 108

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
               + KG+AF HE     ++HRD+K  N+L+++    K+ DFGLA+ F   +   +  +
Sbjct: 109 ----LLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161

Query: 118 AGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
             T  Y AP+ +LG +  +   D++S G ++ E+I+GR
Sbjct: 162 V-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 51/177 (28%), Positives = 93/177 (52%), Gaps = 25/177 (14%)

Query: 1   MTLSNVRHPNLVEL--IGCCVQGTR--RI-LVYEYVENN---SLDRVLLGATKANIKLNW 52
             L  ++HPN+V +  +   V G+   +I +V EYVE++    ++ +     ++ +K   
Sbjct: 56  NILLKLQHPNIVTVKEV---VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC-- 110

Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
                + + +  G+A LH+     I+HRD+K SN+LL+     KI DFGLA+ +   +  
Sbjct: 111 -----LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162

Query: 113 ITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNK 166
             T++  T  Y APE +LG +  +   D++S G +  E+++ +    GK+   Q+NK
Sbjct: 163 Y-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.9 bits (166), Expect = 2e-13
 Identities = 49/223 (21%), Positives = 97/223 (43%), Gaps = 21/223 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS ++HPN++      +     ++  EY    +L   ++   K  +    E        I
Sbjct: 53  LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV-RQKGQL-FEEEMVLWYLFQI 110

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              ++++H+     I+HRDIK  NI L +    K+GDFG++K+     +   T + GT  
Sbjct: 111 VSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPY 166

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           Y++PE   G +   K+D+++ G ++ E+++ + +  A         L    ++ Q     
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA------TNPLNLVVKIVQGNY-- 218

Query: 183 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
               P +  Y  +E+I  +       Q    +RP  ++V+   
Sbjct: 219 ---TPVVSVY-SSELISLVHS---LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 41/100 (41%), Positives = 59/100 (59%), Gaps = 9/100 (9%)

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
           ++IC G    L  LH+E    IV+RD+K  NILLD   + +I D GLA   P+  T I  
Sbjct: 109 AEICCG----LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG 160

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           R+ GT GY+APE V   + T   D ++ G L+ E+I+G++
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.8 bits (165), Expect = 3e-13
 Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 15/158 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVL--LGATKANIKLNWEKRSDI 58
           L N+ H  +V+  GC      R L    E++   S+   L   GA   N+   + ++   
Sbjct: 58  LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ--- 114

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TR 116
              I +G+++LH  +   IVHRDIK +NIL D   N K+GDFG +K         T    
Sbjct: 115 ---ILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           + GT  +++PE + G     KAD++S G  V+E+++ +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.9 bits (166), Expect = 3e-13
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+     I++RD+K  N+LLD + N +I D GLA    D  +  T   AGT 
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTP 161

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           G++APE + G +     D ++ GV + E+I+ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.9 bits (167), Expect = 3e-13
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 42/173 (24%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL-------------VYEYVENNSLDRVLLGATKANIK 49
           L ++RH N++ L          IL             V E +E + L +V+    K+   
Sbjct: 53  LRHLRHENIIGL--------LDILRPPSPEDFNDVYIVTELMETD-LHKVI----KSPQP 99

Query: 50  LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 106
           L  +        I +GL +LH     +++HRD+K SNIL++   + KI DFGLA+     
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156

Query: 107 ---PDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
                 +T ++ TR      Y APE +L      KA D++S G +  E+++ +
Sbjct: 157 EDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 14/156 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T SN  HP LV L  C    +R   V E+V    L    +   +   KL  E        
Sbjct: 51  TASN--HPFLVGLHSCFQTESRLFFVIEFVSGGDL----MFHMQRQRKLPEEHARFYSAE 104

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           I+  L FLHE     I++RD+K  N+LLD E + K+ D+G+ K  + P + T   +   G
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCG 158

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           T  Y+APE + G       D ++ GVL+ E+++GR+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.8 bits (163), Expect = 5e-13
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 4/145 (2%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +RHPN+V      ++  R  +V + +E   L        +   +   E+  +I V +   
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           L +LH+E    IVHRD+  +NI+L ++    I DFGLAK          T + GT  Y  
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSC 181

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEI 150
           PE V       KADV++FG ++ ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 8e-13
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 13/148 (8%)

Query: 8   HPNLVELIGCC--VQGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           HPN+V L+  C   +  R +   LV+E+V+ + L   L    K  +    E   D+   +
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPP--ETIKDLMRQL 116

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +G+ FLH      IVHRD+K  NIL+  +   KI DFGLA+++   +    T +  T  
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLW 171

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEI 150
           Y APE +L        D++S G +  E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 66.6 bits (162), Expect = 8e-13
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 13/157 (8%)

Query: 3   LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L    HPN+V L   C      + T+  LV+E+V+ + L   L    +  +    E   D
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPT--ETIKD 114

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           +   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +     T +
Sbjct: 115 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 169

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             T  Y APE +L        D++S G +  E+   +
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 8e-13
 Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+ GT 
Sbjct: 111 ITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTV 165

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GY+APE V   + T   D +  G L+ E+I G+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.0 bits (163), Expect = 8e-13
 Identities = 47/161 (29%), Positives = 85/161 (52%), Gaps = 24/161 (14%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNW 52
           + ++++ HP+LV L+G C+  T +++        + +YV  +  D +      + + LNW
Sbjct: 61  LIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHK-DNI-----GSQLLLNW 114

Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNIT 111
                 CV IAKG+ +L E     +VHRD+ A N+L+    + KI DFGLA+L   D   
Sbjct: 115 ------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165

Query: 112 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +          ++A E +   + T ++DV+S+GV + E+++
Sbjct: 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGT 120
           I +GL +LH      I+HRDIK  N+L++     KI DFGLA++  PD   H+T  +  T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167

Query: 121 TGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 154
             Y APE ++G +  T   D++S G +  E++  R
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 38/126 (30%), Positives = 73/126 (57%), Gaps = 9/126 (7%)

Query: 29  EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 88
           E+++  SLD+VL  A +   ++       + + + KGL +L E+    I+HRD+K SNIL
Sbjct: 83  EHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK--HKIMHRDVKPSNIL 136

Query: 89  LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 148
           ++     K+ DFG++    D++ +      GT  Y++PE + G   ++++D++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 149 EIISGR 154
           E+  GR
Sbjct: 194 EMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 14/101 (13%)

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-- 122
           G+ +LHE    HI+HRDIKA+NIL+D +   KI DFGLA+ +     +      G T   
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 123 --------YLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
                   Y  PE +LG  + T   D++  G +  E+ + R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 9/158 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS    P + +  G  ++GT+  ++ EY+   S   +L        ++     + +   I
Sbjct: 56  LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEI 110

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL +LH E     +HRDIKA+N+LL ++ + K+ DFG+A    D      T + GT  
Sbjct: 111 LKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPF 166

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 160
           ++APE +       KAD++S G+  +E+  G      M
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           M LS   HP LV+L G C Q     +V E++EN  L   L    +   KL+ +    +C 
Sbjct: 54  MKLS---HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQ 107

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            + +G+ +L        +HRD+ A N L+      K+ DFG+ +   D+    ++     
Sbjct: 108 DVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             +  PE     + + K+DV+SFGVL+ E+ +
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 40/238 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEK 54
           ++ V  P +  L+G C+  T +++        + +YV  N  DR+      +   LNW  
Sbjct: 63  MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENK-DRI-----GSQDLLNW-- 114

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHI 113
               CV IAKG+++L E     +VHRD+ A N+L+    + KI DFGLA+L   D   + 
Sbjct: 115 ----CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA 172
                    ++A E +L  + T ++DV+S+GV V E+++ G      +  +    LLE  
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227

Query: 173 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
            +L Q               PP   I    +   C    +  RP+  +++   ++  R
Sbjct: 228 ERLPQ---------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 51/152 (33%), Positives = 75/152 (49%), Gaps = 16/152 (10%)

Query: 7   RHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAK 64
           +HP L  L  CC Q   R+  V EYV    L   +  + K +     E RS      +  
Sbjct: 54  KHPFLTALH-CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTL 107

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG 122
            L FLH   V   ++RD+K  NILLD E + K+ DFG+ K   + I +   TT   GT  
Sbjct: 108 ALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPD 161

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE +   +     D ++ GVL+ E+++G+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 65.3 bits (159), Expect = 2e-12
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           L +++H N+V+ +G C+      +  E+V   S+  +L   G     +   + K+     
Sbjct: 56  LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ----- 110

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK---LFPDNITH--ITT 115
            I  G+A+LH   V   VHRDIK +N++L      K+ DFG A+       + TH  +  
Sbjct: 111 -ILDGVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            + GT  ++APE +       K+D++S G  V E+ +G+
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L    HPN+V+LIG C Q     +V E V        L    K   +L  ++     +  
Sbjct: 46  LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDA 102

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L  +   + +HRD+ A N L+ +    KI DFG+++   D I   +        
Sbjct: 103 AAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           + APE +  G+ + ++DV+S+G+L+ E  S G      M  Q  +          Q EK 
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---------EQVEKG 210

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
             +  P   +  P+++ + M+    C       RP+ +++ K L 
Sbjct: 211 YRMSCP---QKCPDDVYKVMQR---CWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 45/175 (25%), Positives = 89/175 (50%), Gaps = 27/175 (15%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-T 120
           +A+G+ FL  +   + +HRD+ A N+LL      KI DFGLA+   ++  ++    A   
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM---NKF--LLEWAWQL 175
             ++APE +     T+++DV+S+G+L+ EI S    GK+ +  +   +KF  +++  +Q+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---LGKSPYPGILVNSKFYKMVKRGYQM 334

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
            +             ++ P EI   MK+   C     + RP  +Q+ +++ + + 
Sbjct: 335 SRP------------DFAPPEIYSIMKM---CWNLEPTERPTFSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 8/89 (8%)

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           G+  LH+     I+HRDIK  N+L+DQ  + K+ DFGL++           +  GT  YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYL 160

Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISG 153
           APE +LG      +D +S G ++ E + G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 23/225 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L    HPN+V LIG C Q     +V E V+       L        +L  ++   +    
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENA 103

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-T 121
           A G+ +L  +   H +HRD+ A N L+ ++   KI DFG+++   D +   T  +     
Sbjct: 104 AAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
            + APE +  G+ + ++DV+SFG+L+ E  S G      +  Q  +  +         E+
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI---------EQ 211

Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            + L  PEL    P+ + R M+    C +    +RP  + V + L
Sbjct: 212 GVRLPCPELC---PDAVYRLMER---CWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 13/153 (8%)

Query: 3   LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L    HPN+V L+  C      + T+  LV+E+V+ + L   L       +    E   D
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPA--ETIKD 112

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           +     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++   +    T +
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPV 167

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 150
             T  Y APE +L        D++S G +  E+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 14/169 (8%)

Query: 1   MTLSNVRH----PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           M  + + H    P +V +IG C +    +LV E      L++  L   K  I +      
Sbjct: 43  MREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK-FLSGKKDEITV--SNVV 98

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
           ++   ++ G+ +L  +   + VHRD+ A N+LL  +   KI DFGL+K    + ++   R
Sbjct: 99  ELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155

Query: 117 IAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWG 162
            AG     + APE +   + + ++DV+S+G+ + E  S G+   K M G
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 3e-12
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 12/152 (7%)

Query: 8   HPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDIC 59
           HPN++ LIG C+Q          +++  ++++  L   LL +   +    L  +      
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             IA G+ +L  +     +HRD+ A N +L++  N  + DFGL+K   +   +   RIA 
Sbjct: 119 TDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175

Query: 120 T-TGYLAPEYVLGGQLTMKADVYSFGVLVLEI 150
               ++A E +     T K+DV+SFGV + EI
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 34/77 (44%), Positives = 48/77 (62%), Gaps = 1/77 (1%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           I++RD+K  NILLD+E + K+ DFGL+K   D+         GT  Y+APE V     T 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQ 177

Query: 137 KADVYSFGVLVLEIISG 153
            AD +SFGVL+ E+++G
Sbjct: 178 SADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + +   ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAG 119
              + L FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+      + + G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 178

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  ++APE V       K D++S G++ +E+I G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.6 bits (157), Expect = 4e-12
 Identities = 42/166 (25%), Positives = 82/166 (49%), Gaps = 21/166 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL---------------GATKAN 47
           ++ + HPN+V L+G   Q     +++EY+    L   L+               G  K++
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LF 106
             L+      I + IA G+ +L        VH+D+ A NIL+ ++ + KI D GL++ ++
Sbjct: 121 --LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             +   +  +      ++ PE ++ G+ +  +D++SFGV++ EI S
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.2 bits (156), Expect = 4e-12
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 11/156 (7%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
             ++ +RH NLV+L+G  V+    + +V EY+   SL   L   ++    L  +      
Sbjct: 51  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFS 108

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++  
Sbjct: 109 LDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP- 162

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
              + APE +   + + K+DV+SFG+L+ EI S GR
Sbjct: 163 -VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.1 bits (156), Expect = 4e-12
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 20/174 (11%)

Query: 3   LSNVRHPNLV------ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           LSN++HPN+V      E  G         +V +Y E   L + +    +  +    ++  
Sbjct: 53  LSNMKHPNIVQYQESFEENGNLY------IVMDYCEGGDLYKKINA--QRGVLFPEDQIL 104

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
           D  V I   L  +H+     I+HRDIK+ NI L ++   K+GDFG+A++    +    T 
Sbjct: 105 DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC 161

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 170
           I GT  YL+PE         K+D+++ G ++ E+ + +++ +A  G M   +L+
Sbjct: 162 I-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVLK 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 4e-12
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 29/162 (17%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILV--------YEYVENNSLDRVLLGATKANIKLNW 52
           M L NV HP+++ +    V G    +V        Y Y+   S            I    
Sbjct: 109 MLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--------RPLPI---- 156

Query: 53  EKRSDICV--GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
                + +   I +GL +LH +    I+HRD+K  NI ++      IGD G A+ FP   
Sbjct: 157 --DQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVA 210

Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 +AGT    APE +   +   KAD++S G+++ E+++
Sbjct: 211 PAFLG-LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 24/159 (15%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDI 58
           L+   HP +V+L+G      +  ++ E+    ++D ++L    G T+  I++       I
Sbjct: 63  LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------I 115

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-- 116
           C  + + L +LH      I+HRD+KA N+LL  + + K+ DFG++     N+  +  R  
Sbjct: 116 CRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDS 169

Query: 117 IAGTTGYLAPEYVLGGQLT-----MKADVYSFGVLVLEI 150
             GT  ++APE V+   +       KAD++S G+ ++E+
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 5e-12
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 74  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQAL 128

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++A
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 5e-12
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 22/157 (14%)

Query: 9   PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 68
           P +V+  G         +  EY++  SLD++  G            R  I   + KGL F
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR-ITYAVVKGLKF 117

Query: 69  LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-----AKLFPDNITHITTRIAGTTGY 123
           L EE   +I+HRD+K +N+L++     K+ DFG+     A L   NI        G   Y
Sbjct: 118 LKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--------GCQSY 167

Query: 124 LAPEYVLGGQL------TMKADVYSFGVLVLEIISGR 154
           +APE +  G        T+++DV+S G+ +LE+  GR
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.7 bits (157), Expect = 6e-12
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 49/277 (17%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------------NIKLNWE 53
           +H N++ L+G C Q     ++ EY    +L R  L A +                +L ++
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNL-REYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    ++ +I
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNI 187

Query: 114 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 168
                 T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--LGGSPYPGIPVEEL 245

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            +   + H+ +KP             +E+   M+    C  A  S+RP   Q+++ L + 
Sbjct: 246 FKLLKEGHRMDKPANCT---------HELYMIMRE---CWHAVPSQRPTFKQLVEDLDRV 293

Query: 229 IRLNEE----ELTAPGLFQDSESSSVGTSDKKSSDST 261
           + +       +L+ P      E  S G  D  SS S+
Sbjct: 294 LTVTSTDEYLDLSVP-----FEQYSPGCPDSPSSCSS 325

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.9 bits (155), Expect = 7e-12
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 13/153 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P + +  G  ++ T+  ++ EY+   S LD +  G       L+  + + I   
Sbjct: 56  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILRE 109

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGT 120
           I KGL +LH E     +HRDIKA+N+LL +    K+ DFG+A    D  T I      GT
Sbjct: 110 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGT 164

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             ++APE +       KAD++S G+  +E+  G
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 12/148 (8%)

Query: 8   HPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HP L +L  CC Q   R+  V E+V  N  D  L+   + + + +  +       I   L
Sbjct: 55  HPFLTQLY-CCFQTPDRLFFVMEFV--NGGD--LMFHIQKSRRFDEARARFYAAEITSAL 109

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLA 125
            FLH++    I++RD+K  N+LLD E + K+ DFG+ K    +  T  T+   GT  Y+A
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIA 164

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE +         D ++ GVL+ E++ G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGT 120
           I+ GL FLH      I++RD+K  N++LD E + KI DFG+ K     +  +TTR   GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             Y+APE +         D +++GVL+ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 28/182 (15%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IA G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGK 180

Query: 122 G-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH 176
           G     ++APE +  G  T  +D++SFGV++ EI S               L E  +Q  
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGL 225

Query: 177 QEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
             E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++  +  E
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285

Query: 236 LT 237
           ++
Sbjct: 286 VS 287

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 5/98 (5%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH E   + V+RD+K  NILLD   + +I D GLA   P+    I  R+ GT 
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTV 165

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           GY+APE +   + T+  D +  G L+ E+I G++  + 
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 3/96 (3%)

Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLGGQL 134
           H++HRDIK++NILL      K+GDFG +K++   ++    R   GT  Y+APE       
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 135 TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           + KAD++S GVL+ E+++ +    G+ M   M+K L
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258

Length = 496

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 28/162 (17%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD-------- 57
           + HPN+++ +G C++    +LV E+          LG  K  ++ N    +         
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCP--------LGDLKNYLRSNRGMVAQMAQKDVLQ 103

Query: 58  -ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITT 115
            +   +A GL +LH+      +H D+   N  L  + + KIGD+GLA + +P++      
Sbjct: 104 RMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160

Query: 116 RIAGTTGYLAPEYV-------LGGQLTMKADVYSFGVLVLEI 150
             A    +LAPE V       L    T K++++S GV + E+
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 9/90 (10%)

Query: 66  LAF--LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
           LAF  LH +    I++RD+K  N+LLD + + K+ DFG AK  PD     T  + GT  Y
Sbjct: 129 LAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEY 181

Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           LAPE +         D ++ GVL+ E I+G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  G+  LH      IV+RD+K  N+LLD + N ++ D GLA    D  T   T+ AGT 
Sbjct: 104 ITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTN 158

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GY+APE +     +   D ++ G  + E+++GR
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  L  E    IV+RD+K  NILLD   + +I D GLA   P+  T +  R+ GT GY+
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168

Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           APE +   + T   D +  G L+ E+I G++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 34/242 (14%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLG------ATKANIKLNWEKR 55
           HPN++ L+G C       L  EY  + +L       RVL        A      L+ ++ 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 184 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 239

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
           ++ EKPL   D         E+   M+    C +     RP   Q++  L    R+ EE 
Sbjct: 240 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLN---RMLEER 284

Query: 236 LT 237
            T
Sbjct: 285 KT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 60/247 (24%), Positives = 108/247 (43%), Gaps = 40/247 (16%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------------ANIKLNWE 53
           +H N++ L+G C Q     ++ EY    +L R  L A +                +L+++
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNL-REFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +A+G+ +L        +HRD+ A N+L+ ++   KI DFGLA+     +  I
Sbjct: 135 DLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187

Query: 114 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 168
                 + G     ++APE +     T ++DV+SFG+L+ EI +    G    G   + L
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--LGGSPYPGIPVEEL 245

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            +   + H+ +KP             +E+   M+    C  A  ++RP   Q+++ L K 
Sbjct: 246 FKLLREGHRMDKPSNC---------THELYMLMRE---CWHAVPTQRPTFKQLVEALDKV 293

Query: 229 IRLNEEE 235
           +    EE
Sbjct: 294 LAAVSEE 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 37/95 (38%), Positives = 58/95 (61%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR-IAG 119
           IA GL FLH +    I++RD+K  N++LD E + KI DFG+ K   +N+   +TT+   G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 22/168 (13%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL--------GATKAN--IKL 50
           M  S ++HPN+V L+G   +     +++ Y  ++ L   L+        G+T  +  +K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 51  NWEKRS--DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 108
             E      I   IA G+ FL      H+VH+D+   N+L+  + N KI D G   LF +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG---LFRE 173

Query: 109 NITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                  ++ G +     +++PE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 21/156 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR-------VLLGATKANIKLNWEKR 55
           L+ ++HPN+V       +  R  +V EY +   L +       VL    +    L+W   
Sbjct: 53  LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSW--- 106

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHIT 114
               V I+ GL  +H+     I+HRDIK+ NI L +     K+GDFG+A+   D+   + 
Sbjct: 107 ---FVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELA 159

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 150
               GT  YL+PE         K D++S G ++ E+
Sbjct: 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 4/100 (4%)

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           V IA  L +LHE+   HI+HRD+K  N+ L +    K+GD G+A++  +N   + + + G
Sbjct: 109 VQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIG 164

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           T  Y++PE         K+DV++ G  V E+ + +++  A
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 32/79 (40%), Positives = 43/79 (54%), Gaps = 2/79 (2%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-- 134
           I++RDIK  NILLD E +  + DFGL+K F            GT  Y+APE + GG    
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185

Query: 135 TMKADVYSFGVLVLEIISG 153
               D +S GVL  E+++G
Sbjct: 186 DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 6/149 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-DICVG 61
           L  + HPN+++ +   ++     +V E  +   L R ++   K   +L  E+      V 
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQ 114

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +   L  +H +    I+HRDIK +N+ +      K+GD GL + F    T   + + GT 
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEI 150
            Y++PE +       K+D++S G L+ E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 24/231 (10%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +TL    H N+V L G   +G   ++V EY+ N +LD  L    K   +L   +   +  
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLP 114

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
           G+A G+ +L E      VH+ + A  +L++ +   KI  F   +L  D    I T ++G 
Sbjct: 115 GLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGK 169

Query: 121 TGYL--APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
           +  L  APE +     +  +DV+SFG+++ E++S     +  W    + +++        
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS--YGERPYWDMSGQDVIKAV------ 221

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E    L  P      PN + + M     C Q     RP+ +Q+  +L+K +
Sbjct: 222 EDGFRLPAP---RNCPNLLHQLM---LDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 4e-11
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           +P +V +IG C +    +LV E  E   L++ L    + N  +  +  +++   ++ G+ 
Sbjct: 55  NPYIVRMIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMK 109

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + A
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166

Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWG 162
           PE +   + + K+DV+SFGVL+ E  S G+   K M G
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 17/154 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  V HP ++ L     +  +R L  + EYV    L   L  + + +        S+I  
Sbjct: 55  LKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            +     +LH +    IV+RD+K  NILLD+E + K+ DFG AK   D     T  + GT
Sbjct: 113 ALE----YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGT 161

Query: 121 TGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 153
             YLAPE V+  +   KA D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 6e-11
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 12/161 (7%)

Query: 1   MTLSNVRHPNLVELIGCCVQ-GTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 58
             L  ++H N+V L+   ++   + + L+++Y E++    +        + +       +
Sbjct: 54  ALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHIT 114
              I  G+ +LH      ++HRD+K +NIL+  E       KIGD GLA+LF   +  + 
Sbjct: 114 LWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 115 T--RIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIIS 152
               +  T  Y APE +LG +   KA D+++ G +  E+++
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.4 bits (149), Expect = 7e-11
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 23/172 (13%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-T 120
           +AKG++FL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A   
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQLHQ 177
             ++APE +     T ++DV+S+G+L+ EI S  +S   G  +  +  K + E    L  
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E  P E+ D          I++       C  A   +RP   Q+++++ + +
Sbjct: 340 ECAPSEMYD----------IMKS------CWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 8e-11
 Identities = 31/77 (40%), Positives = 46/77 (59%), Gaps = 1/77 (1%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  NILLD + +  + DFGL KL   +    T    GT  YLAPE +LG   T 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 60.6 bits (148), Expect = 9e-11
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
            HPN+V+L     +      V+EY+E N      L   +     +      I   I +GL
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYMEGNLYQ---LMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTTGY 123
           A +H+       HRD+K  N+L+      KI DFGLA+     P    +++TR      Y
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WY 164

Query: 124 LAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
            APE +L     +   D+++ G ++ E+ + R
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 9e-11
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 12/154 (7%)

Query: 8   HPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDIC 59
           HPN+++LIG C + +        +++  ++++  L   LL +       KL  +      
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           V IA G+ +L      + +HRD+ A N +L ++    + DFGL+K       +   RIA 
Sbjct: 120 VDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 120 T-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               ++A E +     T K+DV++FGV + EI +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 35/95 (36%), Positives = 58/95 (61%), Gaps = 10/95 (10%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGT 120
           I +GL ++H   V   VHRD+K SNIL+++  + KI DFGLA++    +T +++TR    
Sbjct: 117 ILRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170

Query: 121 TGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 154
             Y APE +L  Q   ++ D++S G +  E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS + HP +V+     ++     ++ EY E   LD  L         L+  +  +  + +
Sbjct: 56  LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             G+ ++H+     I+HRD+KA NI L      KIGDFG+++L   +    TT   GT  
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPY 170

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEI 150
           Y++PE +       K+D++S G ++ E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.0 bits (145), Expect = 1e-10
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 16/155 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L++  HPN+V+L+          ++ E+    ++D V+L   +    L   +   +C   
Sbjct: 56  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQT 112

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGT 120
            + L +LHE     I+HRD+KA NIL   + + K+ DFG++     N   I  R    GT
Sbjct: 113 LEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGT 166

Query: 121 TGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI 150
             ++APE V+           KADV+S G+ ++E+
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 10/95 (10%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGT 120
           I +GL ++H      I+HRD+K SNI ++++   KI DFGLA+   D +T ++ TR    
Sbjct: 127 ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179

Query: 121 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR 154
             Y APE +L         D++S G ++ E+++G+
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 118
           +AKG+ FL        +HRD+ A NILL +    KI DFGLA+     PD +     R+ 
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 245 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 55/238 (23%), Positives = 109/238 (45%), Gaps = 39/238 (16%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD-------- 57
           ++HPN+++ +G CV+    +LV+EY E        LG  K+ +      R +        
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCE--------LGDLKSYLSQEQWHRRNSQLLLLQR 103

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITT 115
           +   IA G+  +H+    + +H D+   N  L  +   K+GD+G+  ++   D I     
Sbjct: 104 MACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160

Query: 116 RIAGTTGYLAPEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 168
           +      +LAPE V       +  + T  ++V++ GV + E+    N+ +      ++ +
Sbjct: 161 KCVPLR-WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE--NAAQPYSHLSDREV 217

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L    +    ++ ++L  P+L E P +E  R+ +V  FC   +  +R    +V ++LT
Sbjct: 218 LNHVIK----DQQVKLFKPQL-ELPYSE--RWYEVLQFC-WLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 118
           +A+G+ FL        +HRD+ A NILL +    KI DFGLA+     PD +     R+ 
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               ++APE +     T ++DV+SFGVL+ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 14/161 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATK---ANIKLNWEKRSDI 58
           L+ ++HPN+V             +V EY +   L  ++ L   K    +  L W     +
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--FVQM 109

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C+G+      +HE+ V   +HRDIK+ NI L Q    K+GDFG A+L      +  T + 
Sbjct: 110 CLGVQH----IHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV- 161

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           GT  Y+ PE         K+D++S G ++ E+ + ++  +A
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 1/78 (1%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           IV+RDIK  NILLD E +  + DFGL+K F       T    GT  Y+APE + G     
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185

Query: 137 KA-DVYSFGVLVLEIISG 153
           KA D +S G+L+ E+++G
Sbjct: 186 KAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 8/94 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 118
           +A+G+ FL        +HRD+ A NILL +    KI DFGLA+     PD +   + R+ 
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               ++APE +     T ++DV+SFGVL+ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 20/141 (14%)

Query: 3   LSNVRHPNLVELIGCC---VQGTRR-----ILVYEYVENNSLDRVLLGATKANIKLNWEK 54
           L  ++H N+V LI  C        R      LV+E+ E++ L  +L   +  N+K    +
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSE 120

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP----DNI 110
              +   +  GL ++H      I+HRD+KA+NIL+ ++   K+ DFGLA+ F        
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 111 THITTRIAGTTGYLAPEYVLG 131
              T R+  T  Y  PE +LG
Sbjct: 178 NRYTNRVV-TLWYRPPELLLG 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V L        R  LV+EY++   LD      +  +   N          I
Sbjct: 55  LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTT 121
            +G+A+ H      ++HRD+K  N+L+D+  N  K+ DFGLA+ F   +   T  +  T 
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167

Query: 122 GYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
            Y APE +LG    +   D++S G +  E+++ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 40/90 (44%), Positives = 50/90 (55%), Gaps = 7/90 (7%)

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYL 124
           L  LH+     IV+RD+K  NILLD   +  + DFGL+K    DN T  T    GTT YL
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163

Query: 125 APEYVLGGQ-LTMKADVYSFGVLVLEIISG 153
           APE +L  +  T   D +S GVLV E+  G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 3e-10
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 20/162 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + H +LV   G CV G   I+V EYV+  SLD   L   K  I ++W+      + +
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLD-TYLKKNKNLINISWK------LEV 105

Query: 63  AKGLAF-LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------HIT 114
           AK LA+ LH      + H ++ A N+LL +E + K G+    KL    I+        + 
Sbjct: 106 AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILL 165

Query: 115 TRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN 155
            RI     ++ PE +   Q L++ AD +SFG  + EI SG +
Sbjct: 166 ERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 3e-10
 Identities = 48/161 (29%), Positives = 67/161 (41%), Gaps = 26/161 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L N RHP L  L        R   V EY     L      +RV             E R+
Sbjct: 49  LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-----------EDRA 97

Query: 57  DIC-VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--I 113
                 I   L +LH      +V+RD+K  N++LD++ + KI DFGL K   + I+    
Sbjct: 98  RFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGAT 151

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 2/79 (2%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-- 134
           I++RDIK  NILLD   +  + DFGL+K F ++         GT  Y+AP+ V GG    
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185

Query: 135 TMKADVYSFGVLVLEIISG 153
               D +S GVL+ E+++G
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 40/131 (30%), Positives = 69/131 (52%), Gaps = 10/131 (7%)

Query: 26  LVYEYVENNSLDRVLLGATKAN-IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 84
           LV+EY+     D  L+G  ++  +  + +        + +GL + H++   + +HRDIK 
Sbjct: 93  LVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKC 144

Query: 85  SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSF 143
           SNILL+ +   K+ DFGLA+L+    +   T    T  Y  PE +LG +    A DV+S 
Sbjct: 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204

Query: 144 GVLVLEIISGR 154
           G ++ E+ + +
Sbjct: 205 GCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 21/161 (13%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +S + H +LV+L G CV+    I+V EYV+   LD V L   K N+ L+W  + D+   
Sbjct: 54  LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLD-VFLHREKNNVSLHW--KLDVAKQ 109

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL-----DQEFNP--KIGDFGLAKLFPDNITHIT 114
           +A  L +L ++    +VH ++   NIL+     ++ + P  K+ D G+  +   +     
Sbjct: 110 LASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-ITVLSREERV 165

Query: 115 TRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISG 153
            RI     ++APE +  GQ  LT+ AD +SFG  +LEI S 
Sbjct: 166 ERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 48/154 (31%), Positives = 69/154 (44%), Gaps = 12/154 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EYV    L       ++  +  + ++       I
Sbjct: 49  LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERV-FSEDRTRFYGAEI 104

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGT 120
              L +LH      IV+RD+K  N++LD++ + KI DFGL K   + IT   T     GT
Sbjct: 105 VSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGT 158

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YLAPE +         D +  GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.2 bits (141), Expect = 6e-10
 Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 43/242 (17%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILV-YEYVENNSLDRVL----LGATKANIKLNWEKR 55
             L  + H N++ ++  C++      V Y Y+   +L   L    LG       L+ ++ 
Sbjct: 60  CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHIT 114
             + + IA G+++LH+     ++H+DI A N ++D+E   KI D  L++ LFP +   + 
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
                   ++A E ++  + +  +DV+SFGVL+ E+++         GQ           
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT--------LGQT---------- 218

Query: 175 LHQEEKPLELVDP-ELGEY---------PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 224
                 P   +DP E+  Y         P N       V   C       RP  +Q+++ 
Sbjct: 219 ------PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQC 272

Query: 225 LT 226
           LT
Sbjct: 273 LT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 36/97 (37%), Positives = 58/97 (59%), Gaps = 8/97 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIA 118
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++      H   +T  +A
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 119 GTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
            T  Y APE +L  +   KA D++S G ++ E++S R
Sbjct: 172 -TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.7 bits (139), Expect = 8e-10
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 34/225 (15%)

Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N      + +K   +   IA
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 182

Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
               +++PE +  G  T  +DV+SFGV++ EI +               L E  +Q    
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSN 227

Query: 179 EKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 222
           E+ L  V +  L + P N      ++   C Q     RP   ++I
Sbjct: 228 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 8e-10
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR-----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L  +RHP++VE+    +  +RR      +V+E +E++ L +V+    KAN  L  E    
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVI----KANDDLTPEHHQF 107

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHIT-T 115
               + + L ++H     ++ HRD+K  NIL + +   KI DFGLA++ F D  T I  T
Sbjct: 108 FLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 116 RIAGTTGYLAPEYV--LGGQLTMKADVYSFGVLVLEIISGR 154
               T  Y APE       + T   D++S G +  E+++G+
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 50/161 (31%), Positives = 69/161 (42%), Gaps = 26/161 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L N RHP L  L        R   V EY     L      +RV             E+R+
Sbjct: 49  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----------EERA 97

Query: 57  DIC-VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 I   L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T
Sbjct: 98  RFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGAT 151

Query: 116 --RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.5 bits (139), Expect = 9e-10
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 14/156 (8%)

Query: 3   LSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           + +  HPN++ L+G C+      ++V  Y+++  L   +   T      N   +  I  G
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH-----NPTVKDLIGFG 104

Query: 62  --IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTR 116
             +AKG+ +L  +     VHRD+ A N +LD+ F  K+ DFGLA+   D      H  T 
Sbjct: 105 LQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 ++A E +   + T K+DV+SFGVL+ E+++
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 31/233 (13%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVE-NNSLDRV----LLGATKANIK-------LNWEK 54
            HPN++ L+G C       +  EY    N LD +    +L    A  K       L  ++
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A G+ +L E+     +HRD+ A N+L+ +    KI DFGL++     +    
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
            R+     ++A E +     T K+DV+SFGVL+ EI+S    G    G     L E   Q
Sbjct: 178 GRLP--VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--LGGTPYCGMTCAELYEKLPQ 233

Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
            ++ EKP    D         E+   M+    C +     RP   Q+   L++
Sbjct: 234 GYRMEKPRNCDD---------EVYELMRQ---CWRDRPYERPPFAQISVQLSR 274

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 42/164 (25%), Positives = 81/164 (49%), Gaps = 24/164 (14%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++H N++ L+   V+G    LV + + ++ L +V+       I+L   +   I + I  G
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQILNG 131

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--------------PDNIT 111
           L  LH+    + +HRD+  +NI ++ +   KI DFGLA+ +                   
Sbjct: 132 LNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 112 HITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
            +T+++  T  Y APE ++G +    A D++S G +  E+++G+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 12/96 (12%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GT 120
           +A+G+ FL  +   + VHRD+ A N+LL Q    KI DFGLA+    +I H +  ++ G+
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298

Query: 121 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           T     ++APE +     T  +DV+S+G+L+ EI S
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 29/161 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S V H +L  + G CV+G+  I+V E+VE+  LD V L   K  + + W  +  +   +
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKEKGRVPVAW--KITVAQQL 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL--------DQEF----NPKIGDFGLAKLFPDNI 110
           A  L++L ++   ++VH ++ A NILL           F    +P +    L++      
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------ 177

Query: 111 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEI 150
                RI     ++APE V GG  L+  AD +SFG  +LEI
Sbjct: 178 EERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 13/134 (9%)

Query: 26  LVYEYVENNSLDRVLLGATKAN-IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 84
           LV E+    S+   L+  TK N +K +W   + IC  I +GLA LH      ++HRDIK 
Sbjct: 96  LVMEFCGAGSVTD-LVKNTKGNALKEDW--IAYICREILRGLAHLH---AHKVIHRDIKG 149

Query: 85  SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKAD 139
            N+LL +    K+ DFG++      +    T I GT  ++APE +            ++D
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSD 208

Query: 140 VYSFGVLVLEIISG 153
           ++S G+  +E+  G
Sbjct: 209 IWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 49/159 (30%), Positives = 69/159 (43%), Gaps = 21/159 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L N RHP L  L        R   V EY     L      +RV           + ++  
Sbjct: 49  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF----------SEDRAR 98

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITT 115
                I   L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T  T 
Sbjct: 99  FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 155

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
              GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 156 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 18/163 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           +L N  HPN+V+  G   +     G +  LV E     S+  ++ G      +L+    S
Sbjct: 74  SLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITT 115
            I  G   GL  LH      I+HRD+K +NILL  E   K+ DFG+ A+L    +   T+
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 116 RIAGTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISG 153
              GT  ++APE +   Q        + DV+S G+  +E+  G
Sbjct: 189 --VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 4/77 (5%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
            +HRD+K  N L+D   + K+ DFGL+K     I      + G+  Y+APE + G     
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177

Query: 137 KADVYSFGVLVLEIISG 153
             D +S G ++ E + G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 55/181 (30%), Positives = 79/181 (43%), Gaps = 32/181 (17%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L NV+HP LV L        +   V +Y+    L      +R  L           E R+
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-----------EPRA 98

Query: 57  DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--I 113
                 IA  L +LH     +IV+RD+K  NILLD + +  + DFGL K   +NI H   
Sbjct: 99  RFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGT 152

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG------RNSGKAMWGQMNKF 167
           T+   GT  YLAPE +         D +  G ++ E++ G      RN+ +     +NK 
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212

Query: 168 L 168
           L
Sbjct: 213 L 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 36/148 (24%), Positives = 67/148 (45%), Gaps = 4/148 (2%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+++     ++     +V E  +   L R++    K    +  +      V +
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L  +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  
Sbjct: 116 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEI 150
           Y++PE +       K+D++S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 28/77 (36%), Positives = 50/77 (64%), Gaps = 1/77 (1%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRD+K++NI L      K+GDFG +K + D+++  + +   GT  YLAPE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 136 MKADVYSFGVLVLEIIS 152
            KAD++S GV++ E+++
Sbjct: 250 KKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 34/110 (30%), Positives = 59/110 (53%), Gaps = 11/110 (10%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIA 118
           + +GL ++H     +++HRD+K SN+L++++   +IGDFG+A+     P    +  T   
Sbjct: 116 LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 119 GTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQM 164
            T  Y APE +L   + T   D++S G +  E++ GR     GK    Q+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQL 221

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT 
Sbjct: 106 IILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 159

Query: 122 GYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN 155
           GY+APE +  G      AD +S G ++ +++ G +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 7/90 (7%)

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 125 APEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           APE +  G      AD +S G ++ +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 18/158 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDI 58
           L +++H N++ L+             E   +  L   L+GA   NI    KL  +    +
Sbjct: 70  LKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 117
              I +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR 
Sbjct: 126 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
                Y APE +L         D++S G ++ E+++GR
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 28/104 (26%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAK------------------LFPDNITHITTR--- 116
           +HRDIK  NIL+D + + K+ DFGL K                  LF DN+         
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 117 -------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
                    GT  Y+APE + G    ++ D +S GV++ E++ G
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.0 bits (135), Expect = 4e-09
 Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 26/160 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L NV+HP LV L        +   V +YV    L      +R              E R+
Sbjct: 50  LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP-----------EPRA 98

Query: 57  DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--I 113
                 IA  L +LH     +I++RD+K  NILLD + +  + DFGL K   + I H   
Sbjct: 99  RFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKT 152

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T+   GT  YLAPE +         D +  G ++ E++ G
Sbjct: 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 30/165 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK--LNWEKRSDICV 60
           L  + HP++++L G           + Y   N    ++L   K ++   L  ++   IC 
Sbjct: 137 LRAINHPSIIQLKG----------TFTY---NKFTCLILPRYKTDLYCYLAAKRNIAICD 183

Query: 61  GIA------KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
            +A      + + +LHE     I+HRDIKA NI ++   +  +GDFG A  FP +I    
Sbjct: 184 ILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN--A 237

Query: 115 TRI---AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 156
            +    AGT    APE +         D++S G+++ E+ +  +S
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282

Length = 391

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 7/152 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++  N+VEL     +  +  LV+EYVE N L+   L     N     + RS I   +
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            K + + H+     IVHRDIK  N+L+      K+ DFG A+   +      T    T  
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW 166

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y +PE +LG       D++S G ++ E+  G+
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.5 bits (134), Expect = 5e-09
 Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V L        +  LV+EY + + L +        N  ++ E        +
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQL 108

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGLAF H     +++HRD+K  N+L+++    K+ DFGLA+ F   +   +  +  T  
Sbjct: 109 LKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLW 164

Query: 123 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISG 153
           Y  P+ + G +L +   D++S G +  E+ + 
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 13/152 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L+ + HP  V L G     +   LV E+V        + G     ++ N    +D+    
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFV--------IGGEFFTFLRRNKRFPNDVGCFY 136

Query: 63  AKGLAFLHEELVP-HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           A  +  + E L   +IV+RD+K  N+LLD++   K+ DFG AK+    +   T  + GT 
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYTLCGTP 192

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            Y+APE +L       AD ++ G+ + EI+ G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.1 bits (132), Expect = 7e-09
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 11/133 (8%)

Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           LV E+    S+   L+  TK N  L  E  + IC  I +GL+ LH+     ++HRDIK  
Sbjct: 86  LVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 140

Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADV 140
           N+LL +    K+ DFG++      +    T I GT  ++APE +            K+D+
Sbjct: 141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDL 199

Query: 141 YSFGVLVLEIISG 153
           +S G+  +E+  G
Sbjct: 200 WSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.6 bits (131), Expect = 8e-09
 Identities = 34/148 (22%), Positives = 67/148 (45%), Gaps = 4/148 (2%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+++ +   ++     +V E  +   L +++    K    +         V +
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              +  +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEI 150
           Y++PE +       K+D++S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 17/157 (10%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVE-NNSLD-----RVLLG----ATKANIKLNWEKRS- 56
           HPN++ L+G C       L  EY    N LD     RVL      A   +       +  
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 57  -DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           R+     ++A E +     T  +DV+S+GVL+ EI+S
Sbjct: 172 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 14/154 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           L  V+HP +V+LI     G +  L+ EY+    L    +   +  I +  E  +   +  
Sbjct: 54  LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFM--EDTACFYLSE 108

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           I+  L  LH++    I++RD+K  NILLD + + K+ DFGL K  +    +TH      G
Sbjct: 109 ISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCG 162

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y+APE ++        D +S G L+ ++++G
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)

Query: 47  NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 106
           +++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+  
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173

Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             N   + T    T  Y APE +LG       D++S G ++ E++ G
Sbjct: 174 CTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 24/162 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L ++ H N++ +        R       +VYE ++ + L ++        I+ +     D
Sbjct: 58  LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD-LHQI--------IRSSQTLSDD 108

Query: 58  IC----VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
            C      + +GL ++H     +++HRD+K SN+LL+   + KI DFGLA+   +    +
Sbjct: 109 HCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165

Query: 114 TTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR 154
           T  +  T  Y APE +L   + T   DV+S G +  E++ GR
Sbjct: 166 TEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 41/114 (35%), Positives = 62/114 (54%), Gaps = 11/114 (9%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HITTRI 117
           I  GL ++H   V   +HRD+K  N+L++ +   KI DFGLA+ F +N       +T  +
Sbjct: 114 ILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 118 AGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           A T  Y APE +L  Q   KA DV+S G ++ E++  +    GK    Q+N+ L
Sbjct: 171 A-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 12/96 (12%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GT 120
           +A G+ FL  +   + VHRD+ A N+L+ +    KI DFGLA+    +I   +  I+ G+
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR----DIMRDSNYISKGS 300

Query: 121 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           T     ++APE +     T  +DV+SFG+L+ EI +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 43/180 (23%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS----------- 56
           HP +V +   C  G        Y+E  +L  +L        K  W+K S           
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLL--------KSVWQKESLSKELAEKTSV 112

Query: 57  ----DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-------- 104
                I   I   + ++H +    ++HRD+K  NILL       I D+G A         
Sbjct: 113 GAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169

Query: 105 -LFPD----NITH----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
            L  D    NI +    I  +I GT  Y+APE +LG   +   D+Y+ GV++ ++++   
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229

Length = 932

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 35/116 (30%), Positives = 63/116 (54%), Gaps = 10/116 (8%)

Query: 41  LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 100
           LG    + KL+ ++   +   + KGL ++H      I+HRD+K  N+ ++++   KI DF
Sbjct: 106 LGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 162

Query: 101 GLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           GLA+     +T ++ TR      Y APE +L     T   D++S G ++ E+++G+
Sbjct: 163 GLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.9 bits (127), Expect = 4e-08
 Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 6/97 (6%)

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRI 117
              + KG+A  H+     ++HRD+K  N+L+D++    KI D GL + F   +   T  I
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
             T  Y APE +LG    +   D++S G +  E+   
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 5e-08
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 19/157 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L  ++H N+V L           LV+EYV  +    +D+   G    N+KL         
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FL 109

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRI 117
             + +GL+++H+    +I+HRD+K  N+L+      K+ DFGL  AK  P   +H  +  
Sbjct: 110 FQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNE 163

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
             T  Y  P+ +LG  + +   D++  G + +E+I G
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 8/81 (9%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQ 133
           I+HRD+K SNI++  +   KI DFGLA+    +     ++ TR      Y APE +LG  
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMG 193

Query: 134 LTMKADVYSFGVLVLEIISGR 154
                D++S G ++ E+I G 
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.4 bits (125), Expect = 6e-08
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 18/164 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLG-ATKANIKLNWEKRS--- 56
           L  ++HPN++ L    +  + R   L+++Y E++    +    A+KAN K     RS   
Sbjct: 52  LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNIT 111
            +   I  G+ +LH   V   +HRD+K +NIL+  E  P     KI D G A+LF   + 
Sbjct: 112 SLLYQILDGIHYLHANWV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLK 167

Query: 112 HIT--TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIIS 152
            +     +  T  Y APE +LG +   KA D+++ G +  E+++
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 19/158 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L N++H N+V L           LV+EY++++    LD      +  N+K+         
Sbjct: 57  LKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-------FM 109

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRI 117
             + +GL++ H+     I+HRD+K  N+L++++   K+ DFGL  AK  P   T   +  
Sbjct: 110 FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP---TKTYSNE 163

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
             T  Y  P+ +LG  + +   D++  G ++ E+ +GR
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 6/83 (7%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL------G 131
           VHRDIK  N+L+D+  + K+ DFG A     N    +    GT  Y+APE +        
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 132 GQLTMKADVYSFGVLVLEIISGR 154
           G   ++ D +S GV+  E+I GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 26/160 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L N++HP LV L        +   V +YV    L      +R  L           E R+
Sbjct: 50  LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-----------EPRA 98

Query: 57  DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHI 113
                 +A  + +LH     +I++RD+K  NILLD + +  + DFGL K  + P+     
Sbjct: 99  RFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T+   GT  YLAPE +         D +  G ++ E++ G
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L +++H N+V L           LV+EY++ +    +D      +  N+K+         
Sbjct: 58  LKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKI-------FL 110

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRI 117
             I +GLA+ H      ++HRD+K  N+L+++    K+ DFGL  AK  P   T   +  
Sbjct: 111 YQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP---TKTYSNE 164

Query: 118 AGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR 154
             T  Y  P+ +LG  + + + D++  G +  E+ SGR
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 18/164 (10%)

Query: 3   LSNVRHPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLG-ATKAN---IKLNWEKRS 56
           L  ++HPN++ L    +    R++ L+++Y E++    +    A+KAN   ++L      
Sbjct: 52  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNIT 111
            +   I  G+ +LH   V   +HRD+K +NIL+  E  P     KI D G A+LF   + 
Sbjct: 112 SLLYQILDGIHYLHANWV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLK 167

Query: 112 HIT--TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIIS 152
            +     +  T  Y APE +LG +   KA D+++ G +  E+++
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 14/156 (8%)

Query: 8   HPNLVELIGC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           HPN+V+  G         G +  LV E     S+  ++ G  K   ++     + I    
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             GL  LH       +HRD+K +NILL  E   K+ DFG++           T + GT  
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPF 189

Query: 123 YLAPEYV-----LGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +     L      + DV+S G+  +E+  G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITH--ITTRIAGT 120
           +GL ++H     +++HRD+K +N+ ++ E    KIGDFGLA++   + +H    +    T
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 121 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR 154
             Y +P  +L     T   D+++ G +  E+++G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 12/109 (11%)

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTG 122
            GL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +T ++ TR      
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179

Query: 123 YLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           Y APE +L         D++S G ++ E+++G+    GK    Q+ + L
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IA  L +LH     +IV+RD+K  NILLD + +  + DFGL K      +  TT   GT 
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTP 160

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            YLAPE +         D +  G ++ E++ G
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 5/107 (4%)

Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 175

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
              + + T    T  Y APE +LG       D++S G ++ E+I G 
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 38/121 (31%), Positives = 65/121 (53%), Gaps = 14/121 (11%)

Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL+ E    +   + +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 101 LMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCEL 157

Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           +I DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E++ G
Sbjct: 158 RILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Query: 154 R 154
           +
Sbjct: 213 K 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L +++H N+V L           LV+EY++ +    +D    G +  N++L         
Sbjct: 57  LKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL-------FL 109

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRI 117
             + +GLA+ H+     ++HRD+K  N+L+ +    K+ DFGL  AK  P   +   +  
Sbjct: 110 FQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNE 163

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
             T  Y  P+ +LG  + +   D++  G +  E+ +GR
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 32/95 (33%), Positives = 46/95 (48%), Gaps = 13/95 (13%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 118
           + K L  +H      I HRDIK  NIL+  +   K+ DFG  +     P    +I+TR  
Sbjct: 109 LLKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-- 162

Query: 119 GTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIIS 152
               Y APE +L  G    K D+++ G +  EI+S
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 6e-07
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 168

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
              + + T    T  Y APE +LG       D++S G ++ E++
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 6/81 (7%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG----G 132
           +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + GT  Y++PE +      G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 133 QLTMKADVYSFGVLVLEIISG 153
               + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L +++H N+V L           LV+EY++ +    LD         N+KL         
Sbjct: 58  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL-------FL 110

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRI 117
             + +GL + H      ++HRD+K  N+L+++    K+ DFGL  AK  P   T   +  
Sbjct: 111 FQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSNE 164

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
             T  Y  P+ +LG    + + D++  G +  E+ +GR
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 13/148 (8%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-LGATKANIKLNWEKRSDICVGIAKG 65
           +H N+V   G  +   +  +  EY    SL  +  +    + +++ +     +C    +G
Sbjct: 64  KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQG 118

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           LA+LH +     +HRDIK +NILL    + K+ DFG+A      I    + I GT  ++A
Sbjct: 119 LAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMA 174

Query: 126 PEYVL---GGQLTMKADVYSFGVLVLEI 150
           PE       G      D+++ G+  +E+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 11/153 (7%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + + + +H N+V   G  ++  +  +  E+    SL  +          L+  + + +  
Sbjct: 58  IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSR 113

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
              +GL +LH +     +HRDIK +NILL    + K+ DFG++      I    + I GT
Sbjct: 114 ETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GT 169

Query: 121 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEI 150
             ++APE       G      D+++ G+  +E+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 47.2 bits (112), Expect = 3e-06
 Identities = 35/154 (22%), Positives = 75/154 (48%), Gaps = 12/154 (7%)

Query: 8   HPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--C 59
           HPN+++LIG  ++   +      +++  ++++  L   LL +           ++ +   
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIA 118
           + IA G+ +L  +   + +HRD+ A N +L++     + DFGL+ K++  +         
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +LA E +     T  +DV++FGV + EI++
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 5/83 (6%)

Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
           H VHRDIK  N+LLD   + ++ DFG       + T  ++   GT  Y++PE +      
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 132 -GQLTMKADVYSFGVLVLEIISG 153
            G+   + D +S GV + E++ G
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.4 bits (112), Expect = 3e-06
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 7/84 (8%)

Query: 76  HIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTRIAGTTGYLAPEYVLG--- 131
           H VHRDIK  NIL+D   + ++ DFG   KL  D     +  + GT  Y++PE +     
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMED 180

Query: 132 --GQLTMKADVYSFGVLVLEIISG 153
             G+   + D +S GV + E++ G
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 45.9 bits (109), Expect = 3e-06
 Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 12/102 (11%)

Query: 7   RHPNLV-ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           R    V +++          L+ E++E  +LD           +++ E++ DI   +A+ 
Sbjct: 50  RKGLPVPKVLASGESDGWSYLLMEWIEGETLD-----------EVSEEEKEDIAEQLAEL 98

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           LA LH+  +  + H D+   NIL+D      I D+  A   P
Sbjct: 99  LAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 14/91 (15%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT------HIT--TR------IAGTTG 122
           IVHRD+K  N+L+    + K+ DFGL+K+   ++T      HI   TR      + GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           Y+APE +L        D ++ G+++ E + G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAK 64
           ++H NL++ +G C + T  +LV E+     L   L    KA  +  +      +   IA 
Sbjct: 52  LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT-RIAGTTGY 123
           GL  LH+    + +H D+   N LL  +   KIGD+GL+        ++T  ++     +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 124 LAPEYV--LGGQL-----TMKADVYSFGVLVLEI 150
           +APE V  + G L     T +++V+S GV + E+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 13/97 (13%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRI 117
           + + LA++H +    I HRD+K  N+L+D   +  K+ DFG AK       ++++I +R 
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
                Y APE +LG    T   D++S G ++ E+I G
Sbjct: 236 -----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 49/245 (20%)

Query: 27  VYEYVENNSL---DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 83
           +Y ++ + +    DR LL  T+A +K            +   + ++H++    ++HRDIK
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRAIMK-----------QLLCAVEYIHDKK---LIHRDIK 294

Query: 84  ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 143
             NI L+ +    +GDFG A  F            GT    +PE + G       D++S 
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354

Query: 144 GVLVLEIIS------GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 197
           G+++L+++S      G   GK   G+          QL +    L + D E  + PP ++
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKP--GK----------QLLKIIDSLSVCDEEFPD-PPCKL 401

Query: 198 IRYMKVAFFCTQAAASRRPQMNQ----------VIKMLTKNIRL--NEEELTAPGLFQDS 245
             Y+  A     A  S  P +            ++KMLT +  L     EL A  LF   
Sbjct: 402 FDYIDSAEI-DHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460

Query: 246 ESSSV 250
           E   +
Sbjct: 461 EEEEI 465

Length = 501

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 7e-06
 Identities = 27/74 (36%), Positives = 40/74 (54%), Gaps = 1/74 (1%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLT 135
           I+HRDIK  N+L++   +  +GDFG A     +  T     IAGT    APE + G   T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 136 MKADVYSFGVLVLE 149
              D++S G+++ E
Sbjct: 341 PSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 9/85 (10%)

Query: 76  HIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTRIA-GTTGYLAPEYVLG-- 131
             VHRDIK  N+LLD+  + ++ DFG   +L  D    + + +A GT  Y++PE +    
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAME 179

Query: 132 ---GQLTMKADVYSFGVLVLEIISG 153
              G+   + D +S GV + E++ G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 119
            + + LA+LH      I+HRD+K  NI LD+  N  +GDFG A KL     T      +G
Sbjct: 193 RLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 150
           T    +PE +       K D++S G+++ E+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 6/82 (7%)

Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
           ++HRD+K  N+LLD+  + K+ DFG   K+    +    T + GT  Y++PE +      
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 132 GQLTMKADVYSFGVLVLEIISG 153
           G    + D +S GV + E++ G
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA--KLFPDNITHITTRIAGTT 121
           +GLA++H +   HI+HRD+K  N+L+      K+ DFGLA  K  P   T+ +  +  T 
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVV--TL 167

Query: 122 GYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
            Y  P+ +LG    +   D++  G + +E++ G+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 6/81 (7%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG----G 132
           +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + GT  Y++PE +      G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 133 QLTMKADVYSFGVLVLEIISG 153
               + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 5e-05
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 29/161 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  V H ++V L G CV+    I+V E+VE   LD  L    K+++ L    +  +   +
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDV-LTTPWKFKVAKQL 114

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL-----DQEFNP--KIGDFGLAKLFPDNITHIT- 114
           A  L++L ++    +VH ++   NILL     D E  P  K+ D G+       IT ++ 
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSR 165

Query: 115 ----TRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEI 150
                RI     ++APE V   + L++ AD +SFG  + EI
Sbjct: 166 QECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 7e-05
 Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 37/113 (32%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLF----------------PDNITHITT------ 115
           +HRDIK  N+LLD + + K+ DFGL                    P N     +      
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 116 ---------RIA------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
                    R A      GT  Y+APE  L      + D +S GV++ E++ G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 42/119 (35%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLF----------------------PDNITHITT 115
           +HRDIK  NIL+D++ + K+ DFGL   F                       +  + I  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 116 R--------------------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                                + GT  Y+APE +L    T   D +S GV++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 13/147 (8%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           +PN ++L          +L+ +Y+++  L  +L    K   KL+  +   I   + + L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALN 123

Query: 68  FLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
            LH+    +I+H DIK  N+L D+ +    + D+GL K     I    +   GT  Y +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175

Query: 127 EYVLGGQLTMKADVYSFGVLVLEIISG 153
           E + G    +  D ++ GVL  E+++G
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 27/177 (15%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +  ++H N+V  I   +    + L  + E+ +   L R +    K   K+      DI  
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 61  GIAKGLAFLHE-ELVPH---IVHRDIKASNILLD-----------QEFN------PKIGD 99
            +   LA+ H  +  P+   ++HRD+K  NI L            Q  N       KIGD
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 100 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM--KADVYSFGVLVLEIISGR 154
           FGL+K     I  +     GT  Y +PE +L    +   K+D+++ G ++ E+ SG+
Sbjct: 186 FGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 31/135 (22%), Positives = 61/135 (45%), Gaps = 14/135 (10%)

Query: 23  RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-VPHIVHRD 81
           R  L+ EY     L  VL         L+++ + D+ +   KGL  L++    P+   ++
Sbjct: 96  RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KN 148

Query: 82  IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKAD 139
           + + + L+ + +  KI   GL K+           +     Y + + +     + T+K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDD 204

Query: 140 VYSFGVLVLEIISGR 154
           +YS GV++ EI +G+
Sbjct: 205 IYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 34/110 (30%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLA--------KLFPDNITH----------------- 112
           +HRDIK  N+LLD + + K+ DFGL           F  N+TH                 
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 113 ---------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
                    +     GT  Y+APE  +        D +S GV++ E++ G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 53/191 (27%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--ICV 60
           L+ + HP L  L       T   LV +Y     L R+L            +++    +  
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL------------QRQPGKCLSE 102

Query: 61  GIAK--------GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---- 108
            +A+         L +LH      IV+RD+K  NILL +  +  + DF L+K        
Sbjct: 103 EVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 109 ------------NITHITTRIA------------GTTGYLAPEYVLGGQLTMKADVYSFG 144
                       ++  I +               GT  Y+APE + G       D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219

Query: 145 VLVLEIISGRN 155
           +L+ E++ G  
Sbjct: 220 ILLYEMLYGTT 230

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 24/111 (21%)

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNP-------------KIGDFGLA 103
            G+A  L + H EL  H++H D+K  NIL+   D   +P             +I D G  
Sbjct: 240 TGVA--LDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295

Query: 104 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                +  H  T I  T  Y +PE VLG       D++S G ++ E+ +G+
Sbjct: 296 C----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 8e-04
 Identities = 42/161 (26%), Positives = 66/161 (40%), Gaps = 22/161 (13%)

Query: 1   MTLSNVRHPNLVELIGC-----CVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEK 54
             + N+ H  + +  GC     C    R IL+ + VEN   + + +    K  IK     
Sbjct: 75  KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK----- 129

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
             +I   +   L ++HE     I H DIK  NI++D      I D+G+A  F  +  HI 
Sbjct: 130 --NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIE 184

Query: 115 TRIA------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 149
                     GT  Y   +   G  +T + D+ S G  +L+
Sbjct: 185 YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 46/123 (37%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLFP------------------------------ 107
           +HRDIK  NIL+D++ + K+ DFGL   F                               
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 108 ----DNITHITTRIA------------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               D +  +  R A            GT  Y+APE +L    T   D +S GV++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 152 SGR 154
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 39.3 bits (91), Expect = 0.001
 Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 34/110 (30%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGL----------------------------------A 103
           +HRDIK  N+LLD + + K+ DFGL                                  A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 104 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           + +  N   +     GT  Y+APE  +        D +S GV++ E++ G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 3/44 (6%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 105
           +A  L +LH      I+HRD+K  N+L+  E + K+ DFGL+K+
Sbjct: 113 VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 30/123 (24%), Positives = 49/123 (39%), Gaps = 46/123 (37%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLFP-------------------------DNITH 112
           +HRDIK  NIL+D + + K+ DFGL   F                          D++++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 113 ---------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
                                +   + GT  Y+APE +L    T   D +S GV++ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 152 SGR 154
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 15/29 (51%), Positives = 21/29 (72%)

Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLF 106
           +HRDIK  NIL+D+  + K+ DFGL+  F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	277
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.88
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
PRK09188	365	serine/threonine protein kinase; Provisional	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.76
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.72
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.7
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.69
PRK10345	210	hypothetical protein; Provisional	99.68
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
PRK14879	211	serine/threonine protein kinase; Provisional	99.58
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.57
smart00090	237	RIO RIO-like kinase.	99.55
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.44
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.2
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.12
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.99
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.99
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.91
KOG3087	229	consensus Serine/threonine protein kinase [General	98.83
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.76
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.75
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.69
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.67
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
PRK09902	216	hypothetical protein; Provisional	98.39
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.3
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.02
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.93
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.53
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.49
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.31
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.29
PLN02876	822	acyl-CoA dehydrogenase	97.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.21
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.02
PF01636	239	APH: Phosphotransferase enzyme family This family	96.82
PRK10593	297	hypothetical protein; Provisional	96.69
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.69
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.59
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.54
PRK05231	319	homoserine kinase; Provisional	95.51
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.38
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.14
COG2334	331	Putative homoserine kinase type II (protein kinase	95.13
PHA03111	444	Ser/Thr kinase; Provisional	95.09
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.98
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.89
PRK10271	188	thiK thiamine kinase; Provisional	94.71
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	94.44
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.41
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.37
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.27
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.26
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.1
KOG2270	520	consensus Serine/threonine protein kinase involved	93.9
PLN02236	344	choline kinase	93.31
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.99
PRK06148	1013	hypothetical protein; Provisional	92.86
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.85
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	92.44
PRK11768	325	serine/threonine protein kinase; Provisional	92.41
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	91.8
PF10140	359	YukC: WXG100 protein secretion system (Wss), prote	91.7
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	90.72
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	90.35

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=350.82  Aligned_cols=226  Identities=50%  Similarity=0.823  Sum_probs=197.9

Q ss_pred             ccccccCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++|||+|+++|||.+++ ..+||+||+.+|+|++.|+.....  .++|..|++|+.++|.||+|||..+.+.||||
T Consensus       124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr  201 (361)
T KOG1187|consen  124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHR  201 (361)
T ss_pred             HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence            578999999999999999999 599999999999999999654332  88999999999999999999999988889999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCC-CCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||||+|||||+++++||+|||+++..+. ........ .||.+|+|||++..+..+.|+||||||++++||+||+.+...
T Consensus       202 DiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  202 DIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             CCCHHHeeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence            9999999999999999999999986654 22211111 799999999999999999999999999999999999988776


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCC--CCCH-HHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELG--EYPP-NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ........+..|++.........+++|+.+.  .+.. .++.++..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       281 ~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  281 SRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            5545555689999999999899999999984  4444 689999999999999999999999999999966554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-49  Score=326.17  Aligned_cols=211  Identities=31%  Similarity=0.446  Sum_probs=172.7

Q ss_pred             ccccccCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-IVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-iiH   79 (277)
                      +|++|+|||||+++|+|.+.. ..++||||+.+|+|.++++..  .+..+++..+++|+.|||+||+|||++   + |||
T Consensus        92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIH  166 (362)
T KOG0192|consen   92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIH  166 (362)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeee
Confidence            578899999999999999988 799999999999999999643  466899999999999999999999999   7 999


Q ss_pred             ccCCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccc--cCccccccceEehhHHHHHHHhCCCC
Q 023808           80 RDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL--GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        80 ~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||||+|||++.++ ++||+|||+++...... .......||+.|||||++.  ...++.|+||||||+++|||+||+.|
T Consensus       167 rDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P  245 (362)
T KOG0192|consen  167 RDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP  245 (362)
T ss_pred             cccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence            99999999999997 99999999998765432 2223367999999999999  56899999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      |.....      .+.+..+......     +.++..   ....+..++.+||+.||.+||++.+|+..|+.+....
T Consensus       246 f~~~~~------~~~~~~v~~~~~R-----p~~p~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  246 FEDLAP------VQVASAVVVGGLR-----PPIPKE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCCH------HHHHHHHHhcCCC-----CCCCcc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            876544      1122222222221     122222   3334667777799999999999999999999887644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=310.86  Aligned_cols=203  Identities=27%  Similarity=0.456  Sum_probs=165.7

Q ss_pred             ccccccCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH   79 (277)
                      +|++.+|||||.+||.|.... ...++||||++|+|++++.    ..+.+++....+++.++++||.|||. .   +|||
T Consensus       130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIH  202 (364)
T KOG0581|consen  130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIH  202 (364)
T ss_pred             HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc---Ceee
Confidence            466779999999999999999 4999999999999999994    33679999999999999999999996 6   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||||+|||++..|.|||||||.++.+.+.   ...+..||..|||||.+.+..|+.++||||||++++|+++|+.|+..
T Consensus       203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~  279 (364)
T KOG0581|consen  203 RDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP  279 (364)
T ss_pred             ccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence            999999999999999999999999976554   56788999999999999999999999999999999999999999876


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..+... ...+.......+.      .|.++..  ....++..++..||++||.+||+++|++.
T Consensus       280 ~~~~~~-~~~~Ll~~Iv~~p------pP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  280 PNPPYL-DIFELLCAIVDEP------PPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCCCC-CHHHHHHHHhcCC------CCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            522111 1111111111111      1222221  13445778888899999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=314.03  Aligned_cols=210  Identities=28%  Similarity=0.394  Sum_probs=169.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|+|||+++|+|..+...+|||||+..|+|.++|..  ..+..+...+.+.++.|||.|++||+++   ++||||
T Consensus       254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRD  328 (468)
T KOG0197|consen  254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRD  328 (468)
T ss_pred             HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---Cccchh
Confidence            68899999999999999999999999999999999999954  3456788999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhC-CCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg-~~p~~~~  160 (277)
                      |..+|||++++..+||+|||+++...++.........-...|.|||.+..+.++.|||||||||+||||+|- +.|+..+
T Consensus       329 LAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m  408 (468)
T KOG0197|consen  329 LAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM  408 (468)
T ss_pred             hhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence            999999999999999999999996665554444444456789999999999999999999999999999994 4454433


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ..   ..+   +..+.++.+.         ..++.++..+.++|..||+.+|++|||+..+...|+++...
T Consensus       409 sn---~ev---~~~le~GyRl---------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  409 SN---EEV---LELLERGYRL---------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CH---HHH---HHHHhccCcC---------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            22   122   2222222221         11223333466677779999999999999999999887653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-47  Score=292.88  Aligned_cols=206  Identities=22%  Similarity=0.378  Sum_probs=167.9

Q ss_pred             ccccccCCCccceee-EEEeCCe-eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-CeE
Q 023808            2 TLSNVRHPNLVELIG-CCVQGTR-RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP-HIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ii   78 (277)
                      +|++|+|||||++++ .|.+++. .+||||||++|+|.+.++..++.++.+++..+|+++.|++.||..+|.+.+. -|+
T Consensus        71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm  150 (375)
T KOG0591|consen   71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM  150 (375)
T ss_pred             HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence            689999999999999 5555554 8899999999999999988888888999999999999999999999994321 389


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||||||.||+|+.+|.+||+|||+++++... .......+||+.||+||.+.+..|+.+|||||+||++|||+.-..||+
T Consensus       151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             eccCcchheEEcCCCceeeccchhHhHhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence            9999999999999999999999999988764 344567889999999999999999999999999999999999999987


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCC-HHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..      .+.....+... +        ..+..+ .....++.+++..|+..||+.||+...++.
T Consensus       230 g~------n~~~L~~KI~q-g--------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  230 GD------NLLSLCKKIEQ-G--------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             cc------cHHHHHHHHHc-C--------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence            64      12222222221 1        122223 344556778888899999999998544433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-45  Score=296.20  Aligned_cols=202  Identities=25%  Similarity=0.342  Sum_probs=163.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++++|...+..|+||||++||.|.+.+    -.++.+.+..-.-+++|++.|+.|||++   ||+|||
T Consensus       229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRD  301 (475)
T KOG0615|consen  229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRD  301 (475)
T ss_pred             HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHc---Cccccc
Confidence            689999999999999999999999999999999999998    3555677778888999999999999999   999999


Q ss_pred             CCCCcEEeCCC---CceEEeecccccccCCCCcceeeeecccccccCccccccCcc---ccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+|||+..+   -.+||+|||+|+....  .....+..||+.|.|||++.+...   ..+.|+||+|||||-+|+|.+
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p  379 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP  379 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence            99999999766   5699999999998753  345567889999999999987643   347899999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||........  +.+    ....++.  .+.   +........+..++|.+||..||++||+++|++.
T Consensus       380 PFS~~~~~~s--l~e----QI~~G~y--~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  380 PFSEEYTDPS--LKE----QILKGRY--AFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             CcccccCCcc--HHH----HHhcCcc--ccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            9976554331  111    1111111  111   1223445566888999999999999999999875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=305.06  Aligned_cols=198  Identities=25%  Similarity=0.401  Sum_probs=165.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +.++|+|||||+++++|++.++.|+|.|+|..++|..++    +..+.+++.++..+++||+.||.|||+.   +|+|||
T Consensus        71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRD  143 (592)
T KOG0575|consen   71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRD  143 (592)
T ss_pred             HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---Cceecc
Confidence            457899999999999999999999999999999999999    4566899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      ||..|+||+++.+|||+|||+|..+..+. ....+..||+.|.|||++.....+..+||||+|||+|-||+|++||+...
T Consensus       144 LKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~  222 (592)
T KOG0575|consen  144 LKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT  222 (592)
T ss_pred             cchhheeecCcCcEEecccceeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence            99999999999999999999999876542 34556889999999999998889999999999999999999999997642


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      -.      +....+...+   .    .+   +........+||..+|+.+|.+|||+++|+.
T Consensus       223 vk------ety~~Ik~~~---Y----~~---P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  223 VK------ETYNKIKLNE---Y----SM---PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HH------HHHHHHHhcC---c----cc---ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            21      1111111111   0    11   1122334667888899999999999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=289.05  Aligned_cols=152  Identities=31%  Similarity=0.529  Sum_probs=138.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.|+|||||.+++++..++..|||||||+||+|.+|++    ..+.+++..+...+.||+.||++||++   +|||||
T Consensus        62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRD  134 (429)
T KOG0595|consen   62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRD  134 (429)
T ss_pred             HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            5889999999999999999999999999999999999994    444799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC------CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQE------FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~------~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||.||||+.+      -.+||+|||+|+.+..  .....+..|++-|||||+++..+|+.|+|+||+|+++|++++|+.
T Consensus       135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~  212 (429)
T KOG0595|consen  135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKP  212 (429)
T ss_pred             CCcceEEeccCCCCCCCceEEecccchhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCC
Confidence            99999999765      4589999999998864  345667889999999999999999999999999999999999999


Q ss_pred             CCCcccC
Q 023808          156 SGKAMWG  162 (277)
Q Consensus       156 p~~~~~~  162 (277)
                      ||.....
T Consensus       213 Pf~a~t~  219 (429)
T KOG0595|consen  213 PFDAETP  219 (429)
T ss_pred             CccccCH
Confidence            9875443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=301.47  Aligned_cols=202  Identities=29%  Similarity=0.487  Sum_probs=168.5

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |++|+||||+.+.|+|.....+|||||||..|-|.++|    +.+..+.......|..+||.|+.|||.+   .||||||
T Consensus       166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDL  238 (904)
T KOG4721|consen  166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDL  238 (904)
T ss_pred             HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhcc
Confidence            78999999999999999999999999999999999999    5677889999999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      |.-||||..+..|||+|||.++......++.  .+.||..|||||+++..+.++|.|||||||||||||||..|+.....
T Consensus       239 KSPNiLIs~~d~VKIsDFGTS~e~~~~STkM--SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds  316 (904)
T KOG4721|consen  239 KSPNILISYDDVVKISDFGTSKELSDKSTKM--SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS  316 (904)
T ss_pred             CCCceEeeccceEEeccccchHhhhhhhhhh--hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence            9999999999999999999999776554333  35799999999999999999999999999999999999999765332


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      .      ..+|     +-..+.+.-.++..+++   .|.-|++.||+.+|..||++.+|+.-|+-
T Consensus       317 s------AIIw-----GVGsNsL~LpvPstcP~---GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  317 S------AIIW-----GVGSNSLHLPVPSTCPD---GFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             h------eeEE-----eccCCcccccCcccCch---HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            1      1112     12222233333333444   35555666999999999999999987753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=285.96  Aligned_cols=205  Identities=28%  Similarity=0.434  Sum_probs=159.0

Q ss_pred             ccccccCCCccceeeEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++|+|||||+++|......  .++++|||+.+|+|.+++.+.   +..+++..+.+++.||+.||+|||++   +|+|
T Consensus        67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH  140 (313)
T KOG0198|consen   67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVH  140 (313)
T ss_pred             HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            688999999999999855444  689999999999999999532   22699999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCC-CCceEEeecccccccCC--CCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCC
Q 023808           80 RDIKASNILLDQ-EFNPKIGDFGLAKLFPD--NITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        80 ~dikp~Nill~~-~~~~kl~Dfg~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||||+|||++. ++.+||+|||+++....  ..........||+.|||||++..+. ...++|||||||++.||+||+.
T Consensus       141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~  220 (313)
T KOG0198|consen  141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP  220 (313)
T ss_pred             cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence            999999999999 79999999999987653  2222344678999999999998643 3459999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ||.....     ...+........     ..|.++...+.   +..+++.+|++.+|++|||+.+++.-.
T Consensus       221 PW~~~~~-----~~~~~~~ig~~~-----~~P~ip~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  221 PWSEFFE-----EAEALLLIGRED-----SLPEIPDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             cchhhcc-----hHHHHHHHhccC-----CCCCCCcccCH---HHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            9876411     111111222211     11233333333   355666679999999999999987643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=280.21  Aligned_cols=211  Identities=25%  Similarity=0.354  Sum_probs=165.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.++||||++++..|..+..+++||+||.+|++.++++.....+  +.+..+..|++++++||.|||++   |.||||
T Consensus        77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRd  151 (516)
T KOG0582|consen   77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRD  151 (516)
T ss_pred             HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---Cceecc
Confidence            4677899999999999999999999999999999999997655443  99999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--e-eeecccccccCcccccc--CccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--T-TRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||+.||||+.+|.|||+|||.+-.+-..+...  . .+..||++|||||++..  ..|+.|+|||||||+..||.+|..|
T Consensus       152 vKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aP  231 (516)
T KOG0582|consen  152 VKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAP  231 (516)
T ss_pred             cccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCC
Confidence            99999999999999999999887655443221  2 45689999999999544  3699999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |..+-+..  .+    .....+..+.......-.+......+.+.+++..|++.||.+|||+.++++
T Consensus       232 f~k~pPmk--vL----l~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  232 FSKYPPMK--VL----LLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHH--HH----HHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            87654321  11    112222222111110001112223345778888899999999999999974

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-42  Score=302.86  Aligned_cols=213  Identities=26%  Similarity=0.469  Sum_probs=173.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------C----CccCCHHHHHHHHHHHHHHHHHhhc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------A----NIKLNWEKRSDICVGIAKGLAFLHE   71 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~----~~~~~~~~~~~i~~qi~~~l~~LH~   71 (277)
                      +|..|+|||||+++|+|.+++..++|+|||..|+|.++|..+..      .    ...++..+.+.||.|||.|++||-+
T Consensus       542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~  621 (774)
T KOG1026|consen  542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS  621 (774)
T ss_pred             HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            57889999999999999999999999999999999999953221      1    2238899999999999999999999


Q ss_pred             CCCCCeEeccCCCCcEEeCCCCceEEeeccccccc-CCCCcceeeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           72 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        72 ~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                      +   .+|||||..+|+|+.++..|||+|||+++.+ ..+..+......-..+||+||.+..++|+.+||||||||||||+
T Consensus       622 ~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI  698 (774)
T KOG1026|consen  622 H---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI  698 (774)
T ss_pred             C---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence            9   9999999999999999999999999999954 33333333344556899999999999999999999999999999


Q ss_pred             Hh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          151 IS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ++ |+.|++....   +.+.+.+    +.+..        -+.+..++.++.+|+..||+.+|++||++.||...|+...
T Consensus       699 FsyG~QPy~glSn---~EVIe~i----~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  699 FSYGKQPYYGLSN---QEVIECI----RAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             hccccCcccccch---HHHHHHH----HcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            98 5667765543   2333322    22222        2345555666888889999999999999999999999876


Q ss_pred             ccC
Q 023808          230 RLN  232 (277)
Q Consensus       230 ~~~  232 (277)
                      ...
T Consensus       764 ~~s  766 (774)
T KOG1026|consen  764 QAS  766 (774)
T ss_pred             hcC
Confidence            543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=275.40  Aligned_cols=192  Identities=26%  Similarity=0.332  Sum_probs=158.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||.||+++-.|++...+|+|+||+.||.|...|    ...+.+++..+.-++.+|+.||.|||++   +|||||
T Consensus        78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRD  150 (357)
T KOG0598|consen   78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRD  150 (357)
T ss_pred             HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            678899999999999999999999999999999999999    5666899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||||..|+++|+|||+++..... ...+.+..||+.|||||++....++..+|.||||+++|||++|.+||....
T Consensus       151 lKPENILLd~~GHi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  151 LKPENILLDEQGHIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             CCHHHeeecCCCcEEEeccccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            9999999999999999999999954332 233556889999999999999999999999999999999999999987654


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .      ..+........ .     +..+..   ......+++...++.+|++|-
T Consensus       230 ~------~~~~~~I~~~k-~-----~~~p~~---ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  230 V------KKMYDKILKGK-L-----PLPPGY---LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             H------HHHHHHHhcCc-C-----CCCCcc---CCHHHHHHHHHHhccCHHHhc
Confidence            2      12222222221 0     111111   222366777779999999995

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=287.74  Aligned_cols=200  Identities=26%  Similarity=0.451  Sum_probs=166.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.++|+|||+++..+..++.+++||||++||+|.+++     .+..+++.++..|+.+++.||+|||.+   +|+|||
T Consensus       323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrD  394 (550)
T KOG0578|consen  323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRD  394 (550)
T ss_pred             HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeec
Confidence            678899999999999999999999999999999999998     344599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      ||.+|||++.+|.+||+|||++..+..... ...+..||+.|||||+.....|+++.||||||++++||+-|.+||-...
T Consensus       395 IKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~  473 (550)
T KOG0578|consen  395 IKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN  473 (550)
T ss_pred             cccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence            999999999999999999999987765443 4566789999999999999999999999999999999999999976422


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +      ....+-....+.+..       ..+......+.+++.+||+.|+.+||++.|+|+
T Consensus       474 P------lrAlyLIa~ng~P~l-------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  474 P------LRALYLIATNGTPKL-------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             h------HHHHHHHhhcCCCCc-------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            2      222223333333211       112223334677777899999999999999976

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=285.59  Aligned_cols=198  Identities=25%  Similarity=0.365  Sum_probs=162.9

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++ ||||++++.++......|+||||+.||.|.+++.    ..+++.+..+..++.|+++|++|||+.   +|+||
T Consensus        72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HR  144 (370)
T KOG0583|consen   72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHR  144 (370)
T ss_pred             HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeC
Confidence            467888 9999999999999999999999999999999993    356788999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCC-CceEEeecccccccCCCCcceeeeecccccccCccccccCc-cc-cccceEehhHHHHHHHhCCCCC
Q 023808           81 DIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LT-MKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        81 dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||||+|||++.+ +++||+|||++.... .......+..||+.|+|||++.+.. |+ .++||||+|++||-|++|+.||
T Consensus       145 DLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF  223 (370)
T KOG0583|consen  145 DLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF  223 (370)
T ss_pred             CCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            999999999999 999999999999774 2233456678999999999999877 75 7899999999999999999999


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ......      ..... ...+..      .++....  ...+..++.+|+..+|.+|+++.+|+
T Consensus       224 ~d~~~~------~l~~k-i~~~~~------~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  224 DDSNVP------NLYRK-IRKGEF------KIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCccHH------HHHHH-HhcCCc------cCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            873211      11111 111111      1111111  34578889999999999999999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=283.63  Aligned_cols=199  Identities=24%  Similarity=0.339  Sum_probs=164.2

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|.+| .||.|+++|-.|.++..+|+|+||+++|.|-+++    .+-+.|++.-..-++.||+.||+|||+.   |||||
T Consensus       126 ~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHR  198 (604)
T KOG0592|consen  126 ALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHR  198 (604)
T ss_pred             HHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---Cceec
Confidence            46677 8999999999999999999999999999999999    4556799999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc------------eeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||||+|||||++++++|+|||.|+.+......            ....++||..|.+||++..+..+..+|+|+|||+||
T Consensus       199 DlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCily  278 (604)
T KOG0592|consen  199 DLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILY  278 (604)
T ss_pred             cCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHH
Confidence            99999999999999999999999987542211            124588999999999999999999999999999999


Q ss_pred             HHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          149 EIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +|+.|.+||.....   ....+.+...          +-   .+++.....+.+|+.+.|..||.+|++..+|-+
T Consensus       279 QmlaG~PPFra~Ne---yliFqkI~~l----------~y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  279 QMLAGQPPFRAANE---YLIFQKIQAL----------DY---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHhcCCCCCccccH---HHHHHHHHHh----------cc---cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            99999999976533   1111111111          11   122223345778888899999999999988865

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.5e-41  Score=277.16  Aligned_cols=204  Identities=19%  Similarity=0.315  Sum_probs=161.9

Q ss_pred             ccccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++++||||++++|++.+    ....++||||+.+|+|.+++.    ....+++...++++.|++.||.|||+..  ++
T Consensus        71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~  144 (283)
T PHA02988         71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NK  144 (283)
T ss_pred             HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC--CC
Confidence            5789999999999999987    347789999999999999994    3456899999999999999999999732  78


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc--CccccccceEehhHHHHHHHhCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +||||||+||++++++.+||+|||+++......    ....|+..|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       145 ~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~  220 (283)
T PHA02988        145 PYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI  220 (283)
T ss_pred             CCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence            899999999999999999999999998654321    23457889999999876  678999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ||......   ....   ........     ..++   ......+.+++.+||+.||.+||++.+|+..|+...
T Consensus       221 Pf~~~~~~---~~~~---~i~~~~~~-----~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        221 PFENLTTK---EIYD---LIINKNNS-----LKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCHH---HHHH---HHHhcCCC-----CCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            98754321   1111   11111111     1111   122334778888899999999999999999998653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-41  Score=286.14  Aligned_cols=212  Identities=25%  Similarity=0.398  Sum_probs=163.0

Q ss_pred             ccccc-cCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCC---------------------------------
Q 023808            2 TLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA---------------------------------   46 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------   46 (277)
                      +|.++ +||||++++++|...+ ..++||||+++|+|.+++......                                 
T Consensus        63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (338)
T cd05102          63 ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQA  142 (338)
T ss_pred             HHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccC
Confidence            35567 8999999999988654 578999999999999998642210                                 


Q ss_pred             -------------------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecc
Q 023808           47 -------------------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  101 (277)
Q Consensus        47 -------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg  101 (277)
                                               ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG  219 (338)
T cd05102         143 SVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  219 (338)
T ss_pred             CccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecc
Confidence                                     23478889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccC
Q 023808          102 LAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEE  179 (277)
Q Consensus       102 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  179 (277)
                      +++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.......  ...    .....+
T Consensus       220 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~  293 (338)
T cd05102         220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDG  293 (338)
T ss_pred             cccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcC
Confidence            99865432221 1223345678999999998899999999999999999997 888886543211  111    111111


Q ss_pred             CccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ..     ...   +......+.+++.+||+.||.+||++.+|++.|++++.
T Consensus       294 ~~-----~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         294 TR-----MRA---PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CC-----CCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11     011   11223357788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=281.03  Aligned_cols=211  Identities=23%  Similarity=0.296  Sum_probs=165.6

Q ss_pred             cccccc-CCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVR-HPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      .|++|+ ||||+++.+++.+.+ .+|+|||||+. +|+++++.   .++.|++..+..|+.||+.||+|+|.+   |+.|
T Consensus        61 sL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFH  133 (538)
T KOG0661|consen   61 SLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFH  133 (538)
T ss_pred             HHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---Cccc
Confidence            378898 999999999999888 99999999966 99999964   367899999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||+||+|||+..+..+||+|||+||.+.+...  -+..+.|.+|+|||++.. +.|+.+.|+||+|||++|+.+-++-|.
T Consensus       134 RDlKPENiLi~~~~~iKiaDFGLARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  134 RDLKPENILISGNDVIKIADFGLAREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             ccCChhheEecccceeEecccccccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence            99999999999999999999999997755432  234567899999998864 678999999999999999999887665


Q ss_pred             cccCcchhhHHHHHHHHhcc-----------------CCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQE-----------------EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      +....+.-.   .+-.+...                 -+........+....+....+.++++.+|+++||.+|||+.|.
T Consensus       212 G~sE~Dqi~---KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a  288 (538)
T KOG0661|consen  212 GASEIDQIY---KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA  288 (538)
T ss_pred             CCcHHHHHH---HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH
Confidence            443322211   11111111                 0111111112233344566778999999999999999999999


Q ss_pred             HHH
Q 023808          222 IKM  224 (277)
Q Consensus       222 ~~~  224 (277)
                      ++.
T Consensus       289 l~~  291 (538)
T KOG0661|consen  289 LQH  291 (538)
T ss_pred             hcC
Confidence            863

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=286.18  Aligned_cols=212  Identities=29%  Similarity=0.403  Sum_probs=166.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|||||++||++.....+++|||+|.||+|.++|.   +.+..++..++++++.+.|.||+|||++   +++|||
T Consensus       214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~---k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRD  287 (474)
T KOG0194|consen  214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLK---KNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRD  287 (474)
T ss_pred             HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchh
Confidence            5788999999999999999999999999999999999994   2333699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |-.+|+|++.++.+||+|||+++.-... ........-...|+|||.+..+.++.++|||||||++||+++ |..|+...
T Consensus       288 IAARNcL~~~~~~vKISDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~  366 (474)
T KOG0194|consen  288 IAARNCLYSKKGVVKISDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM  366 (474)
T ss_pred             HhHHHheecCCCeEEeCccccccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence            9999999999999999999999854311 111112234578999999999999999999999999999998 56665543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCcc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE  234 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~  234 (277)
                      ...   .+..   .+...+..     ...+...+.+   +..++..||..+|++||+|.+|.+.|+.+....+.
T Consensus       367 ~~~---~v~~---kI~~~~~r-----~~~~~~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  367 KNY---EVKA---KIVKNGYR-----MPIPSKTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             CHH---HHHH---HHHhcCcc-----CCCCCCCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            321   2222   12121111     1122334444   45555579999999999999999999998876543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-41  Score=283.19  Aligned_cols=203  Identities=24%  Similarity=0.367  Sum_probs=171.2

Q ss_pred             CccccccCCCccceeeEEEeCCe-eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            1 MTLSNVRHPNLVELIGCCVQGTR-RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         1 ~~L~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      ++|++++|||||.+.+.|.+++. .+|||+||+||+|.+.+...  ++.-++++.+++|+.|++.|++|||++   .|+|
T Consensus        55 ~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLH  129 (426)
T KOG0589|consen   55 DLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLH  129 (426)
T ss_pred             HHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhc
Confidence            36889999999999999998887 99999999999999999653  356799999999999999999999998   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||||+.|||+..++.|+|+|||+|+.+.... ....+..||+.|++||.+.+.+|..|+|||||||++|||++-+.+|..
T Consensus       130 RDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a  208 (426)
T KOG0589|consen  130 RDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA  208 (426)
T ss_pred             ccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence            9999999999999999999999999887653 345678899999999999999999999999999999999999998875


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ..-      ...+.+.....         ....+......+..++..|++.+|..||++.+++..
T Consensus       209 ~~m------~~Li~ki~~~~---------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  209 SNM------SELILKINRGL---------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cch------HHHHHHHhhcc---------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            432      11121222111         123344555567788888999999999999999875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-41  Score=263.77  Aligned_cols=214  Identities=24%  Similarity=0.327  Sum_probs=163.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|+|+|.++++|......+||+|||+..-|+++-    .....++...+.+++.|++.|+.|+|++   ++||||
T Consensus        54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRD  126 (396)
T KOG0593|consen   54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRD  126 (396)
T ss_pred             HHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---Ceeccc
Confidence            588999999999999999999999999999885555543    3444688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||||||+|+.+... +..-+..+.|.+|+|||.+.+ .+|....||||+||++.||++|.+-|...
T Consensus       127 IKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~  205 (396)
T KOG0593|consen  127 IKPENILITQNGVVKLCDFGFARTLSAP-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR  205 (396)
T ss_pred             CChhheEEecCCcEEeccchhhHhhcCC-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence            9999999999999999999999987653 223344567999999999988 68999999999999999999999877655


Q ss_pred             cCcchhhHHHH--------HHHHhccCCccccc-cCC------CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEW--------AWQLHQEEKPLELV-DPE------LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .+-+.......        ..+.+.......-+ -|.      +..-.+....-+++++..|++.||.+|++.++++.
T Consensus       206 SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  206 SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             chHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            44332222111        11222222111100 011      11112233445788999999999999999998863

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-41  Score=283.79  Aligned_cols=197  Identities=27%  Similarity=0.347  Sum_probs=164.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+-|.||||+++|+++++..++|+|.||+.||-|.+++    ..++++++.++.+.+.||+.|+.|+|..   +|+|||
T Consensus        65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRD  137 (786)
T KOG0588|consen   65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRD  137 (786)
T ss_pred             HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceecc
Confidence            566779999999999999999999999999999999999    4566899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccc-cccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      +||+|+|||..+++||+|||.|..-..  ...-++..|+++|.|||++.+.+|. .++||||.|||||.||||+.||++.
T Consensus       138 LKpENlLLd~~~nIKIADFGMAsLe~~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd  215 (786)
T KOG0588|consen  138 LKPENLLLDVKNNIKIADFGMASLEVP--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD  215 (786)
T ss_pred             CCchhhhhhcccCEeeeccceeecccC--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999986433  3445667899999999999999884 7899999999999999999999742


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                         .-..+...+.   .+. .         +.+.....+..+|+.+|+..||++|.|+.||++
T Consensus       216 ---Nir~LLlKV~---~G~-f---------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  216 ---NIRVLLLKVQ---RGV-F---------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ---cHHHHHHHHH---cCc-c---------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence               2222332221   111 1         111222334778888999999999999999976

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=299.23  Aligned_cols=213  Identities=27%  Similarity=0.408  Sum_probs=168.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA---NIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++|||||+++|+|.+....++++|||+||+|..+|++.+..   ...++....+.++.+||.|++||+++   ++|
T Consensus       748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fv  824 (1025)
T KOG1095|consen  748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFV  824 (1025)
T ss_pred             HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCc
Confidence            688999999999999999999999999999999999999643211   44689999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCC-CCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC-CC
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NS  156 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~-~p  156 (277)
                      ||||..+|+||+....|||+|||+|+.+-. +.........-...|||||.+..+.++.|+|||||||++||++|.. .|
T Consensus       825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P  904 (1025)
T KOG1095|consen  825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP  904 (1025)
T ss_pred             CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence            999999999999999999999999994433 2222222223456899999999999999999999999999999954 45


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      +.....   ..+..   .....++.         +.+..+..++.++|..||+.+|++||++..|++.+..+....
T Consensus       905 Y~~~~n---~~v~~---~~~~ggRL---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  905 YPSRSN---FEVLL---DVLEGGRL---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             CCCcch---HHHHH---HHHhCCcc---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            443222   11211   12222211         123334445678888899999999999999999888877543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.6e-40  Score=274.06  Aligned_cols=215  Identities=24%  Similarity=0.418  Sum_probs=161.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC---------------CCCccCCHHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------------KANIKLNWEKRSDICVGIAKGL   66 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~~~i~~qi~~~l   66 (277)
                      +|.+++||||+++++++.+.+..++||||+.+|+|.+++....               .....+++..+++++.|++.||
T Consensus        72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al  151 (304)
T cd05096          72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM  151 (304)
T ss_pred             HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999985321               1123478899999999999999


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhH
Q 023808           67 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV  145 (277)
Q Consensus        67 ~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  145 (277)
                      +|||+.   +++||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++||||||+
T Consensus       152 ~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  228 (304)
T cd05096         152 KYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV  228 (304)
T ss_pred             HHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence            999999   999999999999999999999999999986543222 1222344577899999998888999999999999


Q ss_pred             HHHHHHhC--CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          146 LVLEIISG--RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       146 vl~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ++|||+++  ..|+.....   ................ .. ...   .++.....+.+++.+||+.+|++||++.+|.+
T Consensus       229 ~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~-~~-~~~---~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         229 TLWEILMLCKEQPYGELTD---EQVIENAGEFFRDQGR-QV-YLF---RPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHHHHccCCCCCCcCCH---HHHHHHHHHHhhhccc-cc-ccc---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            99999875  445544322   1122212111111110 00 000   11122345788889999999999999999999


Q ss_pred             HHhh
Q 023808          224 MLTK  227 (277)
Q Consensus       224 ~L~~  227 (277)
                      .|++
T Consensus       301 ~l~~  304 (304)
T cd05096         301 FLTE  304 (304)
T ss_pred             HHhC
Confidence            8863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-40  Score=292.38  Aligned_cols=204  Identities=23%  Similarity=0.323  Sum_probs=163.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|..++..|+||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+|||
T Consensus       118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrD  194 (478)
T PTZ00267        118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRD  194 (478)
T ss_pred             HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECC
Confidence            47789999999999999999999999999999999998864434455689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       195 lkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             cCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654322 1233456899999999999889999999999999999999999998643


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ...   .........     .    ..+......+.+++.+||+.+|++||++.+++.
T Consensus       275 ~~---~~~---~~~~~~~~~-----~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        275 SQ---REI---MQQVLYGKY-----D----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CH---HHH---HHHHHhCCC-----C----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            21   111   111111111     0    011122234778888899999999999999864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4e-40  Score=268.69  Aligned_cols=206  Identities=26%  Similarity=0.384  Sum_probs=161.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++..++..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        59 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~d  132 (266)
T cd05064          59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKG  132 (266)
T ss_pred             HHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecc
Confidence            46788999999999999999999999999999999999843   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++++|||.+...............++..|+|||.+.+..++.++||||||+++||+++ |..||...
T Consensus       133 ikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             ccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            99999999999999999999876533221111222335678999999999999999999999999999875 88887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ...   ....   .. ......    + .   +......+.+++..||+.+|.+||++.+|.+.|.+.
T Consensus       213 ~~~---~~~~---~~-~~~~~~----~-~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         213 SGQ---DVIK---AV-EDGFRL----P-A---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CHH---HHHH---HH-HCCCCC----C-C---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            321   1111   11 111110    1 1   122233477888889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=256.23  Aligned_cols=187  Identities=28%  Similarity=0.363  Sum_probs=157.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.+.||.++++++.|.+.+..|+||||.+||-|..++    ++.+++++..+.-++.||+.||+|||+.   +|++||
T Consensus        97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRD  169 (355)
T KOG0616|consen   97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRD  169 (355)
T ss_pred             HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---Ceeecc
Confidence            578899999999999999999999999999999999999    4556899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      +||+|||+|.+|.+||+|||+|+.....    +.+..||+.|+|||.++...+..++|.|||||++|||+.|..||....
T Consensus       170 LKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  170 LKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             CChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence            9999999999999999999999965443    677889999999999999999999999999999999999999998755


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      ..      . +++.+-....         .++.-....+.+|+...++.|-.+|
T Consensus       246 ~~------~-iY~KI~~~~v---------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  246 PI------Q-IYEKILEGKV---------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hH------H-HHHHHHhCcc---------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            41      1 1122222211         1122222236667777888888888

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-40  Score=277.66  Aligned_cols=198  Identities=25%  Similarity=0.289  Sum_probs=159.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+|+|.+++.    .+..+++..+..++.||+.||+|||+.   +|+|||
T Consensus        48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrD  120 (323)
T cd05571          48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRD  120 (323)
T ss_pred             HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCC
Confidence            4678899999999999999999999999999999999983    445789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       121 lkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  199 (323)
T cd05571         121 LKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             CCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence            99999999999999999999987532221 12234568999999999998899999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .   .....   .... ..      ..+   +......+.+++.+||+.||++||     ++.++++
T Consensus       200 ~---~~~~~---~~~~-~~------~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         200 H---EKLFE---LILM-EE------IRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             H---HHHHH---HHHc-CC------CCC---CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1   11111   1111 11      111   112233477888889999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-40  Score=270.56  Aligned_cols=212  Identities=24%  Similarity=0.333  Sum_probs=164.8

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++|+||||+++.+...+.  ...|+|+|||+. +|.-++.   ..+..|++.++..+..|++.||+|+|++   +|+|
T Consensus       169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlH  241 (560)
T KOG0600|consen  169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLH  241 (560)
T ss_pred             HHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---Ceee
Confidence            68999999999999999987  689999999977 8888883   4566799999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||||.+|||||.+|.+||+|||+|+++.......-+..+.|.+|+|||.+.+. .|+.+.|+||.||||.||++|++.+.
T Consensus       242 RDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  242 RDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             ccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence            99999999999999999999999999877665556667789999999999885 69999999999999999999998766


Q ss_pred             cccCcchhhHHHHHHHHhccCC----------ccccccC------CCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEK----------PLELVDP------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ....-.   -+..+........          ....+.+      .+.+.........++|+..+|..||.+|.|+.+++
T Consensus       322 G~tEve---Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL  398 (560)
T KOG0600|consen  322 GRTEVE---QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL  398 (560)
T ss_pred             CccHHH---HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence            543322   1222222211110          0011111      01000111122356777778999999999999887


Q ss_pred             H
Q 023808          223 K  223 (277)
Q Consensus       223 ~  223 (277)
                      .
T Consensus       399 ~  399 (560)
T KOG0600|consen  399 Q  399 (560)
T ss_pred             c
Confidence            5

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-39  Score=272.16  Aligned_cols=194  Identities=24%  Similarity=0.293  Sum_probs=157.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~d  143 (329)
T PTZ00263         71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRD  143 (329)
T ss_pred             HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecC
Confidence            4778999999999999999999999999999999999984    344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        144 LKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             CCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999999865433    234568999999999999889999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVI  222 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~  222 (277)
                      ..   ..   ..... ....      .++...   ...+.+++.+||+.||.+||+     +.+++
T Consensus       220 ~~---~~---~~~i~-~~~~------~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        220 PF---RI---YEKIL-AGRL------KFPNWF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             HH---HH---HHHHh-cCCc------CCCCCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            11   11   11111 1111      111111   234678888899999999997     56665

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-39  Score=268.61  Aligned_cols=212  Identities=25%  Similarity=0.436  Sum_probs=167.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      +|++++|+||+++++++..++..++||||+.+++|.+++..+..            ....+++..++.++.|++.||+||
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  139 (291)
T cd05094          60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL  139 (291)
T ss_pred             HHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999999954321            223589999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++||||||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|
T Consensus       140 H~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  216 (291)
T cd05094         140 ASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW  216 (291)
T ss_pred             HhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHH
Confidence            999   999999999999999999999999999986543321 1122344677899999999888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||+| |..||.......   ..    ..........        ........+.+++.+||+.+|.+||++.+|++.|++
T Consensus       217 el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~  281 (291)
T cd05094         217 EIFTYGKQPWFQLSNTE---VI----ECITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA  281 (291)
T ss_pred             HHHhCCCCCCCCCCHHH---HH----HHHhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            9999 888875433211   11    1111111111        111223457788899999999999999999999998


Q ss_pred             cccc
Q 023808          228 NIRL  231 (277)
Q Consensus       228 ~~~~  231 (277)
                      +.+.
T Consensus       282 ~~~~  285 (291)
T cd05094         282 LGKA  285 (291)
T ss_pred             HHhh
Confidence            8653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-40  Score=272.64  Aligned_cols=200  Identities=25%  Similarity=0.261  Sum_probs=157.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.+++..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrD  118 (312)
T cd05585          46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRD  118 (312)
T ss_pred             HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCC
Confidence            4678899999999999999999999999999999999984    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~  197 (312)
T cd05585         119 LKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN  197 (312)
T ss_pred             CCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence            99999999999999999999998543221 22334568999999999999899999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      .      ...........       ..+.   ......+.+++.+||+.||.+||++..+.+.|
T Consensus       198 ~------~~~~~~~~~~~-------~~~~---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         198 V------NEMYRKILQEP-------LRFP---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             H------HHHHHHHHcCC-------CCCC---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            1      11111111111       0111   11223467888889999999998654333333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-40  Score=267.94  Aligned_cols=204  Identities=32%  Similarity=0.539  Sum_probs=154.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      .|++++||||++++|++...+..++||||+.+|+|.+++...  ....+++..+++|+.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~  128 (259)
T PF07714_consen   54 ILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGN  128 (259)
T ss_dssp             HHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccc---cccccc
Confidence            467889999999999999888899999999999999999643  245689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |+++||+++.++.+||+|||++........ .......+...|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       129 l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~  208 (259)
T PF07714_consen  129 LSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD  208 (259)
T ss_dssp             -SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999987633221 22233456778999999999999999999999999999999 6677654


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ...   .....   .. .......     .   +......+.+++..||+.+|++||++.+|++.|
T Consensus       209 ~~~---~~~~~---~~-~~~~~~~-----~---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  209 YDN---EEIIE---KL-KQGQRLP-----I---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SCH---HHHHH---HH-HTTEETT-----S---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccc---ccccc---cc-cccccce-----e---ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            421   11111   22 1111111     1   112233477888889999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-39  Score=277.76  Aligned_cols=149  Identities=26%  Similarity=0.356  Sum_probs=130.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+||||+++++++..+...++|+|++. ++|..++.    ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus       136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrD  207 (391)
T PHA03212        136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRD  207 (391)
T ss_pred             HHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            5789999999999999999999999999995 68988883    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        208 IKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             CChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            99999999999999999999997543322222334579999999999998899999999999999999999998754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.7e-39  Score=272.02  Aligned_cols=198  Identities=27%  Similarity=0.303  Sum_probs=158.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++|+|..++.    .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~D  120 (323)
T cd05595          48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRD  120 (323)
T ss_pred             HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            4678899999999999999999999999999999999883    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  199 (323)
T cd05595         121 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             CCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987532221 11233568999999999998899999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..   ....   ......       ..+   +......+.+++.+||+.||.+||     ++.++++
T Consensus       200 ~~---~~~~---~~~~~~-------~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         200 HE---RLFE---LILMEE-------IRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HH---HHHH---HHhcCC-------CCC---CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            21   1111   111111       011   111223467888889999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-39  Score=266.96  Aligned_cols=208  Identities=26%  Similarity=0.494  Sum_probs=164.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      +|++++||||+++++++......+++|||+++|+|.+++.....            ....+++..++.++.|++.||+||
T Consensus        61 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l  140 (283)
T cd05048          61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL  140 (283)
T ss_pred             HHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            46788999999999999999999999999999999999854321            114588999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++|+||||+||++++++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|
T Consensus       141 H~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~  217 (283)
T cd05048         141 SSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW  217 (283)
T ss_pred             HhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence            999   999999999999999999999999999986433221 1223345678899999998889999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..||......   ...    .........        ..+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       218 el~~~g~~p~~~~~~~---~~~----~~i~~~~~~--------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         218 EIFSYGLQPYYGFSNQ---EVI----EMIRSRQLL--------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCCCCCCCCCHH---HHH----HHHHcCCcC--------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            9998 88887654321   111    111111111        1122333457888899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.3e-40  Score=280.00  Aligned_cols=211  Identities=23%  Similarity=0.441  Sum_probs=163.3

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-----------------------------------
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-----------------------------------   45 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------   45 (277)
                      +|+++ +|+||++++++|......++||||+.+|+|.+++.....                                   
T Consensus        94 il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (374)
T cd05106          94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF  173 (374)
T ss_pred             HHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccc
Confidence            45677 899999999999999999999999999999999853210                                   


Q ss_pred             -------------------------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCc
Q 023808           46 -------------------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN   94 (277)
Q Consensus        46 -------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~   94 (277)
                                                     ....+++..+++++.|++.||+|||+.   +++||||||+||++++++.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~  250 (374)
T cd05106         174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRV  250 (374)
T ss_pred             cccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCe
Confidence                                           112478899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcccCcchhhHHHHH
Q 023808           95 PKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA  172 (277)
Q Consensus        95 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  172 (277)
                      +||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......  ..    
T Consensus       251 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----  324 (374)
T cd05106         251 AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----  324 (374)
T ss_pred             EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----
Confidence            999999999865443221 1222335567999999988899999999999999999997 998886543211  11    


Q ss_pred             HHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          173 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ........     ........   ...+.+++.+||+.||.+||++.+|++.|++++
T Consensus       325 ~~~~~~~~-----~~~~~~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         325 YKMVKRGY-----QMSRPDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHccc-----CccCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11111110     11111111   234778888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-39  Score=266.42  Aligned_cols=203  Identities=23%  Similarity=0.283  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.+++..++||||+.+|+|.+++...  ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~d  127 (285)
T cd05631          53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRD  127 (285)
T ss_pred             HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCC
Confidence            467889999999999999999999999999999999887432  234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||++++++.++|+|||+++......  ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       128 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         128 LKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             CCHHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998654322  1234568999999999999899999999999999999999999987543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      .......   .........         ...+......+.+++.+||+.||.+||+     ++++++
T Consensus       206 ~~~~~~~---~~~~~~~~~---------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         206 ERVKREE---VDRRVKEDQ---------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cchhHHH---HHHHhhccc---------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            3211110   111111100         0111122334778888899999999997     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=273.26  Aligned_cols=203  Identities=21%  Similarity=0.254  Sum_probs=160.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.+++..|+||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~d  126 (333)
T cd05600          54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRD  126 (333)
T ss_pred             HHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4678899999999999999999999999999999999993    344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++....    ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       127 lkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         127 LKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             CCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence            999999999999999999999986533    2334568999999999998899999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ...   .........  ..+............+.+++.+||..+|.+||++.++++
T Consensus       203 ~~~---~~~---~i~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         203 PNE---TWE---NLKYWKETL--QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             HHH---HHH---HHHhccccc--cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            211   111   111100000  011111000122344778888999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-39  Score=273.35  Aligned_cols=195  Identities=24%  Similarity=0.274  Sum_probs=158.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  156 (340)
T PTZ00426         84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRD  156 (340)
T ss_pred             HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccC
Confidence            4678899999999999999999999999999999999993    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       157 Lkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        157 LKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            9999999999999999999999865432    234568999999999998889999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..   ..   ...... ...      .++...   ...+.+++.+|++.+|++|+     +++++++
T Consensus       233 ~~---~~---~~~i~~-~~~------~~p~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        233 PL---LI---YQKILE-GII------YFPKFL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HH---HH---HHHHhc-CCC------CCCCCC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            21   11   111111 110      011111   23367788889999999995     7888764

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.9e-39  Score=263.19  Aligned_cols=207  Identities=23%  Similarity=0.375  Sum_probs=163.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+.+++|.+++...  ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~d  129 (263)
T cd05052          55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD  129 (263)
T ss_pred             HHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecc
Confidence            467889999999999999999999999999999999998532  234589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..|+...
T Consensus       130 lkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  209 (263)
T cd05052         130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  209 (263)
T ss_pred             cCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999998765432222222334568999999988889999999999999999998 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ...   ...    .......     ....   +......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       210 ~~~---~~~----~~~~~~~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         210 DLS---QVY----ELLEKGY-----RMER---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CHH---HHH----HHHHCCC-----CCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            211   111    1111110     1111   112224477888899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.2e-40  Score=278.74  Aligned_cols=210  Identities=27%  Similarity=0.420  Sum_probs=161.7

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-----------------------------------
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-----------------------------------   45 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------   45 (277)
                      +|.++ +||||++++++|..+...++||||+++|+|.+++.....                                   
T Consensus        91 il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (375)
T cd05104          91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMD  170 (375)
T ss_pred             HHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhh
Confidence            35667 899999999999999999999999999999999854221                                   


Q ss_pred             ------------------------------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEe
Q 023808           46 ------------------------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL   89 (277)
Q Consensus        46 ------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill   89 (277)
                                                          ....+++..+++++.|++.||+|||+.   +++||||||+||++
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill  247 (375)
T cd05104         171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILL  247 (375)
T ss_pred             cCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEE
Confidence                                                112478899999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcccCcchhh
Q 023808           90 DQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKF  167 (277)
Q Consensus        90 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~  167 (277)
                      +.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......  .
T Consensus       248 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~  325 (375)
T cd05104         248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K  325 (375)
T ss_pred             ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H
Confidence            999999999999998654432211 122334567999999999899999999999999999998 777775432211  1


Q ss_pred             HHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          168 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ..    .....+..     .......   ..++.+++.+||+.||++||++.+|++.|++.
T Consensus       326 ~~----~~~~~~~~-----~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         326 FY----KMIKEGYR-----MLSPECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HH----HHHHhCcc-----CCCCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            11    11111111     0011112   23477888889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-39  Score=269.10  Aligned_cols=198  Identities=26%  Similarity=0.309  Sum_probs=158.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..|+||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~d  125 (323)
T cd05584          53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRD  125 (323)
T ss_pred             HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4778999999999999999999999999999999999983    344688899999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         126 LKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             CCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999987543221 12334568999999999988889999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..      ..........       ..+   ++.....+.+++.+||+.+|++||     ++.+++.
T Consensus       205 ~~------~~~~~~~~~~-------~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         205 RK------KTIDKILKGK-------LNL---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HH------HHHHHHHcCC-------CCC---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            21      1111111111       011   111223477888889999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.9e-39  Score=272.66  Aligned_cols=150  Identities=28%  Similarity=0.508  Sum_probs=133.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+..  +++|||
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~d  129 (331)
T cd06649          56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRD  129 (331)
T ss_pred             HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCC
Confidence            4778999999999999999999999999999999999994    3446899999999999999999999852  699999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++.....   ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       130 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             CChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998765332   123456899999999999888999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-39  Score=267.30  Aligned_cols=219  Identities=28%  Similarity=0.405  Sum_probs=162.2

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++...  ...++||||+.+|+|.+++..     ..+++..++.++.|++.||+|||+.   +++|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H  130 (283)
T cd05080          59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIH  130 (283)
T ss_pred             HHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence            47789999999999998754  467899999999999999842     2589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||||+||+++.++.++|+|||+++........  ......++..|+|||.+.+..++.++||||||+++|||+||..|+
T Consensus       131 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~  210 (283)
T cd05080         131 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK  210 (283)
T ss_pred             cccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999866543221  112233556799999998888999999999999999999999887


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      .......... .................+... ...+......+.+++..||+.+|++||++++|+..|+++.
T Consensus       211 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         211 QSPPKKFEEM-IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCcchhhhh-hcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            5443211100 000000000000000111100 1112223345788888899999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-39  Score=273.20  Aligned_cols=198  Identities=25%  Similarity=0.299  Sum_probs=158.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  120 (328)
T cd05593          48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRD  120 (328)
T ss_pred             HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecc
Confidence            4678899999999999999999999999999999999883    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       121 ikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  199 (328)
T cd05593         121 LKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (328)
T ss_pred             cCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence            99999999999999999999987533221 12234568999999999998889999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..   ...   .......       ..+   +......+.+++.+||+.||.+||     ++.++++
T Consensus       200 ~~---~~~---~~~~~~~-------~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         200 HE---KLF---ELILMED-------IKF---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HH---HHH---HHhccCC-------ccC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            21   111   1111111       111   112223477888889999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.5e-39  Score=270.10  Aligned_cols=203  Identities=25%  Similarity=0.299  Sum_probs=158.2

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|.++ +||||+++++++..++..++||||+.+|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++||
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHr  129 (332)
T cd05614          57 VLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYR  129 (332)
T ss_pred             HHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEec
Confidence            35667 59999999999999999999999999999999983    344689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||||+|||++.++.+||+|||+++.+............||..|+|||++.+. .++.++|||||||++|||+||..||..
T Consensus       130 Dlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         130 DIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             CCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            9999999999999999999999986544333333456799999999998765 478899999999999999999999864


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .......  ..........       ++.+...   ....+.+++.+||+.||++||     ++.++++
T Consensus       210 ~~~~~~~--~~~~~~~~~~-------~~~~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         210 EGERNTQ--SEVSRRILKC-------DPPFPSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCH--HHHHHHHhcC-------CCCCCCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            3322211  1111111111       1112111   223467788889999999999     6667754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-39  Score=268.09  Aligned_cols=215  Identities=23%  Similarity=0.281  Sum_probs=160.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.++++..+.    .....+++..+..++.|++.||+|||+.   +++|||
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~d  125 (287)
T cd07848          53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRD  125 (287)
T ss_pred             HHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            467899999999999999999999999999988777655    2344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++..............|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       126 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             CCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765433222334568999999999998889999999999999999999999986543


Q ss_pred             CcchhhHHHHH--------HHHhccC-CccccccCCCC-------CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWA--------WQLHQEE-KPLELVDPELG-------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...........        +...... .......+...       .........+.+++.+||+.||++||+++++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            21111000000        0000000 00000000000       000112335788999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=277.05  Aligned_cols=211  Identities=25%  Similarity=0.430  Sum_probs=164.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++-+|.||+-+.|||.++.. .||+.+|+|.+|+.+++.   ...+|.....+.|+.||+.|+.|||.+   +|||+|
T Consensus       441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrD  513 (678)
T KOG0193|consen  441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRD  513 (678)
T ss_pred             HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhh
Confidence            5788899999999999999988 999999999999999964   345789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCC-CCcceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||..||||.+++.|||+|||++..-.. ..........|...|||||+++.   .+|++.+||||||+|+|||+||..|+
T Consensus       514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy  593 (678)
T KOG0193|consen  514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY  593 (678)
T ss_pred             ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence            999999999999999999999874221 11122233457788999999975   46899999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCC-CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPE-LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ..... +     +.+|.   .++..-..|.. ....++++   +.+|+..||..++++||.+.+|+..|+.+++.
T Consensus       594 si~~~-d-----qIifm---VGrG~l~pd~s~~~s~~pk~---mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  594 SIQNR-D-----QIIFM---VGRGYLMPDLSKIRSNCPKA---MKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             CCCCh-h-----heEEE---ecccccCccchhhhccCHHH---HHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            73221 1     11122   22221111211 12334444   55555669999999999999999999888763

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-39  Score=263.31  Aligned_cols=203  Identities=24%  Similarity=0.416  Sum_probs=160.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  125 (256)
T cd05114          52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRD  125 (256)
T ss_pred             HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            477899999999999999999999999999999999998532   23589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |+|+||++++++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       126 l~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             cCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999998654332222222335568999999988889999999999999999999 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ..   .....   ........   ..+   ..   ....+.+++.+||+.+|.+||++.++++.|
T Consensus       206 ~~---~~~~~---~i~~~~~~---~~~---~~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         206 SN---YEVVE---MISRGFRL---YRP---KL---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CH---HHHHH---HHHCCCCC---CCC---CC---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            22   11111   11111111   011   11   123478889999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.2e-39  Score=267.81  Aligned_cols=196  Identities=27%  Similarity=0.315  Sum_probs=155.5

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      +++++||||+++++++..++..|+||||+++|+|..++.     ...+++..+..++.|++.||+|||+.   +++||||
T Consensus        56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdl  127 (324)
T cd05589          56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDL  127 (324)
T ss_pred             ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCC
Confidence            467899999999999999999999999999999998883     23689999999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      ||+||+++.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       128 kp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~  206 (324)
T cd05589         128 KLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE  206 (324)
T ss_pred             CHHHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999987532221 122345689999999999988899999999999999999999999864322


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      .   ...   ........       ..   +......+.+++.+||+.||.+||+     +.++++
T Consensus       207 ~---~~~---~~i~~~~~-------~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         207 E---EVF---DSIVNDEV-------RY---PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             H---HHH---HHHHhCCC-------CC---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1   111   11111111       11   1112234678888999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=270.24  Aligned_cols=195  Identities=26%  Similarity=0.289  Sum_probs=157.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  126 (291)
T cd05612          54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRD  126 (291)
T ss_pred             HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecC
Confidence            4778999999999999999999999999999999999994    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++.....    .....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       127 lkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         127 LKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             CCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999865432    223468999999999998889999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      ..   ..   ........ .      .+   +......+.+++.+||+.||.+||+     +.++++
T Consensus       203 ~~---~~---~~~i~~~~-~------~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         203 PF---GI---YEKILAGK-L------EF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HH---HH---HHHHHhCC-c------CC---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            21   11   11111111 0      11   1111234778888999999999995     776653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-39  Score=267.21  Aligned_cols=212  Identities=24%  Similarity=0.424  Sum_probs=166.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC---------CCCccCCHHHHHHHHHHHHHHHHHhhcC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------KANIKLNWEKRSDICVGIAKGLAFLHEE   72 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~   72 (277)
                      +|++++||||+++++++...+..++||||+.+++|.+++....         .....+++..++.++.|++.||+|||+.
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~  139 (288)
T cd05093          60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ  139 (288)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999999999999999999999999985432         1223589999999999999999999999


Q ss_pred             CCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           73 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        73 ~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                         +++||||||+||++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus       140 ---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~  216 (288)
T cd05093         140 ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF  216 (288)
T ss_pred             ---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence               9999999999999999999999999999865432211 122233567899999998888999999999999999999


Q ss_pred             h-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          152 S-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       152 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      + |..||......   ....   .. ..+....     ...   .....+.+++.+||+.+|.+||++.+|.+.|+++.+
T Consensus       217 t~g~~p~~~~~~~---~~~~---~i-~~~~~~~-----~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         217 TYGKQPWYQLSNN---EVIE---CI-TQGRVLQ-----RPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             hCCCCCCCCCCHH---HHHH---HH-HcCCcCC-----CCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            9 88887543321   1111   11 1111110     111   122347889999999999999999999999998875


Q ss_pred             c
Q 023808          231 L  231 (277)
Q Consensus       231 ~  231 (277)
                      .
T Consensus       282 ~  282 (288)
T cd05093         282 A  282 (288)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.2e-39  Score=261.88  Aligned_cols=206  Identities=26%  Similarity=0.400  Sum_probs=164.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++..++..++||||+.+|+|.+++...  ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~d  128 (261)
T cd05072          54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD  128 (261)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            467889999999999999999999999999999999998542  344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||+++..............++..|+|||++....++.++||||||+++|+|+| |..||...
T Consensus       129 l~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             cchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            99999999999999999999998765433222223345678999999988889999999999999999998 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   ......   .. ...    .+....    ....+.+++.+||+.+|++||+++++.+.|++
T Consensus       209 ~~~---~~~~~~---~~-~~~----~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         209 SNS---DVMSAL---QR-GYR----MPRMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CHH---HHHHHH---Hc-CCC----CCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            221   111111   11 111    011112    22347788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-39  Score=263.14  Aligned_cols=204  Identities=25%  Similarity=0.423  Sum_probs=160.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++......++||||+.+|+|.+++..   ....+++..+++++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  125 (256)
T cd05113          52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRD  125 (256)
T ss_pred             HHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            47789999999999999999999999999999999999843   223689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.+||+|||.++..............++..|++||.+.+..++.++||||||+++|||++ |..||...
T Consensus       126 l~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             cCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            99999999999999999999988654432222222345678999999988889999999999999999999 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ...   ....   ........      ..   +......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       206 ~~~---~~~~---~~~~~~~~------~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         206 NNS---ETVE---KVSQGLRL------YR---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CHH---HHHH---HHhcCCCC------CC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            321   1111   11111111      00   0112345788888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-39  Score=264.33  Aligned_cols=206  Identities=24%  Similarity=0.317  Sum_probs=161.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++.+++..+...++||||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  122 (280)
T cd05608          46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRD  122 (280)
T ss_pred             HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            57789999999999999999999999999999999988854444556799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||++++++.++|+|||++..+..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       123 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         123 LKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             CCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999986544322 2234568999999999999999999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .....  ......... ..         ...+......+.+++.+||+.||++||     +++++++
T Consensus       202 ~~~~~--~~~~~~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         202 EKVEN--KELKQRILN-DS---------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cchhH--HHHHHhhcc-cC---------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            22111  000111110 00         011122334477888889999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.4e-39  Score=268.29  Aligned_cols=194  Identities=26%  Similarity=0.291  Sum_probs=155.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..++..++||||+++|+|..++.    .+..+++..+..++.||+.||+|||+.   +++|||
T Consensus        49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~d  121 (323)
T cd05575          49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRD  121 (323)
T ss_pred             HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCC
Confidence            3567899999999999999999999999999999999983    345789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++..... ........||..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       122 ikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         122 LKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             CCHHHeEECCCCcEEEeccCCCcccccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            9999999999999999999998753221 112334568999999999999899999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      .   .   .......... .      .+   .+.....+.+++.+|++.||.+||++.
T Consensus       201 ~---~---~~~~~i~~~~-~------~~---~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         201 T---A---EMYDNILNKP-L------RL---KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             H---H---HHHHHHHcCC-C------CC---CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1   1   1111111111 0      11   111233477888899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.5e-39  Score=269.19  Aligned_cols=203  Identities=26%  Similarity=0.352  Sum_probs=157.1

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +.++ +||||+++++++...+..|+||||+++|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        49 l~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~d  121 (329)
T cd05588          49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRD  121 (329)
T ss_pred             HHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            4455 79999999999999999999999999999999883    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++..... ........||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       122 lkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  200 (329)
T cd05588         122 LKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  200 (329)
T ss_pred             CCHHHeEECCCCCEEECcCccccccccC-CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence            9999999999999999999998742221 112334568999999999999899999999999999999999999986322


Q ss_pred             Ccc--hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC------HHHHH
Q 023808          162 GQM--NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ------MNQVI  222 (277)
Q Consensus       162 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs------~~~v~  222 (277)
                      ...  ......+..........      .++   ......+.+++.+||+.||.+||+      +.+++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~------~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         201 MSDNPDQNTEDYLFQVILEKQI------RIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             ccccccccchHHHHHHHHcCCC------CCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            111  11111222222222111      111   112234778888999999999997      55664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.4e-39  Score=268.73  Aligned_cols=194  Identities=24%  Similarity=0.321  Sum_probs=154.5

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      .++||||+++++++..++..++||||++||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||
T Consensus        52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp  124 (316)
T cd05592          52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKL  124 (316)
T ss_pred             ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence            3589999999999999999999999999999999984    344689999999999999999999999   999999999


Q ss_pred             CcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcc
Q 023808           85 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  164 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~  164 (277)
                      +||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..||.....  
T Consensus       125 ~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--  201 (316)
T cd05592         125 DNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--  201 (316)
T ss_pred             HHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--
Confidence            99999999999999999998543322 223345689999999999988899999999999999999999999865322  


Q ss_pred             hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH-HHH
Q 023808          165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVI  222 (277)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~-~v~  222 (277)
                       ...   ...... ..      +.++.   .....+.+++.+||+.+|.+||++. +++
T Consensus       202 -~~~---~~~i~~-~~------~~~~~---~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         202 -DEL---FDSILN-DR------PHFPR---WISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -HHH---HHHHHc-CC------CCCCC---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             111   111111 11      11111   1223466788889999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-38  Score=267.13  Aligned_cols=194  Identities=23%  Similarity=0.263  Sum_probs=155.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+.+..++||||+++|+|..++.    ....+++..+..++.||+.||+|||+.   +++|||
T Consensus        49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~D  121 (321)
T cd05603          49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRD  121 (321)
T ss_pred             HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecc
Confidence            4678899999999999999999999999999999998883    345688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......||..|+|||.+.+..++.++|||||||++|||++|..||....
T Consensus       122 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         122 LKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             CCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            99999999999999999999987532221 22334568999999999998889999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      .   ...   ........       .   ..++.....+.+++.+||+.+|.+||+..
T Consensus       201 ~---~~~---~~~i~~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         201 V---SQM---YDNILHKP-------L---QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             H---HHH---HHHHhcCC-------C---CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1   111   11111111       0   11122234577888999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.1e-39  Score=268.56  Aligned_cols=196  Identities=27%  Similarity=0.375  Sum_probs=153.3

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      .+||||+++++++..++..++||||+++|+|..++.    ....+++..+..++.|++.||+|||+.   +++||||||+
T Consensus        53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~  125 (329)
T cd05618          53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLD  125 (329)
T ss_pred             CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHH
Confidence            389999999999999999999999999999998883    345689999999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcc-
Q 023808           86 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-  164 (277)
Q Consensus        86 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~-  164 (277)
                      ||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       126 Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~  204 (329)
T cd05618         126 NVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN  204 (329)
T ss_pred             HEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC
Confidence            9999999999999999987532211 12234568999999999999899999999999999999999999985322111 


Q ss_pred             -hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          165 -NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       165 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                       ......+..........      .+   +......+.+++.+||+.||++||++
T Consensus       205 ~~~~~~~~~~~~i~~~~~------~~---p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         205 PDQNTEDYLFQVILEKQI------RI---PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             cccccHHHHHHHHhcCCC------CC---CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             11111222222221111      11   12223347788888999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.4e-39  Score=264.16  Aligned_cols=209  Identities=27%  Similarity=0.413  Sum_probs=163.8

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC------------CCCccCCHHHHHHHHHHHHHHHHHh
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------------KANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      +.++ +|+||+++++++..+...++||||+.+|+|.+++....            .....+++..+++++.|++.||+||
T Consensus        69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L  148 (293)
T cd05053          69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL  148 (293)
T ss_pred             HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            4567 89999999999999999999999999999999985422            2345689999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++|+||||+||++++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|
T Consensus       149 H~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  225 (293)
T cd05053         149 ASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW  225 (293)
T ss_pred             HHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence            999   9999999999999999999999999999866443211 122233557899999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..|+......   ...    ........        ...+......+.+++.+||+.+|++|||+.++++.|++
T Consensus       226 el~~~g~~p~~~~~~~---~~~----~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         226 EIFTLGGSPYPGIPVE---ELF----KLLKEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             HHhcCCCCCCCCCCHH---HHH----HHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            9998 87776543211   111    11111111        01112223458889999999999999999999999987


Q ss_pred             cc
Q 023808          228 NI  229 (277)
Q Consensus       228 ~~  229 (277)
                      ++
T Consensus       291 ~~  292 (293)
T cd05053         291 ML  292 (293)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-39  Score=273.00  Aligned_cols=198  Identities=25%  Similarity=0.288  Sum_probs=157.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +|.+++||||+++++++..++..++||||+++|+|.+++.    .+..+++..+..++.|++.||+|||+ .   +++||
T Consensus        48 ~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHr  120 (325)
T cd05594          48 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYR  120 (325)
T ss_pred             HHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEec
Confidence            4677899999999999999999999999999999999883    34568999999999999999999997 7   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||+||..||...
T Consensus       121 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             CCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            9999999999999999999999875332211 123456899999999999889999999999999999999999998643


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ...   ....   ......       ..++.   .....+.+++.+||+.||++|+     ++.++++
T Consensus       200 ~~~---~~~~---~i~~~~-------~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         200 DHE---KLFE---LILMEE-------IRFPR---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CHH---HHHH---HHhcCC-------CCCCC---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            221   1111   111110       01111   1223477888889999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=259.62  Aligned_cols=206  Identities=28%  Similarity=0.458  Sum_probs=163.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+.+++|.+++...  .+..+++..+..++.|++.||.+||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  128 (261)
T cd05068          54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD  128 (261)
T ss_pred             HHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            467899999999999999999999999999999999999532  244689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||+++...............+..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       129 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  208 (261)
T cd05068         129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM  208 (261)
T ss_pred             CCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999998765332221222223457999999988889999999999999999999 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..   .....   ........         ..+......+.+++.+|++.+|.+||++.++++.|++
T Consensus       209 ~~---~~~~~---~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         209 TN---AEVLQ---QVDQGYRM---------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CH---HHHHH---HHHcCCCC---------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            21   11111   11111110         0111223457888999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.3e-39  Score=262.71  Aligned_cols=208  Identities=27%  Similarity=0.403  Sum_probs=162.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.. ...++++||+.+|+|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        62 ~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~d  134 (279)
T cd05111          62 AMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRN  134 (279)
T ss_pred             HHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccc
Confidence            4678899999999999864 456789999999999999943   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||++++++.+||+|||+++........ ......++..|++||.+.+..++.++||||||+++||+++ |..||..
T Consensus       135 lkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  214 (279)
T cd05111         135 LAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG  214 (279)
T ss_pred             cCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999999865433221 1223446778999999988899999999999999999998 8888764


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      .....   ...    .........  .+   ...   ...+.+++.+||..+|.+||++.++++.|..+.+.
T Consensus       215 ~~~~~---~~~----~~~~~~~~~--~~---~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         215 MRPHE---VPD----LLEKGERLA--QP---QIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCHHH---HHH----HHHCCCcCC--CC---CCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            33211   111    111111111  11   111   23467788889999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-39  Score=269.34  Aligned_cols=195  Identities=25%  Similarity=0.273  Sum_probs=157.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..|+||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  123 (318)
T cd05582          51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRD  123 (318)
T ss_pred             HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCC
Confidence            5788999999999999999999999999999999999983    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         124 LKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             CCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            99999999999999999999988654321 22334568999999999988888999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ  220 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~  220 (277)
                      ..   ...   ....... .      .++.   .....+.+++.+||+.||.+||++.+
T Consensus       203 ~~---~~~---~~i~~~~-~------~~p~---~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         203 RK---ETM---TMILKAK-L------GMPQ---FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HH---HHH---HHHHcCC-C------CCCC---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            21   111   1111111 0      1111   12234678888899999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-40  Score=282.06  Aligned_cols=211  Identities=28%  Similarity=0.471  Sum_probs=174.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ||-|++||||+++.|+.......++|+|||++|+|+.+|+.   ....+++-++.-++++|+.|+.||-++   ++||||
T Consensus       683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRD  756 (996)
T KOG0196|consen  683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRD  756 (996)
T ss_pred             hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhh
Confidence            57799999999999999999999999999999999999954   445699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecc--cccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |..+|||++.+..+|++|||++|.+.++.....++..|  ..+|+|||.+...+++.+|||||||||+||.++ |..|+ 
T Consensus       757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY-  835 (996)
T KOG0196|consen  757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-  835 (996)
T ss_pred             hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc-
Confidence            99999999999999999999999887765333333333  357999999999999999999999999999876 66664 


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                        |+-.++++...+.+..   +.         ..+.+++..+.+|++.||++|-.+||.+.+|+..|.++++.+.
T Consensus       836 --WdmSNQdVIkaIe~gy---RL---------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  836 --WDMSNQDVIKAIEQGY---RL---------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             --cccchHHHHHHHHhcc---CC---------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence              3333444433222211   11         2234455668999999999999999999999999999998654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=260.12  Aligned_cols=206  Identities=28%  Similarity=0.454  Sum_probs=163.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+.+++|.+++..   ....+++..+++++.|++.||+|||+.   +++|+|
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~d  131 (266)
T cd05033          58 IMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRD  131 (266)
T ss_pred             HHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            46789999999999999999999999999999999999853   233689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       132 i~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             CCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence            9999999999999999999999976522211 1222334578999999988889999999999999999998 8888754


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ...   .......    ......    +.    +......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       212 ~~~---~~~~~~~----~~~~~~----~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         212 MSN---QDVIKAV----EDGYRL----PP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCH---HHHHHHH----HcCCCC----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            321   1111111    111100    00    112234577889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=270.14  Aligned_cols=199  Identities=28%  Similarity=0.446  Sum_probs=165.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++++||.++||.+..+..++++||||.||++.+.+    +.+..+.+..+.-++.++..||.|||.+   +.+|||
T Consensus        64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrD  136 (467)
T KOG0201|consen   64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRD  136 (467)
T ss_pred             HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceeccc
Confidence            578999999999999999999999999999999999999    4555567888888999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      ||+.|||+..+|.+||+|||++..+...... ..++.||+.|||||++.+..|+.|+||||||++.+||++|.+|+....
T Consensus       137 IKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h  215 (467)
T KOG0201|consen  137 IKAANILLSESGDVKLADFGVAGQLTNTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH  215 (467)
T ss_pred             ccccceeEeccCcEEEEecceeeeeechhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence            9999999999999999999999877655433 378899999999999998899999999999999999999999987655


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +.....+            ......|.+..   .....+.+++..||+.||+.||++.++++
T Consensus       216 Pmrvlfl------------Ipk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  216 PMRVLFL------------IPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cceEEEe------------ccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            4221100            00111223322   23334677777799999999999999875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.5e-39  Score=275.58  Aligned_cols=212  Identities=23%  Similarity=0.345  Sum_probs=164.6

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-----------------------------------
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-----------------------------------   45 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------   45 (277)
                      +|++++ ||||++++++|.+....|+|||||++|+|.+++.....                                   
T Consensus        93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (400)
T cd05105          93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFE  172 (400)
T ss_pred             HHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhc
Confidence            466785 99999999999999999999999999999998854211                                   


Q ss_pred             ---------------------------------------------------------CCccCCHHHHHHHHHHHHHHHHH
Q 023808           46 ---------------------------------------------------------ANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus        46 ---------------------------------------------------------~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                                                                               ....+++..++.++.|++.||+|
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  252 (400)
T cd05105         173 NKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEF  252 (400)
T ss_pred             ccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence                                                                     11347888999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ||+.   +++|+||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++
T Consensus       253 LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil  329 (400)
T cd05105         253 LASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL  329 (400)
T ss_pred             HHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHH
Confidence            9999   9999999999999999999999999999865432221 12234467789999999888899999999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |||++ |..||.......  ..    .........     ..   .+......+.+++.+||+.+|++||++.+|.+.|+
T Consensus       330 ~ellt~g~~P~~~~~~~~--~~----~~~~~~~~~-----~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         330 WEIFSLGGTPYPGMIVDS--TF----YNKIKSGYR-----MA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             HHHHHCCCCCCcccchhH--HH----HHHHhcCCC-----CC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence            99997 888876432211  11    111111111     00   11122345788889999999999999999999998


Q ss_pred             hccc
Q 023808          227 KNIR  230 (277)
Q Consensus       227 ~~~~  230 (277)
                      ++++
T Consensus       396 ~l~~  399 (400)
T cd05105         396 SLLP  399 (400)
T ss_pred             HHcC
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=270.89  Aligned_cols=197  Identities=26%  Similarity=0.397  Sum_probs=168.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++|+||||+.++++|+...+.++|+|||.| +|..+|    .....++++.+..++.+++.||.|||+.   +|+|||
T Consensus        54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd  125 (808)
T KOG0597|consen   54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRD  125 (808)
T ss_pred             HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---Cccccc
Confidence            57899999999999999999999999999977 999999    5667899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      +||.|||++.++.+|++|||+|+.+..+ +.......||+-|||||...+..|+..+|.||+||++||+.+|++||... 
T Consensus       126 ~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-  203 (808)
T KOG0597|consen  126 MKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-  203 (808)
T ss_pred             CCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-
Confidence            9999999999999999999999987653 34456678999999999999999999999999999999999999998642 


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                           ...+.+..+..+..          ..+......+..++...+..||.+|-+..+++.
T Consensus       204 -----si~~Lv~~I~~d~v----------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  204 -----SITQLVKSILKDPV----------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -----HHHHHHHHHhcCCC----------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                 22333333332211          123344556888888899999999999998864

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-38  Score=263.15  Aligned_cols=211  Identities=27%  Similarity=0.413  Sum_probs=165.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC--------------------CCCccCCHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT--------------------KANIKLNWEKRSDICVG   61 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~~~i~~q   61 (277)
                      +|++++||||++++++|..++..++||||+.+|+|.+++....                    .....+++..++.++.|
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~  135 (290)
T cd05045          56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ  135 (290)
T ss_pred             HHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence            4678899999999999999999999999999999999985422                    11235789999999999


Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccce
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      ++.||+|||+.   +++||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||
T Consensus       136 i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di  212 (290)
T cd05045         136 ISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV  212 (290)
T ss_pred             HHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHH
Confidence            99999999999   9999999999999999999999999999865332221 1222345678999999988889999999


Q ss_pred             EehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          141 YSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       141 ~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      ||||+++|||++ |..||......   .+    +........     ...   +......+.+++.+||+.+|.+||++.
T Consensus       213 ~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~-----~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~  277 (290)
T cd05045         213 WSFGVLLWEIVTLGGNPYPGIAPE---RL----FNLLKTGYR-----MER---PENCSEEMYNLMLTCWKQEPDKRPTFA  277 (290)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhCCCC-----CCC---CCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            999999999999 88887543221   11    111111110     011   112223577888999999999999999


Q ss_pred             HHHHHHhhccc
Q 023808          220 QVIKMLTKNIR  230 (277)
Q Consensus       220 ~v~~~L~~~~~  230 (277)
                      ++++.|++++.
T Consensus       278 ~i~~~l~~~~~  288 (290)
T cd05045         278 DISKELEKMMV  288 (290)
T ss_pred             HHHHHHHHHHh
Confidence            99999998765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-38  Score=260.81  Aligned_cols=205  Identities=25%  Similarity=0.301  Sum_probs=160.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+.||+|.+++...  ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~d  120 (277)
T cd05607          46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRD  120 (277)
T ss_pred             HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEcc
Confidence            577899999999999999999999999999999999888432  334588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.++|+|||++.......  ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         121 MKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             CChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999999999988664432  2233568899999999988889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      .....  ............     .....    .....+.+++..||+.||++||++.|+++.
T Consensus       199 ~~~~~--~~~~~~~~~~~~-----~~~~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         199 EKVAK--EELKRRTLEDEV-----KFEHQ----NFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             chhhH--HHHHHHhhcccc-----ccccc----cCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            22111  111111111110     00001    122347788888999999999999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-38  Score=265.63  Aligned_cols=209  Identities=26%  Similarity=0.411  Sum_probs=163.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||++++|+|..+ ..++|+||+.+|+|.+++..   ....+++..+++++.|++.||+|||+.   +++|||
T Consensus        62 ~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~d  134 (316)
T cd05108          62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRD  134 (316)
T ss_pred             HHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---Ceeccc
Confidence            46788999999999999875 46789999999999999853   234588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||++++++.+||+|||+++.+....... .....++..|+|||++.+..++.++||||||+++|||++ |..|+..
T Consensus       135 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         135 LAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             cchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999998765432221 122234668999999998899999999999999999998 8888754


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ....   ...    .........    +    .++.....+.+++.+||+.+|.+||++.+++..|.++.+..
T Consensus       215 ~~~~---~~~----~~~~~~~~~----~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         215 IPAS---EIS----SILEKGERL----P----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCHH---HHH----HHHhCCCCC----C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            3211   111    111111110    0    01122234778888999999999999999999998887644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-38  Score=260.79  Aligned_cols=207  Identities=26%  Similarity=0.464  Sum_probs=163.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC----------CCCccCCHHHHHHHHHHHHHHHHHhhc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT----------KANIKLNWEKRSDICVGIAKGLAFLHE   71 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~LH~   71 (277)
                      +|++++||||+++++++......++||||+.+|+|.+++....          .....+++..+..++.|++.||+|||+
T Consensus        61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~  140 (280)
T cd05049          61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS  140 (280)
T ss_pred             HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            4678999999999999999999999999999999999996432          223457899999999999999999999


Q ss_pred             CCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           72 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        72 ~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                      .   +++|+||||+||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||
T Consensus       141 ~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~  217 (280)
T cd05049         141 Q---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI  217 (280)
T ss_pred             C---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence            9   999999999999999999999999999976433221 112233456789999999999999999999999999999


Q ss_pred             Hh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          151 IS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ++ |..||......   ......    ..+...        ..+......+.+++.+||+.+|.+||++.||++.|+
T Consensus       218 ~~~g~~p~~~~~~~---~~~~~~----~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         218 FTYGKQPWYGLSNE---EVIECI----TQGRLL--------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HhcCCCCCCCCCHH---HHHHHH----HcCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            98 98887543321   111111    111110        111122344788889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-38  Score=266.24  Aligned_cols=199  Identities=26%  Similarity=0.347  Sum_probs=155.5

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +.++ +||||+++++++...+..++||||+++|+|..++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        49 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrD  121 (327)
T cd05617          49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRD  121 (327)
T ss_pred             HHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            3455 69999999999999999999999999999999883    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++..... ........||..|+|||++.+..++.++||||||+++|||++|..||....
T Consensus       122 lkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~  200 (327)
T cd05617         122 LKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT  200 (327)
T ss_pred             CCHHHEEEeCCCCEEEeccccceeccCC-CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence            9999999999999999999998753221 112334568999999999999899999999999999999999999986433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .........+..........      .++   ......+.+++.+||+.||.+|+++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~------~~p---~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         201 DNPDMNTEDYLFQVILEKPI------RIP---RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCcccccHHHHHHHHHhCCC------CCC---CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            22221222222222221111      111   1122346788888999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-38  Score=257.22  Aligned_cols=205  Identities=23%  Similarity=0.382  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.. ...++||||+++|+|.+++..   ....+++..+++++.|++.||+|||+.   +++|+|
T Consensus        48 ~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  120 (257)
T cd05115          48 IMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRD  120 (257)
T ss_pred             HHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---Ceeecc
Confidence            4678999999999999864 477899999999999999842   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee--eeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++..........  ....++..|+|||.+....++.++||||||+++||+++ |..||.
T Consensus       121 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  200 (257)
T cd05115         121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK  200 (257)
T ss_pred             cchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence            999999999999999999999986543322111  11223568999999988889999999999999999996 888876


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ......   ..    ........     ...   +......+.+++.+||..+|++||++.+|.+.|+..
T Consensus       201 ~~~~~~---~~----~~~~~~~~-----~~~---~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         201 KMKGPE---VM----SFIEQGKR-----LDC---PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             cCCHHH---HH----HHHHCCCC-----CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            543211   11    11111111     111   122234577788889999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-38  Score=261.36  Aligned_cols=208  Identities=24%  Similarity=0.382  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC------CccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------NIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      ++++++||||+++++++..+...++||||+.+|+|.+++......      ...+++..++.++.|++.||+|||+.   
T Consensus        62 ~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---  138 (277)
T cd05062          62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---  138 (277)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            467889999999999999999999999999999999998542211      22467889999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      +++|+||||+||++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |
T Consensus       139 ~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~  218 (277)
T cd05062         139 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA  218 (277)
T ss_pred             CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999998765432211 1122345678999999988889999999999999999999 6


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..||......   ....   ...... ..     ..   +......+.+++.+||+.+|++||++.++++.|++
T Consensus       219 ~~p~~~~~~~---~~~~---~~~~~~-~~-----~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         219 EQPYQGMSNE---QVLR---FVMEGG-LL-----DK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCCCHH---HHHH---HHHcCC-cC-----CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            7777543221   1111   111111 10     11   11222347788889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-38  Score=259.62  Aligned_cols=211  Identities=19%  Similarity=0.358  Sum_probs=167.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~d  131 (267)
T cd08228          55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRD  131 (267)
T ss_pred             HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCC
Confidence            46788999999999999999999999999999999999865444455689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+....
T Consensus       132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~  210 (267)
T cd08228         132 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             CCHHHEEEcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence            999999999999999999999887654321 1223457889999999988889999999999999999999999975432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ...    ............      +..  ........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       211 ~~~----~~~~~~~~~~~~------~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         211 MNL----FSLCQKIEQCDY------PPL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ccH----HHHHHHHhcCCC------CCC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            211    111111111110      111  0112334578888899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-38  Score=267.35  Aligned_cols=150  Identities=27%  Similarity=0.494  Sum_probs=132.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|..++..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+..  +++|+|
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~d  129 (333)
T cd06650          56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRD  129 (333)
T ss_pred             HHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecC
Confidence            4678999999999999999999999999999999999994    3346889999999999999999999742  799999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||++..+...   ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       130 lkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             CChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999998765332   123346889999999999888999999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=258.35  Aligned_cols=203  Identities=25%  Similarity=0.393  Sum_probs=159.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d  125 (256)
T cd05059          52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRD  125 (256)
T ss_pred             HHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            46789999999999999999999999999999999999843   233689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.+||+|||+++...+..........++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       126 l~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             ccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence            99999999999999999999998654332222222234457999999988889999999999999999999 78887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ....   .   .........      ....   ......+.+++.+||+.+|++||++.++++.|
T Consensus       206 ~~~~---~---~~~~~~~~~------~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         206 SNSE---V---VESVSAGYR------LYRP---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CHHH---H---HHHHHcCCc------CCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2211   1   111111111      1111   11233578888999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-38  Score=266.05  Aligned_cols=196  Identities=25%  Similarity=0.259  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||+++++++..++..++||||+.+|+|..++.    ....+++..+..++.||+.||+|||+.   +++|||
T Consensus        49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~D  121 (325)
T cd05604          49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRD  121 (325)
T ss_pred             HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecC
Confidence            3667899999999999999999999999999999999883    445789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......|+..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       122 lkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         122 LKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             CCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            99999999999999999999987532211 12234568999999999999899999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      ..   ..   .........       .+   .+.....+.+++.+|++.+|.+||++.+.
T Consensus       201 ~~---~~---~~~~~~~~~-------~~---~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         201 VA---EM---YDNILHKPL-------VL---RPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             HH---HH---HHHHHcCCc-------cC---CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            11   11   111111110       01   11122346788888999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-38  Score=257.21  Aligned_cols=204  Identities=27%  Similarity=0.401  Sum_probs=159.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.. +..++||||+.+|+|.+++.    ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        49 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~d  120 (257)
T cd05116          49 VMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRD  120 (257)
T ss_pred             HHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecc
Confidence            4678899999999999864 46789999999999999993    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++.........  .....++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus       121 lkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  200 (257)
T cd05116         121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK  200 (257)
T ss_pred             cchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998765433221  112234578999999988889999999999999999998 888886


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .....   ....   . ......     +..   +......+.+++.+||+.||.+||++.+|.+.|++.
T Consensus       201 ~~~~~---~~~~---~-i~~~~~-----~~~---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         201 GMKGN---EVTQ---M-IESGER-----MEC---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCHH---HHHH---H-HHCCCC-----CCC---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            54321   1111   1 111111     111   112233477888899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-38  Score=256.90  Aligned_cols=204  Identities=25%  Similarity=0.349  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|......++||||+.+++|.+++..   .+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~d  119 (252)
T cd05084          46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRD  119 (252)
T ss_pred             HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            46789999999999999999999999999999999999842   334588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus       120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~  199 (252)
T cd05084         120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN  199 (252)
T ss_pred             cchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999987544321111 111123456999999988889999999999999999998 7777654


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      .....   ...    .......     ...   +......+.+++.+||+.+|++||++.+|++.|+
T Consensus       200 ~~~~~---~~~----~~~~~~~-----~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         200 LSNQQ---TRE----AIEQGVR-----LPC---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCHHH---HHH----HHHcCCC-----CCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            32211   111    1111111     011   1122345778888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1e-38  Score=259.61  Aligned_cols=205  Identities=26%  Similarity=0.435  Sum_probs=163.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++......++||||+.+|+|.+++...  .+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~d  129 (261)
T cd05148          55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRD  129 (261)
T ss_pred             HHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            477899999999999999999999999999999999999542  345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |+|+||++++++.+||+|||++......... .....++..|++||.+....++.++||||||+++|+|++ |..||...
T Consensus       130 l~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         130 LAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             cCcceEEEcCCceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence            9999999999999999999999866433211 223345678999999988889999999999999999998 78887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..   .......   ......         ..+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus       209 ~~---~~~~~~~---~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         209 NN---HEVYDQI---TAGYRM---------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CH---HHHHHHH---HhCCcC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            31   1111111   111110         1112223447788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.3e-38  Score=268.70  Aligned_cols=202  Identities=18%  Similarity=0.208  Sum_probs=157.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||++||+|.+++..     ..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  167 (370)
T cd05596          96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRD  167 (370)
T ss_pred             HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            46788999999999999999999999999999999999842     3578889999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC----ccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|||++.++.+||+|||+++..............||+.|+|||++.+.    .++.++|||||||++|||++|+.||
T Consensus       168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  247 (370)
T cd05596         168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (370)
T ss_pred             CCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence            999999999999999999999986644332223445799999999988653    4788999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC--CCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~--RPs~~~v~~  223 (277)
                      ......      ..............  .+..    ......+.+++.+|++.+|.+  ||++.+++.
T Consensus       248 ~~~~~~------~~~~~i~~~~~~~~--~~~~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         248 YADSLV------GTYSKIMDHKNSLT--FPDD----IEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCCHH------HHHHHHHcCCCcCC--CCCc----CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            653321      11111111111100  0111    112234778888899999988  999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=260.93  Aligned_cols=207  Identities=24%  Similarity=0.389  Sum_probs=162.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC------CccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------NIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++......++||||+.+|+|.+++......      ...+++..++.++.|++.||+|||+.   
T Consensus        62 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---  138 (277)
T cd05032          62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---  138 (277)
T ss_pred             HHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            467889999999999999999999999999999999998543221      23478999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      +++|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++||++| |
T Consensus       139 ~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  218 (277)
T cd05032         139 KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA  218 (277)
T ss_pred             CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccC
Confidence            999999999999999999999999999886543321 12233446788999999988889999999999999999998 8


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ..|+.....   .......   . .....     ..+.   .....+.+++.+||+.+|++|||+.+++..|+
T Consensus       219 ~~p~~~~~~---~~~~~~~---~-~~~~~-----~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         219 EQPYQGLSN---EEVLKFV---I-DGGHL-----DLPE---NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCccCCH---HHHHHHH---h-cCCCC-----CCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            878754322   1111111   1 11111     1111   12345778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-38  Score=258.70  Aligned_cols=212  Identities=20%  Similarity=0.356  Sum_probs=167.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..+++|||+.+++|.+++......+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~d  131 (267)
T cd08229          55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRD  131 (267)
T ss_pred             HHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            46778999999999999999999999999999999999864444455789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus       132 l~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         132 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             CCHHHEEEcCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            999999999999999999999886644322 1223458889999999988889999999999999999999999975432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ...    .........      ...+...  .......+.+++.+||+.+|.+|||+.+|++.+++..
T Consensus       211 ~~~----~~~~~~~~~------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         211 MNL----YSLCKKIEQ------CDYPPLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             chH----HHHhhhhhc------CCCCCCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            211    111111110      0011110  1123345778888999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-39  Score=263.30  Aligned_cols=213  Identities=26%  Similarity=0.433  Sum_probs=162.0

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++...  ...++||||++|++|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H  132 (284)
T cd05079          59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVH  132 (284)
T ss_pred             HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence            47889999999999999875  578899999999999999842   233589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++.++.++|+|||+++.+......  ......++..|+|||++.+..++.++||||||+++|||+|+..|+
T Consensus       133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            999999999999999999999999876543221  122345667899999998888999999999999999999987664


Q ss_pred             CcccCcc--------hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          158 KAMWGQM--------NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       158 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .......        ..................        ..+......+.+++.+||+.+|.+||++.++++.|+++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         213 SSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL--------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccchhhhhcccccccccHHHHHHHHHcCccC--------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            3322110        000000111111111110        11122334588899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-38  Score=267.52  Aligned_cols=198  Identities=25%  Similarity=0.273  Sum_probs=157.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.++||||+++++++..++..++||||+.+|+|.+++.    ....+++..+..++.||+.||+|||+.   +++|||
T Consensus        49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrD  121 (325)
T cd05602          49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRD  121 (325)
T ss_pred             HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            3567899999999999999999999999999999999983    344688889999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       122 lkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (325)
T cd05602         122 LKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  200 (325)
T ss_pred             CCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999987543221 12334568999999999999899999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ....   ...... .      .+   .+.....+.+++.+|++.+|.+||++.+.+.
T Consensus       201 ~~---~~~~---~i~~~~-~------~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         201 TA---EMYD---NILNKP-L------QL---KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HH---HHHH---HHHhCC-c------CC---CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            21   1111   111111 0      01   1122234778888899999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=268.85  Aligned_cols=202  Identities=22%  Similarity=0.246  Sum_probs=160.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.+++..++||||+.+|+|.+++..    ...+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~D  126 (350)
T cd05573          54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRD  126 (350)
T ss_pred             HHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            46788999999999999999999999999999999999943    35789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC----------------------------cceeeeecccccccCccccccCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI----------------------------THITTRIAGTTGYLAPEYVLGGQ  133 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~  133 (277)
                      |||+||+++.++.+||+|||+++......                            ........||..|+|||++.+..
T Consensus       127 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  206 (350)
T cd05573         127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP  206 (350)
T ss_pred             CCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence            99999999999999999999998654432                            11223456899999999999999


Q ss_pred             cccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          134 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       134 ~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      ++.++|||||||++|||++|+.||.......      ...........  ...+....    ....+.+++.+|+. +|.
T Consensus       207 ~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~~--~~~p~~~~----~~~~~~~li~~ll~-dp~  273 (350)
T cd05573         207 YGLECDWWSLGVILYEMLYGFPPFYSDTLQE------TYNKIINWKES--LRFPPDPP----VSPEAIDLICRLLC-DPE  273 (350)
T ss_pred             CCCceeeEecchhhhhhccCCCCCCCCCHHH------HHHHHhccCCc--ccCCCCCC----CCHHHHHHHHHHcc-Chh
Confidence            9999999999999999999999986543211      11111110000  00111111    22347778888997 999


Q ss_pred             CCCC-HHHHHH
Q 023808          214 RRPQ-MNQVIK  223 (277)
Q Consensus       214 ~RPs-~~~v~~  223 (277)
                      +||+ +.++++
T Consensus       274 ~R~~s~~~ll~  284 (350)
T cd05573         274 DRLGSFEEIKS  284 (350)
T ss_pred             hcCCCHHHHhc
Confidence            9999 999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-38  Score=262.14  Aligned_cols=210  Identities=24%  Similarity=0.354  Sum_probs=155.3

Q ss_pred             cccccCCCccceeeEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            3 LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      |.+++||||++++++|.     .....++||||+. ++|.+++...  ....+++..+..++.|++.||+|||+.   ++
T Consensus        58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i  131 (290)
T cd07862          58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RV  131 (290)
T ss_pred             hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            34568999999999986     2446899999996 5999998532  234589999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||||||+|||++.++.+||+|||+++.....  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus       132 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f  209 (290)
T cd07862         132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF  209 (290)
T ss_pred             eeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence            99999999999999999999999999865433  2233456899999999998888999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccC---C-c------cccccCC----CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEE---K-P------LELVDPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~---~-~------~~~~~~~----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......   ....+.......   . .      .....+.    +....+.....+.+++.+|++.||++||++.++++
T Consensus       210 ~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         210 RGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCCCHHH---HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            7543211   111111110000   0 0      0000000    00011122334678899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-38  Score=243.89  Aligned_cols=212  Identities=25%  Similarity=0.356  Sum_probs=164.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      .|+.++|+||+.++++|-..+...||+||++. +|+.+++   .....++...+..++.++++||+|||++   .|+|||
T Consensus        54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRD  126 (318)
T KOG0659|consen   54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRD  126 (318)
T ss_pred             HHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhccc
Confidence            47789999999999999999999999999976 9999994   5666799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||.|+|++.+|.+||+|||+++.+.......... +-|.+|+|||.+.+. .|+...|+||.||++.||+-|.+-+.+.
T Consensus       127 lKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~  205 (318)
T KOG0659|consen  127 LKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD  205 (318)
T ss_pred             CCccceEEcCCCcEEeecccchhccCCCCcccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence            99999999999999999999999987665443333 678999999998885 6899999999999999999887644433


Q ss_pred             cCcchhhHHHHHHHHhccCCccc---------------cccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLE---------------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      .+-+.   ...+..........+               .-.+.+....+.+..+.++++..++..||.+|.++.|.++.
T Consensus       206 sDidQ---L~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  206 SDIDQ---LSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             chHHH---HHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            22211   111222111110000               00011122334445557889999999999999999998763

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.6e-39  Score=267.43  Aligned_cols=188  Identities=24%  Similarity=0.297  Sum_probs=151.7

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +||||+++++++...+..|+||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~N  126 (320)
T cd05590          54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDN  126 (320)
T ss_pred             CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHH
Confidence            79999999999999999999999999999999883    345689999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchh
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  166 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~  166 (277)
                      |+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   
T Consensus       127 Ili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---  202 (320)
T cd05590         127 VLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---  202 (320)
T ss_pred             eEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---
Confidence            999999999999999987532221 1233456899999999999888999999999999999999999998653321   


Q ss_pred             hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          167 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      ...   ..... ...      ..+.   .....+.+++.+||+.||.+||++
T Consensus       203 ~~~---~~i~~-~~~------~~~~---~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         203 DLF---EAILN-DEV------VYPT---WLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHH---HHHhc-CCC------CCCC---CCCHHHHHHHHHHcccCHHHCCCC
Confidence            111   11111 111      1111   122346788888999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.7e-38  Score=265.70  Aligned_cols=203  Identities=23%  Similarity=0.252  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+++..++||||+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~D  127 (330)
T cd05601          54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRD  127 (330)
T ss_pred             HHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccc
Confidence            45678999999999999999999999999999999999943   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc------cCccccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL------GGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+||+++.++.+||+|||++..+............||..|+|||++.      ...++.++|||||||++|||++|..
T Consensus       128 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~  207 (330)
T cd05601         128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS  207 (330)
T ss_pred             CchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence            9999999999999999999999876544333334456899999999986      4567889999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||.......      ..............  +..    +.....+.+++..|++ +|.+||++.+++.
T Consensus       208 Pf~~~~~~~------~~~~i~~~~~~~~~--~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         208 PFHEGTSAK------TYNNIMNFQRFLKF--PED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCCCHHH------HHHHHHcCCCccCC--CCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            986432211      11111111111110  111    1122346778888997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=257.99  Aligned_cols=196  Identities=24%  Similarity=0.386  Sum_probs=163.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.|+||||+.+|.+|++.+...+||||..+|.|++|+    ...+.+++.++..++.||++|+.|+|.+   +++|||
T Consensus       106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRD  178 (668)
T KOG0611|consen  106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRD  178 (668)
T ss_pred             HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecc
Confidence            578999999999999999999999999999999999999    4556799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||.+|||||.|+++||+|||++..+...  ..-.++.|++-|.+||++.+.+| .+..|-||||++||-|+.|..||...
T Consensus       179 LKLENILLD~N~NiKIADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~  256 (668)
T KOG0611|consen  179 LKLENILLDQNNNIKIADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR  256 (668)
T ss_pred             cchhheeecCCCCeeeeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence            9999999999999999999999987654  33456789999999999999887 47899999999999999999998764


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .+.   .+ +..+...   .|       ...-+..-+|++||-.+|++|.|+.+|..
T Consensus       257 Dhk---~lv---rQ-Is~GaYr---EP-------~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  257 DHK---RLV---RQ-ISRGAYR---EP-------ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             hHH---HHH---HH-hhccccc---CC-------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            321   111   11 1122111   11       11123556788899999999999999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=273.72  Aligned_cols=209  Identities=21%  Similarity=0.362  Sum_probs=168.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.|+|||+|+++|+|..+...|||+|||.+|+|-+||+...+  ..++....+.++.||++|++||..+   ++||||
T Consensus       316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRD  390 (1157)
T KOG4278|consen  316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRD  390 (1157)
T ss_pred             HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhh
Confidence            57889999999999999999999999999999999999965432  2467778889999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC-CCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~-~p~~~~  160 (277)
                      |..+|+|+.++..||++|||+++++..+.........-.+-|+|||-+....++.|+|||+||++|||+.|-. .|+...
T Consensus       391 LAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi  470 (1157)
T KOG4278|consen  391 LAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI  470 (1157)
T ss_pred             hhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence            9999999999999999999999998776544333333456799999999999999999999999999999854 343322


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .       ...++....++-..        +.+..+..++.+|++.||++.|.+||++.||.+.++..+.
T Consensus       471 d-------lSqVY~LLEkgyRM--------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  471 D-------LSQVYGLLEKGYRM--------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             c-------HHHHHHHHhccccc--------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            1       11122233322111        1233445568888999999999999999999999887764

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.1e-38  Score=260.67  Aligned_cols=212  Identities=26%  Similarity=0.413  Sum_probs=164.9

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      ++.+ +||||+++++++......++||||+.+|+|.+++.....            ....+++..++.++.|++.||+||
T Consensus        74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L  153 (304)
T cd05101          74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL  153 (304)
T ss_pred             HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence            5567 899999999999999999999999999999999964322            123578899999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++||||||+||++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|
T Consensus       154 H~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  230 (304)
T cd05101         154 ASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW  230 (304)
T ss_pred             HHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence            999   99999999999999999999999999998765432221 22234567899999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..|+....      ........ .......        .+......+.+++.+||+.+|.+||++.+|++.|++
T Consensus       231 el~~~g~~p~~~~~------~~~~~~~~-~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         231 EIFTLGGSPYPGIP------VEELFKLL-KEGHRMD--------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             HHHcCCCCCcccCC------HHHHHHHH-HcCCcCC--------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            9998 666664321      11111111 1111100        111223457788889999999999999999999999


Q ss_pred             ccccC
Q 023808          228 NIRLN  232 (277)
Q Consensus       228 ~~~~~  232 (277)
                      ++...
T Consensus       296 ~~~~~  300 (304)
T cd05101         296 ILTLT  300 (304)
T ss_pred             HHHhh
Confidence            87653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=257.10  Aligned_cols=208  Identities=26%  Similarity=0.380  Sum_probs=160.3

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|+++ +||||++++++|......++||||+.+|+|.+++.....            ....+++..++.++.|++.||+|
T Consensus        48 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~  127 (270)
T cd05047          48 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  127 (270)
T ss_pred             HHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHH
Confidence            45677 899999999999999999999999999999999854321            12357899999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||+.   +++|+||||+||++++++.+||+|||+++......  .......+..|+|||++....++.++||||||+++|
T Consensus       128 lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~  202 (270)
T cd05047         128 LSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  202 (270)
T ss_pred             HHHC---CEeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence            9998   99999999999999999999999999986322111  111122356799999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..||......   ...   .........      ..   +......+.+++.+||+.+|.+||++.+++..|++
T Consensus       203 el~~~g~~pf~~~~~~---~~~---~~~~~~~~~------~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         203 EIVSLGGTPYCGMTCA---ELY---EKLPQGYRL------EK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             HHHcCCCCCccccCHH---HHH---HHHhCCCCC------CC---CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            9997 88887543211   111   111111110      01   11122347789999999999999999999999987


Q ss_pred             cc
Q 023808          228 NI  229 (277)
Q Consensus       228 ~~  229 (277)
                      ++
T Consensus       268 ~~  269 (270)
T cd05047         268 ML  269 (270)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-38  Score=266.24  Aligned_cols=194  Identities=25%  Similarity=0.310  Sum_probs=154.9

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      .+||||+++++++..++..|+||||+++|+|..++.    ....+++..+..++.|++.||+|||+.   +++||||||+
T Consensus        53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~  125 (321)
T cd05591          53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLD  125 (321)
T ss_pred             cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence            389999999999999999999999999999999883    345689999999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcch
Q 023808           86 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  165 (277)
Q Consensus        86 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~  165 (277)
                      ||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||......  
T Consensus       126 Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--  202 (321)
T cd05591         126 NILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--  202 (321)
T ss_pred             HeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--
Confidence            9999999999999999987543221 1233456899999999999889999999999999999999999998653321  


Q ss_pred             hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-------CHHHHHH
Q 023808          166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-------QMNQVIK  223 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-------s~~~v~~  223 (277)
                       ...   ........       ..+..   ....+.+++..||+.+|++||       ++.++++
T Consensus       203 -~~~---~~i~~~~~-------~~p~~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         203 -DLF---ESILHDDV-------LYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -HHH---HHHHcCCC-------CCCCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             111   11111111       01111   123467888889999999999       6777753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-39  Score=262.73  Aligned_cols=201  Identities=24%  Similarity=0.364  Sum_probs=156.1

Q ss_pred             CccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCcc-CCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            1 MTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIK-LNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         1 ~~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      ++|++++|||||+++.+-.+.  +..|||+|||..|.+...     ...+. +++.++.+++.+++.||+|||.+   +|
T Consensus       160 ailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---gi  231 (576)
T KOG0585|consen  160 AILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GI  231 (576)
T ss_pred             HHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---Ce
Confidence            478999999999999998754  589999999999887543     34445 99999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCC----cceeeeecccccccCccccccCc----cccccceEehhHHHHH
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI----THITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLE  149 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~e  149 (277)
                      |||||||+|+||+++|++||+|||.+.......    ...-....||+.|+|||.+.++.    .+.+.||||+||+||-
T Consensus       232 iHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC  311 (576)
T KOG0585|consen  232 IHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC  311 (576)
T ss_pred             eccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence            999999999999999999999999998763321    11123367999999999988742    3578899999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |+.|+.||-....   ..+.+   . +....   +.-    ...++....+.+++.++|++||++|.+..+|..
T Consensus       312 llfG~~PF~~~~~---~~l~~---K-Ivn~p---L~f----P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  312 LLFGQLPFFDDFE---LELFD---K-IVNDP---LEF----PENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hhhccCCcccchH---HHHHH---H-HhcCc---ccC----CCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            9999999854321   11111   1 11111   111    112234556888999999999999999998854

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-37  Score=295.62  Aligned_cols=216  Identities=32%  Similarity=0.602  Sum_probs=173.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++|+|.+++..++||||+++|+|.++++       .++|..+.+++.|++.||+|||..+.++++|||
T Consensus       736 ~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d  808 (968)
T PLN00113        736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN  808 (968)
T ss_pred             HHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence            4678999999999999999999999999999999999993       278999999999999999999955444999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++..++. ||........     ....++..|+|||++.+..++.++|||||||++|||+||+.|+....
T Consensus       809 lkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~  882 (968)
T PLN00113        809 LSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF  882 (968)
T ss_pred             CCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence            99999999999888775 5655432211     22357899999999999899999999999999999999999985433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCC---CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELG---EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      .. ......|.............+++.+.   .....+..++++++.+||+.+|++||+|.||++.|+++.+.
T Consensus       883 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        883 GV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            32 23344454443333333344555442   33456777889999999999999999999999999987653

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.6e-38  Score=259.40  Aligned_cols=208  Identities=22%  Similarity=0.378  Sum_probs=161.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC------------CCCccCCHHHHHHHHHHHHHHHHHh
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------------KANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      ++++++||||+++++++......++++||+.+++|.+++....            .....+++..+++++.|++.||+||
T Consensus        61 ~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l  140 (283)
T cd05091          61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL  140 (283)
T ss_pred             HHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999999999999999984211            1123588899999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++||||||+||++++++.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|
T Consensus       141 H~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  217 (283)
T cd05091         141 SSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW  217 (283)
T ss_pred             HHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHH
Confidence            999   999999999999999999999999999886543221 1223344567899999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..|+.....   ...   ........ .        ...+......+.+++..||+.+|.+||++.+|+..|+.
T Consensus       218 el~~~g~~p~~~~~~---~~~---~~~i~~~~-~--------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         218 EVFSYGLQPYCGYSN---QDV---IEMIRNRQ-V--------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCCCCCCCCCH---HHH---HHHHHcCC-c--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            9998 7667654322   111   11111111 1        01112223347788889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-37  Score=256.61  Aligned_cols=215  Identities=22%  Similarity=0.416  Sum_probs=161.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC-------CccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------NIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++++|+||+++++++..++..++||||+.+|+|.+++......       ...+++..++.++.|++.||+|||+.  
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--  149 (296)
T cd05095          72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--  149 (296)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--
Confidence            467899999999999999999999999999999999998643211       23478889999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-  152 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-  152 (277)
                       +++|+||||+||+++.++.++|+|||+++.+...... ......++..|++||...++.++.++||||||+++|||++ 
T Consensus       150 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~  228 (296)
T cd05095         150 -NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL  228 (296)
T ss_pred             -CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence             9999999999999999999999999999865432211 1222334678999999888889999999999999999998 


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                       |..|+.......   .............. ....+.    +......+.+++.+||+.||.+||++.+|++.|++
T Consensus       229 ~~~~p~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         229 CKEQPYSQLSDEQ---VIENTGEFFRDQGR-QVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CCCCCccccChHH---HHHHHHHHHhhccc-cccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             556665432211   11111111111100 000111    11122457788889999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1e-37  Score=254.74  Aligned_cols=211  Identities=22%  Similarity=0.373  Sum_probs=155.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||++++++|.+....++||||+++|+|.+++..........++..+..++.|++.||+|||+.   +++|+|
T Consensus        48 ~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d  124 (268)
T cd05086          48 PYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSD  124 (268)
T ss_pred             HHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            35678999999999999999999999999999999999965433334567778889999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCcccccc-------CccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+||+++.++.++|+|||++....... ........++..|+|||++..       ..++.++||||||+++|||+++
T Consensus       125 ikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~  204 (268)
T cd05086         125 LALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFEN  204 (268)
T ss_pred             CccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhC
Confidence            99999999999999999999986432211 111233457889999998743       2457899999999999999985


Q ss_pred             -CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          154 -RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       154 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                       ..|+.....   ...   ....... ......++.+.....   ..+.+++..|| .+|.+||++.+|++.|.
T Consensus       205 ~~~p~~~~~~---~~~---~~~~~~~-~~~~~~~~~~~~~~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         205 AAQPYSHLSD---REV---LNHVIKD-QQVKLFKPQLELPYS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCCCCCCH---HHH---HHHHHhh-cccccCCCccCCCCc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             456543221   111   1111111 112223333322222   34566777799 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=268.24  Aligned_cols=198  Identities=27%  Similarity=0.409  Sum_probs=152.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..++..++||||+++|+|.+..        ...+..+..++.||+.||+|||+.   +++|||
T Consensus       125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  193 (353)
T PLN00034        125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRD  193 (353)
T ss_pred             HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecC
Confidence            467899999999999999999999999999999986532        345778889999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+|||+++++.+||+|||+++.+..... ......||..|+|||++..     ...+.++|||||||++|||++|+.|
T Consensus       194 lkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p  272 (353)
T PLN00034        194 IKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP  272 (353)
T ss_pred             CCHHHEEEcCCCCEEEcccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999986543221 1234568999999998743     2245689999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |...........   .........      +   .........+.+++.+||+.||++||++.||++
T Consensus       273 f~~~~~~~~~~~---~~~~~~~~~------~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        273 FGVGRQGDWASL---MCAICMSQP------P---EAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCCCCccHHHH---HHHHhccCC------C---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            873322111111   111111110      1   111222345788888999999999999999976

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-38  Score=268.72  Aligned_cols=211  Identities=24%  Similarity=0.329  Sum_probs=153.8

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++....     ..|+||||+. ++|.+++.    .+..+++..+..++.|++.||+|||+.   +
T Consensus        52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~  123 (338)
T cd07859          52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---N  123 (338)
T ss_pred             HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            467899999999999986432     5799999995 68999883    344689999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCcccccc--CccccccceEehhHHHHHHHh
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~ellt  152 (277)
                      ++||||||+|||++.++.+||+|||+++.......  .......|+..|+|||++.+  ..++.++|||||||++|||+|
T Consensus       124 ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t  203 (338)
T cd07859         124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT  203 (338)
T ss_pred             eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence            99999999999999999999999999986433211  11234568999999998866  578999999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHh-----------ccCCccc---cccC----CCCCCCHHHHHHHHHHHHhhhhhhhcC
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLH-----------QEEKPLE---LVDP----ELGEYPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~----~~~~~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      |+.||........   ........           .......   .+..    .+....+.....+.+++.+||+.+|++
T Consensus       204 g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  280 (338)
T cd07859         204 GKPLFPGKNVVHQ---LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD  280 (338)
T ss_pred             CCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence            9999864332110   00000000           0000000   0000    000000112234678899999999999


Q ss_pred             CCCHHHHHH
Q 023808          215 RPQMNQVIK  223 (277)
Q Consensus       215 RPs~~~v~~  223 (277)
                      ||++.++++
T Consensus       281 Rpt~~e~l~  289 (338)
T cd07859         281 RPTAEEALA  289 (338)
T ss_pred             CCCHHHHhc
Confidence            999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.1e-38  Score=267.26  Aligned_cols=203  Identities=21%  Similarity=0.282  Sum_probs=154.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrD  126 (381)
T cd05626          54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRD  126 (381)
T ss_pred             HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecC
Confidence            4678899999999999999999999999999999999984    344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc----------------------------------------------ceee
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT----------------------------------------------HITT  115 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------~~~~  115 (277)
                      |||+|||++.++.+||+|||+++.+.....                                              ....
T Consensus       127 lKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (381)
T cd05626         127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH  206 (381)
T ss_pred             CcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence            999999999999999999999764311000                                              0012


Q ss_pred             eecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHH
Q 023808          116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN  195 (277)
Q Consensus       116 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (277)
                      ...||..|+|||++.+..++.++|||||||++|||+||..||........      ............  -+......+ 
T Consensus       207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~--~~~~~~~s~-  277 (381)
T cd05626         207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET------QLKVINWENTLH--IPPQVKLSP-  277 (381)
T ss_pred             cccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccC--CCCCCCCCH-
Confidence            34689999999999888899999999999999999999999875432211      111111111000  011111222 


Q ss_pred             HHHHHHHHHHh--hhhhhhcCCCCHHHHHH
Q 023808          196 EIIRYMKVAFF--CTQAAASRRPQMNQVIK  223 (277)
Q Consensus       196 ~~~~~~~l~~~--c~~~~p~~RPs~~~v~~  223 (277)
                         .+.+++.+  |+..++..||++.+++.
T Consensus       278 ---~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         278 ---EAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             ---HHHHHHHHHccCcccccCCCCHHHHhc
Confidence               35555555  56667777999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=256.96  Aligned_cols=201  Identities=27%  Similarity=0.404  Sum_probs=159.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++|+||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        57 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~d  129 (263)
T cd06625          57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRD  129 (263)
T ss_pred             HHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            4678999999999999999999999999999999999984    334688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee--eeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |+|+||+++.++.++|+|||+++..........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       130 l~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             CCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            999999999999999999999876543211111  234577889999999998899999999999999999999999765


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....     . ..........     ..+   +......+.+++.+||..+|.+||++.+++.
T Consensus       210 ~~~~~-----~-~~~~~~~~~~-----~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         210 FEAMA-----A-IFKIATQPTN-----PQL---PSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             cchHH-----H-HHHHhccCCC-----CCC---CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            32211     1 1111111111     111   1222334777888899999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-38  Score=256.12  Aligned_cols=201  Identities=27%  Similarity=0.383  Sum_probs=161.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++...  .+..+++..++.++.|++.||.|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~d  126 (256)
T cd08529          52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRD  126 (256)
T ss_pred             HHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            467899999999999999999999999999999999999642  245689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||+++.+..... ......|+..|+|||++.+..++.++|+||||+++++|++|+.||....
T Consensus       127 l~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         127 IKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             CCcceEEEeCCCCEEEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999886654322 1233457889999999998889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .   .....   .... ...        ..........+.+++.+||+.+|++||++.++++
T Consensus       206 ~---~~~~~---~~~~-~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         206 Q---GALIL---KIIR-GVF--------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             H---HHHHH---HHHc-CCC--------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            1   11111   1111 111        1111122345788889999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.9e-38  Score=261.47  Aligned_cols=211  Identities=25%  Similarity=0.419  Sum_probs=163.1

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      |+++ +||||++++++|..+...++||||+.+|+|.+++.....            ....+++..+.+++.|++.||.||
T Consensus        71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  150 (314)
T cd05099          71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL  150 (314)
T ss_pred             HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence            5566 699999999999999999999999999999999964321            224589999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++|+||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|
T Consensus       151 H~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  227 (314)
T cd05099         151 ESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW  227 (314)
T ss_pred             HHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence            999   9999999999999999999999999999865432111 111223446799999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..||.....   ......    .......        ..+......+.+++.+||+.+|++||++.++++.|.+
T Consensus       228 el~~~g~~p~~~~~~---~~~~~~----~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         228 EIFTLGGSPYPGIPV---EELFKL----LREGHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             HHHhCCCCCCCCCCH---HHHHHH----HHcCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            9999 7777754321   111111    1111110        1111223357788899999999999999999999998


Q ss_pred             cccc
Q 023808          228 NIRL  231 (277)
Q Consensus       228 ~~~~  231 (277)
                      +...
T Consensus       293 ~~~~  296 (314)
T cd05099         293 VLAA  296 (314)
T ss_pred             HHHH
Confidence            7653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.2e-38  Score=256.46  Aligned_cols=209  Identities=23%  Similarity=0.376  Sum_probs=160.1

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++...      ...++||||+.+|+|.+++....  .....+++..++.++.|++.||+|||+. 
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-  131 (272)
T cd05075          53 CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-  131 (272)
T ss_pred             HHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            46788999999999988632      25689999999999999874321  2334589999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                        +++||||||+||++++++.+||+|||+++.+....... .....++..|++||...+..++.++||||||+++|||++
T Consensus       132 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~  209 (272)
T cd05075         132 --SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT  209 (272)
T ss_pred             --CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence              99999999999999999999999999998765432211 122345678999999998889999999999999999999


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                       |..||.....   ....    ..........        .++.....+.+++.+||+.+|++||++.+|++.|+++
T Consensus       210 ~g~~p~~~~~~---~~~~----~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         210 RGQTPYPGVEN---SEIY----DYLRQGNRLK--------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCCCCH---HHHH----HHHHcCCCCC--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             7777754221   1111    1111111110        1112233478888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7e-38  Score=257.71  Aligned_cols=208  Identities=25%  Similarity=0.445  Sum_probs=161.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC-------------CCCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT-------------KANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|++++||||+++++++..+...++||||+.+|+|.+++....             .....+++..++.++.|++.||+|
T Consensus        60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  139 (283)
T cd05090          60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY  139 (283)
T ss_pred             HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            5788999999999999999999999999999999999984221             112357899999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ||+.   +++|+||||+||++++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++
T Consensus       140 lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il  216 (283)
T cd05090         140 LSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL  216 (283)
T ss_pred             HHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence            9999   999999999999999999999999999986533221 112233456789999999888899999999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |||++ |..||.....   .....    .........     .   +......+.+++.+||+.+|.+||++.+|++.|.
T Consensus       217 ~el~~~g~~p~~~~~~---~~~~~----~~~~~~~~~-----~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         217 WEIFSFGLQPYYGFSN---QEVIE----MVRKRQLLP-----C---SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHcCCCCCCCCCCH---HHHHH----HHHcCCcCC-----C---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            99998 8878754321   11111    111111110     1   1112234777888899999999999999999886


Q ss_pred             h
Q 023808          227 K  227 (277)
Q Consensus       227 ~  227 (277)
                      .
T Consensus       282 ~  282 (283)
T cd05090         282 S  282 (283)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4e-38  Score=265.02  Aligned_cols=212  Identities=25%  Similarity=0.402  Sum_probs=163.0

Q ss_pred             ccccc-cCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCCC---------------------------------
Q 023808            2 TLSNV-RHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKA---------------------------------   46 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------   46 (277)
                      ++.++ +|+||++++++|... ...+++|||+.+|+|.+++......                                 
T Consensus        63 ~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (337)
T cd05054          63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSS  142 (337)
T ss_pred             HHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccc
Confidence            35567 899999999988754 5678999999999999998532211                                 


Q ss_pred             ------------------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeeccc
Q 023808           47 ------------------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  102 (277)
Q Consensus        47 ------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~  102 (277)
                                              ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~  219 (337)
T cd05054         143 ASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGL  219 (337)
T ss_pred             cccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEecccc
Confidence                                    13688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCC
Q 023808          103 AKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK  180 (277)
Q Consensus       103 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  180 (277)
                      ++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......  ...    .......
T Consensus       220 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~  293 (337)
T cd05054         220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGT  293 (337)
T ss_pred             chhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccC
Confidence            98764332221 223445678999999999999999999999999999998 888875432211  111    1111111


Q ss_pred             ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ...        .+......+.+++.+||+.+|++||++.+|++.|++++.
T Consensus       294 ~~~--------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         294 RMR--------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             CCC--------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            100        111223457888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.8e-38  Score=255.32  Aligned_cols=206  Identities=28%  Similarity=0.449  Sum_probs=162.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~d  131 (267)
T cd05066          58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRD  131 (267)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehh
Confidence            46788999999999999999999999999999999999943   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceee--eecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.++|+|||+++.+.........  ...++..|++||.+.+..++.++|+||||+++||+++ |..||.
T Consensus       132 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~  211 (267)
T cd05066         132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  211 (267)
T ss_pred             hchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence            9999999999999999999999876543322211  1223467999999998889999999999999999886 888875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ......   .....    ......    +.    .......+.+++.+||+.+|.+||++.++++.|+++
T Consensus       212 ~~~~~~---~~~~~----~~~~~~----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         212 EMSNQD---VIKAI----EEGYRL----PA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             cCCHHH---HHHHH----hCCCcC----CC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            433211   11111    111100    11    111223477888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-38  Score=254.05  Aligned_cols=204  Identities=25%  Similarity=0.411  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.. +..++||||+.+|+|.+++..    +..+++..++.++.|++.||+|||..   +++|+|
T Consensus        49 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~d  120 (257)
T cd05060          49 VMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRD  120 (257)
T ss_pred             HHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccC
Confidence            4678899999999998864 467999999999999999943    33689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee--eeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++..........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       121 i~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~  200 (257)
T cd05060         121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG  200 (257)
T ss_pred             cccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999999999986644332211  12223467999999988889999999999999999998 888876


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ....   .......    .......        .+......+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       201 ~~~~---~~~~~~~----~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         201 EMKG---AEVIAML----ESGERLP--------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCH---HHHHHHH----HcCCcCC--------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            5432   1122211    1111110        1112224577889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.3e-38  Score=260.27  Aligned_cols=211  Identities=20%  Similarity=0.299  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+ +|.+++..   .+..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~d  128 (288)
T cd07871          56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRD  128 (288)
T ss_pred             HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            46789999999999999999999999999975 89998842   334578999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         129 LKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             CCHHHEEECCCCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999976433221 1223457889999998865 46889999999999999999999998653


Q ss_pred             cCcchhhHHHHHHHHhccC------------CccccccCCCC-----CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEE------------KPLELVDPELG-----EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~-----~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ...........            .......+...     ...+.......+++.+|++.||.+|||+.|+++
T Consensus       208 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         208 TVKEE---LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CHHHH---HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            32211   11111111000            00000000000     001112234678899999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.1e-38  Score=262.07  Aligned_cols=212  Identities=26%  Similarity=0.408  Sum_probs=163.8

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      ++++ +||||+++++++..++..++||||+.+|+|.+++.....            ....+++..+++++.|++.||+||
T Consensus        77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  156 (307)
T cd05098          77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL  156 (307)
T ss_pred             HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence            4566 799999999999999999999999999999999965322            123589999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++|+||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|
T Consensus       157 H~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~  233 (307)
T cd05098         157 ASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW  233 (307)
T ss_pred             HHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence            999   9999999999999999999999999998765432111 112223456899999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..||.....   ....   .. .......        ..+......+.+++.+||+.+|.+||++.+|++.|++
T Consensus       234 el~~~g~~p~~~~~~---~~~~---~~-~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         234 EIFTLGGSPYPGVPV---EELF---KL-LKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             HHHcCCCCCCCcCCH---HHHH---HH-HHcCCCC--------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            9998 7777643221   1111   11 1111110        1112223457788899999999999999999999999


Q ss_pred             ccccC
Q 023808          228 NIRLN  232 (277)
Q Consensus       228 ~~~~~  232 (277)
                      ++...
T Consensus       299 ~~~~~  303 (307)
T cd05098         299 ILALT  303 (307)
T ss_pred             HHHHh
Confidence            87643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-38  Score=255.13  Aligned_cols=196  Identities=23%  Similarity=0.335  Sum_probs=152.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+++|+|..++..   ....+++..+++++.|++.||+|||+.   +++|||
T Consensus        57 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  130 (262)
T cd05077          57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGN  130 (262)
T ss_pred             HHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCC
Confidence            46788999999999999999999999999999999998842   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc-------eEEeecccccccCCCCcceeeeecccccccCccccc-cCccccccceEehhHHHHHHHh-
Q 023808           82 IKASNILLDQEFN-------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIIS-  152 (277)
Q Consensus        82 ikp~Nill~~~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~ellt-  152 (277)
                      |||+||+++.++.       ++++|||++......     ....++..|+|||.+. +..++.++||||||+++|||++ 
T Consensus       131 lkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~  205 (262)
T cd05077         131 VCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN  205 (262)
T ss_pred             CCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence            9999999986654       899999998754322     2345778899999886 4568899999999999999984 


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      |..|+.......   ..    .......  ..    ..    .....+.+++.+||+.||.+||++.+|++.+
T Consensus       206 ~~~p~~~~~~~~---~~----~~~~~~~--~~----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         206 GEIPLKDKTLAE---KE----RFYEGQC--ML----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CCCCCCCcchhH---HH----HHHhcCc--cC----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            666654322111   00    0011100  00    01    1123477888899999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.2e-38  Score=253.00  Aligned_cols=204  Identities=27%  Similarity=0.380  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++......++||||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+|
T Consensus        45 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~d  118 (250)
T cd05085          45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRD  118 (250)
T ss_pred             HHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            46788999999999999999999999999999999999843   233578999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |+|+||+++.++.+||+|||+++..............++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus       119 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             cChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999987544332222222334567999999988889999999999999999998 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ....   ...   ........      .   .+......+.+++.+||+.+|++||++.++++.|.
T Consensus       199 ~~~~---~~~---~~~~~~~~------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         199 TNQQ---ARE---QVEKGYRM------S---CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHH---HHH---HHHcCCCC------C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2211   111   11111110      1   11122345788899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-38  Score=262.64  Aligned_cols=197  Identities=25%  Similarity=0.307  Sum_probs=156.1

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +.++ +||||+++++++...+..++||||+.+|+|..++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        49 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~d  121 (318)
T cd05570          49 LALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRD  121 (318)
T ss_pred             HHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccC
Confidence            3444 79999999999999999999999999999999883    344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       122 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~  200 (318)
T cd05570         122 LKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD  200 (318)
T ss_pred             CCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999987532221 12234568999999999999999999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH-----HHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM-----NQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~-----~~v~~  223 (277)
                      .   .....   .... ...      ..+   ......+.+++.+||+.||.+||++     .+++.
T Consensus       201 ~---~~~~~---~i~~-~~~------~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         201 E---DELFQ---SILE-DEV------RYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             H---HHHHH---HHHc-CCC------CCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1   11111   1111 111      111   1122347788889999999999999     76654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-38  Score=257.23  Aligned_cols=197  Identities=26%  Similarity=0.378  Sum_probs=153.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||++++++|.++...++||||+++|+|..++..   ....+++..+++++.|++.||+|||+.   +++|||
T Consensus        69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~d  142 (274)
T cd05076          69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGN  142 (274)
T ss_pred             HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCC
Confidence            46789999999999999999999999999999999999842   344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC-------ceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHH-h
Q 023808           82 IKASNILLDQEF-------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEII-S  152 (277)
Q Consensus        82 ikp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ell-t  152 (277)
                      |||+||+++..+       .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +
T Consensus       143 lkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         143 VCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             CCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999997543       3799999987643221     22346788999998865 56899999999999999995 6


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |..|+.......   .....    ....       ....   .....+.+++.+||+.+|++||++.+|++.|.
T Consensus       218 g~~p~~~~~~~~---~~~~~----~~~~-------~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPSE---KERFY----EKKH-------RLPE---PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChHH---HHHHH----Hhcc-------CCCC---CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            888875433211   11111    1000       0101   11124778889999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-37  Score=266.33  Aligned_cols=202  Identities=21%  Similarity=0.264  Sum_probs=153.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrD  126 (376)
T cd05598          54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRD  126 (376)
T ss_pred             HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCC
Confidence            4678999999999999999999999999999999999994    344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC------------------------------------------cceeeeecc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI------------------------------------------THITTRIAG  119 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~g  119 (277)
                      |||+|||++.++.+||+|||++..+....                                          ........|
T Consensus       127 lkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  206 (376)
T cd05598         127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVG  206 (376)
T ss_pred             CCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCC
Confidence            99999999999999999999975321000                                          000113468


Q ss_pred             cccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHH
Q 023808          120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR  199 (277)
Q Consensus       120 t~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (277)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||........      ...........  ..+......+    .
T Consensus       207 t~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~--~~~~~~~~s~----~  274 (376)
T cd05598         207 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET------QLKVINWETTL--HIPSQAKLSR----E  274 (376)
T ss_pred             CccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHH------HHHHhccCccc--cCCCCCCCCH----H
Confidence            9999999999998999999999999999999999999875433211      11111111110  0111111222    3


Q ss_pred             HHHHHHhhhhhhhcCCC---CHHHHHH
Q 023808          200 YMKVAFFCTQAAASRRP---QMNQVIK  223 (277)
Q Consensus       200 ~~~l~~~c~~~~p~~RP---s~~~v~~  223 (277)
                      +.+++.+|+ .+|.+|+   ++.+++.
T Consensus       275 ~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         275 ASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             HHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            555666665 4999999   8888864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-37  Score=261.80  Aligned_cols=213  Identities=25%  Similarity=0.404  Sum_probs=165.1

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +++++ +||||++++++|..+...+++|||+.+|+|.+++.....            ....+++..++.++.|++.||+|
T Consensus        70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~  149 (334)
T cd05100          70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY  149 (334)
T ss_pred             HHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence            35677 799999999999999999999999999999999864321            22358899999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ||+.   +++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++
T Consensus       150 LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  226 (334)
T cd05100         150 LASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL  226 (334)
T ss_pred             HHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHH
Confidence            9999   9999999999999999999999999999865432211 12223345679999999988899999999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |||++ |..||.....      ........... ..        ..+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       227 ~el~~~g~~p~~~~~~------~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         227 WEIFTLGGSPYPGIPV------EELFKLLKEGH-RM--------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             HHHHhcCCCCCCCCCH------HHHHHHHHcCC-CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            99998 7777643221      11111111111 10        111122335778889999999999999999999999


Q ss_pred             hccccC
Q 023808          227 KNIRLN  232 (277)
Q Consensus       227 ~~~~~~  232 (277)
                      ++....
T Consensus       292 ~~~~~~  297 (334)
T cd05100         292 RVLTVT  297 (334)
T ss_pred             HHhhhc
Confidence            888644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-38  Score=264.58  Aligned_cols=194  Identities=24%  Similarity=0.324  Sum_probs=154.2

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      .++||||+++++++.+++..++||||+.+|+|..++.    .+..+++..+..++.|++.||+|||+.   +++||||||
T Consensus        52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp  124 (316)
T cd05620          52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKL  124 (316)
T ss_pred             ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCH
Confidence            3589999999999999999999999999999999983    345688999999999999999999999   999999999


Q ss_pred             CcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcc
Q 023808           85 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  164 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~  164 (277)
                      +||+++.++.++|+|||+++..... ........||..|+|||++.+..++.++|||||||++|||++|..||.....  
T Consensus       125 ~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--  201 (316)
T cd05620         125 DNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--  201 (316)
T ss_pred             HHeEECCCCCEEeCccCCCeecccC-CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--
Confidence            9999999999999999998743211 1223345689999999999998999999999999999999999999864321  


Q ss_pred             hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH-HHH
Q 023808          165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVI  222 (277)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~-~v~  222 (277)
                       .....    .....      .+.++..   ...++.+++.+||+.||.+||++. ++.
T Consensus       202 -~~~~~----~~~~~------~~~~~~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         202 -DELFE----SIRVD------TPHYPRW---ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -HHHHH----HHHhC------CCCCCCC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             11111    11111      1111111   223467788889999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.1e-38  Score=257.30  Aligned_cols=207  Identities=26%  Similarity=0.418  Sum_probs=160.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHhh
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-----------ANIKLNWEKRSDICVGIAKGLAFLH   70 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH   70 (277)
                      +|++++|+||+++++++......++||||+.+|+|.+++.....           ....+++..++.++.|++.||+|||
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  139 (280)
T cd05092          60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA  139 (280)
T ss_pred             HHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence            46788999999999999999999999999999999999864321           1134889999999999999999999


Q ss_pred             cCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHH
Q 023808           71 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE  149 (277)
Q Consensus        71 ~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  149 (277)
                      +.   +++|+||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++||
T Consensus       140 ~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  216 (280)
T cd05092         140 SL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE  216 (280)
T ss_pred             HC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence            99   9999999999999999999999999999765432211 1222335678999999998889999999999999999


Q ss_pred             HHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          150 IIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |++ |..||.......   ...   ..... ...     ...   ......+.+++.+||+.||.+||++.+|++.|+
T Consensus       217 l~~~g~~p~~~~~~~~---~~~---~~~~~-~~~-----~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         217 IFTYGKQPWYQLSNTE---AIE---CITQG-REL-----ERP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCCCCCCccCCHHH---HHH---HHHcC-ccC-----CCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            998 888875432211   111   11111 110     011   112234778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.7e-38  Score=261.11  Aligned_cols=212  Identities=26%  Similarity=0.373  Sum_probs=163.2

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +++++ +||||+++++++......++||||+++|+|.+++.....            ....+++..++.++.|++.||+|
T Consensus        55 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  134 (297)
T cd05089          55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQY  134 (297)
T ss_pred             HHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHH
Confidence            35677 799999999999999999999999999999999954221            12358899999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||+.   +++||||||+||++++++.+||+|||++.......  .......+..|+|||++.+..++.++||||||+++|
T Consensus       135 lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~  209 (297)
T cd05089         135 LSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW  209 (297)
T ss_pred             HHHC---CcccCcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence            9999   99999999999999999999999999986432111  111122345799999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++ |..||.......   ...   ... ...     ....   +......+.+++.+||+.+|.+||++.+|++.|++
T Consensus       210 el~t~g~~pf~~~~~~~---~~~---~~~-~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         210 EIVSLGGTPYCGMTCAE---LYE---KLP-QGY-----RMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             HHHcCCCCCCCCCCHHH---HHH---HHh-cCC-----CCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            9998 888886543211   111   111 110     0111   11122347788899999999999999999999998


Q ss_pred             ccccCc
Q 023808          228 NIRLNE  233 (277)
Q Consensus       228 ~~~~~~  233 (277)
                      ++....
T Consensus       275 ~~~~~~  280 (297)
T cd05089         275 MLEARK  280 (297)
T ss_pred             HHHhhc
Confidence            886553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=255.23  Aligned_cols=209  Identities=22%  Similarity=0.405  Sum_probs=161.9

Q ss_pred             ccccccCCCccceeeEEEeCCe------eEEEEeecCCCCHHHHhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTR------RILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      .|++++||||+++++++.....      .++||||+.+|+|..++....  .....+++..++.++.|++.||+|||+. 
T Consensus        54 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-  132 (273)
T cd05035          54 CMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-  132 (273)
T ss_pred             HHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4677899999999999876554      799999999999999985432  2234689999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                        +++|+||||+||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++
T Consensus       133 --~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~  210 (273)
T cd05035         133 --NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT  210 (273)
T ss_pred             --CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence              99999999999999999999999999998654432221 112234668999999988889999999999999999999


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                       |..||.....   .......   .. ....        ..+......+.+++.+||+.||.+||++.+|++.|+++
T Consensus       211 ~g~~p~~~~~~---~~~~~~~---~~-~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         211 RGQTPYPGVEN---HEIYDYL---RH-GNRL--------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCCCCH---HHHHHHH---Hc-CCCC--------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             7777754322   1111111   11 1111        11122334588888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-37  Score=265.12  Aligned_cols=202  Identities=19%  Similarity=0.246  Sum_probs=154.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||+++++++.+++..++||||+.+|+|.+++..     ..+++..+..++.||+.||+|||+.   +|+|||
T Consensus        96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrD  167 (370)
T cd05621          96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRD  167 (370)
T ss_pred             HHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            46678999999999999999999999999999999999832     2578899999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC----ccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|||++.++.+||+|||++...............||+.|+|||++.+.    .++.++|||||||++|||++|+.||
T Consensus       168 LKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf  247 (370)
T cd05621         168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF  247 (370)
T ss_pred             CCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence            999999999999999999999987654333233456799999999998754    3788999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC--CCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~--RPs~~~v~~  223 (277)
                      ......      ...............  +.    .......+.+++..|+..++.+  |+++.++++
T Consensus       248 ~~~~~~------~~~~~i~~~~~~~~~--p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         248 YADSLV------GTYSKIMDHKNSLNF--PE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             CCCCHH------HHHHHHHhCCcccCC--CC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            653221      111111111111110  10    0111233566777788755543  889998876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-37  Score=254.06  Aligned_cols=211  Identities=20%  Similarity=0.361  Sum_probs=168.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..++..++||||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~d  131 (267)
T cd08224          55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRD  131 (267)
T ss_pred             HHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            46788999999999999999999999999999999999865444556689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....
T Consensus       132 l~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08224         132 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             cChhhEEECCCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence            999999999999999999999886544321 1233457889999999988889999999999999999999999875432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCH-HHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP-NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ...    ....... ....        ....+. .....+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus       211 ~~~----~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         211 MNL----YSLCKKI-EKCD--------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ccH----HHHHhhh-hcCC--------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            211    1111111 1111        011111 23345778888999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=242.13  Aligned_cols=212  Identities=23%  Similarity=0.278  Sum_probs=165.1

Q ss_pred             ccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            4 SNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      ++++||||++++++...+.     ..|++++|+..|+|.+.+.....++..+++.+++.|+.++++||++||+.. ++++
T Consensus        73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yA  151 (302)
T KOG2345|consen   73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYA  151 (302)
T ss_pred             HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-Cccc
Confidence            4689999999999987544     489999999999999999877777778999999999999999999999983 3599


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCCcc--------eeeeecccccccCcccccc---CccccccceEehhHHH
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLV  147 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl  147 (277)
                      ||||||.|||+++.+.+++.|||.++...-....        .......|..|+|||.+.-   ...++++|||||||+|
T Consensus       152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL  231 (302)
T KOG2345|consen  152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL  231 (302)
T ss_pred             ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence            9999999999999999999999998754321111        0122357899999998854   4578999999999999


Q ss_pred             HHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |+|+.|..||+........             -......+.+ ..........+.+++.+|++.||.+||++.+++..++
T Consensus       232 Ya~mf~~sPfe~~~~~GgS-------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  232 YAMMFGESPFERIYQQGGS-------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             HHHHHcCCcchHHhhcCCe-------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            9999999998754331111             0111111111 0111124556889999999999999999999999887


Q ss_pred             hcc
Q 023808          227 KNI  229 (277)
Q Consensus       227 ~~~  229 (277)
                      ++.
T Consensus       299 ~Li  301 (302)
T KOG2345|consen  299 DLI  301 (302)
T ss_pred             hhc
Confidence            754

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-38  Score=266.45  Aligned_cols=202  Identities=22%  Similarity=0.271  Sum_probs=155.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.+++..++||||+.+|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~D  126 (364)
T cd05599          54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRD  126 (364)
T ss_pred             HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecc
Confidence            4678899999999999999999999999999999999984    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-------------------------------------eeeeeccccccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-------------------------------------ITTRIAGTTGYL  124 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------------------------------~~~~~~gt~~y~  124 (277)
                      |||+|||++.++.++|+|||+++.+......                                     ......||+.|+
T Consensus       127 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  206 (364)
T cd05599         127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI  206 (364)
T ss_pred             CCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc
Confidence            9999999999999999999998754321100                                     011245899999


Q ss_pred             CccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHH
Q 023808          125 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA  204 (277)
Q Consensus       125 aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  204 (277)
                      |||++....++.++|||||||++|||++|..||.......   .   .............  +.....    ...+.+++
T Consensus       207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~---~---~~~i~~~~~~~~~--~~~~~~----s~~~~~li  274 (364)
T cd05599         207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE---T---YRKIINWKETLQF--PDEVPL----SPEAKDLI  274 (364)
T ss_pred             CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH---H---HHHHHcCCCccCC--CCCCCC----CHHHHHHH
Confidence            9999998889999999999999999999999986543211   1   1111111111000  110111    22366777


Q ss_pred             HhhhhhhhcCCCC---HHHHHH
Q 023808          205 FFCTQAAASRRPQ---MNQVIK  223 (277)
Q Consensus       205 ~~c~~~~p~~RPs---~~~v~~  223 (277)
                      .+|+. +|.+|++   +.+++.
T Consensus       275 ~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         275 KRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHcc-CHhhcCCCCCHHHHhc
Confidence            77886 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-37  Score=253.95  Aligned_cols=207  Identities=29%  Similarity=0.454  Sum_probs=162.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+ ...++||||+.+|+|.+++...  .+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~d  127 (262)
T cd05071          54 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD  127 (262)
T ss_pred             HHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            4678899999999998754 5678999999999999999532  234578999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.++|+|||.++.+............++..|++||+..+..++.++||||||+++|||+| |..||...
T Consensus       128 l~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             cCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999998665433222233446678999999988889999999999999999999 77776543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ...   ....   ........         .........+.+++.+|++.+|++||++.++++.|++.+
T Consensus       208 ~~~---~~~~---~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         208 VNR---EVLD---QVERGYRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ChH---HHHH---HHhcCCCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            221   1111   11111100         111233445788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=252.24  Aligned_cols=207  Identities=29%  Similarity=0.445  Sum_probs=164.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC-----CccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-----NIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      ++++++|+||+++++++..+...++||||+.+++|.+++......     ...+++..++.++.|++.||+|||+.   +
T Consensus        49 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~  125 (262)
T cd00192          49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---K  125 (262)
T ss_pred             HHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---C
Confidence            367789999999999999999999999999999999999543221     36799999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR  154 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~  154 (277)
                      ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+....++.++||||||+++|||++ |.
T Consensus       126 i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  205 (262)
T cd00192         126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA  205 (262)
T ss_pred             cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999987654321 22334557889999999988889999999999999999999 58


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      .||.....   .....   .... ...     .   ..+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       206 ~p~~~~~~---~~~~~---~~~~-~~~-----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         206 TPYPGLSN---EEVLE---YLRK-GYR-----L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCCH---HHHHH---HHHc-CCC-----C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            88765422   11111   1111 111     0   111122345778888999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.8e-38  Score=260.22  Aligned_cols=211  Identities=26%  Similarity=0.371  Sum_probs=162.4

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|.++ +||||+++++++..++..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|
T Consensus        60 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~  139 (303)
T cd05088          60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  139 (303)
T ss_pred             HHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHH
Confidence            35677 899999999999999999999999999999999854321            12358899999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||+.   +++||||||+||+++.++.+||+|||+++.....  .......++..|+|||.+.+..++.++||||||+++|
T Consensus       140 LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  214 (303)
T cd05088         140 LSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  214 (303)
T ss_pred             HHhC---CccccccchheEEecCCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence            9999   9999999999999999999999999998642211  1111222456799999998888899999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||+| |..||......   ....   .. .....     ...   +......+.+++.+||+.+|.+||++.+++..|.+
T Consensus       215 ellt~g~~p~~~~~~~---~~~~---~~-~~~~~-----~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         215 EIVSLGGTPYCGMTCA---ELYE---KL-PQGYR-----LEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HHHhcCCCCcccCChH---HHHH---HH-hcCCc-----CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            9998 88887543221   1111   11 11100     001   11122347788899999999999999999999988


Q ss_pred             ccccC
Q 023808          228 NIRLN  232 (277)
Q Consensus       228 ~~~~~  232 (277)
                      ++...
T Consensus       280 ~~~~~  284 (303)
T cd05088         280 MLEER  284 (303)
T ss_pred             HHHhh
Confidence            76544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.5e-37  Score=253.85  Aligned_cols=211  Identities=26%  Similarity=0.414  Sum_probs=156.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++||||+++++++.+....++||||+++|+|.+++..... .....++..+..++.|++.||+|||+.   +++|+
T Consensus        48 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  124 (269)
T cd05087          48 PYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHS  124 (269)
T ss_pred             HHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEecc
Confidence            46788999999999999999999999999999999999854322 223467788889999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccC-------ccccccceEehhHHHHHHHh
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGG-------QLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~ellt  152 (277)
                      ||||+||+++.++.+||+|||+++......... .....++..|+|||++...       .++.++||||||+++|||++
T Consensus       125 dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  204 (269)
T cd05087         125 DLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE  204 (269)
T ss_pred             ccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence            999999999999999999999997543322211 1234567889999988542       35789999999999999996


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                       |..||.......   .....   . .........+.+......   .+.+++..|| .+|.+||++++|++.|+
T Consensus       205 ~g~~p~~~~~~~~---~~~~~---~-~~~~~~~~~~~~~~~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         205 LGSQPYRHLSDEQ---VLTYT---V-REQQLKLPKPRLKLPLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCCCCChHH---HHHHH---h-hcccCCCCCCccCCCCCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence             988886543221   11111   1 111112222222222223   3556667799 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=257.22  Aligned_cols=213  Identities=24%  Similarity=0.400  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC--------CCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------ANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++|+||+++++++..+...++||||+.+++|.+++.....        ....+++..++.++.|++.||+|||+. 
T Consensus        70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  148 (295)
T cd05097          70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-  148 (295)
T ss_pred             HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-
Confidence            46789999999999999999999999999999999999853211        112478899999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                        +++|+||||+||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       149 --~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~  226 (295)
T cd05097         149 --NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT  226 (295)
T ss_pred             --CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence              999999999999999999999999999986533221 11222345678999999988889999999999999999998


Q ss_pred             C--CCCCCcccCcchhhHHHHHHHHhcc-CCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 G--RNSGKAMWGQMNKFLLEWAWQLHQE-EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 g--~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      +  ..||.....   ............. ......      ..++.....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       227 ~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         227 LCKEQPYSLLSD---EQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             cCCCCCCcccCh---HHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            4  445543222   1111111111111 111000      011112235888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-38  Score=257.59  Aligned_cols=203  Identities=26%  Similarity=0.292  Sum_probs=159.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+|+|.+++..  .....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~d  127 (285)
T cd05605          53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRD  127 (285)
T ss_pred             HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecC
Confidence            46788999999999999999999999999999999988843  2234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||++++++.++|+|||+++.......  .....|+..|+|||++.+..++.++||||+|+++|||++|..||....
T Consensus       128 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~  205 (285)
T cd05605         128 LKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK  205 (285)
T ss_pred             CCHHHEEECCCCCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence            999999999999999999999986543221  223468899999999988889999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ....   ............         ...+......+.+++.+||+.||.+||     ++.+++.
T Consensus       206 ~~~~---~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         206 EKVK---REEVERRVKEDQ---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hhhH---HHHHHHHhhhcc---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            2111   111111111110         111122334477888899999999999     7777744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-37  Score=253.17  Aligned_cols=205  Identities=28%  Similarity=0.438  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||++++++++. .+..++||||+.+|+|.+++...  ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~d  127 (260)
T cd05069          54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRD  127 (260)
T ss_pred             HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecc
Confidence            467889999999999875 45678999999999999999542  234588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |+|+||++++++.++|+|||+++..............++..|+|||...+..++.++||||||+++|||+| |..|+...
T Consensus       128 l~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             cCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998764432222223345678999999988889999999999999999999 78887643


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   ....   ........      .   .+......+.+++.+||+.+|.+||++++|++.|++
T Consensus       208 ~~~---~~~~---~~~~~~~~------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         208 VNR---EVLE---QVERGYRM------P---CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CHH---HHHH---HHHcCCCC------C---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            221   1111   11111110      1   111223457788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-37  Score=254.51  Aligned_cols=206  Identities=25%  Similarity=0.408  Sum_probs=162.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++...+..++||||+++++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~d  132 (268)
T cd05063          59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRD  132 (268)
T ss_pred             HHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            46788999999999999999999999999999999999843   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceee--eecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||++++++.+||+|||++............  ....+..|+|||++....++.++||||||+++|||++ |..||.
T Consensus       133 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~  212 (268)
T cd05063         133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             cchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999865433221111  1223457999999988889999999999999999998 898875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ....   ....   .... ....    .+...    .....+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       213 ~~~~---~~~~---~~i~-~~~~----~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         213 DMSN---HEVM---KAIN-DGFR----LPAPM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cCCH---HHHH---HHHh-cCCC----CCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            4322   1111   1111 1110    01111    1233478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=274.74  Aligned_cols=209  Identities=22%  Similarity=0.265  Sum_probs=163.4

Q ss_pred             cccccc-CCCccceeeE-EEe------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVR-HPNLVELIGC-CVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~-~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++|+ |||||.+++. ...      .-..+|+||||.||+|-+++..+-  ...|++.++++|++++++|+++||.. 
T Consensus        87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-  163 (738)
T KOG1989|consen   87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-  163 (738)
T ss_pred             HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-
Confidence            467886 9999999993 321      125789999999999999996533  23499999999999999999999997 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce--------eeeecccccccCcccc---ccCccccccceEe
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--------TTRIAGTTGYLAPEYV---LGGQLTMKADVYS  142 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s  142 (277)
                      .++|||||||-+||||+.+++.||||||.+...-......        .-...-|+.|+|||++   .+...++|+|||+
T Consensus       164 ~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA  243 (738)
T KOG1989|consen  164 KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA  243 (738)
T ss_pred             CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence            3469999999999999999999999999987432221100        1123468899999987   4567899999999


Q ss_pred             hhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          143 FGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       143 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      |||+||-|+....||+..-                   ...+++... -...+.....+..||..||+.||.+||++.+|
T Consensus       244 LGclLYkLCy~t~PFe~sg-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv  304 (738)
T KOG1989|consen  244 LGCLLYKLCYFTTPFEESG-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV  304 (738)
T ss_pred             HHHHHHHHHHhCCCcCcCc-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence            9999999999999986531                   122333322 11125677789999999999999999999999


Q ss_pred             HHHHhhccccC
Q 023808          222 IKMLTKNIRLN  232 (277)
Q Consensus       222 ~~~L~~~~~~~  232 (277)
                      +..+.++....
T Consensus       305 ~~~~~~l~~~~  315 (738)
T KOG1989|consen  305 LEEIFELANKP  315 (738)
T ss_pred             HHHHHHHhcCC
Confidence            99998877543

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-37  Score=252.68  Aligned_cols=205  Identities=27%  Similarity=0.416  Sum_probs=161.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.. ...++||||+++|+|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        49 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~d  122 (257)
T cd05040          49 IMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRD  122 (257)
T ss_pred             HHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            4788999999999999998 889999999999999999954322  4689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |+|+||+++.++.+||+|||+++.+......  ......++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       123 i~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             cCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999876543221  1223456788999999988889999999999999999999 998875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      .....   ......   .......     ..   +......+.+++.+||+.+|++||++.+|++.|.
T Consensus       203 ~~~~~---~~~~~~---~~~~~~~-----~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         203 GLSGS---QILKKI---DKEGERL-----ER---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCHH---HHHHHH---HhcCCcC-----CC---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            43221   111111   1111100     01   1112235778888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=265.98  Aligned_cols=207  Identities=27%  Similarity=0.409  Sum_probs=174.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++|.|.+. ..++|||++..|-|..||.   ..+..++......++.||+.||+|||+.   .+||||
T Consensus       444 iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRD  516 (974)
T KOG4257|consen  444 IMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRD  516 (974)
T ss_pred             HHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhh
Confidence            68899999999999999876 6799999999999999995   3445689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |..+|||+.....|||+|||+++.+..+......+..-..-|||||-+...+++.+||||.||+.+||++. |..||...
T Consensus       517 IAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv  596 (974)
T KOG4257|consen  517 IAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV  596 (974)
T ss_pred             hhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence            99999999999999999999999988766555555555678999999999999999999999999999865 78888654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ...               +-...+-.......++.++..+..++.+||+.+|.+||.+.++...|.+++.
T Consensus       597 kNs---------------DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  597 KNS---------------DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ccc---------------ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            322               1122222233345566666678899999999999999999999999988765

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-37  Score=258.64  Aligned_cols=208  Identities=28%  Similarity=0.433  Sum_probs=162.9

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ +||||+++++++...+..++||||+.+|+|.+++...  ....+++..++.++.|++.||+|||+.   +++|+
T Consensus        91 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~  165 (302)
T cd05055          91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHR  165 (302)
T ss_pred             HHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceehh
Confidence            46678 7999999999999999999999999999999998532  223489999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      ||||+||+++.++.++++|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       166 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~  245 (302)
T cd05055         166 DLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP  245 (302)
T ss_pred             hhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence            99999999999999999999999865443221 1222345678999999998889999999999999999998 888875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ......  ...    ........     ...   +......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       246 ~~~~~~--~~~----~~~~~~~~-----~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         246 GMPVDS--KFY----KLIKEGYR-----MAQ---PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCchH--HHH----HHHHcCCc-----CCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            433211  111    11111111     001   111223578888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-37  Score=253.09  Aligned_cols=205  Identities=28%  Similarity=0.458  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.. ...++||||+.+++|.+++...  ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~d  127 (260)
T cd05070          54 IMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRD  127 (260)
T ss_pred             HHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4778999999999998854 5678999999999999998532  234589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.++|+|||++..+............++..|+|||...+..++.++||||||+++|||++ |..||...
T Consensus       128 i~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             CccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999998765432222222345668999999988889999999999999999999 78887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   ....   ........         ..+......+.+++.+|++.+|.+|||+.++.+.|++
T Consensus       208 ~~~---~~~~---~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         208 NNR---EVLE---QVERGYRM---------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CHH---HHHH---HHHcCCCC---------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            221   1111   11111110         1111223458889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-37  Score=254.03  Aligned_cols=210  Identities=25%  Similarity=0.389  Sum_probs=153.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC-CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++||||++++++|......++||||+.+|+|.+++...... ....++..+..++.|++.||+|||+.   +++||
T Consensus        48 ~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~  124 (269)
T cd05042          48 PYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHS  124 (269)
T ss_pred             HHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecc
Confidence            356789999999999999999999999999999999999653322 23356888899999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCcccccc-------CccccccceEehhHHHHHHHh
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~ellt  152 (277)
                      ||||+||++++++.+||+|||+++........ ......++..|+|||++..       ..++.++||||||+++|||++
T Consensus       125 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  204 (269)
T cd05042         125 DLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT  204 (269)
T ss_pred             cccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence            99999999999999999999998754332111 1122345677999998743       356789999999999999999


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                       |..||......   ...   ....... ......+.+....+.   .+.+++..|| .||++||++++|++.|
T Consensus       205 ~~~~p~~~~~~~---~~~---~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         205 AADQPYPDLSDE---QVL---KQVVREQ-DIKLPKPQLDLKYSD---RWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCCCCCcCCHH---HHH---HHHhhcc-CccCCCCcccccCCH---HHHHHHHHHh-cCcccccCHHHHHHHh
Confidence             66676543221   111   1111111 111222222222222   3455666688 5999999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.7e-38  Score=253.79  Aligned_cols=197  Identities=27%  Similarity=0.405  Sum_probs=153.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+|+|.+++..   .+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        52 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~d  125 (258)
T cd05078          52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGN  125 (258)
T ss_pred             HHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            46788999999999999999999999999999999999943   233689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc--------eEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHh
Q 023808           82 IKASNILLDQEFN--------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        82 ikp~Nill~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~ellt  152 (277)
                      |||+||+++.++.        ++++|||++......     ....++..|+|||++.+. .++.++||||||+++|||++
T Consensus       126 lkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  200 (258)
T cd05078         126 VCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS  200 (258)
T ss_pred             CccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence            9999999987665        699999988754321     234577889999998874 57899999999999999999


Q ss_pred             CC-CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 GR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |. .|+.......   ..    ......       ..+   +.....++.+++.+||+.+|++||++++|++.|+
T Consensus       201 g~~~~~~~~~~~~---~~----~~~~~~-------~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         201 GGDKPLSALDSQK---KL----QFYEDR-------HQL---PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CCCCChhhccHHH---HH----HHHHcc-------ccC---CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            95 4443221111   00    011110       011   1122245788889999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-37  Score=264.36  Aligned_cols=152  Identities=22%  Similarity=0.324  Sum_probs=133.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.++...|+||||++||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrD  126 (363)
T cd05628          54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRD  126 (363)
T ss_pred             HHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecC
Confidence            4678899999999999999999999999999999999994    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc----------------------------------ceeeeecccccccCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT----------------------------------HITTRIAGTTGYLAPE  127 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE  127 (277)
                      |||+|||++.++.+||+|||+++.+.....                                  .......||..|+|||
T Consensus       127 lKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE  206 (363)
T cd05628         127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE  206 (363)
T ss_pred             CCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHH
Confidence            999999999999999999999875432110                                  0012346999999999


Q ss_pred             ccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808          128 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus       128 ~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ++.+..++.++|||||||++|||++|+.||...
T Consensus       207 ~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             HHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence            999989999999999999999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-37  Score=259.05  Aligned_cols=212  Identities=25%  Similarity=0.330  Sum_probs=155.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+. ++|.+++.   .....+++..+..++.|++.||+|||+.   +++|||
T Consensus        56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~d  128 (303)
T cd07869          56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRD  128 (303)
T ss_pred             HHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4678999999999999999999999999995 58887774   2334688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++...... .......++..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus       129 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         129 LKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987543221 11233457899999998865 45788999999999999999999998754


Q ss_pred             cCcchhhHHHHHHHHhccCC--------ccccccCC-CCCCCH----------HHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEK--------PLELVDPE-LGEYPP----------NEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~----------~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      .... . .............        ......+. .....+          .....+.+++.+|++.||++|||+.|+
T Consensus       208 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~  285 (303)
T cd07869         208 KDIQ-D-QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA  285 (303)
T ss_pred             ccHH-H-HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence            3211 1 1111111100000        00000000 000000          011346688889999999999999998


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      ++
T Consensus       286 l~  287 (303)
T cd07869         286 LS  287 (303)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-37  Score=256.79  Aligned_cols=214  Identities=25%  Similarity=0.416  Sum_probs=162.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-------CCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------ANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++++||||+++++++..++..++||||+.+++|.+++.....       ....+++..++.++.|++.||+|||+.  
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--  149 (296)
T cd05051          72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--  149 (296)
T ss_pred             HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--
Confidence            46789999999999999999999999999999999999854321       123689999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-  152 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-  152 (277)
                       +++|+||||+||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ 
T Consensus       150 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  228 (296)
T cd05051         150 -NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL  228 (296)
T ss_pred             -CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence             999999999999999999999999999986543321 12233446778999999988889999999999999999998 


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                       +..|+.....   ...................     ...+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       229 ~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         229 CREQPYEHLTD---QQVIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCCCCCcCh---HHHHHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             5556543221   1112212111111111000     0111222345888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=267.76  Aligned_cols=214  Identities=28%  Similarity=0.480  Sum_probs=168.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+|+||||++++|+|..++.+++|+||+++|+|.+++..+....  +.-...++|+.||++|++||.+.   ++||||
T Consensus       588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd  662 (807)
T KOG1094|consen  588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRD  662 (807)
T ss_pred             HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhcc
Confidence            5889999999999999999999999999999999999996543222  34556778999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeeccccccc-CCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHH--hCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII--SGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell--tg~~p~~  158 (277)
                      |.++|+|++.++++||+|||.++.+ ..+......+..-..+|||+|.+..++++.++|||+||+++||++  +...|+.
T Consensus       663 ~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  663 LATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             ccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence            9999999999999999999999943 344444555666678999999999999999999999999999975  4566765


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ....+   ...+-.......+....     ....++-+...+.+++.+||..+-++||+++++...|.+.
T Consensus       743 ~lt~e---~vven~~~~~~~~~~~~-----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  743 QLTDE---QVVENAGEFFRDQGRQV-----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhHH---HHHHhhhhhcCCCCcce-----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            54332   22222222222221111     1223344455677999999999999999999999988764

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-37  Score=255.89  Aligned_cols=207  Identities=28%  Similarity=0.364  Sum_probs=159.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++|+||+++++++.+....++||||+.+++|.+++.....   ....+++..+++++.||+.||+|||+.   +++
T Consensus        62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~iv  138 (277)
T cd05036          62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFI  138 (277)
T ss_pred             HHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEe
Confidence            46789999999999999999999999999999999999854321   123589999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC---ceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           79 HRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        79 H~dikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      |+||||+||+++.++   .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |
T Consensus       139 H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g  218 (277)
T cd05036         139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG  218 (277)
T ss_pred             ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCC
Confidence            999999999998654   58999999998653322111 112233567999999998899999999999999999997 8


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ..||......   ....   ........         ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       219 ~~pf~~~~~~---~~~~---~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         219 YMPYPGRTNQ---EVME---FVTGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCCHH---HHHH---HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            8887643221   1111   11111111         111122345778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=265.82  Aligned_cols=202  Identities=20%  Similarity=0.244  Sum_probs=153.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrD  126 (377)
T cd05629          54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRD  126 (377)
T ss_pred             HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccC
Confidence            4678899999999999999999999999999999999984    345688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc----------------------------------------------eee
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH----------------------------------------------ITT  115 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------------------------------------------~~~  115 (277)
                      |||+|||++.++.+||+|||+++.+......                                              ...
T Consensus       127 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (377)
T cd05629         127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY  206 (377)
T ss_pred             CCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence            9999999999999999999998633210000                                              001


Q ss_pred             eecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHH
Q 023808          116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN  195 (277)
Q Consensus       116 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (277)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..   ............  +....    
T Consensus       207 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~---~~i~~~~~~~~~--p~~~~----  274 (377)
T cd05629         207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE---TY---RKIINWRETLYF--PDDIH----  274 (377)
T ss_pred             ccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH---HH---HHHHccCCccCC--CCCCC----
Confidence            2458999999999998889999999999999999999999986543211   11   111111111000  11111    


Q ss_pred             HHHHHHHHHHhhhhhhhcCC---CCHHHHHH
Q 023808          196 EIIRYMKVAFFCTQAAASRR---PQMNQVIK  223 (277)
Q Consensus       196 ~~~~~~~l~~~c~~~~p~~R---Ps~~~v~~  223 (277)
                      ....+.+++.+|+. +|.+|   +++.+++.
T Consensus       275 ~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         275 LSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             CCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            12346778888997 66665   58888875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=267.59  Aligned_cols=215  Identities=20%  Similarity=0.198  Sum_probs=160.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+||||+++++++......++|||++. ++|.+++    .....+++..++.++.|++.||+|||+.   +|+|||
T Consensus       139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrD  210 (392)
T PHA03207        139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRD  210 (392)
T ss_pred             HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            5788999999999999999999999999995 5888888    3345789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.++|+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999999999865443222 233467899999999999889999999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCcc-----------------ccccCCC--CCC--CHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPL-----------------ELVDPEL--GEY--PPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--~~~--~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      ...........+..........                 ....+..  +..  .......+.+++.+||..||++||++.
T Consensus       291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~  370 (392)
T PHA03207        291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ  370 (392)
T ss_pred             CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence            3322111111111111000000                 0000000  000  001123467788899999999999999


Q ss_pred             HHHHH
Q 023808          220 QVIKM  224 (277)
Q Consensus       220 ~v~~~  224 (277)
                      +++..
T Consensus       371 e~l~~  375 (392)
T PHA03207        371 DILSL  375 (392)
T ss_pred             HHhhC
Confidence            99764

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-39  Score=247.39  Aligned_cols=201  Identities=25%  Similarity=0.383  Sum_probs=163.1

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ -||||+++.++++.+...|+|+|.|..|-|.++|    .....+|++...+|..|+..|++|||..   +|+||
T Consensus        75 ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHR  147 (411)
T KOG0599|consen   75 ILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHR  147 (411)
T ss_pred             HHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhc
Confidence            45666 6999999999999999999999999999999999    5667899999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc------CccccccceEehhHHHHHHHhCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      |+||+|||++++.++||+|||+++.+..+  ..-....||++|+|||.+..      ..|+...|+|++|+++|-||.|.
T Consensus       148 DLKpENILlddn~~i~isDFGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc  225 (411)
T KOG0599|consen  148 DLKPENILLDDNMNIKISDFGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC  225 (411)
T ss_pred             ccChhheeeccccceEEeccceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence            99999999999999999999999977553  22345679999999998864      24778899999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +||-.   +.....+..+.    .+.. +.-.+    ...+......+++.+||+.||.+|.|++|+++
T Consensus       226 pPFwH---RkQmlMLR~Im----eGky-qF~sp----eWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  226 PPFWH---RKQMLMLRMIM----EGKY-QFRSP----EWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             CchhH---HHHHHHHHHHH----hccc-ccCCc----chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            99743   22222222111    1111 11122    23344455888999999999999999999975

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-37  Score=254.39  Aligned_cols=208  Identities=30%  Similarity=0.490  Sum_probs=161.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++||||+++++++......++||||+.+|+|.+++.....   ....+++..++.++.|++.||+|||+.   +++
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~  128 (269)
T cd05044          52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFI  128 (269)
T ss_pred             HHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            46789999999999999999999999999999999999854322   223578999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC-----ceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           79 HRDIKASNILLDQEF-----NPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        79 H~dikp~Nill~~~~-----~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                      |+||+|+||+++.++     .++++|||+++....... .......++..|+|||.+.++.++.++||||||+++|||+|
T Consensus       129 H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt  208 (269)
T cd05044         129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT  208 (269)
T ss_pred             cCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHH
Confidence            999999999999877     899999999976533211 11222345678999999999999999999999999999998


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                       |..||.....   .....   ........         ..+......+.+++.+||+.+|.+||++.+|++.|++
T Consensus       209 ~g~~p~~~~~~---~~~~~---~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         209 LGQQPYPALNN---QEVLQ---HVTAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCCCCcccCH---HHHHH---HHhcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             8888754322   11111   11111100         1112223457788889999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.5e-38  Score=261.01  Aligned_cols=199  Identities=22%  Similarity=0.281  Sum_probs=156.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|..-++|+||++|-.|.+.+++||||||++||++..+|    .....+++..+.-++.+++.||+.||+.   ||||||
T Consensus       194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRD  266 (550)
T KOG0605|consen  194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRD  266 (550)
T ss_pred             HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            355568999999999999999999999999999999999    5566899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCC-----------------------CCcc----e-------------------ee
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPD-----------------------NITH----I-------------------TT  115 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~-----------------------~~~~----~-------------------~~  115 (277)
                      |||+|+|||..|++||+||||+.-+..                       ....    .                   ..
T Consensus       267 IKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~  346 (550)
T KOG0605|consen  267 IKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY  346 (550)
T ss_pred             CChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence            999999999999999999999863210                       0000    0                   12


Q ss_pred             eecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcch-hhHHHHHHHHhccCCccccccCCCCCCCH
Q 023808          116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQLHQEEKPLELVDPELGEYPP  194 (277)
Q Consensus       116 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (277)
                      ..+||+.|+|||++.+..|+..+|+||||||+||||.|.+||....+... ..+..|......         |.-    .
T Consensus       347 StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------P~~----~  413 (550)
T KOG0605|consen  347 STVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------PEE----V  413 (550)
T ss_pred             cccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------CCc----C
Confidence            24799999999999999999999999999999999999999987655332 122222211111         100    0


Q ss_pred             HHHHHHHHHHHhhhhhhhcCCCC---HHHH
Q 023808          195 NEIIRYMKVAFFCTQAAASRRPQ---MNQV  221 (277)
Q Consensus       195 ~~~~~~~~l~~~c~~~~p~~RPs---~~~v  221 (277)
                      ....+..++|.+|+. ||++|-.   ++||
T Consensus       414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EI  442 (550)
T KOG0605|consen  414 DLSDEAKDLITRLLC-DPENRLGSKGAEEI  442 (550)
T ss_pred             cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence            111346778888888 9999975   4444

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-37  Score=268.28  Aligned_cols=149  Identities=27%  Similarity=0.378  Sum_probs=130.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|+||+++++++..+...++|||++. ++|.+++..   ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus       213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrD  285 (461)
T PHA03211        213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRD  285 (461)
T ss_pred             HHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECc
Confidence            5788999999999999999999999999995 689888842   234699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            9999999999999999999999865432221 223456899999999999989999999999999999999987654

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.3e-38  Score=260.70  Aligned_cols=193  Identities=27%  Similarity=0.356  Sum_probs=154.1

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      ++||||+++++++.+++..++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+
T Consensus        53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~  125 (316)
T cd05619          53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLD  125 (316)
T ss_pred             cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHH
Confidence            589999999999999999999999999999999983    344688999999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcch
Q 023808           86 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  165 (277)
Q Consensus        86 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~  165 (277)
                      ||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..||.....   
T Consensus       126 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---  201 (316)
T cd05619         126 NILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---  201 (316)
T ss_pred             HEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---
Confidence            9999999999999999987532211 123345689999999999988899999999999999999999999865322   


Q ss_pred             hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH-HHH
Q 023808          166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVI  222 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~-~v~  222 (277)
                      .....   .. ....      +..+..   ....+.+++.+||+.+|.+||++. ++.
T Consensus       202 ~~~~~---~i-~~~~------~~~~~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         202 EELFQ---SI-RMDN------PCYPRW---LTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHHHH---HH-HhCC------CCCCcc---CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            11111   11 1111      111111   223467888889999999999996 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-37  Score=265.05  Aligned_cols=152  Identities=24%  Similarity=0.342  Sum_probs=131.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrD  126 (382)
T cd05625          54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRD  126 (382)
T ss_pred             HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            4678899999999999999999999999999999999984    334688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC----------------------------------------------cceee
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI----------------------------------------------THITT  115 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~----------------------------------------------~~~~~  115 (277)
                      |||+|||++.++.+||+|||+++.+....                                              .....
T Consensus       127 lKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (382)
T cd05625         127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH  206 (382)
T ss_pred             CCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence            99999999999999999999975321000                                              00012


Q ss_pred             eecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808          116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus       116 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence            346899999999999889999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.3e-37  Score=260.00  Aligned_cols=205  Identities=20%  Similarity=0.203  Sum_probs=155.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++.+++|+||+++++++.+++..|+||||+.||+|.+++..   .+..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 ~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrD  127 (331)
T cd05624          54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRD  127 (331)
T ss_pred             HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            45678999999999999999999999999999999999943   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||+++.++.+||+|||+++.+............|+..|+|||++.+     +.++.++||||||+++|||++|+.|
T Consensus       128 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P  207 (331)
T cd05624         128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             CchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence            99999999999999999999998765443333334569999999998875     4678899999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC--CCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~--RPs~~~v~~  223 (277)
                      |......      .............     .++.........+.+++.+|+..++.+  |++++++++
T Consensus       208 f~~~~~~------~~~~~i~~~~~~~-----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         208 FYAESLV------ETYGKIMNHEERF-----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ccCCCHH------HHHHHHHcCCCcc-----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            8643221      1111111111110     011111122334677777888765543  467777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-37  Score=254.58  Aligned_cols=209  Identities=25%  Similarity=0.405  Sum_probs=162.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++... ..+++|||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        62 ~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~d  134 (279)
T cd05109          62 VMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRD  134 (279)
T ss_pred             HHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            46778999999999999764 56789999999999999843   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||++++++.+||+|||+++......... .....++..|++||...+..++.++||||||+++|||++ |..||..
T Consensus       135 lkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         135 LAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             cccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999998765432221 112234668999999988889999999999999999998 7888754


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ...   .......    .......        .+......+.+++.+||+.||++||++.+++..|++..+.+
T Consensus       215 ~~~---~~~~~~~----~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         215 IPA---REIPDLL----EKGERLP--------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCH---HHHHHHH----HCCCcCC--------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            322   1111111    1111100        01122335778888999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-37  Score=253.45  Aligned_cols=208  Identities=24%  Similarity=0.378  Sum_probs=157.8

Q ss_pred             ccccccCCCccceeeEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++||||+++++++. .+...++||||+.+|+|.+++..   .....++..++.++.|++.||+|||+.   +++||
T Consensus        49 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~  122 (262)
T cd05058          49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHR  122 (262)
T ss_pred             HHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            467899999999999876 45568899999999999999843   233467888899999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC-C
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN-S  156 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~-p  156 (277)
                      ||||+||++++++.+||+|||+++........   ......++..|+|||.+.+..++.++||||||+++|||++|.. |
T Consensus       123 dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~  202 (262)
T cd05058         123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  202 (262)
T ss_pred             ccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999755332111   1122345678999999988889999999999999999999654 4


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      +.....   .....   ........      ......   ...+.+++..||+.+|++||++.+|++.|+++..
T Consensus       203 ~~~~~~---~~~~~---~~~~~~~~------~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         203 YPDVDS---FDITV---YLLQGRRL------LQPEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCH---HHHHH---HHhcCCCC------CCCCcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            433211   11111   11111111      111111   2347788889999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-38  Score=276.38  Aligned_cols=204  Identities=23%  Similarity=0.343  Sum_probs=160.9

Q ss_pred             ccccccCCCccceeeEEEeCC--------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|.+++|+||+++++.+...+        ..++||||+.+|+|.+++.........+++..+..++.|++.||.|||+. 
T Consensus        84 ~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-  162 (496)
T PTZ00283         84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-  162 (496)
T ss_pred             HHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            356789999999988776432        36799999999999999976555566799999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                        +|+||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       163 --~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt  240 (496)
T PTZ00283        163 --HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT  240 (496)
T ss_pred             --CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence              999999999999999999999999999987643221 22334678999999999999899999999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |+.||.....      ........... .    .    ..++.....+.+++.+||+.+|.+||++.+++.
T Consensus       241 G~~Pf~~~~~------~~~~~~~~~~~-~----~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        241 LKRPFDGENM------EEVMHKTLAGR-Y----D----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCCCCCCCH------HHHHHHHhcCC-C----C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            9999864321      11111111111 1    1    111222345778888899999999999999875

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-37  Score=263.75  Aligned_cols=147  Identities=29%  Similarity=0.400  Sum_probs=128.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++|||++. ++|.+++.   .....+++..+..++.|++.||+|||+.   +|+|||
T Consensus       110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  182 (357)
T PHA03209        110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRD  182 (357)
T ss_pred             HHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            5789999999999999999999999999995 58888884   2345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++.+||+|||+++......  ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       183 lkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        183 VKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CCHHHEEECCCCCEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99999999999999999999997533221  123456899999999999989999999999999999999976543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.7e-37  Score=262.22  Aligned_cols=203  Identities=18%  Similarity=0.225  Sum_probs=154.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||+++++++.+++..++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  167 (371)
T cd05622          96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRD  167 (371)
T ss_pred             HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence            45678999999999999999999999999999999999842     3478889999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC----ccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|||++.++.+||+|||+++..............||+.|+|||++...    .++.++|||||||++|||++|..||
T Consensus       168 Lkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf  247 (371)
T cd05622         168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (371)
T ss_pred             CCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence            999999999999999999999987654333333456799999999998754    3788999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC--CCCHHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKM  224 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~--RPs~~~v~~~  224 (277)
                      ......      ...............  +..    ......+.+++..|+..++.+  |+++.++++.
T Consensus       248 ~~~~~~------~~~~~i~~~~~~~~~--~~~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         248 YADSLV------GTYSKIMNHKNSLTF--PDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCCHH------HHHHHHHcCCCcccC--CCc----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            653221      111111111111111  111    122334667778899744433  7788888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.3e-37  Score=254.28  Aligned_cols=211  Identities=23%  Similarity=0.369  Sum_probs=163.8

Q ss_pred             ccccccCCCccceeeEEEe-CCeeEEEEeecCCCCHHHHhccCCCC----CccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKA----NIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++.. +...++++||+.+|+|.+++......    +..+++..++.++.|++.||+|||+.   +
T Consensus        61 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~  137 (280)
T cd05043          61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---G  137 (280)
T ss_pred             HHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            4678899999999999876 46789999999999999998543222    14689999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR  154 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~  154 (277)
                      ++|+||||+||++++++.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+
T Consensus       138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~  217 (280)
T cd05043         138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ  217 (280)
T ss_pred             EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence            999999999999999999999999999865432221 1222345678999999988889999999999999999999 88


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .||.....   .....    ........     ..   .......+.+++.+||..+|++||++.++++.|+++.+
T Consensus       218 ~p~~~~~~---~~~~~----~~~~~~~~-----~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         218 TPYVEIDP---FEMAA----YLKDGYRL-----AQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCcCcCCH---HHHHH----HHHcCCCC-----CC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            88764322   11111    11111110     01   11112347788889999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6e-38  Score=258.20  Aligned_cols=213  Identities=25%  Similarity=0.383  Sum_probs=158.0

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++..  ....++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        58 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H  131 (284)
T cd05081          58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVH  131 (284)
T ss_pred             HHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---Ccee
Confidence            4678999999999998764  3467899999999999999842   234589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||||+||++++++.+||+|||+++.........  .....++..|+|||++.+..++.++||||||+++|||++|..++
T Consensus       132 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~  211 (284)
T cd05081         132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS  211 (284)
T ss_pred             ccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence            9999999999999999999999998765432211  11222345699999998888999999999999999999987664


Q ss_pred             CcccCcchh---------hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          158 KAMWGQMNK---------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       158 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .........         ..............        ...........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         212 CSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG--------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CCcchhhhhhcccccccccchHHHHHHHhcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            332110000         00000000000000        0011122234578888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.3e-37  Score=251.85  Aligned_cols=206  Identities=26%  Similarity=0.447  Sum_probs=160.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        58 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~d  131 (269)
T cd05065          58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRD  131 (269)
T ss_pred             HHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecc
Confidence            46788999999999999999999999999999999999843   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee--eeec--ccccccCccccccCccccccceEehhHHHHHHHh-CCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIA--GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p  156 (277)
                      |||+||+++.++.++|+|||+++..........  ....  .+..|+|||.+.+..++.++||||||+++||+++ |..|
T Consensus       132 l~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p  211 (269)
T cd05065         132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP  211 (269)
T ss_pred             cChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCC
Confidence            999999999999999999999886544322111  1111  2357999999998899999999999999999886 8888


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      |.....   .....++    ......    +...+    ....+.+++.+||+.+|.+||++.+|+..|+++
T Consensus       212 ~~~~~~---~~~~~~i----~~~~~~----~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         212 YWDMSN---QDVINAI----EQDYRL----PPPMD----CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCCCH---HHHHHHH----HcCCcC----CCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            754322   1122211    111000    11112    223467888899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-37  Score=254.22  Aligned_cols=200  Identities=28%  Similarity=0.435  Sum_probs=159.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~d  131 (267)
T cd06628          59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRD  131 (267)
T ss_pred             HHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---Cccccc
Confidence            4778999999999999999999999999999999999993    335688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-----eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |+|+||++++++.++|+|||.++........     ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|
T Consensus       132 i~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p  211 (267)
T cd06628         132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP  211 (267)
T ss_pred             CCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCC
Confidence            9999999999999999999999866532111     11234578899999999888899999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.......      ........      ..+.+   +......+.+++.+||+.+|.+||++.+|++
T Consensus       212 ~~~~~~~~------~~~~~~~~------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         212 FPDCTQLQ------AIFKIGEN------ASPEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCCccHHH------HHHHHhcc------CCCcC---CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            86532211      11111110      11111   1222345778888899999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-38  Score=236.99  Aligned_cols=196  Identities=25%  Similarity=0.340  Sum_probs=162.9

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      +.|+||||+++|+||.+....||++||..+|.|.+.|..  .....+++.....++.|+|.||.|+|..   ++||||||
T Consensus        77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiK  151 (281)
T KOG0580|consen   77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIK  151 (281)
T ss_pred             cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCC
Confidence            578999999999999999999999999999999999953  2455688999999999999999999999   99999999


Q ss_pred             CCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCc
Q 023808           84 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  163 (277)
Q Consensus        84 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~  163 (277)
                      |+|+|++..+.+|++|||.+..-+   .....+..||..|++||+..+...+...|+|++|++.||++.|.+||+.....
T Consensus       152 penlLlg~~~~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~  228 (281)
T KOG0580|consen  152 PENLLLGSAGELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS  228 (281)
T ss_pred             HHHhccCCCCCeeccCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence            999999999999999999987643   23356678999999999999999999999999999999999999999865522


Q ss_pred             chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .   ...    .+.+.+   ...      +........++|.+|+..+|.+|.+..||++
T Consensus       229 e---tYk----rI~k~~---~~~------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  229 E---TYK----RIRKVD---LKF------PSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             H---HHH----HHHHcc---ccC------CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            1   111    111111   111      1223334778888899999999999999875

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-37  Score=257.33  Aligned_cols=208  Identities=25%  Similarity=0.459  Sum_probs=160.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------------CCccCCHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------------ANIKLNWEKRSDICVGIA   63 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~   63 (277)
                      +|++++||||+++++++..+...++||||+.+|+|.+++.....                  ....+++..++.++.|++
T Consensus        61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~  140 (288)
T cd05050          61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA  140 (288)
T ss_pred             HHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence            46788999999999999999999999999999999999853211                  123478899999999999


Q ss_pred             HHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEe
Q 023808           64 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYS  142 (277)
Q Consensus        64 ~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  142 (277)
                      .||+|||+.   +++||||||+||++++++.++|+|||+++....... .......++..|+|||.+.+..++.++||||
T Consensus       141 ~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  217 (288)
T cd05050         141 AGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA  217 (288)
T ss_pred             HHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence            999999999   999999999999999999999999999875433221 1112223456799999998888999999999


Q ss_pred             hhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          143 FGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       143 lG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      ||+++|||++ |..||......   ..   ..... .....        ..+......+.+++.+||+.+|.+||++.|+
T Consensus       218 lG~il~el~~~~~~p~~~~~~~---~~---~~~~~-~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         218 YGVVLWEIFSYGMQPYYGMAHE---EV---IYYVR-DGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHH---HH---HHHHh-cCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            9999999998 77776433211   11   11111 11111        1111223457889999999999999999999


Q ss_pred             HHHHhh
Q 023808          222 IKMLTK  227 (277)
Q Consensus       222 ~~~L~~  227 (277)
                      ++.|++
T Consensus       283 ~~~l~~  288 (288)
T cd05050         283 NRILQR  288 (288)
T ss_pred             HHHhhC
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.4e-37  Score=249.35  Aligned_cols=202  Identities=26%  Similarity=0.354  Sum_probs=157.6

Q ss_pred             ccccccCCCccceeeEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++|+||+++++++. .+...++||||+++++|.+++...  ....+++..++.++.|++.||+|||+.   +++||
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~  126 (256)
T cd05082          52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR  126 (256)
T ss_pred             HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecc
Confidence            477899999999999865 455789999999999999998532  233588999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      ||||+||++++++.+||+|||+++......    ....++..|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus       127 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             ccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987543321    22334567999999988889999999999999999998 8888653


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   .....   .. .....     +...   +.....+.+++.+||+.+|++||++.++++.|++
T Consensus       203 ~~~---~~~~~---~~-~~~~~-----~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         203 IPL---KDVVP---RV-EKGYK-----MDAP---DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCH---HHHHH---HH-hcCCC-----CCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            221   11111   11 11111     1111   1223347788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=238.01  Aligned_cols=197  Identities=23%  Similarity=0.273  Sum_probs=157.6

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      +.|+|||||++.....+....|+|+|+++|+.|..-+-    ....+++..+-....||++||.|+|.+   +|||||+|
T Consensus        65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvk  137 (355)
T KOG0033|consen   65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLK  137 (355)
T ss_pred             HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCC
Confidence            46899999999999999999999999999999965542    225688899999999999999999999   99999999


Q ss_pred             CCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           84 ASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        84 p~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|++|..   ..-+||+|||++....  .......+.||++|+|||+++..+|+..+|||+.|++||-||.|..||...
T Consensus       138 P~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~  215 (355)
T KOG0033|consen  138 PENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  215 (355)
T ss_pred             hhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence            99999943   3459999999999876  344566788999999999999999999999999999999999999998652


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccC-CCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDP-ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ..   ..+.+    .+..+..  -+++ ....    ......+++.+||..||.+|.|+.|.+
T Consensus       216 ~~---~rlye----~I~~g~y--d~~~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  216 DQ---HRLYE----QIKAGAY--DYPSPEWDT----VTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             cH---HHHHH----HHhcccc--CCCCcccCc----CCHHHHHHHHHHhccChhhhccHHHHh
Confidence            21   22222    2222211  1122 2222    233477888999999999999998876

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-37  Score=257.46  Aligned_cols=208  Identities=24%  Similarity=0.371  Sum_probs=158.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +|++++||||++++++|..++..++||||+++++|.+++.    ....+++..+..++.|++.||+|||+ .   +++|+
T Consensus        52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~  124 (308)
T cd06615          52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKH---KIMHR  124 (308)
T ss_pred             HHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEEC
Confidence            4778999999999999999999999999999999999994    33568999999999999999999997 5   89999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||||+||++++++.++|+|||++.......   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.|+...
T Consensus       125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         125 DVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             CCChHHEEEecCCcEEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999987553321   23356788999999998888999999999999999999999987543


Q ss_pred             cCcchhhHHHHHHHHhccCCcc---------------------------ccccCCCCCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPL---------------------------ELVDPELGEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      ....   ...............                           ....+.++.  ......+.+++.+||+.+|+
T Consensus       202 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~  276 (308)
T cd06615         202 DAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPK  276 (308)
T ss_pred             chhh---HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChh
Confidence            2111   110000000000000                           000001100  01223477889999999999


Q ss_pred             CCCCHHHHHHH
Q 023808          214 RRPQMNQVIKM  224 (277)
Q Consensus       214 ~RPs~~~v~~~  224 (277)
                      +||++.+|+..
T Consensus       277 ~Rpt~~~ll~~  287 (308)
T cd06615         277 ERADLKELTKH  287 (308)
T ss_pred             hCcCHHHHhcC
Confidence            99999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-37  Score=253.00  Aligned_cols=204  Identities=22%  Similarity=0.345  Sum_probs=157.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        59 ~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  131 (267)
T cd06646          59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRD  131 (267)
T ss_pred             HHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4678899999999999999999999999999999999984    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||+++.++.++|+|||+++....... ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       132 l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         132 IKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             CCHHHEEECCCCCEEECcCccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence            999999999999999999999986543211 122345788999999874   3457889999999999999999999875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ........       ......   ....+... ........+.+++.+||+.+|++||++++|++.
T Consensus       211 ~~~~~~~~-------~~~~~~---~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         211 DLHPMRAL-------FLMSKS---NFQPPKLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ccchhhhh-------eeeecC---CCCCCCCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            33221100       000000   00011111 111223457788899999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.2e-37  Score=250.00  Aligned_cols=205  Identities=30%  Similarity=0.473  Sum_probs=160.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++. .+..++||||+.+++|.+++..  ..+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~d  127 (260)
T cd05067          54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRD  127 (260)
T ss_pred             HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceeccc
Confidence            467899999999999875 4568999999999999999853  2344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.++|+|||++...............++..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus       128 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  207 (260)
T cd05067         128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM  207 (260)
T ss_pred             ccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765332222223345678999999988889999999999999999999 88888643


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   ....   .. ......     ....   .....+.+++.+||+.+|++||+++++...|++
T Consensus       208 ~~~---~~~~---~~-~~~~~~-----~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         208 TNP---EVIQ---NL-ERGYRM-----PRPD---NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ChH---HHHH---HH-HcCCCC-----CCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            321   1111   11 111110     1111   122348888889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-37  Score=251.38  Aligned_cols=196  Identities=25%  Similarity=0.392  Sum_probs=154.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.. ...++||||+.+|+|.+++...   ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~d  126 (259)
T cd05037          54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGN  126 (259)
T ss_pred             HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---Ceeccc
Confidence            5788999999999999988 7789999999999999999432   22689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC-------ceEEeecccccccCCCCcceeeeecccccccCccccccC--ccccccceEehhHHHHHHHh
Q 023808           82 IKASNILLDQEF-------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        82 ikp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~ellt  152 (277)
                      |||+||+++.++       .+||+|||++.....     .....++..|+|||++.+.  .++.++||||||+++|||++
T Consensus       127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~  201 (259)
T cd05037         127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS  201 (259)
T ss_pred             CccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence            999999999887       799999999986543     2233466789999998876  78999999999999999999


Q ss_pred             C-CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 G-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      | ..|+.......   ...+.    .....       ....   ....+.+++.+||..+|.+||++.+|++.|+
T Consensus       202 ~~~~p~~~~~~~~---~~~~~----~~~~~-------~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         202 NGEEPLSTLSSSE---KERFY----QDQHR-------LPMP---DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCCCcccCCchh---HHHHH----hcCCC-------CCCC---CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            5 55654432111   11100    00000       0000   0145788899999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-37  Score=254.72  Aligned_cols=210  Identities=23%  Similarity=0.398  Sum_probs=161.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------CCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      ++++++||||+++++++.+.+..++||||+.+|+|.+++.....      .....++..++.++.|++.||.|||+.   
T Consensus        62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---  138 (288)
T cd05061          62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---  138 (288)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            46788999999999999999999999999999999999954221      112356788899999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      +++||||||+||++++++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus       139 ~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~  218 (288)
T cd05061         139 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA  218 (288)
T ss_pred             CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865432211 1122335678999999988889999999999999999998 6


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ..||.....   ......   .......      ..   +......+.+++.+||+.+|++||++.++++.|++.+
T Consensus       219 ~~p~~~~~~---~~~~~~---~~~~~~~------~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         219 EQPYQGLSN---EQVLKF---VMDGGYL------DQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCH---HHHHHH---HHcCCCC------CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            777754322   111111   1111111      01   1112245888889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=250.02  Aligned_cols=204  Identities=24%  Similarity=0.373  Sum_probs=160.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..+++|||+.+++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~d  126 (262)
T cd06613          53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRD  126 (262)
T ss_pred             HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecC
Confidence            46789999999999999999999999999999999999842   225689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC---ccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.   .++.++|+||||+++|||+||+.|+.
T Consensus       127 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~  205 (262)
T cd06613         127 IKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF  205 (262)
T ss_pred             CChhhEEECCCCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999987654322 122334678899999998776   78899999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......  ..    .......     .+............+.+++.+||+.+|.+||++.+|+.
T Consensus       206 ~~~~~~~--~~----~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         206 DLHPMRA--LF----LISKSNF-----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCCHHHH--HH----HHHhccC-----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            5332111  10    1111100     00011112334456888999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.3e-37  Score=251.18  Aligned_cols=200  Identities=26%  Similarity=0.439  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++++|..+.        .+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  120 (279)
T cd06619          52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRD  120 (279)
T ss_pred             HHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCC
Confidence            467889999999999999999999999999999997653        367888999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.++|+|||++......   ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       121 lkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  197 (279)
T cd06619         121 VKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ  197 (279)
T ss_pred             CCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence            9999999999999999999999865332   1233568899999999998889999999999999999999999986543


Q ss_pred             Ccchhh-HHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKF-LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...... ..... ........     +.+..  ......+.+++.+||+.+|++||++.++++
T Consensus       198 ~~~~~~~~~~~~-~~~~~~~~-----~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         198 KNQGSLMPLQLL-QCIVDEDP-----PVLPV--GQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             ccccccchHHHH-HHHhccCC-----CCCCC--CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            322111 11111 11111111     11100  111234778888999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-37  Score=264.88  Aligned_cols=210  Identities=22%  Similarity=0.286  Sum_probs=156.3

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++...+     ..|+||||+. ++|.+++    ..+..+++..+..++.|++.||+|||+.   +
T Consensus        52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~  123 (372)
T cd07853          52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA---G  123 (372)
T ss_pred             HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            467889999999999998776     7899999996 5888887    3445789999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      ++||||||+||+++.++.+||+|||+++..............++..|+|||.+.+. .++.++|||||||++|||++|+.
T Consensus       124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  203 (372)
T cd07853         124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI  203 (372)
T ss_pred             eeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence            99999999999999999999999999986543322223334578899999998774 47899999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHH-------------------h-ccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          156 SGKAMWGQMNKFLLEWAWQL-------------------H-QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~-------------------~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      ||........   ...+...                   . ......... ..+..........+.+++.+||+.||.+|
T Consensus       204 pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R  279 (372)
T cd07853         204 LFQAQSPIQQ---LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSL-PVLYTLSSQATHEAVHLLCRMLVFDPDKR  279 (372)
T ss_pred             CCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCch-HHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence            9865432111   0100000                   0 000000000 00000111123457788999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.+++.
T Consensus       280 ~t~~e~l~  287 (372)
T cd07853         280 ISAADALA  287 (372)
T ss_pred             cCHHHHhc
Confidence            99999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5e-37  Score=250.90  Aligned_cols=207  Identities=24%  Similarity=0.370  Sum_probs=161.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+. ..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        60 ~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~d  132 (270)
T cd05056          60 IMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRD  132 (270)
T ss_pred             HHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            46788999999999998764 56899999999999999943   233589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||+++..............++..|+|||.+....++.++||||||+++||+++ |..||...
T Consensus       133 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  212 (270)
T cd05056         133 IAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV  212 (270)
T ss_pred             cChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999998665432222223334567999999888889999999999999999986 98887544


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ...   ....   ........      ..   +......+.+++.+|+..+|.+||++.++++.|+++..
T Consensus       213 ~~~---~~~~---~~~~~~~~------~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         213 KNN---DVIG---RIENGERL------PM---PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CHH---HHHH---HHHcCCcC------CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            321   1111   11111111      11   11222347788888999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-37  Score=251.27  Aligned_cols=209  Identities=28%  Similarity=0.424  Sum_probs=163.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.. ...++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        62 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~d  134 (279)
T cd05057          62 VMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRD  134 (279)
T ss_pred             HHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecc
Confidence            4678899999999999987 688999999999999999843   233589999999999999999999998   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee-eeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||+++.++.+||+|||+++.......... ....++..|+|||.+....++.++|+||||+++||+++ |..||..
T Consensus       135 i~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  214 (279)
T cd05057         135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG  214 (279)
T ss_pred             cCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999999987653322111 11223567999999988889999999999999999998 9988765


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ....   ....   .... ....        ..+......+.+++.+||..+|.+||++.++++.|.++.+.+
T Consensus       215 ~~~~---~~~~---~~~~-~~~~--------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         215 IPAV---EIPD---LLEK-GERL--------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCHH---HHHH---HHhC-CCCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            4321   1111   1111 1110        001112234778888999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-36  Score=255.47  Aligned_cols=206  Identities=19%  Similarity=0.192  Sum_probs=154.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++.+++|+||+++++++.+++..++||||+.+|+|.+++..   .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrD  127 (332)
T cd05623          54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRD  127 (332)
T ss_pred             HHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            35678999999999999999999999999999999999943   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||+++.++.+||+|||++...............||..|+|||++..     ..++.++|||||||++|||++|+.|
T Consensus       128 lkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P  207 (332)
T cd05623         128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP  207 (332)
T ss_pred             CCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence            99999999999999999999987654433333334568999999998863     4578899999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhh--hcCCCCHHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA--ASRRPQMNQVIKM  224 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~--p~~RPs~~~v~~~  224 (277)
                      |.....      ..............     .++.........+.+++.+|+..+  +..|+++.++++-
T Consensus       208 f~~~~~------~~~~~~i~~~~~~~-----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         208 FYAESL------VETYGKIMNHKERF-----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCCCH------HHHHHHHhCCCccc-----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            864321      11111221111110     011111122234666777777544  4447888888653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-37  Score=250.40  Aligned_cols=202  Identities=22%  Similarity=0.305  Sum_probs=160.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++..++..++||||+++|+|.+++..  ..+..+++..++.++.|++.||.|||+.   +++|+|
T Consensus        51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d  125 (255)
T cd08219          51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRD  125 (255)
T ss_pred             HHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCC
Confidence            46788999999999999999999999999999999998843  2344588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||++++++.++++|||.++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus       126 l~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  204 (255)
T cd08219         126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS  204 (255)
T ss_pred             CCcceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence            999999999999999999999986543221 2233568889999999988889999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      .      .......... ...        ..+......+.+++.+||+.+|++||++.+|+..
T Consensus       205 ~------~~~~~~~~~~-~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         205 W------KNLILKVCQG-SYK--------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             H------HHHHHHHhcC-CCC--------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1      1111111111 110        1111222347788889999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-37  Score=264.82  Aligned_cols=211  Identities=23%  Similarity=0.360  Sum_probs=162.6

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-----------------------------------
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-----------------------------------   45 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------   45 (277)
                      +|.++. ||||++++++|......++||||+.+|+|.++++....                                   
T Consensus        93 ~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (401)
T cd05107          93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGS  172 (401)
T ss_pred             HHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhh
Confidence            466786 99999999999999999999999999999999964321                                   


Q ss_pred             -----------------------------------------------------------CCccCCHHHHHHHHHHHHHHH
Q 023808           46 -----------------------------------------------------------ANIKLNWEKRSDICVGIAKGL   66 (277)
Q Consensus        46 -----------------------------------------------------------~~~~~~~~~~~~i~~qi~~~l   66 (277)
                                                                                 ....+++..+++++.|++.||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL  252 (401)
T cd05107         173 ESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGM  252 (401)
T ss_pred             ccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHH
Confidence                                                                       112467888999999999999


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhH
Q 023808           67 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV  145 (277)
Q Consensus        67 ~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  145 (277)
                      +|||+.   +++||||||+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+
T Consensus       253 ~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv  329 (401)
T cd05107         253 EFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI  329 (401)
T ss_pred             HHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHH
Confidence            999999   999999999999999999999999999986543221 1122334678899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          146 LVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       146 vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ++|||++ |..||.......  ..    ......+..     +..   +......+.+++.+||..+|.+||++.+|+..
T Consensus       330 il~e~l~~g~~P~~~~~~~~--~~----~~~~~~~~~-----~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         330 LLWEIFTLGGTPYPELPMNE--QF----YNAIKRGYR-----MAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCCCCCCchH--HH----HHHHHcCCC-----CCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999998 777875432111  11    111111111     011   11223457788888999999999999999999


Q ss_pred             Hhhcc
Q 023808          225 LTKNI  229 (277)
Q Consensus       225 L~~~~  229 (277)
                      |++++
T Consensus       396 L~~~~  400 (401)
T cd05107         396 VGDLL  400 (401)
T ss_pred             HHHHh
Confidence            98764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.1e-37  Score=257.85  Aligned_cols=192  Identities=26%  Similarity=0.311  Sum_probs=151.1

Q ss_pred             cccccC-CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |..++| ++|+++++++...+..|+||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~d  126 (324)
T cd05587          54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRD  126 (324)
T ss_pred             HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            455655 568899999999999999999999999999983    344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         127 LKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             CCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987432211 12334568999999999999889999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .   .....   .... ..      ..+   +......+.+++.+||+.+|.+|++.
T Consensus       206 ~---~~~~~---~i~~-~~------~~~---~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         206 E---DELFQ---SIME-HN------VSY---PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             H---HHHHH---HHHc-CC------CCC---CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2   11111   1111 11      111   11122347788888999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=261.50  Aligned_cols=194  Identities=25%  Similarity=0.235  Sum_probs=151.1

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +||||+++++++..++..++||||+.+|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+||||||+|
T Consensus        54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~N  126 (330)
T cd05586          54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPEN  126 (330)
T ss_pred             CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHH
Confidence            79999999999999999999999999999999883    445689999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcccCcch
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  165 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~  165 (277)
                      ||++.++.++|+|||+++...... .......||..|+|||++.+. .++.++|||||||++|||++|+.||......  
T Consensus       127 ili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--  203 (330)
T cd05586         127 ILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--  203 (330)
T ss_pred             eEECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--
Confidence            999999999999999987533221 123345689999999998764 4789999999999999999999998653221  


Q ss_pred             hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC----HHHHHH
Q 023808          166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ----MNQVIK  223 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs----~~~v~~  223 (277)
                          ...........       .+..  ......+.+++.+||+.||.+||+    +.++++
T Consensus       204 ----~~~~~i~~~~~-------~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         204 ----QMYRNIAFGKV-------RFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----HHHHHHHcCCC-------CCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                11111111110       1100  011224667888899999999984    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.2e-37  Score=250.05  Aligned_cols=202  Identities=21%  Similarity=0.360  Sum_probs=162.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.+.+..+++|||+.+|+|.+++...  ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~d  126 (256)
T cd08221          52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRD  126 (256)
T ss_pred             HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccC
Confidence            577899999999999999999999999999999999999532  244689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++++.+||+|||++........ ......++..|+|||...+..++.++||||||+++|||++|..||....
T Consensus       127 l~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         127 IKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             CChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999999999986644332 2334568899999999988888999999999999999999999875432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      .      ........... .        ..........+.+++.+||+.+|.+||++.++++.
T Consensus       206 ~------~~~~~~~~~~~-~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         206 P------LNLVVKIVQGN-Y--------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             H------HHHHHHHHcCC-C--------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1      11111111111 1        11112223457788888999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.4e-37  Score=250.57  Aligned_cols=205  Identities=26%  Similarity=0.349  Sum_probs=162.3

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDI   82 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~di   82 (277)
                      ++++||||+++++++.+++..++||||+++++|.+++.........+++..+++++.|++.||.|||+ .   +++|+||
T Consensus        64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl  140 (269)
T cd08528          64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDL  140 (269)
T ss_pred             hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCC
Confidence            35799999999999999999999999999999999885433445578999999999999999999996 5   8999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      +|+||+++.++.++|+|||.+.......  ......|+..|++||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus       141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~  218 (269)
T cd08528         141 TPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM  218 (269)
T ss_pred             CHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH
Confidence            9999999999999999999998654432  23345688899999999988899999999999999999999998754321


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..   .   ...... ....    +....   .....+.+++.+||+.||++||++.||..++++
T Consensus       219 ~~---~---~~~~~~-~~~~----~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         219 LS---L---ATKIVE-AVYE----PLPEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HH---H---HHHHhh-ccCC----cCCcc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            11   1   111111 1110    10010   112347788888999999999999999998853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.6e-37  Score=257.92  Aligned_cols=153  Identities=20%  Similarity=0.246  Sum_probs=128.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||++++++|..++..++||||+++|+|.+++..+  ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~d  126 (327)
T cd08227          52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRS  126 (327)
T ss_pred             HHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCC
Confidence            466789999999999999999999999999999999998532  223589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc------eeeeecccccccCcccccc--CccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+||+++.++.++++||+...........      ......++..|+|||++.+  ..++.++|||||||++|||++|
T Consensus       127 lkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g  206 (327)
T cd08227         127 VKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG  206 (327)
T ss_pred             CChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence            9999999999999999999865433211110      1122346678999999876  3588999999999999999999


Q ss_pred             CCCCCc
Q 023808          154 RNSGKA  159 (277)
Q Consensus       154 ~~p~~~  159 (277)
                      +.||..
T Consensus       207 ~~pf~~  212 (327)
T cd08227         207 HVPFKD  212 (327)
T ss_pred             CCCCCC
Confidence            999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=263.77  Aligned_cols=199  Identities=25%  Similarity=0.402  Sum_probs=157.5

Q ss_pred             ccccccCCCccceeeEEEeCCe--eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTR--RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|+.|+||||+++|.++.+...  .-+|+|.+..|+|..|++    ..+.+..+.+.+|+.||+.||.|||++. |+|||
T Consensus        94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIH  168 (632)
T KOG0584|consen   94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIH  168 (632)
T ss_pred             HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccc
Confidence            5889999999999999997765  678999999999999994    4556788899999999999999999985 47999


Q ss_pred             ccCCCCcEEeCCC-CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||||.+|||++.+ |.|||+|.|+|.......   .....||+.|||||++. ..|++..||||||+.++||+|+..|+.
T Consensus       169 RDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  169 RDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             cccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            9999999999765 789999999999765443   23478999999999776 789999999999999999999998864


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .=.     ...+...++..+.++..+ .    .....   ++.++|.+|+.. ..+||++.|+++
T Consensus       245 EC~-----n~AQIYKKV~SGiKP~sl-~----kV~dP---evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  245 ECT-----NPAQIYKKVTSGIKPAAL-S----KVKDP---EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hhC-----CHHHHHHHHHcCCCHHHh-h----ccCCH---HHHHHHHHHhcC-chhccCHHHHhh
Confidence            211     122222333333332221 1    11112   267778889998 999999999865

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-37  Score=246.90  Aligned_cols=204  Identities=27%  Similarity=0.379  Sum_probs=159.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++......++||||+.+++|.+++..   ....+++..++.++.+++.||+|||++   +++|||
T Consensus        45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~d  118 (251)
T cd05041          45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRD  118 (251)
T ss_pred             HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhh
Confidence            46789999999999999999999999999999999999843   234688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee-eeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |+|+||+++.++.++|+|||+++.......... ....++..|+|||.+.++.++.++|+||||+++|||+| |..|+..
T Consensus       119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~  198 (251)
T cd05041         119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG  198 (251)
T ss_pred             cCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence            999999999999999999999986542211111 12233567999999988889999999999999999999 6777644


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      .....   ...    .......     ...   +......+.+++.+||..+|.+||++.||++.|+
T Consensus       199 ~~~~~---~~~----~~~~~~~-----~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         199 MSNQQ---TRE----RIESGYR-----MPA---PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHH---HHH----HHhcCCC-----CCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            32211   111    1111100     001   1122335788888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-36  Score=247.76  Aligned_cols=205  Identities=27%  Similarity=0.424  Sum_probs=161.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.+ ...+++|||+.+|+|.+++...  .+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~d  127 (260)
T cd05073          54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD  127 (260)
T ss_pred             HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            4778999999999999888 7789999999999999999542  344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |+|+||+++.++.+||+|||.+...............++..|+|||++....++.++|+||||+++|+++| |..||...
T Consensus       128 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             cCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999998665433222233345678999999988889999999999999999999 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   .....    ........    .    .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       208 ~~~---~~~~~----~~~~~~~~----~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         208 SNP---EVIRA----LERGYRMP----R----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CHH---HHHHH----HhCCCCCC----C----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            221   11111    11111110    1    11223347788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-37  Score=269.01  Aligned_cols=213  Identities=21%  Similarity=0.267  Sum_probs=154.7

Q ss_pred             ccccccCCCccceeeEEEeC--------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG--------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++...        ...++||||+.+ +|.+++......+..+++..+..++.|++.||+|||+. 
T Consensus       112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-  189 (440)
T PTZ00036        112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-  189 (440)
T ss_pred             HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            57889999999999987532        246789999975 78877754444566799999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~ell  151 (277)
                        +|+||||||+|||++.++ .+||+|||+++.+....  ......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus       190 --~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  265 (440)
T PTZ00036        190 --FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI  265 (440)
T ss_pred             --CEecCCcCHHHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence              999999999999998665 69999999998654322  12335678999999988764 6899999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCc----------cccccCC-----C-CCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKP----------LELVDPE-----L-GEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~-----~-~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +|..||.......  .+.. +.........          ....-+.     + ..++.....++.+++.+||+.+|.+|
T Consensus       266 tG~~pf~~~~~~~--~~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R  342 (440)
T PTZ00036        266 LGYPIFSGQSSVD--QLVR-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR  342 (440)
T ss_pred             hCCCCCCCCChHH--HHHH-HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence            9999986543211  1111 1111100000          0000000     0 00111123457888999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.|++.
T Consensus       343 ~ta~e~l~  350 (440)
T PTZ00036        343 LNPIEALA  350 (440)
T ss_pred             cCHHHHhC
Confidence            99999874

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.9e-37  Score=250.55  Aligned_cols=203  Identities=20%  Similarity=0.345  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..++..++||||+++++|.+++.    ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        59 ~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  131 (267)
T cd06645          59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRD  131 (267)
T ss_pred             HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4667899999999999999999999999999999999983    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++.++|+|||++....... .......|+..|+|||++.   ...++.++|+|||||++|+|++|..|+.
T Consensus       132 lkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         132 IKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             CCHHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence            99999999999999999999987654321 1223346889999999874   4458889999999999999999999875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......  .    .........    .+.... .......+.+++.+||+.+|++||++.+|++
T Consensus       211 ~~~~~~~--~----~~~~~~~~~----~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         211 DLHPMRA--L----FLMTKSNFQ----PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccchhh--H----HhhhccCCC----CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            4332111  0    010000000    011100 0011234778888999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-37  Score=249.16  Aligned_cols=206  Identities=30%  Similarity=0.472  Sum_probs=162.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..+...++||||+++++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~d  128 (261)
T cd05034          54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRD  128 (261)
T ss_pred             HHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            467899999999999999989999999999999999999542  334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.++|+|||+++.+............++..|+|||.+.+..++.++|+||||+++||+++ |+.||...
T Consensus       129 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             cchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765432222222334568999999988889999999999999999999 88887533


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..   ......   ......      ...   +......+.+++.+|++.+|.+||+++++...|+.
T Consensus       209 ~~---~~~~~~---~~~~~~------~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         209 TN---REVLEQ---VERGYR------MPR---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CH---HHHHHH---HHcCCC------CCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            21   111111   111100      000   11113357788899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-37  Score=248.63  Aligned_cols=202  Identities=29%  Similarity=0.448  Sum_probs=160.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++......++||||+.+++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~d  127 (256)
T cd05039          53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD  127 (256)
T ss_pred             HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccchh
Confidence            467899999999999999999999999999999999999532  223689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||.++.......    ....+..|+|||++.+..++.++||||||+++||+++ |..||...
T Consensus       128 i~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             cccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999999986533211    2334567999999988889999999999999999997 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..   ..+..    ........     ..   +......+.+++.+||..+|++||++.++++.|+.
T Consensus       204 ~~---~~~~~----~~~~~~~~-----~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         204 PL---KDVVP----HVEKGYRM-----EA---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CH---HHHHH----HHhcCCCC-----CC---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            21   11111    11111110     11   11122347788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.4e-37  Score=249.93  Aligned_cols=203  Identities=26%  Similarity=0.469  Sum_probs=159.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++......++||||+.+++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~d  125 (256)
T cd05112          52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRD  125 (256)
T ss_pred             HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            46789999999999999999999999999999999999842   233588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||.++..............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       126 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  205 (256)
T cd05112         126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR  205 (256)
T ss_pred             cccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            99999999999999999999988654332222222334578999999988889999999999999999998 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ..   .....   ......   ....+..      ....+.+++.+||+.+|++||++.++++.|
T Consensus       206 ~~---~~~~~---~~~~~~---~~~~~~~------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         206 SN---SEVVE---TINAGF---RLYKPRL------ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CH---HHHHH---HHhCCC---CCCCCCC------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            21   11111   111110   1111111      124578889999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.3e-37  Score=248.70  Aligned_cols=202  Identities=26%  Similarity=0.422  Sum_probs=160.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..+...++++||+.+++|.+++.   ..+..+++..+..++.|++.||.|||+.   +++|+|
T Consensus        51 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~d  124 (256)
T cd06612          51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRD  124 (256)
T ss_pred             HHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            3678899999999999999999999999999999999984   2345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus       125 l~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~  203 (256)
T cd06612         125 IKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH  203 (256)
T ss_pred             CCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999999987654321 2233457889999999988889999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....      ... .....     +. ...+......+.+++.+||+.+|.+||++.+|+.
T Consensus       204 ~~~~~------~~~-~~~~~-----~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         204 PMRAI------FMI-PNKPP-----PT-LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhhh------hhh-ccCCC-----CC-CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            21110      000 00000     00 1112222345778888999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.4e-37  Score=255.27  Aligned_cols=155  Identities=26%  Similarity=0.452  Sum_probs=127.4

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCC-----CCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGAT-----KANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++++||||+++++++..  +...++||||+. ++|.+++....     .....+++..+..++.|++.||+|||+.  
T Consensus        51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--  127 (317)
T cd07868          51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--  127 (317)
T ss_pred             HHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5788999999999999864  456889999995 48888874321     1223589999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEe----CCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccC-ccccccceEehhHHH
Q 023808           75 PHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLV  147 (277)
Q Consensus        75 ~~iiH~dikp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl  147 (277)
                       +++||||||+|||+    +.++.+||+|||+++.+......  ......||..|+|||++.+. .++.++||||+||++
T Consensus       128 -~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  206 (317)
T cd07868         128 -WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  206 (317)
T ss_pred             -CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence             99999999999999    45678999999999876543221  22345689999999998774 588999999999999


Q ss_pred             HHHHhCCCCCCcc
Q 023808          148 LEIISGRNSGKAM  160 (277)
Q Consensus       148 ~elltg~~p~~~~  160 (277)
                      |||++|+.||...
T Consensus       207 ~el~~g~~~f~~~  219 (317)
T cd07868         207 AELLTSEPIFHCR  219 (317)
T ss_pred             HHHHhCCCCccCC
Confidence            9999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=253.50  Aligned_cols=152  Identities=24%  Similarity=0.297  Sum_probs=132.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++.+++|+||+++++++.+++..|+||||+.+|+|.+++..   .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~d  127 (331)
T cd05597          54 VLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRD  127 (331)
T ss_pred             HHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECC
Confidence            35678999999999999999999999999999999999942   244689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+|||++.++.+||+|||++..+............||..|+|||++..     ..++.++|||||||++|||++|+.|
T Consensus       128 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P  207 (331)
T cd05597         128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             CCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence            99999999999999999999987654433322333568999999999863     4578899999999999999999999


Q ss_pred             CCc
Q 023808          157 GKA  159 (277)
Q Consensus       157 ~~~  159 (277)
                      |..
T Consensus       208 f~~  210 (331)
T cd05597         208 FYA  210 (331)
T ss_pred             CCC
Confidence            864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-37  Score=251.60  Aligned_cols=203  Identities=25%  Similarity=0.298  Sum_probs=158.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++.+..++..++||||+.+++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~d  127 (285)
T cd05630          53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRD  127 (285)
T ss_pred             HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCC
Confidence            467899999999999999999999999999999999988432  233589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.++|+|||++........  .....|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       128 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         128 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             CCHHHEEECCCCCEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543221  123468999999999998899999999999999999999999987543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      .........   .......      ....   ......+.+++..||+.||++||+     +.|++.
T Consensus       206 ~~~~~~~~~---~~~~~~~------~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         206 KKIKREEVE---RLVKEVQ------EEYS---EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ccchHHHHH---hhhhhhh------hhcC---ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            321111111   1100000      0011   111223678888899999999999     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.8e-37  Score=256.84  Aligned_cols=188  Identities=26%  Similarity=0.336  Sum_probs=151.3

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +|++|+++++++...+..++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~N  131 (323)
T cd05616          59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDN  131 (323)
T ss_pred             CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHH
Confidence            68999999999999999999999999999999983    344689999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchh
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  166 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~  166 (277)
                      ||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....   .
T Consensus       132 ill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~  207 (323)
T cd05616         132 VMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---D  207 (323)
T ss_pred             eEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---H
Confidence            999999999999999987543221 122345689999999999999999999999999999999999999865332   1


Q ss_pred             hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          167 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      ....   ..... ..      .   .+......+.+++.+|++.+|.+|++.
T Consensus       208 ~~~~---~i~~~-~~------~---~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         208 ELFQ---SIMEH-NV------A---YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHH---HHHhC-CC------C---CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1111   11111 10      1   111223457788889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-37  Score=255.27  Aligned_cols=212  Identities=26%  Similarity=0.424  Sum_probs=162.6

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++..  +...++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        59 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H  132 (284)
T cd05038          59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIH  132 (284)
T ss_pred             HHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            4678899999999999987  5688999999999999999943   223589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||||+||+++.++.++|+|||.+..........  .....++..|++||.+.+..++.++||||||++++||+||..|+
T Consensus       133 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~  212 (284)
T cd05038         133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS  212 (284)
T ss_pred             CCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCc
Confidence            9999999999999999999999998765332211  11233456799999998888999999999999999999999887


Q ss_pred             CcccCcchh---------hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          158 KAMWGQMNK---------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       158 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .........         ...... .........        ..+......+.+++.+||+.+|.+||++.+|+++|+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         213 QSPPAEFLRMIGIAQGQMIVTRLL-ELLKEGERL--------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccchhccccccccccccHHHHH-HHHHcCCcC--------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            543321100         011111 111111100        00112224578888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-37  Score=251.70  Aligned_cols=205  Identities=27%  Similarity=0.407  Sum_probs=160.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+....++||||+.+++|.+++.    ....+++..++.++.|++.||++||+.   +++|+|
T Consensus        51 ~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~d  123 (260)
T PF00069_consen   51 ILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRD  123 (260)
T ss_dssp             HHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccc---cccccc
Confidence            4567899999999999999999999999999999999994    455689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-cCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||.+..... .........++..|+|||++. +...+.++||||+|+++|+|++|..|+...
T Consensus       124 ikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  124 IKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             BSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999976422 222344566889999999998 788999999999999999999999998765


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ............   ........   ..   ........+.+++..||+.||++||++.++++
T Consensus       203 ~~~~~~~~~~~~---~~~~~~~~---~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  203 NSDDQLEIIEKI---LKRPLPSS---SQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHHHHHHHHHHH---HHTHHHHH---TT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cchhhhhhhhhc---cccccccc---cc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211111111111   10000000   00   00001155888889999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.7e-37  Score=254.68  Aligned_cols=208  Identities=26%  Similarity=0.420  Sum_probs=161.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||++++|+|... ..++++||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        62 ~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~d  134 (303)
T cd05110          62 IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRD  134 (303)
T ss_pred             HHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---Ceeccc
Confidence            46788999999999999765 46789999999999999842   334588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||+++.++.+||+|||+++........ ......++..|++||++.+..++.++||||||+++|||++ |..||..
T Consensus       135 ikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~  214 (303)
T cd05110         135 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG  214 (303)
T ss_pred             cccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999866433221 1222345678999999988889999999999999999997 8888754


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ...   .....+    .......    +    .++.....+.+++..||..+|++||++.++++.|.++...
T Consensus       215 ~~~---~~~~~~----~~~~~~~----~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         215 IPT---REIPDL----LEKGERL----P----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCH---HHHHHH----HHCCCCC----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            321   111111    1111110    0    0111223577888999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-37  Score=247.91  Aligned_cols=201  Identities=22%  Similarity=0.274  Sum_probs=162.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ||+.++||.++.+|+.|+.++..|+|||||.||+|..+++.  +.++.+++..+.-++.+++-||+|||..   |||+||
T Consensus       130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRD  204 (459)
T KOG0610|consen  130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRD  204 (459)
T ss_pred             HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeecc
Confidence            68899999999999999999999999999999999999853  5667899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCC---------------------------------C-C-----------------
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPD---------------------------------N-I-----------------  110 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~---------------------------------~-~-----------------  110 (277)
                      |||+||||.++|++-|+||.++.....                                 . .                 
T Consensus       205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~  284 (459)
T KOG0610|consen  205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV  284 (459)
T ss_pred             CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence            999999999999999999998753210                                 0 0                 


Q ss_pred             ----cceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCcccccc
Q 023808          111 ----THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  186 (277)
Q Consensus       111 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (277)
                          ......++||-.|+|||++.+..-+.+.|+|+|||++||||.|..||........  +.    ++..+       +
T Consensus       285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~----NIv~~-------~  351 (459)
T KOG0610|consen  285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LR----NIVGQ-------P  351 (459)
T ss_pred             cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HH----HHhcC-------C
Confidence                0012235788999999999999999999999999999999999999987654321  11    11111       1


Q ss_pred             CCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC----HHHH
Q 023808          187 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQ----MNQV  221 (277)
Q Consensus       187 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs----~~~v  221 (277)
                      ..++..+ .....+.+||++.|.+||.+|-.    +.||
T Consensus       352 l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  352 LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            1222222 44456889999999999999988    6665

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-36  Score=249.33  Aligned_cols=202  Identities=26%  Similarity=0.435  Sum_probs=156.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..+...++||||+.+++|..++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~d  128 (282)
T cd06643          55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRD  128 (282)
T ss_pred             HHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecC
Confidence            46788999999999999999999999999999999998742   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||+++.++.++|+|||++....... .......++..|+|||++.     +..++.++|||||||++|||++|+.|
T Consensus       129 lkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  207 (282)
T cd06643         129 LKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP  207 (282)
T ss_pred             CCcccEEEccCCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence            99999999999999999999987543321 1123345888999999874     34577899999999999999999998


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |......  ....    ........ ....      +......+.+++.+||+.+|.+||++.++++
T Consensus       208 ~~~~~~~--~~~~----~~~~~~~~-~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         208 HHELNPM--RVLL----KIAKSEPP-TLAQ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccccCHH--HHHH----HHhhcCCC-CCCC------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            7653221  1111    11111110 0000      1112234778888999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.1e-37  Score=254.14  Aligned_cols=200  Identities=24%  Similarity=0.430  Sum_probs=158.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+.+++|.+++..     ..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        70 ~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~d  141 (296)
T cd06654          70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD  141 (296)
T ss_pred             HHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            46778999999999999999999999999999999999832     3478999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       142 Lkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             CCHHHEEEcCCCCEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876433211 1223457889999999988888999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  .    ......... .     + ..+......+.+++.+||..+|++||++.+|+.
T Consensus       221 ~~~~--~----~~~~~~~~~-~-----~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         221 PLRA--L----YLIATNGTP-E-----L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHh--H----HHHhcCCCC-C-----C-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            2110  1    011111110 0     0 111222344778889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.6e-37  Score=255.52  Aligned_cols=155  Identities=26%  Similarity=0.453  Sum_probs=126.7

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCC-----CCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGAT-----KANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++++||||+++++++..  +...++||||+.+ +|.+++....     .....+++..+..++.|++.||+|||+.  
T Consensus        51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--  127 (317)
T cd07867          51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--  127 (317)
T ss_pred             HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5778999999999999864  4578999999965 7887774221     1223588999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEe----CCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccC-ccccccceEehhHHH
Q 023808           75 PHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLV  147 (277)
Q Consensus        75 ~~iiH~dikp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl  147 (277)
                       +++||||||+||++    +.++.+||+|||+++........  ......||..|+|||.+.+. .++.++||||||+++
T Consensus       128 -~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il  206 (317)
T cd07867         128 -WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  206 (317)
T ss_pred             -CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence             99999999999999    55678999999999876543221  12345688999999998764 578999999999999


Q ss_pred             HHHHhCCCCCCcc
Q 023808          148 LEIISGRNSGKAM  160 (277)
Q Consensus       148 ~elltg~~p~~~~  160 (277)
                      |||+||+.||...
T Consensus       207 ~el~tg~~~f~~~  219 (317)
T cd07867         207 AELLTSEPIFHCR  219 (317)
T ss_pred             HHHHhCCCCcccc
Confidence            9999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-36  Score=249.42  Aligned_cols=208  Identities=25%  Similarity=0.386  Sum_probs=160.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCC-----ccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN-----IKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++|+||+++++++.+....++||||+++|+|.+++.......     ..+++..+..++.|++.||+|||+.   +
T Consensus        61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~  137 (275)
T cd05046          61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---R  137 (275)
T ss_pred             HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---C
Confidence            4788999999999999999999999999999999999995432111     1589999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRN  155 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~  155 (277)
                      ++|+||||+||+++.++.++++|||+++..............++..|++||.+.+..++.++||||||+++|+|++ |..
T Consensus       138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~  217 (275)
T cd05046         138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL  217 (275)
T ss_pred             cccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987543322222223346678999999988888999999999999999999 677


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ||.....   .....   .... .... .   ....   .....+.+++.+||+.+|.+||++.++++.|.
T Consensus       218 p~~~~~~---~~~~~---~~~~-~~~~-~---~~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         218 PFYGLSD---EEVLN---RLQA-GKLE-L---PVPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             Cccccch---HHHHH---HHHc-CCcC-C---CCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            7754322   11111   1111 1110 0   0111   12234778888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=265.41  Aligned_cols=200  Identities=28%  Similarity=0.386  Sum_probs=162.4

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL--NWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++|+|+|||+++|.|.++++.-+.||-.+||+|.++|+.   +=+++  .+...--+.+||+.||.|||++   .|||||
T Consensus       627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRD  700 (1226)
T KOG4279|consen  627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRD  700 (1226)
T ss_pred             HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeecc
Confidence            578999999999999999999999999999999999953   22244  6778888999999999999999   999999


Q ss_pred             CCCCcEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccC--ccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||-+|+|++ -.|.+||+|||.++.+.. ....+.++.||.-|||||++-.+  .|..++|||||||++.||.||++||.
T Consensus       701 IKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  701 IKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             ccCCcEEEeeccceEEecccccchhhcc-CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence            999999995 568899999999987543 23446678899999999999765  48899999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ........        .++-+.  ....   +..+.....+...+|.+|+..+|.+||++.+++.
T Consensus       780 ElgspqAA--------MFkVGm--yKvH---P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  780 ELGSPQAA--------MFKVGM--YKVH---PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ecCChhHh--------hhhhcc--eecC---CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            54332211        111111  1111   3446667778889999999999999999999865

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-37  Score=248.98  Aligned_cols=216  Identities=25%  Similarity=0.299  Sum_probs=161.3

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++|||||++.-+|....     +..+||||++. +|.++++.....+..++.-.+.-+..||.+||+|||+.   +
T Consensus        70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~  145 (364)
T KOG0658|consen   70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---G  145 (364)
T ss_pred             HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---C
Confidence            577899999999998887432     44589999977 99999976556677788888888999999999999998   9


Q ss_pred             eEeccCCCCcEEeCCC-CceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCC
Q 023808           77 IVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        77 iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~  154 (277)
                      |+||||||.|+|+|.+ |.+||||||.|+.+..+...  .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|+
T Consensus       146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~  223 (364)
T KOG0658|consen  146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ  223 (364)
T ss_pred             cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC
Confidence            9999999999999876 88999999999987654333  445678899999999885 6999999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCc-------cccccCCCCC------CCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKP-------LELVDPELGE------YPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      .-|.+....+.....-.+......+..       .+...+.+..      .......+.++++.++++.+|.+|.++.|+
T Consensus       224 plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~  303 (364)
T KOG0658|consen  224 PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA  303 (364)
T ss_pred             cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence            877664433222211111110000000       0111111111      122334457888999999999999999888


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      +.
T Consensus       304 l~  305 (364)
T KOG0658|consen  304 LA  305 (364)
T ss_pred             hc
Confidence            74

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.9e-36  Score=248.48  Aligned_cols=199  Identities=25%  Similarity=0.393  Sum_probs=160.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++..     ..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~d  126 (277)
T cd06640          55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRD  126 (277)
T ss_pred             HHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcC
Confidence            46788999999999999999999999999999999999832     3588899999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||+++|||+||..|+....
T Consensus       127 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06640         127 IKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH  205 (277)
T ss_pred             CChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            999999999999999999999976543221 1223457888999999988889999999999999999999999876433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ....      .... ....        ...........+.+++.+||+.+|++||++.+++..
T Consensus       206 ~~~~------~~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         206 PMRV------LFLI-PKNN--------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hHhH------hhhh-hcCC--------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2110      0010 0000        112233445568889999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-36  Score=275.04  Aligned_cols=214  Identities=21%  Similarity=0.306  Sum_probs=162.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-------CCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------ANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      ++++++||||+++++++.+++..++||||++||+|.+++.....       ....+++..+++++.|++.||+|||+.  
T Consensus        55 ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--  132 (932)
T PRK13184         55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--  132 (932)
T ss_pred             HHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46788999999999999999999999999999999999853211       123467788899999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-----------------ceeeeecccccccCccccccCccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-----------------HITTRIAGTTGYLAPEYVLGGQLTMK  137 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~  137 (277)
                       +++||||||+||+++.++.++|+|||+++.......                 .......||+.|+|||.+.+..++.+
T Consensus       133 -GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k  211 (932)
T PRK13184        133 -GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES  211 (932)
T ss_pred             -CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence             999999999999999999999999999986521110                 01123468999999999999899999


Q ss_pred             cceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-  216 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-  216 (277)
                      +|||||||++|||+||..||........   .. . ...  ......  ......    ...+.+++.+|++.||++|| 
T Consensus       212 SDIWSLGVILyELLTG~~PF~~~~~~ki---~~-~-~~i--~~P~~~--~p~~~i----P~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        212 TDIYALGVILYQMLTLSFPYRRKKGRKI---SY-R-DVI--LSPIEV--APYREI----PPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             hHHHHHHHHHHHHHHCCCCCCCcchhhh---hh-h-hhc--cChhhc--cccccC----CHHHHHHHHHHccCChhhCcC
Confidence            9999999999999999999865322110   00 0 000  000000  001112    23477888899999999996 


Q ss_pred             CHHHHHHHHhhcccc
Q 023808          217 QMNQVIKMLTKNIRL  231 (277)
Q Consensus       217 s~~~v~~~L~~~~~~  231 (277)
                      +++++.+.|+..+..
T Consensus       279 s~eeLl~~Le~~lq~  293 (932)
T PRK13184        279 SVQELKQDLEPHLQG  293 (932)
T ss_pred             HHHHHHHHHHHHHhc
Confidence            577788888877653

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-37  Score=251.15  Aligned_cols=198  Identities=27%  Similarity=0.439  Sum_probs=159.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~d  126 (277)
T cd06642          55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRD  126 (277)
T ss_pred             HHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccC
Confidence            4678999999999999999999999999999999999983     23588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus       127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06642         127 IKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH  205 (277)
T ss_pred             CChheEEEeCCCCEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence            999999999999999999999986543221 1223457889999999998889999999999999999999999875432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ..   ... ....     .+.+   .......+.+++.+||+.+|.+||++.+|+.
T Consensus       206 ~~~---~~---~~~-~~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         206 PMR---VL---FLI-PKNS-----PPTL---EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             hhh---HH---hhh-hcCC-----CCCC---CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            211   00   011 1110     1111   1223345778888999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-36  Score=249.07  Aligned_cols=212  Identities=25%  Similarity=0.349  Sum_probs=160.2

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||++++++|...  ...++||||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|
T Consensus        52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H  128 (287)
T cd06621          52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIH  128 (287)
T ss_pred             HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            46789999999999998754  368999999999999998754334455689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      +||+|+||+++.++.++|+|||++.......   .....++..|++||.+.+..++.++||||||+++|+|++|..|+..
T Consensus       129 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  205 (287)
T cd06621         129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP  205 (287)
T ss_pred             CCCCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987543321   1234577889999999888899999999999999999999999875


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...... ............ ......+. . .........+.+++.+||+.+|.+||++.||++
T Consensus       206 ~~~~~~-~~~~~~~~~~~~-~~~~~~~~-~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         206 EGEPPL-GPIELLSYIVNM-PNPELKDE-P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCCCC-ChHHHHHHHhcC-CchhhccC-C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            532111 111111111111 11111000 0 000112345788999999999999999999976

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.2e-37  Score=251.50  Aligned_cols=214  Identities=22%  Similarity=0.278  Sum_probs=155.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+. ++|.+++.... .+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~d  126 (285)
T cd07861          52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRD  126 (285)
T ss_pred             HHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecC
Confidence            4678899999999999999999999999997 58988885432 235689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|+||+.|+...
T Consensus       127 l~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         127 LKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             CCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999987553321 112233567889999988654 4788999999999999999999888643


Q ss_pred             cCcchhhHHHHHHHH-------hccC--------CccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQL-------HQEE--------KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~-------~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....  ........       +...        ...................++.+++.+||+.||.+|||+.+|+.
T Consensus       206 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         206 SEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CHHHH--HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            22110  00000000       0000        00000000000001112234678899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-36  Score=249.00  Aligned_cols=206  Identities=27%  Similarity=0.417  Sum_probs=161.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +|++++||||+++++++......++||||+++++|.+++.    ....+++..+..++.+++.||.|||+ .   +++|+
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~  128 (284)
T cd06620          56 IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHR  128 (284)
T ss_pred             HHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhc---Ceecc
Confidence            4677899999999999999999999999999999999983    33468999999999999999999997 5   89999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||+|+||++++++.++|+|||++.......   .....|+..|+|||++.+..++.++|||||||++|+|+||..||...
T Consensus       129 dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~  205 (284)
T cd06620         129 DIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS  205 (284)
T ss_pred             CCCHHHEEECCCCcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999999999987543221   22356889999999998888999999999999999999999998754


Q ss_pred             cCcc-----hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          161 WGQM-----NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       161 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ....     ................      +.+..  ......+.+++.+||+.||.+||++.||++..
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         206 NIDDDGQDDPMGILDLLQQIVQEPP------PRLPS--SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             chhhhhhhhhhHHHHHHHHHhhccC------CCCCc--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            4321     1111122212111110      11100  11234577888899999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-36  Score=249.67  Aligned_cols=203  Identities=24%  Similarity=0.269  Sum_probs=157.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..++..++||||+.+++|.+++...  ....+++..+..++.|++.||.|||+.   +|+|||
T Consensus        53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~d  127 (285)
T cd05632          53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRD  127 (285)
T ss_pred             HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecC
Confidence            467899999999999999999999999999999999888432  234699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||++++++.++|+|||++........  .....|+..|+|||++.+..++.++|+||||+++|||++|..||....
T Consensus       128 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         128 LKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             CCHHHEEECCCCCEEEecCCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543211  233468999999999988889999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      ....   ............      ...   .......+.+++..||+.+|++||+     +.+++.
T Consensus       206 ~~~~---~~~~~~~~~~~~------~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         206 EKVK---REEVDRRVLETE------EVY---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HHHH---HHHHHHhhhccc------ccc---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            2111   111111111110      001   1112234677888899999999999     555544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-36  Score=245.06  Aligned_cols=204  Identities=28%  Similarity=0.476  Sum_probs=159.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++|+||+++++++.+.+..+++|||+.+++|.+++....  ...+++..+..++.|++.||++||+.   +++|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~d  128 (258)
T smart00219       54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRD  128 (258)
T ss_pred             HHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---Ceeecc
Confidence            4667899999999999999999999999999999999984321  11289999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |+|+||++++++.++|+|||+++..............++..|+|||.+.+..++.++||||||+++++|++ |..|+...
T Consensus       129 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      129 LAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             cccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765442222212336788999999988889999999999999999998 67776542


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ..   .....   ........      ..   +......+.+++.+|++.+|++|||+.++++.|
T Consensus       209 ~~---~~~~~---~~~~~~~~------~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      209 SN---EEVLE---YLKKGYRL------PK---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CH---HHHHH---HHhcCCCC------CC---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11   11111   11111111      11   111234577888899999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-36  Score=258.83  Aligned_cols=153  Identities=22%  Similarity=0.318  Sum_probs=133.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.+++..++||||++||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 ~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrD  126 (360)
T cd05627          54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRD  126 (360)
T ss_pred             HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccC
Confidence            4678899999999999999999999999999999999983    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc----------------------------------ceeeeecccccccCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT----------------------------------HITTRIAGTTGYLAPE  127 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE  127 (277)
                      |||+||+++.++.++|+|||+++.......                                  .......||..|+|||
T Consensus       127 Lkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  206 (360)
T cd05627         127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE  206 (360)
T ss_pred             CCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHH
Confidence            999999999999999999999875432110                                  0112346899999999


Q ss_pred             ccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808          128 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus       128 ~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      ++.+..++.++|||||||++|||++|+.||....
T Consensus       207 ~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             HHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence            9999899999999999999999999999986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-36  Score=250.00  Aligned_cols=210  Identities=26%  Similarity=0.336  Sum_probs=154.2

Q ss_pred             cccccCCCccceeeEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            3 LSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      |++++||||+++++++..     ....++||||+.+ +|.+++...  ....+++..+..++.|++.||+|||+.   ++
T Consensus        56 l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i  129 (288)
T cd07863          56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CI  129 (288)
T ss_pred             hhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            345689999999999874     3457899999975 898888432  233589999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||||||+||+++.++.+||+|||+++......  ......|+..|+|||++.+..++.++|||||||++|||++|..||
T Consensus       130 vH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f  207 (288)
T cd07863         130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF  207 (288)
T ss_pred             ecCCCCHHHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence            999999999999999999999999998654322  122345788999999998888999999999999999999999988


Q ss_pred             CcccCcchhhHHHHHHHHhccC----Cc------cccccCC----CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEE----KP------LELVDPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~----~~------~~~~~~~----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......   ............    ..      .....+.    .....+.....+.+++.+|++.||++||++.+++.
T Consensus       208 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         208 CGNSEAD---QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCCCHHH---HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            6433211   111111111000    00      0000000    01111223345778899999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.4e-37  Score=247.41  Aligned_cols=201  Identities=23%  Similarity=0.366  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++|+|++++++.+.. +...++||||+++++|.+++...  .+..+++.+++.++.|++.||++||+.   +++|+
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~  126 (257)
T cd08223          52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHR  126 (257)
T ss_pred             HHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            4678899999999998864 44688999999999999998532  344689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++++|++|+.|+...
T Consensus       127 di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             CCCchhEEEecCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999999986643322 223456788999999999888999999999999999999999887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..      .......... ..        ...+......+.+++.+|++.+|.+||++.++++
T Consensus       206 ~~------~~~~~~~~~~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         206 DM------NSLVYRIIEG-KL--------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CH------HHHHHHHHhc-CC--------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            21      1111111111 11        1112223345788899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-36  Score=265.79  Aligned_cols=218  Identities=20%  Similarity=0.266  Sum_probs=155.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||+++++++...+..|+|+|++. ++|.+++..... .........+..++.|++.||+|||+.   +|+||
T Consensus       216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHr  291 (501)
T PHA03210        216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHR  291 (501)
T ss_pred             HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            5788999999999999999999999999995 477777643221 122344667788999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC-CCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS-GKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p-~~~  159 (277)
                      ||||+|||++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..
T Consensus       292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             CCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence            9999999999999999999999987755433334456799999999999998999999999999999999998754 332


Q ss_pred             ccCcchhhHHHHHHHHhc--cCCc------cccccC----CCCCCCHH------HHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQ--EEKP------LELVDP----ELGEYPPN------EIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~--~~~~------~~~~~~----~~~~~~~~------~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      ........+.........  ....      ...++.    ......+.      ....+.+++.+||+.||.+||++.|+
T Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence            222211111111110000  0000      000000    00000000      11236677889999999999999999


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      +.
T Consensus       452 L~  453 (501)
T PHA03210        452 LA  453 (501)
T ss_pred             hh
Confidence            75

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=265.18  Aligned_cols=187  Identities=27%  Similarity=0.366  Sum_probs=154.7

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +||.+++++.+|...++.|+||||+.||++..+.     ....+++..+.-++..++.||.|||++   +||+||||.+|
T Consensus       427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdN  498 (694)
T KOG0694|consen  427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDN  498 (694)
T ss_pred             cCCeEeecccccccCCeEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---Cceeeecchhh
Confidence            7999999999999999999999999999955544     445799999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchh
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  166 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~  166 (277)
                      ||||.+|.+||+|||+++.-.. ....+.++.||+.|+|||++.+..|+.+.|.|||||++||||.|..||.....   .
T Consensus       499 iLLD~eGh~kiADFGlcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---e  574 (694)
T KOG0694|consen  499 LLLDTEGHVKIADFGLCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---E  574 (694)
T ss_pred             eEEcccCcEEecccccccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---H
Confidence            9999999999999999985332 23457789999999999999999999999999999999999999999875432   2


Q ss_pred             hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          167 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .+-+.   +...       ++.   ++.....+..+++.+.+..+|++|-.+
T Consensus       575 e~Fds---I~~d-------~~~---yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 EVFDS---IVND-------EVR---YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHH---HhcC-------CCC---CCCcccHHHHHHHHHHhccCcccccCC
Confidence            12111   1111       122   233344456777888999999999876

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-36  Score=253.43  Aligned_cols=214  Identities=21%  Similarity=0.310  Sum_probs=155.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+ +|.+++..   .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        57 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~d  129 (309)
T cd07872          57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRD  129 (309)
T ss_pred             HHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            46789999999999999999999999999975 88888742   344588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus       130 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         130 LKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             CCHHHEEECCCCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999976433221 1223457889999998865 45789999999999999999999998654


Q ss_pred             cCcchhhHHHH--------HHHHhccCCc-cccccCCC-----CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEW--------AWQLHQEEKP-LELVDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...........        .|........ .....+..     ....+.....+.+++.+|++.||.+|||+.|++.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            32211110000        0000000000 00000000     0001112334678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-36  Score=250.52  Aligned_cols=200  Identities=23%  Similarity=0.432  Sum_probs=158.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..++..++|+||+.+++|..++.     ...+++..+..++.|++.||+|||+.   +++|+|
T Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~d  140 (296)
T cd06655          69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD  140 (296)
T ss_pred             HHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4678899999999999999999999999999999999983     23589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       141 L~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             CCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543221 1223457889999999988889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  . .   ........ ..      ..+......+.+++.+||..+|.+||++.+|+.
T Consensus       220 ~~~~--~-~---~~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         220 PLRA--L-Y---LIATNGTP-EL------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHH--H-H---HHHhcCCc-cc------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            2111  0 0   11111100 00      011112234778888999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-36  Score=250.13  Aligned_cols=214  Identities=24%  Similarity=0.327  Sum_probs=158.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+++++|..++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~d  125 (286)
T cd07847          53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRD  125 (286)
T ss_pred             HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecC
Confidence            4678899999999999999999999999999999988873    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         126 VKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             CChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987644321 1223457788999999876 45788999999999999999999998654


Q ss_pred             cCcchhhHHHHH--------HHHhccCCc-cccccCCCC------CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWA--------WQLHQEEKP-LELVDPELG------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ............        ......... .....+...      ...+.....+.+++.+||+.+|++||++.+++.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         205 SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            322111100000        000000000 000000000      000112345778999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.1e-36  Score=246.59  Aligned_cols=202  Identities=24%  Similarity=0.363  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||++++++|.+.+..++||||+.+++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  127 (265)
T cd06631          55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRD  127 (265)
T ss_pred             HHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            4678899999999999999999999999999999999994    334688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-----cceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-----THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |+|+||+++.++.++|+|||++.......     ........|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus       128 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p  207 (265)
T cd06631         128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP  207 (265)
T ss_pred             cCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence            99999999999999999999987643211     1112234578899999999888899999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.......     .. .........    .+.+   +......+.+++.+||+.+|.+||++.+++.
T Consensus       208 ~~~~~~~~-----~~-~~~~~~~~~----~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         208 LASMDRLA-----AM-FYIGAHRGL----MPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             cccCChHH-----HH-HHhhhccCC----CCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            86432211     10 011111001    1111   1222334778888899999999999998864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-36  Score=256.10  Aligned_cols=147  Identities=31%  Similarity=0.449  Sum_probs=125.8

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++....      ..|+||||+.+ +|.+.+.      ..+++..+..++.|++.||+|||+.   
T Consensus        73 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---  142 (359)
T cd07876          73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---  142 (359)
T ss_pred             HHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            467889999999999987543      57999999965 6766662      2478889999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +|+||||||+||+++.++.+||+|||+++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       143 ~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~  220 (359)
T cd07876         143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV  220 (359)
T ss_pred             CcccCCCCHHHEEECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999997543321  2233568899999999999899999999999999999999999


Q ss_pred             CCCcc
Q 023808          156 SGKAM  160 (277)
Q Consensus       156 p~~~~  160 (277)
                      ||...
T Consensus       221 pf~~~  225 (359)
T cd07876         221 IFQGT  225 (359)
T ss_pred             CCCCC
Confidence            98754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=253.55  Aligned_cols=200  Identities=24%  Similarity=0.276  Sum_probs=165.6

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++|. ||||+.++++++..+..++|||+|+||.|.+.+...     .+++..+..++.|++.|+.|||+.   |++||
T Consensus        88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHr  159 (382)
T KOG0032|consen   88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHR  159 (382)
T ss_pred             HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---Cceec
Confidence            578888 999999999999999999999999999999999543     399999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCC----CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           81 DIKASNILLDQE----FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        81 dikp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||||+|+|+...    +.+|++|||++.....  ........||+.|+|||++....++..+||||+|+++|.|++|..|
T Consensus       160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~P  237 (382)
T KOG0032|consen  160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPP  237 (382)
T ss_pred             cCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCC
Confidence            999999999533    4799999999998766  4456678899999999999999999999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |..........      .+.... . ..-    ....+.......+++..|+..||.+|+++.++++
T Consensus       238 F~~~~~~~~~~------~i~~~~-~-~f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  238 FWGETEFEIFL------AILRGD-F-DFT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CcCCChhHHHH------HHHcCC-C-CCC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            87655322211      111111 1 111    1223334455778888899999999999999987

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3e-36  Score=244.18  Aligned_cols=201  Identities=24%  Similarity=0.389  Sum_probs=157.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+ ..++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.   +++|||
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~d  125 (254)
T cd05083          52 VMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD  125 (254)
T ss_pred             HHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            46789999999999998765 468999999999999999542  234588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||+++.....    ......+..|+|||.+.+..++.++|+||||+++|||++ |..||...
T Consensus       126 l~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         126 LAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             cCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence            9999999999999999999998754322    112234567999999988889999999999999999998 88887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ...   ....   .. ......   +  .   +......+.+++.+||+.+|.+||++++|+..|++
T Consensus       202 ~~~---~~~~---~~-~~~~~~---~--~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         202 SLK---EVKE---CV-EKGYRM---E--P---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHH---HHHH---HH-hCCCCC---C--C---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            221   1111   11 111110   0  1   11223447788889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=276.08  Aligned_cols=205  Identities=22%  Similarity=0.306  Sum_probs=155.7

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC----C
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV----P   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~   75 (277)
                      +|++|+||||++++++|...  ...|+||||+.+|+|.++|.........+++..++.|+.||+.||+|||+...    .
T Consensus        65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k  144 (1021)
T PTZ00266         65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE  144 (1021)
T ss_pred             HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence            57889999999999998653  57899999999999999996544445579999999999999999999998521    1


Q ss_pred             CeEeccCCCCcEEeCC-----------------CCceEEeecccccccCCCCcceeeeecccccccCcccccc--Ccccc
Q 023808           76 HIVHRDIKASNILLDQ-----------------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTM  136 (277)
Q Consensus        76 ~iiH~dikp~Nill~~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~  136 (277)
                      +|+||||||+||||+.                 ...+||+|||++..+....  ......||+.|+|||++.+  ..++.
T Consensus       145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~  222 (1021)
T PTZ00266        145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDD  222 (1021)
T ss_pred             CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCc
Confidence            5999999999999954                 2348999999998654322  2234568999999999864  45889


Q ss_pred             ccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          137 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       137 ~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      ++|||||||++|||+||..||......     ......... ...     ..+...    ...+.+++..||+.+|.+||
T Consensus       223 KSDVWSLG~ILYELLTGk~PF~~~~~~-----~qli~~lk~-~p~-----lpi~~~----S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        223 KSDMWALGCIIYELCSGKTPFHKANNF-----SQLISELKR-GPD-----LPIKGK----SKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             hhHHHHHHHHHHHHHHCCCCCCcCCcH-----HHHHHHHhc-CCC-----CCcCCC----CHHHHHHHHHHhcCChhHCc
Confidence            999999999999999999998643221     111111111 110     011111    23477888889999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      ++.+++.
T Consensus       288 Sa~QlL~  294 (1021)
T PTZ00266        288 SALQCLG  294 (1021)
T ss_pred             CHHHHhc
Confidence            9999984

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-36  Score=241.93  Aligned_cols=215  Identities=23%  Similarity=0.291  Sum_probs=161.9

Q ss_pred             ccccccCCC-ccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPN-LVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~n-iv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++|+|+| |+.+++++...+      ..++|+||++. +|.+++.........++...+..+..||+.||+|||++  
T Consensus        63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~--  139 (323)
T KOG0594|consen   63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH--  139 (323)
T ss_pred             HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            578999999 999999999887      78999999966 99999966544335677789999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhC
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg  153 (277)
                       +|+||||||.|||++++|.+||+|||+|+.+.-+... -....+|.+|+|||++.+. .|+...||||+||++.||+++
T Consensus       140 -~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~  217 (323)
T KOG0594|consen  140 -GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTR  217 (323)
T ss_pred             -CeecccCCcceEEECCCCcEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhC
Confidence             9999999999999999999999999999966533222 3345688999999999987 689999999999999999998


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccC--------CccccccCCCCCC---------CHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEE--------KPLELVDPELGEY---------PPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      +.-|.......   ....+.......        ......+..+...         .+.......+++.+|++.+|.+|.
T Consensus       218 ~~LFpG~se~~---ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~  294 (323)
T KOG0594|consen  218 RPLFPGDSEID---QLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI  294 (323)
T ss_pred             CCCCCCCcHHH---HHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc
Confidence            87665544311   112222221110        0000111111111         111113578889999999999999


Q ss_pred             CHHHHHHH
Q 023808          217 QMNQVIKM  224 (277)
Q Consensus       217 s~~~v~~~  224 (277)
                      |++.++..
T Consensus       295 Sa~~al~h  302 (323)
T KOG0594|consen  295 SAKGALTH  302 (323)
T ss_pred             CHHHHhcC
Confidence            99988653

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-36  Score=247.69  Aligned_cols=205  Identities=24%  Similarity=0.371  Sum_probs=156.0

Q ss_pred             cccc-cCCCccceeeEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            3 LSNV-RHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      ++++ +||||+++++++.     .+...++||||+++++|.+++......+..+++..+..++.|++.||.|||+.   +
T Consensus        68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~  144 (286)
T cd06638          68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---K  144 (286)
T ss_pred             HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            5567 6999999999985     34578999999999999998864434455789999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHHH
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~ell  151 (277)
                      ++||||||+||+++.++.++|+|||+++....... ......|+..|+|||.+..     ..++.++||||||+++|||+
T Consensus       145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~  223 (286)
T cd06638         145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG  223 (286)
T ss_pred             ccccCCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence            99999999999999999999999999886543221 1233468899999998753     34788999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      +|+.|+.......  ..    ... ..........+   .   .....+.+++.+||+.+|.+||++.+|++.
T Consensus       224 ~g~~p~~~~~~~~--~~----~~~-~~~~~~~~~~~---~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         224 DGDPPLADLHPMR--AL----FKI-PRNPPPTLHQP---E---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCCCCCCCchhH--HH----hhc-cccCCCcccCC---C---CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            9999876432211  00    010 01111111111   1   112347788889999999999999999763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-36  Score=256.04  Aligned_cols=212  Identities=25%  Similarity=0.387  Sum_probs=159.7

Q ss_pred             ccccc-cCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCC----------------------------------
Q 023808            2 TLSNV-RHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATK----------------------------------   45 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------   45 (277)
                      +|.++ +||||++++++|... ...++||||+++|+|.+++.....                                  
T Consensus        63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (343)
T cd05103          63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSIT  142 (343)
T ss_pred             HHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccc
Confidence            45677 789999999988754 467899999999999999854211                                  


Q ss_pred             -----------------------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceE
Q 023808           46 -----------------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK   96 (277)
Q Consensus        46 -----------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~k   96 (277)
                                                   ....+++..+.+++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~k  219 (343)
T cd05103         143 SSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVK  219 (343)
T ss_pred             cccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEE
Confidence                                         012478889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHH
Q 023808           97 IGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ  174 (277)
Q Consensus        97 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  174 (277)
                      |+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..|+.......  ...    .
T Consensus       220 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~  293 (343)
T cd05103         220 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----R  293 (343)
T ss_pred             EEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----H
Confidence            9999999865332211 1222345677999999988889999999999999999997 888875432211  111    1


Q ss_pred             HhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ........     ..+...   ...+.+++..||+.+|++||++.+|++.|+.++.
T Consensus       294 ~~~~~~~~-----~~~~~~---~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         294 RLKEGTRM-----RAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHhccCCC-----CCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11111110     111111   1247788889999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=283.97  Aligned_cols=201  Identities=29%  Similarity=0.399  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|..|+|||+|++||+-.+++..+|.||||++|+|.+++    ..++..++.....+..|++.|++|||++   ||||||
T Consensus      1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRD 1359 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRD 1359 (1509)
T ss_pred             HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecC
Confidence            467889999999999999999999999999999999999    4555667777777899999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccCc---cccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+||+|+.+|.+|++|||.|..+..+...   ......||+.|||||++.+..   -..++||||+|||+.||+||+.
T Consensus      1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred             CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence            9999999999999999999999977665322   233567999999999997643   4568999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||........     ..+.+..+..         ++.+......-.+++.+|+..||++|-++.|+++
T Consensus      1440 PW~~~dne~a-----IMy~V~~gh~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1440 PWAELDNEWA-----IMYHVAAGHK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             chhhccchhH-----HHhHHhccCC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            9876543221     0111111111         2233334445667778899999999988876654

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-36  Score=250.28  Aligned_cols=200  Identities=21%  Similarity=0.393  Sum_probs=158.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++..++..++||||+++++|.+++.     ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        71 ~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~d  142 (297)
T cd06659          71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRD  142 (297)
T ss_pred             HHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            4677899999999999999999999999999999999873     23588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++..+..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       143 l~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         143 IKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             CCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543322 1233568899999999988889999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ..   ... .......     . .........+.+++.+||+.+|.+||++.++++
T Consensus       222 ~~~---~~---~~~-~~~~~~~-----~-~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         222 PVQ---AM---KRL-RDSPPPK-----L-KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             HHH---HH---HHH-hccCCCC-----c-cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            211   11   111 1111000     0 001112234677888899999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=247.44  Aligned_cols=199  Identities=27%  Similarity=0.441  Sum_probs=159.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++.++...++|+||+.+++|.+++..    + .+++..+..++.|++.||.|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~d  123 (274)
T cd06609          52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----G-KLDETYIAFILREVLLGLEYLHEE---GKIHRD  123 (274)
T ss_pred             HHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh----c-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            46788999999999999999999999999999999999842    2 789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|+||..||....
T Consensus       124 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         124 IKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             CCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence            99999999999999999999998765432 22234467888999999998889999999999999999999999986433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ..   ....... ..     +.+...  .....+.+++.+||..+|++||++.+++.
T Consensus       203 ~~---~~---~~~~~~~-~~-----~~~~~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         203 PM---RV---LFLIPKN-NP-----PSLEGN--KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             hH---HH---HHHhhhc-CC-----CCCccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            21   11   1111111 11     111111  02234778888999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=245.59  Aligned_cols=210  Identities=22%  Similarity=0.311  Sum_probs=156.8

Q ss_pred             ccccccCCCccceeeEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|+.++|+||+.+++.+.-     -+..|+|+|+| +.+|.+++    +.+..++...+.-+.+|+++||.|+|+.   +
T Consensus        74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---n  145 (359)
T KOG0660|consen   74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---N  145 (359)
T ss_pred             HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---c
Confidence            4778899999999999875     34679999999 45999999    5566699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      ++|||+||+|+|++.+-.+||+|||+|+...... ....+....|.+|+|||.+.. ..|+.+.||||.||++.||++|+
T Consensus       146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK  225 (359)
T ss_pred             ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence            9999999999999999999999999999875431 112244567999999998865 57999999999999999999999


Q ss_pred             CCCCcccCcchhh------------HHHHH-----HHHhccCC--ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          155 NSGKAMWGQMNKF------------LLEWA-----WQLHQEEK--PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       155 ~p~~~~~~~~~~~------------~~~~~-----~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +-|.+...-....            ....+     ........  ...-+...++...    ...++++.+||..||.+|
T Consensus       226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~----p~AidLlekmL~fdP~kR  301 (359)
T KOG0660|consen  226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN----PLAIDLLEKMLVFDPKKR  301 (359)
T ss_pred             CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC----HHHHHHHHHHhccCcccc
Confidence            7665432211110            01000     01111000  0000011122233    347788889999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      +|++|.++
T Consensus       302 ita~eAL~  309 (359)
T KOG0660|consen  302 ITAEEALA  309 (359)
T ss_pred             CCHHHHhc
Confidence            99998875

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8e-36  Score=246.55  Aligned_cols=202  Identities=23%  Similarity=0.420  Sum_probs=156.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..+...++||||+.+++|..++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~d  135 (292)
T cd06644          62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD  135 (292)
T ss_pred             HHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecC
Confidence            46788999999999999999999999999999999988742   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||+++.++.++|+|||++....... .......++..|+|||++.     ...++.++||||||+++|||++|..|
T Consensus       136 lkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  214 (292)
T cd06644         136 LKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  214 (292)
T ss_pred             CCcceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence            99999999999999999999987543221 1123445788999999885     34467899999999999999999998


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +......  ..    ..........      .. ..+......+.+++.+||+.+|++||++.+|++
T Consensus       215 ~~~~~~~--~~----~~~~~~~~~~------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         215 HHELNPM--RV----LLKIAKSEPP------TL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CccccHH--HH----HHHHhcCCCc------cC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            7653321  11    1111111111      00 011122335778889999999999999998865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.8e-36  Score=245.44  Aligned_cols=203  Identities=25%  Similarity=0.364  Sum_probs=162.4

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh-----cCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-----EELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~   74 (277)
                      +|++++||||+++++++..  +...+++|||+++++|.+++......+..+++..++.++.|++.||+|||     +.  
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~--  129 (265)
T cd08217          52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN--  129 (265)
T ss_pred             HHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC--
Confidence            4678899999999998864  45678999999999999999665455667999999999999999999999     77  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                       +++|+||+|+||++++++.+||+|||++......... .....++..|++||.+.+..++.++|+||||+++++|++|.
T Consensus       130 -~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~  207 (265)
T cd08217         130 -TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS  207 (265)
T ss_pred             -cceecCCCHHHEEEecCCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence             9999999999999999999999999999876543321 23346889999999998888999999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .|+.....   .....   .. ....        ....+......+.+++.+|++.+|.+||++.+|++
T Consensus       208 ~p~~~~~~---~~~~~---~~-~~~~--------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         208 PPFTARNQ---LQLAS---KI-KEGK--------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CcccCcCH---HHHHH---HH-hcCC--------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            99865431   11111   11 1111        11222233445788889999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-35  Score=243.03  Aligned_cols=205  Identities=25%  Similarity=0.374  Sum_probs=158.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +++|+|
T Consensus        61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  133 (272)
T cd06629          61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRD  133 (272)
T ss_pred             HHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecC
Confidence            46788999999999999999999999999999999999943    34688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCc--cccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||+++.++.++++|||+++........ ......|+..|+|||.+....  ++.++|+||||+++|++++|..|+.
T Consensus       134 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  213 (272)
T cd06629         134 LKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS  213 (272)
T ss_pred             CChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999998765432211 123345788999999987654  7899999999999999999999975


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....      ............ ..+...   ........+.+++..||..+|.+||++.+|++
T Consensus       214 ~~~~~------~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         214 DEEAI------AAMFKLGNKRSA-PPIPPD---VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcchH------HHHHHhhccccC-CcCCcc---ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            32211      111111111111 111111   11223345778888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-36  Score=246.50  Aligned_cols=204  Identities=22%  Similarity=0.402  Sum_probs=159.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.+.+..++||||+.+++|.+++.    ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~  128 (268)
T cd06630          56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRD  128 (268)
T ss_pred             HHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            4678899999999999999999999999999999999994    334688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC-ceEEeecccccccCCCCcc---eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEF-NPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |+|+||+++.++ .++|+|||.+..+......   ......++..|+|||.+.+..++.++||||+|+++++|++|..||
T Consensus       129 i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  208 (268)
T cd06630         129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW  208 (268)
T ss_pred             CCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence            999999998776 5999999999876543211   122345788999999998888899999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .........   ...........        ....+......+.+++.+|+..+|.+||++.+++.
T Consensus       209 ~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         209 NAEKHSNHL---ALIFKIASATT--------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCCcchH---HHHHHHhccCC--------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            543321111   11111111000        11222333455778889999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.3e-36  Score=246.26  Aligned_cols=201  Identities=24%  Similarity=0.394  Sum_probs=153.9

Q ss_pred             cccc-cCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            3 LSNV-RHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      |+++ +||||+++++++...      ...++||||+.+|+|.+++...  .+..+++..+..++.|++.||+|||+.   
T Consensus        56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---  130 (272)
T cd06637          56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---  130 (272)
T ss_pred             HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            5566 799999999999853      4688999999999999998532  234689999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHH
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el  150 (277)
                      +++|+||||+||++++++.++|+|||++....... .......|+..|+|||++.+     ..++.++||||||+++|||
T Consensus       131 ~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el  209 (272)
T cd06637         131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM  209 (272)
T ss_pred             CCccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999999999998654322 12234568889999998863     3578899999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ++|..|+.........      ...... .....    .   .......+.+++.+||..+|.+||++.+|++
T Consensus       210 ~~g~~p~~~~~~~~~~------~~~~~~-~~~~~----~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         210 AEGAPPLCDMHPMRAL------FLIPRN-PAPRL----K---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HhCCCCccccCHHHHH------HHHhcC-CCCCC----C---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            9999998543221110      011111 00000    0   1112234778888999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-36  Score=246.72  Aligned_cols=200  Identities=27%  Similarity=0.405  Sum_probs=152.7

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++.+  +...+++|||+.+++|.+++.    ....+++..++.++.|++.||+|||+.   +++|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H  129 (266)
T cd06651          57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVH  129 (266)
T ss_pred             HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            5778999999999999875  357889999999999999984    334588999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||+|+||+++.++.++|+|||+++.......  .......++..|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf  209 (266)
T cd06651         130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW  209 (266)
T ss_pred             CCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence            99999999999999999999999875532111  1112345788999999998888999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......      ..........     ..+.+..   .....+..++ .||..+|++||+++||+.
T Consensus       210 ~~~~~~------~~~~~~~~~~-----~~~~~~~---~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         210 AEYEAM------AAIFKIATQP-----TNPQLPS---HISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             cccchH------HHHHHHhcCC-----CCCCCch---hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            643211      1111111111     1122221   2222344444 688889999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-36  Score=250.44  Aligned_cols=200  Identities=21%  Similarity=0.421  Sum_probs=157.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++.+..++..++||||+++++|.+++.     ...+++..++.++.|++.||+|||+.   +++|||
T Consensus        72 ~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~d  143 (292)
T cd06658          72 IMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRD  143 (292)
T ss_pred             HHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecC
Confidence            3677899999999999999999999999999999999883     23588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||++++++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       144 lkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  222 (292)
T cd06658         144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP  222 (292)
T ss_pred             CCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543221 1233568889999999988889999999999999999999999976432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ...   .. ...     +.+.+.. .......+.+++.+||..+|.+||++.++++
T Consensus       223 ~~~---~~~---~~-~~~-----~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         223 PLQ---AMR---RI-RDN-----LPPRVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             HHH---HHH---HH-Hhc-----CCCcccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            211   111   11 100     0111100 1112224667778899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=240.12  Aligned_cols=210  Identities=25%  Similarity=0.356  Sum_probs=158.6

Q ss_pred             CccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            1 MTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         1 ~~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      ++|.+.+|||||.+-.+....  +..|+|||||+. +|..++...   ..+++..++.-+..|+++|++|||..   .|+
T Consensus       127 niLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wil  199 (419)
T KOG0663|consen  127 NILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WIL  199 (419)
T ss_pred             HHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeE
Confidence            468889999999998888744  478999999977 999999643   35799999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCC
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|++|+|++..|.+||+|||+||.+++.... -+..+.|.+|+|||.+.+. .|+...|+||+|||+.||+++++-|
T Consensus       200 HRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf  278 (419)
T KOG0663|consen  200 HRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF  278 (419)
T ss_pred             ecccchhheeeccCCcEEecccchhhhhcCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence            9999999999999999999999999998776332 3456679999999999886 5899999999999999999998765


Q ss_pred             CcccCcchhhHHHHHHHHhc---------------------cCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          158 KAMWGQMNKFLLEWAWQLHQ---------------------EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .....-+.   .+.+.....                     ...+.+.+...+....  ....-++++...+..||.+|-
T Consensus       279 ~G~sE~dQ---l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~--lse~g~~Lln~llt~dP~kR~  353 (419)
T KOG0663|consen  279 PGKSEIDQ---LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS--LSEQGFDLLNKLLTYDPGKRI  353 (419)
T ss_pred             CCCchHHH---HHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccc--cchhHHHHHHHHhccCccccc
Confidence            44332111   111111111                     0011111111111110  123456677779999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      |+.|.++
T Consensus       354 tA~~~L~  360 (419)
T KOG0663|consen  354 TAEDGLK  360 (419)
T ss_pred             cHHHhhc
Confidence            9998754

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.2e-36  Score=251.56  Aligned_cols=191  Identities=25%  Similarity=0.317  Sum_probs=151.4

Q ss_pred             ccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            4 SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         4 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      ..+ +|++|+++++++...+..|+||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||
T Consensus        55 ~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDi  127 (323)
T cd05615          55 ALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDL  127 (323)
T ss_pred             HhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            344 46888999999999999999999999999999983    345699999999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      ||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       128 kp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~  206 (323)
T cd05615         128 KLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE  206 (323)
T ss_pred             CHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999987543221 122345689999999999988899999999999999999999999865432


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                         .....   ...... .      ..   +......+.+++.+|++.+|.+|++.
T Consensus       207 ---~~~~~---~i~~~~-~------~~---p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         207 ---DELFQ---SIMEHN-V------SY---PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---HHHHH---HHHhCC-C------CC---CccCCHHHHHHHHHHcccCHhhCCCC
Confidence               11111   111111 0      11   11122346788889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.2e-36  Score=246.60  Aligned_cols=194  Identities=28%  Similarity=0.333  Sum_probs=156.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~d  126 (290)
T cd05580          54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRD  126 (290)
T ss_pred             HHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCC
Confidence            4778899999999999999999999999999999999984    335789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.+||+|||+++.....    .....++..|+|||.+.+...+.++||||||+++|+|++|..||....
T Consensus       127 l~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         127 LKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             CCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999876543    234458889999999988888999999999999999999999986433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVI  222 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~  222 (277)
                      .   .....   ... ...      ..++.   .....+.+++.+||+.+|.+|+     ++.+++
T Consensus       203 ~---~~~~~---~~~-~~~------~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         203 P---IQIYE---KIL-EGK------VRFPS---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             H---HHHHH---HHh-cCC------ccCCc---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            1   11111   111 111      11111   1123477888889999999999     666664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.1e-36  Score=246.70  Aligned_cols=196  Identities=22%  Similarity=0.273  Sum_probs=154.3

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      ..+||||+.+++++..++..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||||
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp  125 (279)
T cd05633          53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKP  125 (279)
T ss_pred             hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCH
Confidence            4579999999999999999999999999999999983    344699999999999999999999999   999999999


Q ss_pred             CcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcccCc
Q 023808           85 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  163 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~  163 (277)
                      +||++++++.++|+|||++.......   .....|+..|+|||.+.+ ..++.++||||||+++|||++|..||......
T Consensus       126 ~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  202 (279)
T cd05633         126 ANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  202 (279)
T ss_pred             HHEEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc
Confidence            99999999999999999987543321   223458899999998864 45789999999999999999999998654332


Q ss_pred             chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ......    .....      ....+   ++.....+.+++.+||+.||.+||     ++.++++
T Consensus       203 ~~~~~~----~~~~~------~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         203 DKHEID----RMTLT------VNVEL---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CHHHHH----HHhhc------CCcCC---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            221111    11100      11111   122234577888889999999999     5887765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.8e-36  Score=244.51  Aligned_cols=201  Identities=23%  Similarity=0.377  Sum_probs=160.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+.+++|.+++..  .....+++..+++++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~  126 (256)
T cd08218          52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRD  126 (256)
T ss_pred             HHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            47889999999999999999999999999999999999843  2233578999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++......... .....|+..|+|||++.+..++.++|+||||+++++|++|..|+....
T Consensus       127 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08218         127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN  205 (256)
T ss_pred             CCHHHEEEcCCCCEEEeeccceeecCcchhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence            9999999999999999999999865443211 223457888999999988889999999999999999999998875422


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .      .............         ..+......+.+++.+||+.+|.+||++.+|++
T Consensus       206 ~------~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         206 M------KNLVLKIIRGSYP---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             H------HHHHHHHhcCCCC---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1      1111122111111         111222344778888999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.6e-36  Score=250.56  Aligned_cols=211  Identities=20%  Similarity=0.304  Sum_probs=155.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+. ++|.+++..   .+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        57 ~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~d  129 (301)
T cd07873          57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRD  129 (301)
T ss_pred             HHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence            4678999999999999999999999999997 589888843   344688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus       130 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         130 LKPQNLLINERGELKLADFGLARAKSIPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             CCHHHEEECCCCcEEECcCcchhccCCCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999764332211 2233568899999988654 5788999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhcc-----------C-CccccccCCC-----CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQE-----------E-KPLELVDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~~~~-----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ....+......           . .......+..     ....+.....+.+++.+|++.||.+|||+.|++.
T Consensus       209 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         209 TVEE---QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CHHH---HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            3211   11111111000           0 0000000000     0001112234678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.1e-36  Score=243.39  Aligned_cols=193  Identities=24%  Similarity=0.325  Sum_probs=154.1

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +||||+++++++..++..++||||+++|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++|+||||+|
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~n  139 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLEN  139 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHH
Confidence            79999999999999999999999999999999994    333789999999999999999999999   99999999999


Q ss_pred             EEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcch
Q 023808           87 ILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  165 (277)
Q Consensus        87 ill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~  165 (277)
                      |+++.++ .++|+|||+++.....     ....++..|+|||++.+..++.++||||||+++|||++|..||....... 
T Consensus       140 il~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-  213 (267)
T PHA03390        140 VLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-  213 (267)
T ss_pred             EEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-
Confidence            9999988 9999999998865432     22357889999999998889999999999999999999999987443221 


Q ss_pred             hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-HHHHHH
Q 023808          166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIK  223 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-~~~v~~  223 (277)
                      .....+....  . ...        .........+.+++.+||+.+|.+||+ ++++++
T Consensus       214 ~~~~~~~~~~--~-~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        214 LDLESLLKRQ--Q-KKL--------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hhHHHHHHhh--c-ccC--------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1111111111  1 000        111123334778888999999999996 588763

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=247.98  Aligned_cols=212  Identities=23%  Similarity=0.327  Sum_probs=159.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..++..++||||+.++.+..+.    .....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        53 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~d  125 (288)
T cd07833          53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRD  125 (288)
T ss_pred             HHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            467889999999999999999999999999987777666    2344589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++.+||+|||++...............++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       126 l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         126 IKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             CCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987655433233345678889999999887 7899999999999999999999887643


Q ss_pred             cCcchhhHHHHHHHHhc-----------cCCcc---ccccCCCC-----CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQ-----------EEKPL---ELVDPELG-----EYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~-----------~~~~~---~~~~~~~~-----~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      .....   .........           .....   ...+....     .++......+.+++.+||..+|++||++.++
T Consensus       206 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  282 (288)
T cd07833         206 SDIDQ---LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL  282 (288)
T ss_pred             CHHHH---HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence            22111   000000000           00000   00000000     0111124558888999999999999999988


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      ++
T Consensus       283 l~  284 (288)
T cd07833         283 LQ  284 (288)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.7e-36  Score=245.55  Aligned_cols=202  Identities=25%  Similarity=0.373  Sum_probs=154.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL--NWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++|+||+++++++..++..++|+||+.+++|.+++...   ...+  ++..+..++.|++.||+|||+.   +++|
T Consensus        58 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h  131 (268)
T cd06624          58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH  131 (268)
T ss_pred             HHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEee
Confidence            467899999999999999999999999999999999998532   1234  7888899999999999999999   9999


Q ss_pred             ccCCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccCc--cccccceEehhHHHHHHHhCCCC
Q 023808           80 RDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        80 ~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      +||||+||+++. ++.++|+|||++........ ......|+..|+|||.+....  ++.++||||||+++|+|++|+.|
T Consensus       132 ~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p  210 (268)
T cd06624         132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP  210 (268)
T ss_pred             cCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence            999999999976 67899999999876543221 122345788999999986643  78899999999999999999998


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +........   ..+......       ..+.+   +......+.+++.+||+.+|.+||++.+|+.
T Consensus       211 ~~~~~~~~~---~~~~~~~~~-------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         211 FIELGEPQA---AMFKVGMFK-------IHPEI---PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CccccChhh---hHhhhhhhc-------cCCCC---CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            754322111   000000000       01111   2223345778888999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-36  Score=245.77  Aligned_cols=204  Identities=25%  Similarity=0.398  Sum_probs=157.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++++|..++.... ....+++..+..++.|++.||.|||+..  +++|+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~d  128 (286)
T cd06622          52 ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRD  128 (286)
T ss_pred             HHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCC
Confidence            4678999999999999999999999999999999999985321 2346899999999999999999999632  899999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc------cccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ------LTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+||+++.++.++|+|||++..+....   .....++..|+|||.+.+..      ++.++|+|||||++|+|++|+.
T Consensus       129 l~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~  205 (286)
T cd06622         129 VKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY  205 (286)
T ss_pred             CCHHHEEECCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence            99999999999999999999987653321   23345788999999886543      4789999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||.......   .......... ..        ....++.....+.+++.+||+.+|.+||++.+++.
T Consensus       206 pf~~~~~~~---~~~~~~~~~~-~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         206 PYPPETYAN---IFAQLSAIVD-GD--------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCCcchhh---HHHHHHHHhh-cC--------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            986432211   1111111111 11        11122234455778888999999999999998876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.5e-36  Score=249.23  Aligned_cols=200  Identities=24%  Similarity=0.423  Sum_probs=157.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..++..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+|
T Consensus        69 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~d  140 (297)
T cd06656          69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRD  140 (297)
T ss_pred             HHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            46788999999999999999999999999999999999832     3578899999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++|..||....
T Consensus       141 L~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~  219 (297)
T cd06656         141 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (297)
T ss_pred             CCHHHEEECCCCCEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543321 1223457889999999988889999999999999999999999985432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....      .........      .. ..+......+.+++.+||+.+|.+||++.+|++
T Consensus       220 ~~~~~------~~~~~~~~~------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         220 PLRAL------YLIATNGTP------EL-QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cchhe------eeeccCCCC------CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            21100      000000000      00 011122234677888999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-36  Score=256.16  Aligned_cols=208  Identities=23%  Similarity=0.277  Sum_probs=152.6

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...++||||+++ +|.+++.      ..+++..+..++.|++.||+|||+.   
T Consensus        69 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---  138 (355)
T cd07874          69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---  138 (355)
T ss_pred             HHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            46778999999999998744      357999999965 7777762      2478899999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +++||||||+||+++.++.+||+|||+++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  216 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI  216 (355)
T ss_pred             CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998653321  2234568899999999998889999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHH------------------HHhccC-CccccccCC------C---CCCCHHHHHHHHHHHHhh
Q 023808          156 SGKAMWGQMNKFLLEWAW------------------QLHQEE-KPLELVDPE------L---GEYPPNEIIRYMKVAFFC  207 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~------------------~~~~~~-~~~~~~~~~------~---~~~~~~~~~~~~~l~~~c  207 (277)
                      ||........  ......                  ...... .......+.      .   ..........+.+++.+|
T Consensus       217 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  294 (355)
T cd07874         217 LFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM  294 (355)
T ss_pred             CCCCCCHHHH--HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHH
Confidence            9864321110  000000                  000000 000000000      0   001111234567889999


Q ss_pred             hhhhhcCCCCHHHHHH
Q 023808          208 TQAAASRRPQMNQVIK  223 (277)
Q Consensus       208 ~~~~p~~RPs~~~v~~  223 (277)
                      ++.||++|||+.|+++
T Consensus       295 L~~dP~~Rps~~ell~  310 (355)
T cd07874         295 LVIDPAKRISVDEALQ  310 (355)
T ss_pred             hcCCchhcCCHHHHhc
Confidence            9999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-36  Score=249.30  Aligned_cols=207  Identities=21%  Similarity=0.243  Sum_probs=159.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||++|++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  126 (305)
T cd05609          54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRD  126 (305)
T ss_pred             HHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4677899999999999999999999999999999999993    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc--------------ceeeeecccccccCccccccCccccccceEehhHHH
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT--------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      |||+||+++.++.++|+|||+++.......              .......++..|+|||.+.+..++.++|+||||+++
T Consensus       127 l~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl  206 (305)
T cd05609         127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL  206 (305)
T ss_pred             CchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence            999999999999999999999874211100              011124577889999999888899999999999999


Q ss_pred             HHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          148 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      |||++|..||.....   ..+.   .........    .+...   ......+.+++.+||+.+|++||+..++.+.|+.
T Consensus       207 ~el~~g~~pf~~~~~---~~~~---~~~~~~~~~----~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         207 YEFLVGCVPFFGDTP---EELF---GQVISDDIE----WPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhCCCCCCCCCH---HHHH---HHHHhcccC----CCCcc---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            999999999753221   1111   111111100    11111   1122346788888999999999998777777765


Q ss_pred             c
Q 023808          228 N  228 (277)
Q Consensus       228 ~  228 (277)
                      .
T Consensus       274 ~  274 (305)
T cd05609         274 R  274 (305)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.3e-36  Score=247.31  Aligned_cols=212  Identities=25%  Similarity=0.364  Sum_probs=158.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..+...++||||+ +++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  124 (286)
T cd07832          52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRD  124 (286)
T ss_pred             HHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            467889999999999999999999999999 9999999843   235689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.++|+|||++...............++..|+|||++.+. .++.++||||+|++++||+||..++...
T Consensus       125 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             cCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            999999999999999999999987654332222345688899999988654 4689999999999999999997666433


Q ss_pred             cCcchhhHHHHHHHHhccCCc------------cccccCC-----CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKP------------LELVDPE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~-----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ...............            .....+.     +....+.....+.+++.+|++.+|.+||++.+++.
T Consensus       205 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         205 NDI---EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CHH---HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            221   111111111100000            0000000     00111122356888999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=247.29  Aligned_cols=202  Identities=25%  Similarity=0.431  Sum_probs=157.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+++++|.+++..   .+..+++..+..++.|++.||.|||+.   +++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~d  128 (280)
T cd06611          55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD  128 (280)
T ss_pred             HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            46789999999999999999999999999999999999842   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |+|+||+++.++.++|+|||++....... .......++..|++||.+.     ...++.++|+||||+++|||++|+.|
T Consensus       129 l~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p  207 (280)
T cd06611         129 LKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP  207 (280)
T ss_pred             CChhhEEECCCCCEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999887543322 1223456889999999875     34467899999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.......      ...........      .+ ..+......+.+++..||+.+|.+||++.+|++
T Consensus       208 ~~~~~~~~------~~~~~~~~~~~------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         208 HHELNPMR------VLLKILKSEPP------TL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cccCCHHH------HHHHHhcCCCC------Cc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            86542211      11111111110      01 011122234778888899999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.5e-36  Score=241.83  Aligned_cols=199  Identities=26%  Similarity=0.390  Sum_probs=158.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.++...++||||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  127 (258)
T cd06632          55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRD  127 (258)
T ss_pred             HHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4678899999999999999999999999999999999994    334588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.+||+|||++.......  ......|+..|++||.+.... ++.++|+||||+++|+|++|..||...
T Consensus       128 l~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         128 IKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             CCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            99999999999999999999988654332  223456788999999987766 899999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...      ............        ...+......+.+++.+||+.+|.+||++.+++.
T Consensus       206 ~~~------~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         206 EGV------AAVFKIGRSKEL--------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cHH------HHHHHHHhcccC--------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            311      111111110111        1111222344677888999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.7e-36  Score=242.65  Aligned_cols=200  Identities=25%  Similarity=0.386  Sum_probs=158.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~d  126 (256)
T cd08220          52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRD  126 (256)
T ss_pred             HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            467889999999999999999999999999999999999532  234589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++ .++|+|||.+.......  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus       127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         127 LKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             CCHHHEEEcCCCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence            999999998654 58999999998764432  122345788999999998888899999999999999999999887543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ..   ........ .        ...+......+.+++.+||+.+|.+||++.+++.
T Consensus       205 ~~~---~~---~~~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         205 NLP---AL---VLKIMSGT-F--------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             chH---HH---HHHHHhcC-C--------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            221   11   11111111 0        0111122334778889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-35  Score=241.61  Aligned_cols=201  Identities=22%  Similarity=0.266  Sum_probs=159.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+.+++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~d  118 (262)
T cd05572          46 ILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRD  118 (262)
T ss_pred             HHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCC
Confidence            4678899999999999999999999999999999999993    334589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||+++......  ......++..|++||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus       119 l~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            99999999999999999999998765432  2233467889999999888889999999999999999999999987654


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      ....    ............        ...+......+.+++.+||+.+|.+||+     +.|+++
T Consensus       197 ~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         197 EDPM----EIYNDILKGNGK--------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCHH----HHHHHHhccCCC--------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3111    111111110100        1111122345788888999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.1e-35  Score=240.76  Aligned_cols=208  Identities=27%  Similarity=0.413  Sum_probs=161.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++.+..++..++|||++.+++|.+++..... ...+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~  127 (267)
T cd06610          52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRD  127 (267)
T ss_pred             HHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            36788999999999999999999999999999999999954221 24689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |+|+||++++++.++|+|||++..+......   ......|+..|++||++... .++.++|+||||+++|+|++|+.||
T Consensus       128 l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~  207 (267)
T cd06610         128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY  207 (267)
T ss_pred             CCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence            9999999999999999999998866543222   22344688899999998776 7899999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......  ..    ..........  .....  ........+.+++.+||+.+|++||++.+|++
T Consensus       208 ~~~~~~~--~~----~~~~~~~~~~--~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         208 SKYPPMK--VL----MLTLQNDPPS--LETGA--DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccChhh--hH----HHHhcCCCCC--cCCcc--ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            6543211  11    1111111110  00000  01122345778888999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.6e-36  Score=243.17  Aligned_cols=204  Identities=25%  Similarity=0.462  Sum_probs=159.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +|++++||||+++++++..+...++|+||+.+++|.+++...   ...+++..+..++.|++.||+|||+ .   +++|+
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~  125 (265)
T cd06605          52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHR  125 (265)
T ss_pred             HHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecC
Confidence            467889999999999999999999999999999999999532   2578999999999999999999999 8   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||+|+||++++++.++|+|||.+........   ....++..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus       126 dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             CCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876533221   1256788999999998889999999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...... .............      +.+...  .....+.+++..||..+|++||++.+++.
T Consensus       203 ~~~~~~-~~~~~~~~~~~~~------~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         203 NDPPDG-IFELLQYIVNEPP------PRLPSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cccccc-HHHHHHHHhcCCC------CCCChh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            321111 1111111111111      111110  02334778888899999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-35  Score=244.37  Aligned_cols=205  Identities=21%  Similarity=0.247  Sum_probs=152.8

Q ss_pred             cccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            3 LSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +..++|+||+++++++....    ..++++|++. .++.+.+.    .....++..+..++.|++.||+|||+.   +++
T Consensus        77 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ii  148 (294)
T PHA02882         77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GIS  148 (294)
T ss_pred             hccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            34678999999999877554    4578888884 47777773    223457888999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                      ||||||+|||++.++.++|+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       149 HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~  228 (294)
T PHA02882        149 HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG  228 (294)
T ss_pred             cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999866432211      1223468999999999999999999999999999999999


Q ss_pred             CCCCCCcccCcchhhH---HHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          153 GRNSGKAMWGQMNKFL---LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |..||...........   .++....... ..      ..... +   ..+.+++..|++.+|++||++.++.+.++
T Consensus       229 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~-~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        229 IKLPWKGFGHNGNLIHAAKCDFIKRLHEG-KI------KIKNA-N---KFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             CCCCCCccccchHHHHHhHHHHHHHhhhh-hh------ccCCC-C---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            9999976532221110   1111111111 00      01112 2   34667777799999999999999998763

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.1e-36  Score=255.13  Aligned_cols=147  Identities=29%  Similarity=0.433  Sum_probs=126.1

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...|+||||+.+ +|.+++.      ..+++..+..++.|++.||+|||+.   
T Consensus        76 ~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---  145 (364)
T cd07875          76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---  145 (364)
T ss_pred             HHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---
Confidence            46788999999999988643      357999999965 7877772      2478899999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +|+||||||+||+++.++.+||+|||+++......  ......||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus       146 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  223 (364)
T cd07875         146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV  223 (364)
T ss_pred             CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence            99999999999999999999999999998654321  1233568899999999999899999999999999999999999


Q ss_pred             CCCcc
Q 023808          156 SGKAM  160 (277)
Q Consensus       156 p~~~~  160 (277)
                      ||...
T Consensus       224 pf~~~  228 (364)
T cd07875         224 LFPGT  228 (364)
T ss_pred             CCCCC
Confidence            98643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.6e-36  Score=248.49  Aligned_cols=212  Identities=20%  Similarity=0.274  Sum_probs=155.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+....++|+||+.+ +|.+++..   .+..+++..++.++.||+.||.|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~d  124 (284)
T cd07839          52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRD  124 (284)
T ss_pred             HHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCC
Confidence            46788999999999999999999999999965 88887742   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||+++........ .....++..|+|||++.+. .++.++||||||+++|||+||..|+...
T Consensus       125 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~  203 (284)
T cd07839         125 LKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  203 (284)
T ss_pred             CCHHHEEEcCCCcEEECccchhhccCCCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            9999999999999999999999865432211 2234568899999988765 4689999999999999999999885432


Q ss_pred             cCcchhhHHHHHHHHhc-----------cCCccc---cccCCC--CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQ-----------EEKPLE---LVDPEL--GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  ...........           ......   ......  ....+.....+.+++.+||+.||.+|||+.+++.
T Consensus       204 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         204 NDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCHH--HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            2211  11111111000           000000   000000  0111223345778899999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-35  Score=244.94  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=155.6

Q ss_pred             cccc-cCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            3 LSNV-RHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +.++ +||||+++++++...     ...++||||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +
T Consensus        72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~  148 (291)
T cd06639          72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---R  148 (291)
T ss_pred             HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4566 899999999999754     358999999999999998864434455789999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-----ccccccceEehhHHHHHHH
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~ell  151 (277)
                      ++|+||||+||+++.++.+||+|||+++....... ......|+..|+|||.+...     .++.++||||||+++|||+
T Consensus       149 ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~  227 (291)
T cd06639         149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG  227 (291)
T ss_pred             eeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence            99999999999999999999999999886543221 12234578899999987643     3688999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +|+.|+.......  .+    ...... ......+      +......+.+++.+||+.+|++||++.+++.
T Consensus       228 ~g~~p~~~~~~~~--~~----~~~~~~-~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         228 DGDPPLFDMHPVK--TL----FKIPRN-PPPTLLH------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hCCCCCCCCcHHH--HH----HHHhcC-CCCCCCc------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            9999976432211  11    111111 1111111      1122335788899999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-36  Score=254.22  Aligned_cols=205  Identities=21%  Similarity=0.298  Sum_probs=151.7

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...+++++++ +++|.+++.     ...+++..+..++.|++.||+|||+.   
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---  137 (343)
T cd07878          67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---  137 (343)
T ss_pred             HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            57889999999999988643      3568999998 779999883     33589999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +|+||||||+||+++.++.+||+|||+++.....    .....||..|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus       138 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  213 (343)
T cd07878         138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK  213 (343)
T ss_pred             CeecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCC
Confidence            9999999999999999999999999999865432    233468899999999877 46889999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccc-----------cCCCCCCC--------HHHHHHHHHHHHhhhhhhhcCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-----------DPELGEYP--------PNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~--------~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      .||.......  .+.. ....... ......           ...+...+        ......+.+++.+|++.||.+|
T Consensus       214 ~pf~~~~~~~--~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R  289 (343)
T cd07878         214 ALFPGNDYID--QLKR-IMEVVGT-PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR  289 (343)
T ss_pred             CCCCCCCHHH--HHHH-HHHHhCC-CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence            9886432111  0100 0000000 000000           00000000        0111236788999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.+++.
T Consensus       290 ~s~~ell~  297 (343)
T cd07878         290 ISASEALA  297 (343)
T ss_pred             CCHHHHhc
Confidence            99999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-35  Score=241.31  Aligned_cols=202  Identities=28%  Similarity=0.449  Sum_probs=162.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      ++++++|+||+++++++..+...++||||+++++|.+++..    ...+++..++.++.|++.||+|||+ .   +++|+
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~  124 (264)
T cd06623          52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHR  124 (264)
T ss_pred             HHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccC
Confidence            36788999999999999999999999999999999999943    3568999999999999999999999 8   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|+||..|+...
T Consensus       125 ~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  203 (264)
T cd06623         125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP  203 (264)
T ss_pred             CCCHHHEEECCCCCEEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999999866443222 22455788999999998888999999999999999999999998665


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHH-HHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..........   ...... .     +   ..+.. ....+.+++..||+.+|++||++.++++
T Consensus       204 ~~~~~~~~~~---~~~~~~-~-----~---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         204 GQPSFFELMQ---AICDGP-P-----P---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             cccCHHHHHH---HHhcCC-C-----C---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            4211111111   111111 1     1   11111 3345888888899999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-35  Score=243.29  Aligned_cols=197  Identities=22%  Similarity=0.261  Sum_probs=155.9

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      +..+||||+++++++...+..++||||+.||+|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|||
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~  124 (278)
T cd05606          52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLK  124 (278)
T ss_pred             HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCC
Confidence            34589999999999999999999999999999999983    344699999999999999999999999   99999999


Q ss_pred             CCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808           84 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        84 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      |+||+++.++.++|+|||++..+....   .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.....
T Consensus       125 p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~  201 (278)
T cd05606         125 PANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (278)
T ss_pred             HHHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999999987553321   2234688999999998754 688999999999999999999999876533


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .......    ......      ...+..   .....+.+++.+|+..+|.+||     ++.++++
T Consensus       202 ~~~~~~~----~~~~~~------~~~~~~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         202 KDKHEID----RMTLTM------AVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cchHHHH----HHhhcc------CCCCCC---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            2211111    111100      111111   1234577888889999999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=244.00  Aligned_cols=199  Identities=22%  Similarity=0.233  Sum_probs=156.2

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      .+++|+||+++++++..++..++||||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~  124 (260)
T cd05611          52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIK  124 (260)
T ss_pred             hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCC
Confidence            45689999999999999999999999999999999993    334689999999999999999999999   99999999


Q ss_pred             CCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCc
Q 023808           84 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  163 (277)
Q Consensus        84 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~  163 (277)
                      |+||++++++.++|+|||+++....     .....++..|++||.+.+..++.++||||||+++|+|++|..||......
T Consensus       125 p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  199 (260)
T cd05611         125 PENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD  199 (260)
T ss_pred             HHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence            9999999999999999999875432     22345788999999998888899999999999999999999998643221


Q ss_pred             chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                         ...   ..... ....  ......   ......+.+++.+||+.+|++||++.++.+.|.
T Consensus       200 ---~~~---~~~~~-~~~~--~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         200 ---AVF---DNILS-RRIN--WPEEVK---EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ---HHH---HHHHh-cccC--CCCccc---ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence               111   11111 1100  001111   112344788888999999999998876655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-35  Score=243.96  Aligned_cols=202  Identities=25%  Similarity=0.279  Sum_probs=157.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~d  120 (277)
T cd05577          46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRD  120 (277)
T ss_pred             HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            477889999999999999999999999999999999998532  223689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++++.++|+|||++.......  ......++..|++||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       121 i~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         121 LKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             CCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            99999999999999999999988654321  1223457789999999988889999999999999999999999986544


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVI  222 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~  222 (277)
                      ........   .......      ....   +......+.+++.+||+.+|.+||     ++.+++
T Consensus       199 ~~~~~~~~---~~~~~~~------~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll  252 (277)
T cd05577         199 EKVEKEEL---KRRTLEM------AVEY---PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR  252 (277)
T ss_pred             ccccHHHH---Hhccccc------cccC---CccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence            32111110   0100000      0111   111233477888899999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-35  Score=239.90  Aligned_cols=203  Identities=29%  Similarity=0.478  Sum_probs=158.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++...+..++|+||+.+++|.+++.    .+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~d  124 (264)
T cd06626          52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRD  124 (264)
T ss_pred             HHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4678999999999999999999999999999999999994    344588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee---eeecccccccCccccccCc---cccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---TRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |+|+||++++++.+||+|||++...........   ....++..|++||.+.+..   .+.++||||||+++|++++|+.
T Consensus       125 l~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~  204 (264)
T cd06626         125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR  204 (264)
T ss_pred             CCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCC
Confidence            999999999999999999999987654332221   1345788999999988766   8899999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||.......     ........ ..     .+.++... .....+.+++.+||+.+|.+||++.+++.
T Consensus       205 pf~~~~~~~-----~~~~~~~~-~~-----~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         205 PWSELDNEF-----QIMFHVGA-GH-----KPPIPDSL-QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CccCCcchH-----HHHHHHhc-CC-----CCCCCccc-ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            986432111     01111111 10     11111111 11334678888999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=248.56  Aligned_cols=195  Identities=22%  Similarity=0.337  Sum_probs=163.9

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      -++|||||++|++......+|||.|+-++|+|.+|+-   ++...+.+..+.+++.||+.||.|+|+.   .+|||||||
T Consensus        73 LVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKP  146 (864)
T KOG4717|consen   73 LVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKP  146 (864)
T ss_pred             HhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCc
Confidence            3589999999999999999999999999999999995   4555799999999999999999999999   999999999


Q ss_pred             CcEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccc-cccceEehhHHHHHHHhCCCCCCcccC
Q 023808           85 SNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        85 ~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      +|+.+. .-|.|||+|||++..+...  ..-++..|+..|-|||++.+..|+ ++.||||||++||.|++|+.||+...+
T Consensus       147 ENVVFFEKlGlVKLTDFGFSNkf~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND  224 (864)
T KOG4717|consen  147 ENVVFFEKLGLVKLTDFGFSNKFQPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND  224 (864)
T ss_pred             ceeEEeeecCceEeeeccccccCCCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence            999775 5578999999999876543  334567899999999999999886 678999999999999999999987655


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....               -++|-. -..+.....++.++|..||..||++|.+.++|..
T Consensus       225 SETLT---------------mImDCK-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  225 SETLT---------------MIMDCK-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhh---------------hhhccc-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            33211               122221 1335566677899999999999999999999863

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-35  Score=246.56  Aligned_cols=211  Identities=22%  Similarity=0.308  Sum_probs=156.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++.+.+..++||||+ +|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  127 (298)
T cd07841          55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRD  127 (298)
T ss_pred             HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecC
Confidence            467889999999999999999999999999 8899999943   223699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|...
T Consensus       128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~  206 (298)
T cd07841         128 LKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD  206 (298)
T ss_pred             CChhhEEEcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence            999999999999999999999987654321 1222346778999998865 45788999999999999999997766543


Q ss_pred             cCcchhhHHHHHHHHhccC---------Cccccc------cCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEE---------KPLELV------DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~---------~~~~~~------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ............         ......      ..............+.+++.+||+.+|++||++.+|+.
T Consensus       207 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         207 SDID---QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccHH---HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            2211   111111100000         000000      00001111223456788999999999999999999977

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-35  Score=244.12  Aligned_cols=200  Identities=23%  Similarity=0.427  Sum_probs=158.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..++..++|+||+.+++|.+++..     ..+++..+..++.|++.||+|||+.   +++|||
T Consensus        69 ~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~d  140 (285)
T cd06648          69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRD  140 (285)
T ss_pred             HHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            46778999999999999999999999999999999999842     3588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       141 l~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~  219 (285)
T cd06648         141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP  219 (285)
T ss_pred             CChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence            999999999999999999998876543321 1233458889999999988889999999999999999999999875422


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..      ....... ....     +.. .........+.+++.+||+.+|++||++.++++
T Consensus       220 ~~------~~~~~~~-~~~~-----~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         220 PL------QAMKRIR-DNLP-----PKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HH------HHHHHHH-hcCC-----CCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11      1111111 1111     001 001112235788888999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-35  Score=242.35  Aligned_cols=200  Identities=25%  Similarity=0.345  Sum_probs=154.9

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++.+.  ...++||||+++++|.+++.    ....+++..+++++.|++.||+|||+.   +++|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H  129 (265)
T cd06652          57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVH  129 (265)
T ss_pred             HHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            47788999999999998764  46789999999999999984    233578899999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||+|+||+++.++.++|+|||+++.......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus       130 ~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~  209 (265)
T cd06652         130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW  209 (265)
T ss_pred             CCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCC
Confidence            99999999999999999999999885432111  1122345788999999998888999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......     . ........        .....+......+.+++.+|+. +|++||++.+|++
T Consensus       210 ~~~~~~~-----~-~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         210 AEFEAMA-----A-IFKIATQP--------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CccchHH-----H-HHHHhcCC--------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            6432111     1 11111110        1112233344557788888984 9999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-36  Score=248.09  Aligned_cols=211  Identities=27%  Similarity=0.362  Sum_probs=156.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+...++||||+++++|..+..    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~  125 (286)
T cd07846          53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRD  125 (286)
T ss_pred             HHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4678899999999999999999999999999999988873    334589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++.++|+|||++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       126 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         126 IKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             CCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999988654432 22223457889999998875 34678999999999999999999887543


Q ss_pred             cCcchhhHHHHHHHHhcc-----------CCc-cccccCCC------CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQE-----------EKP-LELVDPEL------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~~~------~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ....   ...........           ... .....+..      ....+.....+.+++.+||+.+|.+||++.+|+
T Consensus       205 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il  281 (286)
T cd07846         205 SDID---QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL  281 (286)
T ss_pred             chHH---HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence            2111   00000000000           000 00000000      001122344588899999999999999999986


Q ss_pred             H
Q 023808          223 K  223 (277)
Q Consensus       223 ~  223 (277)
                      +
T Consensus       282 ~  282 (286)
T cd07846         282 H  282 (286)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=244.01  Aligned_cols=205  Identities=27%  Similarity=0.453  Sum_probs=157.0

Q ss_pred             ccccc-cCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNV-RHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +++++ +|+||+++++++....      ..++||||+++++|.+++......+..+++..+..++.|++.||+|||+.  
T Consensus        55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--  132 (275)
T cd06608          55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--  132 (275)
T ss_pred             HHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence            35667 7999999999997644      48999999999999999865443456789999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHH
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLE  149 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~e  149 (277)
                       +++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+..     ..++.++||||||+++|+
T Consensus       133 -~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~  210 (275)
T cd06608         133 -KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE  210 (275)
T ss_pred             -CcccCCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence             99999999999999999999999999987654322 22233458889999998754     246789999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |++|..||.......  ..    ...... ..     +.+ .........+.+++.+||..||.+|||+.++++
T Consensus       211 l~~g~~p~~~~~~~~--~~----~~~~~~-~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         211 LADGKPPLCDMHPMR--AL----FKIPRN-PP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHhCCCCccccchHH--HH----HHhhcc-CC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            999999986432211  11    111111 11     111 111223345778889999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-35  Score=247.30  Aligned_cols=215  Identities=19%  Similarity=0.252  Sum_probs=158.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..+++|||+.+|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~d  126 (314)
T cd08216          52 TSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRS  126 (314)
T ss_pred             HHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            467889999999999999999999999999999999999543  234588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc------ceeeeecccccccCccccccC--ccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+||+++.++.+|++|||.+........      .......++..|+|||++...  .++.++|+||||+++|||++|
T Consensus       127 lk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g  206 (314)
T cd08216         127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG  206 (314)
T ss_pred             CCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhC
Confidence            999999999999999999998875432211      111234467789999998663  578899999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhc----c-------CCccc----cccCC-----CCCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQ----E-------EKPLE----LVDPE-----LGEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~----~-------~~~~~----~~~~~-----~~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      ..||.......  ...........    .       .....    ..++.     -..........+.+++.+||+.+|+
T Consensus       207 ~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  284 (314)
T cd08216         207 HVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE  284 (314)
T ss_pred             CCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence            99986532211  11110000000    0       00000    00000     0111223345677899999999999


Q ss_pred             CCCCHHHHHH
Q 023808          214 RRPQMNQVIK  223 (277)
Q Consensus       214 ~RPs~~~v~~  223 (277)
                      +||++.++++
T Consensus       285 ~Rpt~~~ll~  294 (314)
T cd08216         285 SRPSASQLLN  294 (314)
T ss_pred             cCcCHHHHhc
Confidence            9999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=246.92  Aligned_cols=203  Identities=23%  Similarity=0.260  Sum_probs=157.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+++|.+++..  ..+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  128 (316)
T cd05574          54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRD  128 (316)
T ss_pred             HHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            46788999999999999999999999999999999999853  2345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc----------------------------eeeeecccccccCccccccCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH----------------------------ITTRIAGTTGYLAPEYVLGGQ  133 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~  133 (277)
                      |||+||+++.++.++|+|||++.........                            ......|+..|+|||++.+..
T Consensus       129 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  208 (316)
T cd05574         129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG  208 (316)
T ss_pred             CChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC
Confidence            9999999999999999999998754322110                            011235788999999999888


Q ss_pred             cccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          134 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       134 ~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      ++.++||||||+++|+|++|..||.......  ..    .........       ... .......+.+++.+||+.+|+
T Consensus       209 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~----~~~~~~~~~-------~~~-~~~~~~~~~~li~~~l~~~p~  274 (316)
T cd05574         209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--TF----SNILKKEVT-------FPG-SPPVSSSARDLIRKLLVKDPS  274 (316)
T ss_pred             CCchHHHHHHHHHHHHHhhCCCCCCCCchHH--HH----HHHhcCCcc-------CCC-ccccCHHHHHHHHHHccCCHh
Confidence            9999999999999999999999986443211  11    111111100       100 011234578888889999999


Q ss_pred             CCCC----HHHHHH
Q 023808          214 RRPQ----MNQVIK  223 (277)
Q Consensus       214 ~RPs----~~~v~~  223 (277)
                      +||+    +.+++.
T Consensus       275 ~R~s~~~~~~~ll~  288 (316)
T cd05574         275 KRLGSKRGAAEIKQ  288 (316)
T ss_pred             HCCCchhhHHHHHc
Confidence            9999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.6e-35  Score=241.06  Aligned_cols=209  Identities=21%  Similarity=0.378  Sum_probs=158.8

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++...+      ..++++||+.+|+|.+++....  .....+++..++.++.|++.||+|||+. 
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-  132 (273)
T cd05074          54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-  132 (273)
T ss_pred             HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            477899999999999987542      3478999999999998874321  1223578999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                        +++|+||||+||++++++.+||+|||+++........ ......++..|++||.+.+..++.++||||||+++|||++
T Consensus       133 --~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~  210 (273)
T cd05074         133 --NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT  210 (273)
T ss_pred             --CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence              9999999999999999999999999999865432211 1122334567999999988889999999999999999999


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                       |..|+.....   .....+..   .....         ...+.....+.+++.+||+.+|.+||++.++++.|+++
T Consensus       211 ~g~~p~~~~~~---~~~~~~~~---~~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         211 RGQTPYAGVEN---SEIYNYLI---KGNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCCCCCH---HHHHHHHH---cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             7777654322   11111111   11110         01112234588899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-35  Score=241.36  Aligned_cols=199  Identities=25%  Similarity=0.325  Sum_probs=159.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++|+||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~d  125 (258)
T cd05578          53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRD  125 (258)
T ss_pred             HHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccC
Confidence            4678999999999999999999999999999999999994    235789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++++.++|+|||++.......  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus       126 l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         126 IKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             CCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999988654432  2234557889999999988889999999999999999999999987554


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH--HHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM--NQVI  222 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~--~~v~  222 (277)
                      .......    ......  ..       ...++.....+.+++.+||+.+|.+||++  +|++
T Consensus       204 ~~~~~~~----~~~~~~--~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         204 RTIRDQI----RAKQET--AD-------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccHHHHH----HHHhcc--cc-------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            3211111    111111  00       11112223557788899999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=251.08  Aligned_cols=195  Identities=31%  Similarity=0.466  Sum_probs=159.0

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |.+|+|||++.+-|++..+...+|||||| -|+-.+++.-   ..+++-+.++..|+.+.+.||+|||+.   +.|||||
T Consensus        80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDi  152 (948)
T KOG0577|consen   80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDI  152 (948)
T ss_pred             HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhc
Confidence            67899999999999999999999999999 5588888853   455788999999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCCCc
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |..||||++.|.|||+|||.+.....     ...++||+.|||||++..   +.|+-+.|||||||+-.||..+++|.-.
T Consensus       153 KAGNILLse~g~VKLaDFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn  227 (948)
T KOG0577|consen  153 KAGNILLSEPGLVKLADFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  227 (948)
T ss_pred             cccceEecCCCeeeeccccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence            99999999999999999999876543     467889999999999864   6899999999999999999999988654


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +...      ...+.+..++.      |.+.  .......|..++..||+.-|.+|||..++++
T Consensus       228 MNAM------SALYHIAQNes------PtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  228 MNAM------SALYHIAQNES------PTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             chHH------HHHHHHHhcCC------CCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            4321      11222222222      2221  2334445777777799999999999988763

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.5e-35  Score=240.95  Aligned_cols=198  Identities=27%  Similarity=0.411  Sum_probs=158.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++..++..++||||+.+++|.+++.     ...+++..+..++.|++.|+.+||+.   +++|+|
T Consensus        55 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~d  126 (277)
T cd06641          55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRD  126 (277)
T ss_pred             HHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCC
Confidence            4678899999999999999999999999999999999983     23588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++....... .......++..|++||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus       127 l~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  205 (277)
T cd06641         127 IKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH  205 (277)
T ss_pred             CCHHhEEECCCCCEEEeecccceecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999999999999999987654322 11223457888999999988888999999999999999999999875432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..      ...........      +.+   .......+.+++.+||+.+|.+||++.+++.
T Consensus       206 ~~------~~~~~~~~~~~------~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         206 PM------KVLFLIPKNNP------PTL---EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             hH------HHHHHHhcCCC------CCC---CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            21      11111111110      111   1122334677888899999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.2e-36  Score=242.18  Aligned_cols=201  Identities=24%  Similarity=0.405  Sum_probs=159.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..+...++|+||+.+++|.+++..  ..+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~d  126 (257)
T cd08225          52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRD  126 (257)
T ss_pred             HHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            46788999999999999999999999999999999999853  2233579999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++ .++|+|||.+....... .......|+..|+|||++.+..++.++|+||||++++||++|..|+...
T Consensus       127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             CCHHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            999999998886 46999999998664432 1222345888999999998888999999999999999999999987543


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..      ...........         .....+.....+.+++.+||+.+|++||++.+|++
T Consensus       206 ~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         206 NL------HQLVLKICQGY---------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             cH------HHHHHHHhccc---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            21      11122211111         11111222335788889999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=247.09  Aligned_cols=157  Identities=27%  Similarity=0.423  Sum_probs=130.9

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKAN-IKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++||||+++++++.+.  ...++||||+++ +|.+++....... ..+++..+..++.|++.||+|||+.   +++
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~  130 (316)
T cd07842          55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVL  130 (316)
T ss_pred             HHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEe
Confidence            46789999999999999988  789999999975 7777764333332 3789999999999999999999999   999


Q ss_pred             eccCCCCcEEeCC----CCceEEeecccccccCCCCc--ceeeeecccccccCccccccC-ccccccceEehhHHHHHHH
Q 023808           79 HRDIKASNILLDQ----EFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        79 H~dikp~Nill~~----~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~ell  151 (277)
                      ||||||+||+++.    ++.+||+|||+++.......  .......++..|+|||.+.+. .++.++||||||+++++|+
T Consensus       131 h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  210 (316)
T cd07842         131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (316)
T ss_pred             eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999    89999999999987644322  112334678899999988764 5789999999999999999


Q ss_pred             hCCCCCCcccC
Q 023808          152 SGRNSGKAMWG  162 (277)
Q Consensus       152 tg~~p~~~~~~  162 (277)
                      +|+.||.....
T Consensus       211 ~~~~~~~~~~~  221 (316)
T cd07842         211 TLEPIFKGREA  221 (316)
T ss_pred             hcCCCCcCCcc
Confidence            99999875443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-35  Score=240.33  Aligned_cols=201  Identities=27%  Similarity=0.394  Sum_probs=163.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.+....++||||+++++|.+++......+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~  128 (256)
T cd08530          52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRD  128 (256)
T ss_pred             HHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCC
Confidence            46788999999999999999999999999999999999865444456789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.+||+|||++......   ......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       129 l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         129 LKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             CCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999876543   2223457889999999988889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ....   ....         ......+......+.+++.+|++.+|++||++.+++.
T Consensus       206 ~~---~~~~---~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         206 MQ---DLRY---KVQR---------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HH---HHHH---HHhc---------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            21   1111   1111         1111222344456888999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=244.38  Aligned_cols=212  Identities=21%  Similarity=0.307  Sum_probs=154.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++.+++..++||||+.+ +|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~d  128 (291)
T cd07844          56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRD  128 (291)
T ss_pred             HHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            46789999999999999999999999999975 99998843   233688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus       129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         129 LKPQNLLISERGELKLADFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             CCHHHEEEcCCCCEEECccccccccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998754322111 122346788999998875 45789999999999999999999988644


Q ss_pred             cCcchhhHHHHHHHHhccCCcc----------------cccc-CCCCCCCH--HHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPL----------------ELVD-PELGEYPP--NEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-~~~~~~~~--~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      .....  .....+.........                .... ..+....+  .....+.+++.+|++.+|++||++.++
T Consensus       208 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~  285 (291)
T cd07844         208 TDVED--QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA  285 (291)
T ss_pred             ccHHH--HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence            32111  111111111100000                0000 00000000  011457788999999999999999988


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      +.
T Consensus       286 l~  287 (291)
T cd07844         286 MK  287 (291)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=232.34  Aligned_cols=199  Identities=20%  Similarity=0.231  Sum_probs=155.8

Q ss_pred             cCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            7 RHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         7 ~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      .|||||.+++++.+    ...+++|||.++||.|...+..  .....+++.++..|..||+.|+.|||+.   +|.||||
T Consensus       113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDl  187 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDL  187 (400)
T ss_pred             CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccC
Confidence            59999999999873    4567899999999999999854  3445699999999999999999999999   9999999


Q ss_pred             CCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           83 KASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        83 kp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||+|+|...   |..+||+|||+|+.-....  .-.+..-|+.|.|||++...+|+..+|+||+||++|-||+|.+||+.
T Consensus       188 KpENLLyt~t~~na~lKLtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  188 KPENLLYTTTSPNAPLKLTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             ChhheeeecCCCCcceEecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence            999999954   4569999999999654322  23345578999999999999999999999999999999999999987


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCC--C-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPE--L-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..+..-           ..+....+....  + ........+...++|+..|+.+|.+|-|+.++++
T Consensus       266 ~hg~ai-----------spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  266 NHGLAI-----------SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCCccC-----------ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            654211           111111111111  1 1122345566778888899999999999999875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-35  Score=245.01  Aligned_cols=197  Identities=23%  Similarity=0.356  Sum_probs=153.4

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.+| .|.+|+++|+|-..++++|+||||-+ -+|..+|..   .....+.-.+..+..|++.|+.++|++   ||||.|
T Consensus       413 L~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSD  485 (677)
T KOG0596|consen  413 LNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSD  485 (677)
T ss_pred             HHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecC
Confidence            5667 58999999999999999999999875 599999943   222333237778999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccC-----------ccccccceEehhHHHHH
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGG-----------QLTMKADVYSFGVLVLE  149 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~vl~e  149 (277)
                      |||.|+|+- .|.+||.|||+|..+..+.+.. .....||+.||+||.+...           +.++++|||||||+||+
T Consensus       486 LKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq  564 (677)
T KOG0596|consen  486 LKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ  564 (677)
T ss_pred             CCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence            999999987 4589999999999887766553 4567899999999988542           25688999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccC----CCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |+-|+.||.......       + .      ...+.+|    .++..+...  .++++++.||+.||++||++.++++
T Consensus       565 MvYgktPf~~~~n~~-------a-K------l~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  565 MVYGKTPFGQIINQI-------A-K------LHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHhcCCchHHHHHHH-------H-H------HHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhc
Confidence            999999986542111       1 1      1122222    122222222  1778888999999999999999875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-35  Score=244.00  Aligned_cols=201  Identities=24%  Similarity=0.416  Sum_probs=152.6

Q ss_pred             cccc-cCCCccceeeEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            3 LSNV-RHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      ++++ +||||+++++++..      +...+++|||+.+|+|.+++...  .+..+++..+..++.|++.||+|||+.   
T Consensus        66 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---  140 (282)
T cd06636          66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---  140 (282)
T ss_pred             HHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            4555 79999999999963      45789999999999999998542  234578888999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHH
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el  150 (277)
                      +++|+||+|+||++++++.++|+|||++........ ......|+..|+|||.+.     ...++.++||||||+++|||
T Consensus       141 ~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el  219 (282)
T cd06636         141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM  219 (282)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHH
Confidence            999999999999999999999999999875432211 123355888999999875     34578899999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ++|..||........      ........ .     +..  ........+.+++.+||+.+|.+||++.+|++
T Consensus       220 ~~g~~p~~~~~~~~~------~~~~~~~~-~-----~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         220 AEGAPPLCDMHPMRA------LFLIPRNP-P-----PKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhCCCCccccCHHhh------hhhHhhCC-C-----CCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            999999865332111      00111100 0     001  01112235788889999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-35  Score=240.74  Aligned_cols=203  Identities=25%  Similarity=0.420  Sum_probs=155.5

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      ++.++||||+++++++..+...++||||++ |+|.+++......+..+++..++.++.|++.||+|||++.  +++||||
T Consensus        54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dl  130 (283)
T cd06617          54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDV  130 (283)
T ss_pred             HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCC
Confidence            456789999999999999999999999996 5898888654444567999999999999999999999853  7999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc----CccccccceEehhHHHHHHHhCCCCCC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||+||+++.++.+||+|||+++.+....  ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.|+.
T Consensus       131 kp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         131 KPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             CHHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence            9999999999999999999998654321  1223457889999998865    346889999999999999999999985


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....... ..    ........      +.+..  ......+.+++.+||..+|.+||++.+|+.
T Consensus       209 ~~~~~~~-~~----~~~~~~~~------~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         209 SWKTPFQ-QL----KQVVEEPS------PQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ccccCHH-HH----HHHHhcCC------CCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            4322111 11    11111111      11100  012234778888999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=231.89  Aligned_cols=202  Identities=27%  Similarity=0.439  Sum_probs=156.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++..-+.|+||+.+|||..+...++.||.|.. .++.++.   .-..++++..+-++...++.||.||..+.  +|+|||
T Consensus       144 v~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRD  217 (391)
T KOG0983|consen  144 VLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRD  217 (391)
T ss_pred             HhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecc
Confidence            34455689999999999999999999999954 7777774   34557999999999999999999998764  999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+|||+|+.|++||||||++-.+-+...  ..+..|.+.|||||.+..   ..|+.++||||||+.++||.||+.|+.
T Consensus       218 vKPSNILlDe~GniKlCDFGIsGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~  295 (391)
T KOG0983|consen  218 VKPSNILLDERGNIKLCDFGISGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK  295 (391)
T ss_pred             cCccceEEccCCCEEeecccccceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence            999999999999999999999987654432  345668999999998854   368999999999999999999999976


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .-..+.  .+..   .+.+.+.  ..++...+     ....+.+++..||..|+.+||.+.++++
T Consensus       296 ~c~tdF--e~lt---kvln~eP--P~L~~~~g-----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  296 GCKTDF--EVLT---KVLNEEP--PLLPGHMG-----FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCccH--HHHH---HHHhcCC--CCCCcccC-----cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            532221  1222   1222221  12222222     2334788888899999999999998865

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=241.59  Aligned_cols=198  Identities=26%  Similarity=0.395  Sum_probs=155.7

Q ss_pred             ccccc---CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            3 LSNVR---HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         3 L~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +++++   ||||+++++++..+...++||||+.+++|.+++..     ..+++..++.++.|++.||.|||+.   +++|
T Consensus        53 l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H  124 (277)
T cd06917          53 LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIH  124 (277)
T ss_pred             HHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            44554   99999999999999999999999999999999832     2689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+|+||++++++.++|+|||++........ ......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.
T Consensus       125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  203 (277)
T cd06917         125 RDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS  203 (277)
T ss_pred             CCcCHHHEEEcCCCCEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987654332 22334688899999988754 46889999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......      .... ....     ..+.+...  .....+.+++.+||+.+|++||++.+++.
T Consensus       204 ~~~~~~------~~~~-~~~~-----~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         204 DVDAFR------AMML-IPKS-----KPPRLEDN--GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCChhh------hhhc-cccC-----CCCCCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            432211      1100 0000     11111110  12345778888899999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3e-35  Score=243.28  Aligned_cols=212  Identities=23%  Similarity=0.322  Sum_probs=155.9

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++...  ...++||||+.+ +|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        57 ~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H  129 (293)
T cd07843          57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILH  129 (293)
T ss_pred             HHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence            46788999999999999887  899999999975 99998843   223689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+|+||+++.++.++|+|||+++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus       130 ~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~  208 (293)
T cd07843         130 RDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP  208 (293)
T ss_pred             ccCCHHHEEECCCCcEEEeecCceeeccCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876543211 2234567889999988764 46889999999999999999999886


Q ss_pred             cccCcchhhHHH--------HHHHHhcc------CC----ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHH
Q 023808          159 AMWGQMNKFLLE--------WAWQLHQE------EK----PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ  220 (277)
Q Consensus       159 ~~~~~~~~~~~~--------~~~~~~~~------~~----~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~  220 (277)
                      ............        ..|.....      ..    ....+...+...  .....+.+++..||+.+|++||++.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~e  286 (293)
T cd07843         209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAED  286 (293)
T ss_pred             CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc--CCChHHHHHHHHHhccCccccCCHHH
Confidence            543221110000        00000000      00    000011111111  02345778888999999999999999


Q ss_pred             HHH
Q 023808          221 VIK  223 (277)
Q Consensus       221 v~~  223 (277)
                      ++.
T Consensus       287 ll~  289 (293)
T cd07843         287 ALK  289 (293)
T ss_pred             Hhc
Confidence            874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-35  Score=244.12  Aligned_cols=213  Identities=22%  Similarity=0.309  Sum_probs=154.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+. ++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~  125 (284)
T cd07860          52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRD  125 (284)
T ss_pred             HHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4678999999999999999999999999996 5899888432  344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.+||+|||+++....... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus       126 l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         126 LKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             CCHHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999999876543221 122334678899999887654 588899999999999999999988643


Q ss_pred             cCcchhhHHHHHHHHhccC---------------CccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEE---------------KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...  ..............               .........+....+.....+.+++.+||+.||.+||++.+++.
T Consensus       205 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         205 SEI--DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CHH--HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            221  11111110000000               00000000000001111234678899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=246.95  Aligned_cols=141  Identities=26%  Similarity=0.344  Sum_probs=123.5

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI   87 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Ni   87 (277)
                      --|+|++++||...+++|||+|.++. ||+++++...  -..++...+..++.||+.||.+||+.   +|||+||||+||
T Consensus       247 ~~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENI  320 (586)
T KOG0667|consen  247 KYNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENI  320 (586)
T ss_pred             CeeEEEeeeccccccceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhhe
Confidence            35899999999999999999999965 9999997543  34589999999999999999999999   999999999999


Q ss_pred             EeCCCC--ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           88 LLDQEF--NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        88 ll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||.+.+  .+||+|||.+++.....    .+...+..|+|||++.+.+|+.+.|+||||||+.||++|.+-|.
T Consensus       321 LL~~~~r~~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  321 LLKDPKRSRIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             eeccCCcCceeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            996544  69999999999754432    25567888999999999999999999999999999999976444

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.2e-35  Score=240.51  Aligned_cols=202  Identities=23%  Similarity=0.450  Sum_probs=159.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++......++|+||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        68 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~d  141 (286)
T cd06614          68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRD  141 (286)
T ss_pred             HHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCC
Confidence            4678899999999999999999999999999999999995322   3789999999999999999999998   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus       142 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         142 IKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             CChhhEEEcCCCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998875543221 1233457789999999988889999999999999999999999876432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  ..    ...... ...     . .........+.+++.+||+.+|.+||++.+|+.
T Consensus       221 ~~~~--~~----~~~~~~-~~~-----~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         221 PLRA--LF----LITTKG-IPP-----L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHH--HH----HHHhcC-CCC-----C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2110  10    111111 100     0 001112334778888999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4e-35  Score=242.45  Aligned_cols=201  Identities=24%  Similarity=0.433  Sum_probs=158.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++...+..++|+||+++++|.+++..     ..+++..+..++.|++.||+|||+.   +++|+|
T Consensus        69 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~d  140 (293)
T cd06647          69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD  140 (293)
T ss_pred             HHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeecc
Confidence            46788999999999999999999999999999999999832     3578999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++........ ......++..|++||.+....++.++|+||||+++|++++|+.||....
T Consensus       141 L~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         141 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             CCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998876543322 1223457888999999988888999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ....  +    ........      +.. .........+.+++.+||+.+|.+||++.+++..
T Consensus       220 ~~~~--~----~~~~~~~~------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         220 PLRA--L----YLIATNGT------PEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             hhhh--e----eehhcCCC------CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2110  0    00000000      001 0111223347788889999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.2e-35  Score=241.16  Aligned_cols=200  Identities=22%  Similarity=0.401  Sum_probs=156.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++..++..++||||+++++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+|
T Consensus        70 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~d  141 (292)
T cd06657          70 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRD  141 (292)
T ss_pred             HHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4678899999999999999999999999999999999873     23578999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++........ ......|+..|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       142 l~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~  220 (292)
T cd06657         142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  220 (292)
T ss_pred             CCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543221 1223457889999999988888999999999999999999999976432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .....    .....     ..+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus       221 ~~~---~~~~~----~~~~~-----~~~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         221 PLK---AMKMI----RDNLP-----PKLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHH---HHHHH----HhhCC-----cccCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            211   11111    10000     01100 0112223667888899999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=258.00  Aligned_cols=143  Identities=21%  Similarity=0.268  Sum_probs=121.0

Q ss_pred             cCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCC
Q 023808            7 RHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKA   84 (277)
Q Consensus         7 ~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~dikp   84 (277)
                      +|.+++++++++..+ .+.++|||++ +++|.+++.    ....+++..+..++.||+.||+|||+ .   +|+||||||
T Consensus       189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP  260 (467)
T PTZ00284        189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKP  260 (467)
T ss_pred             cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCH
Confidence            456789999998865 4788999988 778988883    33468999999999999999999997 6   999999999


Q ss_pred             CcEEeCCCC----------------ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           85 SNILLDQEF----------------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        85 ~Nill~~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      +|||++.++                .+||+|||.+.....    ......||..|+|||++.+..++.++|||||||++|
T Consensus       261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~  336 (467)
T PTZ00284        261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY  336 (467)
T ss_pred             HHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence            999998665                499999998764322    233467899999999999999999999999999999


Q ss_pred             HHHhCCCCCCccc
Q 023808          149 EIISGRNSGKAMW  161 (277)
Q Consensus       149 elltg~~p~~~~~  161 (277)
                      ||++|+.||....
T Consensus       337 elltG~~pf~~~~  349 (467)
T PTZ00284        337 ELYTGKLLYDTHD  349 (467)
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999986543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-35  Score=237.61  Aligned_cols=203  Identities=25%  Similarity=0.422  Sum_probs=163.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|||++++++.+..+...++|+||+++++|.+++......+..+++..+..++.+++.||+|||+.   +++|+|
T Consensus        52 ~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~d  128 (258)
T cd08215          52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRD  128 (258)
T ss_pred             HHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEeccc
Confidence            46788999999999999999999999999999999999965443456799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||.+....... .......|+..|+|||...+..++.++|+||+|+++++|++|..|+....
T Consensus       129 l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         129 IKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             CChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999999999999999999998765432 23334568889999999988889999999999999999999999875432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .      ......... ...     +.+   +......+.+++.+||..+|.+||++.+++.
T Consensus       208 ~------~~~~~~~~~-~~~-----~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         208 L------LELALKILK-GQY-----PPI---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             H------HHHHHHHhc-CCC-----CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1      111111111 111     111   1122344778888899999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.6e-35  Score=244.93  Aligned_cols=215  Identities=19%  Similarity=0.262  Sum_probs=155.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||++++++|..++..++||||+.+|+|.+++....  ...+++..+..++.|++.||+|||+.   +++|||
T Consensus        52 ~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrD  126 (328)
T cd08226          52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRN  126 (328)
T ss_pred             HHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            3556899999999999999999999999999999999985432  23588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce------eeeecccccccCccccccC--ccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI------TTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+||+++.++.++++||+.+..........      .....++..|++||++.+.  .++.++||||||+++|||++|
T Consensus       127 lkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g  206 (328)
T cd08226         127 IKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG  206 (328)
T ss_pred             CCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999999999998654322111110      1112345679999998763  478999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHH--------------------------------HhccCCccccccCCC-CCCCHHHHHHH
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQ--------------------------------LHQEEKPLELVDPEL-GEYPPNEIIRY  200 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~-~~~~~~~~~~~  200 (277)
                      ..||........  .......                                ..............+ ..........+
T Consensus       207 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (328)
T cd08226         207 RVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF  284 (328)
T ss_pred             CCCCCCcChHHH--HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence            999865432110  0000000                                000000000000011 11122345568


Q ss_pred             HHHHHhhhhhhhcCCCCHHHHHH
Q 023808          201 MKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       201 ~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .+++.+||+.||++|||+.++++
T Consensus       285 ~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         285 QNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             HHHHHHHccCCcccCCCHHHHhh
Confidence            89999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.4e-35  Score=240.69  Aligned_cols=208  Identities=26%  Similarity=0.305  Sum_probs=161.2

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|.++ +||||+++++.+..+...++||||+.+|+|.+++.    .+..+++..+..++.|++.||.|||+.   +++|+
T Consensus        57 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~  129 (288)
T cd05583          57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYR  129 (288)
T ss_pred             HHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---Ceecc
Confidence            35677 69999999999999999999999999999999983    334688999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc--cccccceEehhHHHHHHHhCCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||+|+||+++.++.++|+|||+++..............|+..|++||.+.+..  .+.++||||||+++|||++|..||.
T Consensus       130 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  209 (288)
T cd05583         130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT  209 (288)
T ss_pred             CCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence            99999999999999999999998865444333333456888999999987655  7889999999999999999999985


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ......  .............       +..   +......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       210 ~~~~~~--~~~~~~~~~~~~~-------~~~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         210 VDGEQN--SQSEISRRILKSK-------PPF---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             cCcccc--hHHHHHHHHHccC-------CCC---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            322111  1111111111111       111   111223467888899999999999999888877653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=250.97  Aligned_cols=223  Identities=26%  Similarity=0.323  Sum_probs=169.0

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++|+|+|||++++.-....      ...+|||||.||+|+.+|..- .....+++.+.+.++..++.||.|||++   
T Consensus        64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---  139 (732)
T KOG4250|consen   64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---  139 (732)
T ss_pred             HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---
Confidence            689999999999999876543      568999999999999999653 3445799999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeC--CCC--ceEEeecccccccCCCCcceeeeecccccccCccccc-cCccccccceEehhHHHHHH
Q 023808           76 HIVHRDIKASNILLD--QEF--NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        76 ~iiH~dikp~Nill~--~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el  150 (277)
                      +|+||||||.||++-  .+|  ..||+|||.|+...++.  ......||..|++||++. ...|+...|.|||||++|+.
T Consensus       140 ~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~c  217 (732)
T KOG4250|consen  140 GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYEC  217 (732)
T ss_pred             CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHH
Confidence            999999999999983  223  47999999999887654  566788999999999998 47899999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccC----------CC---CCCCHHHHHHHHHHHHhhhhhhhcCCC-
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP----------EL---GEYPPNEIIRYMKVAFFCTQAAASRRP-  216 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~l~~~c~~~~p~~RP-  216 (277)
                      +||..||....+.....-..|...........-....          .+   ....+.....+-+++..++..+|.+|- 
T Consensus       218 aTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  218 ATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             hccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence            9999999887765433222222221111111111111          11   122344455566677778999999998 


Q ss_pred             -CHHHHHHHHhhccc
Q 023808          217 -QMNQVIKMLTKNIR  230 (277)
Q Consensus       217 -s~~~v~~~L~~~~~  230 (277)
                       ...+....+.++++
T Consensus       298 ~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  298 EGFDRFFAEVDDILN  312 (732)
T ss_pred             CCcchHHHHHHHHHh
Confidence             66666666666654

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=242.24  Aligned_cols=213  Identities=23%  Similarity=0.319  Sum_probs=155.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||++ ++|.+++....  ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        51 ~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~d  124 (283)
T cd07835          51 LLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRD  124 (283)
T ss_pred             HHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCC
Confidence            4678899999999999999999999999995 69999984322  23689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.++|+|||+++........ .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       125 l~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         125 LKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             CCHHHEEEcCCCcEEEeecccccccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999765432211 1223467889999987664 4688999999999999999999988643


Q ss_pred             cCcchhhHHHHHHHHhccC---------------CccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEE---------------KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  .............               ..............+.....+.+++.+||+.+|.+||++.++++
T Consensus       204 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         204 SEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CHHH--HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            2211  1111000000000               00000000011111222245778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-35  Score=241.74  Aligned_cols=204  Identities=25%  Similarity=0.294  Sum_probs=159.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++.+..+...++||||+.+++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+|
T Consensus        46 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~d  118 (265)
T cd05579          46 ILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRD  118 (265)
T ss_pred             HHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCC
Confidence            46788999999999999999999999999999999999943    23689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc-------ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT-------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      |+|+||++++++.++|+|||++........       .......++..|++||.......+.++||||||+++|++++|.
T Consensus       119 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  198 (265)
T cd05579         119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI  198 (265)
T ss_pred             CCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence            999999999999999999999875433211       1223345778899999998888899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      .||......      ........ ...      ...... .....+.+++.+||+.+|.+||++.++.+.|+
T Consensus       199 ~p~~~~~~~------~~~~~~~~-~~~------~~~~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         199 PPFHGETPE------EIFQNILN-GKI------EWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCCCCCCHH------HHHHHHhc-CCc------CCCccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            998643321      11111111 110      000100 01344778888899999999999977766664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-34  Score=241.54  Aligned_cols=196  Identities=32%  Similarity=0.482  Sum_probs=153.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.+++..++||||+. |+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        68 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~d  140 (307)
T cd06607          68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRD  140 (307)
T ss_pred             HHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecC
Confidence            4678999999999999999999999999996 577777632   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||++++++.++|+|||++......     ....++..|+|||++.   ...++.++||||||+++|||+||..|+.
T Consensus       141 l~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~  215 (307)
T cd06607         141 IKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (307)
T ss_pred             CCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999998765332     2345788999999874   3568889999999999999999999875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......      ..........      +.+.  .......+.+++.+||+.+|.+||++.+|+.
T Consensus       216 ~~~~~~------~~~~~~~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         216 NMNAMS------ALYHIAQNDS------PTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CccHHH------HHHHHhcCCC------CCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            432211      1111111111      1110  1123345788899999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=239.50  Aligned_cols=212  Identities=21%  Similarity=0.276  Sum_probs=152.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..+...++||||+. ++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        56 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~d  128 (291)
T cd07870          56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRD  128 (291)
T ss_pred             HHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            4678899999999999999999999999996 677777632   234578888999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.++|+|||+++........ .....++..|+|||.+.+. .++.++||||||+++|||++|..||...
T Consensus       129 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         129 LKPQNLLISYLGELKLADFGLARAKSIPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CChHHEEEcCCCcEEEeccccccccCCCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999999998754332211 1233468899999988754 5788999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccC-------------Ccccccc----CCCCC--CCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEE-------------KPLELVD----PELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~~----~~~~~--~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      ......  ....+......             .......    ..+..  ........+.+++.+|++.||.+|||+.++
T Consensus       208 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~  285 (291)
T cd07870         208 SDVFEQ--LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA  285 (291)
T ss_pred             hhHHHH--HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence            332111  11111110000             0000000    00000  000012346788889999999999999988


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      +.
T Consensus       286 l~  287 (291)
T cd07870         286 LL  287 (291)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-34  Score=233.55  Aligned_cols=201  Identities=29%  Similarity=0.502  Sum_probs=159.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++..+...++++||+.+++|.+++...   ...+++..+..++.|++.||++||+.   +++|+|
T Consensus        50 ~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~d  123 (253)
T cd05122          50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRD  123 (253)
T ss_pred             HHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCC
Confidence            367889999999999999999999999999999999998432   25689999999999999999999998   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++++.++|+|||.+........  .....++..|++||.+.+...+.++|+||||+++++|++|..|+....
T Consensus       124 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  201 (253)
T cd05122         124 IKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP  201 (253)
T ss_pred             CCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999999987654322  334568889999999988888999999999999999999999876432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .   ..... ........      .......+.+++.+||+.||++||++.++++
T Consensus       202 ~~~~---~---~~~~~-~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         202 PMKA---L---FKIAT-NGPPGLRN------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             hHHH---H---HHHHh-cCCCCcCc------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111   0   01111 11101000      0101234778888999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6e-35  Score=240.28  Aligned_cols=213  Identities=23%  Similarity=0.368  Sum_probs=156.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+.+ +|.+++.... ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~d  125 (284)
T cd07836          51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRD  125 (284)
T ss_pred             HHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCC
Confidence            46788999999999999999999999999975 8888875432 234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++.++|+|||+++........ .....++..|++||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       126 l~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         126 LKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             CCHHHEEECCCCcEEEeecchhhhhcCCccc-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999765432211 1233467889999988664 4688999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCC--------ccccccCCC--------CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEK--------PLELVDPEL--------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--------~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....  ... .........        .........        ....+.....+.+++.+|++.+|.+||++.+++.
T Consensus       205 ~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         205 NNEDQ--LLK-IFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CcHHH--HHH-HHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            32211  111 000000000        000000000        0111122345778889999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=241.06  Aligned_cols=212  Identities=25%  Similarity=0.326  Sum_probs=157.1

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      ++++++|||++++++++...  ...++||||+.+ +|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        51 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h  123 (287)
T cd07840          51 LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILH  123 (287)
T ss_pred             HHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---Ccee
Confidence            46788999999999999988  899999999975 89888842   224789999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+|+||++++++.++|+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       124 ~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~  203 (287)
T cd07840         124 RDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ  203 (287)
T ss_pred             ccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998765443222333456788999998765 357899999999999999999999886


Q ss_pred             cccCcchhhHHHHHHHHhccCCcc---c--------------cccCCCCCCCHH-HHHHHHHHHHhhhhhhhcCCCCHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPL---E--------------LVDPELGEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQ  220 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~---~--------------~~~~~~~~~~~~-~~~~~~~l~~~c~~~~p~~RPs~~~  220 (277)
                      ......   ...............   .              .....+.+.... +...+.+++.+||+.+|.+||++.+
T Consensus       204 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~  280 (287)
T cd07840         204 GSTELE---QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ  280 (287)
T ss_pred             CCChHH---HHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            543211   111111110000000   0              000000000001 1445788999999999999999999


Q ss_pred             HHH
Q 023808          221 VIK  223 (277)
Q Consensus       221 v~~  223 (277)
                      ++.
T Consensus       281 ~l~  283 (287)
T cd07840         281 ALQ  283 (287)
T ss_pred             Hhh
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.4e-35  Score=239.69  Aligned_cols=202  Identities=23%  Similarity=0.365  Sum_probs=160.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+....++||||+.+++|.+++......+..+++..++.++.|++.||.|||+.   +++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~  131 (260)
T cd08222          55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRD  131 (260)
T ss_pred             HHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccC
Confidence            46788999999999999999999999999999999999865444556799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||++++ +.++|+|||+++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus       132 l~~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~  209 (260)
T cd08222         132 LKAKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN  209 (260)
T ss_pred             CChhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999975 569999999988654322 22234457889999999888888999999999999999999999875321


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .      ...........         ....+......+.+++.+||+.+|++||++.++++
T Consensus       210 ~------~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         210 F------LSVVLRIVEGP---------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             H------HHHHHHHHcCC---------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1      11111111111         11112233445778889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=241.68  Aligned_cols=211  Identities=24%  Similarity=0.314  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+||+++++++..++..++||||+.+ +|.+++..   ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        51 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~d  123 (283)
T cd05118          51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRD  123 (283)
T ss_pred             HHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecC
Confidence            46788999999999999999999999999975 88888743   235789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...
T Consensus       124 l~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  202 (283)
T cd05118         124 LKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK  202 (283)
T ss_pred             cCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998765443 112234577889999998776 7899999999999999999999887543


Q ss_pred             cCcchhhHHHHHHHHhccC---Cccccc--------------cCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEE---KPLELV--------------DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ...........   ......              ........+.....+.+++..||+.||.+||++.+++.
T Consensus       203 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         203 SEIDQ---LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CHHHH---HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            32111   00000100000   000000              00001112234556889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-34  Score=233.40  Aligned_cols=202  Identities=30%  Similarity=0.422  Sum_probs=161.6

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      ++++++||||+++++++...  ...++|+||+.+++|.+++..    ...+++..++.++.|++.||+|||+.   +++|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h  124 (260)
T cd06606          52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVH  124 (260)
T ss_pred             HHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            46788999999999999988  899999999999999999943    23789999999999999999999998   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+|+||+++.++.++|+|||.+......... ......++..|++||.+.+...+.++||||||+++++|++|..||.
T Consensus       125 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  204 (260)
T cd06606         125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS  204 (260)
T ss_pred             cCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876554321 1234567889999999988889999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....     .....+........        ...+......+.+++.+|++.+|.+||++.+++.
T Consensus       205 ~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         205 ELGN-----PMAALYKIGSSGEP--------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCc-----hHHHHHhccccCCC--------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            5441     11111111111111        1112222445778888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-34  Score=238.25  Aligned_cols=208  Identities=24%  Similarity=0.290  Sum_probs=153.4

Q ss_pred             cccc-cCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            3 LSNV-RHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      |.++ +|+||+++++++.++  +..++||||+.+ +|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H  123 (282)
T cd07831          51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFH  123 (282)
T ss_pred             HhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---Ccee
Confidence            4566 499999999999987  889999999974 88877742   234689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+|+||+++. +.+||+|||+++........  ....++..|+|||.+.. ..++.++|||||||++|||++|..||.
T Consensus       124 ~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~  200 (282)
T cd07831         124 RDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP  200 (282)
T ss_pred             cccCHHHEEEcC-CCeEEEecccccccccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence            999999999999 99999999999865433221  22457889999997654 457889999999999999999999886


Q ss_pred             cccCcchhhHHHHHHHHh-----------ccCCccccccCC-----CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLH-----------QEEKPLELVDPE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ......   .........           ..........+.     +....+.....+.+++.+||+.+|++||++.+++
T Consensus       201 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l  277 (282)
T cd07831         201 GTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL  277 (282)
T ss_pred             CCCHHH---HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence            543211   111111100           000000000000     0011123346688999999999999999999987


Q ss_pred             H
Q 023808          223 K  223 (277)
Q Consensus       223 ~  223 (277)
                      .
T Consensus       278 ~  278 (282)
T cd07831         278 R  278 (282)
T ss_pred             h
Confidence            5

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=259.11  Aligned_cols=210  Identities=29%  Similarity=0.418  Sum_probs=161.6

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC----------CCC--ccCCHHHHHHHHHHHHHHHHHh
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT----------KAN--IKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~--~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      |+.+ +|+||+.++|+|.++...++|+||+..|+|.++|+..+          ...  ..++....+.++.|||.|++||
T Consensus       355 m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L  434 (609)
T KOG0200|consen  355 LKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL  434 (609)
T ss_pred             HHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence            3344 79999999999999999999999999999999996544          001  2388999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecc--cccccCccccccCccccccceEehhHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ++.   +++|||+-.+|||+.++..+||+|||+++..............|  ...|||||.+....++.++||||||++|
T Consensus       435 ~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L  511 (609)
T KOG0200|consen  435 ASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL  511 (609)
T ss_pred             hhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence            999   99999999999999999999999999999655544333332222  3459999999999999999999999999


Q ss_pred             HHHHhCC-CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ||++|.. .|+.. .... ..+..    ....+...     ..+..+   ..++.++++.||+.+|++||++.++.+.++
T Consensus       512 ~EifsLG~~PYp~-~~~~-~~l~~----~l~~G~r~-----~~P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  512 WEIFTLGGTPYPG-IPPT-EELLE----FLKEGNRM-----EQPEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             HHHhhCCCCCCCC-CCcH-HHHHH----HHhcCCCC-----CCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            9999954 45433 1111 11222    22222211     112223   334567777799999999999999999999


Q ss_pred             hcc
Q 023808          227 KNI  229 (277)
Q Consensus       227 ~~~  229 (277)
                      ..+
T Consensus       578 ~~l  580 (609)
T KOG0200|consen  578 KHL  580 (609)
T ss_pred             HHH
Confidence            854

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=252.77  Aligned_cols=201  Identities=22%  Similarity=0.326  Sum_probs=162.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+|+|||++++||...+ ....+|||++..|+|.+.|+.  .....|.......++.|||.|+.||..+   ++||||
T Consensus       164 ~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRD  237 (1039)
T KOG0199|consen  164 HMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRD  237 (1039)
T ss_pred             HHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhh
Confidence            4678999999999999988 677899999999999999965  3455688889999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhC-CCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg-~~p~~  158 (277)
                      |..+|+||.....|||+|||+.+.+..+...  ......-.+.|+|||.++...++.++|||+|||++|||+|+ ..||.
T Consensus       238 LAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~  317 (1039)
T KOG0199|consen  238 LAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV  317 (1039)
T ss_pred             hhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence            9999999999999999999999987654332  23334456789999999999999999999999999999995 45765


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .-.+..       +.+.+..+        ..-.-+..+.+++.+++..||..+|.+||++..|.+
T Consensus       318 G~~g~q-------IL~~iD~~--------erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  318 GCRGIQ-------ILKNIDAG--------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCCHHH-------HHHhcccc--------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            433211       11111111        111234455667888889999999999999999974

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-34  Score=241.61  Aligned_cols=210  Identities=25%  Similarity=0.344  Sum_probs=152.5

Q ss_pred             ccccccCCCccceeeEEEeCC--------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      ++++++||||+++++++....        ..++||||+.+ +|.+++.   ..+..+++..++.++.|++.||+|||+. 
T Consensus        64 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~-  138 (310)
T cd07865          64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN-  138 (310)
T ss_pred             HHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            467889999999999987654        45999999965 8888873   2334689999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccC-ccccccceEehhHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLE  149 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~e  149 (277)
                        +++|+||||+||+++.++.+||+|||++..+......   ......++..|+|||.+.+. .++.++||||||+++||
T Consensus       139 --~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~e  216 (310)
T cd07865         139 --KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE  216 (310)
T ss_pred             --CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHH
Confidence              9999999999999999999999999999865432211   12234567889999988664 36889999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCc---------------------cccccCCCCCCCHHHHHHHHHHHHhhh
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---------------------LELVDPELGEYPPNEIIRYMKVAFFCT  208 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~~c~  208 (277)
                      |++|..|+........   .............                     .......+...  .....+.+++.+||
T Consensus       217 l~t~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~dli~~~l  291 (310)
T cd07865         217 MWTRSPIMQGNTEQHQ---LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY--VKDPHALDLIDKLL  291 (310)
T ss_pred             HHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc--cCCHHHHHHHHHHh
Confidence            9999988765432211   1111111100000                     00000000000  01234668999999


Q ss_pred             hhhhcCCCCHHHHHH
Q 023808          209 QAAASRRPQMNQVIK  223 (277)
Q Consensus       209 ~~~p~~RPs~~~v~~  223 (277)
                      ..||.+||+++++++
T Consensus       292 ~~~P~~R~t~~e~l~  306 (310)
T cd07865         292 VLDPAKRIDADTALN  306 (310)
T ss_pred             cCChhhccCHHHHhc
Confidence            999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=232.47  Aligned_cols=199  Identities=28%  Similarity=0.454  Sum_probs=159.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|||++++++++.++...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  124 (254)
T cd06627          52 LLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRD  124 (254)
T ss_pred             HHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCC
Confidence            46788999999999999999999999999999999999842    35789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||++......... .....++..|++||...+..++.++||||+|+++|+|++|..|+....
T Consensus       125 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         125 IKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             CCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999999999876543321 233457889999999888788999999999999999999999876433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..      ...+.......      +.+   +......+.+++.+||..+|++||++.+++.
T Consensus       204 ~~------~~~~~~~~~~~------~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         204 PM------AALFRIVQDDH------PPL---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HH------HHHHHHhccCC------CCC---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11      11111111111      111   1122334778888999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3e-34  Score=236.69  Aligned_cols=206  Identities=26%  Similarity=0.401  Sum_probs=153.2

Q ss_pred             ccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhcc-CCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            3 LSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG-ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         3 L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      |.++. |+||+++++++..+...+++|||+.. +|.++... .......+++..+..++.|++.||+|||+..  +++||
T Consensus        56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~  132 (288)
T cd06616          56 VMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHR  132 (288)
T ss_pred             HHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--Ceecc
Confidence            55665 99999999999999999999999964 66554321 1123356899999999999999999999732  89999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC---ccccccceEehhHHHHHHHhCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||||+||+++.++.++|+|||+++.......  .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||
T Consensus       133 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  210 (288)
T cd06616         133 DVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY  210 (288)
T ss_pred             CCCHHHEEEccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence            9999999999999999999999976543221  2233578899999998776   6889999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....     .............. . +.   ..........+.+++.+||+.+|.+||++.+|++
T Consensus       211 ~~~~~-----~~~~~~~~~~~~~~-~-~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         211 PKWNS-----VFDQLTQVVKGDPP-I-LS---NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             hhcch-----HHHHHhhhcCCCCC-c-CC---CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            64321     11111111111111 0 00   1111223345788889999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.8e-35  Score=234.25  Aligned_cols=184  Identities=21%  Similarity=0.165  Sum_probs=146.7

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      ...||||+++++++.+.+..++||||+.+|+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||
T Consensus        41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp  113 (237)
T cd05576          41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNP  113 (237)
T ss_pred             hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCH
Confidence            34699999999999999999999999999999999842    33589999999999999999999999   999999999


Q ss_pred             CcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcc
Q 023808           85 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  164 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~  164 (277)
                      +||+++.++.++++|||.+......    .....++..|+|||...+..++.++||||+|+++|||++|..|+.......
T Consensus       114 ~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~  189 (237)
T cd05576         114 NNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI  189 (237)
T ss_pred             HHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc
Confidence            9999999999999999988755432    122345677999999988888999999999999999999987653211000


Q ss_pred             hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                                  ..     .....+   +......+.+++.+|++.||++||++.
T Consensus       190 ------------~~-----~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         190 ------------NT-----HTTLNI---PEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ------------cc-----ccccCC---cccCCHHHHHHHHHHccCCHHHhcCCC
Confidence                        00     000011   112233477888899999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=247.32  Aligned_cols=189  Identities=24%  Similarity=0.260  Sum_probs=150.7

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      -+||||+++.+.+.++...++|||.+.|+-|.+.+.    ....++ ..+..|+.+|+.|+.|||++   |++|||+||+
T Consensus       373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~  444 (612)
T KOG0603|consen  373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPG  444 (612)
T ss_pred             cCCCcceeecceecCCceeeeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChh
Confidence            379999999999999999999999999988877662    333333 77788999999999999999   9999999999


Q ss_pred             cEEe-CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcc
Q 023808           86 NILL-DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  164 (277)
Q Consensus        86 Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~  164 (277)
                      |||+ ++.++++|+|||.++.....    ..+..-|..|.|||+.....+++++|+||||++||+||+|+.|+...-.+.
T Consensus       445 NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~  520 (612)
T KOG0603|consen  445 NILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI  520 (612)
T ss_pred             heeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH
Confidence            9999 68899999999999876544    223345788999999999999999999999999999999999986544331


Q ss_pred             hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                        .    +.........           .........+++.+||+.||.+||++.++..
T Consensus       521 --e----i~~~i~~~~~-----------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  521 --E----IHTRIQMPKF-----------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --H----HHHhhcCCcc-----------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              1    1111111111           1222334667888899999999999999854

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.2e-34  Score=238.40  Aligned_cols=201  Identities=30%  Similarity=0.438  Sum_probs=156.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||++++++++.+++..++||||+.| +|.+++..   ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        78 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  150 (317)
T cd06635          78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRD  150 (317)
T ss_pred             HHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            46788999999999999999999999999965 78777742   344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||+++.++.++|+|||++......     ....|+..|+|||.+.   .+.++.++||||||+++|||++|+.|+.
T Consensus       151 L~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         151 IKAGNILLTEPGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             CCcccEEECCCCCEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999998754322     2345788999999874   4568899999999999999999999875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ......  .    ..........      ..  ........+.+++.+||+.+|.+||++.+|++.+-..
T Consensus       226 ~~~~~~--~----~~~~~~~~~~------~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         226 NMNAMS--A----LYHIAQNESP------TL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             CccHHH--H----HHHHHhccCC------CC--CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            432111  0    1111111110      00  0112233477888899999999999999998755443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-34  Score=242.61  Aligned_cols=210  Identities=23%  Similarity=0.260  Sum_probs=153.0

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...++||||+.+ +|.+++.    .  .+++..+..++.|++.||+|||+.   
T Consensus        68 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~--~l~~~~~~~~~~ql~~aL~~LH~~---  137 (353)
T cd07850          68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----M--DLDHERMSYLLYQMLCGIKHLHSA---  137 (353)
T ss_pred             HHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            46788999999999998643      357999999964 8888873    1  288899999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +++||||||+||+++.++.+||+|||+++.......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus       138 gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~  215 (353)
T cd07850         138 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV  215 (353)
T ss_pred             CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence            999999999999999999999999999986543221  233457889999999999899999999999999999999999


Q ss_pred             CCCcccCcchh------------hHHH----HHHHHhccCC------ccccccCCC-----CCCCHHHHHHHHHHHHhhh
Q 023808          156 SGKAMWGQMNK------------FLLE----WAWQLHQEEK------PLELVDPEL-----GEYPPNEIIRYMKVAFFCT  208 (277)
Q Consensus       156 p~~~~~~~~~~------------~~~~----~~~~~~~~~~------~~~~~~~~~-----~~~~~~~~~~~~~l~~~c~  208 (277)
                      ||.........            .+..    ..........      .........     ..........+.+++.+||
T Consensus       216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  295 (353)
T cd07850         216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML  295 (353)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence            88643211000            0000    0000000000      000000000     0001123445778899999


Q ss_pred             hhhhcCCCCHHHHHH
Q 023808          209 QAAASRRPQMNQVIK  223 (277)
Q Consensus       209 ~~~p~~RPs~~~v~~  223 (277)
                      +.||.+||++.|++.
T Consensus       296 ~~dP~~R~t~~eiL~  310 (353)
T cd07850         296 VIDPEKRISVDDALQ  310 (353)
T ss_pred             CCChhhCcCHHHHhc
Confidence            999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.8e-35  Score=246.39  Aligned_cols=211  Identities=20%  Similarity=0.322  Sum_probs=154.9

Q ss_pred             ccccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++++||||+++++++..    ....++||||+. |+|.+++.    .+..+++..+..++.|++.||+|||+.   ++
T Consensus        57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i  128 (334)
T cd07855          57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NV  128 (334)
T ss_pred             HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            4678899999999998863    346899999995 58999983    344599999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCcccccc-CccccccceEehhHHHHHHHhC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg  153 (277)
                      +||||||+||+++.++.+||+|||+++........   ......|+..|+|||.+.+ ..++.++||||||+++|||++|
T Consensus       129 vH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g  208 (334)
T cd07855         129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR  208 (334)
T ss_pred             ecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence            99999999999999999999999999865432211   1223468889999998765 4588999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHh-----------ccCCccccc-------cCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLH-----------QEEKPLELV-------DPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +.||........   ........           .........       ........+.....+.+++.+||+.+|.+|
T Consensus       209 ~~pf~~~~~~~~---~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  285 (334)
T cd07855         209 RQLFPGKNYVHQ---LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER  285 (334)
T ss_pred             CCccCCCChHHH---HHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence            999865332110   00000000           000000000       000001112234568889999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      |++.+++.
T Consensus       286 pt~~~~l~  293 (334)
T cd07855         286 ITVEQALQ  293 (334)
T ss_pred             cCHHHHHh
Confidence            99998876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-34  Score=240.17  Aligned_cols=211  Identities=27%  Similarity=0.336  Sum_probs=153.9

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++|+||+++++++.+.  +..++||||+.+ +|.+++..   ....+++..+..++.|++.||+|||+.   +++|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H  131 (309)
T cd07845          59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIH  131 (309)
T ss_pred             HHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            46789999999999999865  468999999965 89888843   235689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||||+||++++++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|..||.
T Consensus       132 ~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~  210 (309)
T cd07845         132 RDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP  210 (309)
T ss_pred             CCCCHHHEEECCCCCEEECccceeeecCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876543211 122335778999998865 457899999999999999999999886


Q ss_pred             cccCcchhhHHHHHHHHhccCC--c---------ccc--ccC-CC---CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEK--P---------LEL--VDP-EL---GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~--~---------~~~--~~~-~~---~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      ......   .............  .         ...  ... ..   ..........+.+++.+|++.||++||++.++
T Consensus       211 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i  287 (309)
T cd07845         211 GKSEIE---QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA  287 (309)
T ss_pred             CCCHHH---HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            543211   1111111110000  0         000  000 00   00001123446788999999999999999998


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      +.
T Consensus       288 l~  289 (309)
T cd07845         288 LE  289 (309)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.4e-34  Score=236.63  Aligned_cols=203  Identities=25%  Similarity=0.328  Sum_probs=155.0

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ +|+||+++++++..+...++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~  129 (290)
T cd05613          57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYR  129 (290)
T ss_pred             HHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            35677 69999999999999999999999999999999984    344688999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC--ccccccceEehhHHHHHHHhCCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||+|+||+++.++.++|+|||+++..............|+..|+|||.+...  .++.++||||||+++|+|++|..|+.
T Consensus       130 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  209 (290)
T cd05613         130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT  209 (290)
T ss_pred             CCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999999999986544332223345688899999988753  46789999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .....  ...............       .   .+......+.+++.+||+.+|++||     ++.+++.
T Consensus       210 ~~~~~--~~~~~~~~~~~~~~~-------~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         210 VDGEK--NSQAEISRRILKSEP-------P---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             cCCcc--ccHHHHHHHhhccCC-------C---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            42221  111111212111111       1   1112223467888889999999997     5555543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-34  Score=240.40  Aligned_cols=212  Identities=25%  Similarity=0.321  Sum_probs=154.2

Q ss_pred             ccccccCCCccceeeEEEeCC----------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc
Q 023808            2 TLSNVRHPNLVELIGCCVQGT----------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE   71 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~   71 (277)
                      ++++++||||+++++++.+..          ..++|+||+++ +|.+++..   ....+++..++.++.|++.||+|||+
T Consensus        59 ~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~  134 (302)
T cd07864          59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK  134 (302)
T ss_pred             HHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            467889999999999998655          78999999976 77777732   23468999999999999999999999


Q ss_pred             CCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHH
Q 023808           72 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        72 ~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el  150 (277)
                      .   +++|+||+|+||++++++.+||+|||++...............++..|++||.+.+. .++.++||||||+++|||
T Consensus       135 ~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el  211 (302)
T cd07864         135 K---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL  211 (302)
T ss_pred             C---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence            9   999999999999999999999999999987654332222223457789999987653 568899999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCcc---cc--------cc------CCCCCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---EL--------VD------PELGEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~------~~~~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      ++|+.||.......   ...............   ..        .+      .............+.+++.+||+.+|.
T Consensus       212 ~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  288 (302)
T cd07864         212 FTKKPIFQANQELA---QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPS  288 (302)
T ss_pred             HhCCCCCCCCChHH---HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChh
Confidence            99998886433211   111111111111000   00        00      000000111234578888899999999


Q ss_pred             CCCCHHHHHH
Q 023808          214 RRPQMNQVIK  223 (277)
Q Consensus       214 ~RPs~~~v~~  223 (277)
                      +||++.+|+.
T Consensus       289 ~Rp~~~~il~  298 (302)
T cd07864         289 KRCTAEEALN  298 (302)
T ss_pred             hCCCHHHHhc
Confidence            9999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=234.51  Aligned_cols=210  Identities=24%  Similarity=0.338  Sum_probs=155.9

Q ss_pred             cccccCCCccceeeEEEeCCe-----eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            3 LSNVRHPNLVELIGCCVQGTR-----RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      |++++||||+++++++...+.     .+++|||+.+ +|.+++...  ....+++..++.++.|++.||+|||+.   ++
T Consensus        55 l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i  128 (287)
T cd07838          55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RI  128 (287)
T ss_pred             hhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            345679999999999998776     8999999975 899988532  223589999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +|+||+|+||+++.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||||+++|||++|..||
T Consensus       129 ~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~  206 (287)
T cd07838         129 VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF  206 (287)
T ss_pred             eeccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence            9999999999999999999999999987643321  12234678899999999888999999999999999999998887


Q ss_pred             CcccCcchhhHHHHHHHHhccCC--------------ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEK--------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......  .... +........              .............+.....+.+++.+||+.||.+||++.+++.
T Consensus       207 ~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         207 RGTSEAD--QLDK-IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCChHH--HHHH-HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            6533211  1111 111000000              0000000011112233456778999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-35  Score=246.70  Aligned_cols=202  Identities=23%  Similarity=0.428  Sum_probs=162.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.-+||+||++++.+..++.++++.|||.||.++.++.   .-+..+.+.++.-+++|++.||.|||++   +|||||
T Consensus        82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRD  155 (1187)
T KOG0579|consen   82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRD  155 (1187)
T ss_pred             hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhh
Confidence            5677789999999999999999999999999999999984   4567899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||..|||+.-+|.++|+|||.+..... .......+.||+.|||||+..     ..+|+.++||||||++|.||..+.+|
T Consensus       156 LKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP  234 (1187)
T KOG0579|consen  156 LKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP  234 (1187)
T ss_pred             ccccceEEEecCcEeeecccccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence            999999999999999999998763221 223355688999999999874     45799999999999999999999988


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....+      ......+...+.+ .++.      +......|.+++.+||..||..||++.++++
T Consensus       235 Hhelnp------MRVllKiaKSePP-TLlq------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  235 HHELNP------MRVLLKIAKSEPP-TLLQ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ccccch------HHHHHHHhhcCCC-cccC------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            654332      2222222222222 2222      2334445778888899999999999999874

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-34  Score=243.07  Aligned_cols=210  Identities=26%  Similarity=0.382  Sum_probs=153.4

Q ss_pred             ccccc-cCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNV-RHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +++++ +||||++++++|...  ...++||||+. ++|.+++..    + .+++..+..++.|++.||+|||+.   +++
T Consensus        59 ~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~  129 (337)
T cd07852          59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSG---NVI  129 (337)
T ss_pred             HHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence            46788 999999999998754  36899999997 599998832    2 678999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCCc----ceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhC
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg  153 (277)
                      |+||+|+||+++.++.+||+|||+++.......    .......|+..|+|||.+.+ ..++.++||||||+++|+|+||
T Consensus       130 H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg  209 (337)
T cd07852         130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG  209 (337)
T ss_pred             cCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence            999999999999999999999999986543321    12233568889999998765 4578899999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHh-----------ccCCcccccc-------CCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLH-----------QEEKPLELVD-------PELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +.||........   ........           ........++       .......+.....+.+++.+||+.+|.+|
T Consensus       210 ~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  286 (337)
T cd07852         210 KPLFPGTSTLNQ---LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR  286 (337)
T ss_pred             CCCCCCCChHHH---HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence            998854332111   00000000           0000000000       00011111123457788899999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      |++.++++
T Consensus       287 ps~~~il~  294 (337)
T cd07852         287 LTAEEALE  294 (337)
T ss_pred             cCHHHHhh
Confidence            99999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-34  Score=238.43  Aligned_cols=214  Identities=21%  Similarity=0.263  Sum_probs=152.9

Q ss_pred             ccccc-cCCCccceeeEEEeCCe-----eEEEEeecCCCCHHHHhccCCCC-CccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTR-----RILVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|+++ +||||+++++++...+.     .|+||||+++ +|.+++...... +..+++..++.++.||+.||+|||+.  
T Consensus        53 ~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--  129 (295)
T cd07837          53 LLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH--  129 (295)
T ss_pred             HHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            35566 46999999999987665     8999999986 898887543222 45689999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHh
Q 023808           75 PHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ellt  152 (277)
                       +++||||+|+||+++. ++.+||+|||+++.+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus       130 -~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~  207 (295)
T cd07837         130 -GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR  207 (295)
T ss_pred             -CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence             9999999999999998 889999999998865432211 122346788999998865 457899999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCC--cc-cc---c----cC-----CCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEK--PL-EL---V----DP-----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~---~----~~-----~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      |..||.......  ...... .......  .. ..   .    -+     .+....+.....+.+++.+||+.+|.+||+
T Consensus       208 g~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~  284 (295)
T cd07837         208 KQPLFPGDSELQ--QLLHIF-KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS  284 (295)
T ss_pred             CCCCCCCCCHHH--HHHHHH-HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence            998886432211  111100 0000000  00 00   0    00     000011123345778899999999999999


Q ss_pred             HHHHHH
Q 023808          218 MNQVIK  223 (277)
Q Consensus       218 ~~~v~~  223 (277)
                      +.+++.
T Consensus       285 ~~eil~  290 (295)
T cd07837         285 AKAALT  290 (295)
T ss_pred             HHHHhc
Confidence            998864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7e-34  Score=236.68  Aligned_cols=197  Identities=30%  Similarity=0.455  Sum_probs=153.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|+|++++++++......++||||+. |+|.+++..   .+..+++..+..++.|++.||.|||+.   +++|+|
T Consensus        68 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~d  140 (308)
T cd06634          68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRD  140 (308)
T ss_pred             HHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            4678899999999999999999999999996 588887742   334588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||+++.++.++|+|||++......     ....++..|+|||.+.   ...++.++||||||+++|+|++|..|+.
T Consensus       141 l~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         141 VKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             CCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999998765432     2345788999999875   3467889999999999999999999875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ......      ..........      +..  ........+.+++.+||+.+|.+||++.+|+..
T Consensus       216 ~~~~~~------~~~~~~~~~~------~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         216 NMNAMS------ALYHIAQNES------PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             cccHHH------HHHHHhhcCC------CCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            432211      0111111111      110  011223447788889999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-34  Score=238.28  Aligned_cols=211  Identities=23%  Similarity=0.311  Sum_probs=152.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||++ ++|.+++..  .....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~d  127 (294)
T PLN00009         54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRD  127 (294)
T ss_pred             HHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence            4678899999999999999999999999996 488887743  2233467888999999999999999999   999999


Q ss_pred             CCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |+|+||+++. ++.+||+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|+||..||..
T Consensus       128 l~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        128 LKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             CCcceEEEECCCCEEEEcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999985 55799999999986543211 12233567899999988664 578899999999999999999998865


Q ss_pred             ccCcchhhHHHHHHHHhccCCcccc-----------------ccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLEL-----------------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      .....  .... ........ ....                 .........+.....+.+++.+|++.+|++||++.+++
T Consensus       207 ~~~~~--~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l  282 (294)
T PLN00009        207 DSEID--ELFK-IFRILGTP-NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL  282 (294)
T ss_pred             CCHHH--HHHH-HHHHhCCC-ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence            33211  1111 00000000 0000                 00000001112233477888999999999999999987


Q ss_pred             H
Q 023808          223 K  223 (277)
Q Consensus       223 ~  223 (277)
                      +
T Consensus       283 ~  283 (294)
T PLN00009        283 E  283 (294)
T ss_pred             c
Confidence            5

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-34  Score=245.63  Aligned_cols=197  Identities=24%  Similarity=0.363  Sum_probs=160.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|..|+|||||+++.+......+|+||||+.+|.+++++.    ++..+.+..+..++.|+++|++|||++   .|+|||
T Consensus       108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrd  180 (596)
T KOG0586|consen  108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRD  180 (596)
T ss_pred             HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccc
Confidence            5778999999999999999999999999999999999994    444566688999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||.+||||+.+.++||+|||++.++...  ....+..|++.|.|||++.+..+ ++.+|+||+|+++|-|++|..||...
T Consensus       181 Lk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  181 LKAENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             cchhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence            9999999999999999999999988643  34556789999999999999776 58999999999999999999998754


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .-..-      ...+.....       ++   +--..-++.+++++++-.+|.+|+++++|.+
T Consensus       259 ~lk~L------r~rvl~gk~-------rI---p~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  259 NLKEL------RPRVLRGKY-------RI---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ccccc------cchheeeee-------cc---cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            32110      001111110       01   1111123667788889999999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=232.76  Aligned_cols=202  Identities=23%  Similarity=0.366  Sum_probs=164.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++-+.|+||++||.+.....+++|||||..|++.++++   ..++.+++.++..++...+.||+|||..   .-||||
T Consensus        81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRD  154 (502)
T KOG0574|consen   81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRD  154 (502)
T ss_pred             HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhh
Confidence            4567789999999999999999999999999999999994   5667899999999999999999999998   889999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      ||..||||+-+|.+||+|||.+..+.+.. ....++.||+.|||||++..-.|+.++||||||++..||..|++|+.+..
T Consensus       155 IKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH  233 (502)
T KOG0574|consen  155 IKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH  233 (502)
T ss_pred             cccccEEEcccchhhhhhccccchhhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence            99999999999999999999998665432 33567889999999999998899999999999999999999999976543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +...-       -......+     |.+ .-+.....++-++++.||-.+|++|-|+.++++
T Consensus       234 PMRAI-------FMIPT~PP-----PTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  234 PMRAI-------FMIPTKPP-----PTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             cccee-------EeccCCCC-----CCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            31110       00000011     111 112334556778888999999999999988764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=236.20  Aligned_cols=213  Identities=23%  Similarity=0.310  Sum_probs=155.7

Q ss_pred             ccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++++ ||||+++++++.+++..++||||+ +|+|.+++...  .+..+++..++.++.|++.||.|||+.   +++|+|
T Consensus        51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~d  124 (283)
T cd07830          51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRD  124 (283)
T ss_pred             HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            55777 999999999999999999999999 77999988532  234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++.++|+|||++........  .....++..|+|||++.. ..++.++|+||||++++||++|+.||...
T Consensus       125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         125 LKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             CChhhEEEcCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            999999999999999999999986543221  123457888999998754 45789999999999999999999887544


Q ss_pred             cCcchhhHH----------HHHHHHhccCCccccc----cCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLL----------EWAWQLHQEEKPLELV----DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~----------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .........          .|.............+    ...+....+.....+.+++.+||+.+|.+||++.|++.
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            321110000          0000000000000000    00011111112345888999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-34  Score=244.18  Aligned_cols=211  Identities=21%  Similarity=0.282  Sum_probs=155.2

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++|+||+++++++...     ...++||||+. ++|.+++.    .+..+++..+..++.|++.||.|||+.   +
T Consensus        57 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  128 (337)
T cd07858          57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---N  128 (337)
T ss_pred             HHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            46778999999999988754     35799999995 68999883    445699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      ++|+||||+||+++.++.+||+|||+++...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.
T Consensus       129 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  207 (337)
T cd07858         129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP  207 (337)
T ss_pred             EecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999998654332 22233457889999998765 468899999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccC-----------C-------ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEE-----------K-------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      ||.......   ............           .       .....+.......+.....+.+++.+||+.+|++||+
T Consensus       208 pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps  284 (337)
T cd07858         208 LFPGKDYVH---QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT  284 (337)
T ss_pred             CCCCCChHH---HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC
Confidence            986432111   011011100000           0       0000001111111223445788999999999999999


Q ss_pred             HHHHHHH
Q 023808          218 MNQVIKM  224 (277)
Q Consensus       218 ~~~v~~~  224 (277)
                      +.+++.-
T Consensus       285 ~~ell~h  291 (337)
T cd07858         285 VEEALAH  291 (337)
T ss_pred             HHHHHcC
Confidence            9998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=242.44  Aligned_cols=211  Identities=23%  Similarity=0.296  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+. |+|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        73 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~d  144 (335)
T PTZ00024         73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRD  144 (335)
T ss_pred             HHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            4678999999999999999999999999996 58999983    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-------------cceeeeecccccccCccccccC-ccccccceEehhHHH
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-------------THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLV  147 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl  147 (277)
                      |+|+||+++.++.++|+|||.++......             ........++..|+|||.+.+. .++.++||||||+++
T Consensus       145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  224 (335)
T PTZ00024        145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF  224 (335)
T ss_pred             ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence            99999999999999999999998654211             0111123467789999988764 468899999999999


Q ss_pred             HHHHhCCCCCCcccCcchhhHHHHHHHHhccCCcc---------------ccccCCCCCCCHHHHHHHHHHHHhhhhhhh
Q 023808          148 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---------------ELVDPELGEYPPNEIIRYMKVAFFCTQAAA  212 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p  212 (277)
                      |||++|..||.......   ....+..........               .................+.+++.+||+.+|
T Consensus       225 ~el~tg~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  301 (335)
T PTZ00024        225 AELLTGKPLFPGENEID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP  301 (335)
T ss_pred             HHHHhCCCCCCCCCHHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence            99999999886543211   111111111100000               000000111111223457788999999999


Q ss_pred             cCCCCHHHHHH
Q 023808          213 SRRPQMNQVIK  223 (277)
Q Consensus       213 ~~RPs~~~v~~  223 (277)
                      ++||++.+++.
T Consensus       302 ~~R~s~~~~l~  312 (335)
T PTZ00024        302 LERISAKEALK  312 (335)
T ss_pred             hhccCHHHHhc
Confidence            99999999975

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-35  Score=245.01  Aligned_cols=211  Identities=22%  Similarity=0.328  Sum_probs=152.6

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++....     ..++|+||+.+ +|.+++.     ...+++..+..++.|++.||+|||+.   +
T Consensus        56 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~  126 (336)
T cd07849          56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---N  126 (336)
T ss_pred             HHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            467889999999999877543     57999999965 8888873     23689999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCcccccc-CccccccceEehhHHHHHHHhC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg  153 (277)
                      ++||||||+||+++.++.+||+|||+++........  ......|+..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus       127 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G  206 (336)
T cd07849         127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN  206 (336)
T ss_pred             eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999999999999999999865432211  1223467889999998755 4688999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCc-----------cccc-----cCCC--CCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKP-----------LELV-----DPEL--GEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-----~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +.||.......   ..............           ....     .+..  ....+.....+.+++.+||+.+|++|
T Consensus       207 ~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  283 (336)
T cd07849         207 RPLFPGKDYLH---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR  283 (336)
T ss_pred             CCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence            98885432110   00000000000000           0000     0000  00011223457889999999999999


Q ss_pred             CCHHHHHHH
Q 023808          216 PQMNQVIKM  224 (277)
Q Consensus       216 Ps~~~v~~~  224 (277)
                      |++.++++.
T Consensus       284 pt~~e~l~h  292 (336)
T cd07849         284 ITVEEALAH  292 (336)
T ss_pred             cCHHHHhcC
Confidence            999999774

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=231.35  Aligned_cols=204  Identities=30%  Similarity=0.389  Sum_probs=156.6

Q ss_pred             ccccCCCccceeeEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            4 SNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      +.|+||.||++|+||. +.+..|-|.|||+|.+|+-||    +.++.++++++..|+.||+.||.||.... ++|||-||
T Consensus       522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDL  596 (775)
T KOG1151|consen  522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDL  596 (775)
T ss_pred             hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeecc
Confidence            5689999999999998 455778999999999999999    56778999999999999999999999864 57999999


Q ss_pred             CCCcEEeCC---CCceEEeecccccccCCCCc------ceeeeecccccccCccccccC----ccccccceEehhHHHHH
Q 023808           83 KASNILLDQ---EFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLE  149 (277)
Q Consensus        83 kp~Nill~~---~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~e  149 (277)
                      ||.||||-+   -|.+||+|||+++.+..+..      ..+....||.+|++||++.-+    +.+.|.||||.||++|.
T Consensus       597 KPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ  676 (775)
T KOG1151|consen  597 KPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ  676 (775)
T ss_pred             CCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence            999999944   46799999999998875432      235567899999999998654    46889999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      .+-|+.||+......  ..+       ....+...-.-.++ ..|.......++|++||+..-++|....++.
T Consensus       677 ClYGrKPFGhnqsQQ--dIL-------qeNTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  677 CLYGRKPFGHNQSQQ--DIL-------QENTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhccCCCCCCchhHH--HHH-------hhhchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            999999997643321  111       11111111111111 1122223366778889999999998776653

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-34  Score=232.02  Aligned_cols=200  Identities=26%  Similarity=0.370  Sum_probs=154.0

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++|+||+++++++.+.  ...++||||+.+++|.+++.    ....+++..+.+++.|++.||.|||+.   +++|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H  129 (264)
T cd06653          57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVH  129 (264)
T ss_pred             HHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            46788999999999998764  46789999999999999984    333588999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||+|+||+++.++.++|+|||+++.......  .......++..|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus       130 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  209 (264)
T cd06653         130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW  209 (264)
T ss_pred             CCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999986532111  1112345788999999998888899999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......     .. .........     .+   ..+......+.+++.+||+ +|..||+..+++.
T Consensus       210 ~~~~~~-----~~-~~~~~~~~~-----~~---~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         210 AEYEAM-----AA-IFKIATQPT-----KP---MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CccCHH-----HH-HHHHHcCCC-----CC---CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            643211     11 111111110     01   1122333457777888999 5799999997754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-34  Score=240.93  Aligned_cols=211  Identities=23%  Similarity=0.301  Sum_probs=157.9

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++....     ..|+||||+. ++|.+++.    .+..+++..++.++.|++.||+|||+.   +
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---g  123 (330)
T cd07834          52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---N  123 (330)
T ss_pred             HHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            467889999999999998775     7899999997 48999883    334799999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg  153 (277)
                      ++|+||||.||+++.++.++|+|||++........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus       124 i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g  203 (330)
T cd07834         124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR  203 (330)
T ss_pred             eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence            99999999999999999999999999987654321  112334578889999999887 789999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccC-----------Ccccccc-------CCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEE-----------KPLELVD-------PELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      ..||........   ...+.......           .....+.       ..+....+.....+.+++.+||+.+|.+|
T Consensus       204 ~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  280 (330)
T cd07834         204 KPLFPGRDYIDQ---LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR  280 (330)
T ss_pred             CCCcCCCCHHHH---HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence            999865432110   00000000000           0000000       00011112233457888999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      |++.+++.
T Consensus       281 pt~~~ll~  288 (330)
T cd07834         281 ITADEALA  288 (330)
T ss_pred             CCHHHHHh
Confidence            99999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.2e-34  Score=234.64  Aligned_cols=198  Identities=23%  Similarity=0.344  Sum_probs=157.4

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++ ||||+++++++.+++..++||||+.+++|.+++.    ....+++..++.++.|++.||++||+.   +++|+
T Consensus        54 ~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~  126 (280)
T cd05581          54 VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHR  126 (280)
T ss_pred             HHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeec
Confidence            356777 9999999999999999999999999999999994    334799999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCc-------------------ceeeeecccccccCccccccCccccccceE
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------------------HITTRIAGTTGYLAPEYVLGGQLTMKADVY  141 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~  141 (277)
                      ||+|+||+++.++.++++|||++........                   .......++..|++||......++.++|+|
T Consensus       127 dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~  206 (280)
T cd05581         127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLW  206 (280)
T ss_pred             CCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHH
Confidence            9999999999999999999999886544321                   122334578899999999888899999999


Q ss_pred             ehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH---
Q 023808          142 SFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM---  218 (277)
Q Consensus       142 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~---  218 (277)
                      |||++++++++|..|+......  . ...   ......       ..+   +......+.+++.+||+.+|.+||++   
T Consensus       207 slG~~l~~l~~g~~p~~~~~~~--~-~~~---~~~~~~-------~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~  270 (280)
T cd05581         207 ALGCIIYQMLTGKPPFRGSNEY--L-TFQ---KILKLE-------YSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEG  270 (280)
T ss_pred             HHHHHHHHHHhCCCCCCCccHH--H-HHH---HHHhcC-------CCC---CCccCHHHHHHHHHHhcCCHhhCCCcccC
Confidence            9999999999999998754311  1 111   111100       011   11123347788888999999999999   


Q ss_pred             -HHHH
Q 023808          219 -NQVI  222 (277)
Q Consensus       219 -~~v~  222 (277)
                       .+++
T Consensus       271 ~~~ll  275 (280)
T cd05581         271 YDELK  275 (280)
T ss_pred             HHHHh
Confidence             6664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-34  Score=228.78  Aligned_cols=195  Identities=29%  Similarity=0.346  Sum_probs=156.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++.+..+...++||||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+|
T Consensus        46 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~  118 (250)
T cd05123          46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRD  118 (250)
T ss_pred             HHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecC
Confidence            4678899999999999999999999999999999999993    334689999999999999999999998   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++|+|||.+....... .......++..|++||...+...+.++|+||||+++|++++|..||....
T Consensus       119 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         119 LKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999999988654332 12334567889999999988888999999999999999999999985432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ  220 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~  220 (277)
                      .   .....   .... .      ...+....   ...+.+++.+||..||++||++.+
T Consensus       198 ~---~~~~~---~~~~-~------~~~~~~~~---~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         198 R---KEIYE---KILK-D------PLRFPEFL---SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             H---HHHHH---HHhc-C------CCCCCCCC---CHHHHHHHHHHhcCCHhhCCCccc
Confidence            2   11111   1111 1      01111111   334678888899999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=236.33  Aligned_cols=197  Identities=25%  Similarity=0.317  Sum_probs=156.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++.+.||.+--.|...+.+++|+..|+||+|.-.|.+..  +..+++..++-++.+|+.||++||+.   .||+||
T Consensus       238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRD  312 (591)
T KOG0986|consen  238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRD  312 (591)
T ss_pred             HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeecc
Confidence            6788999999999888888999999999999999988885443  34699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      +||+|||||+.|+++|+|.|+|..+.....  .....||.+|||||++.+..|+...|.|||||++|||+.|+.||....
T Consensus       313 LKPeNILLDd~GhvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  313 LKPENILLDDHGHVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             CChhheeeccCCCeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            999999999999999999999998766433  334589999999999999999999999999999999999999987654


Q ss_pred             Ccchh-hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNK-FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      ..... .+...+   ..        ++  -.++.....+...+....|+.||.+|-..
T Consensus       391 eKvk~eEvdrr~---~~--------~~--~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  391 EKVKREEVDRRT---LE--------DP--EEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hhhhHHHHHHHH---hc--------ch--hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            32221 111100   00        11  11222333345555555899999998643

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.5e-33  Score=233.87  Aligned_cols=196  Identities=30%  Similarity=0.468  Sum_probs=152.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||++++++++.++...++||||+. |+|.+++.   .....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        74 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~d  146 (313)
T cd06633          74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRD  146 (313)
T ss_pred             HHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4678899999999999999999999999995 57877774   2344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |+|+||+++.++.++|+|||++.....     .....|+..|+|||++.   ...++.++||||||+++|+|++|..|+.
T Consensus       147 l~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         147 IKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             CChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999998864322     22356788999999874   3568889999999999999999999875


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......      .......... ...       .......+.+++.+||+.+|.+||++.+++.
T Consensus       222 ~~~~~~~------~~~~~~~~~~-~~~-------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         222 NMNAMSA------LYHIAQNDSP-TLQ-------SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCChHHH------HHHHHhcCCC-CCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5322111      1111111111 000       0111234777888899999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=227.94  Aligned_cols=191  Identities=27%  Similarity=0.314  Sum_probs=153.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.-+||.+..+--.|...+.+|+||||..||.|.-.|    ...+.+++....-+..+|+.||.|||+.   +||+||
T Consensus       221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRD  293 (516)
T KOG0690|consen  221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRD  293 (516)
T ss_pred             HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---Ceeeee
Confidence            466779999999988889999999999999999998877    4566799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      +|.+|++||.+|++||+|||+++.--. ......++.||+.|+|||++....|..+.|.|.+|+|+|||++|+.||+...
T Consensus       294 lKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  294 LKLENLLLDKDGHIKITDFGLCKEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             chhhhheeccCCceEeeecccchhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence            999999999999999999999985322 2334567899999999999999999999999999999999999999987643


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      ...   +-..+..  .        +-.+   +.....+...++...|..||++|-
T Consensus       373 h~k---LFeLIl~--e--------d~kF---Pr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  373 HEK---LFELILM--E--------DLKF---PRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hhH---HHHHHHh--h--------hccC---CccCCHHHHHHHHHHhhcChHhhc
Confidence            321   1111110  0        1111   112222345566668999999995

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.1e-34  Score=235.77  Aligned_cols=197  Identities=27%  Similarity=0.431  Sum_probs=150.1

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCC
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKAS   85 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~dikp~   85 (277)
                      .||||++++++|..+...++||||+. ++|.+++..   ....+++..+..++.|++.||+|||+ .   +++||||+|+
T Consensus        72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~  144 (296)
T cd06618          72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPS  144 (296)
T ss_pred             CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHH
Confidence            59999999999999999999999995 488887743   23478999999999999999999997 5   8999999999


Q ss_pred             cEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc----cccccceEehhHHHHHHHhCCCCCCccc
Q 023808           86 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        86 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      ||++++++.+||+|||++..+.....  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||....
T Consensus       145 nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  222 (296)
T cd06618         145 NILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK  222 (296)
T ss_pred             HEEEcCCCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence            99999999999999999876543222  12334778899999987553    7889999999999999999999985432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ...  ..   ..........      .... .......+.+++.+||+.+|.+||++.+++..
T Consensus       223 ~~~--~~---~~~~~~~~~~------~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         223 TEF--EV---LTKILQEEPP------SLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hHH--HH---HHHHhcCCCC------CCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111  11   1111111110      0100 00123347888889999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.9e-34  Score=237.78  Aligned_cols=212  Identities=25%  Similarity=0.334  Sum_probs=152.0

Q ss_pred             ccccccCCCccceeeEEEeCC--------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++....        ..++||||+.+ +|...+.   ..+..+++..+..++.|++.||+|||+. 
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~-  134 (311)
T cd07866          60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN-  134 (311)
T ss_pred             HHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            467889999999999886443        46999999965 7777763   2344699999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc----------eeeeecccccccCccccccC-ccccccceEe
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH----------ITTRIAGTTGYLAPEYVLGG-QLTMKADVYS  142 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s  142 (277)
                        +++|+||||+||++++++.++|+|||+++........          ......++..|+|||.+.+. .++.++||||
T Consensus       135 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  212 (311)
T cd07866         135 --HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG  212 (311)
T ss_pred             --CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHH
Confidence              9999999999999999999999999999865432211          11233567889999987654 5789999999


Q ss_pred             hhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCc---------cc----cccCCCCC----CCHHHHHHHHHHHH
Q 023808          143 FGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---------LE----LVDPELGE----YPPNEIIRYMKVAF  205 (277)
Q Consensus       143 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----~~~~~~~~----~~~~~~~~~~~l~~  205 (277)
                      ||+++|||++|+.||........   ....+........         ..    ........    ........+.+++.
T Consensus       213 lG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  289 (311)
T cd07866         213 IGCVFAEMFTRRPILQGKSDIDQ---LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS  289 (311)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHH
Confidence            99999999999998865433211   1111111100000         00    00000000    00111245778999


Q ss_pred             hhhhhhhcCCCCHHHHHH
Q 023808          206 FCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       206 ~c~~~~p~~RPs~~~v~~  223 (277)
                      +|++.+|++||++.+++.
T Consensus       290 ~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         290 KLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHcccCcccCcCHHHHhc
Confidence            999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=231.67  Aligned_cols=211  Identities=26%  Similarity=0.339  Sum_probs=156.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|+||+++++++.+....++||||+. ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+|
T Consensus        51 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~  123 (282)
T cd07829          51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRD  123 (282)
T ss_pred             HHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4677899999999999999999999999997 5999999532   24689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+|+||++++++.++|+|||+++........ .....++..|+|||.+.+. .++.++||||||+++|||++|..||...
T Consensus       124 l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         124 LKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             CChheEEEcCCCCEEEecCCcccccCCCccc-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999999999865443221 2223456789999998776 7899999999999999999998887543


Q ss_pred             cCcchhhHHHHHHHHh-----------ccCCccccccCCC-----CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLH-----------QEEKPLELVDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .........           .........-+..     ....+.....+.+++..||+.+|++||++.+++.
T Consensus       203 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         203 SEID---QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cHHH---HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            3211   111110100           0000000000000     0111112345888999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3e-33  Score=235.28  Aligned_cols=211  Identities=23%  Similarity=0.278  Sum_probs=150.8

Q ss_pred             ccccc-cCCCccceeeEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNV-RHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|+++ +||||+++++++...    ...++++||+. ++|.+++.    .+..+++..+..++.|++.||+|||+.   +
T Consensus        54 ~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---g  125 (332)
T cd07857          54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---N  125 (332)
T ss_pred             HHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            35566 599999999986533    45788999985 58999983    445689999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCcccccc-CccccccceEehhHHHHHHHh
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ellt  152 (277)
                      ++||||||+||+++.++.+||+|||+++.+......   ......|+..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus       126 ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~  205 (332)
T cd07857         126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG  205 (332)
T ss_pred             cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999865432211   1233468899999998765 468899999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHH-----------hccCCcc-------ccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQL-----------HQEEKPL-------ELVDPELGEYPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      |..||.......   ........           .......       ......+....+.....+.+++.+|++.+|.+
T Consensus       206 g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  282 (332)
T cd07857         206 RKPVFKGKDYVD---QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK  282 (332)
T ss_pred             CCcCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence            998876432110   00000000           0000000       00000011111112345778899999999999


Q ss_pred             CCCHHHHHH
Q 023808          215 RPQMNQVIK  223 (277)
Q Consensus       215 RPs~~~v~~  223 (277)
                      ||++.+++.
T Consensus       283 R~t~~~ll~  291 (332)
T cd07857         283 RISVEEALE  291 (332)
T ss_pred             CCCHHHHhc
Confidence            999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-33  Score=236.81  Aligned_cols=211  Identities=20%  Similarity=0.305  Sum_probs=152.6

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++....      ..++|+||+.. +|.+++      +..+++..+..++.|++.||+|||+.   
T Consensus        67 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---  136 (342)
T cd07879          67 LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---  136 (342)
T ss_pred             HHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            467889999999999987543      46899999964 888776      22588999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +++||||||+||+++.++.++|+|||+++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus       137 ~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~  212 (342)
T cd07879         137 GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK  212 (342)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998754322    123456788999998876 46889999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhc-----------cCCccc-------cccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQ-----------EEKPLE-------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .||.......   ..........           ......       .....+....+.....+.+++.+||+.||.+||
T Consensus       213 ~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  289 (342)
T cd07879         213 TLFKGKDYLD---QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL  289 (342)
T ss_pred             CCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence            9986532111   1111111000           000000       000000000112233477899999999999999


Q ss_pred             CHHHHHH--HHhhcc
Q 023808          217 QMNQVIK--MLTKNI  229 (277)
Q Consensus       217 s~~~v~~--~L~~~~  229 (277)
                      ++.+++.  .++...
T Consensus       290 ~~~e~l~h~~f~~~~  304 (342)
T cd07879         290 TATEALEHPYFDSFR  304 (342)
T ss_pred             CHHHHhcCcchhhcc
Confidence            9999984  355543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-33  Score=235.82  Aligned_cols=209  Identities=23%  Similarity=0.296  Sum_probs=151.2

Q ss_pred             ccccccCCCccceeeEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||++++++|.. ....++||||+ +++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+
T Consensus        62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~  132 (328)
T cd07856          62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHR  132 (328)
T ss_pred             HHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            4678899999999999875 55789999999 569999883     23578888999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||+|+||++++++.++|+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus       133 dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         133 DLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             CCCHHHEeECCCCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998854322    123356788999998766 5688999999999999999999988854


Q ss_pred             ccCcchhhHHHH--------HHHHhccCCccccccC-C------CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEW--------AWQLHQEEKPLELVDP-E------LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ............        ................ .      .....+.....+.+++.+||+.+|++||++.+++.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            432110000000        0000000000000000 0      00011112345788899999999999999998865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-33  Score=237.18  Aligned_cols=205  Identities=22%  Similarity=0.300  Sum_probs=152.5

Q ss_pred             ccccccCCCccceeeEEEeCCe------eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTR------RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...+.      .++|+||+ +++|.+++..     ..+++..+..++.|++.||+|||+.   
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---  137 (343)
T cd07851          67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---  137 (343)
T ss_pred             HHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            4678899999999998876654      89999999 6699999832     3689999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +++|+||+|+||++++++.++|+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus       138 gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~  213 (343)
T cd07851         138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK  213 (343)
T ss_pred             CeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865432    223457888999998865 36788999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccc------------cc-------cCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLE------------LV-------DPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~-------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      .||.......   .......... .....            .+       .+.+..........+.+++.+||+.+|.+|
T Consensus       214 ~pf~~~~~~~---~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R  289 (343)
T cd07851         214 TLFPGSDHID---QLKRIMNLVG-TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR  289 (343)
T ss_pred             CCCCCCChHH---HHHHHHHhcC-CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence            9886433211   0111111000 00000            00       000000001123457889999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.+|+.
T Consensus       290 pt~~ell~  297 (343)
T cd07851         290 ITAAEALA  297 (343)
T ss_pred             CCHHHHhc
Confidence            99999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-33  Score=221.28  Aligned_cols=155  Identities=28%  Similarity=0.464  Sum_probs=133.4

Q ss_pred             CccccccCCCccceeeEEEe-CCeeEEEEeecCCCCHHHHhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            1 MTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         1 ~~L~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      |+++.|+||||+.+..+|.+ +...++++||.+. +|.++++.++. ..+.++...+.+|+.||+.|+.|||++   =|+
T Consensus        79 aL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---Wvl  154 (438)
T KOG0666|consen   79 ALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVL  154 (438)
T ss_pred             HHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---hee
Confidence            46788999999999999988 7788999999987 89998865433 334688999999999999999999999   799


Q ss_pred             eccCCCCcEEeCCC----CceEEeecccccccCCCCcce--eeeecccccccCccccccC-ccccccceEehhHHHHHHH
Q 023808           79 HRDIKASNILLDQE----FNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        79 H~dikp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~ell  151 (277)
                      |||+||.||++..+    |.|||+|+|+++.+.+.....  ...++.|.+|+|||.+.+. .|+.+.||||.||++.||+
T Consensus       155 HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL  234 (438)
T KOG0666|consen  155 HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL  234 (438)
T ss_pred             eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence            99999999999877    899999999999887654332  3456789999999999986 5999999999999999999


Q ss_pred             hCCCCCCc
Q 023808          152 SGRNSGKA  159 (277)
Q Consensus       152 tg~~p~~~  159 (277)
                      |-.+-|..
T Consensus       235 tl~PlF~g  242 (438)
T KOG0666|consen  235 TLEPLFKG  242 (438)
T ss_pred             ccCccccc
Confidence            98766554

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=223.60  Aligned_cols=207  Identities=27%  Similarity=0.409  Sum_probs=156.8

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhcc-CCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG-ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++.-+.||||++||.+..++.+++.||+|.- ||+.+... +...+..++++.+..|...++.||.||-...  .|||||
T Consensus       117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRD  193 (361)
T KOG1006|consen  117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRD  193 (361)
T ss_pred             HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhcc
Confidence            4455789999999999999999999999965 77665421 2344557999999999999999999998764  899999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC--ccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++..|.+||||||++-.+.+...  .+...|...|||||.+...  .|+.+|||||||++|||+.||+.|+..
T Consensus       194 vKPSNILldr~G~vKLCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~  271 (361)
T KOG1006|consen  194 VKPSNILLDRHGDVKLCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK  271 (361)
T ss_pred             CChhheEEecCCCEeeecccchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence            999999999999999999999876543322  2345688999999988653  489999999999999999999999765


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...     +.+...++..+..+.-..+...-.    ....+..++..|+-+|-.+||.+.++.+
T Consensus       272 w~s-----vfeql~~Vv~gdpp~l~~~~~~~~----~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  272 WDS-----VFEQLCQVVIGDPPILLFDKECVH----YSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHH-----HHHHHHHHHcCCCCeecCcccccc----cCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            432     222233344443332222222112    2233566666699999999999998764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=225.78  Aligned_cols=221  Identities=28%  Similarity=0.382  Sum_probs=162.6

Q ss_pred             ccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC------
Q 023808            4 SNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL------   73 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------   73 (277)
                      -.++|+||++++++-....    .+.||++|.+.|+|.+||     +...++|....+++.-+++||+|||+..      
T Consensus       259 p~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~  333 (534)
T KOG3653|consen  259 PGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHH  333 (534)
T ss_pred             cCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCC
Confidence            3579999999999987666    789999999999999999     3446999999999999999999999754      


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccC-ccc-----cccceEehhHH
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLT-----MKADVYSFGVL  146 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~Dv~slG~v  146 (277)
                      +|+|+|||||++|||+.++++.-|+|||+|..+..... ......+||.+|||||++.+. .+.     .+.||||+|.|
T Consensus       334 Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLV  413 (534)
T KOG3653|consen  334 KPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLV  413 (534)
T ss_pred             CCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHH
Confidence            46899999999999999999999999999987764322 223447899999999998764 222     35899999999


Q ss_pred             HHHHHhCCCCCC--------cccC---cchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          147 VLEIISGRNSGK--------AMWG---QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       147 l~elltg~~p~~--------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +|||+++-.-..        -+..   +....+.+....+..+.....+.+.....   ..+.-+.+.+..||+.||+-|
T Consensus       414 LWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeAR  490 (534)
T KOG3653|consen  414 LWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEAR  490 (534)
T ss_pred             HHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhh
Confidence            999998753221        1111   01111111111222222222222222222   334557788888999999999


Q ss_pred             CCHHHHHHHHhhccccC
Q 023808          216 PQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       216 Ps~~~v~~~L~~~~~~~  232 (277)
                      -|+.=|.+.+.++....
T Consensus       491 LTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  491 LTAGCVEERMAELMMLW  507 (534)
T ss_pred             hhhHHHHHHHHHHhccC
Confidence            99999988888777654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-33  Score=235.26  Aligned_cols=207  Identities=24%  Similarity=0.323  Sum_probs=151.8

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++..+.      ..++||||+ +++|.+++.     ...+++..+..++.|++.||+|||+.   
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---  137 (343)
T cd07880          67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---  137 (343)
T ss_pred             HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            477899999999999997654      458999999 779998883     23689999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +++||||||+||+++.++.++|+|||++......    .....++..|++||.+.+ ..++.++|+||||+++|++++|.
T Consensus       138 gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~  213 (343)
T cd07880         138 GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK  213 (343)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865432    223456889999998876 35788999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHH----------HHhccCCccc-------cccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAW----------QLHQEEKPLE-------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      .||.......  .......          ..........       .....+....+.....+.+++.+|++.||.+||+
T Consensus       214 ~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t  291 (343)
T cd07880         214 PLFKGHDHLD--QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT  291 (343)
T ss_pred             CCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence            9986432210  0000000          0000000000       0000000111122234778999999999999999


Q ss_pred             HHHHHH
Q 023808          218 MNQVIK  223 (277)
Q Consensus       218 ~~~v~~  223 (277)
                      +.+++.
T Consensus       292 ~~~~l~  297 (343)
T cd07880         292 AAEALA  297 (343)
T ss_pred             HHHHhc
Confidence            999873

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-33  Score=234.28  Aligned_cols=206  Identities=22%  Similarity=0.292  Sum_probs=149.7

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...+++++++ +++|.+++.     ...+++..+..++.|++.||+|||+.   
T Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---  139 (345)
T cd07877          69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---  139 (345)
T ss_pred             HHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            46788999999999998643      3467888887 779999883     23589999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +++||||||+||++++++.+||+|||+++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus       140 ~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  215 (345)
T cd07877         140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR  215 (345)
T ss_pred             CeeecCCChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998854322    233457889999998866 46788999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhcc-----------CCc-------cccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQE-----------EKP-------LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~-------~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .||.......  .... .......           ...       .......+..........+.+++.+|++.+|.+||
T Consensus       216 ~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  292 (345)
T cd07877         216 TLFPGTDHID--QLKL-ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI  292 (345)
T ss_pred             CCCCCCCHHH--HHHH-HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence            9885432211  1100 0000000           000       00000000000011223477889999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      ++.+++.
T Consensus       293 t~~e~l~  299 (345)
T cd07877         293 TAAQALA  299 (345)
T ss_pred             CHHHHhc
Confidence            9998875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=1.3e-32  Score=232.21  Aligned_cols=211  Identities=20%  Similarity=0.295  Sum_probs=148.7

Q ss_pred             ccccccCCCccceeeEEEeC--------------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQG--------------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA   67 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~   67 (277)
                      +|++++||||+++++++...              ...++||||+. ++|.+++.     ...+++..+..++.|++.||+
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~  128 (342)
T cd07854          55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLK  128 (342)
T ss_pred             HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHH
Confidence            46788999999999876643              35789999997 59998883     235889999999999999999


Q ss_pred             HhhcCCCCCeEeccCCCCcEEeCC-CCceEEeecccccccCCCCcce--eeeecccccccCcccccc-CccccccceEeh
Q 023808           68 FLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLG-GQLTMKADVYSF  143 (277)
Q Consensus        68 ~LH~~~~~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~sl  143 (277)
                      |||+.   +++||||||+||+++. ++.++++|||+++.........  .....++..|+|||.+.. ..++.++|||||
T Consensus       129 ~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl  205 (342)
T cd07854         129 YIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  205 (342)
T ss_pred             HHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence            99999   9999999999999974 5578999999998654321111  122357888999998754 457889999999


Q ss_pred             hHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhc----------cCCccccc----cC--CCCCCCHHHHHHHHHHHHhh
Q 023808          144 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ----------EEKPLELV----DP--ELGEYPPNEIIRYMKVAFFC  207 (277)
Q Consensus       144 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~----~~--~~~~~~~~~~~~~~~l~~~c  207 (277)
                      ||++|+|++|+.||.........  .........          ........    ..  ......+.....+.+++..|
T Consensus       206 Gvil~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  283 (342)
T cd07854         206 GCIFAEMLTGKPLFAGAHELEQM--QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQI  283 (342)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHH
Confidence            99999999999998654321110  000000000          00000000    00  00000111224577889999


Q ss_pred             hhhhhcCCCCHHHHHH
Q 023808          208 TQAAASRRPQMNQVIK  223 (277)
Q Consensus       208 ~~~~p~~RPs~~~v~~  223 (277)
                      |+.||.+||++.+++.
T Consensus       284 L~~dP~~R~t~~ell~  299 (342)
T cd07854         284 LTFNPMDRLTAEEALM  299 (342)
T ss_pred             hCCCchhccCHHHHhC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=9.6e-33  Score=221.39  Aligned_cols=201  Identities=26%  Similarity=0.354  Sum_probs=158.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      .+++++|+||+++++++..+...++++||+.+++|.+++..    ...+++..++.++.+++.++.+||+.   +++|+|
T Consensus        40 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~  112 (244)
T smart00220       40 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSN---GIIHRD  112 (244)
T ss_pred             HHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCC
Confidence            35678999999999999999999999999999999999843    22388999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |+|+||+++.++.++++|||.+.......  ......++..|++||.+....++.++||||||++++++++|..|+....
T Consensus       113 i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~  190 (244)
T smart00220      113 LKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD  190 (244)
T ss_pred             cCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765432  2334557889999999988888999999999999999999998875531


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..  ....    ..........      ..........+.+++.+|+..+|++||++.++++
T Consensus       191 ~~--~~~~----~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      191 QL--LELF----KKIGKPKPPF------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cH--HHHH----HHHhccCCCC------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            11  1111    1111111100      0000002245788889999999999999999975

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-32  Score=220.69  Aligned_cols=211  Identities=20%  Similarity=0.320  Sum_probs=162.6

Q ss_pred             CccccccCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCC----CCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            1 MTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGAT----KANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         1 ~~L~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      |+|..+.|||+..+.+++.++ +.+++++.+..-|+|+.+|...+    +..+.++-.+...++.|++.|++|||+.   
T Consensus       339 ~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---  415 (563)
T KOG1024|consen  339 MLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---  415 (563)
T ss_pred             HHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---
Confidence            456778999999999999865 57899999999999999996322    2223477788899999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeeccccccc-CCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      ++||.||..+|+++|+..++||+|=.++|.+ +.+.............||+||.+....|+.++||||||+++|||+| |
T Consensus       416 ~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg  495 (563)
T KOG1024|consen  416 GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG  495 (563)
T ss_pred             CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence            9999999999999999999999999999853 3333333333345678999999999999999999999999999998 4


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      +.|+-...+.+   ...+.    .++...        ..+-+++.+++.++..||...|++||++.|+...|.+.-
T Consensus       496 ~~PyaeIDPfE---m~~yl----kdGyRl--------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  496 KLPYAEIDPFE---MEHYL----KDGYRL--------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             CCCccccCHHH---HHHHH----hcccee--------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            55654332221   22211    111111        112233445777788899999999999999999998753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=3.3e-33  Score=258.85  Aligned_cols=197  Identities=16%  Similarity=0.189  Sum_probs=140.6

Q ss_pred             cccccC-CCccceeeEE-------EeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            3 LSNVRH-PNLVELIGCC-------VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         3 L~~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +++++| +||++++++|       .+....+.++||+ +++|.+++.   .....+++..+..++.||+.||+|||++  
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~--   99 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD---NPDRSVDAFECFHVFRQIVEIVNAAHSQ--   99 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh---cccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence            356778 7999999998       3334667788887 669999994   2345699999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCC-------------------CceEEeecccccccCCCCc---------------ceeeeeccc
Q 023808           75 PHIVHRDIKASNILLDQE-------------------FNPKIGDFGLAKLFPDNIT---------------HITTRIAGT  120 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt  120 (277)
                       +|+||||||+||||+..                   +.+|++|||+++.......               .......||
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             99999999999999543                   4456666666653211000               001123578


Q ss_pred             ccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHH
Q 023808          121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY  200 (277)
Q Consensus       121 ~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (277)
                      +.|+|||++.+..++.++|||||||++|||++|..|+.....    ........         ...+..    .......
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~----~~~~~~~  241 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI----LLNWPKE  241 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh----hhcCHHH
Confidence            889999999999999999999999999999998876432111    11111000         011111    1112235


Q ss_pred             HHHHHhhhhhhhcCCCCHHHHHH
Q 023808          201 MKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       201 ~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..++.+||+.+|.+||++.||++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            57778899999999999999974

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.9e-32  Score=237.67  Aligned_cols=198  Identities=25%  Similarity=0.412  Sum_probs=162.9

Q ss_pred             cCCCccceeeEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            7 RHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         7 ~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|||++.+||+|..     ++.++||||||.|||.-++.++..  +..+.|..+..|++.++.||.+||..   .++|||
T Consensus        74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRD  148 (953)
T KOG0587|consen   74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRD  148 (953)
T ss_pred             CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeec
Confidence            79999999999983     568999999999999999997643  77899999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-----ccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||-.|||++.++.|||+|||++...... .....+..||+.|||||++...     .|+.++|+||||++..||.-|.+|
T Consensus       149 ikG~NiLLT~e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP  227 (953)
T KOG0587|consen  149 IKGQNVLLTENAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP  227 (953)
T ss_pred             ccCceEEEeccCcEEEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence            9999999999999999999999876543 3446678899999999998643     478899999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +.++.+....       -.+....+..     + .-+....+++.++|..|+..|.++||++.++++
T Consensus       228 l~DmHPmraL-------F~IpRNPPPk-----L-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  228 LCDMHPMRAL-------FLIPRNPPPK-----L-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccCcchhhhh-------ccCCCCCCcc-----c-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            8776553211       1111111111     1 224556777889999999999999999988864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-32  Score=221.69  Aligned_cols=216  Identities=26%  Similarity=0.282  Sum_probs=163.6

Q ss_pred             ccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcC-----CCCC
Q 023808            6 VRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE-----LVPH   76 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----~~~~   76 (277)
                      |+|+||+.+++.-..++    .++||++|.+.|||+|||.     ...++....++++.-+|.||++||..     .+|.
T Consensus       262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa  336 (513)
T KOG2052|consen  262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA  336 (513)
T ss_pred             hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence            69999999999887554    6799999999999999992     24688999999999999999999953     4689


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccCc----c--ccccceEehhHHH
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQ----L--TMKADVYSFGVLV  147 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slG~vl  147 (277)
                      |.|||||+.|||+..++.+-|+|+|+|.........   ......||.+|||||++...-    +  -..+||||||.|+
T Consensus       337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl  416 (513)
T KOG2052|consen  337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL  416 (513)
T ss_pred             hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence            999999999999999999999999999876554322   245678999999999885431    1  2358999999999


Q ss_pred             HHHHhCC----------CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          148 LEIISGR----------NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       148 ~elltg~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      ||++.+.          .||++..+.+...- + ...+.-.++....++++  -.....+..+.+++..||..+|.-|-|
T Consensus       417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e-e-MrkVVCv~~~RP~ipnr--W~s~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFE-E-MRKVVCVQKLRPNIPNR--WKSDPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             HHHHHHhhcCCEehhhcCCcccCCCCCCCHH-H-HhcceeecccCCCCCcc--cccCHHHHHHHHHHHHhhcCCchhhhH
Confidence            9998632          46655444332211 1 11111112222222222  223467888999999999999999999


Q ss_pred             HHHHHHHHhhccc
Q 023808          218 MNQVIKMLTKNIR  230 (277)
Q Consensus       218 ~~~v~~~L~~~~~  230 (277)
                      +--|-+.|.++..
T Consensus       493 ALriKKtl~~l~~  505 (513)
T KOG2052|consen  493 ALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHHHhc
Confidence            9999888887664

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=218.86  Aligned_cols=203  Identities=20%  Similarity=0.242  Sum_probs=154.0

Q ss_pred             ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeC
Q 023808           11 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD   90 (277)
Q Consensus        11 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~   90 (277)
                      ++++.+||.-.++.|+|+|.+ |-|+.+++..  +.-.+++...+..++.|++.+++|||+.   +++|.|+||+|||+-
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfv  226 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFV  226 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEe
Confidence            578889999999999999999 6699999943  3455789999999999999999999999   999999999999992


Q ss_pred             --------------------CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           91 --------------------QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        91 --------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                                          .+..+++.|||.|+.-....    .....|..|+|||++.+..++..+||||+||+|+|+
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                                13458999999998754432    456788999999999999999999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHH--------------HhccCCc-----------cccccCCC-----CCCCHHHHHHH
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQ--------------LHQEEKP-----------LELVDPEL-----GEYPPNEIIRY  200 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~--------------~~~~~~~-----------~~~~~~~~-----~~~~~~~~~~~  200 (277)
                      .||..-|+...........+.+..              ....++.           ....++..     -.....+...+
T Consensus       303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            999987765543322222222211              0000100           00000000     12234566679


Q ss_pred             HHHHHhhhhhhhcCCCCHHHHHH
Q 023808          201 MKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       201 ~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ++|+.++|..||.+|+|+.|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            99999999999999999998864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-33  Score=240.83  Aligned_cols=210  Identities=26%  Similarity=0.388  Sum_probs=171.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+|+|||+++++|+|.... ..||++|+++|+|.++++.   ....+..+..+.|..|||+|+.|||.+   .++|||
T Consensus       751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrd  823 (1177)
T KOG1025|consen  751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRD  823 (1177)
T ss_pred             HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhh
Confidence            578999999999999999876 7789999999999999964   444688899999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee-eeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |-.+|||+..-..+|+.|||+++....+..... ....-.+.|+|-|.+....++.++|||||||++||++| |..|+..
T Consensus       824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g  903 (1177)
T KOG1025|consen  824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG  903 (1177)
T ss_pred             hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence            999999999999999999999998765543322 22223467999999999999999999999999999988 6667554


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ....+-       ......+.        .-..++.+..++..++.+||..|+..||+++++...+.+.++.+.
T Consensus       904 i~~~eI-------~dlle~ge--------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  904 IPAEEI-------PDLLEKGE--------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             CCHHHh-------hHHHhccc--------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            332221       12222221        124566777789999999999999999999999999988776543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=216.98  Aligned_cols=205  Identities=26%  Similarity=0.294  Sum_probs=150.9

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      .|+||+++++||++++..|||||.+.||.|-..+    .+.+-+++.++-++.++|+.||.|||.+   ||.|||+||+|
T Consensus       134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPEN  206 (463)
T KOG0607|consen  134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPEN  206 (463)
T ss_pred             CCccHHHHHHHhcccceEEEEEecccCchHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccc
Confidence            5999999999999999999999999999998888    3455699999999999999999999999   99999999999


Q ss_pred             EEeCCCCc---eEEeecccccccCCCC------cceeeeecccccccCcccccc-----CccccccceEehhHHHHHHHh
Q 023808           87 ILLDQEFN---PKIGDFGLAKLFPDNI------THITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        87 ill~~~~~---~kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~ellt  152 (277)
                      ||......   +||+||.+..-+....      +..-.+..|+..|||||+..-     ..|+.++|.||||+|+|-||+
T Consensus       207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs  286 (463)
T KOG0607|consen  207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS  286 (463)
T ss_pred             eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence            99966554   8999999876432211      111234568889999997632     358899999999999999999


Q ss_pred             CCCCCCcccCcch--------hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          153 GRNSGKAMWGQMN--------KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       153 g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |..||...-+.+-        .........-+.++.. +.-|...    ........+++...+..|+.+|-++.+++.
T Consensus       287 GYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdW----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  287 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDW----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC-cCChhhh----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            9999876543211        1111111121222211 1111111    122223456666688899999999988875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.8e-31  Score=242.13  Aligned_cols=96  Identities=29%  Similarity=0.412  Sum_probs=88.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|..++||||+++++++......|+||||+.+++|.+++.    ....+++..++.++.||+.||+|||..   +|+|||
T Consensus        57 ~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrD  129 (669)
T cd05610          57 ALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRD  129 (669)
T ss_pred             HHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCC
Confidence            3567899999999999999999999999999999999994    234588999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeeccccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      |||+|||++.++.+||+|||+++
T Consensus       130 LKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         130 LKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             ccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=228.48  Aligned_cols=193  Identities=20%  Similarity=0.238  Sum_probs=159.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+.+.|.||++|-.|.+..+.|++||-|-||.|+..|    ...+.+......-++..++.|++|||++   +||+||
T Consensus       473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRD  545 (732)
T KOG0614|consen  473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRD  545 (732)
T ss_pred             HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---Cceecc
Confidence            456678999999999999999999999999999999999    4555788888888999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|++|+.+|-+||.|||+|+.+....  .+.++.||+.|.|||++.+...+.+.|.||||+++||||+|.+||....
T Consensus       546 LKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  546 LKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             CChhheeeccCCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999999999999999999999886653  4566789999999999999999999999999999999999999998765


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      +.....+   +......           -.++....+...+++++....+|.+|-.
T Consensus       624 pmktYn~---ILkGid~-----------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  624 PMKTYNL---ILKGIDK-----------IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hHHHHHH---HHhhhhh-----------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            5332211   1111110           1223333444667777777889999975

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=239.09  Aligned_cols=146  Identities=27%  Similarity=0.345  Sum_probs=132.4

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +.+=|+++.-.|.++.++|+||||+.||+|-.++..   .. .+++.-+.-++..|+.||.-||+.   |+|||||||+|
T Consensus       133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk---~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDN  205 (1317)
T KOG0612|consen  133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK---FD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDN  205 (1317)
T ss_pred             CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh---cC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcce
Confidence            455678888888999999999999999999999942   22 699999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-----CccccccceEehhHHHHHHHhCCCCCCc
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||||..|++||+|||.+-.+..++.-.....+|||.|.+||+++.     +.|+..+|.||+||++|||+.|..||+.
T Consensus       206 vLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  206 VLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             eEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            999999999999999998888777777888899999999999863     5689999999999999999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-32  Score=234.93  Aligned_cols=197  Identities=23%  Similarity=0.332  Sum_probs=152.0

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +||||+++|+.-.+++..|+..|.|.. +|.+++...........--..+.+..|+++||++||+.   +||||||||.|
T Consensus       561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQN  636 (903)
T KOG1027|consen  561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQN  636 (903)
T ss_pred             CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCce
Confidence            799999999999999999999999965 99999964311111111134577899999999999998   99999999999


Q ss_pred             EEeCC---C--CceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHhC-CCCCC
Q 023808           87 ILLDQ---E--FNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGK  158 (277)
Q Consensus        87 ill~~---~--~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg-~~p~~  158 (277)
                      |||+.   +  .+++|+|||+++.+..+....  .....||.+|+|||++.....+.+.||||+|||+|+.++| ..||+
T Consensus       637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG  716 (903)
T KOG1027|consen  637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG  716 (903)
T ss_pred             EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence            99965   2  468999999999876554332  4456799999999999998888899999999999999998 67988


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ....+..        ++.........+.+.     +++  ...++|.+|++.+|..||++.+|+
T Consensus       717 d~~~R~~--------NIl~~~~~L~~L~~~-----~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  717 DSLERQA--------NILTGNYTLVHLEPL-----PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             chHHhhh--------hhhcCccceeeeccC-----chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            7655432        222222222222221     111  466888889999999999999997

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-31  Score=205.07  Aligned_cols=212  Identities=24%  Similarity=0.369  Sum_probs=154.2

Q ss_pred             ccccccCCCccceeeEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|..|+|+|++.+++.|..        ....|+||.+|+. +|.-+|.   ....+++..++.++..++..||.|+|+. 
T Consensus        69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-  143 (376)
T KOG0669|consen   69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN-  143 (376)
T ss_pred             HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh-
Confidence            5778899999999998863        2357999999976 8988883   4556799999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccC-ccccccceEehhHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLE  149 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~e  149 (277)
                        .|+|||+|++|+|++.++.+||+|||+++.+......   .-+.+..|.+|++||.+.+. .++.+.|||+-||++.|
T Consensus       144 --kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimae  221 (376)
T KOG0669|consen  144 --KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAE  221 (376)
T ss_pred             --hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHH
Confidence              9999999999999999999999999999866432211   12345668999999999875 68999999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhc---cC-----Ccccccc----CCCCCC----CHHHHH------HHHHHHHhh
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQ---EE-----KPLELVD----PELGEY----PPNEII------RYMKVAFFC  207 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~----~~~~~~----~~~~~~------~~~~l~~~c  207 (277)
                      |.||.+-+.....   ..-...+.....   ++     .-..+..    +.++..    .++..+      ...+++..+
T Consensus       222 Mwtrspimqgnte---qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l  298 (376)
T KOG0669|consen  222 MWTRSPIMQGNTE---QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL  298 (376)
T ss_pred             HHccCccccCChH---HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence            9999865543222   222222221111   11     0001100    001100    111112      355677779


Q ss_pred             hhhhhcCCCCHHHHHH
Q 023808          208 TQAAASRRPQMNQVIK  223 (277)
Q Consensus       208 ~~~~p~~RPs~~~v~~  223 (277)
                      +..||.+|+++++++.
T Consensus       299 l~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  299 LKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCcccCcchHhhhc
Confidence            9999999999998864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=199.38  Aligned_cols=152  Identities=30%  Similarity=0.448  Sum_probs=131.1

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      +....|.+|.+||........++.||.|.. ||+.+-.+.-+.+..+++..+-+|+..++.||.|||++.  .++|||+|
T Consensus       100 r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvK  176 (282)
T KOG0984|consen  100 RTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVK  176 (282)
T ss_pred             cCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCC
Confidence            345689999999999998899999999965 998887666678888999999999999999999999976  89999999


Q ss_pred             CCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc----CccccccceEehhHHHHHHHhCCCCCCc
Q 023808           84 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        84 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |+|||++..|++|+||||.+-.+.+....  +-..|...|+|||.+..    ..|+.++||||||+.+.||.+++.|+..
T Consensus       177 PsNiLIn~~GqVKiCDFGIsG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  177 PSNILINYDGQVKICDFGISGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cceEEEccCCcEEEcccccceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            99999999999999999999876554322  22457889999998854    3689999999999999999999998764


Q ss_pred             c
Q 023808          160 M  160 (277)
Q Consensus       160 ~  160 (277)
                      .
T Consensus       255 w  255 (282)
T KOG0984|consen  255 W  255 (282)
T ss_pred             c
Confidence            3

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=4.7e-31  Score=237.77  Aligned_cols=181  Identities=25%  Similarity=0.362  Sum_probs=133.3

Q ss_pred             CeeEEEEeecCCCCHHHHhccCCCCCccC-CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           22 TRRILVYEYVENNSLDRVLLGATKANIKL-NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        22 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      ..+||-||||+..+|++++..    +... .-...++++.+|+.||+|+|++   |+|||||||.||||++++.|||+||
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDF  741 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDF  741 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeeccc
Confidence            467899999999888888842    2222 4678899999999999999999   9999999999999999999999999


Q ss_pred             ccccccC-----------------CCCcceeeeecccccccCccccccC---ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808          101 GLAKLFP-----------------DNITHITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus       101 g~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |+++...                 .......+...||.-|+|||.+.+.   .|+.|.|+||||||+|||+-   ||...
T Consensus       742 GLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts  818 (1351)
T KOG1035|consen  742 GLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS  818 (1351)
T ss_pred             ccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch
Confidence            9998621                 0011124557899999999998764   49999999999999999984   33322


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..     ... +....+.+....   +  .++..+....-.++|.++++.||.+|||+.|++.
T Consensus       819 ME-----Ra~-iL~~LR~g~iP~---~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  819 ME-----RAS-ILTNLRKGSIPE---P--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HH-----HHH-HHHhcccCCCCC---C--cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            11     111 112222222111   1  2234444455668889999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=2e-30  Score=198.53  Aligned_cols=168  Identities=21%  Similarity=0.203  Sum_probs=125.7

Q ss_pred             CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce
Q 023808           34 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  113 (277)
Q Consensus        34 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  113 (277)
                      |+|.+++..   .+..+++..++.++.|++.||+|||+.   +      ||+||+++.++.+|+  ||.++......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            689999942   345699999999999999999999998   6      999999999999999  99998654321   


Q ss_pred             eeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCC
Q 023808          114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  193 (277)
Q Consensus       114 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (277)
                         ..|+..|+|||++.+..++.++|||||||++|||+||+.||....... .......... ....      +......
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~~------~~~~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGM-PADD------PRDRSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHh-ccCC------ccccccH
Confidence               258899999999999999999999999999999999999985433211 1111111111 1000      0000111


Q ss_pred             HHHHH--HHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          194 PNEII--RYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       194 ~~~~~--~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      .....  .+.+++.+||+.+|.+||++.++++.+....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            12222  5888999999999999999999999876553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=3.3e-30  Score=228.75  Aligned_cols=199  Identities=20%  Similarity=0.199  Sum_probs=129.8

Q ss_pred             EeCCeeEEEEeecCCCCHHHHhccCCCC----------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808           19 VQGTRRILVYEYVENNSLDRVLLGATKA----------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus        19 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      ..+...++||||+.+++|.+++......                +.......+..++.|++.||+|||+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            3556789999999999999998532100                01112344667999999999999999   9999999


Q ss_pred             CCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccC----------------------ccccccc
Q 023808           83 KASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG----------------------QLTMKAD  139 (277)
Q Consensus        83 kp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  139 (277)
                      ||+|||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 57899999999986654433344556789999999965322                      2345679


Q ss_pred             eEehhHHHHHHHhCCCCCCcccCcch-------hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhh
Q 023808          140 VYSFGVLVLEIISGRNSGKAMWGQMN-------KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA  212 (277)
Q Consensus       140 v~slG~vl~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p  212 (277)
                      ||||||++|||+++..++........       .....|....... ...+ ....+ +..........+++.+|++.||
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~-~~~~~-~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPD-LRRGF-EVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchh-hhhhh-hhccccchHHHHHHHHHccCCc
Confidence            99999999999987655332110000       0011111000000 0000 00000 0000011224478889999999


Q ss_pred             cCCCCHHHHHH
Q 023808          213 SRRPQMNQVIK  223 (277)
Q Consensus       213 ~~RPs~~~v~~  223 (277)
                      ++|||+.++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999976

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.1e-30  Score=219.13  Aligned_cols=156  Identities=23%  Similarity=0.307  Sum_probs=133.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ||..-+.+-||+||-.|.+++.+|+||+|+.||++-.+|    -..+.|.+..+.-++.++..|+++.|..   |+||||
T Consensus       682 ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLL----IrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRD  754 (1034)
T KOG0608|consen  682 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRD  754 (1034)
T ss_pred             hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHH----HHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecc
Confidence            466678899999999999999999999999999999988    3445688888999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccC---------CCCc--------------------------------ceeeeeccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFP---------DNIT--------------------------------HITTRIAGT  120 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~---------~~~~--------------------------------~~~~~~~gt  120 (277)
                      |||+|||||.+|++||+|||++.-+.         ++..                                ......+||
T Consensus       755 iKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt  834 (1034)
T KOG0608|consen  755 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGT  834 (1034)
T ss_pred             cCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence            99999999999999999999986321         0000                                001234799


Q ss_pred             ccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcc
Q 023808          121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  164 (277)
Q Consensus       121 ~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~  164 (277)
                      ..|+|||++....++..+|.||.|||||||+.|+.||-...+..
T Consensus       835 ~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  835 PNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             CcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence            99999999999999999999999999999999999997766543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=210.59  Aligned_cols=186  Identities=27%  Similarity=0.327  Sum_probs=148.3

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +-|.++++..+|..-+.+|+||||+.||+|--.+    +.-+++-+..++-++.+||.||-|||++   +||+||||.+|
T Consensus       408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDN  480 (683)
T KOG0696|consen  408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDN  480 (683)
T ss_pred             CCchHHHHHHHhhhhhheeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---Ceeeeeccccc
Confidence            5678889999999999999999999999996666    3444677888899999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchh
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  166 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~  166 (277)
                      |+||.+|++||+|||+++.--- ....+.+..||+.|+|||++...+|+...|.||||++||||+.|++||.....   .
T Consensus       481 vmLd~eGHiKi~DFGmcKEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~  556 (683)
T KOG0696|consen  481 VMLDSEGHIKIADFGMCKENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---D  556 (683)
T ss_pred             eEeccCCceEeeeccccccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---H
Confidence            9999999999999999984211 12335678899999999999999999999999999999999999999876432   2


Q ss_pred             hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          167 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .+-+.+..    ..         -.++....++...++...+...|.+|-
T Consensus       557 elF~aI~e----hn---------vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  557 ELFQAIME----HN---------VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHHHHH----cc---------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            22221111    11         123344445566776677888999885

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=187.16  Aligned_cols=147  Identities=25%  Similarity=0.452  Sum_probs=129.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.|+|+|||++++....++..-+|+|||.. +|..+..   ..++.+..+.+.++..|+++||.|+|++   ++.|||
T Consensus        54 llkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrd  126 (292)
T KOG0662|consen   54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRD  126 (292)
T ss_pred             HHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhcc
Confidence            57889999999999999999999999999955 9999984   5666799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      +||.|.|++.+|.+|++|||+++.++-..... .....|.+|++|.++.+.+ |+...|+||-||++.|+.....|
T Consensus       127 lkpqnllin~ngelkladfglarafgipvrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  127 LKPQNLLINRNGELKLADFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             CCcceEEeccCCcEEecccchhhhcCCceEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            99999999999999999999999876543322 2334689999999998865 78899999999999999876555

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=201.17  Aligned_cols=193  Identities=27%  Similarity=0.370  Sum_probs=151.3

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      +||.+|-+..+|..+..+|+|.||.+||+|--.+    +..++++++.+.-+..+|+.||.|||+.   |||+||+|..|
T Consensus       309 n~pflvglhscfqtesrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldn  381 (593)
T KOG0695|consen  309 NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDN  381 (593)
T ss_pred             CCCeEEehhhhhcccceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---Ceeeeeccccc
Confidence            7999999999999999999999999999986655    5666899999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccC-cch
Q 023808           87 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG-QMN  165 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~-~~~  165 (277)
                      +|+|..|++||+|+|.++.-- .....+.++.||+.|.|||.+++..|....|.|+||++++||+.|+.||...-. ..+
T Consensus       382 vlldaeghikltdygmcke~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d  460 (593)
T KOG0695|consen  382 VLLDAEGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD  460 (593)
T ss_pred             eEEccCCceeecccchhhcCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc
Confidence            999999999999999998532 223446678999999999999999999999999999999999999999864321 112


Q ss_pred             hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      ....++..+++-+...         ..+.....+...+++.-+.+||++|-
T Consensus       461 ~ntedylfqvilekqi---------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  461 MNTEDYLFQVILEKQI---------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cchhHHHHHHHhhhcc---------cccceeehhhHHHHHHhhcCCcHHhc
Confidence            2223333332222111         01112222344555557899999885

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-30  Score=214.00  Aligned_cols=199  Identities=23%  Similarity=0.314  Sum_probs=157.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||.||.+.-.|+..+..|+|||.+.|.-|+-+|   ....+++++....-++.||+.||.|||.+   +|+|+|
T Consensus       616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMIL---SsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCD  689 (888)
T KOG4236|consen  616 ILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMIL---SSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCD  689 (888)
T ss_pred             HHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHH---HhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeecc
Confidence            688999999999999999999999999999776667776   34556799888888999999999999999   999999


Q ss_pred             CCCCcEEeCCCC---ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      +||+||||....   ++||||||+|+++++.  .......||+.|+|||+++...|...-|+||.|+++|--|+|..||.
T Consensus       690 LKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  690 LKPENVLLASASPFPQVKLCDFGFARIIGEK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             CCchheeeccCCCCCceeeccccceeecchh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence            999999996553   6999999999998764  23456789999999999999999999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ...+-.+     .+    .+..   .+-|.  .-..+.....+++|...|+.+-.+|-+.++-+
T Consensus       768 EdEdInd-----QI----QNAa---FMyPp--~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  768 EDEDIND-----QI----QNAA---FMYPP--NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CccchhH-----Hh----hccc---cccCC--CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            5433211     11    1111   11111  01122223366777888999999998877653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=201.66  Aligned_cols=210  Identities=25%  Similarity=0.287  Sum_probs=150.9

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      ++..++|+||++++.+|.-.      ...|+|||++.. +|.+.+.      -.++-..+..+..|++.|+.|||+.   
T Consensus        68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---  137 (369)
T KOG0665|consen   68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---  137 (369)
T ss_pred             hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---
Confidence            35678999999999999843      356899999965 9999884      2455677888999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +|+||||||+||++..+..+||.|||+++.-...  ...+....|..|.|||++.+..+.+..||||+||++.||++|.-
T Consensus       138 ~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V  215 (369)
T KOG0665|consen  138 GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV  215 (369)
T ss_pred             ceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE
Confidence            9999999999999999999999999999854332  34455677889999999999889999999999999999999975


Q ss_pred             CCCcccCcc----------------hhhHHHHHHHHhccC------Cccccc-cCCC---CCCCHHHHHHHHHHHHhhhh
Q 023808          156 SGKAMWGQM----------------NKFLLEWAWQLHQEE------KPLELV-DPEL---GEYPPNEIIRYMKVAFFCTQ  209 (277)
Q Consensus       156 p~~~~~~~~----------------~~~~~~~~~~~~~~~------~~~~~~-~~~~---~~~~~~~~~~~~~l~~~c~~  209 (277)
                      -|.+...-+                ...+...+.......      ...+.+ |..+   .+..+-......+++.+||.
T Consensus       216 lf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv  295 (369)
T KOG0665|consen  216 LFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV  295 (369)
T ss_pred             EecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc
Confidence            443211100                001111111111100      000001 1111   11122233346678888999


Q ss_pred             hhhcCCCCHHHHHH
Q 023808          210 AAASRRPQMNQVIK  223 (277)
Q Consensus       210 ~~p~~RPs~~~v~~  223 (277)
                      .+|++|-+++++++
T Consensus       296 i~pe~Risv~daL~  309 (369)
T KOG0665|consen  296 IDPEKRISVDDALR  309 (369)
T ss_pred             cChhhcccHHHHhc
Confidence            99999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2e-28  Score=212.71  Aligned_cols=208  Identities=22%  Similarity=0.220  Sum_probs=138.7

Q ss_pred             ccccCCCc-----cceeeEEEe--------CCeeEEEEeecCCCCHHHHhccCCC--------------------CCccC
Q 023808            4 SNVRHPNL-----VELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGATK--------------------ANIKL   50 (277)
Q Consensus         4 ~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~   50 (277)
                      .+++|.++     +++++||..        ....++||||+.+|+|.++++....                    ....+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            34555543     778888763        3467999999999999999864211                    11235


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc
Q 023808           51 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL  130 (277)
Q Consensus        51 ~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  130 (277)
                      ++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..............+++.|+|||.+.
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            6788899999999999999999   9999999999999999999999999999765433222222233578999999875


Q ss_pred             cCcc----------------------ccccceEehhHHHHHHHhCCC-CCCcccCcc------hhhHHHHHHHHhccCCc
Q 023808          131 GGQL----------------------TMKADVYSFGVLVLEIISGRN-SGKAMWGQM------NKFLLEWAWQLHQEEKP  181 (277)
Q Consensus       131 ~~~~----------------------~~~~Dv~slG~vl~elltg~~-p~~~~~~~~------~~~~~~~~~~~~~~~~~  181 (277)
                      ....                      ..+.||||+||++++|++|.. |+.......      ......  |........
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r~~~~~~~  461 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WRMYKGQKY  461 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HHhhcccCC
Confidence            4221                      134699999999999999875 543211100      011111  111111111


Q ss_pred             cccccCCCCCCCHHHHHHHHHHHHhhhhhhh---cCCCCHHHHHH
Q 023808          182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAA---SRRPQMNQVIK  223 (277)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p---~~RPs~~~v~~  223 (277)
                          +-..   .........+++.+++..+|   .+|+|+.|+++
T Consensus       462 ----~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        462 ----DFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ----Cccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                0001   11122336677777888655   78999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3.8e-28  Score=190.35  Aligned_cols=169  Identities=34%  Similarity=0.572  Sum_probs=146.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      .+++++|++|+++++++......+++||++.+++|.+++...   ...+++..++.++.+++.++++||+.   +++|+|
T Consensus        44 ~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~d  117 (215)
T cd00180          44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRD  117 (215)
T ss_pred             HHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccC
Confidence            467889999999999999999999999999999999998432   14688999999999999999999999   999999


Q ss_pred             CCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |+|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.++|+|++|++++++         
T Consensus       118 l~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------  187 (215)
T cd00180         118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------  187 (215)
T ss_pred             CCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence            9999999999 89999999999986544321 12334577889999998877 788999999999999999         


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                                                            ..+.+++..|++.+|.+||++.++++.
T Consensus       188 --------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                                  237788888999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=184.30  Aligned_cols=201  Identities=17%  Similarity=0.294  Sum_probs=144.2

Q ss_pred             cCCCccceeeE-EEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            7 RHPNLVELIGC-CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         7 ~h~niv~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      .|.||+.-|+. |+..+.+++++||++.|+|..-+.     ...+.+....+++.|+++||.|||++   ++||||||.+
T Consensus        79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~e  150 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAE  150 (378)
T ss_pred             cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccc
Confidence            58888877754 455668889999999999988772     23577888889999999999999999   9999999999


Q ss_pred             cEEeCC--CCceEEeecccccccCCCCcceeeeecccccccCccccccC-----ccccccceEehhHHHHHHHhCCCCCC
Q 023808           86 NILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        86 Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+-.  ..++||||||+.+..+..    .....-+..|.+||.....     ...+.+|||.||+++|.++||..||+
T Consensus       151 NiLif~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  151 NILIFDADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             eEEEecCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            999932  347999999998854322    2233356679999977542     34678999999999999999999998


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ..+..+..   .|.|..+.++... .....+..+.+.    .+.+.++-+..++++|-...++-++...
T Consensus       227 ka~~~d~~---Y~~~~~w~~rk~~-~~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  227 KASIMDKP---YWEWEQWLKRKNP-ALPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             hhhccCch---HHHHHHHhcccCc-cCchhhcccCHH----HHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            66554433   3333333333222 111122333443    5555566788999999666665554443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-28  Score=203.57  Aligned_cols=147  Identities=25%  Similarity=0.357  Sum_probs=128.9

Q ss_pred             cccccc---CCCccceeeEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVR---HPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|+.|+   |+||++++++|++++++||+||-... -+|.+++    .-+..+++.++.-|+.|++.|+++||++   +|
T Consensus       619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~i  691 (772)
T KOG1152|consen  619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GI  691 (772)
T ss_pred             HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---Cc
Confidence            567776   99999999999999999999998753 4788998    4556799999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||||||-+|+.++.+|-+||.|||.+....+..   ...+.||..|.|||++.+.+| ...-|||++|++||.++....|
T Consensus       692 vhrdikdenvivd~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp  768 (772)
T KOG1152|consen  692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP  768 (772)
T ss_pred             eecccccccEEEecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence            999999999999999999999999987654432   345679999999999999877 4557999999999999988877


Q ss_pred             CC
Q 023808          157 GK  158 (277)
Q Consensus       157 ~~  158 (277)
                      ++
T Consensus       769 yy  770 (772)
T KOG1152|consen  769 YY  770 (772)
T ss_pred             Cc
Confidence            65

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=6.2e-28  Score=200.94  Aligned_cols=205  Identities=21%  Similarity=0.233  Sum_probs=155.2

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI   87 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Ni   87 (277)
                      --|.++++-.|...+++|||+|-+.. +|.++|+.. ..+..+....+..++.|+..||..|-..   +|+|.||||.||
T Consensus       493 k~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi  567 (752)
T KOG0670|consen  493 KFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI  567 (752)
T ss_pred             hhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence            35789999999999999999999965 999999764 3455688899999999999999999887   999999999999


Q ss_pred             EeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchh
Q 023808           88 LLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  166 (277)
Q Consensus        88 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~  166 (277)
                      |++++. .+||||||.|.....+.   .+....+..|.|||++.+..|+...|+||.||+||||.||+.-|.+...   +
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN---N  641 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN---N  641 (752)
T ss_pred             EeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc---H
Confidence            998765 47999999998765432   2233456679999999999999999999999999999999865543221   1


Q ss_pred             hHHHHHHH--------HhccCC---------------------------ccccc------------cCCCCCCCHHHHHH
Q 023808          167 FLLEWAWQ--------LHQEEK---------------------------PLELV------------DPELGEYPPNEIIR  199 (277)
Q Consensus       167 ~~~~~~~~--------~~~~~~---------------------------~~~~~------------~~~~~~~~~~~~~~  199 (277)
                      ..+.+...        ...++.                           +...+            .+.+++..+..+..
T Consensus       642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~  721 (752)
T KOG0670|consen  642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ  721 (752)
T ss_pred             HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence            11111110        000000                           00011            12234455667888


Q ss_pred             HHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          200 YMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       200 ~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.+|+..|+..||++|-+..+.++
T Consensus       722 ~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHhccChhhcCCHHHHhc
Confidence            999999999999999999987754

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-28  Score=189.74  Aligned_cols=152  Identities=28%  Similarity=0.413  Sum_probs=126.5

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|+.++|.|++..++...-..     ..|+|+|.+.. +|.+++    -....++...+.-.++||++||.|||+.   +
T Consensus       105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~  176 (449)
T KOG0664|consen  105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---N  176 (449)
T ss_pred             HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---c
Confidence            467789999999888765432     45788999955 899888    4556788888888999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |+||||||.|+|++.|-.+||+|||+++....+...-.+....|..|+|||.+.+. .|+.+.||||.||++.||+.++.
T Consensus       177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrI  256 (449)
T KOG0664|consen  177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKI  256 (449)
T ss_pred             hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhh
Confidence            99999999999999999999999999997655444434445568889999999886 58999999999999999998876


Q ss_pred             CCCccc
Q 023808          156 SGKAMW  161 (277)
Q Consensus       156 p~~~~~  161 (277)
                      -|+...
T Consensus       257 LFQAq~  262 (449)
T KOG0664|consen  257 LFQAAG  262 (449)
T ss_pred             hhhccC
Confidence            665443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=203.47  Aligned_cols=202  Identities=24%  Similarity=0.380  Sum_probs=155.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.=+||||+.++|.+..++..+++||||.||+|++.-    .....+++.++..++++...||+|||++   +-+|||
T Consensus        65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRd  137 (829)
T KOG0576|consen   65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRD  137 (829)
T ss_pred             eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---Cccccc
Confidence            455668999999999999999999999999999999987    3455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||-.||++++.+.+|++|||.+-.+..... ....+.||+.|||||+..   .+.|..++|||++|+...|+-.-++|..
T Consensus       138 iKGanilltd~gDvklaDfgvsaqitati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf  216 (829)
T KOG0576|consen  138 IKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF  216 (829)
T ss_pred             ccccceeecccCceeecccCchhhhhhhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence            999999999999999999999876654322 245578999999999874   4568999999999999999987776643


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ...+.....+.     ....-.+..+-|+      .....-|-++++.|+..+|++||++..++
T Consensus       217 dlhpmr~l~Lm-----TkS~~qpp~lkDk------~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  217 DLHPMRALFLM-----TKSGFQPPTLKDK------TKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             ccchHHHHHHh-----hccCCCCCcccCC------ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            32222111111     1111111111121      22333466777779999999999998765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.6e-26  Score=183.41  Aligned_cols=150  Identities=33%  Similarity=0.478  Sum_probs=130.2

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCcc-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK-LNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +.+++|+|++++++++......++++|++.+++|.+++...    .. +++..+..++.+++.++.+||+.   +++|+|
T Consensus        51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~d  123 (225)
T smart00221       51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRD  123 (225)
T ss_pred             HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            56789999999999999999999999999999999998432    23 78999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccc-ccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |+|.||+++.++.++|+|||.+...............++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       124 i~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      124 LKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999999999999999999987654421122345577889999998 556778899999999999999999999844

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-25  Score=189.70  Aligned_cols=218  Identities=27%  Similarity=0.389  Sum_probs=164.7

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe-Eecc
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI-VHRD   81 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i-iH~d   81 (277)
                      |+++.|.|+.+++|.+.++...+.|.+||..|+|.+.+.   .....+++.....+.++++.||+|||..   .+ .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            678999999999999999999999999999999999995   3456789999999999999999999997   44 9999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCc-------cccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQ-------LTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~vl~elltg  153 (277)
                      +++.|+++|....+|++|||+........ ........-..-|.|||.+....       .+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            99999999999999999999988764310 01111222345699999987631       46779999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ..||.........  .+.+.....  .......|.+.... .....+..++..||..+|.+||++++|-..++.+.+.
T Consensus       155 ~~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  155 SGPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cCccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9998764433222  222222222  11112222221111 2222588888999999999999999999888877654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-25  Score=183.20  Aligned_cols=77  Identities=27%  Similarity=0.472  Sum_probs=67.8

Q ss_pred             CCCccceeeEEE----eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            8 HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         8 h~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      -.+||+++++|.    .+.+.|+|+|++ |.+|-.++..  ...+.++...+.+|+.|++.||.|||..|  +|||.|||
T Consensus       141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlK  215 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLK  215 (590)
T ss_pred             CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCC
Confidence            467999999998    456899999999 6699999854  33456889999999999999999999997  99999999


Q ss_pred             CCcEEe
Q 023808           84 ASNILL   89 (277)
Q Consensus        84 p~Nill   89 (277)
                      |+|||+
T Consensus       216 PENvLl  221 (590)
T KOG1290|consen  216 PENVLL  221 (590)
T ss_pred             cceeee
Confidence            999999

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5.7e-24  Score=177.74  Aligned_cols=217  Identities=18%  Similarity=0.231  Sum_probs=162.0

Q ss_pred             CCccceeeEE-EeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 023808            9 PNLVELIGCC-VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI   87 (277)
Q Consensus         9 ~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Ni   87 (277)
                      .++..+++.+ ..+...|+||+.+ |.+|.++.....  .+.++..++++++.|++.+|++||+.   |++||||||.|+
T Consensus        80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~  153 (322)
T KOG1164|consen   80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENF  153 (322)
T ss_pred             CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHe
Confidence            6899999999 4788999999999 779999885433  56899999999999999999999999   999999999999


Q ss_pred             EeCCC-----CceEEeeccccc--ccCCCCc----ce---eeeecccccccCccccccCccccccceEehhHHHHHHHhC
Q 023808           88 LLDQE-----FNPKIGDFGLAK--LFPDNIT----HI---TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        88 ll~~~-----~~~kl~Dfg~~~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg  153 (277)
                      ++...     ..++|.|||+++  .+.....    ..   .....||..|.++.++.+...+.+.|+||+++++.|++.|
T Consensus       154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g  233 (322)
T KOG1164|consen  154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG  233 (322)
T ss_pred             eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence            99765     358999999998  3322221    11   2235699999999999999999999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ..||.............   ........    .. .....+.+...+.+.   +-..+...+|.+..+...|.+......
T Consensus       234 ~LPW~~~~~~~~~~~~~---~~~~~~~~----~~-~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  234 SLPWEALEMTDLKSKFE---KDPRKLLT----DR-FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             CCCCccccccchHHHHH---HHhhhhcc----cc-ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence            99986655432211111   11111100    00 334455555555555   555899999999999999988876653


Q ss_pred             cccCCCCcc
Q 023808          234 EELTAPGLF  242 (277)
Q Consensus       234 ~~~~~~~~~  242 (277)
                      .....|..|
T Consensus       303 ~~~~~~~dw  311 (322)
T KOG1164|consen  303 SKEDSPFDW  311 (322)
T ss_pred             CCCCCCCcc
Confidence            333344443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=4.8e-25  Score=166.49  Aligned_cols=148  Identities=22%  Similarity=0.384  Sum_probs=122.0

Q ss_pred             cccccc-CCCccceeeEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVR-HPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|..|. ||||+++++...+..  .+.||+||.++.+...+..       .++...+..+..+++.||.|+|++   ||.
T Consensus        85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GIm  154 (338)
T KOG0668|consen   85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIM  154 (338)
T ss_pred             HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---Ccc
Confidence            567776 999999999998654  6789999999987776651       366778888999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCC
Q 023808           79 HRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        79 H~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||.|+++|... .++|.|+|+|.++.....  -.....+..|--||.+... .|+..-|+|||||++..|+..+.|
T Consensus       155 HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkep  232 (338)
T KOG0668|consen  155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  232 (338)
T ss_pred             cccCCcceeeechhhceeeeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCc
Confidence            999999999998765 589999999998765432  2234456678899988764 578899999999999999999999


Q ss_pred             CCccc
Q 023808          157 GKAMW  161 (277)
Q Consensus       157 ~~~~~  161 (277)
                      |-...
T Consensus       233 FFhG~  237 (338)
T KOG0668|consen  233 FFHGH  237 (338)
T ss_pred             ccCCC
Confidence            75433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7e-26  Score=200.90  Aligned_cols=205  Identities=24%  Similarity=0.316  Sum_probs=157.6

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      ++|+|||++..+..+.+....+-+||||++ +|..++    .....++..++..++.|+..|++|+|+.   |+.|||+|
T Consensus       376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK  447 (601)
T KOG0590|consen  376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLK  447 (601)
T ss_pred             ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCc
Confidence            468999998888777776666666999999 999998    3445688889999999999999999999   99999999


Q ss_pred             CCcEEeCCCCceEEeecccccccCCCCc---ceeeeecccccccCccccccCcccc-ccceEehhHHHHHHHhCCCCCCc
Q 023808           84 ASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTM-KADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        84 p~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ++|+++..++.+||+|||.+..+.....   .......|+..|+|||++.+.+|.+ ..||||.|+++..|.+|+.||..
T Consensus       448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~  527 (601)
T KOG0590|consen  448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV  527 (601)
T ss_pred             cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence            9999999999999999999876544332   3455678999999999999999875 47999999999999999999988


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +........     .. .......... ...............++.++|+.+|.+|.++.+|++
T Consensus       528 a~~~~~~~~-----~~-~~~~~~~~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  528 AKKSDNSFK-----TN-NYSDQRNIFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccchh-----hh-cccccccccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            766554320     00 0000000000 001111223334667888899999999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-24  Score=167.00  Aligned_cols=202  Identities=20%  Similarity=0.344  Sum_probs=149.4

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |+-+.||||+.++|.|.....+.++..|++.|+|+++|++  ..+..+.-.++.+.+.++++|++|||+..+ -|.---+
T Consensus       241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep-~ipr~~l  317 (448)
T KOG0195|consen  241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYL  317 (448)
T ss_pred             eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhc
Confidence            5567899999999999999999999999999999999965  455567888999999999999999999742 3445578


Q ss_pred             CCCcEEeCCCCceEEe--ecccccccCCCCcceeeeecccccccCccccccCcc---ccccceEehhHHHHHHHhCCCCC
Q 023808           83 KASNILLDQEFNPKIG--DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        83 kp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ++..+++|++.+++|+  |--++-        ......-.+.|++||.++..+-   -.++|+|||++++|||.|+.-||
T Consensus       318 ns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf  389 (448)
T KOG0195|consen  318 NSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF  389 (448)
T ss_pred             ccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence            9999999999887765  322111        1222334678999999877653   35789999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ....+..-..      +     ...+-+...++......   +.+++.-|+..||.+||.++.|+-.|++..
T Consensus       390 adlspmecgm------k-----ialeglrv~ippgis~h---m~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  390 ADLSPMECGM------K-----IALEGLRVHIPPGISRH---MNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccCCchhhhh------h-----hhhccccccCCCCccHH---HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            7654422110      0     11112222222333334   444444599999999999999999998753

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1e-23  Score=167.35  Aligned_cols=212  Identities=19%  Similarity=0.275  Sum_probs=169.0

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      --++|..+|-|+.++.+-.||+|++ |.||++++   .-.++.|+.++++.+|.|++.-++|+|++   .+|.|||||+|
T Consensus        82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdN  154 (449)
T KOG1165|consen   82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDN  154 (449)
T ss_pred             CCCCCCceeeeccccchhhhhhhhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccc
Confidence            3588999998988999999999999 88999998   46788899999999999999999999999   99999999999


Q ss_pred             EEeCCC-----CceEEeecccccccCCCCcce------eeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           87 ILLDQE-----FNPKIGDFGLAKLFPDNITHI------TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        87 ill~~~-----~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +||...     ..+.+.|||+|+.+.+..+..      .....||.+||+-..+.+.+.+.+.|.-|||-|+++.|-|..
T Consensus       155 FLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL  234 (449)
T KOG1165|consen  155 FLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL  234 (449)
T ss_pred             eeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence            999644     348999999999876654332      345679999999999999999999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ||+...........+.+-...+...+.     .+....|.++...+..   .-..+-.+-|.++.+...+.+++....
T Consensus       235 PWQGLKA~tnK~kYeKIGe~Kr~T~i~-----~Lc~g~P~efa~Yl~y---vR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  235 PWQGLKADTNKEKYEKIGETKRSTPIE-----VLCEGFPEEFATYLRY---VRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             ccccccCcchHHHHHHhccccccCCHH-----HHHhcCHHHHHHHHHH---HHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            998877655544433332222222111     1233456666666666   455677888999999988888876543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.88  E-value=1.6e-22  Score=164.89  Aligned_cols=146  Identities=29%  Similarity=0.427  Sum_probs=120.6

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      -+.||+++.+++..++...+|+||++...-.++..       .++...+..+++.+..||+++|.+   |||||||||+|
T Consensus        93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsN  162 (418)
T KOG1167|consen   93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSN  162 (418)
T ss_pred             cchhhhcchhhhccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccc
Confidence            47899999999999999999999999988888873       366788999999999999999999   99999999999


Q ss_pred             EEeCCC-CceEEeecccccccCCCC-------------------------------------------cceeeeeccccc
Q 023808           87 ILLDQE-FNPKIGDFGLAKLFPDNI-------------------------------------------THITTRIAGTTG  122 (277)
Q Consensus        87 ill~~~-~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~gt~~  122 (277)
                      +|.+.. +.-.|.|||++.......                                           ........||++
T Consensus       163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G  242 (418)
T KOG1167|consen  163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG  242 (418)
T ss_pred             cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence            999765 457899999997211000                                           000123579999


Q ss_pred             ccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808          123 YLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus       123 y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                      |+|||++.. ...+.+.||||.|++++.+++++.||.....
T Consensus       243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~d  283 (418)
T KOG1167|consen  243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKD  283 (418)
T ss_pred             CCchHHHhhccCcCCccceeeccceeehhhccccccccCcc
Confidence            999999876 4578899999999999999999999865433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.87  E-value=3.1e-23  Score=173.85  Aligned_cols=124  Identities=27%  Similarity=0.446  Sum_probs=108.7

Q ss_pred             CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecc
Q 023808           22 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  101 (277)
Q Consensus        22 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg  101 (277)
                      .++|+.|++|..++|++|+.+. ......++.....++.|++.|++|   +   +.+|+|+||.||++..+..+||.|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence            3578999999999999999643 345567889999999999999999   6   89999999999999999999999999


Q ss_pred             cccccCCCC-----cceeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808          102 LAKLFPDNI-----THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus       102 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                      +........     ....+...||..||+||.+.+..|+.++||||||++|+|++.
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            988665544     223456779999999999999999999999999999999997

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4.4e-22  Score=151.57  Aligned_cols=209  Identities=17%  Similarity=0.220  Sum_probs=157.6

Q ss_pred             CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 023808            9 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL   88 (277)
Q Consensus         9 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nil   88 (277)
                      ..|..+..|+.+..+-.+||+.+ |.+|++++.   -..+.++.++++.++-|++.-++|+|.+   ++|||||||+|+|
T Consensus        71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFL  143 (341)
T KOG1163|consen   71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFL  143 (341)
T ss_pred             CCCchhhhhccccccceeeeecc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCcccee
Confidence            45667788888999999999999 889999983   4566799999999999999999999999   9999999999999


Q ss_pred             eCCC---CceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           89 LDQE---FNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        89 l~~~---~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ..-+   ..+.+.|||+++.+-+..+.      ......||.+|.+-..+.+...+.+.|+-|+|.+|.++.-|..||+.
T Consensus       144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg  223 (341)
T KOG1163|consen  144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG  223 (341)
T ss_pred             eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence            9654   35899999999976543221      23456799999999988888899999999999999999999999988


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ..........+.+.+......+    . .+....|.   ++.-.+.-|-...-++-|+...+.+.+.-+++..
T Consensus       224 lka~tk~QKyEkI~EkK~s~~i----e-~LC~G~P~---EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  224 LKAATKKQKYEKISEKKMSTPI----E-VLCKGFPA---EFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             cchhhHHHHHHHHHHhhcCCCH----H-HHhCCCcH---HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            7665443333333222211111    1 12222233   3555555588889999999888877766655433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=9e-22  Score=159.91  Aligned_cols=197  Identities=22%  Similarity=0.282  Sum_probs=138.3

Q ss_pred             cCCCccceeeEEEe---------------------------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHH
Q 023808            7 RHPNLVELIGCCVQ---------------------------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC   59 (277)
Q Consensus         7 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~   59 (277)
                      +|||||+++++|.+                           ....|+||..+.. +|..|+..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            79999999999863                           3467999999855 99999932     235566778899


Q ss_pred             HHHHHHHHHhhcCCCCCeEeccCCCCcEEe--CCCC--ceEEeecccccccCCCCc-----ceeeeecccccccCccccc
Q 023808           60 VGIAKGLAFLHEELVPHIVHRDIKASNILL--DQEF--NPKIGDFGLAKLFPDNIT-----HITTRIAGTTGYLAPEYVL  130 (277)
Q Consensus        60 ~qi~~~l~~LH~~~~~~iiH~dikp~Nill--~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~  130 (277)
                      .|+++|+.|||++   ||.|||+|++|||+  |+++  .+.++|||.+---...+.     .......|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999999  4444  478999997653222111     1123345677889999876


Q ss_pred             cCc------cccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHH
Q 023808          131 GGQ------LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA  204 (277)
Q Consensus       131 ~~~------~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  204 (277)
                      ..+      --.|+|.|+.|.+.||+++...||+.. ++.......+             -...++..+......+.+++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~Y-------------qe~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRTY-------------QESQLPALPSRVPPVARQLV  490 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhhh-------------hhhhCCCCcccCChHHHHHH
Confidence            532      125899999999999999999998762 1111111111             01122222333334467777


Q ss_pred             HhhhhhhhcCCCCHHHHHHHHh
Q 023808          205 FFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       205 ~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      ...++.||.+|++..=....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            8889999999999765554443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.4e-20  Score=157.45  Aligned_cols=215  Identities=28%  Similarity=0.381  Sum_probs=157.7

Q ss_pred             ccccccCC-CccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHP-NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +++++.|+ +|+++++++......+++++++.++++.+++...... ..++......+..|++.++.|+|+.   +++||
T Consensus        50 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hr  125 (384)
T COG0515          50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHR  125 (384)
T ss_pred             HHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            35678888 7999999998777789999999999999877322111 3688999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCC-ceEEeecccccccCCCCcc-----eeeeecccccccCcccccc---CccccccceEehhHHHHHHH
Q 023808           81 DIKASNILLDQEF-NPKIGDFGLAKLFPDNITH-----ITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        81 dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~ell  151 (277)
                      |+||+||+++..+ .++++|||.++........     ......|+..|++||.+.+   .......|+||+|+++++++
T Consensus       126 d~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~  205 (384)
T COG0515         126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL  205 (384)
T ss_pred             CCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHH
Confidence            9999999999988 6999999999855443322     2356779999999999987   57889999999999999999


Q ss_pred             hCCCCCCcccCc-chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          152 SGRNSGKAMWGQ-MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       152 tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      +|..|+...... ............... ........   .........+.+++..|+..+|..|.+..+....
T Consensus       206 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         206 TGLPPFEGEKNSSATSQTLKIILELPTP-SLASPLSP---SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hCCCCCCCCCccccHHHHHHHHHhcCCc-ccccccCc---cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            999985544321 011111111111111 00000000   0002223457788888999999999998877654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=2.9e-20  Score=149.41  Aligned_cols=164  Identities=19%  Similarity=0.202  Sum_probs=109.6

Q ss_pred             eEEEEeecCCCCHHHHhc---cCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           24 RILVYEYVENNSLDRVLL---GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        24 ~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      .+++|+-+. ++|.+++.   .....+..+....++.+..|++..+++||..   |++|+||+|+|++++.+|.++|+||
T Consensus       114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F  189 (288)
T PF14531_consen  114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDF  189 (288)
T ss_dssp             EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--G
T ss_pred             hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcCh
Confidence            478899885 49988853   2222334455666778889999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcceeeeecccccccCcccccc--------CccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHH
Q 023808          101 GLAKLFPDNITHITTRIAGTTGYLAPEYVLG--------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  172 (277)
Q Consensus       101 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~  172 (277)
                      +.....+...   .. ...+..|.+||....        -.++.+.|.|+||+++|.|.|+..||...........    
T Consensus       190 ~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----  261 (288)
T PF14531_consen  190 SSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----  261 (288)
T ss_dssp             GGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred             HHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence            9877543211   11 334567899996643        2478899999999999999999999876543321110    


Q ss_pred             HHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          173 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                                     .+..+. +....+..+|..+|+.+|.+|
T Consensus       262 ---------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 ---------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ---------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                           222333 566668888899999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=7.8e-20  Score=152.97  Aligned_cols=113  Identities=22%  Similarity=0.249  Sum_probs=88.0

Q ss_pred             ccccccCCCccc-eeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVE-LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++|+|+||+. ++++    ...|+||||++|++|....    ..+       ...++.|++.||+|||+.   +|+||
T Consensus        74 iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~~----~~~-------~~~~~~~i~~aL~~lH~~---gIiHr  135 (365)
T PRK09188         74 ALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLAR----PHG-------DPAWFRSAHRALRDLHRA---GITHN  135 (365)
T ss_pred             HHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHhC----ccc-------hHHHHHHHHHHHHHHHHC---CCeeC
Confidence            578899999985 4432    4579999999999997321    111       146788999999999999   99999


Q ss_pred             cC-CCCcEEeCCCCceEEeecccccccCCCCcce-------eeeecccccccCccccccC
Q 023808           81 DI-KASNILLDQEFNPKIGDFGLAKLFPDNITHI-------TTRIAGTTGYLAPEYVLGG  132 (277)
Q Consensus        81 di-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  132 (277)
                      || ||+|||++.++.+||+|||+++.+.......       .....+++.|.+||.+...
T Consensus       136 DL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        136 DLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99 9999999999999999999999765432111       1356678889999988653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=1.7e-20  Score=168.91  Aligned_cols=200  Identities=23%  Similarity=0.276  Sum_probs=140.0

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      -++|||.+.+.-+-..+...|+|-+|... +|+|.+    ....-+..-+..-|+.|++.||..+|..   ||+|||||.
T Consensus        77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKs  148 (1431)
T KOG1240|consen   77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKS  148 (1431)
T ss_pred             hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---Ccccccccc
Confidence            35899999998887777788999999966 999998    3333456667777899999999999999   999999999


Q ss_pred             CcEEeCCCCceEEeecccccc--cCCCCcce----eeeecccccccCccccccC----------c-cccccceEehhHHH
Q 023808           85 SNILLDQEFNPKIGDFGLAKL--FPDNITHI----TTRIAGTTGYLAPEYVLGG----------Q-LTMKADVYSFGVLV  147 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~~--~~~~~~~~----~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~vl  147 (277)
                      +|||+..=+-+.|+||...+.  ++.+....    ..+...-.+|+|||.+...          . .+++-||||+||++
T Consensus       149 ENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi  228 (1431)
T KOG1240|consen  149 ENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI  228 (1431)
T ss_pred             ceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence            999999988899999987663  22221111    1122233579999988541          1 67889999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      +||++ |+++|.-.      .+..+..  .....+...+.    ....   ..+.+++..|++.||.+|-++++.++.-.
T Consensus       229 aELf~Eg~PlF~LS------QL~aYr~--~~~~~~e~~Le----~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  229 AELFLEGRPLFTLS------QLLAYRS--GNADDPEQLLE----KIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             HHHHhcCCCcccHH------HHHhHhc--cCccCHHHHHH----hCcC---ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            99977 46666421      1111110  00000000000    0000   12678888899999999999999988643


Q ss_pred             h
Q 023808          227 K  227 (277)
Q Consensus       227 ~  227 (277)
                      .
T Consensus       294 G  294 (1431)
T KOG1240|consen  294 G  294 (1431)
T ss_pred             c
Confidence            3

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=3.2e-20  Score=158.87  Aligned_cols=182  Identities=25%  Similarity=0.255  Sum_probs=140.8

Q ss_pred             ccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +...+ ||.++++.-.+..+...++++++..||.|...+    .....+.+.....+...++-|++++|+.   +++|||
T Consensus        50 l~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd  122 (612)
T KOG0603|consen   50 LAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRD  122 (612)
T ss_pred             HhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhc
Confidence            44454 999999998899999999999999999998877    3444566777777888999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      +|++||+++.+|.+++.|||+++..-....     ..||..|||||+++  ....+.|.||||++.+||+||..||..  
T Consensus       123 ~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--  193 (612)
T KOG0603|consen  123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--  193 (612)
T ss_pred             ccccceeecccCccccCCchhhhHhHhhhh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--
Confidence            999999999999999999999986533211     17899999999988  456789999999999999999999865  


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                           ....   ......          ...+.........++..++..+|..|--.
T Consensus       194 -----~~~~---~Il~~~----------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  194 -----DTMK---RILKAE----------LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -----HHHH---HHhhhc----------cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                 1111   111100          11233333445556666788888888654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=4.6e-19  Score=135.66  Aligned_cols=138  Identities=17%  Similarity=0.149  Sum_probs=104.9

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++|. |++|++++++    ...+++|||+.|.+|.+.+.    .       ....++.|++.+|.++|+.   ||+||
T Consensus        54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHr  115 (218)
T PRK12274         54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHN  115 (218)
T ss_pred             HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccC
Confidence            577884 5889999987    34689999999999976541    1       1135778999999999999   99999


Q ss_pred             cC-CCCcEEeCCCCceEEeecccccccCCCCcc----e--------eeeecccccccCccccccC-ccc-cccceEehhH
Q 023808           81 DI-KASNILLDQEFNPKIGDFGLAKLFPDNITH----I--------TTRIAGTTGYLAPEYVLGG-QLT-MKADVYSFGV  145 (277)
Q Consensus        81 di-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~  145 (277)
                      || ||+||+++.++.++|+|||++.........    .        ......++.|++|+...-. ..+ .+.+.++-|.
T Consensus       116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~  195 (218)
T PRK12274        116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK  195 (218)
T ss_pred             CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence            99 799999999999999999999865443210    0        1123357778888765432 233 5678889999


Q ss_pred             HHHHHHhCCCCC
Q 023808          146 LVLEIISGRNSG  157 (277)
Q Consensus       146 vl~elltg~~p~  157 (277)
                      .+|.++|+..+.
T Consensus       196 ~~~~~~~~~~~~  207 (218)
T PRK12274        196 PVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHhccCCc
Confidence            999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.76  E-value=4.2e-19  Score=138.64  Aligned_cols=121  Identities=18%  Similarity=0.243  Sum_probs=93.5

Q ss_pred             ccccccCCCccceeeEEEeC--------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG--------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      .+.+++|++|..+..++...        ...++||||++|.+|.++.        .++.    ....+++.+|..+|+. 
T Consensus        88 ~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-  154 (232)
T PRK10359         88 QTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-  154 (232)
T ss_pred             HHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-
Confidence            36788999999999987643        3578999999999998874        1222    2456999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                        |++|||++|+||+++.++ ++|+|||..+.........             .+.....+..++|+|+||+.+..+.
T Consensus       155 --gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        155 --GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             --CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence              999999999999999888 9999999887543221110             0233344667999999999987664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.72  E-value=1.3e-17  Score=128.56  Aligned_cols=95  Identities=16%  Similarity=0.213  Sum_probs=73.2

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecc
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL-HEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~iiH~d   81 (277)
                      |.++.++++.....+...  ..++||||++|+++.....    ....+++..+..++.|++.+|.++ |+.   +|+|||
T Consensus        73 l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrD  143 (190)
T cd05147          73 LKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHAD  143 (190)
T ss_pred             HHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            455666666433322222  2379999999887765531    234688999999999999999999 688   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFP  107 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~  107 (277)
                      |||+||+++ ++.++|+|||++....
T Consensus       144 lkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         144 LSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCHHHEEEE-CCcEEEEEccccccCC
Confidence            999999998 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.70  E-value=4.4e-17  Score=125.94  Aligned_cols=95  Identities=19%  Similarity=0.272  Sum_probs=74.6

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHH-hccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV-LLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      |.+++|++|.....+...  ..++||||++|+++... +     ....++...+.+++.|++.++.++|+ .   |++||
T Consensus        73 l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHr  142 (190)
T cd05145          73 LKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHG  142 (190)
T ss_pred             HHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence            456677877444333333  24899999998855433 3     22357788999999999999999999 8   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPD  108 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~  108 (277)
                      ||||+||+++ ++.++|+|||++.....
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEcccceecCC
Confidence            9999999999 78999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.6e-17  Score=132.33  Aligned_cols=151  Identities=25%  Similarity=0.342  Sum_probs=119.2

Q ss_pred             ccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            4 SNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      -++.|-|||++..|+.+..     ...+++||++.|+|..+|++..+.+..+......+|+.||..||.|||+. .|.++
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppii  200 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccc
Confidence            4568999999999998654     35789999999999999988878888899999999999999999999995 55899


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccC---CCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFP---DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |+++..+.|++..++-+|+.--.-...-.   ...........+-++|.+||.-.....+..+|||+||+..+||..+.-
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            99999999999999988875321111100   001111223346678999998777778889999999999999987753

>PRK10345 hypothetical protein; Provisional

Probab=99.68  E-value=1.6e-16  Score=123.69  Aligned_cols=88  Identities=16%  Similarity=0.177  Sum_probs=69.7

Q ss_pred             cCCCccceeeEEEeCC---eeE-EEEee--cCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEe
Q 023808            7 RHPNLVELIGCCVQGT---RRI-LVYEY--VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL-AFLHEELVPHIVH   79 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~iiH   79 (277)
                      +||||++++|++..+.   ..+ +|+||  +.+|+|.+++..    + .+++.  ..++.|++.++ +|||++   +|+|
T Consensus        59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~----~-~~~e~--~~~~~~~L~~l~~yLh~~---~Ivh  128 (210)
T PRK10345         59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ----C-RYEED--VAQLRQLLKKLKRYLLDN---RIVT  128 (210)
T ss_pred             CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc----c-cccHh--HHHHHHHHHHHHHHHHHC---CEee
Confidence            6899999999999874   333 78999  557999999942    2 35555  35678888887 999999   9999


Q ss_pred             ccCCCCcEEeCC----CCceEEeeccccc
Q 023808           80 RDIKASNILLDQ----EFNPKIGDFGLAK  104 (277)
Q Consensus        80 ~dikp~Nill~~----~~~~kl~Dfg~~~  104 (277)
                      |||||+||+++.    +..++|+||+.++
T Consensus       129 rDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345        129 MELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             cCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            999999999964    3479999955443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=2.3e-16  Score=143.99  Aligned_cols=191  Identities=16%  Similarity=0.174  Sum_probs=138.0

Q ss_pred             ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeC
Q 023808           11 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD   90 (277)
Q Consensus        11 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~   90 (277)
                      |.++.....-.+..++|+||.+.|+|-+++    +..+.++|..++-++.|++..++.||..   +|||+||||+|++|.
T Consensus       756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  756 IMHISSAHVFQNASVLVSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLR  828 (974)
T ss_pred             hHHHHHHHccCCcceeeeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEee
Confidence            334444444566778999999999999999    5777899999999999999999999999   999999999999993


Q ss_pred             -------CCCceEEeecccccccCCC-CcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccC
Q 023808           91 -------QEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG  162 (277)
Q Consensus        91 -------~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~  162 (277)
                             ++..++|+|||.+-.+.-- ....-...++|-.+-++|+..+..++...|.|.|+-+++-||.|+.--     
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----  903 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----  903 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----
Confidence                   2345899999988644321 122344567888999999999999999999999999999999996421     


Q ss_pred             cchhhHHHHHHHHhccCCccccccCCCCCCC-HHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          163 QMNKFLLEWAWQLHQEEKPLELVDPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                                  .. ++.. ..++..++.+. .+...+++.+   .|..|-..=|...++...|++.+.
T Consensus       904 ------------~~-~g~~-~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  904 ------------VK-NGSS-WMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             ------------hc-CCcc-eeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHHHH
Confidence                        11 1111 11111111111 2233334444   566555556788888888877664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=7.1e-18  Score=150.13  Aligned_cols=199  Identities=23%  Similarity=0.305  Sum_probs=148.3

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCc
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELVPHIVHRDIKASN   86 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~iiH~dikp~N   86 (277)
                      |+|++++++...+.+..+++.+|..||++.+.+..  ......+....-.++.|+..++.|+| ..   ++.|+||||+|
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n  154 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSN  154 (601)
T ss_pred             cccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCcc
Confidence            99999999999999999999999999999887721  11114556677789999999999999 77   99999999999


Q ss_pred             EEeCCCC-ceEEeecccccccCC-CC-cceeeeecc-cccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           87 ILLDQEF-NPKIGDFGLAKLFPD-NI-THITTRIAG-TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        87 ill~~~~-~~kl~Dfg~~~~~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      .+++.++ ..+++|||+|..+.. .. ........| ++.|.|||...+. ......|+||.|+++.-+++|..||....
T Consensus       155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            9999999 999999999987765 32 233445667 9999999988774 45678999999999999999999988766


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ...... ..|...  . ....   .........    ..+++..+++..+|..|.+..++-
T Consensus       235 ~~~~~~-~~~~~~--~-~~~~---~~~~~~~~~----~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  235 RKDGRY-SSWKSN--K-GRFT---QLPWNSISD----QAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccc-eeeccc--c-cccc---cCccccCCh----hhhhcccccccCCchhcccccccc
Confidence            544211 111100  0 0000   001112222    255666667888999999887763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=5.8e-16  Score=139.72  Aligned_cols=139  Identities=22%  Similarity=0.264  Sum_probs=100.1

Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc--------------ceeeeecccccccCcc
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--------------HITTRIAGTTGYLAPE  127 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~gt~~y~aPE  127 (277)
                      ++.+++|||+.   +|+|||+||+|.++..-|++|++|||+++.......              .......||+.|.|||
T Consensus       152 mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  152 MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            37899999999   999999999999999999999999999975322110              1134568999999999


Q ss_pred             ccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhh
Q 023808          128 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC  207 (277)
Q Consensus       128 ~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c  207 (277)
                      ++.-..|....|+|++|+++||.+-|..||....++.  .+...+.....   ..+   . ....++    +..+++...
T Consensus       229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--lfg~visd~i~---wpE---~-dea~p~----Ea~dli~~L  295 (1205)
T KOG0606|consen  229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQVISDDIE---WPE---E-DEALPP----EAQDLIEQL  295 (1205)
T ss_pred             hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--HHhhhhhhhcc---ccc---c-CcCCCH----HHHHHHHHH
Confidence            9999999999999999999999999999886553321  11111111000   000   0 011122    355666668


Q ss_pred             hhhhhcCCC
Q 023808          208 TQAAASRRP  216 (277)
Q Consensus       208 ~~~~p~~RP  216 (277)
                      |+.+|..|-
T Consensus       296 L~qnp~~Rl  304 (1205)
T KOG0606|consen  296 LRQNPLCRL  304 (1205)
T ss_pred             HHhChHhhc
Confidence            999999995

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.58  E-value=5.4e-15  Score=116.32  Aligned_cols=92  Identities=25%  Similarity=0.367  Sum_probs=79.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++|+||.....++...+..++||||++|++|.+++...       .+ .+..++.+++.+|.++|+.   +++|+|
T Consensus        52 ~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~D  120 (211)
T PRK14879         52 IMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGD  120 (211)
T ss_pred             HHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            355678899888777877788889999999999999998321       12 7889999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ++|.||+++ ++.++++|||.++.
T Consensus       121 l~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        121 LTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcccEEEE-CCCEEEEECCcccC
Confidence            999999999 78899999998874

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.57  E-value=6.3e-15  Score=131.36  Aligned_cols=88  Identities=27%  Similarity=0.398  Sum_probs=79.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|++|+....++......++||||++|++|.+++.            ....++.+++.+|.+||+.   +++|||
T Consensus       389 ~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrD  453 (535)
T PRK09605        389 LLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGD  453 (535)
T ss_pred             HHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCC
Confidence            4678899999988888888778899999999999999882            4567899999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      |||+||++ +++.++|+|||+++.
T Consensus       454 lkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        454 LTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CChHHEEE-ECCcEEEEeCccccc
Confidence            99999999 677899999999975

>smart00090 RIO RIO-like kinase

Probab=99.55  E-value=9.4e-15  Score=116.42  Aligned_cols=77  Identities=23%  Similarity=0.309  Sum_probs=64.8

Q ss_pred             eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeccCCCCcEEeCCCCceEEeecc
Q 023808           23 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEFNPKIGDFG  101 (277)
Q Consensus        23 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-iiH~dikp~Nill~~~~~~kl~Dfg  101 (277)
                      ..++||||+.|++|..+..    .+..+....+..++.|++.+|++||+.   + ++|+||||+||+++ ++.++|+|||
T Consensus       122 ~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg  193 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVS  193 (237)
T ss_pred             CceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEECh
Confidence            3479999999988876642    233456667789999999999999999   9 99999999999999 7889999999


Q ss_pred             cccccC
Q 023808          102 LAKLFP  107 (277)
Q Consensus       102 ~~~~~~  107 (277)
                      .+....
T Consensus       194 ~a~~~~  199 (237)
T smart00090      194 QSVELD  199 (237)
T ss_pred             hhhccC
Confidence            987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.54  E-value=1.6e-14  Score=112.53  Aligned_cols=88  Identities=28%  Similarity=0.411  Sum_probs=73.5

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |.+++|+++.....++......++||||++|++|.+++..    ...       .++.+++.+|.+||+.   +++|+|+
T Consensus        51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl  116 (199)
T TIGR03724        51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKA---GIVHGDL  116 (199)
T ss_pred             HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHC---CeecCCC
Confidence            4567777766655666677777899999999999998732    111       7899999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccc
Q 023808           83 KASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      +|.||+++ ++.+++.|||+++.
T Consensus       117 ~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       117 TTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CcceEEEE-CCcEEEEECCCCcC
Confidence            99999999 78999999998874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=2.8e-14  Score=113.94  Aligned_cols=93  Identities=27%  Similarity=0.283  Sum_probs=73.3

Q ss_pred             ccccccCCCc--cceeeEEEeCC----eeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNL--VELIGCCVQGT----RRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~ni--v~~~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      ++.+|+|++|  ++.++++..+.    ..++|||+++| .+|.+++..     ..++..    .+.+++.+|.+||+.  
T Consensus        93 ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~--  161 (239)
T PRK01723         93 LLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA--  161 (239)
T ss_pred             HHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC--
Confidence            3567788775  77777755432    23599999997 699998832     234443    357899999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  106 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  106 (277)
                       ||+|+||||.|||++.++.++|+|||.++..
T Consensus       162 -GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        162 -GVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             -CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence             9999999999999999889999999988753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.45  E-value=1.6e-13  Score=106.91  Aligned_cols=88  Identities=23%  Similarity=0.266  Sum_probs=69.3

Q ss_pred             cccccCC--CccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            3 LSNVRHP--NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         3 L~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +.++.|+  ++++.++.    ...++||||++|++|.++..    .      .....++.+++.++.++|+.   +++|+
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~lh~~---gi~H~  149 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKAYKH---GIIHG  149 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence            3445555  34444442    35589999999999987641    0      23567889999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFP  107 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~  107 (277)
                      ||+|+||++++++.++|+|||.+....
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=1.2e-12  Score=113.91  Aligned_cols=137  Identities=22%  Similarity=0.325  Sum_probs=105.1

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |+.||||||++++.....++..|+|+|-+.  -|..++.+       ++...+.--+.||+.||.|||+.+  +++|++|
T Consensus        63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv  131 (690)
T KOG1243|consen   63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNV  131 (690)
T ss_pred             hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccE
Confidence            677899999999999999999999999994  57878742       224455567889999999999765  9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg  153 (277)
                      .-+.|+++..|..||++|.++........ ......---.|..|+.+....  -..|.|.||++++|++.|
T Consensus       132 ~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  132 CKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            99999999999999999998864332211 111111222466666543322  346999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.38  E-value=1e-12  Score=97.46  Aligned_cols=92  Identities=26%  Similarity=0.320  Sum_probs=77.3

Q ss_pred             cccccC--CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            3 LSNVRH--PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         3 L~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +.+++|  .+++++++++...+..+++|||+.++.+..+           +......++.+++.+++++|.....+++|+
T Consensus        45 ~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~  113 (155)
T cd05120          45 LQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHG  113 (155)
T ss_pred             HHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEec
Confidence            445655  5899999999888889999999998776543           456677889999999999998633379999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      |++|+||++++.+.+++.|||.++.
T Consensus       114 Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         114 DLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCCcceEEEECCcEEEEEecccccC
Confidence            9999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=1.2e-12  Score=112.43  Aligned_cols=193  Identities=21%  Similarity=0.205  Sum_probs=137.3

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEeccC
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK----GLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~iiH~di   82 (277)
                      .|+|.++.+..+..++..|+-+|+|. .+|..+.+.   ....++...++....+...    ||.++|..   +++|-|+
T Consensus       176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~  248 (524)
T KOG0601|consen  176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDL  248 (524)
T ss_pred             ccccccccCcccccCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---ccccccc
Confidence            48999999999999999999999995 688888743   3444677777888888888    99999999   9999999


Q ss_pred             CCCcEEeCCC-CceEEeecccccccCCCCcc----eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           83 KASNILLDQE-FNPKIGDFGLAKLFPDNITH----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        83 kp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||.||+...+ ...+++|||+...+....-.    ......|...|++||.. .+-++..+|+|++|.++.+..++....
T Consensus       249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence            9999999998 78999999999877654311    12233677889999955 456788999999999999998886432


Q ss_pred             Ccc-cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAM-WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      -.. ...         |...+.   .. +..++   +..-...+...+..+++.+|..|++.+.+..
T Consensus       328 ~~g~~~~---------W~~~r~---~~-ip~e~---~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  328 SVGKNSS---------WSQLRQ---GY-IPLEF---CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCCCCCC---------cccccc---cc-Cchhh---hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            111 100         111111   01 11111   1111112333566689999999998876643

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.20  E-value=3.9e-11  Score=92.48  Aligned_cols=71  Identities=27%  Similarity=0.318  Sum_probs=58.7

Q ss_pred             eeEEEEeecCCCCH-----HHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEeCCCCceE
Q 023808           23 RRILVYEYVENNSL-----DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPK   96 (277)
Q Consensus        23 ~~~lv~e~~~~gsL-----~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~dikp~Nill~~~~~~k   96 (277)
                      ..++||||++++.+     .+..         .. ..+..++.+++.++.++|. .   +++|+||||+||+++ ++.++
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~---------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~  154 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVR---------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVY  154 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhh---------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEE
Confidence            45899999998543     3222         11 5677899999999999999 7   999999999999999 88999


Q ss_pred             EeecccccccC
Q 023808           97 IGDFGLAKLFP  107 (277)
Q Consensus        97 l~Dfg~~~~~~  107 (277)
                      ++|||.+....
T Consensus       155 liDfg~a~~~~  165 (187)
T cd05119         155 IIDVPQAVEID  165 (187)
T ss_pred             EEECccccccc
Confidence            99999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.19  E-value=1.8e-11  Score=111.33  Aligned_cols=192  Identities=22%  Similarity=0.208  Sum_probs=132.5

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI   87 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Ni   87 (277)
                      ||-++...-.+......+|+++|+.+++|...|+.-   + ..+..-....+..+..++++||..   .+.|+|++|.|.
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~---~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~  935 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS---G-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSL  935 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcC---C-CcccccccchhHHHHhhhhccccc---hhhcccccccch
Confidence            344444444444566788999999999999998532   1 344455556677888999999998   799999999999


Q ss_pred             EeCCCCceEEeecccccccCC------C------------------------CcceeeeecccccccCccccccCccccc
Q 023808           88 LLDQEFNPKIGDFGLAKLFPD------N------------------------ITHITTRIAGTTGYLAPEYVLGGQLTMK  137 (277)
Q Consensus        88 ll~~~~~~kl~Dfg~~~~~~~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~  137 (277)
                      +...++..+++|||+......      .                        .........||+.|.+||...+..-...
T Consensus       936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen  936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred             hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence            999999999999984332110      0                        0011234568999999999999998999


Q ss_pred             cceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      +|+|++|++++|.++|..||....+...      ..+....       +......+........+++...+..+|.+|-.
T Consensus      1016 ad~~~~g~~l~e~l~g~pp~na~tpq~~------f~ni~~~-------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQI------FENILNR-------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred             chhhhhhhhhhhhhcCCCCCCCcchhhh------hhccccC-------CCCCCCCccccChhhhhhhhhhhccCchhccC
Confidence            9999999999999999999876654221      0111111       11112222222333455555678888999876


Q ss_pred             HH
Q 023808          218 MN  219 (277)
Q Consensus       218 ~~  219 (277)
                      +.
T Consensus      1083 a~ 1084 (1205)
T KOG0606|consen 1083 AK 1084 (1205)
T ss_pred             cc
Confidence            65

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=6.1e-10  Score=92.65  Aligned_cols=201  Identities=14%  Similarity=0.099  Sum_probs=123.1

Q ss_pred             eEEEEeecCCC-CHHHHhcc--CCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           24 RILVYEYVENN-SLDRVLLG--ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        24 ~~lv~e~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      .-++|+.+.|. -+..++..  .+.+...+.|...++.+..++.+.+-||..   |.+-+|++++|+|+++++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence            55778888764 23333321  223333478999999999999999999999   9999999999999999999999885


Q ss_pred             ccccccCCCCcceeeeecccccccCccccccC-----ccccccceEehhHHHHHHHhC-CCCCCcccCcc-hhhHHH-HH
Q 023808          101 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISG-RNSGKAMWGQM-NKFLLE-WA  172 (277)
Q Consensus       101 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg-~~p~~~~~~~~-~~~~~~-~~  172 (277)
                      .......++  .......|...|++||...-.     .-+...|-|.||+++|++|.| +.|+....... .....+ .+
T Consensus       162 Dsfqi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         162 DSFQINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cceeeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            543332222  222334688899999965522     346789999999999999888 77775432211 111111 00


Q ss_pred             HHH---hccCCccccccCCCCCCCHHHHHHHHHHHHhhhhh--hhcCCCCHHHHHHHHhhcc
Q 023808          173 WQL---HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA--AASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       173 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~--~p~~RPs~~~v~~~L~~~~  229 (277)
                      -..   ..++.......+....-.......+..+..+|+..  ++.-||+++..+..|..+.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            000   00001101111111000011122355666678864  3668999988877665543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.12  E-value=2.9e-10  Score=87.15  Aligned_cols=86  Identities=19%  Similarity=0.198  Sum_probs=63.9

Q ss_pred             CCccceeeEEEeCCeeEEEEeecCCCCHHH-HhccCCCCCccCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccCCCCc
Q 023808            9 PNLVELIGCCVQGTRRILVYEYVENNSLDR-VLLGATKANIKLNWEKRSDICVGIAKGLAFL-HEELVPHIVHRDIKASN   86 (277)
Q Consensus         9 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~iiH~dikp~N   86 (277)
                      -++++.+++    ...++||||+.++.+.. .+     ....++......+..+++.+|..| |+.   +++|+|+++.|
T Consensus        88 v~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N  155 (197)
T cd05146          88 IPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN  155 (197)
T ss_pred             CCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            355666654    45679999997654421 22     112345556677889999999998 888   99999999999


Q ss_pred             EEeCCCCceEEeecccccccC
Q 023808           87 ILLDQEFNPKIGDFGLAKLFP  107 (277)
Q Consensus        87 ill~~~~~~kl~Dfg~~~~~~  107 (277)
                      |++++ +.+.|+|||.+....
T Consensus       156 IL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEEC-CcEEEEECCCceeCC
Confidence            99974 679999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=4.6e-11  Score=102.91  Aligned_cols=190  Identities=21%  Similarity=0.219  Sum_probs=130.4

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN   86 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~N   86 (277)
                      -|.|++.++..+......|+=-|||+++++....    .....+.+..++++..|++.++.++|+.   .++|+|++|+|
T Consensus       324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psn  396 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSN  396 (524)
T ss_pred             cccccCCCCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccc
Confidence            5888888887777777788999999999987766    3344577888999999999999999999   99999999999


Q ss_pred             EEeCCC-CceEEeecccccccCCCCcceeeeeccccccc--CccccccCccccccceEehhHHHHHHHhCCCCCCcccCc
Q 023808           87 ILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYL--APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  163 (277)
Q Consensus        87 ill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~  163 (277)
                      |++..+ +..+++|||....+.-    .........++.  ++.......+..+.|+||||.-+.+.+++..--....  
T Consensus       397 i~i~~~~~~~~~~~~~~~t~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--  470 (524)
T KOG0601|consen  397 ILISNDGFFSKLGDFGCWTRLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--  470 (524)
T ss_pred             eeeccchhhhhccccccccccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc--
Confidence            999876 7788999998863211    111122223333  5555556678899999999999999999864211100  


Q ss_pred             chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                                      ....+....... .+.....+..+...+...++..||.+.++....+
T Consensus       471 ----------------~~~~i~~~~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  471 ----------------QSLTIRSGDTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ----------------cceeeecccccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                            000111111100 1111133444444588899999999887755443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=1e-09  Score=81.72  Aligned_cols=75  Identities=32%  Similarity=0.436  Sum_probs=61.8

Q ss_pred             eEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCce
Q 023808           16 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP   95 (277)
Q Consensus        16 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~   95 (277)
                      =|..+.+...++|||.+|..|.+++...           ...++..+-.-+.-||..   +|+|+|+.++||.+...+ +
T Consensus        66 v~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i  130 (204)
T COG3642          66 VYDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-I  130 (204)
T ss_pred             EEEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-E
Confidence            3445666778999999999999998321           255677777888899999   999999999999998765 9


Q ss_pred             EEeecccccc
Q 023808           96 KIGDFGLAKL  105 (277)
Q Consensus        96 kl~Dfg~~~~  105 (277)
                      .+.|||++..
T Consensus       131 ~~IDfGLg~~  140 (204)
T COG3642         131 YFIDFGLGEF  140 (204)
T ss_pred             EEEECCcccc
Confidence            9999999874

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.01  E-value=6.5e-10  Score=96.46  Aligned_cols=77  Identities=19%  Similarity=0.315  Sum_probs=60.0

Q ss_pred             CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHH-HHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           22 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK-GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        22 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      ...++||||++|++|.++.....   ...   ...+++..++. .+..+|..   |++|+|++|.||+++.++.+++.||
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDf  301 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDF  301 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeC
Confidence            35689999999999988763211   112   23446666665 46788998   9999999999999999999999999


Q ss_pred             ccccccC
Q 023808          101 GLAKLFP  107 (277)
Q Consensus       101 g~~~~~~  107 (277)
                      |++..+.
T Consensus       302 G~~~~l~  308 (437)
T TIGR01982       302 GIVGRLS  308 (437)
T ss_pred             CCeeECC
Confidence            9998654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=2.9e-09  Score=86.14  Aligned_cols=89  Identities=15%  Similarity=0.129  Sum_probs=70.0

Q ss_pred             cceeeEEEe-----CCeeEEEEeecCCC-CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808           12 VELIGCCVQ-----GTRRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus        12 v~~~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      ++.++++..     ....++|||++++. +|.+++....  ....+...+..++.+++..+.-||+.   |++|+|++++
T Consensus        93 P~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~  167 (268)
T PRK15123         93 MTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYIC  167 (268)
T ss_pred             CCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChh
Confidence            455666653     23578999999886 8999984221  23455677788999999999999999   9999999999


Q ss_pred             cEEeCC-------CCceEEeecccccc
Q 023808           86 NILLDQ-------EFNPKIGDFGLAKL  105 (277)
Q Consensus        86 Nill~~-------~~~~kl~Dfg~~~~  105 (277)
                      |||++.       +..+.++||+.+..
T Consensus       168 NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        168 HFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             hEEEeccccCCCCCceEEEEECCcccc
Confidence            999975       45789999998863

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=1.3e-10  Score=101.74  Aligned_cols=154  Identities=23%  Similarity=0.333  Sum_probs=98.8

Q ss_pred             HHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc--------eeeeecccccccCccc
Q 023808           57 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGTTGYLAPEY  128 (277)
Q Consensus        57 ~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~gt~~y~aPE~  128 (277)
                      .=+.+++.|+.|+|...  ++||++|.|++|.++.++..||+.|+.+.........        ...-......|.|||+
T Consensus       103 ~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  103 ANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            33456779999999875  8999999999999999999999999987654332110        0111123456999999


Q ss_pred             cccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhh
Q 023808          129 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT  208 (277)
Q Consensus       129 ~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~  208 (277)
                      +.+...+.++|+||+|+++|-+..|..+.-...+..    ..+.......+......    ....+.   ++.+=+.+.+
T Consensus       181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~~~~~~~~~~~~----s~~~p~---el~~~l~k~l  249 (700)
T KOG2137|consen  181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFSRNLLNAGAFGY----SNNLPS---ELRESLKKLL  249 (700)
T ss_pred             hccccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhhhcccccccccc----cccCcH---HHHHHHHHHh
Confidence            999888999999999999999985554422211111    11111111111111111    111222   2444445579


Q ss_pred             hhhhcCCCCHHHHHH
Q 023808          209 QAAASRRPQMNQVIK  223 (277)
Q Consensus       209 ~~~p~~RPs~~~v~~  223 (277)
                      ..+..-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998776643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.99  E-value=6.7e-10  Score=84.14  Aligned_cols=86  Identities=22%  Similarity=0.135  Sum_probs=60.9

Q ss_pred             ccccCCC-ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEec
Q 023808            4 SNVRHPN-LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--VPHIVHR   80 (277)
Q Consensus         4 ~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~iiH~   80 (277)
                      ..+.+.+ +.+++.+..  ...++||||++|.++.+..         .   ....++.+++.+|+.||+..  ..+++|+
T Consensus        47 ~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~Hg  112 (170)
T cd05151          47 KLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHN  112 (170)
T ss_pred             HHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecC
Confidence            3343333 345555543  3457999999998875431         1   11235678999999999982  1235999


Q ss_pred             cCCCCcEEeCCCCceEEeeccccc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      |++|.||+++ ++.+++.||+.+.
T Consensus       113 D~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151         113 DLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCCcCcEEEE-CCeEEEEeccccc
Confidence            9999999999 6689999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=7.8e-09  Score=80.87  Aligned_cols=89  Identities=24%  Similarity=0.271  Sum_probs=72.1

Q ss_pred             ccceeeEEEeCC----eeEEEEeecCCC-CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808           11 LVELIGCCVQGT----RRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus        11 iv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      +++.+++.....    ..++|+|++++. +|.+++...    ...+......++.+++..++-||..   |++|+|+++.
T Consensus        75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~  147 (206)
T PF06293_consen   75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPS  147 (206)
T ss_pred             CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcc
Confidence            466677776533    458999999884 799998432    1255667788999999999999999   9999999999


Q ss_pred             cEEeCCCC---ceEEeeccccccc
Q 023808           86 NILLDQEF---NPKIGDFGLAKLF  106 (277)
Q Consensus        86 Nill~~~~---~~kl~Dfg~~~~~  106 (277)
                      |||++.++   .+.+.||+.++..
T Consensus       148 NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  148 NILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             cEEEeCCCCceeEEEEcchhceeC
Confidence            99998887   7999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.91  E-value=1e-08  Score=87.49  Aligned_cols=132  Identities=17%  Similarity=0.330  Sum_probs=102.8

Q ss_pred             cccccCCCccceeeEEE----eCCeeEEEEeecCC-CCHHHHhccC-----------CCCCccCCHHHHHHHHHHHHHHH
Q 023808            3 LSNVRHPNLVELIGCCV----QGTRRILVYEYVEN-NSLDRVLLGA-----------TKANIKLNWEKRSDICVGIAKGL   66 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~~l   66 (277)
                      .+++.|.|||++..+|.    .+...++|++|+++ ++|.++-...           ...+...++..+|.++.|+..||
T Consensus       327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL  406 (655)
T KOG3741|consen  327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL  406 (655)
T ss_pred             HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence            57889999999999887    44578999999986 5777664321           12234578899999999999999


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHH
Q 023808           67 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL  146 (277)
Q Consensus        67 ~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~v  146 (277)
                      .++|+.   |+.-+-+.+.+|+++++.+++|+..|.......+.             .+|  +.+   -.+-|.=.||.+
T Consensus       407 ~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------------~~~--le~---~Qq~D~~~lG~l  465 (655)
T KOG3741|consen  407 YSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------------TEP--LES---QQQNDLRDLGLL  465 (655)
T ss_pred             HHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCC-------------Ccc--hhH---HhhhhHHHHHHH
Confidence            999999   99999999999999999999999988776554432             011  111   235677789999


Q ss_pred             HHHHHhCCC
Q 023808          147 VLEIISGRN  155 (277)
Q Consensus       147 l~elltg~~  155 (277)
                      ++.|.||..
T Consensus       466 l~aLAt~~~  474 (655)
T KOG3741|consen  466 LLALATGTE  474 (655)
T ss_pred             HHHHhhccc
Confidence            999999954

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.83  E-value=1.9e-08  Score=74.92  Aligned_cols=84  Identities=23%  Similarity=0.414  Sum_probs=63.4

Q ss_pred             EEEeCCeeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCC--
Q 023808           17 CCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--   93 (277)
Q Consensus        17 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~--   93 (277)
                      ++.+.....++|||++| .++.+++......  .........++..|-..+.-||..   +++|+||..+||+|..++  
T Consensus        78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   78 IFIDTYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             EEEecCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCc
Confidence            45566667799999977 4788887543222  222233378899999999999999   999999999999996544  


Q ss_pred             -ceEEeecccccc
Q 023808           94 -NPKIGDFGLAKL  105 (277)
Q Consensus        94 -~~kl~Dfg~~~~  105 (277)
                       .+.+.|||++..
T Consensus       153 ~~~~lIdfgls~~  165 (229)
T KOG3087|consen  153 ITPILIDFGLSSV  165 (229)
T ss_pred             CceEEEeecchhc
Confidence             358999999863

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.76  E-value=3.1e-08  Score=75.96  Aligned_cols=99  Identities=21%  Similarity=0.290  Sum_probs=76.7

Q ss_pred             ccccccC-CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+.+++ +++++++|+|    ..++|+||...+++...-.. -..-...+|..+.+|+.+++..+.+++......+...
T Consensus        12 ll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc   86 (188)
T PF12260_consen   12 LLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC   86 (188)
T ss_pred             HHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            4555655 6999999999    44689999987765421000 0111246899999999999999999998655478899


Q ss_pred             cCCCCcEEeCCCCceEEeecccccc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      |++++|+-+++++.+|+.|.+.+-.
T Consensus        87 Dv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   87 DVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             ecchHHeEEeCCCcEEEEechhcch
Confidence            9999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.75  E-value=1.7e-08  Score=89.10  Aligned_cols=76  Identities=16%  Similarity=0.168  Sum_probs=53.2

Q ss_pred             CeeEEEEeecCCCCHHHHhccCCCCC---ccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCC----c
Q 023808           22 TRRILVYEYVENNSLDRVLLGATKAN---IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----N   94 (277)
Q Consensus        22 ~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~----~   94 (277)
                      ...++||||++|+.+.++-.- ...+   ..+....+..++.|+       ...   |++|+|++|.||+++.++    .
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~  302 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPR  302 (537)
T ss_pred             CCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCe
Confidence            356799999999999875310 1111   123333333344444       456   999999999999999887    8


Q ss_pred             eEEeecccccccCC
Q 023808           95 PKIGDFGLAKLFPD  108 (277)
Q Consensus        95 ~kl~Dfg~~~~~~~  108 (277)
                      +++.|||++..+..
T Consensus       303 i~llDFGivg~l~~  316 (537)
T PRK04750        303 YIALDFGIVGSLNK  316 (537)
T ss_pred             EEEEecceEEECCH
Confidence            99999999986643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=2.5e-08  Score=76.29  Aligned_cols=91  Identities=27%  Similarity=0.325  Sum_probs=56.9

Q ss_pred             cccccCC--CccceeeEEEeCCeeEEEEeecC--CCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHH-hhcCCCCCe
Q 023808            3 LSNVRHP--NLVELIGCCVQGTRRILVYEYVE--NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF-LHEELVPHI   77 (277)
Q Consensus         3 L~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~~~i   77 (277)
                      |.++..-  ++.+.+++.    ..++||||++  |..+..+...      .++......++.+++..+.. +|..   |+
T Consensus        62 L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---gi  128 (188)
T PF01163_consen   62 LKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GI  128 (188)
T ss_dssp             HHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TE
T ss_pred             HHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---Cc
Confidence            4455444  466666552    3469999998  6555444311      11133455677788885555 5788   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFP  107 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~  107 (277)
                      +|+|+.+.||+++++ .+.+.|||.+....
T Consensus       129 vHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  129 VHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             eecCCChhhEEeecc-eEEEEecCcceecC
Confidence            999999999999987 89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.67  E-value=7.7e-08  Score=76.05  Aligned_cols=92  Identities=27%  Similarity=0.357  Sum_probs=70.6

Q ss_pred             CCccceeeEEEeCC---eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC------------
Q 023808            9 PNLVELIGCCVQGT---RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL------------   73 (277)
Q Consensus         9 ~niv~~~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------   73 (277)
                      .++.+++.+.....   ..++||||++|.++.+.+.     ...++......++.+++.+|..||+..            
T Consensus        57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~  131 (223)
T cd05154          57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRP  131 (223)
T ss_pred             CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCC
Confidence            45677888876643   5689999999988877552     134677777888888888888888531            


Q ss_pred             -----------------------------------------CCCeEeccCCCCcEEeCC--CCceEEeecccccc
Q 023808           74 -----------------------------------------VPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKL  105 (277)
Q Consensus        74 -----------------------------------------~~~iiH~dikp~Nill~~--~~~~kl~Dfg~~~~  105 (277)
                                                               ...++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         132 GGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             CchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                                     236799999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=3.3e-07  Score=70.98  Aligned_cols=67  Identities=22%  Similarity=0.345  Sum_probs=52.9

Q ss_pred             eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeeccc
Q 023808           23 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  102 (277)
Q Consensus        23 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~  102 (277)
                      ..++||||++|..|.++.        .+++    .++..++.++..||+.   |++|+|.+|.|+++++++ +++.||+.
T Consensus       117 ~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~  180 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQG  180 (229)
T ss_pred             EEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcc
Confidence            456899999998876654        1222    2456677889999999   999999999999998654 89999987


Q ss_pred             ccc
Q 023808          103 AKL  105 (277)
Q Consensus       103 ~~~  105 (277)
                      .+.
T Consensus       181 k~~  183 (229)
T PF06176_consen  181 KRM  183 (229)
T ss_pred             ccc
Confidence            653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.39  E-value=3e-06  Score=65.45  Aligned_cols=78  Identities=17%  Similarity=0.097  Sum_probs=63.6

Q ss_pred             eeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCc--eEEee
Q 023808           23 RRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--PKIGD   99 (277)
Q Consensus        23 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~--~kl~D   99 (277)
                      ..+||+|-+.| -+|.+++....  -...+...+..++.+++..|.-||+.   |+.|+|+.+.||+++.++.  +.+.|
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEE
Confidence            46799997753 58999984321  22457777889999999999999999   9999999999999986666  89999


Q ss_pred             cccccc
Q 023808          100 FGLAKL  105 (277)
Q Consensus       100 fg~~~~  105 (277)
                      |.-++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            987663

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.30  E-value=1.4e-07  Score=82.56  Aligned_cols=143  Identities=23%  Similarity=0.211  Sum_probs=107.1

Q ss_pred             ccccccCCC-ccceeeEEEeCCeeEEEEeecCCC-CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPN-LVELIGCCVQGTRRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|.+.+||| .+..++-+..+++..++++++.++ +-....   ......+...+...+...-.++++++|+.   .=+|
T Consensus       286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~  359 (829)
T KOG0576|consen  286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVH  359 (829)
T ss_pred             HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccC
Confidence            477899999 788888888888999999999887 221111   11222334445556677778899999987   5588


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +|    ||+..+ +..+.+||+....+....  ......++..+++||+...+.+..+.|+|++|.--.++.-|-.|-
T Consensus       360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  360 RD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            88    777665 578999999887665432  345677999999999999999999999999998777777666553

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.05  E-value=2.1e-05  Score=73.82  Aligned_cols=189  Identities=21%  Similarity=0.232  Sum_probs=126.5

Q ss_pred             cccccCCCccceeeEEEeCCee----EEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            3 LSNVRHPNLVELIGCCVQGTRR----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      |.++.|+|++.+++|..++...    .+..++|..-++...+    ..-..++......+..++..||+|+|+.   ...
T Consensus       236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~---~l~  308 (1351)
T KOG1035|consen  236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSL---SLE  308 (1351)
T ss_pred             HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHh---ccc
Confidence            5678999999999999866533    2456788887887777    4455678889999999999999999998   555


Q ss_pred             eccCCCC---cEEeCCCCceEEe--ecccccccCCCCcceeeeecccccccCccccccCcc--ccccceEehhHHHHHHH
Q 023808           79 HRDIKAS---NILLDQEFNPKIG--DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEII  151 (277)
Q Consensus        79 H~dikp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~slG~vl~ell  151 (277)
                      |.-+..+   +...+..+.+.++  ||+.++.........  ....+..+.++|.......  ....|+|.+|..+..+.
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            5555544   4444566666666  888887665433221  1223445677776665544  44579999999999998


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      .|..+......                  +...++    .....   ...+....|+..++++|++..+++...
T Consensus       387 ~~~~i~~~~~~------------------~~~~l~----~~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  387 QGEDISEKSAV------------------PVSLLD----VLSTS---ELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hcCcccccccc------------------hhhhhc----cccch---hhhhhhhhhcchhhhhccchhhhhhch
Confidence            87653221100                  000111    00111   244556679999999999999886643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.02  E-value=1.1e-05  Score=64.17  Aligned_cols=73  Identities=27%  Similarity=0.316  Sum_probs=51.4

Q ss_pred             CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecc
Q 023808           22 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  101 (277)
Q Consensus        22 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg  101 (277)
                      +...+|||+++|--|...-         +.....-.++..|+.-+..+-..   |+||+|+++-||+++++|.+.+.||-
T Consensus       180 nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwP  247 (304)
T COG0478         180 NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWP  247 (304)
T ss_pred             ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCc
Confidence            4678999999986665442         11222223344444444444455   99999999999999999999999998


Q ss_pred             ccccc
Q 023808          102 LAKLF  106 (277)
Q Consensus       102 ~~~~~  106 (277)
                      .+...
T Consensus       248 Q~v~~  252 (304)
T COG0478         248 QAVPI  252 (304)
T ss_pred             ccccC
Confidence            77643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.93  E-value=0.00012  Score=58.06  Aligned_cols=29  Identities=17%  Similarity=0.161  Sum_probs=25.8

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.++|+|+.|.||++++++ +.+.||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            3678999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.79  E-value=0.00016  Score=58.15  Aligned_cols=30  Identities=23%  Similarity=0.206  Sum_probs=26.7

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.++|+|+.|.||+++++..+.|.||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            469999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.63  E-value=0.00071  Score=52.30  Aligned_cols=88  Identities=20%  Similarity=0.243  Sum_probs=62.4

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCC------CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENN------SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~g------sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      ...+.+|.+++|+...+...-+|+|.+.+.      +|.+++.     ...++. ..   ...+-.-..||-+.   +|+
T Consensus        73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~---~~~L~~f~~~l~~~---~Iv  140 (199)
T PF10707_consen   73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-EL---RQALDEFKRYLLDH---HIV  140 (199)
T ss_pred             CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HH---HHHHHHHHHHHHHc---CCe
Confidence            345889999999999999889999988652      6888882     223544 33   33334445677777   899


Q ss_pred             eccCCCCcEEeCCCC----ceEEee-ccccc
Q 023808           79 HRDIKASNILLDQEF----NPKIGD-FGLAK  104 (277)
Q Consensus        79 H~dikp~Nill~~~~----~~kl~D-fg~~~  104 (277)
                      .+|++|+||++..+.    .+.|.| ||...
T Consensus       141 ~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  141 IRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            999999999994332    467777 45443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.55  E-value=0.00023  Score=56.22  Aligned_cols=78  Identities=23%  Similarity=0.349  Sum_probs=56.1

Q ss_pred             eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeeccc
Q 023808           23 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  102 (277)
Q Consensus        23 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~  102 (277)
                      ...|||||+....+   - .-.-+...+...+...+..+++..+.-|-..+  ++||+||+.-|||+. ++.+.++|||.
T Consensus       140 ~nVLvMEfIg~~g~---p-AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~Q  212 (268)
T COG1718         140 NNVLVMEFIGDDGL---P-APRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQ  212 (268)
T ss_pred             CCeEEEEeccCCCC---C-CCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECcc
Confidence            34689999965311   0 00111222333467778889999999888732  999999999999999 78899999998


Q ss_pred             ccccC
Q 023808          103 AKLFP  107 (277)
Q Consensus       103 ~~~~~  107 (277)
                      +....
T Consensus       213 aV~~~  217 (268)
T COG1718         213 AVTID  217 (268)
T ss_pred             ccccC
Confidence            87554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.53  E-value=0.0002  Score=63.33  Aligned_cols=79  Identities=20%  Similarity=0.315  Sum_probs=54.8

Q ss_pred             CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecc
Q 023808           22 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  101 (277)
Q Consensus        22 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg  101 (277)
                      ....|+|||++|-.+.++..-.   ...++.+.+...+.++.  +..+-..   |+.|.|..|.||+++.++.+.+.|||
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfG  310 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFG  310 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhc---CccccCCCccceEEecCCcEEEEcCc
Confidence            4567999999998888874211   12344333333332222  2333334   89999999999999999999999999


Q ss_pred             cccccCC
Q 023808          102 LAKLFPD  108 (277)
Q Consensus       102 ~~~~~~~  108 (277)
                      ....+..
T Consensus       311 i~g~l~~  317 (517)
T COG0661         311 IVGRLDP  317 (517)
T ss_pred             ceecCCH
Confidence            9986654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.49  E-value=0.00022  Score=62.99  Aligned_cols=88  Identities=17%  Similarity=0.172  Sum_probs=56.7

Q ss_pred             ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeC
Q 023808           11 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD   90 (277)
Q Consensus        11 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~   90 (277)
                      |.++|-.+.  ....|+|||++|.-+.+.-.   -....++...+..-+.++..  +.+=..   |++|+|=.|.||++.
T Consensus       266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~---i~~~gi~~~~i~~~l~~~~~--~qIf~~---GffHaDPHPGNilv~  335 (538)
T KOG1235|consen  266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDA---IDKRGISPHDILNKLVEAYL--EQIFKT---GFFHADPHPGNILVR  335 (538)
T ss_pred             CCeehhhcC--cceEEEEEecCCccCCCHHH---HHHcCCCHHHHHHHHHHHHH--HHHHhc---CCccCCCCCCcEEEe
Confidence            445543333  35679999999987655531   12223555554444444322  222233   899999999999998


Q ss_pred             C----CCceEEeecccccccCC
Q 023808           91 Q----EFNPKIGDFGLAKLFPD  108 (277)
Q Consensus        91 ~----~~~~kl~Dfg~~~~~~~  108 (277)
                      .    ++.+.+.|||+...+..
T Consensus       336 ~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  336 PNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCCCCccEEEEcccccccccH
Confidence            3    56799999999886544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.31  E-value=2.7e-05  Score=75.09  Aligned_cols=152  Identities=13%  Similarity=0.008  Sum_probs=107.8

Q ss_pred             cccCCCccceeeEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC--CCeEec
Q 023808            5 NVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV--PHIVHR   80 (277)
Q Consensus         5 ~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--~~iiH~   80 (277)
                      ...|+++...+.--.  .....+.+++|+.+|.+.+.+-++......+...-+...-.+.+.+..-+|+...  --.+|+
T Consensus      1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred             hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence            356777766655443  2335578999999999999996654444444333333333343566666554331  136899


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ++|+-|.++..+.++|++++|+.+... +.........+++-|+.|+..+.-+++.++|+|..|+-+|+..-|..++
T Consensus      1365 ~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            999999999999999999999998432 2333344556778899999888888898899999999999998776553

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.29  E-value=7.9e-05  Score=64.57  Aligned_cols=40  Identities=28%  Similarity=0.346  Sum_probs=31.7

Q ss_pred             ccccccCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhcc
Q 023808            2 TLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLG   42 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~   42 (277)
                      +|+.+.|+|...++.+-... ....+|||+++ -||++++..
T Consensus        35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~   75 (725)
T KOG1093|consen   35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT   75 (725)
T ss_pred             HHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence            46788999999999887643 35678999994 599999843

>PLN02876 acyl-CoA dehydrogenase

Probab=97.26  E-value=0.0012  Score=62.39  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=24.1

Q ss_pred             CeEeccCCCCcEEeCCC-Cc-eEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQE-FN-PKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~-~~-~kl~Dfg~~~~  105 (277)
                      .++|+|+++.||+++.+ .. +-|.||.++..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            59999999999999753 33 56889988763

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.21  E-value=0.00091  Score=53.44  Aligned_cols=30  Identities=27%  Similarity=0.412  Sum_probs=25.7

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.++|+|+.+.||+++++...-|.||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            368999999999999877656799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.02  E-value=0.0025  Score=53.36  Aligned_cols=73  Identities=22%  Similarity=0.251  Sum_probs=59.3

Q ss_pred             CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           21 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        21 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      ..+.|++|++. |++|.-.=        .-.+.+++.++.+.+.-+.-+....  ..-|||+.-.|||++ +|++.|+||
T Consensus       298 ~~y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         298 TLYLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             ceEEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence            34667888877 55664321        2357889999999999898888765  789999999999999 999999999


Q ss_pred             ccccc
Q 023808          101 GLAKL  105 (277)
Q Consensus       101 g~~~~  105 (277)
                      -++|.
T Consensus       366 klsRl  370 (488)
T COG5072         366 KLSRL  370 (488)
T ss_pred             eeeec
Confidence            99994

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.82  E-value=0.0051  Score=48.69  Aligned_cols=30  Identities=37%  Similarity=0.507  Sum_probs=21.0

Q ss_pred             CCeEeccCCCCcEEeC-CCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLD-QEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~  104 (277)
                      ..++|+|+.|.||+++ +++.+-|.||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3799999999999999 55666799998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK10593 hypothetical protein; Provisional

Probab=96.69  E-value=0.01  Score=49.26  Aligned_cols=28  Identities=14%  Similarity=0.233  Sum_probs=21.9

Q ss_pred             CCccceeeEEEeC---CeeEEEEeecCCCCH
Q 023808            9 PNLVELIGCCVQG---TRRILVYEYVENNSL   36 (277)
Q Consensus         9 ~niv~~~~~~~~~---~~~~lv~e~~~~gsL   36 (277)
                      -.+++++++|..+   +..++|||+++|+++
T Consensus        70 vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         70 VRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            4678888888643   568999999998765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.69  E-value=0.0045  Score=51.38  Aligned_cols=31  Identities=32%  Similarity=0.557  Sum_probs=28.0

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      +.++|+|+.+.|++++.+.-+=+.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4799999999999999988888999998874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.74  E-value=0.008  Score=49.72  Aligned_cols=72  Identities=18%  Similarity=0.182  Sum_probs=51.9

Q ss_pred             CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           21 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        21 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      .+..++|||++.|-.|.+.-+       ......   +...+..-|--|-.+   |+||+|.+-=||++++++.++++||
T Consensus       180 ~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDF  246 (465)
T KOG2268|consen  180 HNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDF  246 (465)
T ss_pred             ccceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeec
Confidence            346789999999988766531       111222   333344445566677   9999999999999999999999999


Q ss_pred             ccccc
Q 023808          101 GLAKL  105 (277)
Q Consensus       101 g~~~~  105 (277)
                      -....
T Consensus       247 PQmvS  251 (465)
T KOG2268|consen  247 PQMVS  251 (465)
T ss_pred             hHhhc
Confidence            76543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.59  E-value=0.022  Score=47.50  Aligned_cols=31  Identities=26%  Similarity=0.356  Sum_probs=27.4

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.+++|+|+++.||++++++.+.+.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3589999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.54  E-value=0.038  Score=45.87  Aligned_cols=31  Identities=29%  Similarity=0.306  Sum_probs=27.3

Q ss_pred             CCCeEeccCCCCcEEeCCC----CceEEeeccccc
Q 023808           74 VPHIVHRDIKASNILLDQE----FNPKIGDFGLAK  104 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~----~~~kl~Dfg~~~  104 (277)
                      ...++|+|+.+.||+++++    +.+.+.||..+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3478999999999999875    789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=95.51  E-value=0.031  Score=46.83  Aligned_cols=31  Identities=23%  Similarity=0.300  Sum_probs=26.7

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.+++|+|+.|.||+++++...-+.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999976656899999876

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.38  E-value=0.031  Score=44.49  Aligned_cols=30  Identities=23%  Similarity=0.349  Sum_probs=26.5

Q ss_pred             CCeEeccCCCCcEEeCC-CCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQ-EFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~  104 (277)
                      ..++|+|+.+.||++++ ++.+.+.||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            37999999999999998 5779999999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.14  E-value=0.05  Score=45.32  Aligned_cols=29  Identities=28%  Similarity=0.340  Sum_probs=25.5

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      .+++|+|+.+.||+++. +.+.+.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 568899999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.13  E-value=0.058  Score=45.30  Aligned_cols=28  Identities=32%  Similarity=0.561  Sum_probs=25.5

Q ss_pred             eEeccCCCCcEEeCCCCc-eEEeeccccc
Q 023808           77 IVHRDIKASNILLDQEFN-PKIGDFGLAK  104 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~-~kl~Dfg~~~  104 (277)
                      +||+|+.|.||+++.+.. +-+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998885 8899999776

>PHA03111 Ser/Thr kinase; Provisional

Probab=95.09  E-value=0.025  Score=46.91  Aligned_cols=38  Identities=26%  Similarity=0.203  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEeCCC
Q 023808           55 RSDICVGIAKGLAFLHEE-LVPHIVHRDIKASNILLDQE   92 (277)
Q Consensus        55 ~~~i~~qi~~~l~~LH~~-~~~~iiH~dikp~Nill~~~   92 (277)
                      +.-+..|++--.-.+-.. +..+.+|.||||.|||+-++
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            344677776554334232 23479999999999999443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.98  E-value=0.028  Score=44.03  Aligned_cols=39  Identities=31%  Similarity=0.242  Sum_probs=32.6

Q ss_pred             HHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeeccc
Q 023808           63 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  102 (277)
Q Consensus        63 ~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~  102 (277)
                      +.+|.-.|+.. .+.+|+|..|+||+-|..|.+||.|-+.
T Consensus       151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence            35677788542 3899999999999999999999999664

The function of this family is unknown.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.89  E-value=0.04  Score=45.58  Aligned_cols=30  Identities=27%  Similarity=0.368  Sum_probs=26.7

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      .+++|+|+.|.||++++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999988777899999775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.71  E-value=0.027  Score=43.02  Aligned_cols=29  Identities=21%  Similarity=0.223  Sum_probs=25.4

Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ..+|+|+.|.|+++.+++ ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            468999999999998777 88999998863

>TIGR02721 ycfN_thiK thiamine kinase

Probab=94.44  E-value=0.033  Score=45.07  Aligned_cols=28  Identities=25%  Similarity=0.326  Sum_probs=25.3

Q ss_pred             CeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      .++|+|+.|.||++++++ +.+.||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            689999999999999876 7899999876

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.41  E-value=0.05  Score=45.39  Aligned_cols=48  Identities=27%  Similarity=0.398  Sum_probs=30.4

Q ss_pred             HHHHHHHHHHHHH--hhcC-CCCCeEeccCCCCcEEeCCCC------------------ceEEeecccccc
Q 023808           56 SDICVGIAKGLAF--LHEE-LVPHIVHRDIKASNILLDQEF------------------NPKIGDFGLAKL  105 (277)
Q Consensus        56 ~~i~~qi~~~l~~--LH~~-~~~~iiH~dikp~Nill~~~~------------------~~kl~Dfg~~~~  105 (277)
                      .-+..|+|  |-|  +-.. +..+.+|.||||.|||+-++.                  .++|.||.+++.
T Consensus       278 kfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  278 KFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             HHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence            34566664  344  3232 233799999999999994332                  246677777764

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.37  E-value=0.077  Score=44.26  Aligned_cols=32  Identities=22%  Similarity=0.262  Sum_probs=28.4

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ..+++|+|+.++|+++++++.+.+.||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34799999999999999998999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.27  E-value=0.064  Score=42.00  Aligned_cols=29  Identities=31%  Similarity=0.494  Sum_probs=21.0

Q ss_pred             CeEeccCCCCcEEe-CCCCceEEeeccccc
Q 023808           76 HIVHRDIKASNILL-DQEFNPKIGDFGLAK  104 (277)
Q Consensus        76 ~iiH~dikp~Nill-~~~~~~kl~Dfg~~~  104 (277)
                      .+.|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            67899999999999 888899999999886

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.26  E-value=0.11  Score=42.50  Aligned_cols=47  Identities=19%  Similarity=0.185  Sum_probs=33.9

Q ss_pred             HHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           58 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        58 i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      .+..+-.++.-.+... .-++|+|+.|.|++.++.+.++|.||..|..
T Consensus       137 ~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3334444444444320 1589999999999999999999999998863

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.10  E-value=0.094  Score=43.19  Aligned_cols=27  Identities=26%  Similarity=0.404  Sum_probs=18.8

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeec
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDF  100 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Df  100 (277)
                      .|.++|+||-+.|++.+.++.+.|.|=
T Consensus       187 ~PsLlHGDLW~GN~~~~~~g~p~l~DP  213 (288)
T PF03881_consen  187 KPSLLHGDLWSGNVGFDADGEPVLFDP  213 (288)
T ss_dssp             --EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred             CceeeEcCccccceeecCCCCceeecc
Confidence            568999999999999999988888873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=93.90  E-value=0.15  Score=43.29  Aligned_cols=76  Identities=17%  Similarity=0.198  Sum_probs=58.2

Q ss_pred             eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccc
Q 023808           24 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  103 (277)
Q Consensus        24 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~  103 (277)
                      ..|||+|+.....-.=    ..+...++...+..+-.|++.-+.-|.+.|  ++||.||.==|+|+.+ |.+.++|.+.+
T Consensus       239 hVLVM~FlGrdgw~aP----kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~lyiIDVSQS  311 (520)
T KOG2270|consen  239 HVLVMEFLGRDGWAAP----KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKLYIIDVSQS  311 (520)
T ss_pred             ceEeeeeccCCCCcCc----ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEEEEEEcccc
Confidence            4689999964322111    123445777788889999999999999886  9999999999999874 57899998877


Q ss_pred             ccc
Q 023808          104 KLF  106 (277)
Q Consensus       104 ~~~  106 (277)
                      ...
T Consensus       312 VE~  314 (520)
T KOG2270|consen  312 VEH  314 (520)
T ss_pred             ccC
Confidence            644

>PLN02236 choline kinase

Probab=93.31  E-value=0.16  Score=43.05  Aligned_cols=30  Identities=27%  Similarity=0.421  Sum_probs=26.2

Q ss_pred             CeEeccCCCCcEEeCC-CCceEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQ-EFNPKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~  105 (277)
                      .++|+|+++.||++++ ++.+.+.||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999976 46799999998863

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.99  E-value=0.084  Score=43.29  Aligned_cols=31  Identities=29%  Similarity=0.499  Sum_probs=25.5

Q ss_pred             CCeEeccCCCCcEEeCCCCc-eEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQEFN-PKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~-~kl~Dfg~~~~  105 (277)
                      +.++|+|+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            36899999999999997555 56999998763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK06148 hypothetical protein; Provisional

Probab=92.86  E-value=0.24  Score=48.28  Aligned_cols=31  Identities=32%  Similarity=0.454  Sum_probs=26.1

Q ss_pred             CCCeEeccCCCCcEEeCCCC--ceE-Eeeccccc
Q 023808           74 VPHIVHRDIKASNILLDQEF--NPK-IGDFGLAK  104 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~--~~k-l~Dfg~~~  104 (277)
                      +.++||+|+++.||+++.++  .+. |.|||-+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            34899999999999998775  555 99999876

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.85  E-value=0.1  Score=40.35  Aligned_cols=30  Identities=27%  Similarity=0.392  Sum_probs=25.2

Q ss_pred             CeEeccCCCCcEEeCCCC-----ceEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQEF-----NPKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~-----~~kl~Dfg~~~~  105 (277)
                      .++|||+.+.||++..++     .+.+.||..++.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            789999999999997543     588999998763

subfamily of choline kinases

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=92.44  E-value=0.6  Score=36.22  Aligned_cols=76  Identities=26%  Similarity=0.356  Sum_probs=50.8

Q ss_pred             cccccCCCc--cceeeEEEeC------------------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHH
Q 023808            3 LSNVRHPNL--VELIGCCVQG------------------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI   62 (277)
Q Consensus         3 L~~l~h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi   62 (277)
                      |+.+.+.++  |+.+||..=.                  ....||.||.....             .+    ..+-+.++
T Consensus       111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~  173 (207)
T PF13095_consen  111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQM  173 (207)
T ss_pred             HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHH
Confidence            445566677  8888887421                  12246677665432             12    22335667


Q ss_pred             HHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccc
Q 023808           63 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  103 (277)
Q Consensus        63 ~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~  103 (277)
                      .+-|..+|..   ||+-+|+++.|..     .=+|+|||.+
T Consensus       174 ~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            7778899999   9999999999986     2388999854

>PRK11768 serine/threonine protein kinase; Provisional

Probab=92.41  E-value=0.28  Score=41.26  Aligned_cols=29  Identities=28%  Similarity=0.355  Sum_probs=24.5

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      ..+++|+|+.+.||+++ + .+.+.||+.+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            34789999999999995 3 57899999876

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=91.80  E-value=0.26  Score=38.98  Aligned_cols=31  Identities=23%  Similarity=0.351  Sum_probs=26.6

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCCCCHH
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVENNSLD   37 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~   37 (277)
                      +--+|.+++.+..+.++.|+|+||++.|.+.
T Consensus        69 ~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          69 NTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            4457889999999999999999999987654

>PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria

Probab=91.70  E-value=0.48  Score=40.15  Aligned_cols=86  Identities=17%  Similarity=0.268  Sum_probs=46.3

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA   84 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp   84 (277)
                      ..||++++. ..-.+++...+.++.-+. -++..+        +.++...+++++.+|..--.+++.     -+|--+.|
T Consensus        20 ~~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~i--------~~~~~~eklr~~~ni~~l~~~~~~-----~~~f~l~P   85 (359)
T PF10140_consen   20 EHDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEEI--------KKLDKSEKLRLLINIAALKEHLNS-----RYTFILHP   85 (359)
T ss_dssp             S--TTB--E-EEEE-SSEEEEEE---TTSEEGGGG--------GGS-HHHHHHHHHHGGGGGGGGGS-----SEE---SG
T ss_pred             ccCcccCCc-eEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhcC-----ceeEEEec
Confidence            468999885 455566665555544432 233322        247788999999995433333443     48999999


Q ss_pred             CcEEeCCCCceEEeecccccc
Q 023808           85 SNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      +|++++.++.+++.-.|+-..
T Consensus        86 ~Nl~fd~~~~p~i~hrGi~~~  106 (359)
T PF10140_consen   86 ENLVFDKNLMPKILHRGIKEI  106 (359)
T ss_dssp             GGEEE-TTS-EEES--EETTT
T ss_pred             hheEEcCCCCEEEEEcCCcCC
Confidence            999999999999998886554

This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=90.72  E-value=0.22  Score=41.99  Aligned_cols=29  Identities=24%  Similarity=0.374  Sum_probs=25.3

Q ss_pred             CeEeccCCCCcEEeCC-CCceEEeeccccc
Q 023808           76 HIVHRDIKASNILLDQ-EFNPKIGDFGLAK  104 (277)
Q Consensus        76 ~iiH~dikp~Nill~~-~~~~kl~Dfg~~~  104 (277)
                      -+.|+|+.+.||++++ ++.+++.||..+.
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            4789999999999975 5689999999886

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=90.35  E-value=0.39  Score=36.39  Aligned_cols=74  Identities=19%  Similarity=0.312  Sum_probs=46.8

Q ss_pred             ceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC--CcEEeC
Q 023808           13 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA--SNILLD   90 (277)
Q Consensus        13 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp--~Nill~   90 (277)
                      ++|.|..+    ++.|||+.|-.|.++-...       .-+.+    ..++..---|-..   ||-|+.|.-  .||++.
T Consensus        80 ~vy~yg~~----~i~me~i~G~~L~~~~~~~-------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~  141 (201)
T COG2112          80 EVYFYGED----FIRMEYIDGRPLGKLEIGG-------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVN  141 (201)
T ss_pred             eEEEechh----hhhhhhhcCcchhhhhhcc-------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEec
Confidence            45555433    3569999998888776221       12233    3334443344455   899999874  466665


Q ss_pred             CCCceEEeecccccc
Q 023808           91 QEFNPKIGDFGLAKL  105 (277)
Q Consensus        91 ~~~~~kl~Dfg~~~~  105 (277)
                      .+ .+.|.||.-|+.
T Consensus       142 ~~-~~~iIDFd~At~  155 (201)
T COG2112         142 DR-DVYIIDFDSATF  155 (201)
T ss_pred             CC-cEEEEEccchhh
Confidence            54 899999998874

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	277
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-45
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-44
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-29
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  179 bits (454), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 92/226 (40%), Positives = 142/226 (62%), Gaps = 3/226 (1%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S   H NL+ L G C+  T R+LVY Y+ N S+   L    ++   L+W KR  I +G 
Sbjct: 89  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 148
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+GLA+LH+   P I+HRD+KA+NILLD+EF   +GDFGLAKL      H+   + GT G
Sbjct: 149 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK--AMWGQMNKFLLEWAWQLHQEEK 180
           ++APEY+  G+ + K DV+ +GV++LE+I+G+ +     +    +  LL+W   L +E+K
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 268
Query: 181 PLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
              LVD +L G Y   E+ + ++VA  CTQ++   RP+M++V++ML
Sbjct: 269 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  177 bits (449), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 91/229 (39%), Positives = 142/229 (62%), Gaps = 3/229 (1%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S   H NL+ L G C+  T R+LVY Y+ N S+   L    ++   L+W KR  I +G 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+GLA+LH+   P I+HRD+KA+NILLD+EF   +GDFGLAKL      H+   + G  G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK--AMWGQMNKFLLEWAWQLHQEEK 180
           ++APEY+  G+ + K DV+ +GV++LE+I+G+ +     +    +  LL+W   L +E+K
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 181 PLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
              LVD +L G Y   E+ + ++VA  CTQ++   RP+M++V++ML  +
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  174 bits (441), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 92/233 (39%), Positives = 140/233 (60%), Gaps = 5/233 (2%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS  RHP+LV LIG C +    IL+Y+Y+EN +L R L G+    + ++WE+R +IC+G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+GL +LH      I+HRD+K+ NILLD+ F PKI DFG++K   + + TH+   + GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTL 205
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GY+ PEY + G+LT K+DVYSFGV++ E++  R++      +    L EWA + H   + 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 182 LELVDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
            ++VDP L +   P  + ++   A  C   ++  RP M  V+  L   +RL E
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  173 bits (438), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 92/233 (39%), Positives = 139/233 (59%), Gaps = 5/233 (2%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS  RHP+LV LIG C +    IL+Y+Y+EN +L R L G+    + ++WE+R +IC+G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+GL +LH      I+HRD+K+ NILLD+ F PKI DFG++K   +   TH+   + GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTL 205
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
           GY+ PEY + G+LT K+DVYSFGV++ E++  R++      +    L EWA + H   + 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 182 LELVDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
            ++VDP L +   P  + ++   A  C   ++  RP M  V+  L   +RL E
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/227 (36%), Positives = 122/227 (53%), Gaps = 13/227 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           ++  +H NLVEL+G    G    LVY Y+ N SL DR  L        L+W  R  I  G
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSWHMRCKIAQG 141
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIA 118
            A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F   +  + +RI 
Sbjct: 142 AANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--MXSRIV 196
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
           GTT Y+APE  L G++T K+D+YSFGV++LEII+G  +      +    L        +E
Sbjct: 197 GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEEIEDEE 254
Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +   + +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  127 bits (318), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 83/227 (36%), Positives = 121/227 (53%), Gaps = 13/227 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           ++  +H NLVEL+G    G    LVY Y+ N SL DR  L        L+W  R  I  G
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSWHMRCKIAQG 141
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIA 118
            A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F   +  +  RI 
Sbjct: 142 AANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--MXXRIV 196
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
           GTT Y+APE  L G++T K+D+YSFGV++LEII+G  +      +    L        +E
Sbjct: 197 GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEEIEDEE 254
Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +   + +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/227 (36%), Positives = 121/227 (53%), Gaps = 13/227 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           ++  +H NLVEL+G    G    LVY Y+ N SL DR  L        L+W  R  I  G
Sbjct: 78  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSWHMRCKIAQG 135
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIA 118
            A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F   +  +  RI 
Sbjct: 136 AANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV--MXXRIV 190
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
           GTT Y+APE  L G++T K+D+YSFGV++LEII+G  +      +    L        +E
Sbjct: 191 GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEEIEDEE 248
Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +   + +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 249 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/224 (36%), Positives = 116/224 (51%), Gaps = 9/224 (4%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGI 62
           +  +H NLVEL+G    G    LVY Y  N SL DR  L        L+W  R  I  G 
Sbjct: 76  AKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLSWHXRCKIAQGA 133
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTT 121
           A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+        +  +RI GTT
Sbjct: 134 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            Y APE  L G++T K+D+YSFGV++LEII+G  +      +    L        +E+  
Sbjct: 191 AYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEEIEDEEKTI 248
Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            + +D +  +     +     VA  C     ++RP + +V ++L
Sbjct: 249 EDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 92/163 (56%), Gaps = 7/163 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RHPN+V  +G   Q     +V EY+   SL R LL  + A  +L+  +R  +   +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDV 146
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           AKG+ +LH    P IVHRD+K+ N+L+D+++  K+ DFGL++L        +   AGT  
Sbjct: 147 AKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPE 204
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
           ++APE +       K+DVYSFGV++ E+ + +      WG +N
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGNLN 243

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 92/159 (57%), Gaps = 22/159 (13%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA-TKANIKLNWEKRSDICVGIAK 64
           ++HPN++ L G C++     LV E+     L+RVL G     +I +NW       V IA+
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIAR 116
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--------KIGDFGLAKLFPDNITHITTR 116
           G+ +LH+E +  I+HRD+K+SNIL+ Q+           KI DFGLA+ +     H TT+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTK 171
Query: 117 I--AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           +  AG   ++APE +     +  +DV+S+GVL+ E+++G
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 96/164 (58%), Gaps = 9/164 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RHPN+V  +G   Q     +V EY+   SL R LL  + A  +L+  +R  +   +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDV 146
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTT 121
           AKG+ +LH    P IVHR++K+ N+L+D+++  K+ DFGL++L     T ++++  AGT 
Sbjct: 147 AKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
            ++APE +       K+DVYSFGV++ E+ + +      WG +N
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGNLN 243

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 113/234 (48%), Gaps = 31/234 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT-----KANIKLNWEKRSD 57
           LS V HPN+V+L G C+      LV EY E  SL  VL GA       A   ++W     
Sbjct: 56  LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW----- 108
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTR 116
            C+  ++G+A+LH      ++HRD+K  N+LL       KI DFG A    D  TH+T  
Sbjct: 109 -CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN 164
Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH 176
             G+  ++APE   G   + K DV+S+G+++ E+I+ R     + G   + +    W +H
Sbjct: 165 -KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVH 219
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
              +      P L +  P  I   M     C     S+RP M +++K++T  +R
Sbjct: 220 NGTR------PPLIKNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 113/234 (48%), Gaps = 31/234 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT-----KANIKLNWEKRSD 57
           LS V HPN+V+L G C+      LV EY E  SL  VL GA       A   ++W     
Sbjct: 55  LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW----- 107
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTR 116
            C+  ++G+A+LH      ++HRD+K  N+LL       KI DFG A    D  TH+T  
Sbjct: 108 -CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN 163
Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH 176
             G+  ++APE   G   + K DV+S+G+++ E+I+ R     + G   + +    W +H
Sbjct: 164 -KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVH 218
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
              +      P L +  P  I   M     C     S+RP M +++K++T  +R
Sbjct: 219 NGTR------PPLIKNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 68  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 125 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 181
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 70  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 126
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 127 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 183
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 71  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 127
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 128 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 184
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 72  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 128
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 129 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 185
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 68  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 125 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 181
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 64  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 121 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 63  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 119
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 120 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 176
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 67  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 124 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 57  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 114 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 170
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  D              
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK 175
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 58  MKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HR+++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 115 AEGMAFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 172 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +    HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GI
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFTVIQLVGMLRGI 133
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
           + G+ +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G   
Sbjct: 134 SAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             + APE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS--YGERPYWEMTNQDVIKAVEEGYRLPS 248
Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
           P++          P  + + M     C Q   + RP+ ++++ ML K IR
Sbjct: 249 PMDC---------PAALYQLM---LDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGLA++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 112/230 (48%), Gaps = 22/230 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +    HPN+V L G   +G   ++V E++EN +LD  L    K + +    +   +  GI
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL---RKHDGQFTVIQLVGMLRGI 154
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
           A G+ +L +      VHRD+ A NIL++     K+ DFGL+++  D+   + T   G   
Sbjct: 155 AAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             + APE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIKAIEEGYRLPA 269
Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
           P++          P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 270 PMDC---------PAGLHQLM---LDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 92/176 (52%), Gaps = 22/176 (12%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL---------DRVLLGATKANIKLNWE 53
           L+N++H ++V+  G CV+G   I+V+EY+++  L         D VL+       +L   
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
           +   I   IA G+ +L  +   H VHRD+   N L+ +    KIGDFG+++   D  +  
Sbjct: 129 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTD 182
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
             R+ G T     ++ PE ++  + T ++DV+S GV++ EI +    GK  W Q++
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT---YGKQPWYQLS 235

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 113/232 (48%), Gaps = 24/232 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +    HPN++ L G   + T  +++ E++EN SLD  L    + + +    +   +  GI
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGI 144
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGT 120
           A G+ +L +    + VHRD+ A NIL++     K+ DFGL++   D+ +    T+ + G 
Sbjct: 145 AAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
               + APE +   + T  +DV+S+G+++ E++S     +  W   N+ ++    Q ++ 
Sbjct: 202 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMTNQDVINAIEQDYRL 259
Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
             P++          P+ + + M     C Q   + RP+  Q++  L K IR
Sbjct: 260 PPPMDC---------PSALHQLM---LDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 159
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 160 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 273
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 274 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 149
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 150 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 206
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 263
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 264 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L     +    I V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 57  MKKLRHEKLVQLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 114 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK 170
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 171 WTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    +++ EY+EN SLD  L    K + +    +   +  GI  G+ 
Sbjct: 89  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFG++++  D+     T   G     + A
Sbjct: 146 YLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 203 PEAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIKAIEEGYRLPPPMDCP 260
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                       I   ++   C Q   S RP+  Q++ ML K IR
Sbjct: 261 ------------IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 132
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 133 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 246
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 247 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL ++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    +++ EY+EN SLD  L    K + +    +   +  GI  G+ 
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFG++++  D+     T   G     + A
Sbjct: 125 YLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIKAIEEGYRLPPPMDCP 239
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                       I   ++   C Q   S RP+  Q++ ML K IR
Sbjct: 240 ------------IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 60  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQI 116
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 117 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 173
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    +++ EY+EN SLD  L    K + +    +   +  GI  G+ 
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFG++++  D+     T   G     + A
Sbjct: 131 YLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIKAIEEGYRLPPPMDCP 245
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                       I   ++   C Q   S RP+  Q++ ML K IR
Sbjct: 246 ------------IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 64  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 121 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 64  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 121 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 233 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQI 289
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 290 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 233 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQI 289
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 290 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 233 MKKLRHEKLVQLYAV-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQI 289
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 290 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 67  MKKIRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G T   ++L   +  D+   I
Sbjct: 316 MKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQI 372
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 373 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L     +    I++ EY+   SL   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 38/240 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG------------ATKANIKL 50
           L+N++H ++V+  G C  G   I+V+EY+++  L++ L                +A  +L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 51  NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
              +   I   IA G+ +L  +   H VHRD+   N L+      KIGDFG+++   D  
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVY 184
Query: 111 THITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-N 165
           +    R+ G T     ++ PE ++  + T ++DV+SFGV++ EI +    GK  W Q+ N
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLSN 241
Query: 166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
             ++E   Q    E+P            P E+     V   C Q    +R  + ++ K+L
Sbjct: 242 TEVIECITQGRVLERP---------RVCPKEV---YDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +G   ++V EY+EN SLD  L      + +    +   +  G+  G+ 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A N+L+D     K+ DFGL+++  D+     T   G     + A
Sbjct: 166 YLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTA 222
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +     +  +DV+SFGV++ E+++     +  W   N+ ++    + ++   P+   
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLA--YGERPYWNMTNRDVISSVEEGYRLPAPMGC- 279
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
                   P+ + + M     C     ++RP+ +Q++ +L   IR  E
Sbjct: 280 --------PHALHQLM---LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L     +    I++ EY+   SL   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +G   ++V EY+EN SLD  L      + +    +   +  G+  G+ 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A N+L+D     K+ DFGL+++  D+     T   G     + A
Sbjct: 166 YLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +     +  +DV+SFGV++ E+++     +  W   N+ ++    + ++   P+   
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLA--YGERPYWNMTNRDVISSVEEGYRLPAPMGC- 279
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
                   P+ + + M     C     ++RP+ +Q++ +L   IR  E
Sbjct: 280 --------PHALHQLM---LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 58  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 115 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + LS V HP ++ + G      +  ++ +Y+E   L  +L  + +    +     +++C+
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
                L +LH +    I++RD+K  NILLD+  + KI DFG AK  PD    +T  + GT
Sbjct: 118 A----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGT 166
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             Y+APE V         D +SFG+L+ E+++G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 56  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 113 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 169
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 170 WTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 23/164 (14%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+++ IG   +  R   + EY++  +L  ++      + +  W +R      IA G+A
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMA 122
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---------------PDNITH 112
           +LH     +I+HRD+ + N L+ +  N  + DFGLA+L                PD    
Sbjct: 123 YLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 156
            T  + G   ++APE + G     K DV+SFG+++ EII   N+
Sbjct: 180 YT--VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 111/227 (48%), Gaps = 24/227 (10%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   + T  +++ E++EN SLD  L    + + +    +   +  GIA G+ 
Sbjct: 67  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGT--TGY 123
           +L +    + VHR + A NIL++     K+ DFGL++   D+ +    T+ + G     +
Sbjct: 124 YLADM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE 183
            APE +   + T  +DV+S+G+++ E++S     +  W   N+ ++    Q ++   P++
Sbjct: 181 TAPEAIQYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMTNQDVINAIEQDYRLPPPMD 238
Query: 184 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                     P+ + + M     C Q   + RP+  Q++  L K IR
Sbjct: 239 C---------PSALHQLM---LDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V E +EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V E +EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 162 YLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 275
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN++ L G   +    ++V E +EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMK 132
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 125
           +L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +
Sbjct: 133 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 185
           PE +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC- 246
Query: 186 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
                   P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 247 --------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD+ A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDIC 59
           +  + HP LV+L G C++     LV+E++E+  L    R   G   A   L       +C
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MC 112
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + + +G+A+L E  V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T    
Sbjct: 113 LDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 169
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 170 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+    L   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDIC 59
           +  + HP LV+L G C++     LV+E++E+  L    R   G   A   L       +C
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MC 109
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + + +G+A+L E  V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T    
Sbjct: 110 LDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 166
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 167 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDIC 59
           +  + HP LV+L G C++     LV+E++E+  L    R   G   A   L       +C
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MC 107
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + + +G+A+L E  V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T    
Sbjct: 108 LDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+    L   L G     ++L   +  D+   I
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN             
Sbjct: 124 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDIC 59
           +  + HP LV+L G C++     LV+E++E+  L    R   G   A   L       +C
Sbjct: 76  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MC 129
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + + +G+A+L E  V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T    
Sbjct: 130 LDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 186
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 187 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 12/151 (7%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVG 61
            + HP LV+L G C++     LV+E++E+  L    R   G   A   L       +C+ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLD 111
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + +G+A+L E     ++HRD+ A N L+ +    K+ DFG+ +   D+    +T      
Sbjct: 112 VCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RH  LV+L    V      +V EY+   SL   L G     ++L   +  D+   I
Sbjct: 234 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQI 290
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + VHRD++A+NIL+ +    K+ DFGL +L  DN             
Sbjct: 291 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK 347
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 348 WTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 119
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T ++GT  Y
Sbjct: 120 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLSGTLDY 173
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 119 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 144
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 145 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 198
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 121
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 117
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 118 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 171
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 135
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 136 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 189
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 123
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 124 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 177
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     +     ++ EY+   SL   L       + L   K  D    I
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQI 119
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+A++  +   + +HRD++A+N+L+ +    KI DFGLA++  DN             
Sbjct: 120 AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 176
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 112/242 (46%), Gaps = 42/242 (17%)
Query: 3   LSNVRHPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H ++++  GCC  QG + + LV EYV   SL   L   +    +L    +     
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---- 125
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I +G+A+LH +   H +HR++ A N+LLD +   KIGDFGLAK  P+   +   R  G 
Sbjct: 126 -ICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKF 167
           +   + APE +   +    +DV+SFGV + E+++  +S ++             GQM   
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 241
Query: 168 ----LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
               LLE   +L + +K             P E+   MK    C +  AS RP    +I 
Sbjct: 242 RLTELLERGERLPRPDK------------CPCEVYHLMKN---CWETEASFRPTFENLIP 286
Query: 224 ML 225
           +L
Sbjct: 287 IL 288

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLN 51
           L+ ++H ++V   G C +G   ++V+EY+ +  L+R L            G   A   L 
Sbjct: 74  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 133
Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNI 110
             +   +   +A G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  + 
Sbjct: 134 LGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 190
Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
             +  R      ++ PE +L  + T ++DV+SFGV++ EI +    GK  W Q++
Sbjct: 191 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---YGKQPWYQLS 242

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 121
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 123
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 124 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 177
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 119
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 120 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 173
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 123
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 124 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 177
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 122
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 123 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 176
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLN 51
           L+ ++H ++V   G C +G   ++V+EY+ +  L+R L            G   A   L 
Sbjct: 68  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 127
Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNI 110
             +   +   +A G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  + 
Sbjct: 128 LGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 184
Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
             +  R      ++ PE +L  + T ++DV+SFGV++ EI +    GK  W Q++
Sbjct: 185 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---YGKQPWYQLS 236

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 115
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 116 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 169
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDIC 59
           +  + HP LV+L G C++     LV E++E+  L    R   G   A   L       +C
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MC 110
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + + +G+A+L E  V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T    
Sbjct: 111 LDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 167
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 44/243 (18%)
Query: 3   LSNVRHPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H ++V+  GCC  QG + + LV EYV   SL   L                  CV
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------------PRHCV 108
Query: 61  GIAK----------GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
           G+A+          G+A+LH +   H +HR + A N+LLD +   KIGDFGLAK  P+  
Sbjct: 109 GLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 165
Query: 111 THITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 168
            +   R  G +   + APE +   +    +DV+SFGV + E+++  +S ++   +  + +
Sbjct: 166 EYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELI 225
Query: 169 LEWAWQL------HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 222
                Q+         E+   L  P+     P EI   MK    C +  AS RP    ++
Sbjct: 226 GHTQGQMTVLRLTELLERGERLPRPDRC---PCEIYHLMKN---CWETEASFRPTFQNLV 279
Query: 223 KML 225
            +L
Sbjct: 280 PIL 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 44/243 (18%)
Query: 3   LSNVRHPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H ++V+  GCC  QG + + LV EYV   SL   L                  CV
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------------PRHCV 109
Query: 61  GIAK----------GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
           G+A+          G+A+LH +   H +HR + A N+LLD +   KIGDFGLAK  P+  
Sbjct: 110 GLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 166
Query: 111 THITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 168
            +   R  G +   + APE +   +    +DV+SFGV + E+++  +S ++   +  + +
Sbjct: 167 EYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELI 226
Query: 169 LEWAWQL------HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 222
                Q+         E+   L  P+     P EI   MK    C +  AS RP    ++
Sbjct: 227 GHTQGQMTVLRLTELLERGERLPRPDRC---PCEIYHLMKN---CWETEASFRPTFQNLV 280
Query: 223 KML 225
            +L
Sbjct: 281 PIL 283

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLN 51
           L+ ++H ++V   G C +G   ++V+EY+ +  L+R L            G   A   L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNI 110
             +   +   +A G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  + 
Sbjct: 157 LGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
             +  R      ++ PE +L  + T ++DV+SFGV++ EI +    GK  W Q++
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---YGKQPWYQLS 265

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 112/242 (46%), Gaps = 42/242 (17%)
Query: 3   LSNVRHPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H ++++  GCC  QG + + LV EYV   SL   L   +    +L    +     
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---- 125
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I +G+A+LH +   H +HR++ A N+LLD +   KIGDFGLAK  P+   +   R  G 
Sbjct: 126 -ICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKF 167
           +   + APE +   +    +DV+SFGV + E+++  +S ++             GQM   
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 241
Query: 168 ----LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
               LLE   +L + +K             P E+   MK    C +  AS RP    +I 
Sbjct: 242 RLTELLERGERLPRPDK------------CPCEVYHLMKN---CWETEASFRPTFENLIP 286
Query: 224 ML 225
           +L
Sbjct: 287 IL 288

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+  + HP LV+  G C +     +V EY+ N  L   L    K    L   +  ++C  
Sbjct: 56  TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYD 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITHITTRIAG 119
           + +G+AFL        +HRD+ A N L+D++   K+ DFG+ +   D+  ++ + T+   
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP- 168
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE     + + K+DV++FG+L+ E+ S
Sbjct: 169 -VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY     + + L   +K     + ++ +     +A
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELA 123
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 124 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 177
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-- 60
           +    HPN++ L G        +++ E++EN +LD  L        +LN  + + I +  
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--------RLNDGQFTVIQLVG 120
Query: 61  ---GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITT 115
              GIA G+ +L E      VHRD+ A NIL++     K+ DFGL++   +N +    T+
Sbjct: 121 MLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 116 RIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 173
            + G     + APE +   + T  +D +S+G+++ E++S     +  W   N+ ++    
Sbjct: 178 SLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS--FGERPYWDMSNQDVIN--- 232
Query: 174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
            + Q+ +    + P     PP+      ++   C Q   + RP+  QV+  L K IR
Sbjct: 233 AIEQDYR----LPP-----PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTR----RILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           +L  ++H N+++ IG   +GT       L+  + E  SL   L    KAN+ ++W +   
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANV-VSWNELCH 125
Query: 58  ICVGIAKGLAFLHEEL-------VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
           I   +A+GLA+LHE++        P I HRDIK+ N+LL       I DFGLA  F    
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 111 THITTR-IAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIIS 152
           +   T    GT  Y+APE + G         ++ D+Y+ G+++ E+ S
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 111/249 (44%), Gaps = 40/249 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 263 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 310
Query: 230 RL--NEEEL 236
            L  N+E L
Sbjct: 311 ALTSNQEXL 319

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV+L     +    I+  E++   SL   L     +   L   K  D    I
Sbjct: 64  MKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ +    + +HRD++A+NIL+      KI DFGLA++  DN             
Sbjct: 121 AEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
           + APE +  G  T+K+DV+SFG+L++EI++ GR
Sbjct: 178 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 120
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI +FG +   P +     T + GT  Y
Sbjct: 121 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDY 174
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 121
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 144
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 145 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDY 198
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 15/151 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN ++  GC ++     LV EY   ++ D  LL   K    L   + + +  G 
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAVTHGA 163
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+LH     +++HRD+KA NILL +    K+GDFG A     +I        GT  
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPY 215
Query: 123 YLAPEYVLG---GQLTMKADVYSFGVLVLEI 150
           ++APE +L    GQ   K DV+S G+  +E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 120
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 121 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDY 174
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   ++     + ++ +     +A
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELA 122
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  Y
Sbjct: 123 NALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---TTLCGTLDY 176
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           L PE + G     K D++S GVL  E + G
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 119
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 120 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGTLDY 173
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 121
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI +FG +   P +     T + GT  Y
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 121
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 10/156 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           +  ++H N+V L        +  LV+E+++N+    +D   +G T   ++LN  K     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY--FQ 114
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + +GLAF HE     I+HRD+K  N+L+++    K+GDFGLA+ F   +   ++ +  
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV- 170
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 154
           T  Y AP+ ++G +  +   D++S G ++ E+I+G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +    H N++ L G   +    +++ EY+EN +LD+ L    + + + +  +   +  GI
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGI 156
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITHITTRIAGT 120
           A G+ +L      + VHRD+ A NIL++     K+ DFGL+++  D+   T+ T+     
Sbjct: 157 AAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             + APE +   + T  +DV+SFG+++ E+++     +  W   N  +++      +   
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT--YGERPYWELSNHEVMKAINDGFRLPT 271
Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
           P++          P+ I + M     C Q   +RRP+   ++ +L K IR
Sbjct: 272 PMDC---------PSAIYQLM---MQCWQQERARRPKFADIVSILDKLIR 309

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 107/242 (44%), Gaps = 42/242 (17%)
Query: 3   LSNVRHPNLVELIGCC--VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H ++++  GCC         LV EYV   SL   L   +    +L    +     
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---- 142
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I +G+A+LH +   H +HRD+ A N+LLD +   KIGDFGLAK  P+       R  G 
Sbjct: 143 -ICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGD 198
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKF 167
           +   + APE +   +    +DV+SFGV + E+++  +S ++             GQM   
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 168 ----LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
               LLE   +L + +K             P E+   MK    C +  AS RP    +I 
Sbjct: 259 RLTELLERGERLPRPDK------------CPAEVYHLMKN---CWETEASFRPTFENLIP 303
Query: 224 ML 225
           +L
Sbjct: 304 IL 305

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 34/237 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-- 60
           +    HPN++ L G        +++ E++EN +LD  L        +LN  + + I +  
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--------RLNDGQFTVIQLVG 122
Query: 61  ---GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TT 115
              GIA G+ +L E      VHRD+ A NIL++     K+ DFGL++   +N +    T+
Sbjct: 123 MLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETS 179
Query: 116 RIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 173
            + G     + APE +   + T  +D +S+G+++ E++S     +  W   N+ ++    
Sbjct: 180 SLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS--FGERPYWDMSNQDVINAIE 237
Query: 174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
           Q ++       + P     PP+      ++   C Q   + RP+  QV+  L K IR
Sbjct: 238 QDYR-------LPP-----PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 15/151 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN ++  GC ++     LV EY   ++ D  LL   K    L   + + +  G 
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAVTHGA 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+LH     +++HRD+KA NILL +    K+GDFG A     +I        GT  
Sbjct: 125 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPY 176
Query: 123 YLAPEYVLG---GQLTMKADVYSFGVLVLEI 150
           ++APE +L    GQ   K DV+S G+  +E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV+L     +    I V EY+   SL   L       +KL      D+   +
Sbjct: 58  MKKLKHDKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQV 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A++      + +HRD++++NIL+      KI DFGLA+L  DN             
Sbjct: 115 AAGMAYIERM---NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
           + APE  L G+ T+K+DV+SFG+L+ E+++    G+  +  MN
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVT---KGRVPYPGMN 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 118
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 119 NALSYCHSKKV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDY 172
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------ANIKLNWEKRS 56
           +H N+V L+G C  G   +++ EY     L   L   ++          AN  L+     
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
                +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I   
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 117 IAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 121
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK------LNWEKRSDICV 60
           +H N+V L+G C  G   +++ EY     L   L    +A++       L          
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG- 119
            +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I    A  
Sbjct: 160 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 245
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 303
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 304 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 351
Query: 230 RLNEEE 235
            L   +
Sbjct: 352 ALTSNQ 357

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY     + + L   +K     + ++ +     +A
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELA 123
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 124 NALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTLDY 177
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           L PE + G     K D++S GVL  E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 82/151 (54%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    ++ E+++  +L  ++     + ++LN E+ + +C  +
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAV 150
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + LA+LH +    ++HRDIK+ +ILL  +   K+ DFG       ++      + GT  
Sbjct: 151 LQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPY 206
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK------LNWEKRSDICV 60
           +H N+V L+G C  G   +++ EY     L   L    +A++       L          
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG- 119
            +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I    A  
Sbjct: 168 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 3/96 (3%)
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
           D    IA+G+AF+ +    + +HRD++A+NIL+      KI DFGLA++  DN       
Sbjct: 288 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 + APE +  G  T+K+DV+SFG+L++EI++
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 196
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 197 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 308
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 309 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 351

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 263 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 310
Query: 230 RLNEEE 235
            L   +
Sbjct: 311 ALTSNQ 316

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 144 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 196
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 254
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 255 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 302
Query: 230 RLNEEE 235
            L   +
Sbjct: 303 ALTSNQ 308

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 263 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 310
Query: 230 RLNEEE 235
            L   +
Sbjct: 311 ALTSNQ 316

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 137
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 138 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 249
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 250 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 292

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 141 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 193
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 251
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 252 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 299
Query: 230 RLNEEE 235
            L   +
Sbjct: 300 ALTSNQ 305

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 135
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 136 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 192
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 247
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 248 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 290

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 88  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 142
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 143 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 199
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 200 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 254
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 255 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 297

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +         
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 145 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 197
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 255
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 256 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 303
Query: 230 RLNEEE 235
            L   +
Sbjct: 304 ALTSNQ 309

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 137
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 138 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 249
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 250 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 292

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWE 53
           H N+V L+G C  G   +++ EY     L        D  +   T   I       L+ E
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++
Sbjct: 169 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 114 TTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLL 169
               A     ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + 
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E    L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 286 EGFRMLSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 329

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 138
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 139 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 195
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 250
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 251 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 293

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 138
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHIT 114
            G  +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  
Sbjct: 139 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNK 195
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 250
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 251 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 88/156 (56%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L  +     K   +K  DI    
Sbjct: 62  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQT 117
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 118 ARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWE 53
           H N+V L+G C  G   +++ EY     L        D  +   T   I       L+ E
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++
Sbjct: 169 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 114 TTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLL 169
               A     ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + 
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E    L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 286 EGFRMLSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 329

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWE 53
           H N+V L+G C  G   +++ EY     L        D  +   T   I       L+ E
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++
Sbjct: 164 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 114 TTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLL 169
               A     ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + 
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E    L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 281 EGFRMLSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 324

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     +     ++ E++   SL   L       + L   K  D    I
Sbjct: 61  MKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+A++  +   + +HRD++A+N+L+ +    KI DFGLA++  DN             
Sbjct: 119 AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 175
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +  G  T+K++V+SFG+L+ EI++
Sbjct: 176 WTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HP LV L  C    +R   V EYV    L    +   +   KL  E        I+  L 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 125
           +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+A
Sbjct: 136 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 189
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           PE + G       D ++ GVL+ E+++GR+
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 219

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWE 53
           H N+V L+G C  G   +++ EY     L        D  +   T   I       L+ E
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++
Sbjct: 162 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 114 TTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLL 169
               A     ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + 
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E    L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 279 EGFRMLSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 322

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 121
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HP LV L  C    +R   V EYV    L    +   +   KL  E        I+  L 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 125
           +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+A
Sbjct: 121 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 174
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           PE + G       D ++ GVL+ E+++GR+
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 204

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWE 53
           H N+V L+G C  G   +++ EY     L        D  +   T   I       L+ E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 114 TTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLL 169
               A     ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           E    L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 263 EGFRMLSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 306

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HP LV L  C    +R   V EYV    L    +   +   KL  E        I+  L 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 125
           +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+A
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 178
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           PE + G       D ++ GVL+ E+++GR+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L     P +V   G         +  E+++  SLD+VL    K   ++  E    + + +
Sbjct: 68  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAV 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLA+L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  
Sbjct: 124 LRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRS 178
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE + G   ++++D++S G+ ++E+  GR
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATK--ANIKLNWEKRSDI 58
           L +++H N+V+  G C    RR   L+ EY+   SL   L    +   +IKL  +  S I
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-LQYTSQI 126
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C    KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  
Sbjct: 127 C----KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 119 GTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 40/249 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI------------KLNWEK 54
           +H N++ L+G C Q     ++ EY    +L   L       +            +L+ + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 263 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 310
Query: 230 RL--NEEEL 236
            L  N+E L
Sbjct: 311 ALTSNQEYL 319

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ L G     TR  L+ EY    ++ R L   ++     + ++ +     +A
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELA 122
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L++ H + V   +HRDIK  N+LL      KI DFG +   P +       + GT  Y
Sbjct: 123 NALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDY 176
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           L PE + G     K D++S GVL  E + G
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 152
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HP LV L  C    +R   V EYV    L    +   +   KL  E        I+  L 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 125
           +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+A
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 221
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           PE + G       D ++ GVL+ E+++GR+
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 127
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 128 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI------------KLNWEK 54
           +H N++ L+G C Q     ++ EY    +L   L       +            +L+ + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 189
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 247
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIV 295
Query: 230 RLNEEE 235
            L   +
Sbjct: 296 ALTSNQ 301

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 126
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 127 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 119
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 120 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 177 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 125
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 126 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 121
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 120
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 121 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + +  H N+V++    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 96  MRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSV 150
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L++LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 151 LRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKXLVGTPY 206
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E+I G
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 128
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 129 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 186 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 124
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 121
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 140 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 197 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 140 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 197 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 3   LSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L N+ H N+V+  G C +  G    L+ E++ + SL   L    K   K+N +++    V
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAV 133
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        VHRD+ A N+L++ E   KIGDFGL K    +    T +    
Sbjct: 134 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 190
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           +   + APE ++  +  + +DV+SFGV + E+++  +S  +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 3   LSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L N+ H N+V+  G C +  G    L+ E++ + SL   L    K   K+N +++    V
Sbjct: 65  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAV 121
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        VHRD+ A N+L++ E   KIGDFGL K    +    T +    
Sbjct: 122 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 178
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           +   + APE ++  +  + +DV+SFGV + E+++  +S  +
Sbjct: 179 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 219

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------ANIKLNWEKRS 56
           +H N+V L+G C  G   +++ EY     L   L   ++          AN   +     
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
                +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I   
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 117 IAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 40/249 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RL--NEEEL 236
            L  NEE L
Sbjct: 318 TLTTNEEYL 326

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ EY+   SL   L    K   +++  K      
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTS 122
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HR++   NIL++ E   KIGDFGL K+ P +  +   +  G 
Sbjct: 123 QICKGMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 40/249 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RL--NEEEL 236
            L  NEE L
Sbjct: 318 TLTTNEEYL 326

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 102 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 156
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 157 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 213
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 214 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 268
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 269 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L  +     K   +K  DI    
Sbjct: 74  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQT 129
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+ 
Sbjct: 130 ARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 136
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 137 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNK 193
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 248
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 249 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 291

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L +++H N+V+  G C    RR   L+ E++   SL   L    K   +++  K      
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL---QKHKERIDHIKLLQYTS 124
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I KG+ +L        +HRD+   NIL++ E   KIGDFGL K+ P +      +  G 
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 121 TG--YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +   + APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 101 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 155
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 156 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 212
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 213 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 267
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 268 LLQGRR---LLQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 310

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 134
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 135 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 191
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 246
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 247 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 137
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 138 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 249
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 250 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 75  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 129
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 130 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 186
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 187 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 241
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 242 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 136
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 137 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 193
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 248
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 249 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 80  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 134
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 135 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPY 190
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 191 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 135
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 136 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 192
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 247
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 248 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 82  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 136
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 137 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPY 192
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 193 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G      +  +V ++ E +SL   L  +     K   +K  DI    
Sbjct: 74  LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQT 129
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+ 
Sbjct: 130 ARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 137
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 138 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 249
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 250 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVG 61
           S + H N+V +I    +     LV EY+E  +L   +   G    +  +N+  +      
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ------ 119
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  G+   H+     IVHRDIK  NIL+D     KI DFG+AK   +     T  + GT 
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y +PE   G       D+YS G+++ E++ G 
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 8   HPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HP L  +  C  Q    +  V EY+    L    +   ++  K +  + +     I  GL
Sbjct: 78  HPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAEIILGL 132
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYL 124
            FLH +    IV+RD+K  NILLD++ + KI DFG+ K   +N+     T    GT  Y+
Sbjct: 133 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFCGTPDYI 186
Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           APE +LG +     D +SFGVL+ E++ G++
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQS 217

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           + + +  HPN++ L+G C++     ++V  Y+++  L   +   T      N   +  I 
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIG 132
Query: 60  VG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHIT 114
            G  +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  
Sbjct: 133 FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVY 244
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           L Q  +   L+ P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 245 LLQGRR---LLQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 125
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 126 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPY 181
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 179
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 180 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPY 235
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 236 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RH NLV L+  C +  R  LV+E+V++  LD + L        L+++        I
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQI 133
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             G+ F H     +I+HRDIK  NIL+ Q    K+ DFG A+            +A T  
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRW 189
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 153
           Y APE ++G     KA DV++ G LV E+  G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 256
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 257 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPY 312
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 32/243 (13%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+   +NI +  
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 260
Query: 115 TRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 172
               G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L +  
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPVEELFKLL 318
Query: 173 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 232
            + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + + L 
Sbjct: 319 KEGHRMDKPANCT---------NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILTLT 366
Query: 233 EEE 235
             E
Sbjct: 367 TNE 369

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ +
Sbjct: 75  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAV 129
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L+ LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  
Sbjct: 130 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPY 185
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 186 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 8   HPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HP L  +  C  Q    +  V EY+    L    +   ++  K +  + +     I  GL
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYL 124
            FLH +    IV+RD+K  NILLD++ + KI DFG+ K   +N+     T    GT  Y+
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFCGTPDYI 185
Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           APE +LG +     D +SFGVL+ E++ G++
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 14/156 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL---DRVLLGATKANIKLNWEKRSD 57
           + + ++ H ++V L+G C  G+   LV +Y+   SL    R   GA    + LNW     
Sbjct: 85  LAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----- 138
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
             V IAKG+ +L E     +VHR++ A N+LL      ++ DFG+A L P +   +    
Sbjct: 139 -GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           A T   ++A E +  G+ T ++DV+S+GV V E+++
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 34/244 (13%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+   +NI +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 115 TRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 172
               G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L +  
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLL 272
Query: 173 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL- 231
            + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + + L 
Sbjct: 273 KEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRILTLT 320
Query: 232 -NEE 234
            NEE
Sbjct: 321 TNEE 324

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RL--NEE 234
            L  NEE
Sbjct: 318 TLTTNEE 324

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           I +   K L  L E L   I+HRDIK SNILLD+  N K+ DFG++    D+I    TR 
Sbjct: 130 ITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRD 185
Query: 118 AGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGR---NSGKAMWGQMNKFLLE 170
           AG   Y+APE +          +++DV+S G+ + E+ +GR       +++ Q+ + +  
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-- 243
Query: 171 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
                  +  P +L + E  E+ P+    ++     C     S+RP+  +++K
Sbjct: 244 -------KGDPPQLSNSEEREFSPS----FINFVNLCLTKDESKRPKYKELLK 285

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N+V L+G C  G   +++ EY     L   L       ++ ++    +         
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 58  ---ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I 
Sbjct: 168 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 115 TRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 148 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 200
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 258
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 259 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 306
Query: 230 RLNEEE 235
            L   E
Sbjct: 307 TLTTNE 312

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 151 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 203
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 261
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 262 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 309
Query: 230 RLNEEE 235
            L   E
Sbjct: 310 TLTTNE 315

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RL--NEE 234
            L  NEE
Sbjct: 318 TLTTNEE 324

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 14/156 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL---DRVLLGATKANIKLNWEKRSD 57
           + + ++ H ++V L+G C  G+   LV +Y+   SL    R   GA    + LNW     
Sbjct: 67  LAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----- 120
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
             V IAKG+ +L E     +VHR++ A N+LL      ++ DFG+A L P +   +    
Sbjct: 121 -GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           A T   ++A E +  G+ T ++DV+S+GV V E+++
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 81/155 (52%), Gaps = 11/155 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L ++ HPN++++           +V E  E   L   ++ A      L+    +++   +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
              LA+ H +   H+VH+D+K  NIL  Q+ +P    KI DFGLA+LF  +    +T  A
Sbjct: 134 MNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD--EHSTNAA 187
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE V    +T K D++S GV++  +++G
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RLNEEE 235
            L   E
Sbjct: 318 TLTTNE 323

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 76  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 131
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 132 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 186
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEW 171
            Y++PE + G   ++++D++S G+ ++E+  GR    +  G M  F LL++
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDY 237

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           +  + +P +V LIG C Q    +LV E      L + L+G           KR +I V  
Sbjct: 64  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-----------KREEIPVSN 111
Query: 62  -------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  ++ G+ +L E+   + VHRD+ A N+LL      KI DFGL+K    + ++ T
Sbjct: 112 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168
Query: 115 TRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWG 162
            R AG     + APE +   + + ++DV+S+GV + E +S G+   K M G
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 58  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 31/233 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDI 131
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLD--QEFNP---KIGDFGLAKLFPDNITHITTRI 117
           A G+ ++  +  P IVHRD+++ NI L    E  P   K+ DFGL++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 118 AGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS-GKAMWGQMNKFLLEWAWQ 174
            G   ++APE +   +   T KAD YSF +++  I++G     +  +G++ KF+      
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI-----N 240
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           + +EE  L    PE  + PP    R   V   C      +RP  + ++K L++
Sbjct: 241 MIREEG-LRPTIPE--DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 38/242 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 146 LVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR----DINNID 198
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 256
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 257 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 304
Query: 230 RL 231
            L
Sbjct: 305 TL 306

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 63  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 119 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 60  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 116 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    +I DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RL--NEE 234
            L  NEE
Sbjct: 318 TLTTNEE 324

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 63  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 119 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + +
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 175
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  
Sbjct: 176 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRS 230
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +V EYV+  +L  ++        K   E  +D C    + L F H+     I+HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC----QALNFSHQN---GIIHRDVKPA 145
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTTGYLAPEYVLGGQLTMKADVYSF 143
           NI++      K+ DFG+A+   D+   +T   A  GT  YL+PE   G  +  ++DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 144 GVLVLEIISG 153
           G ++ E+++G
Sbjct: 206 GCVLYEVLTG 215

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G      +  +V ++ E +SL   L        K    K  DI    
Sbjct: 58  LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +V EYV+  +L  ++        K   E  +D C    + L F H+     I+HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC----QALNFSHQN---GIIHRDVKPA 145
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTTGYLAPEYVLGGQLTMKADVYSF 143
           NI++      K+ DFG+A+   D+   +T   A  GT  YL+PE   G  +  ++DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 144 GVLVLEIISG 153
           G ++ E+++G
Sbjct: 206 GCVLYEVLTG 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P +    G  ++ T+  ++ EY+   S LD +  G       L     + I   
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILRE 124
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGT 120
           I KGL +LH E     +HRDIKA+N+LL ++ + K+ DFG+A    D  T I      GT
Sbjct: 125 ILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGT 179
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-----------------RNSGKAMWGQ 163
             ++APE +       KAD++S G+  +E+  G                 +NS   + GQ
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ 239
Query: 164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 209
            +K   E+      ++        EL ++    I RY K   F T+
Sbjct: 240 HSKPFKEFVEACLNKDPRFRPTAKELLKH--KFITRYTKKTSFLTE 283

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 85  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 140
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 141 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +V EYV+  +L  ++        K   E  +D C    + L F H+     I+HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC----QALNFSHQN---GIIHRDVKPA 145
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTTGYLAPEYVLGGQLTMKADVYSF 143
           NI++      K+ DFG+A+   D+   +T   A  GT  YL+PE   G  +  ++DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 144 GVLVLEIISG 153
           G ++ E+++G
Sbjct: 206 GCVLYEVLTG 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +V EYV+  +L  ++        K   E  +D C    + L F H+     I+HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC----QALNFSHQN---GIIHRDVKPA 145
Query: 86  NILLDQEFNPKIGDFGLAKLFPD--NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 143
           NIL+      K+ DFG+A+   D  N    T  + GT  YL+PE   G  +  ++DVYS 
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 144 GVLVLEIISG 153
           G ++ E+++G
Sbjct: 206 GCVLYEVLTG 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P + +  G  ++ T+  ++ EY+   S LD +  G       L+  + + I   
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILRE 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I KGL +LH E     +HRDIKA+N+LL +    K+ DFG+A    D      T + GT 
Sbjct: 113 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTP 168
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            ++APE +       KAD++S G+  +E+  G
Sbjct: 169 FWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +V EYV+  +L  ++        K   E  +D C    + L F H+     I+HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC----QALNFSHQN---GIIHRDVKPA 145
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTTGYLAPEYVLGGQLTMKADVYSF 143
           NI++      K+ DFG+A+   D+   +T   A  GT  YL+PE   G  +  ++DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 144 GVLVLEIISG 153
           G ++ E+++G
Sbjct: 206 GCVLYEVLTG 215

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 86  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 141
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+ 
Sbjct: 142 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +V EYV+  +L  ++        K   E  +D C    + L F H+     I+HRD+K +
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC----QALNFSHQN---GIIHRDVKPA 162
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTTGYLAPEYVLGGQLTMKADVYSF 143
           NI++      K+ DFG+A+   D+   +T   A  GT  YL+PE   G  +  ++DVYS 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 144 GVLVLEIISG 153
           G ++ E+++G
Sbjct: 223 GCVLYEVLTG 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 139
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 140 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 194
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQAL 129
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E+I G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 5/154 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  ++HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 61  GIAKGLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            +   L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++   + +   T   
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FV 177
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           GT  Y++PE +       K+D++S G L+ E+ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNW 52
           + ++++ HP+LV L+G C+  T +++        + EYV  +  D +      + + LNW
Sbjct: 92  LIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHK-DNI-----GSQLLLNW 145
Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNIT 111
                 CV IAKG+ +L E     +VHRD+ A N+L+    + KI DFGLA+L   D   
Sbjct: 146 ------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 112 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW 171
           +          ++A E +   + T ++DV+S+GV + E+++    GK   G         
Sbjct: 197 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT--FGGKPYDG--------- 245
Query: 172 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 231
              +   E P  L   E    PP   I    V   C    A  RP+  ++    ++  R 
Sbjct: 246 ---IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 302
Query: 232 NEEELTAPG 240
            +  L   G
Sbjct: 303 PQRYLVIQG 311

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 167
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 167
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 85/161 (52%), Gaps = 24/161 (14%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNW 52
           + ++++ HP+LV L+G C+  T +++        + EYV  +  D +      + + LNW
Sbjct: 69  LIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHK-DNI-----GSQLLLNW 122
Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNIT 111
                 CV IAKG+ +L E     +VHRD+ A N+L+    + KI DFGLA+L   D   
Sbjct: 123 ------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173
Query: 112 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +          ++A E +   + T ++DV+S+GV + E+++
Sbjct: 174 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 60  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 115
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++      I  +     GT 
Sbjct: 116 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTR 170
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL  A +    +  +    + + 
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIA 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 167
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 5/154 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  ++HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 61  GIAKGLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            +   L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++  ++ T       
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFV 177
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           GT  Y++PE +       K+D++S G L+ E+ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 167
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT 
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 167
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE + G   ++++D++S G+ ++E+  GR
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQAL 129
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMA 184
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E+I G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P + +  G  ++ T+  ++ EY+   S LD +  G       L+  + + I   
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILRE 132
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I KGL +LH E     +HRDIKA+N+LL +    K+ DFG+A    D      T + GT 
Sbjct: 133 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTP 188
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +       KAD++S G+  +E+  G 
Sbjct: 189 FWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 3   LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENN---SLDRVLL-GATKANIKLNWE 53
           L    HPN+V L   C      + T+  LV+E+V+ +    LD+V   G     IK    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
              D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +    
Sbjct: 124 ---DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMA 175
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
            T +  T  Y APE +L        D++S G +  E+   +    G +   Q+ K L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 76  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQAL 130
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++A
Sbjct: 131 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMA 185
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E+I G
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQAL 129
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMA 184
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E+I G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 26/183 (14%)
Query: 5   NVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            ++H NL++ I    +G+       L+  + +  SL   L    K NI + W +   +  
Sbjct: 65  GMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL----KGNI-ITWNELCHVAE 119
Query: 61  GIAKGLAFLHEEL--------VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNIT 111
            +++GL++LHE++         P I HRD K+ N+LL  +    + DFGLA  F P    
Sbjct: 120 TMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPP 179
Query: 112 HITTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK 166
             T    GT  Y+APE + G         ++ D+Y+ G+++ E++S     KA  G +++
Sbjct: 180 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS---RCKAADGPVDE 236
Query: 167 FLL 169
           ++L
Sbjct: 237 YML 239

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++  Y    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RLNEEE 235
            L   E
Sbjct: 318 TLTTNE 323

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 3   LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENN---SLDRVLL-GATKANIKLNWE 53
           L    HPN+V L   C      + T+  LV+E+V+ +    LD+V   G     IK    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
              D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +    
Sbjct: 124 ---DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMA 175
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
            T +  T  Y APE +L        D++S G +  E+   +    G +   Q+ K L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           +H N+V L+G C  G   +++ EY     L   L    +A +  +     D         
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 58  ----------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
                         +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 108 DNITHITTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           ++  +I    A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P + +  G  ++ T+  ++ EY+   S LD +  G       L+  + + I   
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILRE 127
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGT 120
           I KGL +LH E     +HRDIKA+N+LL +    K+ DFG+A    D  T I      GT
Sbjct: 128 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGT 182
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             ++APE +       KAD++S G+  +E+  G
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 58  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+ 
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 170
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 3   LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENN---SLDRVLL-GATKANIKLNWE 53
           L    HPN+V L   C      + T+  LV+E+V+ +    LD+V   G     IK    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
              D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +    
Sbjct: 124 ---DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMA 175
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
            T +  T  Y APE +L        D++S G +  E+   +    G +   Q+ K L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           RHP++++L       +   +V EYV    L          N +L+ ++   +   I  G+
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGV 129
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
            + H  +V   VHRD+K  N+LLD   N KI DFGL+ +  D          G+  Y AP
Sbjct: 130 DYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRXSCGSPNYAAP 184
Query: 127 EYVLGGQLTM--KADVYSFGVLVLEIISG 153
           E V+ G+L    + D++S GV++  ++ G
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVG 61
           LS    P + +  G  ++ T+  ++ EY+   S LD +  G       L+  + + I   
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILRE 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGT 120
           I KGL +LH E     +HRDIKA+N+LL +    K+ DFG+A    D  T I      GT
Sbjct: 113 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGT 167
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             ++APE +       KAD++S G+  +E+  G
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 78  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 133
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+ 
Sbjct: 134 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 11/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    
Sbjct: 86  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQT 141
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+ 
Sbjct: 142 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 154
            ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 31/233 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDI 131
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLD--QEFNP---KIGDFGLAKLFPDNITHITTRI 117
           A G+ ++  +  P IVHRD+++ NI L    E  P   K+ DFG ++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 118 AGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS-GKAMWGQMNKFLLEWAWQ 174
            G   ++APE +   +   T KAD YSF +++  I++G     +  +G++ KF+      
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI-----N 240
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           + +EE  L    PE  + PP    R   V   C      +RP  + ++K L++
Sbjct: 241 MIREEG-LRPTIPE--DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 31/233 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDI 131
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLD--QEFNP---KIGDFGLAKLFPDNITHITTRI 117
           A G+ ++  +  P IVHRD+++ NI L    E  P   K+ DF L++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 118 AGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS-GKAMWGQMNKFLLEWAWQ 174
            G   ++APE +   +   T KAD YSF +++  I++G     +  +G++ KF+      
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI-----N 240
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           + +EE  L    PE  + PP    R   V   C      +RP  + ++K L++
Sbjct: 241 MIREEG-LRPTIPE--DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE-----------KR 55
           +H N++ L+G C Q     ++  Y    +L   L       ++ +++           K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 56  SDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 115 TRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELF 269
Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + +
Sbjct: 270 KLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRIL 317
Query: 230 RLNEEE 235
            L   E
Sbjct: 318 TLTTNE 323

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           +  + +P +V LIG C Q    +LV E      L + L+G           KR +I V  
Sbjct: 390 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-----------KREEIPVSN 437
Query: 62  -------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  ++ G+ +L E+   + VHR++ A N+LL      KI DFGL+K    + ++ T
Sbjct: 438 VAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 115 TRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWG 162
            R AG     + APE +   + + ++DV+S+GV + E +S G+   K M G
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS      + +  G  ++G++  ++ EY+   S   +L        ++     + +   I
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEI 129
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL +LH E     +HRDIKA+N+LL ++ + K+ DFG+A    D      T + GT  
Sbjct: 130 LKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPF 185
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       KAD++S G+  +E+  G
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 119
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 120 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 175
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 5/154 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  ++HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 61  GIAKGLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            +   L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++  ++         
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKEFV 177
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           GT  Y++PE +       K+D++S G L+ E+ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 23/156 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV+L     +    I+  E++   SL   L     +   L   K  D    I
Sbjct: 231 MKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQI 287
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIAG 119
           A+G+AF+ +    + +HRD++A+NIL+      KI DFGLA++   FP   T        
Sbjct: 288 AEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT-------- 336
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 154
                APE +  G  T+K+DV+SFG+L++EI++ GR
Sbjct: 337 -----APEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C    + L
Sbjct: 76  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQAL 130
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLA 125
            FLH      ++HR+IK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++A
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 185
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISG 153
           PE V       K D++S G++ +E+I G
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 111
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 111
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 111
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L  + HPN+V LI          LV+E++E +    LD    G   + IK+         
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YL 125
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + +G+A  H+     I+HRD+K  N+L++ +   K+ DFGLA+ F   +   T  +  
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV- 181
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           T  Y AP+ ++G  + +   D++S G +  E+I+G+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L  + HPN+V LI          LV+E++E +    LD    G   + IK+         
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YL 125
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + +G+A  H+     I+HRD+K  N+L++ +   K+ DFGLA+ F   +   T  +  
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV- 181
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           T  Y AP+ ++G  + +   D++S G +  E+I+G+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 116
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 117 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 172
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 119
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 120 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 175
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 169
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+ GT 
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTV 349
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           GY+APE V   + T   D ++ G L+ E+I+G++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T   AGT 
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E+V  + L   +  +    I L   K       +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIK--SYLFQL 111
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T   AGT 
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+ GT 
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTV 349
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
           GY+APE V   + T   D ++ G L+ E+I+G++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T   AGT 
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T   AGT 
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 24/159 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDI 58
           L+   HP +V+L+G      +  ++ E+    ++D ++L    G T+  I++       +
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------V 122
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C  + + L FLH +    I+HRD+KA N+L+  E + ++ DFG++     N+  +  R +
Sbjct: 123 CRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDS 176
Query: 119 --GTTGYLAPEYVLGGQL-----TMKADVYSFGVLVLEI 150
             GT  ++APE V+   +       KAD++S G+ ++E+
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E+V+ + L + +  +    I L   K       +
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIK--SYLFQL 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 182
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 9   PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 68
           P++V+  G   + T   +V EY    S+  ++    K    L  ++ + I     KGL +
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEY 140
Query: 69  LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 128
           LH       +HRDIKA NILL+ E + K+ DFG+A    D +      + GT  ++APE 
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEV 196
Query: 129 VLGGQLTMKADVYSFGVLVLEIISGR 154
           +        AD++S G+  +E+  G+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 24/159 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDI 58
           L+   HP +V+L+G      +  ++ E+    ++D ++L    G T+  I++       +
Sbjct: 62  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------V 114
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C  + + L FLH +    I+HRD+KA N+L+  E + ++ DFG++     N+  +  R +
Sbjct: 115 CRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDS 168
Query: 119 --GTTGYLAPEYVLGGQL-----TMKADVYSFGVLVLEI 150
             GT  ++APE V+   +       KAD++S G+ ++E+
Sbjct: 169 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L ++ HPN+++L           LV E+ E   L   ++   K     +    ++I   I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQI 155
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAG 119
             G+ +LH+    +IVHRDIK  NILL+ +    N KI DFGL+  F  +   +  R+ G
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-G 210
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y+APE VL  +   K DV+S GV++  ++ G
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GL+F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  
Sbjct: 113 LQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 121
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 122 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 178
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 24/162 (14%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   D         
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 58  --ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNI 110
             IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 111 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 206 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 121
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 122 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 178
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG--------------ATKANI 48
           ++   +PN+V+L+G C  G    L++EY+    L+  L                +T+A +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 49  K------LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 102
                  L+  ++  I   +A G+A+L E      VHRD+   N L+ +    KI DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 103 AK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           ++ ++  +        A    ++ PE +   + T ++DV+++GV++ EI S
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 179
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 133
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 134 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 190
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 86/168 (51%), Gaps = 8/168 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L+N++HPN+V+      +     +V +Y E   L + +    +  +    ++  D  V I
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQI 134
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L  +H+     I+HRDIK+ NI L ++   ++GDFG+A++  ++   +     GT  
Sbjct: 135 CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPY 190
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 170
           YL+PE         K+D+++ G ++ E+ + +++ +A  G M   +L+
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--GSMKNLVLK 236

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L   RH N++  +G   +    I V ++ E +SL + L        K    +  DI    
Sbjct: 86  LRKTRHVNILLFMGYMTKDNLAI-VTQWCEGSSLYKHL---HVQETKFQMFQLIDIARQT 141
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTT 121
           A+G+ +LH +   +I+HRD+K++NI L +    KIGDFGLA +    + +    +  G+ 
Sbjct: 142 AQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 122 GYLAPEYVL---GGQLTMKADVYSFGVLVLEIISG 153
            ++APE +        + ++DVYS+G+++ E+++G
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYV--REHKDNIGSQYLLNW----- 123
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 124 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 239
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 240 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 284
Query: 236 LTAPG 240
           L   G
Sbjct: 285 LVIQG 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 129
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR 186
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYV--REHKDNIGSQYLLNW----- 122
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 239 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
Query: 236 LTAPG 240
           L   G
Sbjct: 284 LVIQG 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 115 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 114 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 170
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 171 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 111
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 129
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 111
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 122
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 239 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
Query: 236 LTAPG 240
           L   G
Sbjct: 284 LVIQG 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 109
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 110 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 123
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 124 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 239
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 240 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 284
Query: 236 LTAPG 240
           L   G
Sbjct: 285 LVIQG 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 105 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------ 156
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 157 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 273
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 274 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 318
Query: 237 TAPG 240
              G
Sbjct: 319 VIQG 322

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 116
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 117 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 172
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 64  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 121 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQL 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 124
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 241 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 285
Query: 236 LTAPG 240
           L   G
Sbjct: 286 LVIQG 290

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +RHP++++L          I+V EY  N   D ++        K++ ++       I   
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISA 115
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           + + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y A
Sbjct: 116 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 170
Query: 126 PEYVLGGQLTM--KADVYSFGVLVLEIISGR 154
           PE V+ G+L    + DV+S GV++  ++  R
Sbjct: 171 PE-VISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 125
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 126 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 242 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 286
Query: 236 LTAPG 240
           L   G
Sbjct: 287 LVIQG 291

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 81  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 135
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 136 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 81  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 135
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 136 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 129
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 130 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 246 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 290
Query: 236 LTAPG 240
           L   G
Sbjct: 291 LVIQG 295

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           LV EY+ +  L   L    +   +L+  +       I KG+ +L        VHRD+ A 
Sbjct: 90  LVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 143
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSF 143
           NIL++ E + KI DFGLAKL P +  +   R  G +   + APE +     + ++DV+SF
Sbjct: 144 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 203
Query: 144 GVLVLEIIS 152
           GV++ E+ +
Sbjct: 204 GVVLYELFT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 115
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +          
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 172
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 122
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 239 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
Query: 236 LTAPG 240
           L   G
Sbjct: 284 LVIQG 288

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           LV EY+ +  L   L    +   +L+  +       I KG+ +L        VHRD+ A 
Sbjct: 91  LVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 144
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSF 143
           NIL++ E + KI DFGLAKL P +  +   R  G +   + APE +     + ++DV+SF
Sbjct: 145 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 204
Query: 144 GVLVLEIIS 152
           GV++ E+ +
Sbjct: 205 GVVLYELFT 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 126
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 127 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 243 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 287
Query: 236 LTAPG 240
           L   G
Sbjct: 288 LVIQG 292

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +RHP++++L          I+V EY  N   D ++        K++ ++       I   
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISA 125
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           + + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y A
Sbjct: 126 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 180
Query: 126 PEYVLGGQLTM--KADVYSFGVLVLEIISGR 154
           PE V+ G+L    + DV+S GV++  ++  R
Sbjct: 181 PE-VISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +RHP++++L          I+V EY  N   D ++        K++ ++       I   
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISA 124
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           + + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y A
Sbjct: 125 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 179
Query: 126 PEYVLGGQLTM--KADVYSFGVLVLEIISGR 154
           PE V+ G+L    + DV+S GV++  ++  R
Sbjct: 180 PE-VISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 83/175 (47%), Gaps = 33/175 (18%)
Query: 6   VRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGAT---KANIKLNWEKRSDI 58
           +RH N++  I   ++GT    +  L+ +Y EN SL   L   T   K+ +KL +   S  
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS-- 145
Query: 59  CVGIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                 GL  LH E+      P I HRD+K+ NIL+ +     I D GLA  F  +   +
Sbjct: 146 ------GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 114 ----TTRIAGTTGYLAPEYVLGGQLT-------MKADVYSFGVLVLEIISGRNSG 157
                TR+ GT  Y+ PE VL   L        + AD+YSFG+++ E+     SG
Sbjct: 200 DIPPNTRV-GTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 116
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 117 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 233 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 277
Query: 236 LTAPG 240
           L   G
Sbjct: 278 LVIQG 282

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------ 122
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 240 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
Query: 237 TAPG 240
              G
Sbjct: 285 VIQG 288

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKR 55
           HPN++ L+G C       L  EY  + +L            D     A      L+ ++ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 191
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 192 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 247
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           ++ EKPL   D         E+   M+    C +     RP   Q++  L +
Sbjct: 248 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLNR 287

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +RHP++++L          I+V EY  N   D ++        K++ ++       I   
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISA 119
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           + + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y A
Sbjct: 120 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 174
Query: 126 PEYVLGGQLTM--KADVYSFGVLVLEIISGR 154
           PE V+ G+L    + DV+S GV++  ++  R
Sbjct: 175 PE-VISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           LV EY+ +  L   L    +   +L+  +       I KG+ +L        VHRD+ A 
Sbjct: 103 LVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 156
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSF 143
           NIL++ E + KI DFGLAKL P +  +   R  G +   + APE +     + ++DV+SF
Sbjct: 157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 144 GVLVLEIIS 152
           GV++ E+ +
Sbjct: 217 GVVLYELFT 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKR 55
           HPN++ L+G C       L  EY  + +L            D     A      L+ ++ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 202 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 257
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           ++ EKPL   D         E+   M+    C +     RP   Q++  L +
Sbjct: 258 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLNR 297

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L    +   +   ++  ++C  +
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+    +        
Sbjct: 115 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  PE ++  + + K+D+++FGVL+ EI S
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 79  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 133
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 134 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           ++ V  P +  L+G C+  T +++         LD V    G   +   LNW      C+
Sbjct: 73  MAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CM 126
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAG 119
            IAKG+++L +     +VHRD+ A N+L+    + KI DFGLA+L   D   +       
Sbjct: 127 QIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              ++A E +L  + T ++DV+S+GV V E+++
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 119 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 147
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 148 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 264
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 265 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 309
Query: 237 TAPG 240
              G
Sbjct: 310 VIQG 313

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 124
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 242 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 286
Query: 237 TAPG 240
              G
Sbjct: 287 VIQG 290

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 81/152 (53%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V+L        R +LV+E+++ +   + LL   +  ++    K     + +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK--SFLLQL 109
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             G+A+ H+     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  I  T  
Sbjct: 110 LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLW 165
Query: 123 YLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           Y AP+ ++G  + +   D++S G +  E+++G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 71  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 125
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 126 VSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIK-LNWEKRSDI 58
           L  ++HPNLV L+    +  R  LV+EY ++   + LDR   G  +  +K + W+     
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ----- 110
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
                + + F H+    + +HRD+K  NIL+ +    K+ DFG A+L      +    +A
Sbjct: 111 ---TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 119 GTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
            T  Y +PE ++G  Q     DV++ G +  E++SG
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIK--------LNWEKRSDI 58
           H N+V L+G C + G   +++ E+ +  +L   L       +         L  E     
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITT 115
              +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +     
Sbjct: 150 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 207 RLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 125
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 126 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 242 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 286
Query: 236 LTAPG 240
           L   G
Sbjct: 287 LVIQG 291

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 125
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 243 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 287
Query: 237 TAPG 240
              G
Sbjct: 288 VIQG 291

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 128
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 129 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 245
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 246 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 290
Query: 237 TAPG 240
              G
Sbjct: 291 VIQG 294

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 129
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 247 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 291
Query: 237 TAPG 240
              G
Sbjct: 292 VIQG 295

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       +   +V E Y      D ++        + +    + I   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQ 129
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N T +  RI 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI- 184
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 192
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q   + RP   +++ +L  ++
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 129
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 130 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 246 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 290
Query: 236 LTAPG 240
           L   G
Sbjct: 291 LVIQG 295

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 122
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +          
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 117
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +          
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 65  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 119
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 120 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFR-QIVSAVQ 128
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++   +IVHRD+KA N+LLD + N KI DFG +  F   + +      G+  Y APE
Sbjct: 129 YCHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLDTFCGSPPYAAPE 183
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 117
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +          
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 61  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 115
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 116 VSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 117
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +          
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 192
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       +   +V E Y      D ++        + +    + I   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQ 129
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N T +  RI 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI- 184
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 59  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 113
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G  
Sbjct: 114 VSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 121 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       +   +V E Y      D ++        + +    + I   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQ 129
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N T +  RI 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI- 184
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 137 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 189
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 190 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 234
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++
Sbjct: 235 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 287

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 115
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +          
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF 172
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   +
Sbjct: 424 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQV 478
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
           + G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G   
Sbjct: 479 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
             + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSD------ 57
           H N+V L+G C       L++EY     L   L       ++  I+   +KR +      
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 58  -------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 108
                  +C    +AKG+ FL        VHRD+ A N+L+      KI DFGLA+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 109 NITHITTRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +  ++    A     ++APE +  G  T+K+DV+S+G+L+ EI S
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   +
Sbjct: 425 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQV 479
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
           + G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G   
Sbjct: 480 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
             + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 537 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 587

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIK--SYLFQL 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L + +  +    I L   K       +
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIK--SYLFQL 113
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 81/152 (53%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V+L        R +LV+E+++ +   + LL   +  ++    K     + +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK--SFLLQL 109
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             G+A+ H+     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  +  T  
Sbjct: 110 LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLW 165
Query: 123 YLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           Y AP+ ++G  + +   D++S G +  E+++G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 81/152 (53%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V+L        R +LV+E+++ +   + LL   +  ++    K     + +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK--SFLLQL 109
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             G+A+ H+     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  +  T  
Sbjct: 110 LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLW 165
Query: 123 YLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           Y AP+ ++G  + +   D++S G +  E+++G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           LV EY+ +  L   L    +   +L+  +       I KG+ +L        VHRD+ A 
Sbjct: 87  LVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 140
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSF 143
           NIL++ E + KI DFGLAKL P +      R  G +   + APE +     + ++DV+SF
Sbjct: 141 NILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 200
Query: 144 GVLVLEIIS 152
           GV++ E+ +
Sbjct: 201 GVVLYELFT 209

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + +++  +         
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 150 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 207 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN------------IK 49
            L  V HP++++L G C Q    +L+ EY +  SL   L  + K                
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 50  LNWEKRSDICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 101
           L+      + +G        I++G+ +L E     +VHRD+ A NIL+ +    KI DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG 195
Query: 102 LAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           L++   +  +++  R  G     ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 196 LSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------ 132
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 133 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 249
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 250 Q---------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 294
Query: 237 TAPG 240
              G
Sbjct: 295 VIQG 298

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C +    +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 65  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 119
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--PDNITHITTRIAG 119
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K     +N     T    
Sbjct: 120 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
              + APE +   + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKF-RQIVSAVQ 127
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPE 182
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 19/159 (11%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIK----------LNWEKRS 56
           H N+V L+G C + G   +++ E+ +  +L   L       +           L  E   
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHI 113
                +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +   
Sbjct: 152 XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 209 DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 125
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL             
Sbjct: 126 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 243 Q---------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 287
Query: 237 TAPG 240
              G
Sbjct: 288 VIQG 291

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 122
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 239 PQ---------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
Query: 236 LTAPG 240
           L   G
Sbjct: 284 LVIQG 288

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L   +  +    I L   K       +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIK--SYLFQL 112
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++HP+++EL           LV E   N  ++R L    K     +  +       I  G
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITG 124
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYL 124
           + +LH      I+HRD+  SN+LL +  N KI DFGLA +L   +  H T  + GT  Y+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           +PE        +++DV+S G +   ++ GR
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C       +V EY+   +L   L    +  +         +   I
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV--VLLYMATQI 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 140 SSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +     ++K+DV++FGVL+ EI +
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           + P L +L  C     R   V EYV    L    +   +   K    +       I+ GL
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL----MYHIQQVGKFKEPQAVFYAAEISIGL 133
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLA 125
            FLH+     I++RD+K  N++LD E + KI DFG+ K     +  +TTR   GT  Y+A
Sbjct: 134 FFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIA 188
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           PE +         D +++GVL+ E+++G+
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L   +  +    I L   K       +
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIK--SYLFQL 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKF-RQIVSAVQ 127
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPE 182
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKF-RQIVSAVQ 127
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPE 182
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIK--------LNWEKRSDI 58
           H N+V L+G C + G   +++ E+ +  +L   L       +         L  E     
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITT 115
              +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +     
Sbjct: 150 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 207 RLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-LGATKANIKLNWEKRS--- 56
           M  + ++HPN+V L+G   +     +++ Y  +  L   L + +  +++    + R+   
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 57  --------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFP 107
                    +   IA G+ +L      H+VH+D+   N+L+  + N KI D GL + ++ 
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            +   +         ++APE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKF-RQIVSAVQ 127
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPE 182
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           L+ EY     +   L+   +   K   E RS     I   + 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKF-RQIVSAVQ 125
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F   +        G+  Y APE
Sbjct: 126 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDTFCGSPPYAAPE 180
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 36/241 (14%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKG 192
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
            E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++  +  E+
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297
Query: 237 T 237
           +
Sbjct: 298 S 298

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 205 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T +++         LD V     K NI     LNW     
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 119
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IA+G+ +L +     +VHRD+ A N+L+    + KI DFGLAKL            
Sbjct: 120 -CVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 235
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 236 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 280
Query: 236 LTAPG 240
           L   G
Sbjct: 281 LVIQG 285

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 196 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-LGATKANIKLNWEKRS--- 56
           M  + ++HPN+V L+G   +     +++ Y  +  L   L + +  +++    + R+   
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 57  --------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFP 107
                    +   IA G+ +L      H+VH+D+   N+L+  + N KI D GL + ++ 
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            +   +         ++APE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 196 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 192
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 205 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN------------IK 49
            L  V HP++++L G C Q    +L+ EY +  SL   L  + K                
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 50  LNWEKRSDICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 101
           L+      + +G        I++G+ +L E     +VHRD+ A NIL+ +    KI DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFG 195
Query: 102 LAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           L++    ++    + +  + G     ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 196 LSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 3   LSNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L    HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKD 124
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           +     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++  +     T +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPV 179
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQL 175
             T  Y APE +L        D++S G +  E+   +    G +   Q+ K + +     
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLP 238
Query: 176 HQEEKPLELVDPELGEYPPN 195
            +++ P ++  P  G +PP 
Sbjct: 239 PEDDWPRDVSLPR-GAFPPR 257

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHP++++L       T  ++V EY      D ++        ++  ++       I
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV-----EKKRMTEDEGRRFFQQI 117
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              + + H      IVHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  
Sbjct: 118 ICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPN 172
Query: 123 YLAPEYVLGGQLTM--KADVYSFGVLVLEIISGR 154
           Y APE V+ G+L    + DV+S G+++  ++ GR
Sbjct: 173 YAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN------------IK 49
            L  V HP++++L G C Q    +L+ EY +  SL   L  + K                
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 50  LNWEKRSDICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 101
           L+      + +G        I++G+ +L E     +VHRD+ A NIL+ +    KI DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG 195
Query: 102 LAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           L++    ++    + +  + G     ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 196 LSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 116
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L   +  +    I L   K       +
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIK--SYLFQL 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 139 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 191
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 236
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++
Sbjct: 237 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKR 55
           HPN++ L+G C       L  EY  + +L            D     A      L+ ++ 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 +A+G+ +L ++     +HR++ A NIL+ + +  KI DFGL++     +     
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 198
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 199 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 254
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           ++ EKPL   D         E+   M+    C +     RP   Q++  L +
Sbjct: 255 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLNR 294

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 117
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 116
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKF-RQIVSAVQ 127
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G   Y APE
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPE 182
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 116
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+V+L+       +  LV+E++  + L   +  +    I L   K       +
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIK--SYLFQL 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 123 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
           Y APE +LG +    A D++S G +  E+++ R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 184
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 185 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 242 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 115
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 117
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 205 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 117
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 117
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 116
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 116
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 117
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 196 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 115
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 115
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 116
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 115
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 118
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 118
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 8   HPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 57
           H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +         
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 58  ---ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 109
              IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 196 VRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 118
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 115
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L++V HP +V+L        +  L+ +++    L           +    E        +
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAEL 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A GL  LH      I++RD+K  NILLD+E + K+ DFGL+K   D+     +   GT  
Sbjct: 140 ALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVE 195
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           Y+APE V     +  AD +S+GVL+ E+++G
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           L+ EY     +   L+   +   K   E RS     I   + 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKF-RQIVSAVQ 128
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F   +        G   Y APE
Sbjct: 129 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPE 183
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW----- 126
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFG AKL            
Sbjct: 127 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 243 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 287
Query: 236 LTAPG 240
           L   G
Sbjct: 288 LVIQG 292

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 124
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFG AKL            
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 241 PQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 285
Query: 236 LTAPG 240
           L   G
Sbjct: 286 LVIQG 290

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGV 117
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 125
            +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 126 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           PE +   +   +  DV+S G+++  +++G
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
           + H N+V+  G   +G  + L  EY     L DR+     + +I +           +  
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA 115
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGY 123
           G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 124 LAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
           +APE +   +   +  DV+S G+++  +++G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 366
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  + +L ++   + +HR++ A N L+ +    K+ DFGL++L   +             
Sbjct: 367 SSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 423
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V HP +V+L        +  L+ +++    L   L       +    E        +
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAEL 135
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGT 120
           A  L  LH      I++RD+K  NILLD+E + K+ DFGL+K   ++I H        GT
Sbjct: 136 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGT 189
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             Y+APE V     T  AD +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           RHP++++L       T   +V EYV    L   +    +       E R  +   I   +
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARR-LFQQILSAV 124
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
            + H  +V   VHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  Y AP
Sbjct: 125 DYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 179
Query: 127 EYVLGGQLTM--KADVYSFGVLVLEIISG 153
           E V+ G+L    + D++S GV++  ++ G
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 122
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFG AKL             
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 240 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
Query: 237 TAPG 240
              G
Sbjct: 285 VIQG 288

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 24/230 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L    HPN+V LIG C Q     +V E V+       L        +L  +    +    
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDA 222
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-T 121
           A G+ +L  +     +HRD+ A N L+ ++   KI DFG+++   D +   +  +     
Sbjct: 223 AAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV 279
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
            + APE +  G+ + ++DV+SFG+L+ E  S G +    +  Q  +  +         EK
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---------EK 330
Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
              L  PEL    P+ + R M+    C      +RP  + + + L ++IR
Sbjct: 331 GGRLPCPELC---PDAVFRLMEQ---CWAYEPGQRPSFSTIYQEL-QSIR 373

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+V+L           LV EY     +   L+   +   K   E R+     I   + 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK---EARAKF-RQIVSAVQ 127
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
           + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G   Y APE
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPE 182
Query: 128 YVLGGQLTM-KADVYSFGVLVLEIISG 153
              G +    + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +  + ++       I
Sbjct: 205 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEI 260
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T  T    GT 
Sbjct: 261 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 316
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/79 (44%), Positives = 50/79 (63%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQL 134
           I++RD+K  NILLD+E + K+ DFGL+K   ++I H        GT  Y+APE V     
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 135 TMKADVYSFGVLVLEIISG 153
           T  AD +SFGVL+ E+++G
Sbjct: 205 TQSADWWSFGVLMFEMLTG 223

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +  + ++       I
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEI 257
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T  T    GT 
Sbjct: 258 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 313
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 139 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 130 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 129
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFG AKL             
Sbjct: 130 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 247 Q---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 291
Query: 237 TAPG 240
              G
Sbjct: 292 VIQG 295

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/79 (44%), Positives = 50/79 (63%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQL 134
           I++RD+K  NILLD+E + K+ DFGL+K   ++I H        GT  Y+APE V     
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 135 TMKADVYSFGVLVLEIISG 153
           T  AD +SFGVL+ E+++G
Sbjct: 204 TQSADWWSFGVLMFEMLTG 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSD 57
            +++V +P++  L+G C+  T ++++        LD V     K NI     LNW     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR--EHKDNIGSQYLLNW----- 124
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFG AKL            
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 118 AGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
                 ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            Q               PP   I    +   C    A  RP+  ++I   +K  R  +  
Sbjct: 241 PQ---------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 285
Query: 236 LTAPG 240
           L   G
Sbjct: 286 LVIQG 290

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG---I 62
           + HPN+V+L           LV EY     +   L+          W K  +       I
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-------GWMKEKEARAKFRQI 115
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              + + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  
Sbjct: 116 VSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPP 170
Query: 123 YLAPEYVLGGQLTM-KADVYSFGVLVLEIISG 153
           Y APE   G +    + DV+S GV++  ++SG
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 24/230 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L    HPN+V LIG C Q     +V E V+       L        +L  +    +    
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDA 222
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-T 121
           A G+ +L  +     +HRD+ A N L+ ++   KI DFG+++   D +   +  +     
Sbjct: 223 AAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
            + APE +  G+ + ++DV+SFG+L+ E  S G +    +  Q  +  +         EK
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---------EK 330
Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
              L  PEL    P+ + R M+    C      +RP  + + + L ++IR
Sbjct: 331 GGRLPCPELC---PDAVFRLMEQ---CWAYEPGQRPSFSTIYQEL-QSIR 373

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 141 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           RHP++++L       T   +V EYV    L   +    +       E R  +   I   +
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARR-LFQQILSAV 124
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
            + H  +V   VHRD+K  N+LLD   N KI DFGL+ +  D          G+  Y AP
Sbjct: 125 DYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRDSCGSPNYAAP 179
Query: 127 EYVLGGQLTM--KADVYSFGVLVLEIISG 153
           E V+ G+L    + D++S GV++  ++ G
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 8   HPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HP L +L  CC Q   R+  V E+V    L    +   + + + +  +       I   L
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYL 124
            FLH++    I++RD+K  N+LLD E + K+ DFG+ K   + I +   T    GT  Y+
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYI 191
Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
           APE +         D ++ GVL+ E++ G    +A
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 22/163 (13%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 69
           N V+ +    + +   +  EY EN +L  ++      N+    ++   +   I + L+++
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENRTLYDLI---HSENLNQQRDEYWRLFRQILEALSYI 132
Query: 70  HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--------------LFPDNITHITT 115
           H +    I+HRD+K  NI +D+  N KIGDFGLAK                P +  ++T+
Sbjct: 133 HSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 116 RIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSG 157
            I GT  Y+A E + G G    K D+YS G++  E+I   ++G
Sbjct: 190 AI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 66/153 (43%), Gaps = 10/153 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 62  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 117
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH      +V+RDIK  N++LD++ + KI DFGL K    D  T  T    GT 
Sbjct: 118 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTP 172
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ +        R  L+ E+     L + L    + + + + ++ +     +A
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELA 125
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L + HE  V   +HRDIK  N+L+  +   KI DFG +   P   +     + GT  Y
Sbjct: 126 DALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDY 179
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           L PE + G     K D++  GVL  E + G
Sbjct: 180 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDIC 59
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +    L +     + 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 324
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I+  + +L ++   + +HR++ A N L+ +    K+ DFGL++L   +          
Sbjct: 325 TQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 66/153 (43%), Gaps = 10/153 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH      +V+RDIK  N++LD++ + KI DFGL K    D  T  T    GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTP 169
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           S++RHPN++ +        R  L+ E+     L + L    + + + + ++ +     +A
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELA 124
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L + HE  V   +HRDIK  N+L+  +   KI DFG +   P   +     + GT  Y
Sbjct: 125 DALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDY 178
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           L PE + G     K D++  GVL  E + G
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 32/244 (13%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDI 58
           +++V +P++  L+G C+  T +++         LD V     K NI     LNW      
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNW------ 124
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           CV IAKG+ +L +     +VHRD+ A N+L+    + KI DFG AKL             
Sbjct: 125 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 119 GT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH 176
                ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 236
           Q               PP   I    +   C    A  RP+  ++I   +K  R  +  L
Sbjct: 242 Q---------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 286
Query: 237 TAPG 240
              G
Sbjct: 287 VIQG 290

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 14/130 (10%)
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           + V I K L +L E+    ++HRD+K SNILLD+    K+ DFG++    D+      R 
Sbjct: 129 MTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRS 184
Query: 118 AGTTGYLAPEYVLGGQLT-----MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 172
           AG   Y+APE +     T     ++ADV+S G+ ++E+ +G+   K       K   E  
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-----KTDFEVL 239
Query: 173 WQLHQEEKPL 182
            ++ QEE PL
Sbjct: 240 TKVLQEEPPL 249

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 66/153 (43%), Gaps = 10/153 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH      +V+RDIK  N++LD++ + KI DFGL K    D  T  T    GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTP 169
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 22/163 (13%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 69
           N V+ +    + +   +  EY EN +L  ++      N+    ++   +   I + L+++
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYI 132
Query: 70  HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--------------LFPDNITHITT 115
           H +    I+HRD+K  NI +D+  N KIGDFGLAK                P +  ++T+
Sbjct: 133 HSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 116 RIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSG 157
            I GT  Y+A E + G G    K D+YS G++  E+I   ++G
Sbjct: 190 AI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 18/158 (11%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDI 58
           L +++H N++ L+      T      E   +  L   L+GA   NI    KL  +    +
Sbjct: 104 LKHMKHENVIGLLDVFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 159
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 117
              I +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR 
Sbjct: 160 IYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 215
Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
                Y APE +L      M  D++S G ++ E+++GR
Sbjct: 216 ----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHR++ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 141 ADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 193
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 194 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 238
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q   + RP   +++ +L  ++
Sbjct: 239 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 291

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDI 58
           L++  HPN+V+L+          ++ E+    ++D V+L      T++ I++       +
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------V 140
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C      L +LH+     I+HRD+KA NIL   + + K+ DFG++     N   I  R +
Sbjct: 141 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDS 194
Query: 119 --GTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI 150
             GT  ++APE V+           KADV+S G+ ++E+
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDI 58
           L++  HPN+V+L+          ++ E+    ++D V+L      T++ I++       +
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------V 140
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           C      L +LH+     I+HRD+KA NIL   + + K+ DFG++      I    + I 
Sbjct: 141 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI- 196
Query: 119 GTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI 150
           GT  ++APE V+           KADV+S G+ ++E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 60/132 (45%), Gaps = 9/132 (6%)
Query: 25  ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 84
           +L  EY E   L R  L   +    L       +   I+  L +LHE     I+HRD+K 
Sbjct: 95  LLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKP 150
Query: 85  SNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVY 141
            NI+L    Q    KI D G AK    +   + T   GT  YLAPE +   + T+  D +
Sbjct: 151 ENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYW 208
Query: 142 SFGVLVLEIISG 153
           SFG L  E I+G
Sbjct: 209 SFGTLAFECITG 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 64  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 119
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGT 120
              L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT
Sbjct: 120 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 173
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YLAPE +         D +  GV++ E++ GR
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGT 120
              L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 168
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YLAPE +         D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 62
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A G+A+L+ +     VHR++ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 140 ADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 192
Query: 123 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 178 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            E+ L+ V D    + P N   R   +   C Q   + RP   +++ +L  ++
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           ++ +RH NLV+L+G  V+    + +V EY+   SL   L   ++    L  +      + 
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLD 110
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++    
Sbjct: 111 VCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--V 163
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE +   + + K+DV+SFG+L+ EI S
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 60/132 (45%), Gaps = 9/132 (6%)
Query: 25  ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 84
           +L  EY E   L R  L   +    L       +   I+  L +LHE     I+HRD+K 
Sbjct: 94  LLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKP 149
Query: 85  SNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVY 141
            NI+L    Q    KI D G AK    +   + T   GT  YLAPE +   + T+  D +
Sbjct: 150 ENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYW 207
Query: 142 SFGVLVLEIISG 153
           SFG L  E I+G
Sbjct: 208 SFGTLAFECITG 219

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           ++ +RH NLV+L+G  V+    + +V EY+   SL   L   ++    L  +      + 
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLD 125
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++    
Sbjct: 126 VCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--V 178
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE +   + + K+DV+SFG+L+ EI S
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 24/159 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDI 58
           L++  HPN+V+L+          ++ E+    ++D V+L      T++ I++       +
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------V 140
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-- 116
           C      L +LH+     I+HRD+KA NIL   + + K+ DFG++     N   I  R  
Sbjct: 141 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDX 194
Query: 117 IAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI 150
             GT  ++APE V+           KADV+S G+ ++E+
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDI 58
           N  H  +V L+G   QG   +++ E +    L    R L  A   N  L   +  K   +
Sbjct: 86  NCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        
Sbjct: 144 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK 196
Query: 119 GTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGT 120
              L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 168
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YLAPE +         D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 9   PNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGL 66
           P L +L  C     R   V EYV    L   +  +G  K    + +         IA GL
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGL 134
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR-IAGTTGYL 124
            FL  +    I++RD+K  N++LD E + KI DFG+ K   +NI   +TT+   GT  Y+
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYI 188
Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           APE +         D ++FGVL+ E+++G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +    E+       I
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEI 114
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGT 120
              L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 168
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             YLAPE +         D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           ++ +RH NLV+L+G  V+    + +V EY+   SL   L   ++    L  +      + 
Sbjct: 59  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLD 116
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++    
Sbjct: 117 VCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PV 169
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE +     + K+DV+SFG+L+ EI S
Sbjct: 170 KWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 3   LSNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L    HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKD 116
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           +     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++   +      +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV 173
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQL 175
             T  Y APE +L        D++S G +  E+   +    G +   Q+ K + +     
Sbjct: 174 --TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLP 230
Query: 176 HQEEKPLELVDPELGEYPPN 195
            +++ P ++  P  G +PP 
Sbjct: 231 PEDDWPRDVSLPR-GAFPPR 249

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           +++H N+V+ +G   +     +  E V   SL   LL +    +K N +        I +
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGY 123
           GL +LH+     IVHRDIK  N+L++      KI DFG +K     I   T    GT  Y
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQY 189
Query: 124 LAPEYVLGG--QLTMKADVYSFGVLVLEIISGR 154
           +APE +  G       AD++S G  ++E+ +G+
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L  C     +      Y +N  L + +  +G+        +        
Sbjct: 91  MSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 144
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 145 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 3   LSNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L    HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKD 116
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           +     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++  +       +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPV 171
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQL 175
             T  Y APE +L        D++S G +  E+   +    G +   Q+ K + +     
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLP 230
Query: 176 HQEEKPLELVDPELGEYPPN 195
            +++ P ++  P  G +PP 
Sbjct: 231 PEDDWPRDVSLPR-GAFPPR 249

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           ++ +RH NLV+L+G  V+    + +V EY+   SL   L   ++    L  +      + 
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLD 297
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++    
Sbjct: 298 VCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--V 350
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE +   + + K+DV+SFG+L+ EI S
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           +++H N+V+ +G   +     +  E V   SL   LL +    +K N +        I +
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILE 119
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGY 123
           GL +LH+     IVHRDIK  N+L++      KI DFG +K     I   T    GT  Y
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQY 175
Query: 124 LAPEYVLGG--QLTMKADVYSFGVLVLEIISGR 154
           +APE +  G       AD++S G  ++E+ +G+
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L  A   N  L   +  K   +   IA
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 191
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 192 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 9   PNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGL 66
           P L +L  C     R   V EYV    L   +  +G  K    + +         IA GL
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGL 455
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR-IAGTTGYL 124
            FL  +    I++RD+K  N++LD E + KI DFG+ K   +NI   +TT+   GT  Y+
Sbjct: 456 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYI 509
Query: 125 APEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           APE +         D ++FGVL+ E+++G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 58  ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 112
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 201 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 257
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 258 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S + H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 160 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 212
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 58  ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 112
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 203 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 259
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 260 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 56
           L NV+HP LV L        +   V +Y+    L      +R  L           E R+
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-----------EPRA 141
Query: 57  DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--I 113
                 IA  L +LH     +IV+RD+K  NILLD + +  + DFGL K   +NI H   
Sbjct: 142 RFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNST 195
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG------RNSGKAMWGQMNK 166
           T+   GT  YLAPE +         D +  G ++ E++ G      RN+ +     +NK
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S + H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 146 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 198
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 58  ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 112
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 253 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGL 186
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 187 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 13/154 (8%)
Query: 3   LSNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L    HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKD 116
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           +     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++  +       +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPV 171
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
             T  Y APE +L        D++S G +  E+ 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 58  ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 112
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 194 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 250
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 251 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V+HP +V+LI     G +  L+ EY+    L    +   +  I +  +        I
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFME-DTACFYLAEI 130
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  L  LH++    I++RD+K  NI+L+ + + K+ DFGL K    + T +T    GT  
Sbjct: 131 SMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIE 186
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           Y+APE ++        D +S G L+ ++++G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V+HP +V+LI     G +  L+ EY+    L    +   +  I +  +        I
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFME-DTACFYLAEI 130
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           +  L  LH++    I++RD+K  NI+L+ + + K+ DFGL K    + T +T    GT  
Sbjct: 131 SMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIE 186
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           Y+APE ++        D +S G L+ ++++G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 172 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 224
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 118
           +A+G+ FL        +HRD+ A NILL +    KI DFGLA+     PD +    TR+ 
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               ++APE +     + K+DV+S+GVL+ EI S
Sbjct: 265 --LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 145 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 197
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDI 58
           N  H  +V L+G   QG   +++ E +    L    R L    + N  L   +  K   +
Sbjct: 80  NCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        
Sbjct: 138 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRK 190
Query: 119 GTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 1   MTLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 58
           + +  + HPN++ LIG  +  +G   +L+      + L  +        +K         
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK----DLISF 129
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-----ITHI 113
            + +A+G+ +L E+     VHRD+ A N +LD+ F  K+ DFGLA+   D        H 
Sbjct: 130 GLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 173
             R+     + A E +   + T K+DV+SFGVL+ E+++    G   +  ++ F L    
Sbjct: 187 HARLP--VKWTALESLQTYRFTTKSDVWSFGVLLWELLT---RGAPPYRHIDPFDLT--- 238
Query: 174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 222
             H   +   L  P   EY P+ + + M+    C +A  + RP    ++
Sbjct: 239 --HFLAQGRRLPQP---EYCPDSLYQVMQQ---CWEADPAVRPTFRVLV 279

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+S +RHP LV L          +++YE++    L          + K++ ++  +    
Sbjct: 101 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQ 157
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGL-AKLFPDNITHITTRIA 118
           + KGL  +HE    + VH D+K  NI+   + +   K+ DFGL A L P     +TT   
Sbjct: 158 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 211
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  + APE   G  +    D++S GVL   ++SG
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 145 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 197
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 3   LSNVRHPNLVE----LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 58
           L   RH N++     L    ++  R + + + +    L ++L     +N  + +      
Sbjct: 95  LLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----F 149
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTR 116
              I +GL ++H     +++HRD+K SN+L++   + KI DFGLA++      H    T 
Sbjct: 150 LYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTE 206
Query: 117 IAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
              T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 207 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 160 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 212
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 160 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 212
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 136
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 137 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 189
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 190 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 146 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 198
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 161
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 162 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 214
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +  + ++       I
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEI 118
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T       GT 
Sbjct: 119 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTP 174
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +  + ++       I
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEI 119
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T       GT 
Sbjct: 120 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTP 175
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L       ++  +  + ++       I
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEI 117
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTT 121
              L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T       GT 
Sbjct: 118 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTP 173
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YLAPE +         D +  GV++ E++ GR
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+S +RHP LV L          +++YE++    L          + K++ ++  +    
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQ 263
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGL-AKLFPDNITHITTRIA 118
           + KGL  +HE    + VH D+K  NI+   + +   K+ DFGL A L P     +TT   
Sbjct: 264 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 317
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  + APE   G  +    D++S GVL   ++SG
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 151
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 152 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAS 204
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 205 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 4/150 (2%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+++     ++     +V E  +   L R++    K    +         V +
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L  +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 201
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           Y++PE +       K+D++S G L+ E+ +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T        
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 8/112 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++  PD + T        
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 120 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           T  Y APE +L  +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 146 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ---DIYRAS 198
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 186 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAG 238
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDI 58
           N  H  +V L+G   QG   +++ E +    L    R L    + N  L   +  K   +
Sbjct: 86  NCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 143
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        
Sbjct: 144 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK 196
Query: 119 GTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 116
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 113
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 114 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--- 57
           + +S   H N+V  IG  +Q   R ++ E +    L   L        + +     D   
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 162
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHI 113
           +   IA G  +L E    H +HRDI A N LL     P    KIGDFG+A+   D     
Sbjct: 163 VARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAG 215
Query: 114 TTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             R  G       ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 216 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 116
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 91  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 144
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 145 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 201
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 202 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 46/81 (56%), Gaps = 5/81 (6%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQ 133
           I+HRD+K  NILLD+  +  I DF +A + P   T ITT +AGT  Y+APE      G  
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT-MAGTKPYMAPEMFSSRKGAG 193
Query: 134 LTMKADVYSFGVLVLEIISGR 154
            +   D +S GV   E++ GR
Sbjct: 194 YSFAVDWWSLGVTAYELLRGR 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 118
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 175
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 176 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 119
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 120 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 176
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 177 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 140 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 192
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 193 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILY 121
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 122 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDI 58
           N  H  +V L+G   QG   +++ E +    L    R L    + N  L   +  K   +
Sbjct: 79  NCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        
Sbjct: 137 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK 189
Query: 119 GTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 188
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 194
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----GATKANIKLNWEKRS 56
            +S   HPN+V      V      LV + +   S+  ++      G  K+ + L+    +
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIA 124
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP--DNITHIT 114
            I   + +GL +LH+      +HRD+KA NILL ++ + +I DFG++       +IT   
Sbjct: 125 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 115 TR--IAGTTGYLAPEY---VLGGQLTMKADVYSFGVLVLEIISG 153
            R    GT  ++APE    V G     KAD++SFG+  +E+ +G
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRG--YDFKADIWSFGITAIELATG 223

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 195
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 196 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKFSLDLA----SLILY 116
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++  
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----GATKANIKLNWEKRS 56
            +S   HPN+V      V      LV + +   S+  ++      G  K+ + L+    +
Sbjct: 61  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIA 119
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP--DNITHIT 114
            I   + +GL +LH+      +HRD+KA NILL ++ + +I DFG++       +IT   
Sbjct: 120 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 115 TR--IAGTTGYLAPEY---VLGGQLTMKADVYSFGVLVLEIISG 153
            R    GT  ++APE    V G     KAD++SFG+  +E+ +G
Sbjct: 177 VRKTFVGTPCWMAPEVMEQVRG--YDFKADIWSFGITAIELATG 218

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 17/156 (10%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI---KLNWEKRSD 57
           +T+    HP++V+LIG   +    I+         ++   LG  ++ +   K + +  S 
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASL 493
Query: 58  ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
           I     ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  +
Sbjct: 494 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
           +      ++APE +   + T  +DV+ FGV + EI+
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 34/171 (19%)
Query: 8   HPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           H N+V L+        R   LV++Y+E +     L    +ANI L    +  +   + K 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANI-LEPVHKQYVVYQLIKV 121
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI-------- 117
           + +LH      ++HRD+K SNILL+ E + K+ DFGL++ F  NI  +T  I        
Sbjct: 122 IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV-NIRRVTNNIPLSINENT 177
Query: 118 -------------AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
                          T  Y APE +LG  + T   D++S G ++ EI+ G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 3   LSNVRHPNLVELIGC---CVQGTRRI-LVYEYVENNSLDRVLLGATKANIKL--NWEKRS 56
           L  ++HPN+V         V+G + I LV E   + +L   L       IK+  +W    
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW---- 134
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITT 115
             C  I KGL FLH    P I+HRD+K  NI +       KIGD GLA L          
Sbjct: 135 --CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAK 188
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 149
            + GT  + APE     +     DVY+FG   LE
Sbjct: 189 AVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G  G 
Sbjct: 171 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 223
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 224 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 74/136 (54%), Gaps = 11/136 (8%)
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           I V I K L  LH +L   ++HRD+K SN+L++     K+ DFG++    D++    T  
Sbjct: 158 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TID 213
Query: 118 AGTTGYLAPEYV---LGGQ-LTMKADVYSFGVLVLEIISGR---NSGKAMWGQMNKFLLE 170
           AG   Y+APE +   L  +  ++K+D++S G+ ++E+   R   +S    + Q+ + + E
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 273
Query: 171 WAWQLHQEEKPLELVD 186
            + QL  ++   E VD
Sbjct: 274 PSPQLPADKFSAEFVD 289

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 6   VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I    +     T+  LV +Y E+ SL   L   T     +  E    + + 
Sbjct: 55  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 109
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHI 113
            A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I   
Sbjct: 110 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 169
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMK-------ADVYSFGVLVLEI 150
                GT  Y+APE VL   + MK       AD+Y+ G++  EI
Sbjct: 170 PNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S I  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKFSLDLA----SLILY 116
Query: 61  G--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+     ++  
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGK 173
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
               ++APE +   + T  +DV+ FGV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 6   VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I    +     T+  LV +Y E+ SL   L   T     +  E    + + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 147
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHI 113
            A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I   
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMK-------ADVYSFGVLVLEI 150
                GT  Y+APE VL   + MK       AD+Y+ G++  EI
Sbjct: 208 PNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 6   VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I    +     T+  LV +Y E+ SL   L   T     +  E    + + 
Sbjct: 60  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 114
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHI 113
            A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I   
Sbjct: 115 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 174
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMK-------ADVYSFGVLVLEI 150
                GT  Y+APE VL   + MK       AD+Y+ G++  EI
Sbjct: 175 PNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 6   VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I    +     T+  LV +Y E+ SL   L   T     +  E    + + 
Sbjct: 54  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 108
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHI 113
            A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I   
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMK-------ADVYSFGVLVLEI 150
                GT  Y+APE VL   + MK       AD+Y+ G++  EI
Sbjct: 169 PNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 6   VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I    +     T+  LV +Y E+ SL   L   T     +  E    + + 
Sbjct: 80  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 134
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHI 113
            A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I   
Sbjct: 135 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 194
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMK-------ADVYSFGVLVLEI 150
                GT  Y+APE VL   + MK       AD+Y+ G++  EI
Sbjct: 195 PNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 15/150 (10%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HPN+++L           LV E  +   L D ++       +K N    + I   +  G+
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGV 149
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 123
            +LH+    +IVHRD+K  N+LL+ +      KI DFGL+ +F +N   +  R+ GT  Y
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYY 204
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           +APE VL  +   K DV+S GV++  +++G
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 17/156 (10%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI---KLNWEKRSD 57
           +T+    HP++V+LIG   +    I+         ++   LG  ++ +   K + +  S 
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASL 493
Query: 58  ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
           I     ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  +
Sbjct: 494 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
           +      ++APE +   + T  +DV+ FGV + EI+
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 6   VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I    +     T+  LV +Y E+ SL   L   T     +  E    + + 
Sbjct: 57  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 111
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHI 113
            A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I   
Sbjct: 112 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 171
Query: 114 TTRIAGTTGYLAPEYVLGGQLTMK-------ADVYSFGVLVLEI 150
                GT  Y+APE VL   + MK       AD+Y+ G++  EI
Sbjct: 172 PNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       T   LV E V    L DR++     +         +D    
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE-----RDAADAVKQ 156
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIA 118
           I + +A+LHE     IVHRD+K  N+L      +   KI DFGL+K+    +   T  + 
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VC 211
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT GY APE + G     + D++S G++   ++ G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
            L  ++HPN+V L      G    L+ + V    L DR++               S +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIF 123
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            +   + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +  
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA 178
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT GY+APE +     +   D +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIA 63
           ++V L+G   QG   +++ E +    L    R L    + N  L   +  K   +   IA
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 122
            G+A+L+       VHRD+ A N  + ++F  KIGDFG+ +    +I        G  G 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 188
Query: 123 ----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 14/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  ++HPN+V L      G    L+ + V    L DR++               S +   
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIFQ 124
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +   + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT GY+APE +     +   D +S GV+   ++ G
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 69
           N V+      + +   +  EY EN +L  ++      N+    ++   +   I + L+++
Sbjct: 76  NFVKPXTAVKKKSTLFIQXEYCENRTLYDLI---HSENLNQQRDEYWRLFRQILEALSYI 132
Query: 70  HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--------------LFPDNITHITT 115
           H +    I+HR++K  NI +D+  N KIGDFGLAK                P +  ++T+
Sbjct: 133 HSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 116 RIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSG 157
            I GT  Y+A E + G G    K D YS G++  E I   ++G
Sbjct: 190 AI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTG 231

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
            L  ++HPN+V L      G    L+ + V    L DR++               S +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIF 123
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            +   + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +  
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA 178
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT GY+APE +     +   D +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
            L  ++HPN+V L      G    L+ + V    L DR++               S +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIF 123
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRI 117
            +   + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +  
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA 178
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT GY+APE +     +   D +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 27/148 (18%)
Query: 25  ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL------VPHIV 78
           +LV EY  N SL + L   T      +W     +   + +GLA+LH EL       P I 
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142
Query: 79  HRDIKASNILLDQEFNPKIGDFGLAKLF-------PDNITHITTRIAGTTGYLAPEYVLG 131
           HRD+ + N+L+  +    I DFGL+          P    +      GT  Y+APE VL 
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLE 201
Query: 132 GQLTMK--------ADVYSFGVLVLEII 151
           G + ++         D+Y+ G++  EI 
Sbjct: 202 GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY------TA 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +     +  +D+++ G ++ ++++G
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 13/137 (9%)
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           I V I K L  LH +L   ++HRD+K SN+L++     K+ DFG++    D++       
Sbjct: 114 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-- 169
Query: 118 AGTTGYLAPEYV---LGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWG----QMNKFLL 169
           AG   Y+APE +   L  +  ++K+D++S G+ ++E+   R    + WG    Q+ + + 
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-WGTPFQQLKQVVE 228
Query: 170 EWAWQLHQEEKPLELVD 186
           E + QL  ++   E VD
Sbjct: 229 EPSPQLPADKFSAEFVD 245

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 125 APEYVLGG-QLTMKADVYSFGVLVLEIISGRN 155
           APE +  G      AD +S G ++ +++ G +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+
Sbjct: 303 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 356
Query: 125 APEYVLGG-QLTMKADVYSFGVLVLEIISGRN 155
           APE +  G      AD +S G ++ +++ G +
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 125 APEYVLGG-QLTMKADVYSFGVLVLEIISGRN 155
           APE +  G      AD +S G ++ +++ G +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 125 APEYVLGG-QLTMKADVYSFGVLVLEIISGRN 155
           APE +  G      AD +S G ++ +++ G +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           LV E+    S+  ++       +K  W   + IC  I +GL+ LH+  V   +HRDIK  
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQHKV---IHRDIKGQ 158
Query: 86  NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-----LTMKADV 140
           N+LL +    K+ DFG++      +    T I GT  ++APE +   +        K+D+
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 141 YSFGVLVLEIISG 153
           +S G+  +E+  G
Sbjct: 218 WSLGITAIEMAEG 230

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 31/163 (19%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N++EL        R  L++EY EN             ++K   +K  D+ + +
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-------------DLKKYMDKNPDVSMRV 133
Query: 63  AK--------GLAFLHEELVPHIVHRDIKASNILL---DQEFNP--KIGDFGLAKLFPDN 109
            K        G+ F H       +HRD+K  N+LL   D    P  KIGDFGLA+ F   
Sbjct: 134 IKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 110 ITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 151
           I   T  I  T  Y  PE +LG +  +   D++S   +  E++
Sbjct: 191 IRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 115 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 171
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 172 KILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 154 R 154
           R
Sbjct: 227 R 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 18/158 (11%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDI 58
           L +++H N++ L+        R L  E   +  L   L+GA   NI    KL  +    +
Sbjct: 75  LKHMKHENVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 117
              I +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 186
Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
                Y APE +L         D++S G ++ E+++GR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 115 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 171
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 172 KILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 154 R 154
           R
Sbjct: 227 R 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 113 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXEL 169
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 170 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 154 R 154
           R
Sbjct: 225 R 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 18/158 (11%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDI 58
           L +++H N++ L+        R L  E   +  L   L+GA   NI    KL  +    +
Sbjct: 86  LKHMKHENVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 117
              I +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR 
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 197
Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
                Y APE +L         D++S G ++ E+++GR
Sbjct: 198 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 113 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXEL 169
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 170 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 154 R 154
           R
Sbjct: 225 R 225

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 116
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 117 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 117
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 118 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I KG+ ++H +    ++HRD+K SNI L      KIGDFGL     ++     TR  GT 
Sbjct: 145 ITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTL 199
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
            Y++PE +       + D+Y+ G+++ E++
Sbjct: 200 RYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 115 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 171
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 172 KILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 154 R 154
           R
Sbjct: 227 R 227

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 115
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 116 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 115 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 171
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 172 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 154 R 154
           R
Sbjct: 227 R 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 113 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 169
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 170 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 154 R 154
           R
Sbjct: 225 R 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 107 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 163
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 164 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218
Query: 154 R 154
           R
Sbjct: 219 R 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 114
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 115 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 114 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 170
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 171 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 154 R 154
           R
Sbjct: 226 R 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 110 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 166
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 167 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 154 R 154
           R
Sbjct: 222 R 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 110 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 166
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 167 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 154 R 154
           R
Sbjct: 222 R 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 120 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 176
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 177 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 154 R 154
           R
Sbjct: 232 R 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 114 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSEL 170
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 171 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 154 R 154
           R
Sbjct: 226 R 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 120 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 176
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 177 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 154 R 154
           R
Sbjct: 232 R 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 119 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 175
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 176 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 154 R 154
           R
Sbjct: 231 R 231

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 118 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 174
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 175 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229
Query: 154 R 154
           R
Sbjct: 230 R 230

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 136
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 137 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 120 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 176
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 177 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 154 R 154
           R
Sbjct: 232 R 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 113 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 169
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 170 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 154 R 154
           R
Sbjct: 225 R 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 18/107 (16%)
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL------------ 105
           I + IA+ + FLH +    ++HRD+K SNI    +   K+GDFGL               
Sbjct: 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 106 -FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
             P   TH      GT  Y++PE + G   + K D++S G+++ E++
Sbjct: 226 PMPAYATHXGQ--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 140
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 141 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 110 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 166
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 167 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 154 R 154
           R
Sbjct: 222 R 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 110 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSEL 166
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 167 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 154 R 154
           R
Sbjct: 222 R 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 114 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 170
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 171 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 154 R 154
           R
Sbjct: 226 R 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 131 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 187
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 188 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242
Query: 154 R 154
           R
Sbjct: 243 R 243

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 47  NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 106
           +++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+  
Sbjct: 120 HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             N   + T    T  Y APE +LG       D++S G ++ E++ G
Sbjct: 177 CTNF--MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 105 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 161
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 162 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216
Query: 154 R 154
           R
Sbjct: 217 R 217

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 137
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 128 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 184
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 185 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 154 R 154
           R
Sbjct: 240 R 240

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 137
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 161 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 154 R 154
           R
Sbjct: 216 R 216

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 137
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 127 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 183
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 184 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 154 R 154
           R
Sbjct: 239 R 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 140
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 141 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 161 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 154 R 154
           R
Sbjct: 216 R 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 128 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 184
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 185 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 154 R 154
           R
Sbjct: 240 R 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 106 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 162
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 163 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217
Query: 154 R 154
           R
Sbjct: 218 R 218

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 114 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 170
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 171 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 154 R 154
           R
Sbjct: 226 R 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 105 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 161
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 162 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216
Query: 154 R 154
           R
Sbjct: 217 R 217

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 136
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 137 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 127 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 183
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 184 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 154 R 154
           R
Sbjct: 239 R 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 121
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 122 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 142
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 143 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 137
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V HPN++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 104 LMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 161 KILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 154 R 154
           R
Sbjct: 216 R 216

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICV 60
           +S + HP  V+L        +      Y +N  L + +  +G+        +        
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TA 139
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 119
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  Y++PE +        +D+++ G ++ ++++G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           M  + +  P +V L G   +G    +  E +E  SL +++    K    L  E R+   +
Sbjct: 118 MACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLP-EDRALYYL 172
Query: 61  GIA-KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLA-KLFPDNITH---IT 114
           G A +GL +LH      I+H D+KA N+LL  +  +  + DFG A  L PD +       
Sbjct: 173 GQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             I GT  ++APE VLG     K DV+S   ++L +++G
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 47  NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 106
           +++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+  
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 174
Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             N   + T    T  Y APE +LG       D++S G ++ E++ G
Sbjct: 175 STNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S GV++ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           M  + +  P +V L G   +G    +  E +E  SL +++    K    L  E R+   +
Sbjct: 137 MACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLP-EDRALYYL 191
Query: 61  GIA-KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLA-KLFPDNITH---IT 114
           G A +GL +LH      I+H D+KA N+LL  +  +  + DFG A  L PD +       
Sbjct: 192 GQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             I GT  ++APE VLG     K DV+S   ++L +++G
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 12/120 (10%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           KI DFGLA+   D +    T    T  Y APE +L         D++S G ++ E+++GR
Sbjct: 165 KILDFGLARHTDDEM----TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S GV++ E+I G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  ++H N+V L       T   LV + V    L DR+L            EK + + + 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYT------EKDASLVIQ 113
Query: 62  -IAKGLAFLHEELVPHIVHRDIKASNIL-LDQEFNPKI--GDFGLAKLFPDNITHITTRI 117
            +   + +LHE     IVHRD+K  N+L L  E N KI   DFGL+K+  + I    +  
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STA 167
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT GY+APE +     +   D +S GV+   ++ G
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HP+++ LI      +   LV++ +    L   L       + L+ ++   I   + + ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVS 214
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 126
           FLH     +IVHRD+K  NILLD     ++ DFG +  L P         + GT GYLAP
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAP 268
Query: 127 EYVLGGQLT-------MKADVYSFGVLVLEIISG 153
           E +L   +         + D+++ GV++  +++G
Sbjct: 269 E-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 18/114 (15%)
Query: 53  EKRSDICVGI----AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 108
           E+   +C+ I    A+ + FLH +    ++HRD+K SNI    +   K+GDFGL      
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 109 NITHIT-----------TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
           +    T           T   GT  Y++PE + G   + K D++S G+++ E++
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++RHPN+V      +  T   +V EY     L   +  A +     + ++       +  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLIS 126
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIA-GTT 121
           G+++ H      + HRD+K  N LLD    P  KI DFG +K    ++ H   + A GT 
Sbjct: 127 GVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTP 180
Query: 122 GYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
            Y+APE +L  +   K ADV+S GV +  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-- 134
           I++RDIK  NILLD   +  + DFGL+K F  + T       GT  Y+AP+ V GG    
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 135 TMKADVYSFGVLVLEIISG 153
               D +S GVL+ E+++G
Sbjct: 240 DKAVDWWSLGVLMYELLTG 258

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++HP++VEL+          +V+E+++   L   ++    A    +    S     I + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 122
           L + H+    +I+HRD+K  N+LL  + N    K+GDFG+A    ++      R+ GT  
Sbjct: 143 LRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPH 198
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE V         DV+  GV++  ++SG
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 45/77 (58%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFGLAK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           ++ + HP L+ L          +L+ E++    L DR+       + K++  +  +    
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQ 157
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLA-KLFPDNITHITTRIA 118
             +GL  +HE     IVH DIK  NI+ +  +  + KI DFGLA KL PD I  +TT   
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--- 211
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            T  + APE V    +    D+++ GVL   ++SG
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 65/121 (53%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI D+GLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 18/123 (14%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII 151
           KI DFGLA+       H    +AG   T  Y APE +L         D++S G ++ E++
Sbjct: 165 KILDFGLAR-------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 152 SGR 154
           +GR
Sbjct: 218 TGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 18/123 (14%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII 151
           KI DFGLA+       H    +AG   T  Y APE +L         D++S G ++ E++
Sbjct: 165 KILDFGLAR-------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 152 SGR 154
           +GR
Sbjct: 218 TGR 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 45/77 (58%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  +AGT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
           +G+ +LH      ++HRD+K  N+ L+ + + KIGDFGLA     +     T + GT  Y
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNY 208
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           +APE +     + + D++S G ++  ++ G+
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V L        +  LV+E+ + + L +        N  L+ E        +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQL 110
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL F H     +++HRD+K  N+L+++    K+ DFGLA+ F   +   +  +  T  
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLW 166
Query: 123 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISG 153
           Y  P+ + G +L +   D++S G +  E+ + 
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 17/154 (11%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL----LGATKANIKLNWEKRSDI 58
           L  + HPN++ L+      +   LV++++E + L+ ++    L  T ++IK         
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKA-------Y 117
Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            +   +GL +LH+     I+HRD+K +N+LLD+    K+ DFGLAK F         ++ 
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174
Query: 119 GTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEII 151
            T  Y APE + G ++  +  D+++ G ++ E++
Sbjct: 175 -TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 18/123 (14%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 96  KIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII 151
           KI DFGLA+       H    +AG   T  Y APE +L         D++S G ++ E++
Sbjct: 161 KILDFGLAR-------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 152 SGR 154
           +GR
Sbjct: 214 TGR 216

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 4   SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           +++ HPN++ L        R  L+ EY     L + L    + +   + ++ + I   +A
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELA 133
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
             L + H + V   +HRDIK  N+LL  +   KI DFG +   P ++   T  + GT  Y
Sbjct: 134 DALMYCHGKKV---IHRDIKPENLLLGLKGELKIADFGWSVHAP-SLRRKT--MCGTLDY 187
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           L PE + G     K D++  GVL  E++ G
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGL +   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA     +     T + GT 
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTP 181
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y+APE +     + + DV+S G ++  ++ G+
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGT 120
           +GL ++H      ++HRD+K SN+L+++    KIGDFG+A+     P    +  T    T
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 121 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRN 155
             Y APE +L   + T   D++S G +  E+++ R 
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA     +     T + GT 
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTP 181
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y+APE +     + + DV+S G ++  ++ G+
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA     +     T + GT 
Sbjct: 130 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTP 185
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y+APE +     + + DV+S G ++  ++ G+
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 177
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 177
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           I V I K L  LH +L   ++HRD+K SN+L++     K  DFG++    D++       
Sbjct: 141 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 118 AGTTGYLAPEYV---LGGQ-LTMKADVYSFGVLVLEIISGR---NSGKAMWGQMNKFLLE 170
           AG   Y APE +   L  +  ++K+D++S G+  +E+   R   +S    + Q+ + + E
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE 256
Query: 171 WAWQLHQEEKPLELVD 186
            + QL  ++   E VD
Sbjct: 257 PSPQLPADKFSAEFVD 272

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGT 120
           +GL ++H      ++HRD+K SN+L+++    KIGDFG+A+     P    +  T    T
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 121 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRN 155
             Y APE +L   + T   D++S G +  E+++ R 
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 131 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 187
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DFGLA+   D +  ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 188 KILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242
Query: 154 R 154
           R
Sbjct: 243 R 243

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 177
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 178 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V L        +  LV+E+ + + L +        N  L+ E        +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQL 110
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL F H     +++HRD+K  N+L+++    K+ +FGLA+ F   +   +  +  T  
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 123 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMW 161
           Y  P+ + G +L +   D++S G +  E+    N+G+ ++
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELA---NAGRPLF 203

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 45/77 (58%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   ++ DFGLAK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E Y      D ++     +  + +    + I   
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQ 140
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I 
Sbjct: 141 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI- 195
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 196 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 82/179 (45%), Gaps = 27/179 (15%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEY-----VENNSLDRVLLGATKANIKLNWEKR 55
           + L +++H N++ L+      +     Y++          L +++       +K + EK 
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKI 128
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
             +   + KGL ++H      +VHRD+K  N+ ++++   KI DFGLA+       H   
Sbjct: 129 QYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADA 178
Query: 116 RIAG---TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
            + G   T  Y APE +L         D++S G ++ E+++G+    GK    Q+ + L
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + H +LV   G CV G   ILV E+V+  SLD   L   K  I + W  + ++   +
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD-TYLKKNKNCINILW--KLEVAKQL 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----IA 118
           A  + FL E     ++H ++ A NILL +E + K G+    KL    I+ IT      + 
Sbjct: 123 AAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQ 178
Query: 119 GTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISG 153
               ++ PE +   + L +  D +SFG  + EI SG
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 23/156 (14%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+++L       T   LV++ ++   L   L       + L+ ++   I   + + + 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 125
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 126
            LH+    +IVHRD+K  NILLD + N K+ DFG + +L P         + GT  YLAP
Sbjct: 126 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAP 179
Query: 127 EYVLGGQLTM---------KADVYSFGVLVLEIISG 153
           E +   + +M         + D++S GV++  +++G
Sbjct: 180 EII---ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPEIILSKGYNK 238
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 239 AVDWWALGVLIYEMAAG 255

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTG 122
           +G+ +LH      ++HRD+K  N+ L+ + + KIGDFGLA K+  D        + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKXLCGTPN 207
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE +     + + D++S G ++  ++ G+
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN++ L       T  +L+ E V    L   L  A K +  L  ++ +     I
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKES--LTEDEATQFLKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNI-LLDQEF-NPKIG--DFGLA-KLFPDNITHITTRI 117
             G+ +LH +    I H D+K  NI LLD+   NP+I   DFG+A K+   N       I
Sbjct: 125 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 178
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 23/156 (14%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+++L       T   LV++ ++   L   L       + L+ ++   I   + + + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 138
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 126
            LH+    +IVHRD+K  NILLD + N K+ DFG + +L P         + GT  YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAP 192
Query: 127 EYVLGGQLTM---------KADVYSFGVLVLEIISG 153
           E +   + +M         + D++S GV++  +++G
Sbjct: 193 EII---ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 61/120 (50%), Gaps = 12/120 (10%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 128 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 184
Query: 96  KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           KI DFGLA+   D +         T  Y APE +L         D++S G ++ E+++GR
Sbjct: 185 KILDFGLARHTDDEM----XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTG 122
           +G+ +LH      ++HRD+K  N+ L+ + + KIGDFGLA K+  D        + GT  
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPN 191
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE +     + + D++S G ++  ++ G+
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTG 122
           +G+ +LH      ++HRD+K  N+ L+ + + KIGDFGLA K+  D        + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPN 207
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE +     + + D++S G ++  ++ G+
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IA 118
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA      + +   R   + 
Sbjct: 148 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT----KVEYDGERKKVLC 200
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE +     + + DV+S G ++  ++ G+
Sbjct: 201 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IA 118
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA      + +   R   + 
Sbjct: 150 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT----KVEYDGERKKVLC 202
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE +     + + DV+S G ++  ++ G+
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQI 123
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + + T    T  Y APE +LG       D++S G ++ E+I G
Sbjct: 176 AGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 23/156 (14%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+++L       T   LV++ ++   L   L       + L+ ++   I   + + + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 138
Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 126
            LH+    +IVHRD+K  NILLD + N K+ DFG + +L P         + GT  YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAP 192
Query: 127 EYVLGGQLTM---------KADVYSFGVLVLEIISG 153
           E +   + +M         + D++S GV++  +++G
Sbjct: 193 EII---ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 211 AVDWWALGVLIYEMAAG 227

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IA 118
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA      + +   R   + 
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKVLC 176
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE +     + + DV+S G ++  ++ G+
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 211 AVDWWALGVLIYEMAAG 227

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E Y      D ++     +  + +    + I   
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQ 134
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I 
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI- 189
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 212
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 213 AVDWWALGVLIYEMAAG 229

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++RHPN+V      +  T   ++ EY     L   +  A +     + ++       +  
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLS 127
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTT 121
           G+++ H      I HRD+K  N LLD    P  KI DFG +K    ++ H   +   GT 
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 181
Query: 122 GYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
            Y+APE +L  +   K ADV+S GV +  ++ G
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN++ L       T  +L+ E V    L   L  A K +  L  ++ +     I
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKES--LTEDEATQFLKQI 117
Query: 63  AKGLAFLHEELVPHIVHRDIKASNI-LLDQEF-NPKIG--DFGLA-KLFPDNITHITTRI 117
             G+ +LH +    I H D+K  NI LLD+   NP+I   DFG+A K+   N       I
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 171
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEIILSKGYNK 203
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 204 AVDWWALGVLIYEMAAG 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI  FGLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN++ L       T  +L+ E V    L   L  A K +  L  ++ +     I
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKES--LTEDEATQFLKQI 138
Query: 63  AKGLAFLHEELVPHIVHRDIKASNI-LLDQEF-NPKIG--DFGLA-KLFPDNITHITTRI 117
             G+ +LH +    I H D+K  NI LLD+   NP+I   DFG+A K+   N       I
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 192
Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 239 AVDWWALGVLIYEMAAG 255

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++RHPN+V      +  T   +V EY     L   +  A +     + ++       +  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLIS 126
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTT 121
           G+++ H      + HRD+K  N LLD    P  KI DFG +K    ++ H   +   GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 180
Query: 122 GYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
            Y+APE +L  +   K ADV+S GV +  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++RHPN+V      +  T   +V EY     L   +  A +     + ++       +  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLIS 125
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTT 121
           G+++ H      + HRD+K  N LLD    P  KI DFG +K    ++ H   +   GT 
Sbjct: 126 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 179
Query: 122 GYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
            Y+APE +L  +   K ADV+S GV +  ++ G
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 239 AVDWWALGVLIYEMAAG 255

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI DF LA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDFYLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI D GLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 114 MELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLART-- 168
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
Query: 166 KFL 168
           K +
Sbjct: 229 KVI 231

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVY--------EYVENNSLDRVLLGATKANIKLNWEK 54
           + N+ HP++V+LIG   +    I++          Y+E N     +L     +++     
Sbjct: 79  MKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ----- 133
Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  I K +A+L      + VHRDI   NIL+      K+GDFGL++   D   +  
Sbjct: 134 -------ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           +       +++PE +   + T  +DV+ F V + EI+S        +G+   F LE    
Sbjct: 184 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLENKDV 235
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
           +   EK   L  P+L   PP   + Y  +   C     S RP+  +++  L+   ++ ++
Sbjct: 236 IGVLEKGDRLPKPDLC--PP---VLYTLMT-RCWDYDPSDRPRFTELVCSLSDVYQMEKD 289

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E Y      D ++     +  + +    + I   
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQ 157
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I 
Sbjct: 158 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI- 212
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 213 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVY--------EYVENNSLDRVLLGATKANIKLNWEK 54
           + N+ HP++V+LIG   +    I++          Y+E N     +L     +++     
Sbjct: 63  MKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ----- 117
Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  I K +A+L      + VHRDI   NIL+      K+GDFGL++   D   +  
Sbjct: 118 -------ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 167
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           +       +++PE +   + T  +DV+ F V + EI+S        +G+   F LE    
Sbjct: 168 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLENKDV 219
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
           +   EK   L  P+L   PP   + Y  +   C     S RP+  +++  L+   ++ ++
Sbjct: 220 IGVLEKGDRLPKPDLC--PP---VLYTLMT-RCWDYDPSDRPRFTELVCSLSDVYQMEKD 273

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 5/106 (4%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 123 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 178
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
              + +      T  Y APE +LG       D++S G ++ E+I G
Sbjct: 179 -GTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVY--------EYVENNSLDRVLLGATKANIKLNWEK 54
           + N+ HP++V+LIG   +    I++          Y+E N     +L     +++     
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ----- 121
Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  I K +A+L      + VHRDI   NIL+      K+GDFGL++   D   +  
Sbjct: 122 -------ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
           +       +++PE +   + T  +DV+ F V + EI+S        +G+   F LE    
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLENKDV 223
Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
           +   EK   L  P+L   PP   + Y  +   C     S RP+  +++  L+   ++ ++
Sbjct: 224 IGVLEKGDRLPKPDLC--PP---VLYTLMT-RCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E Y      D ++     +  + +    + I   
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQ 158
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I 
Sbjct: 159 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI- 213
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 214 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI D GLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +  + +  P +V L G   +G    +  E +E  SL +++       +    E R+   +
Sbjct: 118 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYL 172
Query: 61  GIA-KGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLA-KLFPDNITH---IT 114
           G A +GL +LH      I+H D+KA N+LL  + +   + DFG A  L PD +       
Sbjct: 173 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 229
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             I GT  ++APE V+G     K D++S   ++L +++G
Sbjct: 230 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +  + +  P +V L G   +G    +  E +E  SL +++       +    E R+   +
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYL 156
Query: 61  GIA-KGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLA-KLFPDNITH---IT 114
           G A +GL +LH      I+H D+KA N+LL  + +   + DFG A  L PD +       
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             I GT  ++APE V+G     K D++S   ++L +++G
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRR-----ILVYEYVENNSLDRVLLGA--TKANIKLNWEKR 55
           + +  HPN++ L+G C++ + +     +++  +++   L   LL +        +  +  
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
               V IA G+ +L      + +HRD+ A N +L  +    + DFGL+K       +   
Sbjct: 150 LKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 116 RIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW-GQMNKFLLEWAW 173
           RIA     ++A E +     T K+DV++FGV + EI +    G   + G  N  + ++  
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT---RGMTPYPGVQNHEMYDYLL 263
Query: 174 QLHQEEKPLELVD 186
             H+ ++P + +D
Sbjct: 264 HGHRLKQPEDCLD 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +  + +  P +V L G   +G    +  E +E  SL +++       +    E R+   +
Sbjct: 116 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYL 170
Query: 61  GIA-KGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLA-KLFPDNITH---IT 114
           G A +GL +LH      I+H D+KA N+LL  + +   + DFG A  L PD +       
Sbjct: 171 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 227
Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             I GT  ++APE V+G     K D++S   ++L +++G
Sbjct: 228 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L     S   V 
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQ 119
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 219

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 24/161 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS---LDRVLLGATKANI----KLNWEKR 55
           L +++H N++ L+      T        +E+ S   L   L+GA   NI     L+ E  
Sbjct: 73  LKHLKHENVIGLLDVFTPATS-------IEDFSEVYLVTTLMGADLNNIVKCQALSDEHV 125
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HIT 114
             +   + +GL ++H      I+HRD+K SN+ ++++   +I DFGLA+   + +T ++ 
Sbjct: 126 QFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVA 182
Query: 115 TRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           TR      Y APE +L         D++S G ++ E++ G+
Sbjct: 183 TR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 24/161 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS---LDRVLLGATKANI----KLNWEKR 55
           L +++H N++ L+      T        +E+ S   L   L+GA   NI     L+ E  
Sbjct: 81  LKHLKHENVIGLLDVFTPATS-------IEDFSEVYLVTTLMGADLNNIVKSQALSDEHV 133
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HIT 114
             +   + +GL ++H      I+HRD+K SN+ ++++   +I DFGLA+   + +T ++ 
Sbjct: 134 QFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA 190
Query: 115 TRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           TR      Y APE +L         D++S G ++ E++ G+
Sbjct: 191 TR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 40  LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 95
           L+GA   NI    KL  +    +   I +GL ++H      I+HRD+K SN+ ++++   
Sbjct: 108 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 164
Query: 96  KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 153
           KI D GLA+   D +T ++ TR      Y APE +L         D++S G ++ E+++G
Sbjct: 165 KILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 154 R 154
           R
Sbjct: 220 R 220

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L     S   V 
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQ 119
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 219

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLG-ATKAN---IKLNWEKRS 56
           L  ++HPN++ L    +    R   L+++Y E++    +    A+KAN   ++L      
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNIT 111
            +   I  G+ +LH   V   +HRD+K +NIL+  E  P     KI D G A+LF   + 
Sbjct: 132 SLLYQILDGIHYLHANWV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLK 187
Query: 112 HIT--TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 153
            +     +  T  Y APE +LG +   KA D+++ G +  E+++ 
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L     S   V 
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQ 119
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L    R    V 
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSR--YAVQ 129
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 24/161 (14%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS---LDRVLLGATKANI----KLNWEKR 55
           L +++H N++ L+      T        +E+ S   L   L+GA   NI     L+ E  
Sbjct: 81  LKHLKHENVIGLLDVFTPATS-------IEDFSEVYLVTTLMGADLNNIVKCQALSDEHV 133
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HIT 114
             +   + +GL ++H      I+HRD+K SN+ ++++   +I DFGLA+   + +T ++ 
Sbjct: 134 QFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA 190
Query: 115 TRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           TR      Y APE +L         D++S G ++ E++ G+
Sbjct: 191 TR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 168
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
Query: 166 KFL 168
           K +
Sbjct: 229 KVI 231

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L    R    V 
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSR--YAVQ 129
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 229

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 169
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 170 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 229
Query: 166 KFL 168
           K +
Sbjct: 230 KVI 232

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 169
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 170 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 229
Query: 166 KFL 168
           K +
Sbjct: 230 KVI 232

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L     S   V 
Sbjct: 68  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQ 123
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 223

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    +++       + LDR  L   + +  L    R    V 
Sbjct: 68  AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSR--YAVQ 123
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +     
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 122 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
              + APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 236
Query: 166 KFL 168
           K +
Sbjct: 237 KVI 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 120 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 174
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 175 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 234
Query: 166 KFL 168
           K +
Sbjct: 235 KVI 237

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 10  NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 69
           N++ELI      TR  LV+E ++  S+    L   +     N  + S +   +A  L FL
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSI----LAHIQKQKHFNEREASRVVRDVAAALDFL 127
Query: 70  HEELVPHIVHRDIKASNILLD--QEFNP-KIGDFGLAK--LFPDNITHIT----TRIAGT 120
           H      I HRD+K  NIL +  ++ +P KI DF L       ++ T IT    T   G+
Sbjct: 128 H---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 121 TGYLAPEY--VLGGQLTM---KADVYSFGVLVLEIISG 153
             Y+APE   V   Q T    + D++S GV++  ++SG
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 6   VRHPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I   +      T+  L+  Y E  SL   L   T   +         I + 
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLS 113
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT- 115
           IA GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   +   
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 116 ---RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEI 150
              R+ GT  Y+APE VL   + +       + D+++FG+++ E+
Sbjct: 174 NNPRV-GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 236
Query: 166 KFL 168
           K +
Sbjct: 237 KVI 239

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV-GIAK 64
           +HPN++ L      G    LV E +    L D++L        K   E+ +   +  I K
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGK 132
Query: 65  GLAFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAK-LFPDNITHITTRIAG 119
            + +LH + V   VHRD+K SNIL +D+  NP   +I DFG AK L  +N   +T     
Sbjct: 133 TVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CY 187
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  ++APE +         D++S G+L+  +++G
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 6   VRHPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +RH N++  I   +      T+  L+  Y E  SL   L   T   +         I + 
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLS 113
Query: 62  IAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT- 115
           IA GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   +   
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 116 ---RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEI 150
              R+ GT  Y+APE VL   + +       + D+++FG+++ E+
Sbjct: 174 NNPRV-GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ ++ +G
Sbjct: 218 AVDWWALGVLIYQMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+D++   ++ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 204
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 205 AVDWWALGVLIYEMAAG 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 82/179 (45%), Gaps = 27/179 (15%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEY-----VENNSLDRVLLGATKANIKLNWEKR 55
           + L +++H N++ L+      +     Y++          L +++       ++ + EK 
Sbjct: 93  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM------GMEFSEEKI 146
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
             +   + KGL ++H      +VHRD+K  N+ ++++   KI DFGLA+       H   
Sbjct: 147 QYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADA 196
Query: 116 RIAG---TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
            + G   T  Y APE +L         D++S G ++ E+++G+    GK    Q+ + L
Sbjct: 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--T 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 213
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 166 KFL 168
           K +
Sbjct: 274 KVI 276

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +HPN++ L      G    +V E ++   L D++L          +  + S +   I K 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-----FSEREASAVLFTITKT 128
Query: 66  LAFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAK-LFPDNITHITTRIAGT 120
           + +LH + V   VHRD+K SNIL +D+  NP   +I DFG AK L  +N   +T     T
Sbjct: 129 VEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYT 183
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             ++APE +         D++S GVL+  +++G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV-GIAK 64
           +HPN++ L      G    LV E +    L D++L        K   E+ +   +  I K
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGK 132
Query: 65  GLAFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAK-LFPDNITHITTRIAG 119
            + +LH + V   VHRD+K SNIL +D+  NP   +I DFG AK L  +N   +T     
Sbjct: 133 TVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CY 187
Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           T  ++APE +         D++S G+L+  +++G
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 214
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 215 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 166 KFL 168
           K +
Sbjct: 274 KVI 276

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 169
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 170 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 229
Query: 166 KFL 168
           K +
Sbjct: 230 KVI 232

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + H +LV   G C  G   ILV E+V+  SLD   L   K  I + W  + ++   +
Sbjct: 66  MSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD-TYLKKNKNCINILW--KLEVAKQL 122
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----IA 118
           A  + FL E     ++H ++ A NILL +E + K G+    KL    I+ IT      + 
Sbjct: 123 AWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQ 178
Query: 119 GTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISG 153
               ++ PE +   + L +  D +SFG  + EI SG
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 18/109 (16%)
Query: 58  ICVGIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
           I + IA GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   
Sbjct: 139 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 198
Query: 113 ITT----RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEI 150
           +      R+ GT  Y+APE VL   + +       + D+++FG+++ E+
Sbjct: 199 LDVGNNPRV-GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I KG+ ++H +    +++RD+K SNI L      KIGDFGL     ++      R  GT 
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--XRSKGTL 185
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEII 151
            Y++PE +       + D+Y+ G+++ E++
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 126 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-- 180
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + + T    T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 181 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 240
Query: 166 KFL 168
           K +
Sbjct: 241 KVI 243

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+++DQ+   ++ DFG AK     +   T  + GT  YLAPE ++      
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIIISKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 29/166 (17%)
Query: 6   VRHPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGAT-KANIKLNWEKRSDICV 60
           +RH N++  I   +      T+  L+  Y E+ SL   L   T + ++ L       + V
Sbjct: 59  LRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALR------LAV 112
Query: 61  GIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-- 113
             A GLA LH E+      P I HRD K+ N+L+       I D GLA +      ++  
Sbjct: 113 SAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDI 172
Query: 114 --TTRIAGTTGYLAPEYVLGGQLTMKA-------DVYSFGVLVLEI 150
               R+ GT  Y+APE VL  Q+           D+++FG+++ EI
Sbjct: 173 GNNPRV-GTKRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 3   LSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           L ++RH N++ L+            T   LV  ++  +      LG    + KL  ++  
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD------LGKLMKHEKLGEDRIQ 131
Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
            +   + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +      
Sbjct: 132 FLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV- 187
Query: 117 IAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 155
              T  Y APE +L   + T   D++S G ++ E+I+G+ 
Sbjct: 188 ---TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAP  +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPAIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ + H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F    +       
Sbjct: 135 VLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKI 189
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L +++H N+V L           LV+EY++ +    LD         N+KL         
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL-------FL 106
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRI 117
             + +GLA+ H +    ++HRD+K  N+L+++    K+ DFGL  AK  P   T      
Sbjct: 107 FQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYDNE 160
Query: 118 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
             T  Y  P+ +LG    + + D++  G +  E+ +GR
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E      L D ++L    + +       + I   
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA-----AVIMKQ 129
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIA 118
           +  G  +LH+    +IVHRD+K  N+LL+ +      KI DFGL+  F   +        
Sbjct: 130 VLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERL 184
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL  +   K DV+S GV++  ++ G
Sbjct: 185 GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++RHPN+V      +  T   +V EY     L   +  A +     + ++       +  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLIS 126
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTT 121
           G+++ H      + HRD+K  N LLD    P  KI  FG +K    ++ H   +   GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTP 180
Query: 122 GYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
            Y+APE +L  +   K ADV+S GV +  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++RHPN+V      +  T   +V EY     L   +  A +     + ++       +  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLIS 126
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTT 121
           G+++ H      + HRD+K  N LLD    P  KI  FG +K    ++ H   +   GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTP 180
Query: 122 GYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISG 153
            Y+APE +L  +   K ADV+S GV +  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 136
           +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT   LAPE +L      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEALAPEIILSKGYNK 217
Query: 137 KADVYSFGVLVLEIISG 153
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
           H VHRDIK  N+LLD   + ++ DFG      D+ T  ++   GT  Y++PE +      
Sbjct: 195 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 254
Query: 132 -GQLTMKADVYSFGVLVLEIISG 153
            G+   + D +S GV + E++ G
Sbjct: 255 MGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKG 65
           +HPN++ L      G    +V E  +   L D++L          +  + S +   I K 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-----FSEREASAVLFTITKT 128
Query: 66  LAFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
           + +LH + V   VHRD+K SNIL +D+  NP   +I DFG AK        + T    T 
Sbjct: 129 VEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TA 184
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            ++APE +         D++S GVL+   ++G
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
           H VHRDIK  N+LLD   + ++ DFG      D+ T  ++   GT  Y++PE +      
Sbjct: 211 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 270
Query: 132 -GQLTMKADVYSFGVLVLEIISG 153
            G+   + D +S GV + E++ G
Sbjct: 271 MGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++HP++VEL+          +V+E+++   L   ++    A    +    S     I + 
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 122
           L + H+    +I+HRD+K   +LL  + N    K+G FG+A    ++      R+ GT  
Sbjct: 145 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 200
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE V         DV+  GV++  ++SG
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E      L D ++L    + +       + I   
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA-----AVIMKQ 112
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIA 118
           +  G  +LH+    +IVHRD+K  N+LL+ +      KI DFGL+  F   +        
Sbjct: 113 VLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERL 167
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GT  Y+APE VL  +   K DV+S GV++  ++ G
Sbjct: 168 GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 77  IVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 133
           IVHRD+K  N+L    D+E    I DFGL+K+  +    + +   GT GY+APE +    
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLAQKP 198
Query: 134 LTMKADVYSFGVLVLEIISG 153
            +   D +S GV+   ++ G
Sbjct: 199 YSKAVDCWSIGVIAYILLCG 218

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++HP++VEL+          +V+E+++   L   ++    A    +    S     I + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 122
           L + H+    +I+HRD+K   +LL  + N    K+G FG+A    ++      R+ GT  
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE V         DV+  GV++  ++SG
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IA 63
            ++HPN+V L     + +   LV++ V    L   ++       +   E  +  C+  I 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 115
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 120
           + +A+ H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 170
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GYL+PE +     +   D+++ GV++  ++ G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAK 64
           ++HPN+V L     + +   LV++ V    L   ++       +   E  +  C+  I +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILE 139
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            +A+ H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT 
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTP 194
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GYL+PE +     +   D+++ GV++  ++ G
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + +      T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 176 AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 69/125 (55%), Gaps = 10/125 (8%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAG- 119
           + +GL ++H     +++HRD+K +N+ ++ E    KIGDFGLA++   + +H      G 
Sbjct: 129 LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 120 -TTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQL 175
            T  Y +P  +L      KA D+++ G +  E+++G+   +G     QM + +LE    +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILESIPVV 244
Query: 176 HQEEK 180
           H+E++
Sbjct: 245 HEEDR 249

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IA 63
            ++HPN+V L     + +   LV++ V    L   ++       +   E  +  C+  I 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 115
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 120
           + +A+ H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 170
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GYL+PE +     +   D+++ GV++  ++ G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IA 63
            ++HPN+V L     + +   LV++ V    L   ++       +   E  +  C+  I 
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 114
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 120
           + +A+ H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT
Sbjct: 115 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 169
Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            GYL+PE +     +   D+++ GV++  ++ G
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 7/96 (7%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KG+ +LH +    I+HRDIK SN+L+ ++ + KI DFG++  F  +   ++  + GT 
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTP 201
Query: 122 GYLAPEYVLGGQ--LTMKA-DVYSFGVLVLEIISGR 154
            ++APE +   +   + KA DV++ GV +   + G+
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMN 165
              + +      T  Y APE +LG       D++S G ++ E++  +    G+    Q N
Sbjct: 177 -GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 235
Query: 166 KFL 168
           K +
Sbjct: 236 KVI 238

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG--- 131
           H VHRDIK  NIL+D   + ++ DFG   KL  D     +  + GT  Y++PE +     
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEG 253
Query: 132 --GQLTMKADVYSFGVLVLEIISG 153
             G+   + D +S GV + E++ G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 20/148 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAW 173
              Y APE + G    T   DV+S G ++ E++ G+     +SG     ++ K L     
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 174 QLHQEEKP--LELVDPELGEYPPNEIIR 199
           +  +E  P   E   P++  +P  ++ R
Sbjct: 245 EQIREMNPNYTEFAFPQIKAHPWTKVFR 272

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 75/156 (48%), Gaps = 16/156 (10%)
Query: 8   HPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLL----GATKANIKLNWEKRSD 57
           HP++ +L+G  ++   +      +++  ++++  L   LL    G    N+ L    R  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR-- 141
Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTR 116
             V IA G+ +L      + +HRD+ A N +L ++    + DFGL+ K++  +       
Sbjct: 142 FMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 +LA E +     T+ +DV++FGV + EI++
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 161 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 216 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 226 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 224 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 267 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 20/148 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 138 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAW 173
              Y APE + G    T   DV+S G ++ E++ G+     +SG     ++ K L     
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 249
Query: 174 QLHQEEKP--LELVDPELGEYPPNEIIR 199
           +  +E  P   E   P++  +P  ++ R
Sbjct: 250 EQIREMNPNYTEFKFPQIKAHPWTKVFR 277

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           LA LH +    +VH D+K +NI L      K+GDFGL  L             G   Y+A
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMA 224
Query: 126 PEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLL 169
           PE +L G     ADV+S G+ +LE+        G   W Q+ +  L
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 146 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 200
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 201 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 37/184 (20%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGI 62
           HPN++     C + T R L Y  +E  +L+   L  +K     N+KL  E     +   I
Sbjct: 68  HPNVIRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDN 109
           A G+A LH      I+HRD+K  NIL+        DQ+   +     I DFGL K     
Sbjct: 125 ASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 110 ITHITTRI---AGTTGYLAPEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
            +   T +   +GT+G+ APE +          +LT   D++S G +   I+S    GK 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS---KGKH 238
Query: 160 MWGQ 163
            +G 
Sbjct: 239 PFGD 242

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 39/257 (15%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           M     RH N+V  +G C+      ++    +  +L  V+     A I L+  K   I  
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQ 137
Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK--IGDFGL---AKLFPDNITHITT 115
            I KG+ +LH +    I+H+D+K+ N+  D   N K  I DFGL   + +          
Sbjct: 138 EIVKGMGYLHAK---GILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKL 191
Query: 116 RIA-GTTGYLAPEYVLGGQ---------LTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 165
           RI  G   +LAPE +              +  +DV++ G +  E+ +        W    
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKT 245
Query: 166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +      WQ+    KP  L    +G+   +       +  FC       RP   +++ ML
Sbjct: 246 QPAEAIIWQMGTGMKP-NLSQIGMGKEISD-------ILLFCWAFEQEERPTFTKLMDML 297
Query: 226 TKNIRLNEEELTAPGLF 242
            K  + N   L+ PG F
Sbjct: 298 EKLPKRN-RRLSHPGHF 313

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           M  +N   P +V+L  C  Q  + + +V EY+    L  ++   +  ++   W K     
Sbjct: 129 MAFAN--SPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAE 182
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIA 118
           V +A  L  +H      ++HRD+K  N+LLD+  + K+ DFG   K+    + H  T + 
Sbjct: 183 VVLA--LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV- 236
Query: 119 GTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 153
           GT  Y++PE +      G    + D +S GV + E++ G
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N+++I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 125 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 179
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAW 173
              Y APE + G    T   DV+S G ++ E++ G+     +SG     ++ K L     
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 174 QLHQEEKP--LELVDPELGEYPPNEIIR 199
           +  +E  P   E   P++  +P  ++ R
Sbjct: 245 EQIREMNPNYTEFAFPQIKAHPWTKVFR 272

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 132 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 186
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 305
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            + +LHE     I+HRD+K  N+LL  +      KI DFG +K+  +  T +   + GT 
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 319
Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
            YLAPE ++           D +S GV++   +SG
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 221
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 21/185 (11%)
Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV- 60
           ++ + H NL++L          +LV EYV+   L DR++      +   N  +   I   
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII------DESYNLTELDTILFM 193
Query: 61  -GIAKGLAFLHEELVPHIVHRDIKASNIL-LDQEFNP-KIGDFGLAKLF-PDNITHITTR 116
             I +G+  +H+    +I+H D+K  NIL ++++    KI DFGLA+ + P     +   
Sbjct: 194 KQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF- 249
Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS--GKAMWGQMNKFLLEWAWQ 174
             GT  +LAPE V    ++   D++S GV+   ++SG +   G      +N  +L   W 
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN-ILACRWD 306
Query: 175 LHQEE 179
           L  EE
Sbjct: 307 LEDEE 311

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 152 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 206
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 207 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 15/139 (10%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKLFPDNITHITTR--I 117
           GLA LH     +IVHRD+K  NIL+       +    I DFGL K         + R  +
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 118 AGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNS--GKAMWGQMNKFLLEWA 172
            GT G++APE +        T   D++S G +   +IS  +   GK++  Q N  L   +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246
Query: 173 WQLHQEEKPLELVDPELGE 191
                 EK  +++  EL E
Sbjct: 247 LDCLHPEKHEDVIARELIE 265

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 141 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 195
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 196 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 137 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 191
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 192 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 134 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 188
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 189 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD +    K+ DFG AK       N++ I +R   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HPN+V+L           LV E +    L +R+     K     +  + S I   +   +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-----KKKKHFSETEASYIMRKLVSAV 119
Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 123
           + +H+     +VHRD+K  N+L   E +    KI DFG A+L P +   + T    T  Y
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHY 175
Query: 124 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            APE +         D++S GV++  ++SG+
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 76  HIVHRDIKASNILLDQ-EFNPKIGDFGLA-KLFPD--NITHITTRIAGTTGYLAPEYVLG 131
           ++ HRDIK  N+L+++ +   K+ DFG A KL P   N+ +I +R      Y APE + G
Sbjct: 151 NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFG 205
Query: 132 GQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
            Q  T   D++S G +  E++ G     G    GQ+++ +
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 25/135 (18%)
Query: 26  LVYEYVENNSLDR------VLLGATKANIKLNWEKRSDICV--GIAKGLAFLHEELVPHI 77
           ++YEY+EN+S+ +      VL       I +   K    C+   +    +++H E   +I
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK----CIIKSVLNSFSYIHNE--KNI 173
Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPEYVLGGQL 134
            HRD+K SNIL+D+    K+ DFG ++   D       +I G+ G   ++ PE+      
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVD------KKIKGSRGTYEFMPPEFFSNESS 227
Query: 135 T--MKADVYSFGVLV 147
               K D++S G+ +
Sbjct: 228 YNGAKVDIWSLGICL 242

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 33/180 (18%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGI 62
           HPN++     C + T R L Y  +E  +L+   L  +K     N+KL  E     +   I
Sbjct: 86  HPNVIRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDN 109
           A G+A LH      I+HRD+K  NIL+        DQ+   +     I DFGL K     
Sbjct: 143 ASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 110 ITHITTRI---AGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 163
                  +   +GT+G+ APE +      +LT   D++S G +   I+S    GK  +G 
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS---KGKHPFGD 256

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 33/180 (18%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGI 62
           HPN++     C + T R L Y  +E  +L+   L  +K     N+KL  E     +   I
Sbjct: 86  HPNVIRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDN 109
           A G+A LH      I+HRD+K  NIL+        DQ+   +     I DFGL K     
Sbjct: 143 ASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 110 ITHITTRI---AGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 163
                  +   +GT+G+ APE +      +LT   D++S G +   I+S    GK  +G 
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS---KGKHPFGD 256

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAG 119
           + LA++H      I HRDIK  N+LLD      K+ DFG AK+      N++ I +R   
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-- 206
Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
              Y APE + G    T   D++S G ++ E++ G+
Sbjct: 207 ---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNITHITTRIA 118
           GL ++H      I+H DIK  N+L++   +P      KI D G A  + +   H T  I 
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQ 197
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            T  Y +PE +LG      AD++S   L+ E+I+G
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNITHITTRIA 118
           GL ++H      I+H DIK  N+L++   +P      KI D G A  + +   H T  I 
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQ 197
Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            T  Y +PE +LG      AD++S   L+ E+I+G
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---------TRIAGTTGYLAP 126
           +++HRD+K SN+L++   + K+ DFGLA++  ++    +         T    T  Y AP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 127 EYVL-GGQLTMKADVYSFGVLVLEIISGR 154
           E +L   + +   DV+S G ++ E+   R
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 26/141 (18%)
Query: 6   VRHPNLVELIGCC---------VQGTRRILVYEYVENNS---LDRVLLGATKANIKLNWE 53
           ++H N+V LI  C          +G+   LV+++ E++    L  VL+  T + IK    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK---- 128
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
               +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F       
Sbjct: 129 ---RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 114 TTRIAG---TTGYLAPEYVLG 131
             R      T  Y  PE +LG
Sbjct: 183 PNRYXNRVVTLWYRPPELLLG 203

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---------TRIAGTTGYLAP 126
           +++HRD+K SN+L++   + K+ DFGLA++  ++    +         T    T  Y AP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 127 EYVL-GGQLTMKADVYSFGVLVLEIISGR 154
           E +L   + +   DV+S G ++ E+   R
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 26/141 (18%)
Query: 6   VRHPNLVELIGCC---------VQGTRRILVYEYVENNS---LDRVLLGATKANIKLNWE 53
           ++H N+V LI  C          +G+   LV+++ E++    L  VL+  T + IK    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK---- 127
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
               +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F       
Sbjct: 128 ---RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 114 TTRIAG---TTGYLAPEYVLG 131
             R      T  Y  PE +LG
Sbjct: 182 PNRYXNRVVTLWYRPPELLLG 202

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAK 64
           ++HPN+V L     +     LV++ V    L   ++     +     E  +  C+  I +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-----EADASHCIHQILE 141
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            +  +H+     IVHRD+K  N+LL  +      K+ DFGLA +            AGT 
Sbjct: 142 SVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTP 197
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GYL+PE +         D+++ GV++  ++ G
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           ++ EYV + +L +VL    ++   +     S     + + + F+H      I HRDIK  
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 86  NILLDQEFNP-KIGDFGLA-KLFPD--NITHITTRIAGTTGYLAPEYVLGG-QLTMKADV 140
           N+L++ + N  K+ DFG A KL P   ++  I +R      Y APE +LG  + T   D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-----YRAPELMLGATEYTPSIDL 225
Query: 141 YSFGVLVLEIISGR 154
           +S G +  E+I G+
Sbjct: 226 WSIGCVFGELILGK 239

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 26/141 (18%)
Query: 6   VRHPNLVELIGCC---------VQGTRRILVYEYVENNS---LDRVLLGATKANIKLNWE 53
           ++H N+V LI  C          +G+   LV+++ E++    L  VL+  T + IK    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK---- 128
Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
               +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F       
Sbjct: 129 ---RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 114 TTRIAG---TTGYLAPEYVLG 131
             R      T  Y  PE +LG
Sbjct: 183 PNRYXNRVVTLWYRPPELLLG 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 6   VRHPNLVELIGCCVQGTRRI--------LVYEYVENNS---LDRVLLGATKANIKLNWEK 54
           ++H N+V LI  C               LV+++ E++    L  VL+  T + IK     
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK----- 128
Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
              +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F        
Sbjct: 129 --RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 115 TRIAG---TTGYLAPEYVLG 131
            R      T  Y  PE +LG
Sbjct: 184 NRYXNRVVTLWYRPPELLLG 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITT--R 116
           I +G+ +LH+    +IVH D+K  NILL   +   + KI DFG+++     I H      
Sbjct: 140 ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHACELRE 192
Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
           I GT  YLAPE +    +T   D+++ G++   +++
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 8/80 (10%)
Query: 77  IVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQ 133
           I+H D+K  NILL Q+     K+ DFG +      + T I +R      Y APE +LG +
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----YRAPEVILGAR 275
Query: 134 LTMKADVYSFGVLVLEIISG 153
             M  D++S G ++ E+++G
Sbjct: 276 YGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 8/80 (10%)
Query: 77  IVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQ 133
           I+H D+K  NILL Q+     K+ DFG +      + T I +R      Y APE +LG +
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----YRAPEVILGAR 275
Query: 134 LTMKADVYSFGVLVLEIISG 153
             M  D++S G ++ E+++G
Sbjct: 276 YGMPIDMWSLGCILAELLTG 295

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL- 134
           +VHRDIK  NIL+D +    K+ DFG   L  D      T   GT  Y  PE++   Q  
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYH 216
Query: 135 TMKADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 217 ALPATVWSLGILLYDMVCG 235

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 80/184 (43%), Gaps = 37/184 (20%)
Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGI 62
           HPN++     C + T R L Y  +E  +L+   L  +K     N+KL  E     +   I
Sbjct: 68  HPNVIRYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDN 109
           A G+A LH      I+HRD+K  NIL+        DQ+   +     I DFGL K     
Sbjct: 125 ASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 110 ITHITTRI---AGTTGYLAPEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKA 159
                  +   +GT+G+ APE +          +LT   D++S G +   I+S    GK 
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS---KGKH 238
Query: 160 MWGQ 163
            +G 
Sbjct: 239 PFGD 242

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
            +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + GT  Y++PE +      
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 252
Query: 132 GQLTMKADVYSFGVLVLEIISG 153
           G    + D +S GV + E++ G
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
            +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + GT  Y++PE +      
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 247
Query: 132 GQLTMKADVYSFGVLVLEIISG 153
           G    + D +S GV + E++ G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG 269

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++HPN+V L     +     LV++ V    L   +       +   +   +D    I + 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI-------VAREYYSEADASHCIQQI 112
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 122
           L  ++   +  IVHRD+K  N+LL  +      K+ DFGLA +            AGT G
Sbjct: 113 LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           YL+PE +         D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 36/76 (47%)
Query: 78  VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 137
            HRD+K  NIL+  +    + DFG+A    D          GT  Y APE       T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 138 ADVYSFGVLVLEIISG 153
           AD+Y+   ++ E ++G
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 77  IVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG---- 131
            +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + GT  Y++PE +      
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 252
Query: 132 GQLTMKADVYSFGVLVLEIISG 153
           G    + D +S GV + E++ G
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG 274

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAK 64
           ++HPN+V L     +     L+++ V    L   ++     +     E  +  C+  I +
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-----EADASHCIQQILE 132
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 121
            +   H+  V   VHRD+K  N+LL  +      K+ DFGLA +  +         AGT 
Sbjct: 133 AVLHCHQMGV---VHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTP 188
Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           GYL+PE +         D+++ GV++  ++ G
Sbjct: 189 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           ++HPN+V L     +     LV++ V    L   ++          +   +D    I + 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQQI 112
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 122
           L  ++   +  IVHRD+K  N+LL  +      K+ DFGLA +            AGT G
Sbjct: 113 LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           YL+PE +         D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 3   LSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           LS V H N+++++     QG  ++++ ++   + LD  L      + +L+    S I   
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH--GSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +   + +L    +  I+HRDIK  NI++ ++F  K+ DFG A          T    GT 
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTI 193
Query: 122 GYLAPEYVLGGQLTM-KADVYSFGVLVLEIISGRN 155
            Y APE ++G      + +++S GV +  ++   N
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 76  HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---------YLAP 126
           +++HRD+K SN+L++   + K+ DFGLA++  ++    +      +G         Y AP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 127 EYVL-GGQLTMKADVYSFGVLVLEIISGR 154
           E +L   + +   DV+S G ++ E+   R
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 8   HPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
           HPN++ ++G C         L+  ++   SL  VL   T  N  ++  +     + +A+G
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARG 123
Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 125
           +AFLH  L P I    + + ++++D++   +I           ++  +           A
Sbjct: 124 MAFLHT-LEPLIPRHALNSRSVMIDEDMTARI-----------SMADVKFSFQSPGRMYA 171
Query: 126 PEYVLGGQLTMK--------ADVYSFGVLVLEIIS 152
           P +V    L  K        AD++SF VL+ E+++
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 65/145 (44%), Gaps = 21/145 (14%)
Query: 23  RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI 82
           R  LV+E +   S+    L         N  + S +   +A  L FLH +    I HRD+
Sbjct: 85  RFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDL 137
Query: 83  KASNILLDQ--EFNP-KIGDFGLA---KLFPDNITHITTRI---AGTTGYLAPEYVLGGQ 133
           K  NIL +   + +P KI DFGL    KL  D     T  +    G+  Y+APE V    
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 134 -----LTMKADVYSFGVLVLEIISG 153
                   + D++S GV++  ++SG
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 61/143 (42%), Gaps = 35/143 (24%)
Query: 37  DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 96
           D  L    K  I L  E    I   +  G  F+HE     I+HRD+K +N LL+Q+ + K
Sbjct: 113 DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVK 169
Query: 97  IGDFGLAKLF-------------------PDN-------ITHITTRIAGTTGYLAPEYVL 130
           + DFGLA+                     P N        +H+ TR      Y APE +L
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELIL 224
Query: 131 GGQ-LTMKADVYSFGVLVLEIIS 152
             +  T   D++S G +  E+++
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLN 247

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITH 112
           ++I   I   + FLH     +I HRD+K  N+L    +++   K+ DFG AK    N   
Sbjct: 112 AEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 168
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-----RNSGKAMWGQMNK 166
                  T  Y+APE +   +     D++S GV++  ++ G      N+G+A+   M +
Sbjct: 169 TPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 224

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  LHE  V   VHRD+   NILL    +  I DF LA+   D      T       Y 
Sbjct: 146 GLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWYR 200
Query: 125 APEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           APE V+  +  T   D++S G ++ E+ + +    G   + Q+NK +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 235 GRSAAVWSLGILLYDMVCG 253

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITH 112
           ++I   I   + FLH     +I HRD+K  N+L    +++   K+ DFG AK    N   
Sbjct: 131 AEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187
Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-----RNSGKAMWGQMNK 166
                  T  Y+APE +   +     D++S GV++  ++ G      N+G+A+   M +
Sbjct: 188 TPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           GL  LHE  V   VHRD+   NILL    +  I DF LA+   D      T       Y 
Sbjct: 146 GLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWYR 200
Query: 125 APEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 168
           APE V+  +  T   D++S G ++ E+ + +    G   + Q+NK +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 17/154 (11%)
Query: 3   LSNVRH-PNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
           L N+R  PN++ L         R   LV+E+V N    ++    T  +I+          
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YM 137
Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIA 118
             I K L + H      I+HRD+K  N+L+D E    ++ D+GLA+ +     +   R+A
Sbjct: 138 YEILKALDYCHS---MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA 193
Query: 119 GTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEII 151
            +  +  PE ++  Q+     D++S G ++  +I
Sbjct: 194 -SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 28/113 (24%)
Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG---- 119
           G  F+HE     I+HRD+K +N LL+Q+ + KI DFGLA+ +  D   HI   +      
Sbjct: 143 GEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 120 -------------------TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIIS 152
                              T  Y APE +L  +  T   D++S G +  E+++
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 190
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 191 GRSAAVWSLGILLYDMVCG 209

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 67/165 (40%), Gaps = 29/165 (17%)
Query: 3   LSNVRHPNLVELIGCCV--QGTRRILVYEYV---ENNSLDRVLLGATKANIKLNWEKRSD 57
           L  +RH N+++L+      +  +  +V EY        LD V             EKR  
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP------------EKRFP 107
Query: 58  ICVG------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 111
           +C        +  GL +LH +    IVH+DIK  N+LL      KI   G+A+       
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 112 HITTRIAGTTGYLAPEYVLGGQLT---MKADVYSFGVLVLEIISG 153
             T R +  +    P  +  G  T    K D++S GV +  I +G
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 8/80 (10%)
Query: 77  IVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQ 133
           I+H D+K  NILL Q+     K+ DFG +      +   I +R      Y APE +LG +
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRF-----YRAPEVILGAR 275
Query: 134 LTMKADVYSFGVLVLEIISG 153
             M  D++S G ++ E+++G
Sbjct: 276 YGMPIDMWSLGCILAELLTG 295

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 219
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 220 GRSAAVWSLGILLYDMVCG 238

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 191
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 192 GRSAAVWSLGILLYDMVCG 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 193 GRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 191
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 192 GRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 193 GRSAAVWSLGILLYDMVCG 211

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 219
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 220 GRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 235 GRSAAVWSLGILLYDMVCG 253

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 220
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 221 GRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 220
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 221 GRSAAVWSLGILLYDMVCG 239

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 188 GRSAAVWSLGILLYDMVCG 206

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 219
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 220 GRSAAVWSLGILLYDMVCG 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 239
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 240 GRSAAVWSLGILLYDMVCG 258

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 188 GRSAAVWSLGILLYDMVCG 206

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 220
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 221 GRSAAVWSLGILLYDMVCG 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 206
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 207 GRSAAVWSLGILLYDMVCG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 208 GRSAAVWSLGILLYDMVCG 226

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 220
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 221 GRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 206
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 207 GRSAAVWSLGILLYDMVCG 225

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 219
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 220 GRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 235 GRSAAVWSLGILLYDMVCG 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 208 GRSAAVWSLGILLYDMVCG 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 77  IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 135
           ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y  PE++   +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 136 MK-ADVYSFGVLVLEIISG 153
            + A V+S G+L+ +++ G
Sbjct: 193 GRSAAVWSLGILLYDMVCG 211

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNIT 111
           S+I   I + + +LH     +I HRD+K  N+L   +  P    K+ DFG AK   +  +
Sbjct: 118 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAK---ETTS 170
Query: 112 HIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           H + T    T  Y+APE +   +     D++S GV++  ++ G
Sbjct: 171 HNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	277
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-135
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-120
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-113
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-69
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-49
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-45
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-24
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  383 bits (987), Expect = e-135
 Identities = 95/228 (41%), Positives = 145/228 (63%), Gaps = 3/228 (1%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +S   H NL+ L G C+  T R+LVY Y+ N S+   L    ++   L+W KR  I +G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A+GLA+LH+   P I+HRD+KA+NILLD+EF   +GDFGLAKL     TH+TT + GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS--GKAMWGQMNKFLLEWAWQLHQEE 179
           G++APEY+  G+ + K DV+ +GV++LE+I+G+ +     +    +  LL+W   L +E+
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259

Query: 180 KPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 226
           K   LVD +L G Y   E+ + ++VA  CTQ++   RP+M++V++ML 
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  344 bits (886), Expect = e-120
 Identities = 86/226 (38%), Positives = 124/226 (54%), Gaps = 9/226 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            ++  +H NLVEL+G    G    LVY Y+ N SL   L         L+W  R  I  G
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQG 141

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGT 120
            A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+       T +T+RI GT
Sbjct: 142 AANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
           T Y+APE  L G++T K+D+YSFGV++LEII+G  +           LL+   ++  EEK
Sbjct: 199 TAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEK 255

Query: 181 PLE-LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            +E  +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  328 bits (844), Expect = e-113
 Identities = 94/234 (40%), Positives = 143/234 (61%), Gaps = 5/234 (2%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           TLS  RHP+LV LIG C +    IL+Y+Y+EN +L R L G+    + ++WE+R +IC+G
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 120
            A+GL +LH      I+HRD+K+ NILLD+ F PKI DFG++K   + + TH++T + GT
Sbjct: 148 AARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
            GY+ PEY + G+LT K+DVYSFGV++ E++  R++      +    L EWA + H   +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 181 PLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
             ++VDP L  +  P  + ++   A  C   ++  RP M  V+  L   +RL E
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  215 bits (549), Expect = 6e-69
 Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 29/251 (11%)

Query: 1   MTLSNVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
            +L  ++H N+++ IG   +G        L+  + E  SL   L         ++W +  
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELC 124

Query: 57  DICVGIAKGLAFLHEELV-------PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 109
            I   +A+GLA+LHE++        P I HRDIK+ N+LL       I DFGLA  F   
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 110 ITHI-TTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 163
            +   T    GT  Y+APE + G         ++ D+Y+ G+++ E+ S   +      +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 164 MNKFLLEWAWQLHQEEKPLELV-----DPEL-GEYPPNEIIRYM-KVAFFCTQAAASRRP 216
                 E   Q    E   E+V      P L   +  +  +  + +    C    A  R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 217 QMNQVIKMLTK 227
               V + +T+
Sbjct: 305 SAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  176 bits (448), Expect = 1e-53
 Identities = 54/271 (19%), Positives = 97/271 (35%), Gaps = 42/271 (15%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKR 55
             +  + H N+   I    + T        LV EY  N SL + L   T      +W   
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113

Query: 56  SDICVGIAKGLAFLHEELV------PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 106
             +   + +GLA+LH EL       P I HRD+ + N+L+  +    I DFGL+      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 107 ----PDNITHITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIISGRN 155
               P    +      GT  Y+APE + G            + D+Y+ G++  EI   R 
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RC 232

Query: 156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVD--------PELGE-YPPNEII--RYMKVA 204
           +       + ++ + +  ++       ++          P+  E +  N +      +  
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 205 FFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
             C    A  R       + + + + + E  
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERN 323

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  163 bits (415), Expect = 4e-49
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 21/227 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            LS V HPN+V+L G C+      LV EY E  SL  VL GA +             C+ 
Sbjct: 54  QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQ 110

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLAKLFPDNITHITTRIAGT 120
            ++G+A+LH      ++HRD+K  N+LL       KI DFG A     +I    T   G+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGS 166

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             ++APE   G   + K DV+S+G+++ E+I+ R      + ++        W +H   +
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTR 222

Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
                 P L +  P  I   M     C     S+RP M +++K++T 
Sbjct: 223 ------PPLIKNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTH 260

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  157 bits (399), Expect = 1e-46
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 29/229 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  +RHPN+V  +G   Q     +V EY+   SL R+L   + A  +L+  +R  +   +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDV 146

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           AKG+ +LH    P IVHR++K+ N+L+D+++  K+ DFGL++L        +   AGT  
Sbjct: 147 AKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPE 204

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR------NSGKAMWGQMNKFLLEWAWQLH 176
           ++APE +       K+DVYSFGV++ E+ + +      N  + +     K          
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------- 257

Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
                      E+      ++   ++    C      +RP    ++ +L
Sbjct: 258 ----------LEIPRNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  156 bits (396), Expect = 2e-46
 Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 31/233 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDI 131

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKLFPDNITHITTRI 117
           A G+ ++  +  P IVHRD+++ NI L           K+ DFGL++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGL 186

Query: 118 AGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
            G   ++APE  +G +    T KAD YSF +++  I+    +G+  + + +   +++   
Sbjct: 187 LGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTIL----TGEGPFDEYSYGKIKFINM 241

Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           + +E        P + E  P  +   +++   C      +RP  + ++K L++
Sbjct: 242 IREEGL-----RPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  153 bits (390), Expect = 1e-45
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 30/233 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
            + ++HPN++ L G C++     LV E+     L+RVL     +  ++  +   +  V I
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQI 114

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--------KIGDFGLAKLFPDNITHIT 114
           A+G+ +LH+E +  I+HRD+K+SNIL+ Q+           KI DFGLA+ +        
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TK 171

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
              AG   ++APE +     +  +DV+S+GVL+ E++    +G+  +  ++   L  A+ 
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL----TGEVPFRGID--GLAVAYG 225

Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           +   +         +    P    + M+    C       RP    ++  LT 
Sbjct: 226 VAMNKLA-----LPIPSTCPEPFAKLMED---CWNPDPHSRPSFTNILDQLTT 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  153 bits (389), Expect = 4e-45
 Identities = 57/269 (21%), Positives = 107/269 (39%), Gaps = 33/269 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + HPN+++ IG   +  R   + EY++  +L  ++      + +  W +R      I
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDI 117

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR------ 116
           A G+A+LH     +I+HRD+ + N L+ +  N  + DFGLA+L  D  T           
Sbjct: 118 ASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 117 -------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 169
                  + G   ++APE + G     K DV+SFG+++ EII   N             +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----ADPDYLPRTM 230

Query: 170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
           ++          L+   P     PP     +  +   C      +RP   ++   L + +
Sbjct: 231 DFG---LNVRGFLDRYCPP--NCPP----SFFPITVRCCDLDPEKRPSFVKLEHWL-ETL 280

Query: 230 RLNEEELTAPGLFQDSESSSVGTSDKKSS 258
           R++       G   +        + ++  
Sbjct: 281 RMHLAGHLPLGPQLEQLDRGFWETYRRGE 309

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  153 bits (389), Expect = 5e-45
 Identities = 60/252 (23%), Positives = 94/252 (37%), Gaps = 31/252 (12%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI----LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
                +RH N++  I   ++GT       L+ +Y EN SL   L      +  L+ +   
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSML 137

Query: 57  DICVGIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 111
            +      GL  LH E+      P I HRD+K+ NIL+ +     I D GLA  F  +  
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 112 HI---TTRIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEIISGRNSGKAMW 161
            +        GT  Y+ PE VL   L          AD+YSFG+++ E+     SG  + 
Sbjct: 198 EVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

Query: 162 GQMNKFLLEWAWQLHQEEKPLELVD----PELGEYPPNEII--RYMKVAFFCTQAAASRR 215
                +          E+    +      P       ++    +  K+   C     + R
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

Query: 216 PQMNQVIKMLTK 227
               +V K L K
Sbjct: 317 LTALRVKKTLAK 328

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  148 bits (376), Expect = 2e-43
 Identities = 57/230 (24%), Positives = 108/230 (46%), Gaps = 23/230 (10%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             L   RH N++  +G        I V ++ E +SL   L     +  K   +K  DI  
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIAR 127

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAG 119
             A+G+ +LH      I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G
Sbjct: 128 QTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 120 TTGYLAPEYVLGGQL----TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
           +  ++APE V+  Q     + ++DVY+FG+++ E+++G+      +  +N    +    +
Sbjct: 185 SILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNIN-NRDQIIEMV 238

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            +     +L   ++    P  + R M     C +     RP   +++  +
Sbjct: 239 GRGSLSPDL--SKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  146 bits (371), Expect = 7e-43
 Identities = 45/231 (19%), Positives = 97/231 (41%), Gaps = 30/231 (12%)

Query: 3   LSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L    HPN++ ++G C         L+  ++   SL  VL      N  ++  +     +
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFAL 118

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            +A+G+AFLH  L P I    + + ++++D++   +I    +   F       +      
Sbjct: 119 DMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYA 171

Query: 121 TGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH 176
             ++APE  L  +        AD++SF VL+ E+++     +  +  ++   +E   ++ 
Sbjct: 172 PAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTR----EVPFADLS--NMEIGMKVA 224

Query: 177 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
            E        P +       + + MK+   C     ++RP+ + ++ +L K
Sbjct: 225 LEGL-----RPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEK 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  147 bits (372), Expect = 1e-42
 Identities = 53/240 (22%), Positives = 88/240 (36%), Gaps = 34/240 (14%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           M     RH N+V  +G C+      ++    +  +L  V+     A I L+  K   I  
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQ 137

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL----FPDNITHITTR 116
            I KG+ +LH      I+H+D+K+ N+  D      I DFGL  +               
Sbjct: 138 EIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI 193

Query: 117 IAGTTGYLAPEYVLGGQL---------TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF 167
             G   +LAPE +              +  +DV++ G +  E+ +        +      
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKTQPAE 249

Query: 168 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
            +   WQ+    KP      ++G     EI   +    FC       RP   +++ ML K
Sbjct: 250 AI--IWQMGTGMKPN---LSQIGM--GKEISDILL---FCWAFEQEERPTFTKLMDMLEK 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  144 bits (366), Expect = 7e-42
 Identities = 59/256 (23%), Positives = 96/256 (37%), Gaps = 39/256 (15%)

Query: 1   MTLSNVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
                +RH N++  I   +      T+  L+  Y E  SL   L         L+     
Sbjct: 54  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCL 108

Query: 57  DICVGIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 111
            I + IA GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +  
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 112 HI---TTRIAGTTGYLAPEYVLGGQL-------TMKADVYSFGVLVLEIISGRNSGKA-- 159
            +        GT  Y+APE VL   +         + D+++FG+++ E+     S     
Sbjct: 169 QLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

Query: 160 --------MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 211
                   +      F          +++P  + +    +     + + MK    C    
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFSDPTLTSLAKLMKE---CWYQN 283

Query: 212 ASRRPQMNQVIKMLTK 227
            S R    ++ K LTK
Sbjct: 284 PSARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  139 bits (353), Expect = 1e-39
 Identities = 60/256 (23%), Positives = 95/256 (37%), Gaps = 39/256 (15%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI----LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
                +RH N++  I    +         LV +Y E+ SL   L   T     +  E   
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMI 142

Query: 57  DICVGIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 111
            + +  A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA        
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 112 HIT---TRIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEIISGRNSG---- 157
            I        GT  Y+APE VL   + M       +AD+Y+ G++  EI    + G    
Sbjct: 203 TIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 158 ------KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 211
                   +                Q+ +P  + +          + + M+    C  A 
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRP-NIPNRWQSCEALRVMAKIMRE---CWYAN 317

Query: 212 ASRRPQMNQVIKMLTK 227
            + R    ++ K L++
Sbjct: 318 GAARLTALRIKKTLSQ 333

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  115 bits (290), Expect = 8e-31
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 14/157 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 58
           L  ++HPN+V          +     +LV E + + +L   L    K    +  +     
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSW 134

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRI 117
           C  I KGL FLH    P I+HRD+K  NI +     + KIGD GLA L   +       +
Sbjct: 135 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AV 190

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            GT  ++APE           DVY+FG+ +LE+ +  
Sbjct: 191 IGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (293), Expect = 2e-30
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 13/155 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L    HPN+V LIG C Q     +V E V+       L        +L  +    +   
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGD 221

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
            A G+ +L  +     +HRD+ A N L+ ++   KI DFG+++   D    +     G  
Sbjct: 222 AAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLR 275

Query: 122 GY----LAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                  APE +  G+ + ++DV+SFG+L+ E  S
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  114 bits (288), Expect = 2e-30
 Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 30/242 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L N+ H N+V+  G C +       L+ E++ + SL   L        K+N +++    V
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAV 133

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG- 119
            I KG+ +L        VHRD+ A N+L++ E   KIGDFGL K    +  + T +    
Sbjct: 134 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 120 -----TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
                     APE ++  +  + +DV+SFGV + E+++  +S  +      K +     Q
Sbjct: 191 SPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246

Query: 175 LHQEEKPLELVDPELG---EYP---PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
           +      +  +  + G     P   P+E+ + M+    C +   S R     +I+     
Sbjct: 247 MTVTRL-VNTL--KEGKRLPCPPNCPDEVYQLMRK---CWEFQPSNRTSFQNLIEGFEAL 300

Query: 229 IR 230
           ++
Sbjct: 301 LK 302

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  113 bits (284), Expect = 7e-30
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 18/159 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
            L +++H N+V+  G C    RR   L+ EY+   SL   L    +   +++  K     
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYT 120

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I KG+ +L  +     +HRD+   NIL++ E   KIGDFGL K+ P +      +  G
Sbjct: 121 SQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177

Query: 120 ------TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                      APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 178 ESPIFWY----APESLTESKFSVASDVWSFGVVLYELFT 212

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (291), Expect = 1e-29
 Identities = 36/151 (23%), Positives = 75/151 (49%), Gaps = 5/151 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQ 326

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I+  + +L ++   + +HR++ A N L+ +    K+ DFGL++L   +            
Sbjct: 327 ISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (282), Expect = 2e-29
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 18/159 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
            L +++H N+V+  G C    RR   L+ EY+   SL   L    +   +++  K     
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYT 151

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I KG+ +L  +     +HRD+   NIL++ E   KIGDFGL K+ P +  +   +  G
Sbjct: 152 SQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208

Query: 120 ------TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                      APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 209 ESPIFWY----APESLTESKFSVASDVWSFGVVLYELFT 243

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  112 bits (281), Expect = 2e-29
 Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 32/239 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H ++++  GCC         LV EYV   SL   L      +  +   +      
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRH-SIGLAQLLLFAQ 141

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I +G+A+LH +   H +HRD+ A N+LLD +   KIGDFGLAK  P+   +   R    
Sbjct: 142 QICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR---E 195

Query: 121 TGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ 174
            G       APE +   +    +DV+SFGV + E+++   +S       +    +    Q
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQ 254

Query: 175 LHQEEKPLELVDPELGEY---PPN---EIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           +       EL+  E GE    P     E+   MK    C +  AS RP    +I +L  
Sbjct: 255 MTVLRL-TELL--ERGERLPRPDKCPAEVYHLMKN---CWETEASFRPTFENLIPILKT 307

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  112 bits (281), Expect = 3e-29
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 4/152 (2%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN+++     ++     +V E  +   L R++    K    +         V +
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L  +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y++PE +       K+D++S G L+ E+ + +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (278), Expect = 7e-29
 Identities = 39/152 (25%), Positives = 55/152 (36%), Gaps = 10/152 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
               +HP  V L     +G    L  E    +               L   +        
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCE----AWGASLPEAQVWGYLRDT 166

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              LA LH +    +VH D+K +NI L      K+GDFGL             +  G   
Sbjct: 167 LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPR 221

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE +L G     ADV+S G+ +LE+    
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (277), Expect = 1e-28
 Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 13/153 (8%)

Query: 8   HPNLVEL--IGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 63
           HP +V +   G        +  +V EYV+  +L  ++         +  ++  ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADAC 126

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTT 121
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T    + GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YL+PE   G  +  ++DVYS G ++ E+++G 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  110 bits (276), Expect = 1e-28
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 7/147 (4%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           H N+V +I    +     LV EY+E  +L   +    +++  L+ +   +    I  G+ 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
             H+     IVHRDIK  NIL+D     KI DFG+AK   +     T  + GT  Y +PE
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

Query: 128 YVLGGQLTMKADVYSFGVLVLEIISGR 154
              G       D+YS G+++ E++ G 
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 1e-28
 Identities = 32/159 (20%), Positives = 68/159 (42%), Gaps = 13/159 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-- 60
           ++++++   +   G         ++YEY+EN+S+ +        +          +    
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 61  --GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              +    +++H E   +I HRD+K SNIL+D+    K+ DFG ++   D      +   
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--R 211

Query: 119 GTTGYLAPEYVLGGQLTM---KADVYSFGVLVLEIISGR 154
           GT  ++ PE     + +    K D++S G+ +  +    
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  110 bits (277), Expect = 2e-28
 Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 8/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVG 61
           L+N++HPN+V+      +     +V +Y E   L + +        +   E +  D  V 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ---EDQILDWFVQ 133

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I   L  +H+     I+HRDIK+ NI L ++   ++GDFG+A++    +      I GT 
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTP 189

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YL+PE         K+D+++ G ++ E+ + +
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  109 bits (275), Expect = 2e-28
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 16/157 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +    H N++ L G   +    +++ EY+EN +LD+ L    + + + +  +   +  G
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRG 155

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-- 119
           IA G+ +L      + VHRD+ A NIL++     K+ DFGL+++  D+     T   G  
Sbjct: 156 IAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 120 ----TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               T    APE +   + T  +DV+SFG+++ E+++
Sbjct: 213 PIRWT----APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (272), Expect = 3e-28
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 5/156 (3%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  ++HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118

Query: 61  GIAKGLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            +   L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++   + +   T + 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y++PE +       K+D++S G L+ E+ +  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (272), Expect = 6e-28
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 16/157 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +    HPN++ L G   +G   ++V EY+EN SLD  L      + +    +   +  G
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRG 159

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-- 119
           +  G+ +L +      VHRD+ A N+L+D     K+ DFGL+++  D+     T   G  
Sbjct: 160 VGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 120 ----TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               T    APE +     +  +DV+SFGV++ E+++
Sbjct: 217 PIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLA 249

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  108 bits (272), Expect = 6e-28
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 16/155 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +++V +P++  L+G C+  T ++ + + +    L   +    +    +  +   + CV I
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQI 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----I 117
           AKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL                I
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                  A E +L    T ++DV+S+GV V E+++
Sbjct: 184 KWM----ALESILHRIYTHQSDVWSYGVTVWELMT 214

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  107 bits (270), Expect = 9e-28
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 37/195 (18%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRI-------------LVYEYVENNSL-DRVLLGATKA 46
           M L+++ H  +V      ++    +             +  EY EN +L D +       
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSE 109

Query: 47  NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 106
           N+    ++   +   I + L+++H +    I+HRD+K  NI +D+  N KIGDFGLAK  
Sbjct: 110 NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

Query: 107 --------------PDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEII 151
                         P +  ++T+ I GT  Y+A E + G G    K D+YS G++  E+I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

Query: 152 SGRNSGKAMWGQMNK 166
              ++G      + K
Sbjct: 226 YPFSTGMERVNILKK 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (270), Expect = 1e-27
 Identities = 62/257 (24%), Positives = 104/257 (40%), Gaps = 43/257 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-----------LGATKANIKLN 51
           L+ ++H ++V   G C +G   ++V+EY+ +  L+R L            G   A   L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 111
             +   +   +A G+ +L      H VHRD+   N L+ Q    KIGDFG+++    +I 
Sbjct: 157 LGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIY 209

Query: 112 HITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM--WGQ 163
                  G    L      PE +L  + T ++DV+SFGV++ EI + G+        +  
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK-----QPWYQL 264

Query: 164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
            N   ++   Q  + E+P            P E+   M+    C Q    +R  +  V  
Sbjct: 265 SNTEAIDCITQGRELERP---------RACPPEVYAIMRG---CWQREPQQRHSIKDVHA 312

Query: 224 MLTKNIRLNEEELTAPG 240
            L    +     L   G
Sbjct: 313 RLQALAQAPPVYLDVLG 329

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (272), Expect = 1e-27
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 16/157 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +    HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  G
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-- 119
           IA G+ +L +      VHRD+ A NIL++     K+ DFGL ++  D+     T   G  
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212

Query: 120 ----TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               T    +PE +   + T  +DV+S+G+++ E++S
Sbjct: 213 PIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (270), Expect = 1e-27
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 18/158 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  +    +V+  G      R+   LV EY+ +  L   L    +   +L+  +      
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSS 134

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG- 119
            I KG+ +L        VHRD+ A NIL++ E + KI DFGLAKL P +  +   R  G 
Sbjct: 135 QICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 120 -----TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                     APE +     + ++DV+SFGV++ E+ +
Sbjct: 192 SPIFWY----APESLSDNIFSRQSDVWSFGVVLYELFT 225

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  107 bits (270), Expect = 2e-27
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 41/248 (16%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL----------DRVLLGATKANIKLNWEKRS 56
           +H N+V L+G C  G   +++ EY     L                   AN   +     
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
                +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+    +I + +  
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNY 220

Query: 117 IAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQMNKFL 168
           I      L     APE +     T+++DV+S+G+L+ EI S G N   G  +  +  K +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            +     +Q  +P          + P  I   M+    C     + RP   Q+   L + 
Sbjct: 281 KDG----YQMAQP---------AFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQ 324

Query: 229 IRLNEEEL 236
            + +  E 
Sbjct: 325 AQEDRRER 332

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  109 bits (273), Expect = 2e-27
 Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 18/157 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  ++H  LV+L     +    I + E++   SL   L     +   L   K  D    
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQ 292

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           IA+G+AF+ +    + +HRD++A+NIL+      KI DFGLA++  DN     T   G  
Sbjct: 293 IAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAK 346

Query: 121 -----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                T   APE +  G  T+K+DV+SFG+L++EI++
Sbjct: 347 FPIKWT---APEAINFGSFTIKSDVWSFGILLMEIVT 380

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  105 bits (265), Expect = 2e-27
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 18/156 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + HP LV+L G C++     LV E++E+  L   L            E    +C+ +
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDV 113

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
            +G+A+L E     ++HRD+ A N L+ +    K+ DFG+ +   D+     T   GT  
Sbjct: 114 CEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKF 167

Query: 121 ----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                   +PE     + + K+DV+SFGVL+ E+ S
Sbjct: 168 PVKWA---SPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (266), Expect = 2e-27
 Identities = 39/156 (25%), Positives = 76/156 (48%), Gaps = 18/156 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ H  LV+L G C +     ++ EY+ N  L   L        +   ++  ++C  +
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDV 129

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-- 120
            + + +L  +     +HRD+ A N L++ +   K+ DFGL++   D+     T   G+  
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKF 183

Query: 121 ----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
               +    PE ++  + + K+D+++FGVL+ EI S
Sbjct: 184 PVRWS---PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  108 bits (272), Expect = 3e-27
 Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 6/151 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  +RH  LV+L     +    I V EY+   SL   L    +    L   +  D+   
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQ 288

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IA G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN            
Sbjct: 289 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 345

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  109 bits (273), Expect = 3e-27
 Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 6/151 (3%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  +RH  LV+L     +    I V EY+   SL   L    +    L   +  D+   
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQ 371

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           IA G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN            
Sbjct: 372 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 428

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
            + APE  L G+ T+K+DV+SFG+L+ E+ +
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  105 bits (265), Expect = 3e-27
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 32/165 (19%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + H +LV   G CV G   ILV E+V+  SLD  L    K  I + W+   ++   +
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKL--EVAKQL 122

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--------KIGDFGLAKLFPDNITHIT 114
           A  + FL E     ++H ++ A NILL +E +         K+ D G++           
Sbjct: 123 AAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------- 170

Query: 115 TRIAGTTGY------LAPEYVL-GGQLTMKADVYSFGVLVLEIIS 152
             +            + PE +     L +  D +SFG  + EI S
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  105 bits (265), Expect = 3e-27
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 32/241 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           + +  HPN++ L+G C++     L V  Y+++  L   +            +      + 
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQ 136

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D        +   T
Sbjct: 137 VAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKT 190

Query: 122 GYL------APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ 174
           G        A E +   + T K+DV+SFGVL+ E+++ G              +  +  Q
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA---PPYPDVNTFDITVYLLQ 247

Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
             +  +P         EY P+ +   M     C    A  RP  ++++  ++        
Sbjct: 248 GRRLLQP---------EYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFSTFIG 295

Query: 235 E 235
           E
Sbjct: 296 E 296

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  105 bits (264), Expect = 3e-27
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 18/157 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+  + HP LV+  G C +     +V EY+ N  L   L    K    L   +  ++C  
Sbjct: 56  TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYD 112

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           + +G+AFL        +HRD+ A N L+D++   K+ DFG+ +   D+         GT 
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTK 166

Query: 121 -----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                +   APE     + + K+DV++FG+L+ E+ S
Sbjct: 167 FPVKWS---APEVFHYFKYSSKSDVWAFGILMWEVFS 200

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (271), Expect = 3e-27
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 22/158 (13%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            ++ +RH NLV+L+G  V+    + +V EY+   SL   L    ++ +    +      +
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSL 296

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K         ++     
Sbjct: 297 DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTG 346

Query: 121 ------TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 T   APE +   + + K+DV+SFG+L+ EI S
Sbjct: 347 KLPVKWT---APEALREKKFSTKSDVWSFGILLWEIYS 381

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  105 bits (264), Expect = 4e-27
 Identities = 39/156 (25%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQ 119

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I+  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +     T  A   
Sbjct: 120 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAG 171

Query: 122 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
                   APE +   + ++K+DV++FGVL+ EI +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (265), Expect = 5e-27
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 45/252 (17%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS---- 56
            H N+V L+G C  G   +++ EY     L       R     +K +  +  +       
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 57  ----DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
                    +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+    +I +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DIKN 197

Query: 113 ITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQM 164
            +  +      L     APE +     T ++DV+S+G+ + E+ S G +   G  +  + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 224
            K + E      +   P         E+ P E+   MK    C  A   +RP   Q++++
Sbjct: 258 YKMIKEG----FRMLSP---------EHAPAEMYDIMKT---CWDADPLKRPTFKQIVQL 301

Query: 225 LTKNIRLNEEEL 236
           + K I  +   +
Sbjct: 302 IEKQISESTNHI 313

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (265), Expect = 6e-27
 Identities = 62/259 (23%), Positives = 95/259 (36%), Gaps = 35/259 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL---GATKANIKLNWEKRSDIC 59
           +S   H N+V  IG  +Q   R ++ E +    L   L            L       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTR 116
             IA G  +L E    H +HRDI A N LL         KIGDFG+A+    +I   +  
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 199

Query: 117 IAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
             G    L      PE  + G  T K D +SFGVL+ EI S G         + N+ +LE
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPYPSKSNQEVLE 256

Query: 171 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
           +     + + P         +  P  + R M     C Q     RP    +++ + +   
Sbjct: 257 FVTSGGRMDPP---------KNCPGPVYRIMTQ---CWQHQPEDRPNFAIILERI-EYCT 303

Query: 231 LNEEELTAPGLFQDSESSS 249
            + + +      +      
Sbjct: 304 QDPDVINTALPIEYGPLVE 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  105 bits (265), Expect = 7e-27
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 12/158 (7%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
             + +  P +V L G   +G    +  E +E  SL +++    K    L  ++       
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQ 158

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTR---- 116
             +GL +LH      I+H D+KA N+LL  + +   + DFG A     +    +      
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           I GT  ++APE V+G     K D++S   ++L +++G 
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  105 bits (263), Expect = 7e-27
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 18/156 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + +P +V +IG C   +  + V E  E   L++ L    + N  +  +   ++   +
Sbjct: 72  MQQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYL----QQNRHVKDKNIIELVHQV 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--- 119
           + G+ +L EE   + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G   
Sbjct: 127 SMGMKYL-EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 120 ---TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                   APE +   + + K+DV+SFGVL+ E  S
Sbjct: 184 VKWY----APECINYYKFSSKSDVWSFGVLMWEAFS 215

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (262), Expect = 7e-27
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
            S++RHPN++ L G     TR  L+ EY    ++ R L    +   K + ++ +     +
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITEL 118

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A  L++ H +    ++HRDIK  N+LL      KI DFG +   P +         GT  
Sbjct: 119 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDL--CGTLD 172

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           YL PE + G     K D++S GVL  E + G+
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  104 bits (262), Expect = 8e-27
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 17/156 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + +P +V LIG C Q    +LV E      L + L+G  +   ++     +++   +
Sbjct: 64  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQV 119

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--- 119
           + G+ +L EE   + VHRD+ A N+LL      KI DFGL+K    + ++ T R AG   
Sbjct: 120 SMGMKYL-EEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176

Query: 120 ---TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                   APE +   + + ++DV+S+GV + E +S
Sbjct: 177 LKWY----APECINFRKFSSRSDVWSYGVTMWEALS 208

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (264), Expect = 8e-27
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 18/161 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD------RVLLGATKANIKLNWEKRS 56
           +      ++V L+G   QG   +++ E +    L       R  +         +  K  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
            +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 194

Query: 117 IAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
             G  G L     +PE +  G  T  +DV+SFGV++ EI +
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (261), Expect = 1e-26
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 10/153 (6%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
             S++RHPN++ +        R  L+ E+     L + L    + + + + ++ +     
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEE 122

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A  L + HE     ++HRDIK  N+L+  +   KI DFG +   P      T    GT 
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTL 176

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            YL PE + G     K D++  GVL  E + G 
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  104 bits (262), Expect = 1e-26
 Identities = 34/148 (22%), Positives = 57/148 (38%), Gaps = 9/148 (6%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
            P++V +        +  +    +    L  +L    +    L   +   I   I   L 
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALD 148

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAP 126
             H        HRD+K  NIL+  +    + DFG+A    D  +T       GT  Y+AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAP 204

Query: 127 EYVLGGQLTMKADVYSFGVLVLEIISGR 154
           E       T +AD+Y+   ++ E ++G 
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  105 bits (264), Expect = 2e-26
 Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 40/247 (16%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS---------- 56
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++             
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 57  --DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 257

Query: 115 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFL 168
                T G L     APE +     T ++DV+SFGVL+ EI +    G + +  +  + L
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---GGSPYPGIPVEEL 314

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + 
Sbjct: 315 FKLLKEGHRMDKP---------ANCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 362

Query: 229 IRLNEEE 235
           + L   E
Sbjct: 363 LTLTTNE 369

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  105 bits (263), Expect = 2e-26
 Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 9/204 (4%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 139

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D++ +  + + GT 
Sbjct: 140 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTR 194

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            Y++PE + G   ++++D++S G+ ++E+  GR        +  + +     +    E P
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254

Query: 182 LELVDPELGEYPPNEIIRYMKVAF 205
                P           R     F
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIF 278

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  103 bits (260), Expect = 2e-26
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 8/156 (5%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
              +++H N+V+ +G   +     +  E V   SL   LL +    +K N +        
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGT 120
           I +GL +LH+     IVHRDIK  N+L++      KI DFG +K          T   GT
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186

Query: 121 TGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
             Y+APE +  G       AD++S G  ++E+ +G+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  104 bits (261), Expect = 2e-26
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 16/155 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +++V +P++  L+G C+  T ++ + + +    L   +    +    +  +   + CV I
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQI 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----I 117
           AKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL                I
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                  A E +L    T ++DV+S+GV V E+++
Sbjct: 184 KWM----ALESILHRIYTHQSDVWSYGVTVWELMT 214

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (262), Expect = 2e-26
 Identities = 62/259 (23%), Positives = 94/259 (36%), Gaps = 35/259 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDIC 59
           +S   H N+V  IG  +Q   R ++ E +    L    R           L       + 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTR 116
             IA G  +L E    H +HRDI A N LL         KIGDFG+A+    +I      
Sbjct: 188 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYY 240

Query: 117 IAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 170
             G    L      PE  + G  T K D +SFGVL+ EI S G         + N+ +LE
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPYPSKSNQEVLE 297

Query: 171 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 230
           +     + + P         +  P  + R M     C Q     RP    +++ + +   
Sbjct: 298 FVTSGGRMDPP---------KNCPGPVYRIMTQ---CWQHQPEDRPNFAIILERI-EYCT 344

Query: 231 LNEEELTAPGLFQDSESSS 249
            + + +      +      
Sbjct: 345 QDPDVINTALPIEYGPLVE 363

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  106 bits (267), Expect = 2e-26
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 17/156 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  + +P +V LIG C Q    +LV E      L + L+       ++     +++   +
Sbjct: 390 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQV 445

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--- 119
           + G+ +L EE   + VHR++ A N+LL      KI DFGL+K    + ++ T R AG   
Sbjct: 446 SMGMKYL-EEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 120 ---TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                   APE +   + + ++DV+S+GV + E +S
Sbjct: 503 LKWY----APECINFRKFSSRSDVWSYGVTMWEALS 534

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  103 bits (259), Expect = 3e-26
 Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 40/243 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKL 50
           L+N++H ++V+  G C  G   I+V+EY+++  L++ L                +A  +L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 51  NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
              +   I   IA G+ +L  +   H VHRD+   N L+      KIGDFG+++    ++
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR----DV 183

Query: 111 THITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM- 164
                   G    L      PE ++  + T ++DV+SFGV++ EI +    GK  W Q+ 
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLS 240

Query: 165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 224
           N  ++E   Q    E+P            P E+   M     C Q    +R  + ++ K+
Sbjct: 241 NTEVIECITQGRVLERP---------RVCPKEVYDVMLG---CWQREPQQRLNIKEIYKI 288

Query: 225 LTK 227
           L  
Sbjct: 289 LHA 291

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  103 bits (260), Expect = 3e-26
 Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 40/247 (16%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS---------- 56
           +H N++ L+G C Q     ++ EY    +L   L       ++ +++             
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 57  --DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211

Query: 115 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFL 168
                T G L     APE +     T ++DV+SFGVL+ EI +    G + +  +  + L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---GGSPYPGIPVEEL 268

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + 
Sbjct: 269 FKLLKEGHRMDKP---------ANCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 316

Query: 229 IRLNEEE 235
           + L   E
Sbjct: 317 LTLTTNE 323

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  102 bits (257), Expect = 4e-26
 Identities = 59/157 (37%), Positives = 85/157 (54%), Gaps = 18/157 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  ++H  LV L     Q    I + EY+EN SL   L   T + IKL   K  D+   
Sbjct: 61  LMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQ 117

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           IA+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN     T   G  
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAK 171

Query: 121 -----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                T   APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 172 FPIKWT---APEAINYGTFTIKSDVWSFGILLTEIVT 205

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  102 bits (257), Expect = 7e-26
 Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 44/250 (17%)

Query: 7   RHPNLVELIGCCVQGTRRILV-YEYVENNSLDRVLLGATKANIKLNWEKRS--------- 56
            H N+V L+G C +    ++V  E+ +  +L   L       +                 
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 57  ---DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
                   +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+    +I   
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKD 201

Query: 114 TTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQMN 165
              +      L     APE +     T+++DV+SFGVL+ EI S G +   G  +  +  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

Query: 166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           + L E      +   P         +Y   E+ + M     C     S+RP  +++++ L
Sbjct: 262 RRLKEG----TRMRAP---------DYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL 305

Query: 226 TKNIRLNEEE 235
              ++ N ++
Sbjct: 306 GNLLQANAQQ 315

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (258), Expect = 7e-26
 Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 34/265 (12%)

Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++ H ++V L+G C   + ++ V +Y+   SL   +    +    L  +   +  V IAK
Sbjct: 71  SLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAK 126

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----IAG 119
           G+ +L E     +VHR++ A N+LL      ++ DFG+A L P +   +        I  
Sbjct: 127 GMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQE 178
                A E +  G+ T ++DV+S+GV V E+++ G    +   G     + +   +  + 
Sbjct: 184 M----ALESIHFGKYTHQSDVWSYGVTVWELMTFGA---EPYAGLRLAEVPDLLEKGERL 236

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTA 238
            +P         +    ++   M     C     + RP   ++    T+  R     L  
Sbjct: 237 AQP---------QICTIDVYMVMVK---CWMIDENIRPTFKELANEFTRMARDPPRYLVI 284

Query: 239 PGLFQDSESSSVGTSDKKSSDSTLQ 263
               +     + G      ++  L+
Sbjct: 285 KR--ESGPGIAPGPEPHGLTNKKLE 307

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  102 bits (256), Expect = 8e-26
 Identities = 53/240 (22%), Positives = 100/240 (41%), Gaps = 30/240 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +  + HPN++ LIG  +        +  Y+ +  L + +    +       +      + 
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQ 132

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A+G+ +L E+     VHRD+ A N +LD+ F  K+ DFGLA+   D      +      
Sbjct: 133 VARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR--EYYSVQQHRH 187

Query: 122 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
             L     A E +   + T K+DV+SFGVL+ E+++ G              L  +  Q 
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA---PPYRHIDPFDLTHFLAQG 244

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            +  +P         EY P+ + + M+    C +A  + RP    ++  + + +     +
Sbjct: 245 RRLPQP---------EYCPDSLYQVMQQ---CWEADPAVRPTFRVLVGEVEQIVSALLGD 292

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (256), Expect = 8e-26
 Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 24/167 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKL 50
            + ++HPN+V L+G   +     +++ Y  +  L   L                     L
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 51  NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 110
                  +   IA G+ +L      H+VH+D+   N+L+  + N KI D GL +     +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR----EV 178

Query: 111 THITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
                        L     APE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (255), Expect = 2e-25
 Identities = 60/270 (22%), Positives = 108/270 (40%), Gaps = 44/270 (16%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS---------- 56
            HPN++ L+G C       L  EY  + +L   L  +        +   +          
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 57  --DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++   +      
Sbjct: 144 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV--- 196

Query: 115 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFL 168
                T G L     A E +     T  +DV+S+GVL+ EI+S G   G    G     L
Sbjct: 197 ---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG---GTPYCGMTCAEL 250

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            E   Q ++ EKP             +E+   M+    C +     RP   Q++  L + 
Sbjct: 251 YEKLPQGYRLEKP---------LNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRM 298

Query: 229 IRLNEEELTAPGLFQDSESSSVGTSDKKSS 258
           +   +  +    L++    + +  S ++++
Sbjct: 299 LEERKTYVNT-TLYEKFTYAGIDCSAEEAA 327

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  100 bits (252), Expect = 2e-25
 Identities = 39/180 (21%), Positives = 77/180 (42%), Gaps = 23/180 (12%)

Query: 3   LSNVRHPNLVELIGC----------------CVQGTRRILVYEYVENNSLDRVLLGATKA 46
           L+ + H N+V   GC                  +     +  E+ +  +L++ +    + 
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRR 115

Query: 47  NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 106
             KL+     ++   I KG+ ++H +    +++RD+K SNI L      KIGDFGL    
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK 166
            ++     TR  GT  Y++PE +       + D+Y+ G+++ E++   ++          
Sbjct: 173 KNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  102 bits (255), Expect = 3e-25
 Identities = 57/240 (23%), Positives = 99/240 (41%), Gaps = 30/240 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           + +  HPN++ L+G C++     L V  Y+++  L   +            +      + 
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQ 200

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +AKG+ FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D           T 
Sbjct: 201 VAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTG 255

Query: 122 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
             L     A E +   + T K+DV+SFGVL+ E+++ G              +  +  Q 
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA---PPYPDVNTFDITVYLLQG 312

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
            +  +P         EY P+ +   M     C    A  RP  ++++  ++        E
Sbjct: 313 RRLLQP---------EYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFSTFIGE 360

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  100 bits (251), Expect = 3e-25
 Identities = 34/169 (20%), Positives = 59/169 (34%), Gaps = 30/169 (17%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           +H ++V       +    ++  EY    SL   +    +        +  D+ + + +GL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNP-------------------KIGDFGLAKLFP 107
            ++H      +VH DIK SNI + +   P                   KIGD G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
                      G + +LA E VL        KAD+++  + V+      
Sbjct: 186 SPQVEE-----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  101 bits (254), Expect = 4e-25
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 24/163 (14%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEK 54
           +H N++ L+G C Q     ++ EY    +L            +     +     +L+ + 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I HI 
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 245

Query: 115 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
                T G L     APE +     T ++DV+SFGVL+ EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 99.6 bits (249), Expect = 6e-25
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 39/242 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           ++ +RH NLV+L+G  V+    + +V EY+   SL   L    ++ +    +      + 
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLD 125

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K         ++      
Sbjct: 126 VCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGK 175

Query: 121 -----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ 174
                T   APE +   + + K+DV+SFG+L+ EI S GR           K ++    +
Sbjct: 176 LPVKWT---APEALREKKFSTKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVEK 229

Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
            ++ + P         +  P  +   MK    C    A+ RP   Q+ + L ++I+ +E 
Sbjct: 230 GYKMDAP---------DGCPPAVYEVMKN---CWHLDAAMRPSFLQLREQL-EHIKTHEL 276

Query: 235 EL 236
            L
Sbjct: 277 HL 278

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (250), Expect = 6e-25
 Identities = 36/168 (21%), Positives = 64/168 (38%), Gaps = 20/168 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR----ILVYEYVENNSLDRVLLGATKANIKLNWEKRS-D 57
                HPN++ L+  C++         L+  + +  +L   +         L  E +   
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILW 138

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
           + +GI +GL  +H        HRD+K +NILL  E  P + D G       ++      +
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 118 A--------GTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGR 154
                     T  Y APE         +  + DV+S G ++  ++ G 
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 6e-25
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 9/158 (5%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           +++  V  P  V   G   +     +  E + + SLD+           +  +    I V
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I K L  LH +L   ++HRD+K SN+L++     K+ DFG++    D++       AG 
Sbjct: 117 SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGC 172

Query: 121 TGYLAPEYVLGGQL----TMKADVYSFGVLVLEIISGR 154
             Y+APE +         ++K+D++S G+ ++E+   R
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.6 bits (249), Expect = 6e-25
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 17/156 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+    HP++V+LIG   +    I + E      L   L         L+          
Sbjct: 69  TMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKY---SLDLASLILYAYQ 124

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+          + 
Sbjct: 125 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASK 176

Query: 122 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
           G L     APE +   + T  +DV+ FGV + EI+ 
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  100 bits (251), Expect = 7e-25
 Identities = 63/257 (24%), Positives = 99/257 (38%), Gaps = 50/257 (19%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSL-------------------DRVLLGATKAN 47
            H N+V L+G C       L++EY     L                   ++  L   +  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
             L +E        +AKG+ FL  +     VHRD+ A N+L+      KI DFGLA+   
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR--- 220

Query: 108 DNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKA 159
            +I   +  +      L     APE +  G  T+K+DV+S+G+L+ EI S G N   G  
Sbjct: 221 -DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN 219
           +     K +        + ++P          Y   EI   M+    C    + +RP   
Sbjct: 280 VDANFYKLIQNG----FKMDQP---------FYATEEIYIIMQS---CWAFDSRKRPSFP 323

Query: 220 QVIKMLTKNIRLNEEEL 236
            +   L   +   EE +
Sbjct: 324 NLTSFLGCQLADAEEAM 340

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (250), Expect = 8e-25
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 10/159 (6%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDIC 59
           + + +   P +V+  G   +     +  E + + S D+           +  E+    I 
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           +   K L  L E L   I+HRDIK SNILLD+  N K+ DFG++    D+I    TR AG
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAG 187

Query: 120 TTGYLAPEYVLGGQL----TMKADVYSFGVLVLEIISGR 154
              Y+APE +          +++DV+S G+ + E+ +GR
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 99.2 bits (248), Expect = 1e-24
 Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 9/150 (6%)

Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           ++ H NL+ L G  +    ++ V E     SL   L    + +  L     S   V +A+
Sbjct: 77  SLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK-HQGHFLL--GTLSRYAVQVAE 132

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY- 123
           G+ +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +      + 
Sbjct: 133 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189

Query: 124 -LAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
             APE +     +  +D + FGV + E+ +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.8 bits (247), Expect = 1e-24
 Identities = 42/155 (27%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + N+ HP++V+LIG   +    I + E      L   L         L         + I
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQI 122

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            K +A+L      + VHRDI   NIL+      K+GDFGL++   D           +  
Sbjct: 123 CKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASVT 174

Query: 123 YL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
            L     +PE +   + T  +DV+ F V + EI+S
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 99.0 bits (247), Expect = 1e-24
 Identities = 48/247 (19%), Positives = 89/247 (36%), Gaps = 48/247 (19%)

Query: 2   TLSNVRHPNLVELIGC---------CVQGTRRILVY---EYVENNSLDRVLLGATKANIK 49
            L+ + HP +V                  + ++ +Y   +     +L    +       +
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEE 114

Query: 50  LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 106
                   I + IA+ + FLH +    ++HRD+K SNI    +   K+GDFGL       
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171

Query: 107 --------PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK 158
                   P       T   GT  Y++PE + G   + K D++S G+++ E++       
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------ 225

Query: 159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE--IIRYMKVAFFCTQAAASRRP 216
               QM +          +  K      P   +  P E  +++ M         +   RP
Sbjct: 226 PFSTQMERVRT---LTDVRNLKF----PPLFTQKYPCEYVMVQDM------LSPSPMERP 272

Query: 217 QMNQVIK 223
           +   +I+
Sbjct: 273 EAINIIE 279

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.7 bits (249), Expect = 1e-24
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 14/156 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-WEKRSDICV 60
              ++ H ++V   G         +V E     SL  +     K    L   E R     
Sbjct: 94  IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY-YLR 148

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 119
            I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA K+  D        + G
Sbjct: 149 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCG 203

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y+APE VL  +  + + DV+S G ++  ++ G+
Sbjct: 204 TPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.4 bits (246), Expect = 1e-24
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 11/154 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
              ++HP+++EL           LV E   N  ++R L    K     +  +       I
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQI 121

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTT 121
             G+ +LH      I+HRD+  SN+LL +  N KI DFGLA +L   +  H T  + GT 
Sbjct: 122 ITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTP 176

Query: 122 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
            Y++PE +       +++DV+S G +   ++ GR
Sbjct: 177 NYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 99.2 bits (248), Expect = 1e-24
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 32/175 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKL 50
           L  V HP++++L G C Q    +L+ EY +  SL              +  G ++ +  L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 51  NWEKRS--------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 102
           +                  I++G+ +L E     +VHRD+ A NIL+ +    KI DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGL 196

Query: 103 AKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
           ++    ++    + +  + G +     A E +     T ++DV+SFGVL+ EI++
Sbjct: 197 SR----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.4 bits (246), Expect = 2e-24
 Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 12/155 (7%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
              ++ H ++V   G         +V E     SL  +     K    L   +       
Sbjct: 68  IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQ 123

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGT 120
           I  G  +LH      ++HRD+K  N+ L+++   KIGDFGLA K+  D        + GT
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGT 178

Query: 121 TGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
             Y+APE VL  +  + + DV+S G ++  ++ G+
Sbjct: 179 PNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  101 bits (253), Expect = 2e-24
 Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 15/154 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +    HP++V+LIG   +    I + E      L   L         L+          +
Sbjct: 445 MRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQ---VRKFSLDLASLILYAYQL 500

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----IA 118
           +  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++    I 
Sbjct: 501 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 152
                 APE +   + T  +DV+ FGV + EI+ 
Sbjct: 558 WM----APESINFRRFTSASDVWMFGVCMWEILM 587

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.8 bits (246), Expect = 2e-24
 Identities = 42/212 (19%), Positives = 81/212 (38%), Gaps = 42/212 (19%)

Query: 29  EYVENNSLDRVL---LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 85
           +     +L   +            +       I + IA+ + FLH +    ++HRD+K S
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCL----HIFIQIAEAVEFLHSK---GLMHRDLKPS 193

Query: 86  NILLDQEFNPKIGDFGLAK-----------LFPDNITHITTRIAGTTGYLAPEYVLGGQL 134
           NI    +   K+GDFGL             L P       T   GT  Y++PE + G   
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253

Query: 135 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 194
           + K D++S G+++ E++   ++       M +  +     +   + P         +  P
Sbjct: 254 SHKVDIFSLGLILFELLYSFSTQ------MERVRI--ITDVRNLKFP-----LLFTQKYP 300

Query: 195 NE--IIRYMKVAFFCTQAAASRRPQMNQVIKM 224
            E  +++ M         + + RP+   +I+ 
Sbjct: 301 QEHMMVQDM------LSPSPTERPEATDIIEN 326

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 36/163 (22%), Positives = 71/163 (43%), Gaps = 20/163 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKAN--IKLNWEK 54
           +    HP++ +L+G  ++   +       ++  ++++  L   LL +        L  + 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                V IA G+ +L      + +HRD+ A N +L ++    + DFGL++     I    
Sbjct: 139 LVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGD 191

Query: 115 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
               G    L     A E +     T+ +DV++FGV + EI++
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  100 bits (250), Expect = 2e-24
 Identities = 38/157 (24%), Positives = 60/157 (38%), Gaps = 17/157 (10%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
            HPN++           + +  E       + V     + +      +   +      GL
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVE----QKDFAHLGLEPITLLQQTTSGL 131

Query: 67  AFLHEELVPHIVHRDIKASNILL-----DQEFNPKIGDFGLAKLFPDNITHITTR--IAG 119
           A LH     +IVHRD+K  NIL+       +    I DFGL K         + R  + G
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 120 TTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 153
           T G++APE +        T   D++S G +   +IS 
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 98.1 bits (245), Expect = 3e-24
 Identities = 38/162 (23%), Positives = 72/162 (44%), Gaps = 19/162 (11%)

Query: 3   LSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS- 56
           + +  HPN++ L+G C++       + +++  +++   L   LL +       +   ++ 
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 57  -DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
               V IA G+ +L      + +HRD+ A N +L  +    + DFGL+K     I     
Sbjct: 150 LKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDY 202

Query: 116 RIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
              G    +     A E +     T K+DV++FGV + EI +
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (251), Expect = 3e-24
 Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 2   TLSNVRHPNLVEL--IGCCVQGTRRILVY---EYVENNSLDRVLLGATKANIKLNWEKRS 56
            L+ V HP++V++             + Y   EYV   SL R          KL   +  
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAI 185

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
              + I   L++LH      +V+ D+K  NI+L +E   K+ D G        I      
Sbjct: 186 AYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINS-FGY 236

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           + GT G+ APE V  G  T+  D+Y+ G  +  +    
Sbjct: 237 LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDL 273

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 97.8 bits (244), Expect = 4e-24
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 7/151 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +     P++V+  G   + T   +V EY    S+  ++      N  L  ++ + I    
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQST 134

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL +LH       +HRDIKA NILL+ E + K+ DFG+A    D +    T I GT  
Sbjct: 135 LKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPF 190

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +        AD++S G+  +E+  G
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.2 bits (245), Expect = 5e-24
 Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 32/175 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 57
           ++   +PN+V+L+G C  G    L++EY+    L+  L   +   +              
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 58  ---------------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 102
                          I   +A G+A+L E      VHRD+   N L+ +    KI DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 220

Query: 103 AKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 152
           ++    NI       A     +      PE +   + T ++DV+++GV++ EI S
Sbjct: 221 SR----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.4 bits (243), Expect = 5e-24
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + +   ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
              + L FLH      ++HRDIK+ NILL  + + K+ DFG         +  +T + GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
             ++APE V       K D++S G++ +E+I G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.5 bits (245), Expect = 6e-24
 Identities = 40/250 (16%), Positives = 77/250 (30%), Gaps = 24/250 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L        ++     +     +LV E     +L + + L        +         + 
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----------KIGDFGLA---KLFP 107
           +   +  +H+     I+H DIK  N +L   F              + D G +   KLFP
Sbjct: 181 MLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR----NSGKAMWGQ 163
                 T +   T+G+   E +       + D +     V  ++ G      +       
Sbjct: 238 KGTI-FTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295

Query: 164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
              F       +  E   + L  P+    P  +++R      F        R   N++I 
Sbjct: 296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355

Query: 224 MLTKNIRLNE 233
           +L +  R  +
Sbjct: 356 LLLECKRSRK 365

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.7 bits (241), Expect = 1e-23
 Identities = 38/151 (25%), Positives = 82/151 (54%), Gaps = 9/151 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + + +H N+VE+    + G    ++ E+++  +L  ++       ++LN E+ + +C  +
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAV 150

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + LA+LH +    ++HRDIK+ +ILL  +   K+ DFG       ++    + + GT  
Sbjct: 151 LQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPY 206

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           ++APE +       + D++S G++V+E++ G
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 99.4 bits (247), Expect = 1e-23
 Identities = 61/279 (21%), Positives = 96/279 (34%), Gaps = 26/279 (9%)

Query: 3   LSNVRHPNLVELI------GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           +  + HPN+V                  +L  EY E   L R  L   +    L      
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCGLKEGPIR 124

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHI 113
            +   I+  L +LHE     I+HRD+K  NI+L         KI D G AK         
Sbjct: 125 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELC 180

Query: 114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 173
           T  + GT  YLAPE +   + T+  D +SFG L  E I+G       W  +         
Sbjct: 181 TEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV--------- 230

Query: 174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI--RL 231
           Q H + +        + +     +     +      +          +  ML  +   R 
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290

Query: 232 NEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVT 270
            + +    G FQ  +S          +  + ++ + PVT
Sbjct: 291 TDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVT 329

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            LS    P + +  G  ++ T+  ++ EY+   S   +L    +    L+  + + I   
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPG-PLDETQIATILRE 127

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I KGL +LH E     +HRDIKA+N+LL +    K+ DFG+A    D      T + GT 
Sbjct: 128 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTP 183

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
            ++APE +       KAD++S G+  +E+  G
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 96.3 bits (239), Expect = 6e-23
 Identities = 27/161 (16%), Positives = 54/161 (33%), Gaps = 15/161 (9%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYV-------ENNSLDRVLLGATKANIKLNWEKRSDI 58
           V+ P   ++I   +      ++  +           +   VLL  +  +  L    R  +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            + + + LA LH      +VH  ++  +I+LDQ     +  F        +      R  
Sbjct: 217 TLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF 273

Query: 119 GTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISGR 154
                 A   +  GQ     +T   D ++ G+ +  I    
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.5 bits (237), Expect = 7e-23
 Identities = 26/167 (15%), Positives = 60/167 (35%), Gaps = 23/167 (13%)

Query: 3   LSNVRHPNLVELIGCC--VQGTRRILVYEYVENNSLDRV--LLGATKANIKLNWEKRSDI 58
           + + +   ++ +      +    R  +Y  +++N       LL  +  +  L    R  +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
            + + + LA LH      +VH  ++  +I+LDQ     +  F       D    +++   
Sbjct: 212 TLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARVVSS--- 263

Query: 119 GTTGYLAPEYVL-----------GGQLTMKADVYSFGVLVLEIISGR 154
            + G+  PE                 +T   D ++ G+++  I    
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.6 bits (233), Expect = 2e-22
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 13/157 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L +   P +V+  G  +  T   +  E +     +++     +    +       + V I
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAI 133

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            K L +L E+    ++HRD+K SNILLD+    K+ DFG++    D+      R AG   
Sbjct: 134 VKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAA 189

Query: 123 YLAPE-----YVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE             ++ADV+S G+ ++E+ +G+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.1 bits (232), Expect = 2e-22
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 11/147 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L ++ HPN++++           +V E  E   L +R++    +    L+    +++   
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQ 132

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +   LA+ H +   H+VH+D+K  NIL          KI DFGLA+LF  +    +T  A
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAA 187

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGV 145
           GT  Y+APE V    +T K D++S GV
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGV 213

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.3 bits (232), Expect = 2e-22
 Identities = 43/166 (25%), Positives = 65/166 (39%), Gaps = 20/166 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L  + H N+V+L     + T R  +L+ E+    SL  VL         L   +   +  
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLR 119

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTR 116
            +  G+  L E     IVHR+IK  NI+     D +   K+ DFG A+   D+     + 
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSL 175

Query: 117 IAGTTGYLAPEYVLGGQLTM--------KADVYSFGVLVLEIISGR 154
             GT  YL P+      L            D++S GV      +G 
Sbjct: 176 Y-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 92.4 bits (230), Expect = 3e-22
 Identities = 39/156 (25%), Positives = 79/156 (50%), Gaps = 12/156 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L+   HP +V+L+G      +  ++ E+    ++D ++    + +  L   +   +C  +
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQM 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            + L FLH +    I+HRD+KA N+L+  E + ++ DFG++      +    + I GT  
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPY 182

Query: 123 YLAPEYVLGGQLT-----MKADVYSFGVLVLEIISG 153
           ++APE V+   +       KAD++S G+ ++E+   
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 92.3 bits (230), Expect = 4e-22
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 19/146 (13%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HPN+++L       T   LV++ ++   L D +        + L+ ++   I   + + +
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVI 137

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
             LH+    +IVHRD+K  NILLD + N K+ DFG +             + GT  YLAP
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAP 192

Query: 127 EYVLGGQLTM-------KADVYSFGV 145
           E ++   +         + D++S GV
Sbjct: 193 E-IIECSMNDNHPGYGKEVDMWSTGV 217

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 93.2 bits (231), Expect = 5e-22
 Identities = 15/134 (11%), Positives = 32/134 (23%), Gaps = 13/134 (9%)

Query: 26  LVYEYVENN--SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 83
           L+      +   L   L                 +   + +  A L  +    +VH    
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFT 221

Query: 84  ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ---LTMKADV 140
             N+ +  +    +GD                  +      AP   L       T   + 
Sbjct: 222 PDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNA 276

Query: 141 YSFGVLVLEIISGR 154
           +  G+ +  +    
Sbjct: 277 WQLGLSIYRVWCLF 290

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 92.0 bits (229), Expect = 5e-22
 Identities = 34/166 (20%), Positives = 68/166 (40%), Gaps = 23/166 (13%)

Query: 3   LSNVRHPNL--VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L+ ++  +   + L    +      +V E   N  L+  L    K    ++  +R     
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWK 134

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAG 119
            + + +  +H+     IVH D+K +N L+      K+ DFG+A     + T +      G
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 120 TTGYLAPEYVLG-----------GQLTMKADVYSFGVLVLEIISGR 154
           T  Y+ PE +              +++ K+DV+S G ++  +  G+
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.5 bits (228), Expect = 6e-22
 Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 15/147 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           + ++ HPN++ L       T   LV E      L +RV+               + I   
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV-----HKRVFRESDAARIMKD 114

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +   +A+ H+    ++ HRD+K  N L      +   K+ DFGLA  F      +     
Sbjct: 115 VLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV 169

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGV 145
           GT  Y++P+ VL G    + D +S GV
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGV 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 91.5 bits (228), Expect = 6e-22
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 15/147 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       +   +V E      L D ++        + +    + I   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQ 129

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N         
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI 184

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGV 145
           GT  Y+APE VL G    K DV+S GV
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 92.7 bits (230), Expect = 9e-22
 Identities = 34/162 (20%), Positives = 60/162 (37%), Gaps = 15/162 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
                 HPN+V      +      +V  ++   S  + L+     +  +N    + I  G
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMD-GMNELAIAYILQG 136

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI---- 117
           + K L ++H       VHR +KAS+IL+  +    +           +            
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 118 --AGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGR 154
                  +L+PE VL   L     K+D+YS G+   E+ +G 
Sbjct: 194 YSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.6 bits (230), Expect = 1e-21
 Identities = 42/167 (25%), Positives = 64/167 (38%), Gaps = 22/167 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDIC 59
           L  + H N+V+L     + T R  +L+ E+    SL     L        L   +   + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTV--LEEPSNAYGLPESEFLIVL 118

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITT 115
             +  G+  L E     IVHR+IK  NI+     D +   K+ DFG A+   D+     +
Sbjct: 119 RDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS 174

Query: 116 RIAGTTGYLAPEYVLGGQLTM--------KADVYSFGVLVLEIISGR 154
              GT  YL P+      L            D++S GV      +G 
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.1 bits (229), Expect = 1e-21
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HP+++ LI      +   LV++ +    L D +        + L+ ++   I   + + +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAV 213

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
           +FLH     +IVHRD+K  NILLD     ++ DFG +             + GT GYLAP
Sbjct: 214 SFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAP 268

Query: 127 EYVLGGQLTM-------KADVYSFGV 145
           E +L   +         + D+++ GV
Sbjct: 269 E-ILKCSMDETHPGYGKEVDLWACGV 293

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.7 bits (228), Expect = 1e-21
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 19/156 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  +RHPN ++  GC ++     LV EY   ++ D + +        L   + + +  G 
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGA 163

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGT 120
            +GLA+LH     +++HRD+KA NILL +    K+GDFG A       + +       GT
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGT 213

Query: 121 TGYLAPEYVLGGQLT---MKADVYSFGVLVLEIISG 153
             ++APE +L         K DV+S G+  +E+   
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 90.9 bits (226), Expect = 2e-21
 Identities = 34/166 (20%), Positives = 68/166 (40%), Gaps = 23/166 (13%)

Query: 3   LSNVRHPNL--VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L+ ++  +   + L    +      +V E   N  L+  L    K    ++  +R     
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWK 115

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAG 119
            + + +  +H+     IVH D+K +N L+      K+ DFG+A     + T +      G
Sbjct: 116 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 120 TTGYLAPEYVLG-----------GQLTMKADVYSFGVLVLEIISGR 154
           T  Y+ PE +              +++ K+DV+S G ++  +  G+
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L ++ HPN+++L           LV E+ E   L ++++        K +    ++I   
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQ 154

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           I  G+ +LH+    +IVHRDIK  NILL   +   N KI DFGL+  F  +  +      
Sbjct: 155 ILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRL 209

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE VL  +   K DV+S GV++  ++ G 
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 33/166 (19%), Positives = 67/166 (40%), Gaps = 23/166 (13%)

Query: 3   LSNVRHPNL--VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L+ ++  +   + L    +      +V E   N  L+  L    K    ++  +R     
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWK 162

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAG 119
            + + +  +H+     IVH D+K +N L+      K+ DFG+A     + T +      G
Sbjct: 163 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 120 TTGYLAPEYVLG-----------GQLTMKADVYSFGVLVLEIISGR 154
              Y+ PE +              +++ K+DV+S G ++  +  G+
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 6/153 (3%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           L+ V    +V L       T   LV   +    +   +    + N     E R+      
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQ 297

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T      AGT 
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTP 353

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           G++APE +LG +     D ++ GV + E+I+ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 45/172 (26%), Positives = 66/172 (38%), Gaps = 28/172 (16%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-GATKANIKLNWEKR-SDICVGIAK 64
            HPN++             +  E    N  D V     +  N+KL  E     +   IA 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 65  GLAFLHEELVPHIVHRDIKASNILLD-------------QEFNPKIGDFGLAKLFPDNIT 111
           G+A LH      I+HRD+K  NIL+              +     I DFGL K      +
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 112 HITTR---IAGTTGYLAPEYVLGG-------QLTMKADVYSFGVLVLEIISG 153
              T     +GT+G+ APE +          +LT   D++S G +   I+S 
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E  +   L D ++       +K N    + I   
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-----HRMKFNEVDAAVIIKQ 144

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ +LH+    +IVHRD+K  N+LL   +++   KI DFGL+ +F +          
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERL 199

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE VL  +   K DV+S GV++  +++G 
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 89.6 bits (223), Expect = 5e-21
 Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L  +RH NLV L+  C +  R  LV+E+V++     L+    G     ++          
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK-------YL 130

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             I  G+ F H     +I+HRDIK  NIL+ Q    K+ DFG A+            +A 
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA- 186

Query: 120 TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 154
           T  Y APE ++G  +     DV++ G LV E+  G 
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.1 bits (224), Expect = 6e-21
 Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 9/148 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
              ++HP++VEL+          +V+E+++   L   ++     A    +    S     
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQ 138

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIA 118
           I + L + H+    +I+HRD+K   +LL  + N    K+G FG+A    ++      R+ 
Sbjct: 139 ILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV- 194

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVL 146
           GT  ++APE V         DV+  GV+
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.9 bits (226), Expect = 6e-21
 Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L           LV E      L D ++     +  + +    + I   
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQ 134

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+     IVHRD+K  N+LL    ++ N +I DFGL+  F  +         
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKI 189

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE VL G    K DV+S GV++  ++SG 
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.0 bits (226), Expect = 7e-21
 Identities = 48/153 (31%), Positives = 66/153 (43%), Gaps = 9/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           L  V    +V L           LV   +    L   +    +A      E R+      
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAE 294

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T       GT 
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 349

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GY+APE V   + T   D ++ G L+ E+I+G+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 88.0 bits (219), Expect = 1e-20
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 16/148 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
              ++HPN+V L     + +   LV++ V    L + ++     A    +    S     
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQ 113

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIA 118
           I + +A+ H      IVHR++K  N+LL  +      K+ DFGLA    D+        A
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFA 168

Query: 119 GTTGYLAPEYVLGGQL-TMKADVYSFGV 145
           GT GYL+PE VL     +   D+++ GV
Sbjct: 169 GTPGYLSPE-VLKKDPYSKPVDIWACGV 195

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 15/149 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  V H N++ L       T  +L+ E V    L D +          L+ E+ +     
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQ 123

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRI 117
           I  G+ +LH +    I H D+K  NI+L  +  P    K+ DFGLA    D        I
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNI 178

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVL 146
            GT  ++APE V    L ++AD++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.2 bits (217), Expect = 2e-20
 Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 15/149 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  +RHPN++ L       T  +L+ E V    L D +          L  ++ +     
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQ 116

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRI 117
           I  G+ +LH +    I H D+K  NI+L  +  P    K+ DFG+A        +    I
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNI 171

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVL 146
            GT  ++APE V    L ++AD++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       +   +V E      L D ++        + +    + I   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQ 129

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +  G+ ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N         
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI 184

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           GT  Y+APE VL G    K DV+S GV++  ++SG 
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 87.6 bits (218), Expect = 2e-20
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDIC 59
           L  ++HPNLV L+    +  R  LV+EY ++     LDR   G  +  +K        I 
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-------SIT 108

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
               + + F H+    + +HRD+K  NIL+ +    K+ DFG A+L      +    +A 
Sbjct: 109 WQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA- 164

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y +PE ++G        DV++ G +  E++SG 
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 87.6 bits (218), Expect = 2e-20
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDIC 59
           L  + HPN+V LI          LV+E++E      LD    G   + IK+         
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YL 125

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + +G+A  H+     I+HRD+K  N+L++ +   K+ DFGLA+ F   +   T  +  
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV- 181

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y AP+ ++G +  +   D++S G +  E+I+G+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 12/162 (7%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRSD 57
            +S   HPN+V      V      LV + +   S+  ++          +  L+    + 
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTR 116
           I   + +GL +LH+      +HRD+KA NILL ++ + +I DFG+ A L           
Sbjct: 126 ILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 117 ---IAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGR 154
                GT  ++APE +        KAD++SFG+  +E+ +G 
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 87.3 bits (217), Expect = 3e-20
 Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 22/152 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
           L  + HP ++++            +V E +E   L D+V       N +L          
Sbjct: 69  LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKV-----VGNKRLKEATCKLYFY 121

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRI 117
            +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +    +   +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL 176

Query: 118 AGTTGYLAPEYVLGGQL----TMKADVYSFGV 145
            GT  YLAPE VL            D +S GV
Sbjct: 177 CGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGV 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 20/153 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HP ++++           +V E +E   L D+V+      N +L           
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQ 247

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +    +   + 
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 302

Query: 119 GTTGYLAPEYVLGGQL----TMKADVYSFGVLV 147
           GT  YLAPE VL            D +S GV++
Sbjct: 303 GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 334

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 16/147 (10%)

Query: 6   VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 64
            +HPN++ L      G    +V E ++   L D++L          +  + S +   I K
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-----RQKFFSEREASAVLFTITK 127

Query: 65  GLAFLHEELVPHIVHRDIKASNILL-DQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 120
            + +LH +    +VHRD+K SNIL  D+  NP   +I DFG AK        + T    T
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYT 183

Query: 121 TGYLAPEYVLGGQL-TMKADVYSFGVL 146
             ++APE VL  Q      D++S GVL
Sbjct: 184 ANFVAPE-VLERQGYDAACDIWSLGVL 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.0 bits (216), Expect = 4e-20
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 7   RHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            H N+    G  ++           LV E+    S+   L+  TK N  L  E  + IC 
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYICR 136

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I +GL+ LH+     ++HRDIK  N+LL +    K+ DFG++      +    T I GT
Sbjct: 137 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 192

Query: 121 TGYLAPEYVLGGQLT-----MKADVYSFGVLVLEIISG 153
             ++APE +   +        K+D++S G+  +E+  G
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 87.0 bits (216), Expect = 6e-20
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 15/149 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  V HPN++ L       T  +L+ E V    L D +          L+ E+ +     
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQ 123

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRI 117
           I  G+ +LH +    I H D+K  NI+L  +  P    K+ DFGLA    D        I
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNI 178

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVL 146
            GT  ++APE V    L ++AD++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.0 bits (214), Expect = 7e-20
 Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDIC 59
           L  ++H N+V L        +  LV+E+ +       D          +K          
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS-------FL 107

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + KGL F H     +++HRD+K  N+L+++    K+ +FGLA+ F   +   +  +  
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV- 163

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y  P+ + G +L +   D++S G +  E+ +  
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.1 bits (214), Expect = 7e-20
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 15/147 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  ++H N+V L       T   LV + V    L DR+L            +  S +   
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL-----ERGVYTEKDASLVIQQ 114

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           +   + +LHE     IVHRD+K  N+L    ++     I DFGL+K+  + I    +   
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STAC 168

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGV 145
           GT GY+APE +     +   D +S GV
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.5 bits (215), Expect = 7e-20
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDIC 59
           L +++H N+V L           LV+EY++      LD         N+KL         
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL-------FL 106

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + +GLA+ H      ++HRD+K  N+L+++    K+ DFGLA+            +  
Sbjct: 107 FQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV- 162

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y  P+ +LG    + + D++  G +  E+ +GR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.0 bits (218), Expect = 7e-20
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I  GL  +H      +V+RD+K +NILLD+  + +I D GLA  F     H      GT 
Sbjct: 301 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-VGTH 354

Query: 122 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           GY+APE +  G      AD +S G ++ +++ G 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 85.6 bits (213), Expect = 9e-20
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 15/156 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDIC 59
           L  ++H N+V+L        R +LV+E+++      LD    G      K          
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS-------FL 106

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           + +  G+A+ H+     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  I  
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV- 162

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y AP+ ++G +  +   D++S G +  E+++G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.7 bits (213), Expect = 1e-19
 Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 22/160 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           +S + HP  V+L     Q   ++     Y +N  L + +                D    
Sbjct: 84  MSRLDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI----------RKIGSFDETCT 132

Query: 62  ------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 115
                 I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK+          
Sbjct: 133 RFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189

Query: 116 R-IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
               GT  Y++PE +        +D+++ G ++ ++++G 
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 86.2 bits (214), Expect = 1e-19
 Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 14/147 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  + HPN+++L       T   LV E V    L DR++          +    +D    
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-----EKGYYSERDAADAVKQ 156

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           I + +A+LHE     IVHRD+K  N+L      +   KI DFGL+K+       +   + 
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVC 211

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGV 145
           GT GY APE + G     + D++S G+
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGI 238

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 32/147 (21%), Positives = 61/147 (41%), Gaps = 12/147 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L+  RH N++ L          ++++E++    + +R+      +  +LN  +       
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQ 110

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL-DQEFNP-KIGDFGLAKLFPDNITHITTRIAG 119
           + + L FLH     +I H DI+  NI+   +  +  KI +FG A+            +  
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFT 165

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVL 146
              Y APE      ++   D++S G L
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTL 192

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 14/147 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
              ++HPN+V L     + +   LV++ V    L + ++     A    +    S     
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQ 136

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIA 118
           I + +A+ H      IVHR++K  N+LL  +      K+ DFGLA    D+        A
Sbjct: 137 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFA 191

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGV 145
           GT GYL+PE +     +   D+++ GV
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGV 218

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.6 bits (210), Expect = 2e-19
 Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 16/150 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDI 58
            L  + HPN+V+L+            +V+E V    + +   L        L+ ++    
Sbjct: 89  ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQARFY 142

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              + KG+ +LH +    I+HRDIK SN+L+ ++ + KI DFG++  F  +   ++    
Sbjct: 143 FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-V 198

Query: 119 GTTGYLAPEYVLGGQLT---MKADVYSFGV 145
           GT  ++APE +   +        DV++ GV
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.5 bits (212), Expect = 2e-19
 Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 12/147 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           ++ + H NL++L          +LV EYV+   L DR+       +  L           
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI----IDESYNLTELDTILFMKQ 195

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAG 119
           I +G+  +H+    +I+H D+K  NIL         KI DFGLA+ +            G
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFG 250

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVL 146
           T  +LAPE V    ++   D++S GV+
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 15/149 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           L  ++HPN++ L       T  IL+ E V    L D +          L  E+ ++    
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATEFLKQ 122

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRI 117
           I  G+ +LH      I H D+K  NI+L     P    KI DFGLA        +    I
Sbjct: 123 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNI 177

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVL 146
            GT  ++APE V    L ++AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +   L +L  +    I+HRD+K  NILLD+  +  I DF +A + P      T  +AGT 
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178

Query: 122 GYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGR 154
            Y+APE     +    +   D +S GV   E++ GR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.2 bits (211), Expect = 3e-19
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 12/147 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           ++ + HP L+ L          +L+ E++    L DR+       + K++  +  +    
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQ 157

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAG 119
             +GL  +HE     IVH DIK  NI+ + +     KI DFGLA     +   I      
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTA 212

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVL 146
           T  + APE V    +    D+++ GVL
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVL 239

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 12/148 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           +S +RHP LV L          +++YE++    L ++V       + K++ ++  +    
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQ 263

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAG 119
           + KGL  +HE    + VH D+K  NI+   + +   K+ DFGL                G
Sbjct: 264 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTG 318

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLV 147
           T  + APE   G  +    D++S GVL 
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.4 bits (207), Expect = 7e-19
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 23/162 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVL-----LGATKANIKLNW 52
           L    HPN+V L+  C            LV+E+V+ + L   L      G     IK   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIK--- 123

Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
               D+     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++   +  
Sbjct: 124 ----DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA- 175

Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           +T  +  T  Y APE +L        D++S G +  E+   +
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 10/156 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDIC 59
           +  ++H N+V L        +  LV+E+++N     +D   +G T   ++LN  K     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY--FQ 114

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
             + +GLAF HE     I+HRD+K  N+L+++    K+GDFGLA+ F   +   ++ +  
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV- 170

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           T  Y AP+ ++G +  +   D++S G ++ E+I+G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 23/162 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVL-----LGATKANIKLNW 52
           L    HPN+V L   C            LV+E+V+ + L   L      G     IK   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK--- 123

Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
               D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++   +  
Sbjct: 124 ----DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 175

Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           +T+ +  T  Y APE +L        D++S G +  E+   +
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 15/148 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
              ++HPN+V L     +     L+++ V    L + ++     A    +    S     
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-----AREYYSEADASHCIQQ 118

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 118
           I + +   H+     +VHR++K  N+LL    +    K+ DFGLA              A
Sbjct: 119 ILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFA 174

Query: 119 GTTGYLAPEYVLGGQL-TMKADVYSFGV 145
           GT GYL+PE VL         D+++ GV
Sbjct: 175 GTPGYLSPE-VLRKDPYGKPVDLWACGV 201

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 15/144 (10%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           HPN+V+L           LV E +    L +R+           +  + S I   +   +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-----KKKHFSETEASYIMRKLVSAV 119

Query: 67  AFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
           + +H+     +VHRD+K  N+L    +     KI DFG A+L P +   + T    T  Y
Sbjct: 120 SHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHY 175

Query: 124 LAPEYVLGGQL-TMKADVYSFGVL 146
            APE +L         D++S GV+
Sbjct: 176 AAPE-LLNQNGYDESCDLWSLGVI 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 20/146 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDIC 59
           L  + HPN++ L+      +   LV++++E      +    L  T ++IK          
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA-------YM 118

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
           +   +GL +LH+     I+HRD+K +N+LLD+    K+ DFGLAK F       T ++  
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV- 174

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGV 145
           T  Y APE + G      A +Y  GV
Sbjct: 175 TRWYRAPELLFG------ARMYGVGV 194

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 12/143 (8%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
            P ++ L       +  IL+ EY     +    L    +    ++      +   I +G+
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEGV 144

Query: 67  AFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
            +LH+    +IVH D+K  NILL       + KI DFG+++            I GT  Y
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199

Query: 124 LAPEYVLGGQLTMKADVYSFGVL 146
           LAPE +    +T   D+++ G++
Sbjct: 200 LAPEILNYDPITTATDMWNIGII 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 29/169 (17%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR-------ILVYEYVENNSLDRVLLGATKANIKLNWEKR 55
           L+ + HPN+V+L         R        +V EYV +  L R      +  +       
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAP----- 126

Query: 56  SDICVG-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF--- 106
             I +      + + +  LH     ++ HRDIK  N+L+++     K+ DFG AK     
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 107 PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
             N+ +I +R      Y APE + G Q  T   D++S G +  E++ G 
Sbjct: 186 EPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 32/170 (18%), Positives = 62/170 (36%), Gaps = 25/170 (14%)

Query: 7   RHPNLVELIGCCVQGTRR--------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 58
            HPN+V+       G           +L+ E  +   ++   L   ++   L+ +    I
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKI 141

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
                + +  +H    P I+HRD+K  N+LL  +   K+ DFG A        +  +   
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 119 -----------GTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGR 154
                       T  Y  PE +       +  K D+++ G ++  +   +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 82.6 bits (204), Expect = 2e-18
 Identities = 48/196 (24%), Positives = 70/196 (35%), Gaps = 48/196 (24%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKR------ 55
           +  + HPN+  L           LV E      L D++ +    +  K   +        
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 56  -----------------------------SDICVGIAKGLAFLHEELVPHIVHRDIKASN 86
                                        S+I   I   L +LH +    I HRDIK  N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPEN 198

Query: 87  ILL--DQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYLAPEYVLGGQL---TMKA 138
            L   ++ F  K+ DFGL+K F        +  T  AGT  ++APE VL         K 
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKC 257

Query: 139 DVYSFGVLVLEIISGR 154
           D +S GVL+  ++ G 
Sbjct: 258 DAWSAGVLLHLLLMGA 273

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 21/161 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL---LGATKANIKLNWEKRSDIC 59
           L  ++H N++EL        R  L++EY EN+ L + +      +   IK          
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKS-------FL 138

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHIT 114
             +  G+ F H       +HRD+K  N+LL           KIGDFGLA+ F   I   T
Sbjct: 139 YQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 115 TRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
             I  T  Y  PE +LG +  +   D++S   +  E++   
Sbjct: 196 HEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 27/162 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKR 55
           L N RHP L  L     Q   R+  V EY     L      +RV             E R
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS-----------EDR 249

Query: 56  SDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-- 112
           +      I   L +LH E   ++V+RD+K  N++LD++ + KI DFGL K   + I    
Sbjct: 250 ARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGA 304

Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                 GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 5e-18
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 30/168 (17%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           +  + H N+V L         +       LV +YV    + RV    ++A   L      
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTL-----P 154

Query: 57  DICVG-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---P 107
            I V      + + LA++H      I HRDIK  N+LLD +    K+ DFG AK      
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
            N+++I +R      Y APE + G    T   DV+S G ++ E++ G+
Sbjct: 212 PNVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.6 bits (202), Expect = 5e-18
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 61
           L  V  P LV+L       +   +V EYV    +   L    + +     E  +      
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARFYAAQ 149

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I     +LH      +++RD+K  N+L+DQ+   ++ DFG AK         T  + GT 
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTP 202

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             LAPE +L        D ++ GVL+ E+ +G 
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 81.6 bits (202), Expect = 5e-18
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 19/148 (12%)

Query: 8   HPNLVELIGCC---VQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGI 62
            P++V ++        G R + ++ E +E   L  R+     + +      + ++I   I
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ---ERGDQAFTEREAAEIMRDI 137

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
              + FLH     +I HRD+K  N+L    +++   K+ DFG AK    N   + T    
Sbjct: 138 GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCY 191

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVL 146
           T  Y+APE VLG +      D++S GV+
Sbjct: 192 TPYYVAPE-VLGPEKYDKSCDMWSLGVI 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 20/169 (11%)

Query: 1   MTLSNVRHPNLVELIGCCVQGT-RRI-LVYEYVENNSLDRVL-----LGATKANIKLNWE 53
             L  ++HPN++ L    +    R++ L+++Y E++ L  ++       A K  ++L   
Sbjct: 70  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRG 128

Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLF--P 107
               +   I  G+ +LH      ++HRD+K +NIL+  E       KI D G A+LF  P
Sbjct: 129 MVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

Query: 108 DN-ITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
              +  +   +  T  Y APE +LG +  T   D+++ G +  E+++  
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 28/162 (17%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKR 55
           L N RHP L  L     Q   R+  V EY     L      +RV             E+R
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----------EER 106

Query: 56  SDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-- 112
           +      I   L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   
Sbjct: 107 ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGA 160

Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                 GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 79.6 bits (197), Expect = 2e-17
 Identities = 42/155 (27%), Positives = 61/155 (39%), Gaps = 25/155 (16%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 66
           H N++ELI    +  R  LV+E +   S+   +           N  + S +   +A  L
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH-----KRRHFNELEASVVVQDVASAL 124

Query: 67  AFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTR------I 117
            FLH      I HRD+K  NIL    +Q    KI DF L      N              
Sbjct: 125 DFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 118 AGTTGYLAPEYVLGGQLTM------KADVYSFGVL 146
            G+  Y+APE V+            + D++S GV+
Sbjct: 182 CGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVI 215

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 30/168 (17%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           +  V+HPN+V+L         +       LV EYV    + R      K    +      
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTM-----P 139

Query: 57  DICVG-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---P 107
            + +      + + LA++H      I HRDIK  N+LLD      K+ DFG AK+     
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
            N+++I +R      Y APE + G    T   D++S G ++ E++ G+
Sbjct: 197 PNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 12/154 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 61
           +  + HPN+V+L           L+ EY     + D +      A+ ++  ++       
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQ 122

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I   + + H++    IVHRD+KA N+LLD + N KI DFG +  F      +     G  
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAF-CGAP 177

Query: 122 GYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGR 154
            Y APE   G +    + DV+S GV++  ++SG 
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 25/165 (15%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNS---LDRVLLGATKANIKLN-WEKR 55
            L  +RH N+++L+       ++   +V EY        LD V         +    +  
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------RFPVCQAH 112

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----PDNIT 111
                 +  GL +LH +    IVH+DIK  N+LL      KI   G+A+       D+  
Sbjct: 113 -GYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168

Query: 112 HITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
             T+   G+  +  PE   G       K D++S GV +  I +G 
Sbjct: 169 R-TS--QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 18/148 (12%)

Query: 8   HPNLVELIGCC---VQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGI 62
            P++V ++        G + + +V E ++   L  R+     + +      + S+I   I
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSI 170

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
            + + +LH     +I HRD+K  N+L          K+ DFG AK    + +  T     
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCY 225

Query: 120 TTGYLAPEYVLGGQL-TMKADVYSFGVL 146
           T  Y+APE VLG +      D++S GV+
Sbjct: 226 TPYYVAPE-VLGPEKYDKSCDMWSLGVI 252

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.1 bits (196), Expect = 3e-17
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 28/162 (17%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKR 55
           L  V+HP +V+LI    Q   ++ L+ EY+    L      + + +           E  
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM-----------EDT 122

Query: 56  SDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-- 112
           +   +  I+  L  LH++    I++RD+K  NI+L+ + + K+ DFGL K    +I    
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGT 176

Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           +T    GT  Y+APE ++        D +S G L+ ++++G 
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 3e-17
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 15/154 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           LS V HP ++ + G   Q  ++I ++ +Y+E   L  +L  + +          +     
Sbjct: 60  LSIVTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAA 113

Query: 62  -IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            +   L +LH +    I++RD+K  NILLD+  + KI DFG AK  PD    +T  + GT
Sbjct: 114 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGT 166

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             Y+APE V         D +SFG+L+ E+++G 
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.9 bits (195), Expect = 4e-17
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I   L  LH+     I++RDIK  NILLD   +  + DFGL+K F  + T       GT 
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 122 GYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
            Y+AP+ V GG        D +S GVL+ E+++G 
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 5e-17
 Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 119
           +A  L  LH      I++RD+K  NILLD+E + K+ DFGL+K    +I H        G
Sbjct: 135 LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCG 188

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE V     T  AD +SFGVL+ E+++G 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.4 bits (194), Expect = 6e-17
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 27/168 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI--------LVYEYVENN---SLDRVLLGATKANIKLN 51
           L  ++H N+V LI  C               LV+++ E++    L  VL+  T + IK  
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-- 127

Query: 52  WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----P 107
                 +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F     
Sbjct: 128 -----RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 108 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
                 T R+  T  Y  PE +LG +      D++  G ++ E+ +  
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 78.2 bits (193), Expect = 7e-17
 Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 17/159 (10%)

Query: 3   LSNVRH--PNLVELIGCCVQGTRRILVYEYVENNS--LDRVLLGATKANIKLNWEKRSDI 58
           L  V      ++ L+    +    +L+ E  E      D +          L  E     
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSF 154

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRI 117
              + + +   H      ++HRDIK  NIL+D      K+ DFG   L  D +       
Sbjct: 155 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DF-- 208

Query: 118 AGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRN 155
            GT  Y  PE++   +     A V+S G+L+ +++ G  
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 78.2 bits (193), Expect = 8e-17
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 15/157 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
           LS V H N+++++          LV E +     L   +       + +L+    S I  
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFR 137

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            +   + +L  +    I+HRDIK  NI++ ++F  K+ DFG A          T    GT
Sbjct: 138 QLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGT 192

Query: 121 TGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGRN 155
             Y APE VL G      + +++S GV +  ++   N
Sbjct: 193 IEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 13/157 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
               + H N+V+  G   +G  + L  EY     L DR+       +I +          
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFH 112

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-G 119
            +  G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  N          G
Sbjct: 113 QLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 120 TTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
           T  Y+APE +L  +       DV+S G+++  +++G 
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 8/96 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGT 120
           +   +   H      +VHRDIK  NIL+D      K+ DFG   L  D          GT
Sbjct: 148 VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGT 201

Query: 121 TGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRN 155
             Y  PE++   Q   + A V+S G+L+ +++ G  
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 119
           IA GL FL  +    I++RD+K  N++LD E + KI DFG+ K   +NI     T    G
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCG 504

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 15/159 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L N     +  L     Q    + LV +Y     L  +L   +K   +L  E+ +   + 
Sbjct: 128 LVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLP-EEMARFYLA 182

Query: 62  -IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            +   +  +H+    H VHRDIK  NIL+D   + ++ DFG      ++ T  ++   GT
Sbjct: 183 EMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239

Query: 121 TGYLAPEYVLGGQL-----TMKADVYSFGVLVLEIISGR 154
             Y++PE +   +        + D +S GV + E++ G 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 119
           IA  L +LH     +IV+RD+K  NILLD + +  + DFGL K   +NI H   T+   G
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCG 201

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  YLAPE +         D +  G ++ E++ G 
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           IA GL FL  +    I++RD+K  N++LD E + KI DFG+ K  ++    T  T    G
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-T--FCG 183

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.1 bits (188), Expect = 2e-16
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDI 58
            L   RHP++++L    V  T     +V EYV    L D +       + ++   +   +
Sbjct: 64  NLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYIC-----KHGRVEEMEARRL 116

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              I   + + H      +VHRD+K  N+LLD   N KI DFGL+ +  D     T+   
Sbjct: 117 FQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--C 171

Query: 119 GTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
           G+  Y APE V+ G+L    + D++S GV++  ++ G 
Sbjct: 172 GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 13/157 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 60
               + H N+V+  G   +G  + L  EY     L DR+       +I +          
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFH 112

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-G 119
            +  G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  N          G
Sbjct: 113 QLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 120 TTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
           T  Y+APE +L  +       DV+S G+++  +++G 
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 27/172 (15%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+    +I      +    
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254

Query: 122 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL 175
             L     APE +     T+++DV+SFGVL+ EI S G +    +  ++++       + 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--KIDEEFCRRLKEG 312

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
            +   P         +Y   E+ + M     C     S+RP  +++++ L  
Sbjct: 313 TRMRAP---------DYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGN 352

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 2e-16
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           I+  L +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T  T    G
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T--FCG 172

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE + G       D ++ GVL+ E+++GR
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           I+  L +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T  T    G
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T--FCG 215

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE + G       D ++ GVL+ E+++GR
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.7 bits (187), Expect = 5e-16
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 119
           I   L FLH++    I++RD+K  N+LLD E + K+ DFG+ K  +     T  T    G
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-T--FCG 186

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE +         D ++ GVL+ E++ G 
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.7 bits (187), Expect = 6e-16
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 8/95 (8%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 119
           I  GL FLH +    IV+RD+K  NILLD++ + KI DFG+ K   +N+     T    G
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCG 180

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T  Y+APE +LG +     D +SFGVL+ E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 17/161 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L N     + +L     Q    + LV EY     L  +L   +K   ++   + +   + 
Sbjct: 115 LVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIP-AEMARFYLA 169

Query: 62  -IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            I   +  +H       VHRDIK  NILLD+  + ++ DFG       + T  +    GT
Sbjct: 170 EIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226

Query: 121 TGYLAPEYVLGGQLTMKADVY-------SFGVLVLEIISGR 154
             YL+PE +           Y       + GV   E+  G+
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 16/150 (10%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDIC 59
           +   ++RHPN+V      +  T   ++ EY     L +R+         + + ++     
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC-----NAGRFSEDEARFFF 122

Query: 60  VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRI 117
             +  G+++ H      I HRD+K  N LLD    P  KI DFG +K    +    +T  
Sbjct: 123 QQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 177

Query: 118 AGTTGYLAPEYVLGGQL--TMKADVYSFGV 145
            GT  Y+APE VL  Q      ADV+S GV
Sbjct: 178 VGTPAYIAPE-VLLRQEYDGKIADVWSCGV 206

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 30/165 (18%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           ++    P +V+L     Q  R + +V EY+    L             +N     D+   
Sbjct: 123 MAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEK 168

Query: 62  IAK--------GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 113
            A+         L  +H       +HRD+K  N+LLD+  + K+ DFG            
Sbjct: 169 WARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 114 TTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISGR 154
                GT  Y++PE +      G    + D +S GV + E++ G 
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 24/139 (17%)

Query: 26  LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHR 80
           ++ EYV +  L +VL    ++   +         +      + + + F+H      I HR
Sbjct: 115 VIMEYVPDT-LHKVLKSFIRSGRSI-----PMNLISIYIYQLFRAVGFIHSL---GICHR 165

Query: 81  DIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-T 135
           DIK  N+L++ + N  K+ DFG AK       ++ +I +R      Y APE +LG    T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYT 220

Query: 136 MKADVYSFGVLVLEIISGR 154
              D++S G +  E+I G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.6 bits (181), Expect = 3e-15
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 18/158 (11%)

Query: 3   LSNVRHPNLVELIGC-CVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           +  V H N++ L+     Q +        +V E ++ N L +V+       ++L+ E+ S
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERMS 130

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
            +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+    +   + T 
Sbjct: 131 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTP 185

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
              T  Y APE +LG       D++S G ++ E+I G 
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.3 bits (180), Expect = 6e-15
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 18/158 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           +  V H N++ L+                LV E ++ N L +V+       ++L+ E+ S
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMS 167

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 116
            +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+    +   + T 
Sbjct: 168 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTP 222

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
              T  Y APE +LG       D++S G ++ E++  +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L  +RHP++++L       T  ++V EY      D ++        ++  ++       
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV-----EKKRMTEDEGRRFFQQ 116

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I   + + H      IVHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+ 
Sbjct: 117 IICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSP 171

Query: 122 GYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
            Y APE V+ G+L    + DV+S G+++  ++ GR
Sbjct: 172 NYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.0 bits (177), Expect = 1e-14
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 22/160 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           L ++RH N++ L+                LV  ++  + L +++    K   KL  ++  
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM----KHE-KLGEDRIQ 131

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITT 115
            +   + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +T ++ T
Sbjct: 132 FLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188

Query: 116 RIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           R      Y APE +L     T   D++S G ++ E+I+G+
Sbjct: 189 RW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 18/158 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDI 58
            L   RHP++++L    V  T     +V EYV    L D +       N +L+ ++   +
Sbjct: 69  NLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYIC-----KNGRLDEKESRRL 121

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 118
              I  G+ + H      +VHRD+K  N+LLD   N KI DFGL+ +  D     T+   
Sbjct: 122 FQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--C 176

Query: 119 GTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 154
           G+  Y APE V+ G+L    + D++S GV++  ++ G 
Sbjct: 177 GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 17/194 (8%), Positives = 43/194 (22%), Gaps = 53/194 (27%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
           + LS +  P +  ++         ++V E++   SL  V   +       +         
Sbjct: 83  LRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQ 136

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            +A      H      +       S + +  + +  +                       
Sbjct: 137 SLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP-------------------- 173

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
              +            + D+   G  +  ++  R                W         
Sbjct: 174 -ATMPDA-------NPQDDIRGIGASLYALLVNR----------------WPLPEAGVRS 209

Query: 181 PLELVDPELGEYPP 194
            L   + +    P 
Sbjct: 210 GLAPAERDTAGQPI 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 40/160 (25%), Positives = 79/160 (49%), Gaps = 23/160 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           L +++H N++ L+      +         LV  +++ + L +++       +K + EK  
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKIQ 129

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITT 115
            +   + KGL ++H      +VHRD+K  N+ ++++   KI DFGLA+     +T  + T
Sbjct: 130 YLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186

Query: 116 RIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           R      Y APE +L         D++S G ++ E+++G+
Sbjct: 187 RW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.7 bits (171), Expect = 7e-14
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 22/160 (13%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
           L +++H N++ L+                LV   +  + L+ ++    K   KL  +   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV----KCQ-KLTDDHVQ 135

Query: 57  DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITT 115
            +   I +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ T
Sbjct: 136 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192

Query: 116 RIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           R      Y APE +L         D++S G ++ E+++GR
Sbjct: 193 RW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 25/163 (15%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L++  HPN++ L    V           LV E +  + L +V        I       S 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQV--------IHDQRIVISP 133

Query: 58  ICVG-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
             +      I  GL  LHE     +VHRD+   NILL    +  I DF LA+    +  +
Sbjct: 134 QHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD-AN 189

Query: 113 ITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
            T  +     Y APE V+  +   K  D++S G ++ E+ + +
Sbjct: 190 KTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 21/159 (13%)

Query: 3   LSNVR-HPNLVELIGCCV---QGTRRILVYEYVENNSLDRVLLGATKANIK-LNWEKRSD 57
           L N+R  PN++ L    V         LV+E+V N    ++    T  +I+   +E    
Sbjct: 84  LENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE---- 138

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTR 116
               I K L + H      I+HRD+K  N+++D E    ++ D+GLA+ F         R
Sbjct: 139 ----ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVR 190

Query: 117 IAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
           +A +  +  PE ++  Q+     D++S G ++  +I  +
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 14/98 (14%)

Query: 64  KGLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNIT-HITTR 116
            GL ++H      I+H DIK  N+L++   +P      KI D G A  + ++ T  I TR
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 117 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
                 Y +PE +LG      AD++S   L+ E+I+G 
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.8 bits (161), Expect = 1e-12
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 19/161 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L   RH N++ +       T        +V + +E + L ++L    K    L+ +    
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLL----KTQH-LSNDHICY 132

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHIT 114
               I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++     D+   +T
Sbjct: 133 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 154
             +A T  Y APE +L  +   K+ D++S G ++ E++S R
Sbjct: 190 EYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.4 bits (155), Expect = 8e-12
 Identities = 33/167 (19%), Positives = 72/167 (43%), Gaps = 24/167 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L + +H N++ +       +        ++ E ++ + L RV+       + L+ +    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVI----STQM-LSDDHIQY 116

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
                 + +  LH     +++HRD+K SN+L++   + K+ DFGLA++  ++    +   
Sbjct: 117 FIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 118 AGT---TGYL------APEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
                   ++      APE +L     +   DV+S G ++ E+   R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 35/139 (25%), Positives = 60/139 (43%), Gaps = 14/139 (10%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L+ ++   ++ L    +           +V E  +++ L ++     K  I L  E    
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLF----KTPIFLTEEHIKT 133

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTR 116
           I   +  G  F+HE     I+HRD+K +N LL+Q+ + K+ DFGLA  +  +  T+I   
Sbjct: 134 ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 117 IAGTTGYLAPEYVLGGQLT 135
           +            L  QLT
Sbjct: 191 LEENEEPGPHNKNLKKQLT 209

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 39/171 (22%), Positives = 78/171 (45%), Gaps = 29/171 (16%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI--------------LVYEYVENNSLDRVLLGATKANI 48
           +  + H N+V++         ++              +V EY+E + L  VL    +   
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVL----EQG- 115

Query: 49  KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLF- 106
            L  E        + +GL ++H     +++HRD+K +N+ ++ E    KIGDFGLA++  
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 107 --PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
               +  H++  +  T  Y +P  +L     T   D+++ G +  E+++G+
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.8 bits (150), Expect = 4e-11
 Identities = 31/147 (21%), Positives = 47/147 (31%), Gaps = 57/147 (38%)

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILL---------------------------- 89
           I   + +GL +LH +    I+H DIK  NILL                            
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 90  ---------------------DQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 127
                                 ++   KI D G A     + T  I TR      Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLE 263

Query: 128 YVLGGQLTMKADVYSFGVLVLEIISGR 154
            ++G      AD++S   +  E+ +G 
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGD 290

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.9 bits (148), Expect = 7e-11
 Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 22/131 (16%)

Query: 27  VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 86
           +YE ++ N      L   +                I + L  LH+     I+H D+K  N
Sbjct: 185 LYELIKKNKFQGFSLPLVRK-----------FAHSILQCLDALHKN---RIIHCDLKPEN 230

Query: 87  ILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 143
           ILL Q+     K+ DFG +      + T+I +R      Y APE +LG +  M  D++S 
Sbjct: 231 ILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSL 285

Query: 144 GVLVLEIISGR 154
           G ++ E+++G 
Sbjct: 286 GCILAELLTGY 296

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 37/147 (25%)

Query: 8   HPNLVELIGCC---VQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGI 62
            P++V ++        G + + +V E ++   L  R+     + +      + S+I   I
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSI 126

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAG 119
            + + +LH     +I HRD+K  N+L          K+ DFG                  
Sbjct: 127 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG------------------ 165

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVL 146
                A E   G +     D++S GV+
Sbjct: 166 ----FAKE-TTGEKYDKSCDMWSLGVI 187

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.5 bits (142), Expect = 4e-10
 Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 24/114 (21%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 120
           + K + +LH      ++HRD+K SNILL+ E + K+ DFGL++ F +             
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 121 -------------TGYL------APEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
                        T Y+      APE +LG    T   D++S G ++ EI+ G+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.8 bits (140), Expect = 8e-10
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIA 118
           +   L FL    +  I+H D+K  NILL        KI DFG +      I  +I +R  
Sbjct: 166 MCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
               Y +PE +LG    +  D++S G +++E+ +G 
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 22/106 (20%), Positives = 51/106 (48%), Gaps = 13/106 (12%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
           L+ + H ++V+++   +           +V E  +++   ++     +  + L       
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF----RTPVYLTELHIKT 160

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA 103
           +   +  G+ ++H      I+HRD+K +N L++Q+ + K+ DFGLA
Sbjct: 161 LLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 35/152 (23%), Positives = 58/152 (38%), Gaps = 27/152 (17%)

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLFPDNITHI------TTRI 117
           L ++HE      VH DIKA+N+LL  +   ++   D+GL+  +  N  H           
Sbjct: 164 LEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220

Query: 118 AGTTGYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 172
            GT      E+       G  L+ ++DV   G  +L  + G    K  W Q  K  +   
Sbjct: 221 NGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCG----KLPWEQNLKDPVAVQ 271

Query: 173 WQLHQ--EEKPLELVDPELGEYPPNEIIRYMK 202
                  +E P  ++          EI +++ 
Sbjct: 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLV 303

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 15/50 (30%), Positives = 24/50 (48%), Gaps = 5/50 (10%)

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLFPDNITHI 113
           L FLHE      VH ++ A NI +D E   ++    +G A  +  +  H+
Sbjct: 172 LEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 18/50 (36%), Positives = 27/50 (54%), Gaps = 5/50 (10%)

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLFPDNITHI 113
           L ++HE      VH DIKASN+LL+ +   ++   D+GLA  +     H 
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.5 bits (117), Expect = 4e-07
 Identities = 18/108 (16%), Positives = 31/108 (28%), Gaps = 15/108 (13%)

Query: 49  KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-- 106
             +      I   +   LA     L     HRD+   N+LL +    K+      K    
Sbjct: 157 LSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

Query: 107 ------PDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSF 143
                    I +  +R+      +       E +  G    + D+Y  
Sbjct: 215 PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 21/67 (31%), Positives = 33/67 (49%), Gaps = 14/67 (20%)

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPK-----IGDFGLAKLFPDNIT--HITTR---- 116
           ++H +   ++++RD+K  N L+ +  N       I DF LAK + D  T  HI  R    
Sbjct: 120 YVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176

Query: 117 IAGTTGY 123
           + GT  Y
Sbjct: 177 LTGTARY 183

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 28/112 (25%), Positives = 40/112 (35%), Gaps = 28/112 (25%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------------KIGDFGL 102
           +   L FLHE     + H D+K  NIL                          ++ DFG 
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 103 AKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           A    ++  T + TR      Y  PE +L        DV+S G ++ E   G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.1 bits (110), Expect = 5e-06
 Identities = 31/112 (27%), Positives = 45/112 (40%), Gaps = 28/112 (25%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------------KIGDFGL 102
           I K + FLH      + H D+K  NIL  Q                       K+ DFG 
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 103 AKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           A    ++  T ++TR      Y APE +L    +   DV+S G +++E   G
Sbjct: 184 ATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.0 bits (107), Expect = 9e-06
 Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 14/67 (20%)

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPK-----IGDFGLAKLFPDNIT--HITTR---- 116
            +HE+    +V+RDIK  N L+ +  +       + DFG+ K + D +T  HI  R    
Sbjct: 121 SIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177

Query: 117 IAGTTGY 123
           ++GT  Y
Sbjct: 178 LSGTARY 184

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 1e-05
 Identities = 38/249 (15%), Positives = 75/249 (30%), Gaps = 61/249 (24%)

Query: 47  NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 106
            I  NW  RSD    I   +  +  EL   +  +  +   ++L    N K         F
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA-----WNAF 262

Query: 107 PDNI---THITTRIAGTTGYLAPEY--------------------VLGGQLTMKAD---- 139
             N+     +TTR    T +L+                       +L   L  +      
Sbjct: 263 --NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 140 -VYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 197
            V +     L II+     G A W           W+    +K   +++  L    P E 
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDN---------WKHVNCDKLTTIIESSLNVLEPAEY 371

Query: 198 -IRYMKVAFFCTQAAASRRPQMN---QVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTS 253
              + +++ F         P  +    ++ ++  ++  ++  +            S+   
Sbjct: 372 RKMFDRLSVF--------PPSAHIPTILLSLIWFDVIKSDVMVVV----NKLHKYSLVEK 419

Query: 254 DKKSSDSTL 262
             K S  ++
Sbjct: 420 QPKESTISI 428

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 2e-04
 Identities = 26/146 (17%), Positives = 51/146 (34%), Gaps = 35/146 (23%)

Query: 3   LSNVRHPNLVEL--IGC-CVQGTRRILVYEYVENN-----SLDRVLLGATKANIK---LN 51
           L NV++        + C  +  TR   V +++        SLD   +  T   +K   L 
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309

Query: 52  W------EKRSDICVGIAKGLAFLHEELVPHIVHRD-------------IKAS-NILLDQ 91
           +      +   ++     + L+ + E +   +   D             I++S N+L   
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

Query: 92  EFNPKIGDFGLAKLFPDNITHITTRI 117
           E+           +FP +  HI T +
Sbjct: 370 EYRKMFDRLS---VFPPS-AHIPTIL 391

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.1 bits (102), Expect = 5e-05
 Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 34/118 (28%)

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------------------K 96
           I K L +L +     + H D+K  NILLD  +                           K
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 97  IGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 153
           + DFG A    D   + I TR      Y APE +L     + +D++SFG ++ E+ +G
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 9e-05
 Identities = 22/65 (33%), Positives = 31/65 (47%), Gaps = 12/65 (18%)

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPK---IGDFGLAKLFPDNIT--HITTR----IA 118
           ++H +   + +HRD+K  N L+          I DFGLAK + D  T  HI  R    + 
Sbjct: 120 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176

Query: 119 GTTGY 123
           GT  Y
Sbjct: 177 GTARY 181

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 24/67 (35%), Positives = 31/67 (46%), Gaps = 12/67 (17%)

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNPK---IGDFGLAKLFPDNIT--HITTR---- 116
           + F+H +     +HRDIK  N L+          I DFGLAK + D  T  HI  R    
Sbjct: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 117 IAGTTGY 123
           + GT  Y
Sbjct: 173 LTGTARY 179

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	277
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.57
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.25
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.05
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.82
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.82
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.19
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.99
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.8
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.74
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.68
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.84
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.65
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.51
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.41
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.64
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	95.23
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	94.21
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.13
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	93.2
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.03
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.45
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	91.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.68
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.33
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.49
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.93

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-54  Score=353.31  Aligned_cols=211  Identities=24%  Similarity=0.405  Sum_probs=163.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++|+|.+ +..++|||||+||+|.+++..   ....++|..+++|+.||+.||+|||++   +|||||
T Consensus        85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRD  157 (307)
T 3omv_A           85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRD  157 (307)
T ss_dssp             HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred             HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCc
Confidence            5789999999999999865 467999999999999999953   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||||++++++||+|||+|+...... ........||+.|+|||++.+   +.++.++|||||||++|||+||+.||
T Consensus       158 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf  237 (307)
T 3omv_A          158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY  237 (307)
T ss_dssp             CCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence            99999999999999999999998765422 223445679999999999864   35899999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      .......  ..    ......+.    ..+.+...+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       238 ~~~~~~~--~~----~~~~~~~~----~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          238 SHINNRD--QI----IFMVGRGY----ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             TTCCCHH--HH----HHHHHTTC----CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             CCCChHH--HH----HHHHhcCC----CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            6543321  11    11111111    112222223333445778888999999999999999999997654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.9e-55  Score=357.49  Aligned_cols=212  Identities=24%  Similarity=0.426  Sum_probs=172.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC---------CCCccCCHHHHHHHHHHHHHHHHHhhcC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------KANIKLNWEKRSDICVGIAKGLAFLHEE   72 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~   72 (277)
                      +|++|+|||||+++|+|.+++..++|||||++|+|.++|....         .....++|..+++++.||+.||+|||++
T Consensus        68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~  147 (299)
T 4asz_A           68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ  147 (299)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            5889999999999999999999999999999999999996432         2345699999999999999999999999


Q ss_pred             CCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           73 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        73 ~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                         +|+||||||+||||++++++||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       148 ---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell  224 (299)
T 4asz_A          148 ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF  224 (299)
T ss_dssp             ---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence               9999999999999999999999999999876543322 233456899999999999999999999999999999999


Q ss_pred             h-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          152 S-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       152 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      | |+.||.....   ..+..   ........      ..   +......+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus       225 t~G~~Pf~~~~~---~~~~~---~i~~~~~~------~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          225 TYGKQPWYQLSN---NEVIE---CITQGRVL------QR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             TTTCCTTTTSCH---HHHHH---HHHHTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCH---HHHHH---HHHcCCCC------CC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            9 8999865432   22222   22221111      11   12223457788888999999999999999999998765


Q ss_pred             c
Q 023808          231 L  231 (277)
Q Consensus       231 ~  231 (277)
                      .
T Consensus       290 ~  290 (299)
T 4asz_A          290 A  290 (299)
T ss_dssp             H
T ss_pred             c
Confidence            3

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.1e-54  Score=357.25  Aligned_cols=213  Identities=24%  Similarity=0.388  Sum_probs=165.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHhh
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-----------ANIKLNWEKRSDICVGIAKGLAFLH   70 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH   70 (277)
                      +|++|+|||||+++|+|.+++..|+|||||++|+|.+++.....           ....++|.++++|+.||+.||+|||
T Consensus        96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH  175 (329)
T 4aoj_A           96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA  175 (329)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            58899999999999999999999999999999999999965432           2246999999999999999999999


Q ss_pred             cCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCccccccceEehhHHHHH
Q 023808           71 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE  149 (277)
Q Consensus        71 ~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  149 (277)
                      +.   +|+||||||+||||++++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++||
T Consensus       176 ~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E  252 (329)
T 4aoj_A          176 GL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE  252 (329)
T ss_dssp             HT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             cC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence            99   99999999999999999999999999998764432 223345679999999999999999999999999999999


Q ss_pred             HHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          150 IIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      |+| |+.||.....   ..+...   .....+      +..+.   .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus       253 llt~G~~Pf~~~~~---~~~~~~---i~~g~~------~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          253 IFTYGKQPWYQLSN---TEAIDC---ITQGRE------LERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HHTTSCCTTCSSCH---HHHHHH---HHHTCC------CCCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCCH---HHHHHH---HHcCCC------CCCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            999 8999865432   122221   222111      11112   2223477888889999999999999999999988


Q ss_pred             cccC
Q 023808          229 IRLN  232 (277)
Q Consensus       229 ~~~~  232 (277)
                      .+.+
T Consensus       318 ~~~p  321 (329)
T 4aoj_A          318 AQAP  321 (329)
T ss_dssp             HHSC
T ss_pred             hhCC
Confidence            7643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-54  Score=355.82  Aligned_cols=209  Identities=22%  Similarity=0.389  Sum_probs=170.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      +|++|+|||||+++|+|.+++..++|||||++|+|.++|.....            ....++|..+++++.||+.||+||
T Consensus        82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL  161 (308)
T 4gt4_A           82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL  161 (308)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            57889999999999999999999999999999999999964321            124589999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |++   +||||||||+||||++++++||+|||+++...... ........||+.|+|||++.++.++.++|||||||++|
T Consensus       162 H~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~  238 (308)
T 4gt4_A          162 SSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW  238 (308)
T ss_dssp             HHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence            999   99999999999999999999999999998654322 22334567999999999999999999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||+| |..||.....   ..+..   .+.. +...        ..+..+...+.+++.+||+.||++|||+.||++.|+.
T Consensus       239 El~t~g~~Pf~~~~~---~~~~~---~i~~-~~~~--------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          239 EVFSYGLQPYCGYSN---QDVVE---MIRN-RQVL--------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHTTTCCTTTTCCH---HHHHH---HHHT-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHhCCCCCCCCCCH---HHHHH---HHHc-CCCC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            9999 7888865432   22222   2222 2111        1122233457788889999999999999999999986


Q ss_pred             c
Q 023808          228 N  228 (277)
Q Consensus       228 ~  228 (277)
                      .
T Consensus       304 ~  304 (308)
T 4gt4_A          304 W  304 (308)
T ss_dssp             S
T ss_pred             c
Confidence            4

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4e-53  Score=350.81  Aligned_cols=210  Identities=22%  Similarity=0.297  Sum_probs=168.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++++|.+++..|||||||+||+|.+++.    ....+++..+..++.||+.||+|||++   +|+|||
T Consensus       103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRD  175 (336)
T 4g3f_A          103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGD  175 (336)
T ss_dssp             TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---Cceecc
Confidence            5789999999999999999999999999999999999994    344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC-ceEEeecccccccCCCCcc----eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEF-NPKIGDFGLAKLFPDNITH----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||||+.++ .+||+|||+|+.+......    ......||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus       176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P  255 (336)
T 4g3f_A          176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP  255 (336)
T ss_dssp             CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence            999999999887 6999999999976543221    12345799999999999999999999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      |........   ..   ..........       ..++.....+.+++.+||+.||.+|||+.|+++.|...+..
T Consensus       256 f~~~~~~~~---~~---~i~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          256 WTQYFRGPL---CL---KIASEPPPIR-------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             STTTCCSCC---HH---HHHHSCCGGG-------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHH---HH---HHHcCCCCch-------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            975443221   11   1112211111       11222233477888899999999999999999988877653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-53  Score=353.99  Aligned_cols=201  Identities=23%  Similarity=0.380  Sum_probs=164.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||++++++.+++..|+|||||+||+|.+++..  ..+..+++..++.++.||+.||+|||++   +|+|||
T Consensus        76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRD  150 (350)
T 4b9d_A           76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRD  150 (350)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETT
T ss_pred             HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            57889999999999999999999999999999999999953  2344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||||+.++.+||+|||+|+.+... ........||+.|+|||++.+..|+.++|||||||++|||+||+.||....
T Consensus       151 lKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  229 (350)
T 4b9d_A          151 IKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS  229 (350)
T ss_dssp             CCGGGEEECTTCCEEECSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCHHHEEECCCCCEEEcccccceeecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            9999999999999999999999876432 122345679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .   ..+   ..........      .+   +......+.+++.+||+.||++|||+.|+++
T Consensus       230 ~---~~~---~~~i~~~~~~------~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          230 M---KNL---VLKIISGSFP------PV---SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             H---HHH---HHHHHHTCCC------CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHH---HHHHHcCCCC------CC---CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2   111   2222222111      11   1122234778888999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.6e-52  Score=343.80  Aligned_cols=200  Identities=21%  Similarity=0.368  Sum_probs=164.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++++|.+++..|||||||+||+|.+++..     ..+++..+..++.||+.||+|||++   +|+|||
T Consensus       124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRD  195 (346)
T 4fih_A          124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRD  195 (346)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            57889999999999999999999999999999999999942     3599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||||+.++.+||+|||+++.+.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       196 lKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          196 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCHHHEEECCCCCEEEecCcCceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            99999999999999999999999765432 22445789999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .   ......+   .....      +.+ .........+.+++.+||+.||++|||+.|+++
T Consensus       275 ~---~~~~~~i---~~~~~------~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          275 P---LKAMKMI---RDNLP------PRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             H---HHHHHHH---HHSSC------CCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             H---HHHHHHH---HcCCC------CCC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2   1111111   11111      111 111222345778889999999999999998864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-51  Score=333.39  Aligned_cols=198  Identities=25%  Similarity=0.382  Sum_probs=156.9

Q ss_pred             ccccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-
Q 023808            2 TLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-   76 (277)
                      +|++|+|||||+++++|.+    +...|+|||||+||+|.+++.    ....+++..+..|+.||+.||+|||++   + 
T Consensus        78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~  150 (290)
T 3fpq_A           78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TP  150 (290)
T ss_dssp             HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SS
T ss_pred             HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            5789999999999999975    346799999999999999994    345799999999999999999999998   6 


Q ss_pred             -eEeccCCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           77 -IVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        77 -iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                       |+||||||+||||+. ++.+||+|||+|+.....   ...+..||+.|+|||++.+ .++.++|||||||++|||+||+
T Consensus       151 ~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~  226 (290)
T 3fpq_A          151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE  226 (290)
T ss_dssp             CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCC
Confidence             999999999999974 789999999999864432   2345689999999998865 6999999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .||.......     ...........+ ...+.   ...    ..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~Pf~~~~~~~-----~~~~~i~~~~~~-~~~~~---~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          227 YPYSECQNAA-----QIYRRVTSGVKP-ASFDK---VAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CTTTTCSSHH-----HHHHHHTTTCCC-GGGGG---CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCcHH-----HHHHHHHcCCCC-CCCCc---cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            9986432211     111122221111 11111   112    24778888999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-51  Score=339.51  Aligned_cols=220  Identities=25%  Similarity=0.301  Sum_probs=166.2

Q ss_pred             ccccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC----
Q 023808            2 TLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL----   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----   73 (277)
                      .+.+++|||||+++|+|.+++    ..|||||||++|+|.++++.     ..++|..+++++.|++.||+|||++.    
T Consensus        50 ~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~  124 (303)
T 3hmm_A           50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQ  124 (303)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred             HHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence            467899999999999998764    57999999999999999943     35899999999999999999999752    


Q ss_pred             -CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccC------ccccccceEeh
Q 023808           74 -VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG------QLTMKADVYSF  143 (277)
Q Consensus        74 -~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~sl  143 (277)
                       .++|+||||||+||||+.++++||+|||+++........   ......||+.|+|||++.+.      .++.++|||||
T Consensus       125 ~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~  204 (303)
T 3hmm_A          125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             CBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             CCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence             348999999999999999999999999999876543322   22346799999999998754      57889999999


Q ss_pred             hHHHHHHHhCCCCCCcccCcc---------hhhHHHHHHHHhccCCccccccCCCCC--CCHHHHHHHHHHHHhhhhhhh
Q 023808          144 GVLVLEIISGRNSGKAMWGQM---------NKFLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAA  212 (277)
Q Consensus       144 G~vl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~c~~~~p  212 (277)
                      ||++|||+||..|+.......         ..............     ..++.++.  ...+....+.+++.+||+.||
T Consensus       205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP  279 (303)
T 3hmm_A          205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANG  279 (303)
T ss_dssp             HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred             HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcc-----cCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence            999999999987654322110         01111111111111     11222221  123456678899999999999


Q ss_pred             cCCCCHHHHHHHHhhcccc
Q 023808          213 SRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       213 ~~RPs~~~v~~~L~~~~~~  231 (277)
                      ++|||+.||++.|+++.+.
T Consensus       280 ~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          280 AARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             GGSCCHHHHHHHHHHHHHC
T ss_pred             hHCcCHHHHHHHHHHHHHH
Confidence            9999999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.9e-52  Score=349.36  Aligned_cols=214  Identities=26%  Similarity=0.379  Sum_probs=170.3

Q ss_pred             ccccccC-CCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHH
Q 023808            2 TLSNVRH-PNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLA   67 (277)
Q Consensus         2 ~L~~l~h-~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~   67 (277)
                      +|++++| ||||+++|+|.+. +..++|||||++|+|.++|+....            ....+++..++.++.||+.||+
T Consensus       120 il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~  199 (353)
T 4ase_A          120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME  199 (353)
T ss_dssp             HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHH
Confidence            4677855 9999999999765 568999999999999999964321            2345899999999999999999


Q ss_pred             HhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHH
Q 023808           68 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL  146 (277)
Q Consensus        68 ~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~v  146 (277)
                      |||++   +||||||||+|||+++++.+||+|||+|+.+..... .......||+.|+|||++.+..++.++|||||||+
T Consensus       200 yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~  276 (353)
T 4ase_A          200 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL  276 (353)
T ss_dssp             HHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             hHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHH
Confidence            99999   999999999999999999999999999997654433 23445678999999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          147 VLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       147 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      +|||+| |+.||......  ..+...    ...+..     +..++..   ...+.+++.+||+.||++|||+.||++.|
T Consensus       277 l~El~t~G~~Pf~~~~~~--~~~~~~----i~~g~~-----~~~p~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L  342 (353)
T 4ase_A          277 LWEIFSLGASPYPGVKID--EEFCRR----LKEGTR-----MRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHL  342 (353)
T ss_dssp             HHHHTTTSCCSSTTCCCS--HHHHHH----HHHTCC-----CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCCHH--HHHHHH----HHcCCC-----CCCCccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            999998 89998654322  112111    111111     1122222   23477788889999999999999999999


Q ss_pred             hhccccC
Q 023808          226 TKNIRLN  232 (277)
Q Consensus       226 ~~~~~~~  232 (277)
                      +++++..
T Consensus       343 ~~llq~~  349 (353)
T 4ase_A          343 GNLLQAN  349 (353)
T ss_dssp             HHHHHHT
T ss_pred             HHHHHHh
Confidence            9887643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.8e-52  Score=340.01  Aligned_cols=198  Identities=20%  Similarity=0.311  Sum_probs=164.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||++++++.+++..|+|||||+||+|.+++.    ....+++..+..++.||+.||+|||++   +|+|||
T Consensus        85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRD  157 (311)
T 4aw0_A           85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRD  157 (311)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCC
Confidence            5789999999999999999999999999999999999994    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+|+.+.... .....+..||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       158 lKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999875432 23355678999999999999999999999999999999999999999653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ..   ..+..   ......       ..++.   .....+.+++.+||+.||++|||+.|++
T Consensus       238 ~~---~~~~~---~i~~~~-------~~~p~---~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          238 NE---GLIFA---KIIKLE-------YDFPE---KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             SH---HHHHH---HHHHTC-------CCCCT---TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CH---HHHHH---HHHcCC-------CCCCc---ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            22   22222   222211       11111   1223477888899999999999998864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-51  Score=335.53  Aligned_cols=193  Identities=26%  Similarity=0.288  Sum_probs=157.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||++++++.+++..|+|||||+||+|.+++.    ....+++..+..++.||+.||+|||++   +|+|||
T Consensus        79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRD  151 (304)
T 3ubd_A           79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRD  151 (304)
T ss_dssp             CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSS
T ss_pred             HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence            6889999999999999999999999999999999999994    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+|+...... ....+..||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       152 lKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  230 (304)
T 3ubd_A          152 LKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD  230 (304)
T ss_dssp             CCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCHHHeEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence            99999999999999999999998654322 22345679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .   .....   .......       .++.   .....+.+++.+||+.||++|||+
T Consensus       231 ~---~~~~~---~i~~~~~-------~~p~---~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          231 R---KETMT---MILKAKL-------GMPQ---FLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             H---HHHHH---HHHHCCC-------CCCT---TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             H---HHHHH---HHHcCCC-------CCCC---cCCHHHHHHHHHHcccCHHHCCCC
Confidence            2   11221   2222111       1111   122347788889999999999984

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=345.15  Aligned_cols=200  Identities=21%  Similarity=0.374  Sum_probs=163.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++++|.+++..|||||||+||+|.+++..     ..+++..+..++.||+.||+|||++   +|+|||
T Consensus       201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRD  272 (423)
T 4fie_A          201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRD  272 (423)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            57889999999999999999999999999999999999942     3599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||||+.++.+||+|||+|+.+.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       273 iKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          273 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             CSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCHHHEEEcCCCCEEEecCccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            99999999999999999999999765432 23445689999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .   .....   .......      +.+ .........+.+++.+||+.||++|||+.|+++
T Consensus       352 ~---~~~~~---~i~~~~~------~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          352 P---LKAMK---MIRDNLP------PRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             H---HHHHH---HHHHSCC------CCC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             H---HHHHH---HHHcCCC------CCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2   11111   1111111      111 011112234778888999999999999998865

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-50  Score=326.50  Aligned_cols=196  Identities=24%  Similarity=0.365  Sum_probs=151.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||++++++.+++..|+||||| +|+|.+++.    .+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRD  137 (275)
T 3hyh_A           66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRD  137 (275)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            578899999999999999999999999999 679999984    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++++||+|||+|+......  ...+..||+.|+|||++.+..+ +.++||||+||++|||+||+.||...
T Consensus       138 iKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          138 LKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             CCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CChHHeEECCCCCEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999998754322  2345679999999999988776 57999999999999999999998653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ..+..   .......       .++..   ....+.+++.+||+.||++|||+.|+++
T Consensus       216 ~~---~~~~~---~i~~~~~-------~~p~~---~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          216 SI---PVLFK---NISNGVY-------TLPKF---LSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             SH---HHHHH---HHHHTCC-------CCCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CH---HHHHH---HHHcCCC-------CCCCC---CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            21   11111   1111111       11111   2234778888999999999999999976

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.4e-49  Score=323.28  Aligned_cols=201  Identities=20%  Similarity=0.318  Sum_probs=148.3

Q ss_pred             ccccccCCCccceeeEEEeCC------------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHh
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      +|++|+|||||++++++.+.+            +.|+|||||+||+|.+++.... .....++..++.++.||+.||+||
T Consensus        56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yl  134 (299)
T 4g31_A           56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFL  134 (299)
T ss_dssp             HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHH
Confidence            578999999999999997544            3689999999999999995432 223456778899999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-----------eeeeecccccccCccccccCcccccc
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-----------ITTRIAGTTGYLAPEYVLGGQLTMKA  138 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~  138 (277)
                      |++   +|+||||||+|||++.++.+||+|||+|+.+......           ......||+.|+|||++.+..++.++
T Consensus       135 H~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~  211 (299)
T 4g31_A          135 HSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV  211 (299)
T ss_dssp             HHT---TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHH
T ss_pred             HHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHH
Confidence            999   9999999999999999999999999999876543211           12345799999999999999999999


Q ss_pred             ceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          139 DVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       139 Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      |||||||++|||++   ||....     .......... ...        .+...........+++.+||+.||++|||+
T Consensus       212 DiwSlGvilyell~---Pf~~~~-----~~~~~~~~~~-~~~--------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~  274 (299)
T 4g31_A          212 DIFSLGLILFELLY---PFSTQM-----ERVRTLTDVR-NLK--------FPPLFTQKYPCEYVMVQDMLSPSPMERPEA  274 (299)
T ss_dssp             HHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHH-TTC--------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHcc---CCCCcc-----HHHHHHHHHh-cCC--------CCCCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence            99999999999996   553211     1111111111 111        111122333446778999999999999999


Q ss_pred             HHHHH
Q 023808          219 NQVIK  223 (277)
Q Consensus       219 ~~v~~  223 (277)
                      .|+++
T Consensus       275 ~eil~  279 (299)
T 4g31_A          275 INIIE  279 (299)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99865

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.5e-46  Score=309.60  Aligned_cols=229  Identities=41%  Similarity=0.737  Sum_probs=193.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +++|||
T Consensus        88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~d  164 (321)
T 2qkw_B           88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRD  164 (321)
T ss_dssp             GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCC
Confidence            57889999999999999999999999999999999999965544455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++...... ........||..|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus       165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~  244 (321)
T 2qkw_B          165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS  244 (321)
T ss_dssp             CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred             CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence            99999999999999999999998654322 22233456899999999999889999999999999999999999998766


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ..........|.............+++.+ ....+.....+.+++.+||+.||++||++.+|++.|+.+++..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            65554455555555555555555566555 45667888899999999999999999999999999999887653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-45  Score=306.71  Aligned_cols=227  Identities=42%  Similarity=0.745  Sum_probs=191.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+.+|+|.+++.........+++..+..++.|++.||+|||+...++++|||
T Consensus        80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D  159 (326)
T 3uim_A           80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD  159 (326)
T ss_dssp             GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCC
T ss_pred             HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Confidence            57889999999999999999999999999999999999977666666799999999999999999999998666899999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++..............||..|+|||++.+..++.++||||||+++|||+||..||....
T Consensus       160 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (326)
T 3uim_A          160 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR  239 (326)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred             CchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence            99999999999999999999999876555555556679999999999999999999999999999999999999986322


Q ss_pred             --CcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          162 --GQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       162 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                        .........+..............+..+ ..........+.+++.+||+.||.+|||+.+|++.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence              1222334444444444444555555544 566788889999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.7e-46  Score=329.89  Aligned_cols=198  Identities=22%  Similarity=0.241  Sum_probs=161.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++|||||+++++|.+.+..|+|||||+||+|.+++.    ....+++..+..++.||+.||+|||++   +|||||
T Consensus       245 ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRD  317 (689)
T 3v5w_A          245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRD  317 (689)
T ss_dssp             HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCC
T ss_pred             HHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            3567899999999999999999999999999999999994    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||||+.+|.+||+|||+|+.+....   ..+..||+.|+|||++.. ..|+.++|||||||++|||++|..||...
T Consensus       318 LKPeNILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          318 LKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CchHHeEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998765432   345689999999999975 57999999999999999999999999765


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVI  222 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~  222 (277)
                      ..........   ......       ..+   +......+.+++.+||+.||.+|++     +.||.
T Consensus       395 ~~~~~~~i~~---~i~~~~-------~~~---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          395 KTKDKHEIDR---MTLTMA-------VEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             GCCCHHHHHH---HHHHCC-------CCC---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             ChHHHHHHHH---hhcCCC-------CCC---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            4433222211   111111       111   1122234778888999999999998     57765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=313.50  Aligned_cols=211  Identities=21%  Similarity=0.298  Sum_probs=157.9

Q ss_pred             ccccccCCCccceeeEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++|+|||||++++++..      .+..|+|||||+ |+|.+++    ..+..+++..+..++.||+.||+|||++   
T Consensus       106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---  177 (398)
T 4b99_A          106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---  177 (398)
T ss_dssp             HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            5788999999999999864      357899999996 6899999    3456799999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCC---cceeeeecccccccCccccccC-ccccccceEehhHHHHHHH
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI---THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~ell  151 (277)
                      +|+||||||+|||++.++.+||+|||+++.+....   ........||+.|+|||++.+. .++.++||||+||++|||+
T Consensus       178 ~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            99999999999999999999999999998764322   2224457899999999998875 4689999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCcccc-----------c--cCCCCCC-----CHHHHHHHHHHHHhhhhhhhc
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL-----------V--DPELGEY-----PPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~--~~~~~~~-----~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      +|+.||.....   ......+............           +  .+.....     .+.....+.+++.+||+.||.
T Consensus       258 ~G~~pF~g~~~---~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  334 (398)
T 4b99_A          258 ARRQLFPGKNY---VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS  334 (398)
T ss_dssp             HTSCSSCCSSH---HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred             HCCCCCCCCCH---HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence            99999865432   1222222221111100000           0  0000000     011123477889999999999


Q ss_pred             CCCCHHHHHH
Q 023808          214 RRPQMNQVIK  223 (277)
Q Consensus       214 ~RPs~~~v~~  223 (277)
                      +|||+.|+++
T Consensus       335 ~R~ta~e~L~  344 (398)
T 4b99_A          335 ARISAAAALR  344 (398)
T ss_dssp             TSCCHHHHTT
T ss_pred             HCcCHHHHhc
Confidence            9999998865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.3e-45  Score=305.64  Aligned_cols=150  Identities=28%  Similarity=0.403  Sum_probs=129.0

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ +||||+++++++.++++.|+|||||+||+|.+++.       .+++..+..++.|++.||+|||++   +|+||
T Consensus        72 ~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHR  141 (361)
T 4f9c_A           72 CLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHR  141 (361)
T ss_dssp             HHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeC
Confidence            35566 69999999999999999999999999999999982       389999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCC-CceEEeecccccccCCCCc---------------------------ceeeeecccccccCccccccC
Q 023808           81 DIKASNILLDQE-FNPKIGDFGLAKLFPDNIT---------------------------HITTRIAGTTGYLAPEYVLGG  132 (277)
Q Consensus        81 dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~  132 (277)
                      ||||+|||++.+ +.+||+|||+|+.......                           .......||+.|+|||++.+.
T Consensus       142 DiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~  221 (361)
T 4f9c_A          142 DVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC  221 (361)
T ss_dssp             CCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred             cCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence            999999999876 7999999999986543211                           112335799999999999875


Q ss_pred             -ccccccceEehhHHHHHHHhCCCCCCccc
Q 023808          133 -QLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus       133 -~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                       .++.++||||+||++|||+||+.||....
T Consensus       222 ~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          222 PNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             CCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence             58999999999999999999999986443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-44  Score=322.10  Aligned_cols=202  Identities=23%  Similarity=0.321  Sum_probs=163.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++++|.+++..|+|||||+||+|.+++.   .....+++..+..++.||+.||+|||++   +|+|||
T Consensus       207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRD  280 (573)
T 3uto_A          207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD  280 (573)
T ss_dssp             HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            5788999999999999999999999999999999999984   3345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC--CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQE--FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++.+  +.+||+|||+++.+....  ......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       281 lKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~  358 (573)
T 3uto_A          281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  358 (573)
T ss_dssp             CCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CChhhccccCCCCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999754  789999999999875432  33456799999999999999999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ....   ........  ..+.......    ..+.+++.+||+.||.+||++.|+++
T Consensus       359 ~~~~---~~~~---~i~~~~~~--~~~~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          359 ENDD---ETLR---NVKSCDWN--MDDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SSHH---HHHH---HHHTTCCC--CCSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCHH---HHHH---HHHhCCCC--CCcccccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4321   1111   11111110  0011111222    34778889999999999999999976

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=296.34  Aligned_cols=208  Identities=25%  Similarity=0.456  Sum_probs=167.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~d  133 (310)
T 3s95_A           60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRD  133 (310)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence            47889999999999999999999999999999999999953   245699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce-------------eeeecccccccCccccccCccccccceEehhHHHH
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI-------------TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |||+||+++.++.+||+|||+++.........             .....||+.|+|||++.+..++.++||||||+++|
T Consensus       134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~  213 (310)
T 3s95_A          134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC  213 (310)
T ss_dssp             CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred             CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence            99999999999999999999998765432211             12457999999999999999999999999999999


Q ss_pred             HHHhCCCCCCcccCcchh---hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          149 EIISGRNSGKAMWGQMNK---FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       149 elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ||++|..|+.........   .......             ....   +.....+.+++.+||+.||++||++.++++.|
T Consensus       214 el~~g~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L  277 (310)
T 3s95_A          214 EIIGRVNADPDYLPRTMDFGLNVRGFLD-------------RYCP---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL  277 (310)
T ss_dssp             HHHHTCCSSTTTSCBCTTSSBCHHHHHH-------------HTCC---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcCCCCCcchhhhHHHHhhhhhcccc-------------ccCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            999999887654332211   1111100             0010   11112377888899999999999999999999


Q ss_pred             hhcccc
Q 023808          226 TKNIRL  231 (277)
Q Consensus       226 ~~~~~~  231 (277)
                      +.+...
T Consensus       278 ~~l~~~  283 (310)
T 3s95_A          278 ETLRMH  283 (310)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-44  Score=304.36  Aligned_cols=231  Identities=16%  Similarity=0.180  Sum_probs=174.7

Q ss_pred             cccccCCCccceeeEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            3 LSNVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +++++||||+++++++...    ...++||||+ +++|.+++..   .+..+++..++.++.|++.||+|||+.   +|+
T Consensus       102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ii  174 (364)
T 3op5_A          102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYV  174 (364)
T ss_dssp             HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeE
Confidence            5678999999999999875    4689999999 9999999953   345699999999999999999999999   999


Q ss_pred             eccCCCCcEEeC--CCCceEEeecccccccCCCCcce------eeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           79 HRDIKASNILLD--QEFNPKIGDFGLAKLFPDNITHI------TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        79 H~dikp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                      ||||||+|||++  .++.+||+|||+++.+.......      .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el  254 (364)
T 3op5_A          175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW  254 (364)
T ss_dssp             CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence            999999999998  88999999999998764332111      1334599999999999998999999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCC-CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      +||+.||........  .......... ......+++.+. ...+   ..+.+++..||+.+|.+||++.+|++.|++++
T Consensus       255 ~~g~~Pf~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          255 LTGHLPWEDNLKDPK--YVRDSKIRYR-ENIASLMDKCFPAANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHSCCTTGGGTTCHH--HHHHHHHHHH-HCHHHHHHHHSCTTCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HhCCCCccccccCHH--HHHHHHHHhh-hhHHHHHHHhcccccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            999999975433221  1111111111 111222222220 1112   34677788899999999999999999999998


Q ss_pred             ccCccccCCCCccccCC
Q 023808          230 RLNEEELTAPGLFQDSE  246 (277)
Q Consensus       230 ~~~~~~~~~~~~~~~~~  246 (277)
                      .........+..|....
T Consensus       329 ~~~~~~~~~~~dw~~~~  345 (364)
T 3op5_A          329 KAIGSKDDGKLDLSVVE  345 (364)
T ss_dssp             HHTTCCCCCCCCC----
T ss_pred             HHcCCCcCCccceEecc
Confidence            87665555555555444

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.9e-44  Score=294.78  Aligned_cols=212  Identities=28%  Similarity=0.468  Sum_probs=160.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--iiH   79 (277)
                      +|++++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +  ++|
T Consensus        87 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH  162 (309)
T 3p86_A           87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVH  162 (309)
T ss_dssp             HHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCC
T ss_pred             HHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEC
Confidence            4778999999999999999999999999999999999995321 122499999999999999999999999   8  999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++||||||+++|||++|..||..
T Consensus       163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             TTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             CCCChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999998644322 223345789999999999999999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      .....   ...   ........     ..+   +......+.+++.+||+.+|.+||++.+|++.|+.+++..
T Consensus       242 ~~~~~---~~~---~~~~~~~~-----~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          242 LNPAQ---VVA---AVGFKCKR-----LEI---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             SCHHH---HHH---HHHHSCCC-----CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCHHH---HHH---HHHhcCCC-----CCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            43211   111   11111111     111   1122234778888999999999999999999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=295.62  Aligned_cols=210  Identities=26%  Similarity=0.426  Sum_probs=167.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus       103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  176 (325)
T 3kul_A          103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRD  176 (325)
T ss_dssp             HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCC
Confidence            47889999999999999999999999999999999999943   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++........  ......+|..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       177 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999876543222  2223446778999999998999999999999999999999 999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      .....   ....   ........         ..+......+.+++.+||+.||.+||++.+|++.|+.+++..
T Consensus       257 ~~~~~---~~~~---~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          257 NMTNR---DVIS---SVEEGYRL---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TSCHH---HHHH---HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             cCCHH---HHHH---HHHcCCCC---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            54321   1111   11111111         111122334778888999999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.9e-43  Score=300.08  Aligned_cols=212  Identities=25%  Similarity=0.413  Sum_probs=169.4

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|+++ +||||++++++|.+++..|+||||+.+|+|.+++.....            ....+++..++.++.||+.||+|
T Consensus       139 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  218 (370)
T 2psq_A          139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY  218 (370)
T ss_dssp             HHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            46677 899999999999999999999999999999999965432            12358999999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ||+.   +|+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++
T Consensus       219 LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il  295 (370)
T 2psq_A          219 LASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM  295 (370)
T ss_dssp             HHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred             HHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHH
Confidence            9999   999999999999999999999999999986654322 122334567899999999999999999999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |||+| |..||.......   ....    ......     +..   +......+.+++.+||+.+|.+||++.|+++.|+
T Consensus       296 ~ellt~g~~p~~~~~~~~---~~~~----~~~~~~-----~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          296 WEIFTLGGSPYPGIPVEE---LFKL----LKEGHR-----MDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             HHHHTTSCCSSTTCCGGG---HHHH----HHTTCC-----CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCHHH---HHHH----HhcCCC-----CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999 888886543221   1111    111111     111   1222335778888999999999999999999999


Q ss_pred             hcccc
Q 023808          227 KNIRL  231 (277)
Q Consensus       227 ~~~~~  231 (277)
                      +++..
T Consensus       361 ~il~~  365 (370)
T 2psq_A          361 RILTL  365 (370)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-43  Score=289.93  Aligned_cols=213  Identities=25%  Similarity=0.363  Sum_probs=164.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+++..++||||+++|+|.+++.    ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        64 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~D  136 (294)
T 4eqm_A           64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRD  136 (294)
T ss_dssp             HHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4678999999999999999999999999999999999994    334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus       137 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          137 IKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             CCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             CCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765544334445679999999999999999999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-CHHHHHHHHhhccccC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNIRLN  232 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~~  232 (277)
                      ...      ........... ... ...   .+.....+.+++.+||+.||.+|| +++++.+.|+.++...
T Consensus       217 ~~~------~~~~~~~~~~~-~~~-~~~---~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          217 AVS------IAIKHIQDSVP-NVT-TDV---RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHH------HHHHHHSSCCC-CHH-HHS---CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hHH------HHHHHhhccCC-Ccc-hhc---ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            211      11112221111 110 011   111223477888899999999998 8999999998877644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.4e-43  Score=292.60  Aligned_cols=226  Identities=16%  Similarity=0.200  Sum_probs=176.3

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++| +||||+++++++..++..++||||+ +++|.+++...   +..+++..++.++.|++.||+|||+.   +|+||
T Consensus        57 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHr  129 (330)
T 2izr_A           57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYR  129 (330)
T ss_dssp             HHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             HHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            46677 9999999999999999999999999 89999999532   45799999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCc-----eEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHH
Q 023808           81 DIKASNILLDQEFN-----PKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE  149 (277)
Q Consensus        81 dikp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  149 (277)
                      ||||+|||++.++.     +||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++||
T Consensus       130 Dlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  209 (330)
T 2izr_A          130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY  209 (330)
T ss_dssp             CCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHH
Confidence            99999999998887     999999999876443221      1245679999999999999999999999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      |++|..||..............+......... ..    +....+    .+.+++..||+.+|.+||++.+|.+.|+++.
T Consensus       210 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~----~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          210 FLRGSLPWQGLKADTLKERYQKIGDTKRATPI-EV----LCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-HH----HTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HhcCCCCccccccccHHHHHHHHHhhhccCCH-HH----HhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            99999999765443322222222111111110 00    011122    5778888899999999999999999999887


Q ss_pred             ccCccccCCCCccc
Q 023808          230 RLNEEELTAPGLFQ  243 (277)
Q Consensus       230 ~~~~~~~~~~~~~~  243 (277)
                      ............|.
T Consensus       281 ~~~~~~~~~~~dw~  294 (330)
T 2izr_A          281 DRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHTTCCCSCCCTTT
T ss_pred             HHcCCCCCCCccCC
Confidence            76544433334443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.3e-43  Score=288.01  Aligned_cols=225  Identities=18%  Similarity=0.237  Sum_probs=176.0

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++ +|+|++++++++.++...++||||+ +++|.+++..   .+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        59 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~D  131 (298)
T 1csn_A           59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD  131 (298)
T ss_dssp             HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCC
T ss_pred             HHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            4566 7999999999999999999999999 9999999953   234699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc-----eEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           82 IKASNILLDQEFN-----PKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        82 ikp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                      |||+||+++.++.     +||+|||+++........      ......||..|+|||++.+..++.++||||||+++|||
T Consensus       132 lkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  211 (298)
T 1csn_A          132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF  211 (298)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence            9999999987765     999999999876543221      23456799999999999998999999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ++|+.||........................... .   ...    ...+.+++.+||+.||.+||++.+|++.|+++..
T Consensus       212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          212 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-C---AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-T---TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HcCCCCcchhhccccHHHHHHHHhhccCccHHHH-H---hhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            9999999775543333222222221111111110 0   112    2347788888999999999999999999999987


Q ss_pred             cCccccCCCCcc
Q 023808          231 LNEEELTAPGLF  242 (277)
Q Consensus       231 ~~~~~~~~~~~~  242 (277)
                      ........+..|
T Consensus       284 ~~~~~~~~~~dw  295 (298)
T 1csn_A          284 RLNTTEDENFDW  295 (298)
T ss_dssp             HTTCCSCSCCGG
T ss_pred             hcCCCCCCcccc
Confidence            655444444444

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3e-43  Score=293.59  Aligned_cols=220  Identities=28%  Similarity=0.427  Sum_probs=169.0

Q ss_pred             ccccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC----
Q 023808            2 TLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL----   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----   73 (277)
                      +|++++||||+++++++....    ..++||||+++|+|.+++..     ..+++..++.++.|++.||+|||+..    
T Consensus        71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~  145 (322)
T 3soc_A           71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLK  145 (322)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred             HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            478899999999999999754    46999999999999999943     34899999999999999999999861    


Q ss_pred             ---CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCcccccc-----CccccccceEehh
Q 023808           74 ---VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFG  144 (277)
Q Consensus        74 ---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG  144 (277)
                         .++++||||||+|||++.++.+||+|||+++.+...... ......||+.|+|||++.+     ..++.++||||||
T Consensus       146 ~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  225 (322)
T 3soc_A          146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG  225 (322)
T ss_dssp             TEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred             cccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence               227999999999999999999999999999876543322 2334578999999999886     3677899999999


Q ss_pred             HHHHHHHhCCCCCCcccCcchh----------hHHHHHHHHhccCCccccccCCCCC--CCHHHHHHHHHHHHhhhhhhh
Q 023808          145 VLVLEIISGRNSGKAMWGQMNK----------FLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAA  212 (277)
Q Consensus       145 ~vl~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~c~~~~p  212 (277)
                      +++|||+||+.||.........          ..............     .+.+..  ........+.+++.+||+.||
T Consensus       226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP  300 (322)
T 3soc_A          226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK-----RPVLRDYWQKHAGMAMLCETIEECWDHDA  300 (322)
T ss_dssp             HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-----CCCCCGGGGSSHHHHHHHHHHHHHTCSSG
T ss_pred             HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC-----CCCccccccccchHHHHHHHHHHHccCCh
Confidence            9999999999998754332111          11111111111111     111111  122345668899999999999


Q ss_pred             cCCCCHHHHHHHHhhcccc
Q 023808          213 SRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       213 ~~RPs~~~v~~~L~~~~~~  231 (277)
                      ++|||+.+|++.|+++.+.
T Consensus       301 ~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          301 EARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             GGSCCHHHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHHHH
Confidence            9999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.2e-43  Score=284.28  Aligned_cols=209  Identities=23%  Similarity=0.395  Sum_probs=169.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.++...++||||+++++|.+++..   .+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d  129 (268)
T 3sxs_A           56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRD  129 (268)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESS
T ss_pred             HHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            46788999999999999999999999999999999999943   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............+|..|+|||.+.+..++.++||||||+++|+|+| |..||...
T Consensus       130 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (268)
T 3sxs_A          130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY  209 (268)
T ss_dssp             CSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence            99999999999999999999998776554444444556778999999999899999999999999999999 88888654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ....   .   ..........      ......   ...+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       210 ~~~~---~---~~~~~~~~~~------~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          210 TNSE---V---VLKVSQGHRL------YRPHLA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CHHH---H---HHHHHTTCCC------CCCTTS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ChHH---H---HHHHHcCCCC------CCCCcC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            3221   1   1111111110      011111   23477888889999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-43  Score=300.09  Aligned_cols=208  Identities=24%  Similarity=0.342  Sum_probs=165.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.+++..++||||+++|+|.+++..   .+..+++..++.++.|++.||+|||+.   +++|||
T Consensus       165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrD  238 (377)
T 3cbl_A          165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRD  238 (377)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcc
Confidence            47889999999999999999999999999999999999952   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCccee-eeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+|||++.++.+||+|||+++.......... ....++..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999986543321111 12335678999999999999999999999999999998 8888765


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ....   .....    ......     ...+...   ...+.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus       319 ~~~~---~~~~~----~~~~~~-----~~~~~~~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          319 LSNQ---QTREF----VEKGGR-----LPCPELC---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             SCHH---HHHHH----HHTTCC-----CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHH---HHHHH----HHcCCC-----CCCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            4321   11111    111111     1111212   2347778888999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-42  Score=285.75  Aligned_cols=210  Identities=25%  Similarity=0.337  Sum_probs=162.7

Q ss_pred             cccCCCccceeeEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh--------cC
Q 023808            5 NVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH--------EE   72 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~   72 (277)
                      +++||||+++++++...    ...++||||+++|+|.+++.     ...+++..++.++.|++.||+|||        +.
T Consensus        58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~  132 (301)
T 3q4u_A           58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP  132 (301)
T ss_dssp             CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred             hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence            48999999999997653    46789999999999999993     336999999999999999999999        88


Q ss_pred             CCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce---eeeecccccccCccccccC------ccccccceEeh
Q 023808           73 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYVLGG------QLTMKADVYSF  143 (277)
Q Consensus        73 ~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~sl  143 (277)
                         +++||||||+|||++.++.+||+|||+++.........   .....||+.|+|||++.+.      .++.++|||||
T Consensus       133 ---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl  209 (301)
T 3q4u_A          133 ---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF  209 (301)
T ss_dssp             ---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred             ---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence               99999999999999999999999999998665433322   2234799999999999876      56789999999


Q ss_pred             hHHHHHHHhC----------CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCC--CCCHHHHHHHHHHHHhhhhhh
Q 023808          144 GVLVLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG--EYPPNEIIRYMKVAFFCTQAA  211 (277)
Q Consensus       144 G~vl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~c~~~~  211 (277)
                      |+++|||+||          ..||.......... .............     +.+.  .........+.+++.+||+.|
T Consensus       210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~d  283 (301)
T 3q4u_A          210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF-EDMRKVVCVDQQR-----PNIPNRWFSDPTLTSLAKLMKECWYQN  283 (301)
T ss_dssp             HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHHHHTTSCCC-----CCCCGGGGGSHHHHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHhhhcCccccccccccccccCCCCcch-hhhhHHHhccCCC-----CCCChhhccCccHHHHHHHHHHHhhcC
Confidence            9999999999          77775543322211 1111111111111     1111  112345677889999999999


Q ss_pred             hcCCCCHHHHHHHHhhc
Q 023808          212 ASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       212 p~~RPs~~~v~~~L~~~  228 (277)
                      |.+|||+.+|++.|+++
T Consensus       284 P~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          284 PSARLTALRIKKTLTKI  300 (301)
T ss_dssp             GGGSCCHHHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHhcc
Confidence            99999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-42  Score=286.97  Aligned_cols=200  Identities=23%  Similarity=0.409  Sum_probs=162.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +++|||
T Consensus        70 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~D  141 (297)
T 3fxz_A           70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD  141 (297)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCC
Confidence            46788999999999999999999999999999999999943     2589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus       142 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  220 (297)
T 3fxz_A          142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (297)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999987654332 2344579999999999999999999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .   ...........       ..+......+.+++.+||+.||.+||++.|+++
T Consensus       221 ~~~~---~---~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          221 PLRA---L---YLIATNGTPEL-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHH---H---HHHHHHCSCCC-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHH---H---HHHHhCCCCCC-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            2111   1   11111111100       111222344778888999999999999999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-43  Score=285.14  Aligned_cols=208  Identities=23%  Similarity=0.399  Sum_probs=168.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  131 (269)
T 4hcu_A           58 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRD  131 (269)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            47789999999999999999999999999999999999943   344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus       132 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999998765443333344556788999999998899999999999999999999 88888653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ...   ...   ........      .....   .....+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       212 ~~~---~~~---~~~~~~~~------~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          212 SNS---EVV---EDISTGFR------LYKPR---LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CHH---HHH---HHHHTTCC------CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHH---HHH---HHHhcCcc------CCCCC---cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            321   111   11111111      11111   112347788888999999999999999999998765

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8e-43  Score=291.63  Aligned_cols=209  Identities=25%  Similarity=0.378  Sum_probs=166.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.++. .++|+||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus        70 ~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~D  142 (327)
T 3poz_A           70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRD  142 (327)
T ss_dssp             HHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCC
Confidence            467899999999999998765 6789999999999999953   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       143 ikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  222 (327)
T 3poz_A          143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             CCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence            9999999999999999999999876543322 2334456889999999999999999999999999999999 9999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      .....   ....    ......        ...+......+.+++.+||+.+|.+||++.+|++.|+.+.+..
T Consensus       223 ~~~~~---~~~~----~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          223 IPASE---ISSI----LEKGER--------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             CCGGG---HHHH----HHTTCC--------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCHHH---HHHH----HHcCCC--------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            43322   1111    111111        0112223345788889999999999999999999999887643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.5e-43  Score=296.98  Aligned_cols=210  Identities=27%  Similarity=0.434  Sum_probs=157.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++..   .+..+++..++.++.|++.||+|||+.   +|+|||
T Consensus        99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  172 (373)
T 2qol_A           99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRD  172 (373)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCC
Confidence            47889999999999999999999999999999999999953   345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++.........  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus       173 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~  252 (373)
T 2qol_A          173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW  252 (373)
T ss_dssp             CCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred             CCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998765432221  122345678999999999999999999999999999998 998886


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ....   .....   .. .....     .   ..+......+.+++.+||+.||.+||++.+|++.|+++.+..
T Consensus       253 ~~~~---~~~~~---~i-~~~~~-----~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          253 EMSN---QDVIK---AV-DEGYR-----L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TCCH---HHHHH---HH-HTTEE-----C---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CCCH---HHHHH---HH-HcCCC-----C---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            5432   11111   11 11100     0   011122344778888999999999999999999999987654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.2e-42  Score=284.15  Aligned_cols=222  Identities=36%  Similarity=0.598  Sum_probs=178.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  158 (307)
T 2nru_A           83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD  158 (307)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence            4678899999999999999999999999999999999985422 234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++........ ......||..|+|||.+.+ .++.++||||||+++|+|++|..||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            9999999999999999999999876543222 2334568999999998764 6899999999999999999999998754


Q ss_pred             cCcchhhHHHHHHHHhc-cCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQ-EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .....  ...+...... .......+++.+...+......+.+++.+||+.+|.+||++.+|++.|+++..
T Consensus       238 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          238 REPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BSSSB--TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cchHH--HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            43221  1111111111 12233445555666778888889999999999999999999999999988653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=292.43  Aligned_cols=212  Identities=25%  Similarity=0.380  Sum_probs=162.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|..+. .++|+||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus        70 ~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  142 (327)
T 3lzb_A           70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRD  142 (327)
T ss_dssp             HHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCC
Confidence            477899999999999998765 7789999999999999953   344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       143 ikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  222 (327)
T 3lzb_A          143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             CCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999999999876543222 2233456788999999999999999999999999999999 9999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE  235 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~  235 (277)
                      .....   ....    .......        ..+......+.+++.+||+.||.+||++.++++.|+++.......
T Consensus       223 ~~~~~---~~~~----~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  283 (327)
T 3lzb_A          223 IPASE---ISSI----LEKGERL--------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY  283 (327)
T ss_dssp             CCGGG---HHHH----HHTTCCC--------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred             CCHHH---HHHH----HHcCCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence            43322   1111    1111110        111222334778888999999999999999999999988654333

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-42  Score=305.17  Aligned_cols=209  Identities=22%  Similarity=0.369  Sum_probs=169.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.++...++||||+.+|+|.+++...  ....+++..++.++.|++.||+|||++   +|+|||
T Consensus       269 ~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrD  343 (495)
T 1opk_A          269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRN  343 (495)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            477899999999999999999999999999999999999642  234589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++..............++..|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus       344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~  423 (495)
T 1opk_A          344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  423 (495)
T ss_dssp             CSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999765443333334456788999999999999999999999999999999 88887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ....   +...    ......     ...   +......+.+++.+||+.||.+||++.+|++.|+.++.
T Consensus       424 ~~~~---~~~~----~~~~~~-----~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          424 DLSQ---VYEL----LEKDYR-----MER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CGGG---HHHH----HHTTCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CHHH---HHHH----HHcCCC-----CCC---CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            3221   1111    111111     111   11223347788888999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-42  Score=287.47  Aligned_cols=212  Identities=28%  Similarity=0.413  Sum_probs=169.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC--------------------CCccCCHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------------------ANIKLNWEKRSDICVG   61 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~q   61 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++.....                    ....+++..++.++.|
T Consensus        79 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  158 (314)
T 2ivs_A           79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ  158 (314)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred             HHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence            47789999999999999999999999999999999999965432                    1234899999999999


Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccce
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      ++.||+|||+.   +++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||
T Consensus       159 i~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  235 (314)
T 2ivs_A          159 ISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV  235 (314)
T ss_dssp             HHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhH
Confidence            99999999999   9999999999999999999999999999876543322 2233456788999999999899999999


Q ss_pred             EehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          141 YSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       141 ~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      ||||+++|||++ |..||.......   ...    .......     ...   +......+.+++.+||+.||.+||++.
T Consensus       236 ~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~-----~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          236 WSFGVLLWEIVTLGGNPYPGIPPER---LFN----LLKTGHR-----MER---PDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HhhcCCc-----CCC---CccCCHHHHHHHHHHccCChhhCcCHH
Confidence            999999999999 988886543322   111    1111111     111   112223477888899999999999999


Q ss_pred             HHHHHHhhcccc
Q 023808          220 QVIKMLTKNIRL  231 (277)
Q Consensus       220 ~v~~~L~~~~~~  231 (277)
                      +|++.|++++..
T Consensus       301 ~l~~~l~~~~~~  312 (314)
T 2ivs_A          301 DISKDLEKMMVK  312 (314)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhh
Confidence            999999987653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-43  Score=293.26  Aligned_cols=213  Identities=24%  Similarity=0.414  Sum_probs=168.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC--------------------CccCCHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA--------------------NIKLNWEKRSDICVG   61 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~~i~~q   61 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++......                    ...+++..++.++.|
T Consensus       103 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  182 (343)
T 1luf_A          103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ  182 (343)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred             HHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHH
Confidence            477899999999999999999999999999999999999653221                    256899999999999


Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccce
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      ++.||+|||+.   +++||||||+||+++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||
T Consensus       183 i~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  259 (343)
T 1luf_A          183 VAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV  259 (343)
T ss_dssp             HHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCccccc
Confidence            99999999999   999999999999999999999999999986543221 22334567889999999998899999999


Q ss_pred             EehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          141 YSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       141 ~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      ||||+++|||+| |..||......   ..   ...... ....        ..+......+.+++.+||+.||.+||++.
T Consensus       260 ~slG~il~el~t~g~~p~~~~~~~---~~---~~~~~~-~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          260 WAYGVVLWEIFSYGLQPYYGMAHE---EV---IYYVRD-GNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             HHHHHHHHHHHTTTCCTTTTSCHH---HH---HHHHHT-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHhcCCCcCCCCChH---HH---HHHHhC-CCcC--------CCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            999999999999 88888653321   11   111111 1111        11112223477888889999999999999


Q ss_pred             HHHHHHhhccccC
Q 023808          220 QVIKMLTKNIRLN  232 (277)
Q Consensus       220 ~v~~~L~~~~~~~  232 (277)
                      +|++.|+++....
T Consensus       325 ~~~~~L~~~~~~~  337 (343)
T 1luf_A          325 SIHRILQRMCERA  337 (343)
T ss_dssp             HHHHHHHHTTC--
T ss_pred             HHHHHHHHHHhhh
Confidence            9999999987644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.7e-43  Score=285.71  Aligned_cols=207  Identities=25%  Similarity=0.375  Sum_probs=154.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++. ++..++||||+.+|+|.+++..   .+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        69 ~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  141 (281)
T 1mp8_A           69 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRD  141 (281)
T ss_dssp             HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            467899999999999984 4578899999999999999953   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       142 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          142 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             CSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            99999999999999999999998765543333344557788999999998899999999999999999997 88888654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ....   ....   .......      .+   ++.....+.+++.+||+.||.+||++.++++.|++++.
T Consensus       222 ~~~~---~~~~---i~~~~~~------~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          222 KNND---VIGR---IENGERL------PM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             CGGG---HHHH---HHTTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHH---HHHH---HHcCCCC------CC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            3321   1111   1111110      11   12223347788889999999999999999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-42  Score=289.41  Aligned_cols=202  Identities=24%  Similarity=0.359  Sum_probs=161.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++    .....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        58 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~D  130 (323)
T 3tki_A           58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD  130 (323)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            467889999999999999999999999999999999998    3455699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+||+++.++.+||+|||+++.+.... ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..
T Consensus       131 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  210 (323)
T 3tki_A          131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (323)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998654322 122335679999999999988765 7899999999999999999999976


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....... ...+    .......        .........+.+++.+||+.||.+|||+.|+++
T Consensus       211 ~~~~~~~-~~~~----~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          211 PSDSCQE-YSDW----KEKKTYL--------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             SCTTSHH-HHHH----HTTCTTS--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CchHHHH-HHHH----hcccccC--------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            5433211 1111    1111100        001122334778889999999999999999865

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-42  Score=289.20  Aligned_cols=209  Identities=25%  Similarity=0.369  Sum_probs=164.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+ ...++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus        68 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  140 (325)
T 3kex_A           68 AIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRN  140 (325)
T ss_dssp             HHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCc
Confidence            4678899999999999874 568899999999999999943   345789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+|||++.++.+||+|||+++........ ......|+..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       141 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  220 (325)
T 3kex_A          141 LAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG  220 (325)
T ss_dssp             CSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence            9999999999999999999999977554322 2344567889999999998999999999999999999999 9999875


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      .....   .....    .......     .   +......+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus       221 ~~~~~---~~~~~----~~~~~~~-----~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          221 LRLAE---VPDLL----EKGERLA-----Q---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             SCTTH---HHHHH----HTTCBCC-----C---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             cCHHH---HHHHH----HcCCCCC-----C---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            43322   11111    1111100     0   0111123667888899999999999999999999887643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.4e-43  Score=303.36  Aligned_cols=210  Identities=27%  Similarity=0.404  Sum_probs=167.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++. ++..++||||+.+|+|.+++...  .+..+++..++.++.|++.||+|||++   +|+|||
T Consensus       236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrD  309 (454)
T 1qcf_A          236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD  309 (454)
T ss_dssp             HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSS
T ss_pred             HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence            578899999999999987 56789999999999999999532  223688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++..............++..|+|||++....++.++||||||+++|||+| |+.||...
T Consensus       310 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~  389 (454)
T 1qcf_A          310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  389 (454)
T ss_dssp             CSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765432222233446788999999998899999999999999999999 99888654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ..   ......   .......      ..   +......+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       390 ~~---~~~~~~---i~~~~~~------~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          390 SN---PEVIRA---LERGYRM------PR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CH---HHHHHH---HHHTCCC------CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CH---HHHHHH---HHcCCCC------CC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            32   112111   1111111      01   1122334778888999999999999999999999887644

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=294.50  Aligned_cols=213  Identities=26%  Similarity=0.416  Sum_probs=170.1

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC------------CccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------------NIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|+++ +||||++++++|..++..++||||+++|+|.+++......            ...+++..++.++.|++.||+|
T Consensus       127 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  206 (382)
T 3tt0_A          127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY  206 (382)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            35667 8999999999999999999999999999999999654321            2459999999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ||+.   +|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||++.+..++.++||||||+++
T Consensus       207 LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il  283 (382)
T 3tt0_A          207 LASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL  283 (382)
T ss_dssp             HHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred             HHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHH
Confidence            9999   999999999999999999999999999986654322 223345578899999999999999999999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |||++ |..||.....   ....    .........     ..   +......+.+++.+||+.||.+||++.+|++.|+
T Consensus       284 ~ellt~g~~p~~~~~~---~~~~----~~~~~~~~~-----~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          284 WEIFTLGGSPYPGVPV---EELF----KLLKEGHRM-----DK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             HHHHTTSCCSSTTCCH---HHHH----HHHHTTCCC-----CC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhCCCCCCCCCCH---HHHH----HHHHcCCCC-----CC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999 8888764322   1111    111111111     11   1122234778888899999999999999999999


Q ss_pred             hccccC
Q 023808          227 KNIRLN  232 (277)
Q Consensus       227 ~~~~~~  232 (277)
                      ++....
T Consensus       349 ~~~~~~  354 (382)
T 3tt0_A          349 RIVALT  354 (382)
T ss_dssp             HHHHHS
T ss_pred             HHHHHH
Confidence            988654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-42  Score=284.14  Aligned_cols=208  Identities=21%  Similarity=0.376  Sum_probs=168.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||+++++++.+++..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        72 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d  145 (283)
T 3gen_A           72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRD  145 (283)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSS
T ss_pred             HHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCC
Confidence            46789999999999999999999999999999999999943   245699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............+|..|+|||.+.+..++.++||||||+++|+|+| |+.||...
T Consensus       146 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             CSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999998765433333334456788999999998899999999999999999998 99898654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ....   ..   ........      .......   ...+.+++.+||+.+|.+||++.++++.|++++.
T Consensus       226 ~~~~---~~---~~~~~~~~------~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          226 TNSE---TA---EHIAQGLR------LYRPHLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CHHH---HH---HHHHTTCC------CCCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ChhH---HH---HHHhcccC------CCCCCcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            3211   11   11111111      1111111   2347788888999999999999999999998775

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-42  Score=302.47  Aligned_cols=211  Identities=29%  Similarity=0.451  Sum_probs=162.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+ +..++||||+.+|+|.+++...  .+..+++..++.++.|++.||+|||++   +++|||
T Consensus       232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrD  305 (452)
T 1fmk_A          232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD  305 (452)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence            4778999999999999876 6789999999999999999431  224589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus       306 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765433333334457789999999998899999999999999999999 88887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ...   ....   ........         ..+......+.+++.+||+.||++|||+.+|++.|+++....+
T Consensus       386 ~~~---~~~~---~i~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          386 VNR---EVLD---QVERGYRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             CHH---HHHH---HHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHH---HHHH---HHHcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            321   1111   11111110         1112223457788889999999999999999999999876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-43  Score=291.84  Aligned_cols=214  Identities=26%  Similarity=0.401  Sum_probs=166.5

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++...  ...++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        76 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H  149 (302)
T 4e5w_A           76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVH  149 (302)
T ss_dssp             HHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---Cccc
Confidence            46789999999999999876  678999999999999999943   234589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++.++.+||+|||+++........  ......||..|+|||.+.+..++.++||||||+++|+|+||..|+
T Consensus       150 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             SCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999877654332  233456788899999999999999999999999999999998875


Q ss_pred             CcccCc--------chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          158 KAMWGQ--------MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       158 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ......        ..................        ...+......+.+++.+||+.||.+|||+.++++.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          230 SSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR--------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             GSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhhHHhhccCCcccccCHHHHHHHHhccCC--------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            433210        001111111111111111        1112222345788888999999999999999999998865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-41  Score=279.51  Aligned_cols=212  Identities=26%  Similarity=0.461  Sum_probs=155.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++ .....++||||+.+++|.+++.   .....+++..++.++.|++.||+|||+.   +++|||
T Consensus        73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~D  145 (289)
T 3og7_A           73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRD  145 (289)
T ss_dssp             HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            47889999999999976 4556789999999999999994   3445699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++.+||+|||+++...... ........||..|+|||.+.   +..++.++||||||+++|+|++|+.||
T Consensus       146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  225 (289)
T 3og7_A          146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY  225 (289)
T ss_dssp             CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence            99999999999999999999998654322 22233456899999999986   566888999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .......  ......    ......    +.+..........+.+++.+||+.+|.+||++.++++.|+++.+
T Consensus       226 ~~~~~~~--~~~~~~----~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          226 SNINNRD--QIIEMV----GRGSLS----PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SSCCCHH--HHHHHH----HHTSCC----CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccchHH--HHHHHh----cccccC----cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            6543321  111111    111111    11111122223457888889999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=288.38  Aligned_cols=214  Identities=18%  Similarity=0.209  Sum_probs=164.4

Q ss_pred             cccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            3 LSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +++++||||+++++++..    ....++||||+ +++|.+++.    ....+++..++.++.|++.||+|||+.   +|+
T Consensus       102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv  173 (345)
T 2v62_A          102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYV  173 (345)
T ss_dssp             HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            567899999999999998    77899999999 999999994    333799999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC--ceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           79 HRDIKASNILLDQEF--NPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        79 H~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                      ||||||+||+++.++  .+||+|||+++.+......      ......||..|+|||++.+..++.++||||||+++|||
T Consensus       174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  253 (345)
T 2v62_A          174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW  253 (345)
T ss_dssp             CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence            999999999998777  9999999999876432211      12345789999999999998999999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ++|+.||......... ... .............. ....  .......+.+++.+||+.||.+||++.+|++.|++..
T Consensus       254 l~g~~pf~~~~~~~~~-~~~-~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          254 LCGKLPWEQNLKDPVA-VQT-AKTNLLDELPQSVL-KWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHSSCTTGGGTTCHHH-HHH-HHHHHHHTTTHHHH-HHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HhCCCCccccccccHH-HHH-HHHhhcccccHHHH-hhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            9999998643322211 111 11111111111100 0000  0011224778888899999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-42  Score=288.18  Aligned_cols=197  Identities=23%  Similarity=0.332  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++|||
T Consensus        67 ~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrD  139 (328)
T 3fe3_A           67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRD  139 (328)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccC
Confidence            46788999999999999999999999999999999999843    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccc-cccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++......  ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...
T Consensus       140 lkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  217 (328)
T 3fe3_A          140 LKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ  217 (328)
T ss_dssp             CCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCHHHEEEcCCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998765432  23445699999999999887765 7999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ...   ........       .++.   .....+.+++.+||+.||.+|||+.|+++
T Consensus       218 ~~~---~~~---~~i~~~~~-------~~p~---~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          218 NLK---ELR---ERVLRGKY-------RIPF---YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             SHH---HHH---HHHHHCCC-------CCCT---TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CHH---HHH---HHHHhCCC-------CCCC---CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            321   111   11111111       1111   12234778888899999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.6e-42  Score=284.47  Aligned_cols=215  Identities=23%  Similarity=0.372  Sum_probs=162.1

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++..  ....++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        64 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH  137 (295)
T 3ugc_A           64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIH  137 (295)
T ss_dssp             HHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             HHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcC---Cccc
Confidence            4788999999999999964  3568999999999999999953   234599999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++.++.+||+|||+++........  ......++..|+|||.+.+..++.++||||||+++|||+||..|+
T Consensus       138 ~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  217 (295)
T 3ugc_A          138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS  217 (295)
T ss_dssp             SCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             CCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence            999999999999999999999999876543221  223345677899999999999999999999999999999999887


Q ss_pred             CcccCcc---------hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          158 KAMWGQM---------NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       158 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .......         .................        ...+......+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             CSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCChHHHHhhhcCccccchhHHHHHHHHhccCc--------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            6432110         00011111111111111        111222234577888899999999999999999999987


Q ss_pred             cc
Q 023808          229 IR  230 (277)
Q Consensus       229 ~~  230 (277)
                      .+
T Consensus       290 ~~  291 (295)
T 3ugc_A          290 RD  291 (295)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=295.23  Aligned_cols=213  Identities=26%  Similarity=0.344  Sum_probs=167.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++||||+++++++.++...++||||+.+|+|.+++.....   ....+++..++.++.|++.||+|||+.   +|+
T Consensus       127 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv  203 (367)
T 3l9p_A          127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFI  203 (367)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             HHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            46788999999999999999999999999999999999965332   224589999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC---ceEEeecccccccCCC-CcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           79 HRDIKASNILLDQEF---NPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        79 H~dikp~Nill~~~~---~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      ||||||+|||++.++   .+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus       204 HrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g  283 (367)
T 3l9p_A          204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG  283 (367)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999998554   5999999999854321 1122334567889999999999999999999999999999998 8


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ..||.....   .....   ........      ..   +......+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus       284 ~~pf~~~~~---~~~~~---~i~~~~~~------~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          284 YMPYPSKSN---QEVLE---FVTSGGRM------DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             CCSSTTCCH---HHHHH---HHHTTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCH---HHHHH---HHHcCCCC------CC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            888865332   11111   11111111      11   1122234778888999999999999999999999877644

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.6e-43  Score=290.70  Aligned_cols=214  Identities=27%  Similarity=0.398  Sum_probs=167.3

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++.+.  ...++||||+++|+|.+++..     ..+++..++.++.|++.||+|||+.   +++|
T Consensus        86 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH  157 (318)
T 3lxp_A           86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIH  157 (318)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence            46789999999999999984  678999999999999999943     2489999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++.++.+||+|||+++........  ......++..|+|||.+.+..++.++||||||+++|+|+||..||
T Consensus       158 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~  237 (318)
T 3lxp_A          158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS  237 (318)
T ss_dssp             SCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence            999999999999999999999999977654322  233455788899999999999999999999999999999999987


Q ss_pred             CcccCcc---------hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          158 KAMWGQM---------NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       158 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .......         ...... ..........        ...+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          238 QSPPTKFLELIGIAQGQMTVLR-LTELLERGER--------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             GSHHHHHHHHHCSCCHHHHHHH-HHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccchhhhhhhcccccchhHHH-HHHHHhcccC--------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            6432210         000111 1111111111        111222234578888899999999999999999999988


Q ss_pred             cccC
Q 023808          229 IRLN  232 (277)
Q Consensus       229 ~~~~  232 (277)
                      ....
T Consensus       309 ~~~~  312 (318)
T 3lxp_A          309 HEKY  312 (318)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            7544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-42  Score=284.45  Aligned_cols=202  Identities=21%  Similarity=0.281  Sum_probs=162.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||++||+|.+++.   ..+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~D  127 (321)
T 1tki_A           54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD  127 (321)
T ss_dssp             HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence            4678899999999999999999999999999999999993   2334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCC--CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+||+++.  ++.+||+|||+++.+....  ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus       128 lkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             CCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence            9999999987  7899999999998765432  23446689999999999988899999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .....   ..........  .......    ...+.+++.+||+.||.+|||+.|+++
T Consensus       206 ~~~---~~~~~---~i~~~~~~~~--~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          206 ETN---QQIIE---NIMNAEYTFD--EEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SSH---HHHHH---HHHHTCCCCC--HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCH---HHHHH---HHHcCCCCCC--hhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            332   11111   1111111100  0000111    234788899999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-41  Score=287.97  Aligned_cols=201  Identities=26%  Similarity=0.322  Sum_probs=161.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||++||+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrD  140 (361)
T 2yab_A           68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFD  140 (361)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4788999999999999999999999999999999999993    445799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC----ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++    .+||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf  218 (361)
T 2yab_A          141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  218 (361)
T ss_dssp             CSGGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCHHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999998776    79999999998765432  233456999999999999889999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......   ....   ........   .++..   .......+.+++.+||..||.+|||+.|+++
T Consensus       219 ~~~~~~---~~~~---~i~~~~~~---~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          219 LGDTKQ---ETLA---NITAVSYD---FDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCSSHH---HHHH---HHHTTCCC---CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCHH---HHHH---HHHhcCCC---CCchh---ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            653221   1111   11111100   00000   0111234778888999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-42  Score=289.77  Aligned_cols=210  Identities=25%  Similarity=0.407  Sum_probs=156.5

Q ss_pred             ccccccCCCccceeeEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||++++++|.. ++..++||||+++|+|.+++.   .....+++..++.++.|++.||+|||+.   +|+||
T Consensus       143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHr  216 (373)
T 3c1x_A          143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHR  216 (373)
T ss_dssp             TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecC
Confidence            5788999999999999764 457899999999999999994   3344688999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNS  156 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p  156 (277)
                      ||||+||+++.++.+||+|||+++........   ......++..|+|||.+.+..++.++||||||+++|||+| |..|
T Consensus       217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p  296 (373)
T 3c1x_A          217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  296 (373)
T ss_dssp             CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence            99999999999999999999999865433211   1233457788999999999999999999999999999999 5666


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      |.......   ....   .......      ..+...   ...+.+++.+||+.||.+||++.++++.|+++....
T Consensus       297 ~~~~~~~~---~~~~---~~~~~~~------~~p~~~---~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          297 YPDVNTFD---ITVY---LLQGRRL------LQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             CTTSCSSC---HHHH---HHTTCCC------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCHHH---HHHH---HHcCCCC------CCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            65443322   1111   1111111      111112   234778888899999999999999999999987644

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=287.96  Aligned_cols=200  Identities=24%  Similarity=0.343  Sum_probs=161.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.+.+..|+||||+.||+|.+++.    .+..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrD  140 (384)
T 4fr4_A           68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRD  140 (384)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Cceecc
Confidence            4778999999999999999999999999999999999994    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++.++.+||+|||+++.+....  ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.
T Consensus       141 lkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          141 MKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcHHHeEECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence            99999999999999999999998765432  2345679999999999864   458999999999999999999999987


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-HHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-~~~v~~  223 (277)
                      ..............   ....       .   ..+......+.+++.+||+.||.+||+ +.+|..
T Consensus       219 ~~~~~~~~~~~~~~---~~~~-------~---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          219 IRSSTSSKEIVHTF---ETTV-------V---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCTTSCHHHHHHHH---HHCC-------C---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCCCccHHHHHHHH---hhcc-------c---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            54443322222211   1111       0   111222335778888999999999998 666653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=279.58  Aligned_cols=222  Identities=22%  Similarity=0.240  Sum_probs=171.0

Q ss_pred             ccccccCCCccceeeEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++....  ..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+|
T Consensus        60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH  135 (319)
T 4euu_A           60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVH  135 (319)
T ss_dssp             HHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEec
Confidence            467899999999999998765  7799999999999999995432 222489999999999999999999999   9999


Q ss_pred             ccCCCCcEEe----CCCCceEEeecccccccCCCCcceeeeecccccccCccccc--------cCccccccceEehhHHH
Q 023808           80 RDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL--------GGQLTMKADVYSFGVLV  147 (277)
Q Consensus        80 ~dikp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~vl  147 (277)
                      |||||+||++    +.++.+||+|||+++.......  .....||..|+|||++.        +..++.++||||||+++
T Consensus       136 ~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il  213 (319)
T 4euu_A          136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF  213 (319)
T ss_dssp             SCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred             CCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence            9999999999    7888899999999987654332  23456899999999886        46789999999999999


Q ss_pred             HHHHhCCCCCCcccCcc-hhhHHHHHHHHhccCCccccc---------c---CCCCCCCHHHHHHHHHHHHhhhhhhhcC
Q 023808          148 LEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELV---------D---PELGEYPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      |||+||..||....... .....................         .   +............+.+++.+||+.||++
T Consensus       214 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~  293 (319)
T 4euu_A          214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK  293 (319)
T ss_dssp             HHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred             HHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhh
Confidence            99999999986544322 222222222211111111000         0   1112345666777889999999999999


Q ss_pred             CCCHHHHHHHHhhcc
Q 023808          215 RPQMNQVIKMLTKNI  229 (277)
Q Consensus       215 RPs~~~v~~~L~~~~  229 (277)
                      ||++.|+++-..+..
T Consensus       294 R~s~~ell~h~~d~~  308 (319)
T 4euu_A          294 CWGFDQFFAETSDIL  308 (319)
T ss_dssp             SCCHHHHHHHHHHHT
T ss_pred             hccHHHhhhccHHHh
Confidence            999999999887654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-42  Score=286.45  Aligned_cols=211  Identities=25%  Similarity=0.420  Sum_probs=162.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        99 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  172 (333)
T 1mqb_A           99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRD  172 (333)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence            46789999999999999999999999999999999999953   335699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       173 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  252 (333)
T 1mqb_A          173 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  252 (333)
T ss_dssp             CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999876543221  1223346788999999998899999999999999999999 999886


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ....   .....   ........         ..+......+.+++.+||+.+|.+||++.+|++.|+++.+...
T Consensus       253 ~~~~---~~~~~---~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          253 ELSN---HEVMK---AINDGFRL---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TCCH---HHHHH---HHHTTCCC---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             cCCH---HHHHH---HHHCCCcC---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            4322   11111   11111111         0111223347788889999999999999999999999886543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.7e-42  Score=288.27  Aligned_cols=205  Identities=20%  Similarity=0.290  Sum_probs=162.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++......+..+++..+..++.||+.||+|||+.   +|+|||
T Consensus        79 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrD  155 (351)
T 3c0i_A           79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRD  155 (351)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---Cceecc
Confidence            46788999999999999999999999999999999988854434455689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc---eEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++.   +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       156 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (351)
T 3c0i_A          156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY  234 (351)
T ss_dssp             CSGGGEEECSSSTTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHHeEEecCCCCCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence            9999999986654   99999999987654322 2334579999999999999899999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...    .....   ..........  .......    ...+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~----~~~~~---~i~~~~~~~~--~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          235 GTK----ERLFE---GIIKGKYKMN--PRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             SSH----HHHHH---HHHHTCCCCC--HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CcH----HHHHH---HHHcCCCCCC--ccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            532    11111   1111111000  0000111    234778888999999999999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-41  Score=284.76  Aligned_cols=198  Identities=26%  Similarity=0.290  Sum_probs=160.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||++||+|.+++.    ....+++..+..++.||+.||+|||++   +|+|||
T Consensus        58 ~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  130 (337)
T 1o6l_A           58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRD  130 (337)
T ss_dssp             HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCc
Confidence            4678899999999999999999999999999999999984    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus       131 lkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  209 (337)
T 1o6l_A          131 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence            99999999999999999999998643322 22345679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .   .....   .......       .++.   .....+.+++.+||+.||.+||     ++.+|++
T Consensus       210 ~---~~~~~---~i~~~~~-------~~p~---~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          210 H---ERLFE---LILMEEI-------RFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             H---HHHHH---HHHHCCC-------CCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             H---HHHHH---HHHcCCC-------CCCC---CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            2   11111   1111111       1111   1223477888889999999999     8988865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-42  Score=306.60  Aligned_cols=209  Identities=24%  Similarity=0.385  Sum_probs=163.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.. +..++||||+.+|+|.+++.   .....+++..++.++.||+.||+|||+.   +|+|||
T Consensus       389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrD  461 (613)
T 2ozo_A          389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRN  461 (613)
T ss_dssp             HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCc
Confidence            5788999999999999976 56899999999999999994   2345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+|||++.++.+||+|||+++.........  .....++..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       462 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~  541 (613)
T 2ozo_A          462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  541 (613)
T ss_dssp             CSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999998765432221  223345688999999998999999999999999999998 999987


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ......   +...   . ..+...     ..   +......+.+++..||+.+|++||++.+|++.|+.+....
T Consensus       542 ~~~~~~---~~~~---i-~~~~~~-----~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          542 KMKGPE---VMAF---I-EQGKRM-----EC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             TCCSHH---HHHH---H-HTTCCC-----CC---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHH---HHHH---H-HcCCCC-----CC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            644321   2211   1 111111     11   1222344778888899999999999999999999877543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=293.82  Aligned_cols=202  Identities=21%  Similarity=0.278  Sum_probs=161.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.||+|.+++..    ...+++..+..++.||+.||+|||+.   +|+|||
T Consensus        63 il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrD  135 (444)
T 3soa_A           63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRN  135 (444)
T ss_dssp             HHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            46789999999999999999999999999999999999843    34699999999999999999999999   999999


Q ss_pred             CCCCcEEeC---CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++   .++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       136 lKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCHHHEEEeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            999999998   467899999999987654322 2334679999999999999899999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....   .......  ....+.....+    ..+.+++.+||+.||.+||++.|+++
T Consensus       215 ~~~~---~~~~~---~i~~~~~--~~~~~~~~~~s----~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          215 DEDQ---HRLYQ---QIKAGAY--DFPSPEWDTVT----PEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CSSH---HHHHH---HHHHTCC--CCCTTTTTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CccH---HHHHH---HHHhCCC--CCCccccccCC----HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            4322   11111   1111111  11111122223    34778888999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-41  Score=295.02  Aligned_cols=205  Identities=25%  Similarity=0.359  Sum_probs=163.4

Q ss_pred             ccccccCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||+++++++.+.. ..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +++||
T Consensus       239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHr  313 (450)
T 1k9a_A          239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR  313 (450)
T ss_dssp             HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCC
Confidence            578899999999999988765 789999999999999999542  223478999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      ||||+|||++.++.+||+|||+++.....    .....++..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       314 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  389 (450)
T 1k9a_A          314 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  389 (450)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999854332    122356889999999999999999999999999999998 9988865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .....   ...   .... +..     ...   +......+.+++.+||+.||.+||++.+|++.|+++..
T Consensus       390 ~~~~~---~~~---~i~~-~~~-----~~~---p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          390 IPLKD---VVP---RVEK-GYK-----MDA---PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             SCTTT---HHH---HHHT-TCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHH---HHH---HHHc-CCC-----CCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            43322   111   1111 111     111   12223347788888999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=280.10  Aligned_cols=211  Identities=32%  Similarity=0.529  Sum_probs=158.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+  ..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+....+++|||
T Consensus        54 ~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~d  130 (307)
T 2eva_A           54 QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD  130 (307)
T ss_dssp             HHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred             HHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCC
Confidence            4678899999999999874  4789999999999999995432 223478999999999999999999992111899999


Q ss_pred             CCCCcEEeCCCCc-eEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFN-PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++. +||+|||++......    .....||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          131 LKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             CSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             CChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            9999999988876 799999999765432    22345899999999999989999999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      .....    ...+........     +.....+    ..+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus       207 ~~~~~----~~~~~~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          207 GGPAF----RIMWAVHNGTRP-----PLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CSSHH----HHHHHHHTTCCC-----CCBTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CccHH----HHHHHHhcCCCC-----CcccccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            33211    111122221111     0111222    34778888999999999999999999999887654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.4e-42  Score=280.71  Aligned_cols=210  Identities=22%  Similarity=0.368  Sum_probs=171.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++...  ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        62 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  136 (288)
T 3kfa_A           62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD  136 (288)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCC
Confidence            467889999999999999999999999999999999999542  334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus       137 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             CSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999776554444455667889999999998899999999999999999999 88887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ....   .....    .....     ...   +......+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       217 ~~~~---~~~~~----~~~~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          217 DLSQ---VYELL----EKDYR-----MER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CGGG---HHHHH----HTTCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHH---HHHHH----hccCC-----CCC---CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            3322   11111    11110     111   112223477888889999999999999999999987753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-41  Score=284.48  Aligned_cols=213  Identities=20%  Similarity=0.375  Sum_probs=159.0

Q ss_pred             ccccccCCCccceeeEEEeCCee------EEEEeecCCCCHHHHhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++......      ++||||+.+|+|.+++....  .....+++..++.++.|++.||+|||+. 
T Consensus        78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-  156 (323)
T 3qup_A           78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-  156 (323)
T ss_dssp             HHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-
Confidence            46789999999999999877655      99999999999999985432  2223589999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                        +++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++
T Consensus       157 --~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  234 (323)
T 3qup_A          157 --NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT  234 (323)
T ss_dssp             --TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence              9999999999999999999999999999876443221 2233456788999999999899999999999999999999


Q ss_pred             -CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          153 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                       |..||.......   ...   ........         ..++.....+.+++.+||+.||.+||++.++++.|++++..
T Consensus       235 ~g~~p~~~~~~~~---~~~---~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          235 RGQTPYAGIENAE---IYN---YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             TSCCTTTTCCGGG---HHH---HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccccChHH---HHH---HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence             888886543322   111   11111111         11122234578888999999999999999999999998875


Q ss_pred             C
Q 023808          232 N  232 (277)
Q Consensus       232 ~  232 (277)
                      .
T Consensus       300 ~  300 (323)
T 3qup_A          300 L  300 (323)
T ss_dssp             -
T ss_pred             h
Confidence            4

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-42  Score=288.95  Aligned_cols=214  Identities=26%  Similarity=0.365  Sum_probs=167.6

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC-------------------CccCCHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------------------NIKLNWEKRSDICVG   61 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~q   61 (277)
                      +|+++ +||||+++++++..++..++||||+++|+|.+++......                   ...+++..++.++.|
T Consensus       101 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  180 (344)
T 1rjb_A          101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ  180 (344)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred             HHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHH
Confidence            46678 8999999999999999999999999999999999643221                   134899999999999


Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccce
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      ++.||+|||+.   +++||||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||
T Consensus       181 i~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  257 (344)
T 1rjb_A          181 VAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV  257 (344)
T ss_dssp             HHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhH
Confidence            99999999999   999999999999999999999999999986644322 22334567889999999998899999999


Q ss_pred             EehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          141 YSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       141 ~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      ||||+++|||+| |..||.......  ...    ........     ...   +......+.+++.+||+.||.+||++.
T Consensus       258 ~slG~il~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          258 WSYGILLWEIFSLGVNPYPGIPVDA--NFY----KLIQNGFK-----MDQ---PFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             HHHHHHHHHHTTTSCCSSTTCCCSH--HHH----HHHHTTCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHcCCCCCcccCCcHH--HHH----HHHhcCCC-----CCC---CCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            999999999998 998886543321  111    11111111     111   111223477888889999999999999


Q ss_pred             HHHHHHhhccccC
Q 023808          220 QVIKMLTKNIRLN  232 (277)
Q Consensus       220 ~v~~~L~~~~~~~  232 (277)
                      +|++.|+.++...
T Consensus       324 ~l~~~l~~~~~~~  336 (344)
T 1rjb_A          324 NLTSFLGCQLADA  336 (344)
T ss_dssp             HHHHHHHHHC---
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-42  Score=279.55  Aligned_cols=205  Identities=29%  Similarity=0.494  Sum_probs=154.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+++..++||||+++++|.+++.     +..+++..++.++.|++.||+|||+....+++|||
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~d  133 (271)
T 3dtc_A           59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD  133 (271)
T ss_dssp             HHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSC
T ss_pred             HHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Confidence            3667899999999999999999999999999999999983     34689999999999999999999999211299999


Q ss_pred             CCCCcEEeCC--------CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQ--------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~--------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+||+++.        ++.+||+|||+++......   .....||..|+|||.+.+..++.++||||||+++|+|++|
T Consensus       134 ikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  210 (271)
T 3dtc_A          134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG  210 (271)
T ss_dssp             CSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred             CchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence            9999999986        6789999999998654432   2245689999999999988899999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      +.||.......      ...........     ...   +......+.+++.+||+.||.+||++.|+++.|+++
T Consensus       211 ~~p~~~~~~~~------~~~~~~~~~~~-----~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          211 EVPFRGIDGLA------VAYGVAMNKLA-----LPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCTTTTSCHHH------HHHHHHTSCCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCCCCHHH------HHHhhhcCCCC-----CCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            99986543211      11111111111     111   112223477888889999999999999999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.5e-42  Score=285.52  Aligned_cols=196  Identities=23%  Similarity=0.358  Sum_probs=158.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+ +|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        62 ~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~D  133 (336)
T 3h4j_B           62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRD  133 (336)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCC
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            467899999999999999999999999999 679988884    334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus       134 lkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          134 LKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             CSTTTEEECTTCCEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             CchhhEEEcCCCCEEEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999998765432  2234569999999999988776 68999999999999999999998653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....                ...+.......+......+.+++.+||+.||.+|||+.|+++
T Consensus       212 ~~~~~----------------~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          212 FIPNL----------------FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SSTTC----------------BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cHHHH----------------HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            32110                011111111112222334778889999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.2e-41  Score=276.85  Aligned_cols=203  Identities=28%  Similarity=0.478  Sum_probs=159.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--iiH   79 (277)
                      +|++++||||+++++++.+..  ++||||+++|+|.+++.   .....+++..++.++.|++.||+|||+.   +  ++|
T Consensus        76 ~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH  147 (287)
T 4f0f_A           76 IMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVH  147 (287)
T ss_dssp             HHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBC
T ss_pred             HHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeec
Confidence            467899999999999997665  69999999999988884   3445799999999999999999999999   8  999


Q ss_pred             ccCCCCcEEeCCCCc-----eEEeecccccccCCCCcceeeeecccccccCccccc--cCccccccceEehhHHHHHHHh
Q 023808           80 RDIKASNILLDQEFN-----PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL--GGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        80 ~dikp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~vl~ellt  152 (277)
                      |||||+||+++.++.     +||+|||+++....    ......||..|+|||++.  ...++.++||||||+++|||++
T Consensus       148 ~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~  223 (287)
T 4f0f_A          148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT  223 (287)
T ss_dssp             SCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence            999999999987776     99999999985433    234467899999999984  4567899999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      |+.||...........    ........     .+.+   +......+.+++.+||+.||.+||++.++++.|+++
T Consensus       224 g~~pf~~~~~~~~~~~----~~~~~~~~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          224 GEGPFDEYSYGKIKFI----NMIREEGL-----RPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             SSCTTTTCCCCHHHHH----HHHHHSCC-----CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCccccccHHHHH----HHHhccCC-----CCCC---CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            9999875443322111    11111111     1111   112223477888889999999999999999999763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.1e-41  Score=279.98  Aligned_cols=200  Identities=21%  Similarity=0.401  Sum_probs=161.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++|+|.+++.     ...+++..+..++.|++.||+|||+.   +++|||
T Consensus        95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  166 (321)
T 2c30_A           95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD  166 (321)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4778999999999999999999999999999999999983     23689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999987654322 2334579999999999999899999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ....   .......      +.+ .........+.+++.+||+.||.+||++.++++
T Consensus       246 ~~---~~~~---~~~~~~~------~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          246 PV---QAMK---RLRDSPP------PKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HH---HHHH---HHHHSSC------CCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH---HHHH---HHhcCCC------CCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            21   1111   1111111      111 001122234778888899999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-42  Score=291.97  Aligned_cols=212  Identities=25%  Similarity=0.366  Sum_probs=166.1

Q ss_pred             ccccc-cCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCC---------------------------------
Q 023808            2 TLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA---------------------------------   46 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------   46 (277)
                      +|.++ +||||+++++++.+.+ ..++||||+.+|+|.+++......                                 
T Consensus        78 ~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (359)
T 3vhe_A           78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT  157 (359)
T ss_dssp             HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------
T ss_pred             HHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccC
Confidence            35667 7999999999998765 489999999999999999654321                                 


Q ss_pred             -----------------------------CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEE
Q 023808           47 -----------------------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI   97 (277)
Q Consensus        47 -----------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl   97 (277)
                                                   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl  234 (359)
T 3vhe_A          158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKI  234 (359)
T ss_dssp             --------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             ccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEE
Confidence                                         12289999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHH
Q 023808           98 GDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL  175 (277)
Q Consensus        98 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  175 (277)
                      +|||+++....... .......||..|+|||++.+..++.++||||||+++|||+| |..||.......  ......   
T Consensus       235 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---  309 (359)
T 3vhe_A          235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL---  309 (359)
T ss_dssp             CCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH---
T ss_pred             EeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHH---
Confidence            99999986644332 23345668899999999999999999999999999999998 999986543321  111111   


Q ss_pred             hccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                       .....     .....   .....+.+++..||+.||.+||++.+|++.|++++.
T Consensus       310 -~~~~~-----~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          310 -KEGTR-----MRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             -HHTCC-----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HcCCC-----CCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence             11111     11111   122347788888999999999999999999998775

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-41  Score=279.33  Aligned_cols=227  Identities=18%  Similarity=0.251  Sum_probs=173.0

Q ss_pred             ccccccCCCccceeeEE-EeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCC-VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++|+|++..++++ ..++..++||||+ +++|.+++..   ....+++..++.++.|++.||+|||+.   +++||
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~  129 (296)
T 4hgt_A           57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR  129 (296)
T ss_dssp             HHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecC
Confidence            35677887777666665 6777889999999 8999999853   244699999999999999999999999   99999


Q ss_pred             cCCCCcEEe---CCCCceEEeecccccccCCCCc------ceeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           81 DIKASNILL---DQEFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        81 dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                      ||||+||++   +.++.+||+|||+++.......      .......||..|+|||.+.+..++.++||||||+++|+|+
T Consensus       130 Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  209 (296)
T 4hgt_A          130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN  209 (296)
T ss_dssp             CCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence            999999999   7888999999999987654322      1223567899999999999999999999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      +|+.||........................ ....   ...+    ..+.+++.+||+.||++||++.+|++.|+++...
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          210 LGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLC---KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHHT---TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCcccchhhhhhhhhhhhcccccchh-hhhh---ccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            999999765443322222222111111110 0000   1112    3477888889999999999999999999999876


Q ss_pred             CccccCCCCccc
Q 023808          232 NEEELTAPGLFQ  243 (277)
Q Consensus       232 ~~~~~~~~~~~~  243 (277)
                      .......+..|.
T Consensus       282 ~~~~~~~~~dw~  293 (296)
T 4hgt_A          282 QGFSYDYVFDWN  293 (296)
T ss_dssp             HTCCTTCCCGGG
T ss_pred             hCCCccCccchh
Confidence            655555555554

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.8e-43  Score=291.38  Aligned_cols=217  Identities=24%  Similarity=0.312  Sum_probs=166.5

Q ss_pred             ccccccCCCccceeeEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++.  +....++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        77 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH  150 (327)
T 3lxl_A           77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVH  150 (327)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence            477899999999999987  45678999999999999999953   234699999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++.++.+||+|||+++........  ......||..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       151 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~  230 (327)
T 3lxl_A          151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS  230 (327)
T ss_dssp             SCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876544322  223456788899999999999999999999999999999999887


Q ss_pred             CcccCcchh--------hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          158 KAMWGQMNK--------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       158 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      .........        ...............        ...+......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          231 CSPSAEFLRMMGCERDVPALSRLLELLEEGQR--------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             GSHHHHHHHHCC----CCHHHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             ccccchhhhhcccccccccHHHHHHHhhcccC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            543221000        000011111111111        1112223345788888999999999999999999999887


Q ss_pred             ccC
Q 023808          230 RLN  232 (277)
Q Consensus       230 ~~~  232 (277)
                      ...
T Consensus       303 ~~~  305 (327)
T 3lxl_A          303 SGS  305 (327)
T ss_dssp             ---
T ss_pred             hhh
Confidence            644

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=283.40  Aligned_cols=201  Identities=25%  Similarity=0.287  Sum_probs=160.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+++|+|.+++.    ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        67 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~D  139 (326)
T 2y0a_A           67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFD  139 (326)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCC
Confidence            4678899999999999999999999999999999999993    445799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC----ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++    .+||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  217 (326)
T 2y0a_A          140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  217 (326)
T ss_dssp             CCGGGEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCHHHEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence            999999998877    79999999998765332  223456999999999999889999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......   ....   .........  ........    ...+.+++.+||+.||.+|||+.++++
T Consensus       218 ~~~~~~---~~~~---~~~~~~~~~--~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          218 LGDTKQ---ETLA---NVSAVNYEF--EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCSSHH---HHHH---HHHHTCCCC--CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCHH---HHHH---HHHhcCCCc--CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            653221   1111   111111000  00000111    234778888999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-42  Score=288.00  Aligned_cols=229  Identities=17%  Similarity=0.181  Sum_probs=173.8

Q ss_pred             ccccccCCCccc---------------eeeEEEe-CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVE---------------LIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG   65 (277)
Q Consensus         2 ~L~~l~h~niv~---------------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~   65 (277)
                      +|++++||||++               +++++.. +...++||||+ +++|.+++...  .+..+++..++.++.|++.|
T Consensus        95 ~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~  171 (352)
T 2jii_A           95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDA  171 (352)
T ss_dssp             HHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHH
Confidence            356778888877               7888887 67899999999 99999999532  23579999999999999999


Q ss_pred             HHHhhcCCCCCeEeccCCCCcEEeCCCC--ceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccc
Q 023808           66 LAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMK  137 (277)
Q Consensus        66 l~~LH~~~~~~iiH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~  137 (277)
                      |+|||+.   +++||||||+||+++.++  .+||+|||+++.+......      ......||..|+|||++.+..++.+
T Consensus       172 L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  248 (352)
T 2jii_A          172 LEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR  248 (352)
T ss_dssp             HHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred             HHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch
Confidence            9999999   999999999999999988  8999999999866432211      1233478999999999999899999


Q ss_pred             cceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCC--CCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL--GEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +||||||+++|||++|+.||........ ............  .....+...  ...+    ..+.+++.+||+.||.+|
T Consensus       249 ~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~R  321 (352)
T 2jii_A          249 SDLQSLGYCMLKWLYGFLPWTNCLPNTE-DIMKQKQKFVDK--PGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEK  321 (352)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTGGGTTCHH-HHHHHHHHHHHS--CCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCC
T ss_pred             hhHHHHHHHHHHHHhCCCCcccCCcCHH-HHHHHHHhccCC--hhhhhhhccccCCCc----HHHHHHHHHHHhCChhhC
Confidence            9999999999999999999876543222 122211111111  111111111  1122    347788888999999999


Q ss_pred             CCHHHHHHHHhhccccCccccCCCCccc
Q 023808          216 PQMNQVIKMLTKNIRLNEEELTAPGLFQ  243 (277)
Q Consensus       216 Ps~~~v~~~L~~~~~~~~~~~~~~~~~~  243 (277)
                      |++.+|++.|++++.........+..|.
T Consensus       322 ps~~~l~~~L~~~~~~~~~~~~~~~dw~  349 (352)
T 2jii_A          322 PPYAMLRNNLEALLQDLRVSPYDPIGLP  349 (352)
T ss_dssp             CCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred             CCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence            9999999999999877655544554443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=278.67  Aligned_cols=209  Identities=25%  Similarity=0.378  Sum_probs=167.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++ ..+..++||||+.+++|.+++.   .....+++..++.++.|++.||+|||+.   +++|||
T Consensus        63 ~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  135 (287)
T 1u59_A           63 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRD  135 (287)
T ss_dssp             HHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCC
Confidence            46788999999999999 5567899999999999999994   3345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++.........  .....+|..|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus       136 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  215 (287)
T 1u59_A          136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  215 (287)
T ss_dssp             CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999998765433222  223456789999999988899999999999999999998 999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ......   ...   .... ...     +..   +......+.+++..||+.+|.+||++.++++.|+.+....
T Consensus       216 ~~~~~~---~~~---~i~~-~~~-----~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          216 KMKGPE---VMA---FIEQ-GKR-----MEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TCCTHH---HHH---HHHT-TCC-----CCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCHHH---HHH---HHhc-CCc-----CCC---CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            543321   111   1111 111     111   1222335778888999999999999999999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-41  Score=283.35  Aligned_cols=211  Identities=25%  Similarity=0.353  Sum_probs=167.1

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC------------CCCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------------KANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|+++ +||||+++++++.+++..++||||+++|+|.+++....            .....+++..++.++.|++.||+|
T Consensus        78 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  157 (327)
T 1fvr_A           78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  157 (327)
T ss_dssp             HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            46788 89999999999999999999999999999999996432            223469999999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||+.   +++||||||+||+++.++.+||+|||+++.....  .......++..|+|||.+.+..++.++||||||+++|
T Consensus       158 LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  232 (327)
T 1fvr_A          158 LSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  232 (327)
T ss_dssp             HHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             HHhC---CccCCCCccceEEEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence            9999   9999999999999999999999999998743221  1123345678899999999888999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||+| |..||......      ..... ......     ...   +......+.+++.+||+.+|.+||++.++++.|++
T Consensus       233 ellt~g~~pf~~~~~~------~~~~~-~~~~~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          233 EIVSLGGTPYCGMTCA------ELYEK-LPQGYR-----LEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HHHTTSCCTTTTCCHH------HHHHH-GGGTCC-----CCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCcHH------HHHHH-hhcCCC-----CCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            9998 99998654321      11111 111110     111   11222347788889999999999999999999999


Q ss_pred             ccccC
Q 023808          228 NIRLN  232 (277)
Q Consensus       228 ~~~~~  232 (277)
                      ++...
T Consensus       298 ~~~~~  302 (327)
T 1fvr_A          298 MLEER  302 (327)
T ss_dssp             HHHSS
T ss_pred             HHHhh
Confidence            88654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-41  Score=279.26  Aligned_cols=210  Identities=19%  Similarity=0.197  Sum_probs=157.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++++|.+++..    ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        87 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d  159 (309)
T 2h34_A           87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRD  159 (309)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCC
Confidence            46789999999999999999999999999999999999943    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++...............|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (309)
T 2h34_A          160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ  239 (309)
T ss_dssp             CCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred             CChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence            99999999999999999999998765443333345568999999999999899999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCc-cccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-CHHHHHHHHhhccccC
Q 023808          162 GQMNKFLLEWAWQLHQEEKP-LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNIRLN  232 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~~  232 (277)
                      ..   .    .......... .....   ...+    ..+.+++.+||+.||++|| ++.++++.|+..+...
T Consensus       240 ~~---~----~~~~~~~~~~~~~~~~---~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          240 LS---V----MGAHINQAIPRPSTVR---PGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HH---H----HHHHHHSCCCCGGGTS---TTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HH---H----HHHHhccCCCCccccC---CCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            21   1    1111111111 11111   1122    2477888889999999999 9999999999887654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.6e-42  Score=278.38  Aligned_cols=208  Identities=23%  Similarity=0.388  Sum_probs=167.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  129 (267)
T 3t9t_A           56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRD  129 (267)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSS
T ss_pred             HHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            46788999999999999999999999999999999999953   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       130 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (267)
T 3t9t_A          130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  209 (267)
T ss_dssp             CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence            99999999999999999999998765432222334456788999999998889999999999999999999 88887653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ...   ...   .........      ....   .....+.+++.+||+.||.+||++.++++.|+++..
T Consensus       210 ~~~---~~~---~~i~~~~~~------~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          210 SNS---EVV---EDISTGFRL------YKPR---LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CHH---HHH---HHHHTTCCC------CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHH---HHH---HHHhcCCcC------CCCc---cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            221   111   111111110      1111   122347788888999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-41  Score=286.93  Aligned_cols=201  Identities=24%  Similarity=0.306  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+||||+++++++.+++..++||||+.+|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        81 il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~D  153 (362)
T 2bdw_A           81 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRN  153 (362)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecc
Confidence            4678999999999999999999999999999999999983    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC---ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++.++   .+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       154 lkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  231 (362)
T 2bdw_A          154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  231 (362)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CchHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            999999997654   59999999998765432  2234579999999999998899999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....   ........  ...+..    ......+.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~---~~~~~---~i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          232 DEDQ---HRLYA---QIKAGAYD--YPSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CSSH---HHHHH---HHHHTCCC--CCTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCH---HHHHH---HHHhCCCC--CCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            5322   11111   11111110  000111    112234778888999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-41  Score=285.74  Aligned_cols=202  Identities=21%  Similarity=0.281  Sum_probs=161.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+.+|+|.+++.   ..+..+++..++.++.|++.||+|||+.   +|+|||
T Consensus       101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrD  174 (387)
T 1kob_A          101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLD  174 (387)
T ss_dssp             HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            5788999999999999999999999999999999999984   2344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCC--CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++.  ++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          175 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             CCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             cchHHeEEecCCCCceEEEecccceecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            9999999974  4679999999998765432  23345699999999999998999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .....   ........  .........+    ..+.+++.+||+.||.+||++.++++
T Consensus       253 ~~~---~~~~~---~i~~~~~~--~~~~~~~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          253 EDD---LETLQ---NVKRCDWE--FDEDAFSSVS----PEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SSH---HHHHH---HHHHCCCC--CCSSTTTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCH---HHHHH---HHHhCCCC--CCccccccCC----HHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            322   11111   11111110  0011112222    34778889999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-41  Score=277.68  Aligned_cols=227  Identities=18%  Similarity=0.258  Sum_probs=172.6

Q ss_pred             ccccccCCCccceeeEE-EeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCC-VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++|++++..++++ ..+...++||||+ +++|.+++..   ....+++..++.++.|++.||+|||+.   +++||
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  129 (296)
T 3uzp_A           57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR  129 (296)
T ss_dssp             HHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeC
Confidence            35678888766666555 5677889999999 8899999952   334699999999999999999999999   99999


Q ss_pred             cCCCCcEEeC---CCCceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           81 DIKASNILLD---QEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        81 dikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                      ||||+||+++   .++.+||+|||+++........      ......||..|+|||.+.+..++.++||||||+++|||+
T Consensus       130 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  209 (296)
T 3uzp_A          130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN  209 (296)
T ss_dssp             CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence            9999999994   7889999999999876543321      124557899999999999989999999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      +|+.||........................ ....   ...+    ..+.+++.+||+.||.+||++.+|++.|+++...
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          210 LGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLC---KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHHT---TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCCCCCcCchhhhhhhhhhcccccCCch-HHHH---hhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            999999765433222222222111111110 0000   1122    3477888889999999999999999999999877


Q ss_pred             CccccCCCCccc
Q 023808          232 NEEELTAPGLFQ  243 (277)
Q Consensus       232 ~~~~~~~~~~~~  243 (277)
                      .......+..|.
T Consensus       282 ~~~~~~~~~dw~  293 (296)
T 3uzp_A          282 QGFSYDYVFDWN  293 (296)
T ss_dssp             TTCCSSCCCGGG
T ss_pred             cCCccccccccc
Confidence            665555555554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.9e-42  Score=281.42  Aligned_cols=203  Identities=25%  Similarity=0.372  Sum_probs=160.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  138 (289)
T 4fvq_A           65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGN  138 (289)
T ss_dssp             HHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCC
Confidence            47789999999999999999999999999999999999953   334589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc--------eEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHh
Q 023808           82 IKASNILLDQEFN--------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        82 ikp~Nill~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ellt  152 (277)
                      |||+||+++.++.        +||+|||++......     ....|+..|+|||++.+ ..++.++||||||+++|||++
T Consensus       139 lkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  213 (289)
T 4fvq_A          139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS  213 (289)
T ss_dssp             CCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred             cCcceEEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence            9999999988876        999999998754322     23457889999999987 678999999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      |..|+........  ..    .......       .+....   ...+.+++.+||+.||.+||++.++++.|++++..
T Consensus       214 g~~~~~~~~~~~~--~~----~~~~~~~-------~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          214 GGDKPLSALDSQR--KL----QFYEDRH-------QLPAPK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             TTCCTTTTSCHHH--HH----HHHHTTC-------CCCCCS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             CCCCCccccchHH--HH----HHhhccC-------CCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            7655433222111  11    1111110       010111   12367888889999999999999999999988753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-41  Score=281.21  Aligned_cols=195  Identities=26%  Similarity=0.345  Sum_probs=160.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..|+||||++||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        59 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  131 (318)
T 1fot_A           59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRD  131 (318)
T ss_dssp             HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCC
T ss_pred             HHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4678899999999999999999999999999999999994    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus       132 lkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  207 (318)
T 1fot_A          132 LKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  207 (318)
T ss_dssp             CCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CChheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999875432    334679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..   ..   .........       .++   +.....+.+++.+||+.||.+||     ++.+|++
T Consensus       208 ~~---~~---~~~i~~~~~-------~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          208 TM---KT---YEKILNAEL-------RFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HH---HH---HHHHHHCCC-------CCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HH---HH---HHHHHhCCC-------CCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            21   11   112222111       111   11223477888889999999999     8888864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=278.26  Aligned_cols=217  Identities=25%  Similarity=0.346  Sum_probs=163.7

Q ss_pred             cccCCCccceeeEEEeC----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----CC
Q 023808            5 NVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----VP   75 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~   75 (277)
                      .++||||+++++++...    ...++||||+++|+|.+++..     ..+++..++.++.|++.||+|||+..     .+
T Consensus        87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~  161 (337)
T 3mdy_A           87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP  161 (337)
T ss_dssp             TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred             hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence            45999999999999987    789999999999999999943     25899999999999999999999752     23


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce---eeeecccccccCccccccCccccc------cceEehhHH
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYVLGGQLTMK------ADVYSFGVL  146 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~v  146 (277)
                      +++||||||+||+++.++.+||+|||+++.+.......   .....||..|+|||++.+.....+      +||||||++
T Consensus       162 ~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i  241 (337)
T 3mdy_A          162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI  241 (337)
T ss_dssp             CEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHH
T ss_pred             CEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHH
Confidence            79999999999999999999999999998765433221   224579999999999987655544      999999999


Q ss_pred             HHHHHhC----------CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCC--CCHHHHHHHHHHHHhhhhhhhcC
Q 023808          147 VLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       147 l~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      +|||+||          ..||......... ..... .......    ..+.+..  ........+.+++.+||+.||.+
T Consensus       242 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  315 (337)
T 3mdy_A          242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPS-YEDMR-EIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPAS  315 (337)
T ss_dssp             HHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHH-HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred             HHHHHhccCcccccccccccHhhhcCCCCc-hhhhH-HHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhh
Confidence            9999999          5555443322211 11111 1111111    1111111  12256677889999999999999


Q ss_pred             CCCHHHHHHHHhhccccC
Q 023808          215 RPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       215 RPs~~~v~~~L~~~~~~~  232 (277)
                      ||++.+|++.|+.+....
T Consensus       316 Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          316 RLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCCHHHHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHHHHhhc
Confidence            999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-41  Score=291.57  Aligned_cols=205  Identities=20%  Similarity=0.192  Sum_probs=162.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||++++++|.+++..|+||||+.||+|.+++..   ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus       127 il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrD  200 (437)
T 4aw2_A          127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRD  200 (437)
T ss_dssp             HHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecc
Confidence            46678999999999999999999999999999999999953   245699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+|||++.++.+||+|||+++..............||+.|+|||++.     ...++.++|||||||++|||++|+.|
T Consensus       201 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P  280 (437)
T 4aw2_A          201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP  280 (437)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999876655444445567999999999987     46789999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC--CCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~--RPs~~~v~~  223 (277)
                      |......   .....+........    +........    ..+.+++.+||..+|++  ||++.|+++
T Consensus       281 f~~~~~~---~~~~~i~~~~~~~~----~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          281 FYAESLV---ETYGKIMNHKERFQ----FPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             TCCSSHH---HHHHHHHTHHHHCC----CCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCCCChh---HHHHhhhhcccccc----CCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            8754321   11111111000000    001111222    34778888899888888  999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-41  Score=288.58  Aligned_cols=199  Identities=27%  Similarity=0.384  Sum_probs=155.9

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+.+..++||||+.||+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus       106 l~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrD  178 (396)
T 4dc2_A          106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRD  178 (396)
T ss_dssp             HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecc
Confidence            3444 89999999999999999999999999999999984    344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       179 LKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~  257 (396)
T 4dc2_A          179 LKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  257 (396)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred             CCHHHEEECCCCCEEEeecceeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999999853322 223445679999999999999999999999999999999999999996432


Q ss_pred             Ccch--hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMN--KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      ....  ................      .+   +......+.+++.+||+.||.+||++
T Consensus       258 ~~~~~~~~~~~~~~~~i~~~~~------~~---p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          258 SSDNPDQNTEDYLFQVILEKQI------RI---PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             C------CCHHHHHHHHHHCCC------CC---CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cccccchhhHHHHHHHHhcccc------CC---CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            2111  0011111111111111      11   11222347788889999999999995

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-41  Score=283.03  Aligned_cols=213  Identities=25%  Similarity=0.413  Sum_probs=168.5

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC------------CccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------------NIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|+++ +||||+++++++.+++..++||||+.+|+|.+++......            ...+++..++.++.|++.||+|
T Consensus        93 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  172 (334)
T 2pvf_A           93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY  172 (334)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            35667 8999999999999999999999999999999999654321            2348999999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  147 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  147 (277)
                      ||+.   +++||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++
T Consensus       173 LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  249 (334)
T 2pvf_A          173 LASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM  249 (334)
T ss_dssp             HHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred             HHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHH
Confidence            9999   9999999999999999999999999999876543322 22334567889999999988999999999999999


Q ss_pred             HHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          148 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      |||++ |..||.....   .....   .......      ...   +......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       250 ~ellt~g~~p~~~~~~---~~~~~---~~~~~~~------~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          250 WEIFTLGGSPYPGIPV---EELFK---LLKEGHR------MDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             HHHHTTSCCSSTTCCH---HHHHH---HHHHTCC------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhCCCCCcCcCCH---HHHHH---HHhcCCC------CCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            99999 8888764322   11111   1111111      011   1122234778888899999999999999999999


Q ss_pred             hccccC
Q 023808          227 KNIRLN  232 (277)
Q Consensus       227 ~~~~~~  232 (277)
                      +++...
T Consensus       315 ~l~~~~  320 (334)
T 2pvf_A          315 RILTLT  320 (334)
T ss_dssp             HHHHHH
T ss_pred             HHHhcc
Confidence            987643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-41  Score=291.05  Aligned_cols=202  Identities=18%  Similarity=0.204  Sum_probs=161.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.+++..|+||||++||+|.+++..     ..+++..+..++.||+.||+|||+.   +|+|||
T Consensus       122 il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrD  193 (410)
T 3v8s_A          122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRD  193 (410)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecc
Confidence            46778999999999999999999999999999999999943     3589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc----cccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|||++.++.+||+|||+++..............||+.|+|||++.+..    ++.++|||||||++|||++|+.||
T Consensus       194 LKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf  273 (410)
T 3v8s_A          194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  273 (410)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence            9999999999999999999999877655444445678999999999997654    889999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC--CCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~--RPs~~~v~~  223 (277)
                      ......   .....+........     -+......    ..+.+++.+||+.+|.+  ||++.||++
T Consensus       274 ~~~~~~---~~~~~i~~~~~~~~-----~p~~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          274 YADSLV---GTYSKIMNHKNSLT-----FPDDNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCSSHH---HHHHHHHTHHHHCC-----CCTTCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCCChh---hHHHHHHhcccccc-----CCCccccc----HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            653321   11111111000000     01111222    34778888899999988  999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-41  Score=281.25  Aligned_cols=214  Identities=27%  Similarity=0.428  Sum_probs=169.9

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC--------------CccCCHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA--------------NIKLNWEKRSDICVGIAKGL   66 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~i~~qi~~~l   66 (277)
                      +|+++ +||||+++++++..++..++||||+++|+|.+++......              ...+++..++.++.|++.||
T Consensus        79 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  158 (313)
T 1t46_A           79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM  158 (313)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence            46677 8999999999999999999999999999999999654321              23589999999999999999


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhH
Q 023808           67 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV  145 (277)
Q Consensus        67 ~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  145 (277)
                      +|||+.   +++||||||+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+
T Consensus       159 ~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  235 (313)
T 1t46_A          159 AFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI  235 (313)
T ss_dssp             HHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHH
Confidence            999999   9999999999999999999999999999876554332 233455788999999999889999999999999


Q ss_pred             HHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHH
Q 023808          146 LVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  224 (277)
Q Consensus       146 vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~  224 (277)
                      ++|||+| |..||.......  ......    .....     ...   +......+.+++.+||+.||.+||++.++++.
T Consensus       236 il~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          236 FLWELFSLGSSPYPGMPVDS--KFYKMI----KEGFR-----MLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHTTTCCSSTTCCSSH--HHHHHH----HHTCC-----CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCCcccchh--HHHHHh----ccCCC-----CCC---cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            9999999 888886543321  111111    11110     111   11122347788889999999999999999999


Q ss_pred             HhhccccC
Q 023808          225 LTKNIRLN  232 (277)
Q Consensus       225 L~~~~~~~  232 (277)
                      |++++...
T Consensus       302 L~~~~~~~  309 (313)
T 1t46_A          302 IEKQISES  309 (313)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHh
Confidence            99887643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.2e-42  Score=279.27  Aligned_cols=208  Identities=22%  Similarity=0.279  Sum_probs=162.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++ ..++||||+.+++|.+++..   ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        66 ~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  138 (281)
T 3cc6_A           66 IMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRD  138 (281)
T ss_dssp             HHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            46788999999999998754 56899999999999999953   234589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||++...............++..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       139 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          139 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             CSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            99999999999999999999998765543333344557889999999988889999999999999999998 99998654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ....   ......   .....      ...   ......+.+++.+||+.||.+||++.++++.|+++...
T Consensus       219 ~~~~---~~~~~~---~~~~~------~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          219 ENKD---VIGVLE---KGDRL------PKP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CGGG---HHHHHH---HTCCC------CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ChHH---HHHHHh---cCCCC------CCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            3322   111111   11110      011   11223477888889999999999999999999987653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-41  Score=278.55  Aligned_cols=207  Identities=26%  Similarity=0.384  Sum_probs=165.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++ ..+..++||||+.+++|.+++..    +..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        71 ~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~d  142 (291)
T 1xbb_A           71 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRD  142 (291)
T ss_dssp             HHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCC
Confidence            46788999999999999 66678999999999999999943    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++.........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       143 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  222 (291)
T 1xbb_A          143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  222 (291)
T ss_dssp             CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence            99999999999999999999998765543322  223346788999999998899999999999999999999 999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      .....   ...    ........     +..   +......+.+++.+||+.||.+||++.+|++.|+++...
T Consensus       223 ~~~~~---~~~----~~~~~~~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          223 GMKGS---EVT----AMLEKGER-----MGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             TCCHH---HHH----HHHHTTCC-----CCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCHH---HHH----HHHHcCCC-----CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            54321   111    11111111     111   122233477888889999999999999999999988753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-41  Score=276.45  Aligned_cols=210  Identities=30%  Similarity=0.441  Sum_probs=166.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+ +..++||||+.+++|.+++..  ..+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        61 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d  134 (279)
T 1qpc_A           61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRD  134 (279)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            4678899999999999874 468899999999999999942  1123689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       135 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999998765543333334456788999999998899999999999999999999 88887643


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ...   ...   ........      ....   ......+.+++.+||+.+|++||++.++++.|+++....
T Consensus       215 ~~~---~~~---~~~~~~~~------~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          215 TNP---EVI---QNLERGYR------MVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CHH---HHH---HHHHTTCC------CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CHH---HHH---HHHhcccC------CCCc---ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            221   111   11111111      1111   112234778888899999999999999999999987643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=282.22  Aligned_cols=202  Identities=25%  Similarity=0.374  Sum_probs=153.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++|+|.+++.    ....+++..++.++.|++.||+|||+.   +++|||
T Consensus       101 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  173 (349)
T 2w4o_A          101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRD  173 (349)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecC
Confidence            4678899999999999999999999999999999999993    445689999999999999999999999   999999


Q ss_pred             CCCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.   ++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       174 ikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  251 (349)
T 2w4o_A          174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY  251 (349)
T ss_dssp             CCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCcccEEEecCCCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            9999999975   7899999999998654321  2334568999999999999899999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......  ....   ...... . ....+....    ....+.+++.+||+.||++||++.++++
T Consensus       252 ~~~~~~--~~~~---~i~~~~-~-~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          252 DERGDQ--FMFR---RILNCE-Y-YFISPWWDE----VSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CTTCHH--HHHH---HHHTTC-C-CCCTTTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcccH--HHHH---HHHhCC-C-ccCCchhhh----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            543321  1111   111111 1 111111122    2334788899999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.1e-41  Score=280.61  Aligned_cols=213  Identities=22%  Similarity=0.353  Sum_probs=167.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------KANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++....      .....+++..++.++.|++.||+|||+.   
T Consensus        81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---  157 (322)
T 1p4o_A           81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---  157 (322)
T ss_dssp             HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---
Confidence            4788999999999999999999999999999999999985321      1123578999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      +++||||||+||+++.++.+||+|||+++........ ......+|..|+|||++.+..++.++||||||+++|||++ |
T Consensus       158 ~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g  237 (322)
T 1p4o_A          158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA  237 (322)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence            9999999999999999999999999999865432211 1223456888999999998889999999999999999999 7


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ..||......   ....   ...... .        ...+......+.+++.+||+.||.+||++.++++.|++.....
T Consensus       238 ~~p~~~~~~~---~~~~---~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          238 EQPYQGLSNE---QVLR---FVMEGG-L--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             CCTTTTSCHH---HHHH---HHHTTC-C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             CCccccCCHH---HHHH---HHHcCC-c--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            8887653221   1111   111111 1        0111222334778888899999999999999999999876643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-41  Score=284.16  Aligned_cols=195  Identities=23%  Similarity=0.261  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...|+||||++||+|.+++..    ...+++..+..++.||+.||+|||+.   +|+|||
T Consensus        94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  166 (350)
T 1rdq_E           94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRD  166 (350)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            47789999999999999999999999999999999999943    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       167 lkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  242 (350)
T 1rdq_E          167 LKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence            9999999999999999999999876443    234579999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      .   ....   ....... .      .+   +......+.+++.+||+.||.+||+     +.+|++
T Consensus       243 ~---~~~~---~~i~~~~-~------~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          243 P---IQIY---EKIVSGK-V------RF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             H---HHHH---HHHHHCC-C------CC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             H---HHHH---HHHHcCC-C------CC---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2   1111   1111111 1      11   1112234778888999999999998     777754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-41  Score=280.88  Aligned_cols=215  Identities=19%  Similarity=0.335  Sum_probs=160.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+|+|.+++......+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        85 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~d  161 (310)
T 2wqm_A           85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRD  161 (310)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCC
Confidence            46788999999999999999999999999999999999865434456789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       162 l~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  240 (310)
T 2wqm_A          162 IKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  240 (310)
T ss_dssp             CCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             CcHHHEEEcCCCCEEEEeccceeeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999998654432 12234568999999999999899999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ...    ......... ....    +....   .....+.+++.+||+.||.+||++.+|++.|+++....
T Consensus       241 ~~~----~~~~~~~~~-~~~~----~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          241 MNL----YSLCKKIEQ-CDYP----PLPSD---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CCH----HHHHHHHHT-TCSC----CCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhH----HHHHHHhhc-ccCC----CCccc---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            211    111111111 1110    00111   11234778888899999999999999999999887654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.6e-41  Score=277.37  Aligned_cols=210  Identities=25%  Similarity=0.388  Sum_probs=162.9

Q ss_pred             ccccccCCCccceeeEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||+++++++. .++..++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++||
T Consensus        79 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~  152 (298)
T 3f66_A           79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHR  152 (298)
T ss_dssp             HHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             HHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence            477899999999999975 45578999999999999999943   345689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCc---ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC-CC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NS  156 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~-~p  156 (277)
                      ||||+||+++.++.+||+|||+++.......   .......+|..|+|||.+.+..++.++||||||+++|+|++|. .|
T Consensus       153 dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  232 (298)
T 3f66_A          153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  232 (298)
T ss_dssp             CCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999986654322   1233455778899999999989999999999999999999955 45


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      +.......   ...   ........      ......   ...+.+++.+||+.+|.+||++.++++.|+++....
T Consensus       233 ~~~~~~~~---~~~---~~~~~~~~------~~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          233 YPDVNTFD---ITV---YLLQGRRL------LQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             STTSCTTT---HHH---HHHTTCCC------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CccCCHHH---HHH---HHhcCCCC------CCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            44332211   111   11111110      011111   234778888899999999999999999999987644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.3e-41  Score=271.90  Aligned_cols=204  Identities=20%  Similarity=0.365  Sum_probs=161.8

Q ss_pred             ccccccCCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC--e
Q 023808            2 TLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--I   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--i   77 (277)
                      +|++++||||+++++++.+.  ...++||||+++|+|.+++...  .+..+++..++.++.|++.||+|||+.   +  +
T Consensus        60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i  134 (271)
T 3kmu_A           60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLI  134 (271)
T ss_dssp             GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCC
T ss_pred             HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCce
Confidence            57889999999999999987  7889999999999999999542  233589999999999999999999998   8  9


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcccc---ccceEehhHHHHHHHhCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM---KADVYSFGVLVLEIISGR  154 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~vl~elltg~  154 (277)
                      +||||||+||+++.++.++|+|||+......      ....||+.|+|||.+.+...+.   ++||||||+++|||++|.
T Consensus       135 ~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  208 (271)
T 3kmu_A          135 PRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE  208 (271)
T ss_dssp             TTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCS
T ss_pred             ecCCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999888764322      2345789999999998765544   799999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .||.......      ...........     +.+.   ......+.+++.+||+.||.+||++.++++.|+++..
T Consensus       209 ~p~~~~~~~~------~~~~~~~~~~~-----~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          209 VPFADLSNME------IGMKVALEGLR-----PTIP---PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CTTTTSCHHH------HHHHHHHSCCC-----CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCccccChHH------HHHHHHhcCCC-----CCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            9986543211      11111111111     1111   1222347788888999999999999999999988653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.6e-41  Score=281.87  Aligned_cols=201  Identities=19%  Similarity=0.331  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCC---------------------------------------------------------ee
Q 023808            2 TLSNVRHPNLVELIGCCVQGT---------------------------------------------------------RR   24 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~---------------------------------------------------------~~   24 (277)
                      +|++++||||++++++|.+..                                                         ..
T Consensus        57 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (332)
T 3qd2_B           57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL  136 (332)
T ss_dssp             HHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEE
T ss_pred             HHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceE
Confidence            578899999999999987654                                                         37


Q ss_pred             EEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           25 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        25 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      ++||||+++|+|.+++.... .....++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus       137 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  212 (332)
T 3qd2_B          137 YIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVT  212 (332)
T ss_dssp             EEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCccc
Confidence            99999999999999996532 334567778999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc-----------ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHH
Q 023808          105 LFPDNIT-----------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW  173 (277)
Q Consensus       105 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~  173 (277)
                      .......           .......||+.|+|||++.+..++.++||||||+++|||++|..|+..        ......
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~  284 (332)
T 3qd2_B          213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIIT  284 (332)
T ss_dssp             ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHH
T ss_pred             ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHH
Confidence            7655421           112335689999999999999999999999999999999998765321        111111


Q ss_pred             HHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .... .        ............+.+++.+||+.||.+||++.|+++
T Consensus       285 ~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          285 DVRN-L--------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHT-T--------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             Hhhc-c--------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            1111 1        111112333455788999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5e-42  Score=304.16  Aligned_cols=211  Identities=29%  Similarity=0.451  Sum_probs=167.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+||||+++++++.+ +..++||||+.+|+|.+++...  .+..+++..++.++.||+.||+|||++   +|+|||
T Consensus       315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrD  388 (535)
T 2h8h_A          315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD  388 (535)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence            4778999999999999876 6789999999999999999431  223589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++..............++..|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus       389 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             CSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             CCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998765432222233456788999999998899999999999999999999 88887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccCc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  233 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~  233 (277)
                      ..   .....   ........      ..   +......+.+++.+||+.||++||++.+|++.|+++....+
T Consensus       469 ~~---~~~~~---~i~~~~~~------~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          469 VN---REVLD---QVERGYRM------PC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CH---HHHHH---HHHTTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CH---HHHHH---HHHcCCCC------CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            32   11111   11111110      11   11223347788888999999999999999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=279.25  Aligned_cols=191  Identities=22%  Similarity=0.292  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCC-CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||+++++++.+.+..++||||+.+| +|.+++.    ....+++..+..++.|++.||+|||+.   +|+||
T Consensus        82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~  154 (335)
T 3dls_A           82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHR  154 (335)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEe
Confidence            477899999999999999999999999999777 9999994    344699999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      ||||+||+++.++.+||+|||+++.......  .....||+.|+|||++.+..+ +.++||||||+++|||++|..||..
T Consensus       155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          155 DIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ccCHHHEEEcCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9999999999999999999999987654322  334569999999999988776 7899999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....            ..     ...  .+.   .....+.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~------------~~-----~~~--~~~---~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          233 LEETV------------EA-----AIH--PPY---LVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             GGGGT------------TT-----CCC--CSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHH------------hh-----ccC--CCc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            32110            00     000  011   11234778888899999999999999976

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=285.86  Aligned_cols=197  Identities=25%  Similarity=0.316  Sum_probs=155.1

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |+++ +||||+++++++.+.+..|+||||++||+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        77 l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrD  149 (353)
T 3txo_A           77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRD  149 (353)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccC
Confidence            4455 79999999999999999999999999999999994    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       150 lkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  228 (353)
T 3txo_A          150 LKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN  228 (353)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCHHHEEECCCCCEEEccccceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999854322 223445679999999999998889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH------HHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM------NQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~------~~v~~  223 (277)
                      ..   ....   .......       .++.   .....+.+++.+||+.||.+||++      .+|++
T Consensus       229 ~~---~~~~---~i~~~~~-------~~p~---~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          229 ED---DLFE---AILNDEV-------VYPT---WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HH---HHHH---HHHHCCC-------CCCT---TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HH---HHHH---HHHcCCC-------CCCC---CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            21   1111   1121111       1111   122347788888999999999998      66654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.4e-41  Score=275.08  Aligned_cols=212  Identities=20%  Similarity=0.289  Sum_probs=159.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++ +|.+++.   ..+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~d  126 (292)
T 3o0g_A           54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRD  126 (292)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            47789999999999999999999999999976 5655553   2345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......||..|+|||++.+.. ++.++||||||+++|||++|..|+...
T Consensus       127 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~  205 (292)
T 3o0g_A          127 LKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred             CCHHHEEEcCCCCEEEeecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence            999999999999999999999987653322 233456899999999998765 799999999999999999998886433


Q ss_pred             cCcchhhHHHHHHHHhccCCccc---c-------------ccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLE---L-------------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~---~-------------~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...  ..................   .             ....+....+.....+.+++.+||+.||++|||+.|+++
T Consensus       206 ~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          206 NDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             SSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCH--HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            221  122222222111110000   0             000111112223345778889999999999999999865

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.1e-41  Score=277.78  Aligned_cols=212  Identities=21%  Similarity=0.383  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++++||||+++++++.+..     ..++||||+++|+|.+++....  .....+++..++.++.|++.||.|||+.  
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--  166 (313)
T 3brb_A           89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--  166 (313)
T ss_dssp             HHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            467899999999999998655     3599999999999999984322  3345699999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-  152 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-  152 (277)
                       +++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       167 -~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  245 (313)
T 3brb_A          167 -NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR  245 (313)
T ss_dssp             -TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence             9999999999999999999999999999866443221 2233457789999999999899999999999999999999 


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      |..||.......   ....   .......         ..+......+.+++.+||+.||.+||++.++++.|++++..
T Consensus       246 g~~p~~~~~~~~---~~~~---~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          246 GMTPYPGVQNHE---MYDY---LLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             SCCSSTTCCGGG---HHHH---HHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHH---HHHH---HHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            788876543321   1111   1111111         11112223478888899999999999999999999988753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.9e-41  Score=282.73  Aligned_cols=204  Identities=23%  Similarity=0.276  Sum_probs=159.0

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+++..|+||||++||+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        69 l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrD  141 (342)
T 2qr7_A           69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRD  141 (342)
T ss_dssp             HHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecc
Confidence            4455 79999999999999999999999999999999984    344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC----CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQE----FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||++.++    +.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|..||
T Consensus       142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  220 (342)
T 2qr7_A          142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF  220 (342)
T ss_dssp             CCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence            99999998443    3599999999987644322 233456899999999998888999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..............+   ......  . ..   .........+.+++.+||+.||++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~i---~~~~~~--~-~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          221 ANGPDDTPEEILARI---GSGKFS--L-SG---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CSSTTSCHHHHHHHH---HHCCCC--C-CS---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcCCHHHHHHHH---ccCCcc--c-Cc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            754333222222211   111110  0 01   111122234778888999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-41  Score=275.48  Aligned_cols=211  Identities=22%  Similarity=0.320  Sum_probs=165.5

Q ss_pred             ccccccCCCccceeeEEEeCCee-EEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||+++++++.+.+.. ++||||+.+|+|.+++..   .+..+++..++.++.|++.||+|||+.   +++||
T Consensus        75 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~  148 (298)
T 3pls_A           75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHR  148 (298)
T ss_dssp             HHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             HHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            46789999999999999876654 999999999999999953   345689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCc---ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||||+||+++.++.+||+|||+++.......   .......++..|+|||.+.+..++.++||||||+++|+|++|..|+
T Consensus       149 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             CCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            9999999999999999999999986544321   1223456788999999999999999999999999999999976654


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ......  .......    .....     ...   +......+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       229 ~~~~~~--~~~~~~~----~~~~~-----~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          229 YRHIDP--FDLTHFL----AQGRR-----LPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             TTTSCG--GGHHHHH----HTTCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CccCCH--HHHHHHh----hcCCC-----CCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            332221  1111111    11111     001   1112234778888899999999999999999999987643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=277.60  Aligned_cols=212  Identities=25%  Similarity=0.373  Sum_probs=159.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++..   .+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~d  155 (319)
T 2y4i_B           82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKD  155 (319)
T ss_dssp             GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccC
Confidence            57889999999999999999999999999999999999942   344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC----cceeeeecccccccCcccccc---------CccccccceEehhHHHH
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI----THITTRIAGTTGYLAPEYVLG---------GQLTMKADVYSFGVLVL  148 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~vl~  148 (277)
                      |||+||+++ ++.+||+|||+++......    ........|+..|+|||++.+         ..++.++||||||+++|
T Consensus       156 lkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~  234 (319)
T 2y4i_B          156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY  234 (319)
T ss_dssp             CCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred             CChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence            999999998 6799999999987643211    112233458899999999874         34788999999999999


Q ss_pred             HHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          149 EIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ||++|..||......      ...+........ ....   ...+    ..+.+++.+||+.||.+||++.++++.|+++
T Consensus       235 el~~g~~p~~~~~~~------~~~~~~~~~~~~-~~~~---~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          235 ELHAREWPFKTQPAE------AIIWQMGTGMKP-NLSQ---IGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             HHHHSSCSSSSCCHH------HHHHHHHTTCCC-CCCC---SSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             HHHhCCCCCCCCCHH------HHHHHhccCCCC-CCCc---CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            999999998653321      111122221111 1100   1112    2377888889999999999999999999998


Q ss_pred             cccCcc
Q 023808          229 IRLNEE  234 (277)
Q Consensus       229 ~~~~~~  234 (277)
                      .+....
T Consensus       301 ~~~~~~  306 (319)
T 2y4i_B          301 PKRNRR  306 (319)
T ss_dssp             ------
T ss_pred             HHhhcc
Confidence            775533

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=288.32  Aligned_cols=204  Identities=21%  Similarity=0.154  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|.+++||||++++++|.+++..|+||||+.||+|.+++..   .+..+++..+..++.||+.||+|||+.   +|+|||
T Consensus       114 il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrD  187 (412)
T 2vd5_A          114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRD  187 (412)
T ss_dssp             HHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            46678999999999999999999999999999999999953   234699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-------cCccccccceEehhHHHHHHHhCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-------GGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      |||+|||++.++.+||+|||+++..............||+.|+|||++.       ...++.++|||||||++|||++|+
T Consensus       188 LKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~  267 (412)
T 2vd5_A          188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ  267 (412)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred             cCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence            9999999999999999999999877654443344567999999999987       357899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC---CCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR---PQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R---Ps~~~v~~  223 (277)
                      .||.......   ....+........     -+..   .......+.+++.+||. +|.+|   |++.||++
T Consensus       268 ~Pf~~~~~~~---~~~~i~~~~~~~~-----~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          268 TPFYADSTAE---TYGKIVHYKEHLS-----LPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CTTCCSSHHH---HHHHHHTHHHHCC-----CC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCCCCCCHHH---HHHHHHhcccCcC-----CCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            9986543211   1111111000000     0111   11122347788889999 99998   58888864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-41  Score=282.57  Aligned_cols=199  Identities=27%  Similarity=0.375  Sum_probs=155.5

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+.+..|+||||+++|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        63 l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  135 (345)
T 3a8x_A           63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRD  135 (345)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecC
Confidence            4555 89999999999999999999999999999999984    334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       136 lkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  214 (345)
T 3a8x_A          136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  214 (345)
T ss_dssp             CCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred             CCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence            99999999999999999999998543221 22345679999999999999899999999999999999999999986432


Q ss_pred             Ccchh--hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNK--FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .....  ...............      .+   +......+.+++.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~~~------~~---p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          215 SSDNPDQNTEDYLFQVILEKQI------RI---PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             C-------CHHHHHHHHHHCCC------CC---CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             cccccccccHHHHHHHHHcCCC------CC---CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            21100  001111111111111      11   11222347788888999999999995

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=284.45  Aligned_cols=202  Identities=24%  Similarity=0.277  Sum_probs=161.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus       139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  212 (373)
T 2x4f_A          139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLD  212 (373)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            57889999999999999999999999999999999998842   344689999999999999999999999   999999


Q ss_pred             CCCCcEEe--CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILL--DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||+  +.++.+||+|||+++.+.....  .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       213 lkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          213 LKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             CCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999  6778899999999987654322  2334689999999999988999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ....   ........  .........+    ..+.+++.+||+.||.+||++.|+++
T Consensus       291 ~~~~---~~~~---~i~~~~~~--~~~~~~~~~~----~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          291 DNDA---ETLN---NILACRWD--LEDEEFQDIS----EEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SSHH---HHHH---HHHHTCCC--SCSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHH---HHHH---HHHhccCC--CChhhhccCC----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4321   1111   11111110  0011111222    34788899999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-41  Score=292.25  Aligned_cols=198  Identities=25%  Similarity=0.296  Sum_probs=160.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +|++++||||++++++|...+..++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+ .   +|+||
T Consensus       201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHr  273 (446)
T 4ejn_A          201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYR  273 (446)
T ss_dssp             CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCC
T ss_pred             HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEEC
Confidence            5788999999999999999999999999999999999984    34468999999999999999999998 8   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          274 DLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             CCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCHHHEEECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            999999999999999999999998643322 2234467999999999999999999999999999999999999998653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ...   ....   .......       .+   +......+.+++.+||+.||.+||     ++.|+++
T Consensus       353 ~~~---~~~~---~i~~~~~-------~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          353 DHE---KLFE---LILMEEI-------RF---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             SHH---HHHH---HHHHCCC-------CC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CHH---HHHH---HHHhCCC-------CC---CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            321   1111   1111111       11   111223477888899999999999     9999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-41  Score=284.64  Aligned_cols=206  Identities=22%  Similarity=0.250  Sum_probs=140.3

Q ss_pred             ccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.+++ ||||+++++++.++...++||||+++|+|.+++..    +..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  131 (325)
T 3kn6_A           59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRD  131 (325)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecC
Confidence            55665 99999999999999999999999999999999943    45699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC---ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++   .+||+|||+++...... .......||..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  210 (325)
T 3kn6_A          132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ  210 (325)
T ss_dssp             CCGGGEEEEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            999999997655   79999999998655432 22334568999999999999899999999999999999999999987


Q ss_pred             cccCcch-hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMN-KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ....... ....... .....+...  ...   .........+.+++.+||+.||.+||++.+++
T Consensus       211 ~~~~~~~~~~~~~~~-~~i~~~~~~--~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          211 SHDRSLTCTSAVEIM-KKIKKGDFS--FEG---EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             -------CCCHHHHH-HHHTTTCCC--CCS---HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CCccccccccHHHHH-HHHHcCCCC--CCc---ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            5443211 1111111 111111110  000   00011234578888999999999999998875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=279.33  Aligned_cols=225  Identities=23%  Similarity=0.286  Sum_probs=164.2

Q ss_pred             cccccCCCccceeeEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC----
Q 023808            3 LSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL----   73 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----   73 (277)
                      +..++||||+++++++..     ....++||||+++|+|.+++..     ...++..++.++.|++.||+|||+..    
T Consensus        61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~  135 (336)
T 3g2f_A           61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGD  135 (336)
T ss_dssp             STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred             HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence            456899999999987653     2367899999999999999943     23589999999999999999999862    


Q ss_pred             --CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-------ceeeeecccccccCcccccc-------Cccccc
Q 023808           74 --VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------HITTRIAGTTGYLAPEYVLG-------GQLTMK  137 (277)
Q Consensus        74 --~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~  137 (277)
                        .++|+||||||+|||++.++.+||+|||+++.+.....       .......||..|+|||++.+       ..++.+
T Consensus       136 ~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  215 (336)
T 3g2f_A          136 HYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ  215 (336)
T ss_dssp             GCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred             ccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence              22799999999999999999999999999987654221       11224568999999999876       467789


Q ss_pred             cceEehhHHHHHHHhCCCCCCcccCcchh------------hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHH
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAMWGQMNK------------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF  205 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  205 (277)
                      +||||||+++|||++|..|+.........            ...... ...........+.. ...........+.+++.
T Consensus       216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  293 (336)
T 3g2f_A          216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ-VLVSREKQRPKFPE-AWKENSLAVRSLKETIE  293 (336)
T ss_dssp             HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHH-HHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHH-hhhcccccCCCCCc-ccccccchHHHHHHHHH
Confidence            99999999999999997765332211100            011111 11111111111111 11122345667899999


Q ss_pred             hhhhhhhcCCCCHHHHHHHHhhccccCcc
Q 023808          206 FCTQAAASRRPQMNQVIKMLTKNIRLNEE  234 (277)
Q Consensus       206 ~c~~~~p~~RPs~~~v~~~L~~~~~~~~~  234 (277)
                      +||+.||++|||+.|+++.|++++...+.
T Consensus       294 ~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          294 DCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             HHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence            99999999999999999999998865543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-41  Score=305.58  Aligned_cols=206  Identities=26%  Similarity=0.391  Sum_probs=161.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.. +..++||||+.+|+|.+++.    .+..+++..++.++.||+.||+|||++   +|+|||
T Consensus       423 il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrD  494 (635)
T 4fl3_A          423 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRD  494 (635)
T ss_dssp             HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCC
Confidence            4778999999999999965 45789999999999999994    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+|||++.++.+||+|||+++.+.....  .......+|..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       495 Lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~  574 (635)
T 4fl3_A          495 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  574 (635)
T ss_dssp             CSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987654332  12233456788999999999999999999999999999998 999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .....   ....    .......     ...   +......+.+++..||+.||++||++.+|++.|+++..
T Consensus       575 ~~~~~---~~~~----~i~~~~~-----~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          575 GMKGS---EVTA----MLEKGER-----MGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             TCCHH---HHHH----HHHTTCC-----CCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCHH---HHHH----HHHcCCC-----CCC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            54322   1111    1111111     111   12223447788888999999999999999999988653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.2e-41  Score=284.75  Aligned_cols=196  Identities=25%  Similarity=0.284  Sum_probs=158.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++.++||||+++++++.+.+..|+||||+.||+|.+++.    ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        92 ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrD  164 (373)
T 2r5t_A           92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRD  164 (373)
T ss_dssp             CBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecC
Confidence            3677899999999999999999999999999999999984    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       165 lkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          165 LKPENILLDSQGHIVLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             CCGGGEEECTTSCEEECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             CCHHHEEECCCCCEEEeeCccccccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999999864322 122345679999999999999899999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      .   .....   .......       .+.   +.....+.+++.+||+.||.+||++.+.
T Consensus       244 ~---~~~~~---~i~~~~~-------~~~---~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          244 T---AEMYD---NILNKPL-------QLK---PNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             H---HHHHH---HHHHSCC-------CCC---SSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             H---HHHHH---HHHhccc-------CCC---CCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence            2   11111   1111110       111   1122347788888999999999998543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=275.41  Aligned_cols=199  Identities=22%  Similarity=0.310  Sum_probs=157.0

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++.+  +...++||||+++|+|.+++     ....+++..+..++.|++.||+|||+.   +++|
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH  160 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIH  160 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence            4678999999999999987  56889999999999998865     334699999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc---cccccceEehhHHHHHHHhCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||||+||+++.++.+||+|||+++....... ......||..|+|||.+.+..   .+.++||||||+++|||++|..|
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            99999999999999999999999987654322 233457999999999987654   47889999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.....   ...   ..........    .+.....+    ..+.+++.+||+.||.+||++.|+++
T Consensus       240 f~~~~~---~~~---~~~~~~~~~~----~~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERI---MCL---HSKIKSQALE----FPDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSH---HHH---HHHHHHCCCC----CCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccH---HHH---HHHHhcccCC----CCCccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            864321   111   1111111110    01111222    34778888999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.3e-40  Score=278.31  Aligned_cols=214  Identities=24%  Similarity=0.293  Sum_probs=166.4

Q ss_pred             cccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh--------cC
Q 023808            5 NVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH--------EE   72 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~   72 (277)
                      +++||||+++++++....    ..++||||+.+|+|.+++..     ..+++..++.++.|++.||+|||        +.
T Consensus        92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~  166 (342)
T 1b6c_B           92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP  166 (342)
T ss_dssp             CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred             hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence            379999999999999876    78999999999999999943     35899999999999999999999        77


Q ss_pred             CCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccC------ccccccceEeh
Q 023808           73 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG------QLTMKADVYSF  143 (277)
Q Consensus        73 ~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~sl  143 (277)
                         +++||||||+||+++.++.+||+|||+++........   ......||..|+|||++.+.      .++.++|||||
T Consensus       167 ---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl  243 (342)
T 1b6c_B          167 ---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  243 (342)
T ss_dssp             ---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred             ---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence               9999999999999999999999999999876544322   12345689999999998765      45578999999


Q ss_pred             hHHHHHHHhC----------CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCC--CCHHHHHHHHHHHHhhhhhh
Q 023808          144 GVLVLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAA  211 (277)
Q Consensus       144 G~vl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~c~~~~  211 (277)
                      |+++|||+||          ..||........ ....+........     ..+.+..  ........+.+++.+||+.|
T Consensus       244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~d  317 (342)
T 1b6c_B          244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP-SVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYAN  317 (342)
T ss_dssp             HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-CHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHhccCcCCcccccccCccccCcCcc-cHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccC
Confidence            9999999999          567654432211 1111111111111     1111111  12356667889999999999


Q ss_pred             hcCCCCHHHHHHHHhhccccC
Q 023808          212 ASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       212 p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      |.+||++.+|++.|+++....
T Consensus       318 p~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          318 GAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             GGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhCCCHHHHHHHHHHHHHHh
Confidence            999999999999999887643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-40  Score=284.99  Aligned_cols=155  Identities=21%  Similarity=0.243  Sum_probs=134.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++...  ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        79 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrD  153 (389)
T 3gni_B           79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRS  153 (389)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            467889999999999999999999999999999999999543  234589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc------ceeeeecccccccCcccccc--CccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+|||++.++.+||+|||.+........      .......||..|+|||++.+  ..++.++|||||||++|||++|
T Consensus       154 lkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g  233 (389)
T 3gni_B          154 VKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG  233 (389)
T ss_dssp             CSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHC
Confidence            999999999999999999998865432111      11223468899999999987  5789999999999999999999


Q ss_pred             CCCCCccc
Q 023808          154 RNSGKAMW  161 (277)
Q Consensus       154 ~~p~~~~~  161 (277)
                      +.||....
T Consensus       234 ~~pf~~~~  241 (389)
T 3gni_B          234 HVPFKDMP  241 (389)
T ss_dssp             SCTTTTCC
T ss_pred             CCCCCCCC
Confidence            99986543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-40  Score=288.70  Aligned_cols=197  Identities=24%  Similarity=0.385  Sum_probs=161.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++|+|.+++.    .+..+++..+..++.||+.||+|||+.   +|+|||
T Consensus        69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrD  141 (476)
T 2y94_A           69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRD  141 (476)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCccc
Confidence            4678999999999999999999999999999999999993    455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus       142 Lkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          142 LKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccHHHEEEecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999998765432  2334569999999999988765 68999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ....   .... +..      ..+..   ....+.+++.+||+.||.+|||+.+|++
T Consensus       220 ~~~---~~~~---~i~~-~~~------~~p~~---~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          220 HVP---TLFK---KICD-GIF------YTPQY---LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             SSH---HHHH---HHHT-TCC------CCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHH---HHHH---HHhc-CCc------CCCcc---CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            321   1111   1111 111      01111   1234778888999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.1e-41  Score=291.58  Aligned_cols=216  Identities=20%  Similarity=0.294  Sum_probs=168.6

Q ss_pred             ccccccC-CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++|+| ++|..+..++...+..++||||+ +++|.+++..   ....+++..++.++.||+.||+|||+.   +|+||
T Consensus        55 il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHr  127 (483)
T 3sv0_A           55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHR  127 (483)
T ss_dssp             HHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             HHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeec
Confidence            3556766 67777777888889999999999 8899999953   244699999999999999999999999   99999


Q ss_pred             cCCCCcEEe---CCCCceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           81 DIKASNILL---DQEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        81 dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                      ||||+|||+   +.++.+||+|||+++.+......      ......||..|+|||++.+..++.++|||||||++|||+
T Consensus       128 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell  207 (483)
T 3sv0_A          128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL  207 (483)
T ss_dssp             CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH
Confidence            999999999   57889999999999876543321      123567999999999999999999999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      +|+.||..............+...........+.    ..++    ..+.+++..||+.+|++||++.+|++.|++++..
T Consensus       208 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~----~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          208 RGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC----RGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH----TTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCCCccccchhHHHHHHHHhhccccccHHHHh----cCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            9999998765543333222222221111111100    1122    3477888889999999999999999999998764


Q ss_pred             C
Q 023808          232 N  232 (277)
Q Consensus       232 ~  232 (277)
                      .
T Consensus       280 ~  280 (483)
T 3sv0_A          280 E  280 (483)
T ss_dssp             T
T ss_pred             c
Confidence            4

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=284.73  Aligned_cols=224  Identities=21%  Similarity=0.231  Sum_probs=171.7

Q ss_pred             ccccccCCCccceeeEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++....  ..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+|
T Consensus        60 ~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  135 (396)
T 4eut_A           60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVH  135 (396)
T ss_dssp             HHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEE
Confidence            467899999999999998765  7799999999999999995322 222399999999999999999999999   9999


Q ss_pred             ccCCCCcEEe----CCCCceEEeecccccccCCCCcceeeeecccccccCcccccc--------CccccccceEehhHHH
Q 023808           80 RDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--------GQLTMKADVYSFGVLV  147 (277)
Q Consensus        80 ~dikp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~vl  147 (277)
                      |||||+||++    +.++.+||+|||+++......  ......||..|+|||++.+        ..++.++|||||||++
T Consensus       136 ~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il  213 (396)
T 4eut_A          136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF  213 (396)
T ss_dssp             CCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred             CCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence            9999999999    777889999999998765432  2234568999999998865        5688999999999999


Q ss_pred             HHHHhCCCCCCcccCcc-hhhHHHHHHHHhccCCcccc---------cc---CCCCCCCHHHHHHHHHHHHhhhhhhhcC
Q 023808          148 LEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLEL---------VD---PELGEYPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      |||++|+.||....... ....................         ..   +............+.+++.+||+.||++
T Consensus       214 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~  293 (396)
T 4eut_A          214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK  293 (396)
T ss_dssp             HHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred             HHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhh
Confidence            99999999986544322 12222111111111100000         00   1112344667777889999999999999


Q ss_pred             CCCHHHHHHHHhhcccc
Q 023808          215 RPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       215 RPs~~~v~~~L~~~~~~  231 (277)
                      ||++.++++.+++++..
T Consensus       294 R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          294 CWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCHHHHHHHHHHHHTC
T ss_pred             hccHHHHHHHHHHHhhc
Confidence            99999999999988753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-40  Score=283.43  Aligned_cols=204  Identities=20%  Similarity=0.264  Sum_probs=152.5

Q ss_pred             ccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            4 SNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +.++||||+++++++..    +...|+||||+.||+|.+++...  ....+++..+..++.||+.||+|||+.   +|+|
T Consensus       110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  184 (400)
T 1nxk_A          110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAH  184 (400)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            34589999999999876    56789999999999999999532  234699999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           80 RDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        80 ~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||||+|||++.   ++.+||+|||+++......  ......||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus       185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  262 (400)
T 1nxk_A          185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP  262 (400)
T ss_dssp             CCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCcceEEEecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence            999999999987   7889999999998654322  23345689999999999988999999999999999999999999


Q ss_pred             CCcccCcch-hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMN-KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |........ ......+.   ....  ....+......    ..+.+++.+||+.||.+|||+.++++
T Consensus       263 f~~~~~~~~~~~~~~~i~---~~~~--~~~~~~~~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          263 FYSNHGLAISPGMKTRIR---MGQY--EFPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCCCTTCSSCCSHHHHHH---HTCC--CCCTTTTTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCccccccHHHHHHHH---cCcc--cCCCcccccCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            875443211 11111111   1110  00111112222    34788899999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-40  Score=276.74  Aligned_cols=210  Identities=22%  Similarity=0.328  Sum_probs=153.7

Q ss_pred             ccccccCCCccceeeEEEeCCe----eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTR----RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++++||||+++++++.....    .|+||||+++|+|.+++.    ....+++..++.++.|++.||+|||+.   ++
T Consensus        65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i  137 (311)
T 3ork_A           65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GI  137 (311)
T ss_dssp             TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            5788999999999999986543    499999999999999994    334689999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +||||||+||+++.++.+||+|||+++.+......  ......||..|+|||++.+..++.++||||||+++|||+||+.
T Consensus       138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~  217 (311)
T 3ork_A          138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP  217 (311)
T ss_dssp             CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999876543222  2334568999999999999999999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHH-HHHHHhhccc
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ-VIKMLTKNIR  230 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~-v~~~L~~~~~  230 (277)
                      ||......      ................  ....    ....+.+++.+||+.||.+||+..+ +...+.....
T Consensus       218 pf~~~~~~------~~~~~~~~~~~~~~~~--~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          218 PFTGDSPV------SVAYQHVREDPIPPSA--RHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             SCCCSSHH------HHHHHHHHCCCCCHHH--HSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCCCChH------HHHHHHhcCCCCCccc--ccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            98653321      1111222221111000  0011    2234778888999999999997555 4455555443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-40  Score=277.02  Aligned_cols=211  Identities=23%  Similarity=0.350  Sum_probs=159.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++ +|.+++.   .....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        72 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~D  144 (311)
T 3niz_A           72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRD  144 (311)
T ss_dssp             HHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            46788999999999999999999999999975 8888874   3344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus       145 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          145 LKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CchHhEEECCCCCEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987653322 2334568999999999876 46899999999999999999999998755


Q ss_pred             cCcchhhHHHHHHHHhccCCccc----------------cccCC-CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLE----------------LVDPE-LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ...............                ..... .....+.....+.+++.+||+.||.+|||+.|+++
T Consensus       224 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          224 TDDDQ---LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             STTTH---HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ChHHH---HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            43322   121222111111100                00000 00001112235778899999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.5e-41  Score=283.95  Aligned_cols=196  Identities=27%  Similarity=0.344  Sum_probs=157.8

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+.+..|+||||++||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        71 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrD  143 (345)
T 1xjd_A           71 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRD  143 (345)
T ss_dssp             HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCC
Confidence            3444 89999999999999999999999999999999994    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       144 lkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          144 LKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CChhhEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999998543221 22445679999999999999899999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH-HHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVI  222 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~-~v~  222 (277)
                      .   .....   ......       +.++.   .....+.+++.+||+.||.+||++. +|+
T Consensus       223 ~---~~~~~---~i~~~~-------~~~p~---~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          223 E---EELFH---SIRMDN-------PFYPR---WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             H---HHHHH---HHHHCC-------CCCCT---TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             H---HHHHH---HHHhCC-------CCCCc---ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            2   11111   111111       11111   1223477888889999999999997 554

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.8e-41  Score=282.75  Aligned_cols=203  Identities=22%  Similarity=0.270  Sum_probs=149.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+.+..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        69 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~D  141 (361)
T 3uc3_A           69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRD  141 (361)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCC
T ss_pred             HHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            4678899999999999999999999999999999999984    334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc--eEEeecccccccCCCCcceeeeecccccccCccccccCccccc-cceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFN--PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++.  +||+|||+++.....  .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.
T Consensus       142 lkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  219 (361)
T 3uc3_A          142 LKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE  219 (361)
T ss_dssp             CCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCHHHEEEcCCCCceEEEeecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence            9999999987765  999999999843322  12234569999999999988777655 899999999999999999987


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .......  ...............    +......    ..+.+++.+||+.||.+|||+.|+++
T Consensus       220 ~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~s----~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          220 DPEEPRD--YRKTIQRILSVKYSI----PDDIRIS----PECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ----CCC--HHHHHHHHHTTCCCC----CTTSCCC----HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCccHHH--HHHHHHHHhcCCCCC----CCcCCCC----HHHHHHHHHHccCChhHCcCHHHHHh
Confidence            6443221  111111211111100    0001122    34778889999999999999999976

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=270.77  Aligned_cols=199  Identities=24%  Similarity=0.341  Sum_probs=140.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+.+..++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        64 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  137 (278)
T 3cok_A           64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRD  137 (278)
T ss_dssp             HHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSS
T ss_pred             HHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            46788999999999999999999999999999999999953   335689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       138 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          138 LTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCHHHEEEcCCCCEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            999999999999999999999987643322 1234568999999999998889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  .     ...   ..   .+...+.   .....+.+++.+||+.||.+||++.++++
T Consensus       217 ~~~~--~-----~~~---~~---~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          217 VKNT--L-----NKV---VL---ADYEMPS---FLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CC------------C---CS---SCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHH--H-----HHH---hh---cccCCcc---ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            2110  0     000   00   0111111   12234778888899999999999998864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-41  Score=284.42  Aligned_cols=213  Identities=25%  Similarity=0.420  Sum_probs=167.1

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC----------CCccCCHHHHHHHHHHHHHHHHHhh
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------ANIKLNWEKRSDICVGIAKGLAFLH   70 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH   70 (277)
                      +|+++ +||||+++++++.+++..++||||+++|+|.+++.....          .+..+++..++.++.|++.||+|||
T Consensus       102 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  181 (333)
T 2i1m_A          102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA  181 (333)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            46677 899999999999999999999999999999999853211          1345899999999999999999999


Q ss_pred             cCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHH
Q 023808           71 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE  149 (277)
Q Consensus        71 ~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  149 (277)
                      +.   +++||||||+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++||
T Consensus       182 ~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  258 (333)
T 2i1m_A          182 SK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE  258 (333)
T ss_dssp             HT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             cC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHH
Confidence            99   9999999999999999999999999999865433222 2334557889999999998899999999999999999


Q ss_pred             HHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          150 IIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      |+| |..||.......  .....    ......     .......   ...+.+++.+||+.||.+||++.+|++.|++.
T Consensus       259 l~t~g~~p~~~~~~~~--~~~~~----~~~~~~-----~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          259 IFSLGLNPYPGILVNS--KFYKL----VKDGYQ-----MAQPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HTTTSCCSSTTCCSSH--HHHHH----HHHTCC-----CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCcccchhH--HHHHH----HhcCCC-----CCCCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            999 888876543321  11111    111110     1111111   23477888889999999999999999999987


Q ss_pred             ccc
Q 023808          229 IRL  231 (277)
Q Consensus       229 ~~~  231 (277)
                      ...
T Consensus       325 ~~~  327 (333)
T 2i1m_A          325 AQE  327 (333)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=279.18  Aligned_cols=213  Identities=19%  Similarity=0.281  Sum_probs=163.7

Q ss_pred             ccccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++++||||+++++++..    ....++||||+.+|+|.+++......+..+++..++.++.|++.||+|||+.   ++
T Consensus        79 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i  155 (317)
T 2buj_A           79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GY  155 (317)
T ss_dssp             HHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            4678899999999999973    3478899999999999999965444566799999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcc--------eeeeecccccccCccccccCc---cccccceEehhHH
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVL  146 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~v  146 (277)
                      +||||||+||+++.++.+||+|||+++........        ......||..|+|||.+.+..   ++.++||||||++
T Consensus       156 vH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  235 (317)
T 2buj_A          156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV  235 (317)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred             ccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998764321110        012235789999999987543   6889999999999


Q ss_pred             HHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          147 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       147 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      +|||++|+.||......... ...   . ......    .+.    .+.....+.+++.+||+.||.+||++.++++.|+
T Consensus       236 l~el~~g~~p~~~~~~~~~~-~~~---~-~~~~~~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          236 LYAMMFGEGPYDMVFQKGDS-VAL---A-VQNQLS----IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHHHHHSSCTTHHHHHTTSC-HHH---H-HHCC------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhCCCChhhhhcccch-hhH---H-hhccCC----CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            99999999998542211111 111   0 111000    011    1122234788888999999999999999999998


Q ss_pred             hccc
Q 023808          227 KNIR  230 (277)
Q Consensus       227 ~~~~  230 (277)
                      .+..
T Consensus       303 ~~~~  306 (317)
T 2buj_A          303 ALQP  306 (317)
T ss_dssp             HTCC
T ss_pred             hcCC
Confidence            8654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-40  Score=271.57  Aligned_cols=211  Identities=22%  Similarity=0.343  Sum_probs=157.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+.+ +|.+++..   ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  125 (288)
T 1ob3_A           53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD  125 (288)
T ss_dssp             GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            57889999999999999999999999999975 99998843   335689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......||..|+|||++.+. .++.++||||||+++|||++|..||...
T Consensus       126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          126 LKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             CCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCHHHEEEcCCCCEEEeECccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987643322 12344689999999998764 5899999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCc--------cccccCCCC--------CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKP--------LELVDPELG--------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--------~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ...............        ....++.+.        .........+.+++.+||+.||++|||+.|+++
T Consensus       205 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          205 SEA---DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             SHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHH---HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            321   111112121111100        000111110        011122344778889999999999999999865

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=281.81  Aligned_cols=204  Identities=25%  Similarity=0.318  Sum_probs=160.6

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ +||||+++++++..+...++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||
T Consensus       111 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~  183 (355)
T 1vzo_A          111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYR  183 (355)
T ss_dssp             HHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred             HHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccC
Confidence            35567 699999999999999999999999999999999943    34689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC--ccccccceEehhHHHHHHHhCCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||||+|||++.++.+||+|||+++.+............||..|+|||++.+.  .++.++||||||+++|||++|+.||.
T Consensus       184 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~  263 (355)
T 1vzo_A          184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT  263 (355)
T ss_dssp             CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            9999999999999999999999987654433334456799999999999863  47889999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  224 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~~  224 (277)
                      ........  ...........       +..   +......+.+++.+||+.||.+||     ++.++++.
T Consensus       264 ~~~~~~~~--~~~~~~~~~~~-------~~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          264 VDGEKNSQ--AEISRRILKSE-------PPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CTTSCCCH--HHHHHHHHHCC-------CCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cCCccchH--HHHHHHHhccC-------CCC---CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            54332211  11111111111       111   122223477888899999999999     89888763

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-40  Score=290.62  Aligned_cols=201  Identities=24%  Similarity=0.320  Sum_probs=162.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..|+||||++||+|.+++.........+++..++.++.||+.||+|||+.   +|+|||
T Consensus       238 iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrD  314 (543)
T 3c4z_A          238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRD  314 (543)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccC
Confidence            46788999999999999999999999999999999999966544456799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       315 LKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          315 LKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             CChHHEEEeCCCCEEEeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            999999999999999999999987654322 2334579999999999999999999999999999999999999997653


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .....  ............       .+   +......+.+++.+||+.||.+||++
T Consensus       394 ~~~~~--~~~~~~i~~~~~-------~~---p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          394 EKVEN--KELKQRVLEQAV-------TY---PDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CCCCH--HHHHHHHHHCCC-------CC---CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             cchhH--HHHHHHHhhccc-------CC---CcccCHHHHHHHHHhccCCHhHCCCC
Confidence            32111  111111111111       11   11222347788888999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.5e-41  Score=273.87  Aligned_cols=203  Identities=26%  Similarity=0.354  Sum_probs=155.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+....++||||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +++|||
T Consensus        73 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~d  149 (285)
T 3is5_A           73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKD  149 (285)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECC
Confidence            47789999999999999999999999999999999999854433446799999999999999999999999   999999


Q ss_pred             CCCCcEEe---CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||++   +.++.+||+|||+++.+....  ......||..|+|||.+. ..++.++||||||+++|||++|+.||.
T Consensus       150 ikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~  226 (285)
T 3is5_A          150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT  226 (285)
T ss_dssp             CSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEEecCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence            99999999   456789999999998654432  233456899999999875 568899999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......   ..   ...........   ......+    ..+.+++.+||+.||.+||++.|+++
T Consensus       227 ~~~~~~---~~---~~~~~~~~~~~---~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          227 GTSLEE---VQ---QKATYKEPNYA---VECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CSSHHH---HH---HHHHHCCCCCC---C--CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCCHHH---HH---hhhccCCcccc---cccCcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            543211   11   11111111110   0111122    34778888999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-40  Score=271.17  Aligned_cols=196  Identities=28%  Similarity=0.422  Sum_probs=156.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+....++||||+++|+|.+++..    ...+++..++.++.|++.||+|||+.   +++|||
T Consensus        62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~d  134 (279)
T 3fdn_A           62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRD  134 (279)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECC
T ss_pred             HHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccc
Confidence            46788999999999999999999999999999999999843    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       135 lkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  211 (279)
T 3fdn_A          135 IKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  211 (279)
T ss_dssp             CCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CChHhEEEcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence            9999999999999999999998654332   2234568999999999998889999999999999999999999986432


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   ...   ......       ......   ....+.+++.+||+.||.+||++.|+++
T Consensus       212 ~~~---~~~---~~~~~~-------~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          212 YQE---TYK---RISRVE-------FTFPDF---VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHH---HHH---HHHHTC-------CCCCTT---SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHH---HHH---HHHhCC-------CCCCCc---CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            211   111   111111       111111   2234778888899999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.1e-41  Score=281.73  Aligned_cols=207  Identities=23%  Similarity=0.208  Sum_probs=156.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------------------------------
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------------------------------   45 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------   45 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.....                                    
T Consensus        81 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (345)
T 3hko_A           81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES  160 (345)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEE
T ss_pred             HHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            46788999999999999999999999999999999999842111                                    


Q ss_pred             CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCC--ceEEeecccccccCCCC---cceeeeeccc
Q 023808           46 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAKLFPDNI---THITTRIAGT  120 (277)
Q Consensus        46 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~gt  120 (277)
                      ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++  .+||+|||+++.+....   ........||
T Consensus       161 ~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt  237 (345)
T 3hko_A          161 LDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT  237 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCC
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCC
Confidence            122346788899999999999999999   999999999999998776  89999999998653321   1123456799


Q ss_pred             ccccCcccccc--CccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHH
Q 023808          121 TGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII  198 (277)
Q Consensus       121 ~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (277)
                      +.|+|||.+.+  ..++.++||||||+++|||++|+.||.......      .............  .+...    ....
T Consensus       238 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~--~~~~~----~~~~  305 (345)
T 3hko_A          238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLCFE--NPNYN----VLSP  305 (345)
T ss_dssp             GGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCTT--SGGGG----GSCH
T ss_pred             ccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccccC--Ccccc----cCCH
Confidence            99999999875  678899999999999999999999986543211      1112222111110  11111    1223


Q ss_pred             HHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          199 RYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       199 ~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .+.+++.+||+.||.+||++.++++
T Consensus       306 ~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          306 LARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            4778889999999999999999976

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.2e-41  Score=279.10  Aligned_cols=198  Identities=24%  Similarity=0.327  Sum_probs=155.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..|+||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        74 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~D  146 (327)
T 3a62_A           74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRD  146 (327)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEccc
Confidence            4678899999999999999999999999999999999994    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus       147 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          147 LKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             CCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999999998543321 22334568999999999998889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..   ....   ......       ..+   ++.....+.+++.+||+.||.+||     ++.++++
T Consensus       226 ~~---~~~~---~i~~~~-------~~~---p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          226 RK---KTID---KILKCK-------LNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HH---HHHH---HHHHTC-------CCC---CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HH---HHHH---HHHhCC-------CCC---CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            21   1111   111111       011   112223477888889999999999     6777765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.6e-41  Score=280.09  Aligned_cols=213  Identities=25%  Similarity=0.366  Sum_probs=166.8

Q ss_pred             ccccc-cCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCCC------------CccCCHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA------------NIKLNWEKRSDICVGIAKGLA   67 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~   67 (277)
                      +|+++ +||||+++++++...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||+
T Consensus        83 ~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~  162 (316)
T 2xir_A           83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME  162 (316)
T ss_dssp             HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHH
Confidence            35667 7999999999998765 589999999999999999653321            123889999999999999999


Q ss_pred             HhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHH
Q 023808           68 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL  146 (277)
Q Consensus        68 ~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~v  146 (277)
                      |||+.   +++||||||+||+++.++.+||+|||+++....... .......||..|+|||++.+..++.++||||||++
T Consensus       163 ~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i  239 (316)
T 2xir_A          163 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL  239 (316)
T ss_dssp             HHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHH
Confidence            99999   999999999999999999999999999987654332 22334567889999999999899999999999999


Q ss_pred             HHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          147 VLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       147 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      +|||+| |..||.......  .....   ... ...     .....   .....+.+++.+||+.||.+||++.+|++.|
T Consensus       240 l~~l~t~g~~p~~~~~~~~--~~~~~---~~~-~~~-----~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          240 LWEIFSLGASPYPGVKIDE--EFCRR---LKE-GTR-----MRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHTTSCCSSTTCCCSH--HHHHH---HHH-TCC-----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCcccchhH--HHHHH---hcc-Ccc-----CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999998 888886543221  11111   111 111     11111   1223477888889999999999999999999


Q ss_pred             hhcccc
Q 023808          226 TKNIRL  231 (277)
Q Consensus       226 ~~~~~~  231 (277)
                      +.++..
T Consensus       306 ~~~~~~  311 (316)
T 2xir_A          306 GNLLQA  311 (316)
T ss_dssp             HHHHHH
T ss_pred             HHHHhh
Confidence            988753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-40  Score=279.58  Aligned_cols=197  Identities=24%  Similarity=0.302  Sum_probs=158.0

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+.+..|+||||++||+|.+++..    ...+++..+..++.||+.||+|||+.   +|+|||
T Consensus        74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrD  146 (353)
T 2i0e_A           74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRD  146 (353)
T ss_dssp             HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecc
Confidence            4555 899999999999999999999999999999999942    34699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       147 lkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  225 (353)
T 2i0e_A          147 LKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  225 (353)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999998543221 22345679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      .   .....   .......       .+   +......+.+++.+||+.||.+||+     +.+|++
T Consensus       226 ~---~~~~~---~i~~~~~-------~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          226 E---DELFQ---SIMEHNV-------AY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             H---HHHHH---HHHHCCC-------CC---CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             H---HHHHH---HHHhCCC-------CC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            2   11111   1111111       11   1122234778888999999999995     466643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.6e-40  Score=273.23  Aligned_cols=214  Identities=23%  Similarity=0.338  Sum_probs=160.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++..++..++||||++ |+|.+++....  .....+++..+..++.|++.||+|||+.   +|+|
T Consensus        56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH  131 (317)
T 2pmi_A           56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILH  131 (317)
T ss_dssp             HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence            4788999999999999999999999999997 59999885422  2234589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||||+||+++.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  210 (317)
T 2pmi_A          132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP  210 (317)
T ss_dssp             CCCCGGGEEECTTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCChHHeEEcCCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987643322 12345689999999998764 68999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCC--cc------ccccCCCC----C---------CCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEK--PL------ELVDPELG----E---------YPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~--~~------~~~~~~~~----~---------~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      .....   .....+........  ..      ....+.+.    .         ........+.+++.+||+.||.+|||
T Consensus       211 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  287 (317)
T 2pmi_A          211 GTNDE---EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS  287 (317)
T ss_dssp             CSSHH---HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCChH---HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC
Confidence            54322   11121212111100  00      00000000    0         00011235788899999999999999


Q ss_pred             HHHHHH
Q 023808          218 MNQVIK  223 (277)
Q Consensus       218 ~~~v~~  223 (277)
                      +.|+++
T Consensus       288 ~~e~l~  293 (317)
T 2pmi_A          288 AKQALH  293 (317)
T ss_dssp             HHHHTT
T ss_pred             HHHHhC
Confidence            998864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=273.69  Aligned_cols=211  Identities=21%  Similarity=0.308  Sum_probs=155.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||++ |+|.+++..   .+..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~D  125 (324)
T 3mtl_A           53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRD  125 (324)
T ss_dssp             HHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESS
T ss_pred             HHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCC
Confidence            4778999999999999999999999999997 589998853   344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++...... .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus       126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          126 LKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             CCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998654322 22234568999999999876 56899999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCcc---cccc---------CCC-----CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPL---ELVD---------PEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~~-----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ....+..........   ....         +..     ....+.....+.+++.+||+.||.+|||+.|+++
T Consensus       205 ~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          205 TVEE---QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             SHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CHHH---HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            3221   222222221111000   0000         000     0000112234778899999999999999999976

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.2e-40  Score=291.02  Aligned_cols=202  Identities=23%  Similarity=0.270  Sum_probs=162.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..|+||||++||+|.+++...  ....+++..+..++.||+.||+|||+.   +|+|||
T Consensus       237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrD  311 (576)
T 2acx_A          237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRD  311 (576)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccC
Confidence            467889999999999999999999999999999999998542  233599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       312 LKPeNILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          312 LKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             CchheEEEeCCCCeEEEecccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999998765432  2334579999999999999899999999999999999999999997654


Q ss_pred             Ccchh-hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNK-FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      ..... .....+   .. ..      ..+   +......+.+++.+||+.||.+||     ++.||++
T Consensus       390 ~~~~~~~i~~~i---~~-~~------~~~---p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          390 KKIKREEVERLV---KE-VP------EEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             SCCCHHHHHHHH---HH-CC------CCC---CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cchhHHHHHHHh---hc-cc------ccC---CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            32221 111111   11 11      111   111223477888899999999999     6788764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-40  Score=278.71  Aligned_cols=198  Identities=21%  Similarity=0.316  Sum_probs=161.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++.    ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        94 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~d  166 (335)
T 2owb_A           94 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRD  166 (335)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecC
Confidence            4678999999999999999999999999999999999984    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       167 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  245 (335)
T 2owb_A          167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  245 (335)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCchhEEEcCCCCEEEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence            999999999999999999999987653322 2334568999999999998889999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .   .........       .+...   ....+.+++.+||+.||.+||++.++++
T Consensus       246 ~~~---~---~~~~~~~~~-------~~~~~---~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          246 LKE---T---YLRIKKNEY-------SIPKH---INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHH---H---HHHHHHTCC-------CCCTT---SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHH---H---HHHHhcCCC-------CCCcc---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211   1   111111111       11111   1234677888899999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-40  Score=269.69  Aligned_cols=204  Identities=21%  Similarity=0.367  Sum_probs=162.8

Q ss_pred             ccccccCCCccceeeEEEe----------------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQ----------------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG   65 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~   65 (277)
                      +|++++||||+++++++..                ....++||||+++|+|.+++...  .+..+++..++.++.|++.|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~  134 (284)
T 2a19_B           57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKG  134 (284)
T ss_dssp             HHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHH
Confidence            4678899999999999865                44579999999999999999542  23468999999999999999


Q ss_pred             HHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhH
Q 023808           66 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV  145 (277)
Q Consensus        66 l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  145 (277)
                      |+|||+.   +++|+||||+||+++.++.+||+|||++........  .....|+..|+|||.+.+..++.++||||||+
T Consensus       135 l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  209 (284)
T 2a19_B          135 VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGL  209 (284)
T ss_dssp             HHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred             HHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence            9999999   999999999999999999999999999987654322  23446899999999999988999999999999


Q ss_pred             HHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          146 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       146 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ++|||++|..|+...        ... ........        +....+   ..+.+++.+||+.||.+||++.++++.|
T Consensus       210 il~~l~~~~~~~~~~--------~~~-~~~~~~~~--------~~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l  269 (284)
T 2a19_B          210 ILAELLHVCDTAFET--------SKF-FTDLRDGI--------ISDIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTL  269 (284)
T ss_dssp             HHHHHHSCCSSHHHH--------HHH-HHHHHTTC--------CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhcCCcchhH--------HHH-HHHhhccc--------ccccCC---HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            999999998775321        011 11111111        111112   2367888889999999999999999999


Q ss_pred             hhccccC
Q 023808          226 TKNIRLN  232 (277)
Q Consensus       226 ~~~~~~~  232 (277)
                      ..+.+..
T Consensus       270 ~~~~~~~  276 (284)
T 2a19_B          270 TVWKKSP  276 (284)
T ss_dssp             HHHTC--
T ss_pred             HHHhhCC
Confidence            8877654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=276.42  Aligned_cols=215  Identities=23%  Similarity=0.367  Sum_probs=164.6

Q ss_pred             ccccccCCCccceeeEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++...+  ..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|
T Consensus        95 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH  168 (326)
T 2w1i_A           95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIH  168 (326)
T ss_dssp             HHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            467899999999999987654  78999999999999999953   234589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++.++.+||+|||+++.........  .....++..|+|||.+.+..++.++||||||+++|||+||..|+
T Consensus       169 ~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~  248 (326)
T 2w1i_A          169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS  248 (326)
T ss_dssp             SCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred             cCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999998765543221  22345677899999999889999999999999999999999886


Q ss_pred             CcccCcc---------hhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          158 KAMWGQM---------NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       158 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .......         .................     .   ..+......+.+++.+||+.||.+||++.+|++.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR-----L---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             GSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC-----C---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHHHHHHhhccccchhhhHHHHHHHhhcCCC-----C---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            5431100         00011111111111111     0   11122234577888899999999999999999999887


Q ss_pred             cc
Q 023808          229 IR  230 (277)
Q Consensus       229 ~~  230 (277)
                      ..
T Consensus       321 ~~  322 (326)
T 2w1i_A          321 RD  322 (326)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.6e-40  Score=270.12  Aligned_cols=201  Identities=24%  Similarity=0.320  Sum_probs=159.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  130 (284)
T 3kk8_A           58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRN  130 (284)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCC
Confidence            4678899999999999999999999999999999998884    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc---eEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++.   +||+|||++........  .....||..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus       131 ikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             CCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence            9999999976655   99999999986654322  234568999999999999999999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ....   .......  ....+.....+    ..+.+++.+||+.||.+||++.|+++
T Consensus       209 ~~~~~---~~~~---~~~~~~~--~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          209 DEDQH---RLYA---QIKAGAY--DYPSPEWDTVT----PEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CSSHH---HHHH---HHHHTCC--CCCTTTTTTSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCchh---HHHH---HHHhccc--cCCchhhcccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            53221   1111   1111111  11111112223    34778888999999999999999976

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.9e-40  Score=268.79  Aligned_cols=202  Identities=24%  Similarity=0.353  Sum_probs=160.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||+++++++.+++..++||||+++++|.+++.    ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  130 (276)
T 2yex_A           58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD  130 (276)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccC
Confidence            4678899999999999999999999999999999999983    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+||+++.++.+||+|||.+........ .......|+..|+|||.+.+..+ +.++||||||+++|||++|..||..
T Consensus       131 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  210 (276)
T 2yex_A          131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (276)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred             CChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999986543221 12334568999999999987665 7899999999999999999999876


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....... ...+    .......    +.    .......+.+++.+||+.||.+||++.++++
T Consensus       211 ~~~~~~~-~~~~----~~~~~~~----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          211 PSDSCQE-YSDW----KEKKTYL----NP----WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             SCTTSHH-HHHH----HTTCTTS----TT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CchHHHH-HHHh----hhccccc----Cc----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            5432211 1111    1111100    00    1122234778888999999999999998865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=274.01  Aligned_cols=211  Identities=23%  Similarity=0.313  Sum_probs=156.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~d  127 (311)
T 4agu_A           55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRD  127 (311)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence            4678899999999999999999999999999999999883    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......||..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus       128 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          128 VKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CChhhEEEcCCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654322 2234568999999999876 56899999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhcc-----------CCc---cccccCCC-CC---CCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQE-----------EKP---LELVDPEL-GE---YPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-----------~~~---~~~~~~~~-~~---~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ......   .........           ...   ....++.. ..   ..+.....+.+++.+||+.||.+|||+.|++
T Consensus       207 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  283 (311)
T 4agu_A          207 SDVDQL---YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL  283 (311)
T ss_dssp             SHHHHH---HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred             CHHHHH---HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence            332211   111111100           000   00000000 00   0012233477889999999999999999997


Q ss_pred             H
Q 023808          223 K  223 (277)
Q Consensus       223 ~  223 (277)
                      +
T Consensus       284 ~  284 (311)
T 4agu_A          284 H  284 (311)
T ss_dssp             T
T ss_pred             c
Confidence            5

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-40  Score=274.95  Aligned_cols=200  Identities=26%  Similarity=0.309  Sum_probs=160.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++.    ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~d  140 (321)
T 2a2a_A           68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFD  140 (321)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            4678899999999999999999999999999999999994    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC----ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++    .+||+|||+++.......  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus       141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  218 (321)
T 2a2a_A          141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  218 (321)
T ss_dssp             CSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CChHHEEEecCCCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence            999999999887    799999999987654322  23456899999999999889999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......   ...   .........   .++.. ...    ...+.+++.+||+.||.+||++.++++
T Consensus       219 ~~~~~~---~~~---~~i~~~~~~---~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          219 LGDTKQ---ETL---ANITSVSYD---FDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCSSHH---HHH---HHHHTTCCC---CCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             CCCCHH---HHH---HHHHhcccc---cChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            653221   111   111111100   00000 111    234778889999999999999999976

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-40  Score=275.69  Aligned_cols=202  Identities=20%  Similarity=0.267  Sum_probs=155.7

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+....++||||+.+|+|.+++..  .....+++..++.++.|++.||+|||+.   +++|||
T Consensus        82 l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~D  156 (327)
T 3lm5_A           82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLD  156 (327)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCc
Confidence            4455 579999999999999999999999999999999843  2345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.   ++.+||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       157 ikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (327)
T 3lm5_A          157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV  234 (327)
T ss_dssp             CCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHHEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999987   7899999999998764432  2234568999999999999999999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......   ...   .......  .........    ....+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~---~~~---~i~~~~~--~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          235 GEDNQE---TYL---NISQVNV--DYSEETFSS----VSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             CSSHHH---HHH---HHHHTCC--CCCTTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCchH---HHH---HHHhccc--ccCchhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            543211   111   1111110  000111112    2234778888999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-40  Score=273.37  Aligned_cols=195  Identities=18%  Similarity=0.282  Sum_probs=153.1

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +.++ +||||+++++++.+++..++||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +++|||
T Consensus        64 ~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~D  140 (289)
T 1x8b_A           64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMD  140 (289)
T ss_dssp             HHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecC
Confidence            4455 899999999999999999999999999999999964333335689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC-------------------CceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceE
Q 023808           82 IKASNILLDQE-------------------FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVY  141 (277)
Q Consensus        82 ikp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~  141 (277)
                      |||+||+++.+                   ..+||+|||.+.......     ...||..|+|||.+.+. .++.++|||
T Consensus       141 ikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~  215 (289)
T 1x8b_A          141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIF  215 (289)
T ss_dssp             CSGGGEEEC--------------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHH
T ss_pred             CCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHH
Confidence            99999999844                   479999999998765432     23489999999999776 567899999


Q ss_pred             ehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHH
Q 023808          142 SFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  221 (277)
Q Consensus       142 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v  221 (277)
                      |||+++|+|++|..++....     ..     ........     +.+.   ......+.+++.+||+.||.+||++.++
T Consensus       216 slG~il~~l~~~~~~~~~~~-----~~-----~~~~~~~~-----~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~l  277 (289)
T 1x8b_A          216 ALALTVVCAAGAEPLPRNGD-----QW-----HEIRQGRL-----PRIP---QVLSQEFTELLKVMIHPDPERRPSAMAL  277 (289)
T ss_dssp             HHHHHHHHHTTCCCCCSSSH-----HH-----HHHHTTCC-----CCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHhcCCCCCcchh-----HH-----HHHHcCCC-----CCCC---cccCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            99999999999987653221     11     11111111     1111   1222347788888999999999999998


Q ss_pred             HH
Q 023808          222 IK  223 (277)
Q Consensus       222 ~~  223 (277)
                      ++
T Consensus       278 l~  279 (289)
T 1x8b_A          278 VK  279 (289)
T ss_dssp             HT
T ss_pred             hh
Confidence            65

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-40  Score=277.26  Aligned_cols=213  Identities=26%  Similarity=0.344  Sum_probs=165.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCC---CccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA---NIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++||||+++++++.+....++||||+++|+|.+++......   ...+++..++.++.|++.||+|||+.   +++
T Consensus        86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~  162 (327)
T 2yfx_A           86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFI  162 (327)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             HHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Cee
Confidence            467889999999999999999999999999999999999654322   24589999999999999999999999   999


Q ss_pred             eccCCCCcEEeCC---CCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHh-C
Q 023808           79 HRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G  153 (277)
Q Consensus        79 H~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g  153 (277)
                      ||||||+||+++.   +..+||+|||+++....... .......|+..|+|||.+.+..++.++||||||+++|+|+| |
T Consensus       163 H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  242 (327)
T 2yfx_A          163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG  242 (327)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCC
Confidence            9999999999984   44699999999985433221 22334567889999999988899999999999999999998 8


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ..||.....   .....   ........      ..   +......+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus       243 ~~p~~~~~~---~~~~~---~~~~~~~~------~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          243 YMPYPSKSN---QEVLE---FVTSGGRM------DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCSSTTCCH---HHHHH---HHHTTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCcCH---HHHHH---HHhcCCCC------CC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            888764322   11111   11111111      11   1122234778888899999999999999999999876543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5e-40  Score=269.36  Aligned_cols=196  Identities=22%  Similarity=0.309  Sum_probs=160.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++..    ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        67 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  139 (284)
T 2vgo_A           67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRD  139 (284)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCC
T ss_pred             HHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecC
Confidence            46788999999999999999999999999999999999943    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++.......   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       140 l~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  216 (284)
T 2vgo_A          140 IKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS  216 (284)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCHHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999999987654321   234568999999999999899999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .   ........       ..+..   .....+.+++.+||+.||.+||++.++++
T Consensus       217 ~~~---~---~~~~~~~~-------~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          217 HTE---T---HRRIVNVD-------LKFPP---FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHH---H---HHHHHTTC-------CCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhH---H---HHHHhccc-------cCCCC---cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            211   1   11111111       11111   12234778888899999999999999976

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.4e-41  Score=273.91  Aligned_cols=206  Identities=25%  Similarity=0.366  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC---
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH---   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~---   76 (277)
                      +|++++||||+++++++.+  +...++||||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +   
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~  134 (279)
T 2w5a_A           58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGG  134 (279)
T ss_dssp             HHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C---
T ss_pred             HHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCC
Confidence            4678899999999999864  5688999999999999999965444455699999999999999999999998   7   


Q ss_pred             --eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           77 --IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        77 --iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                        ++|+||||+||+++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       135 ~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  213 (279)
T 2w5a_A          135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM  213 (279)
T ss_dssp             ---CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             CeeEEeccchhhEEEcCCCCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence              99999999999999999999999999987644321 123356899999999999888999999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHh
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  226 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~  226 (277)
                      .||.....   .....   .... ...     +.+   +......+.+++.+||+.||.+||++.+|++.+.
T Consensus       214 ~p~~~~~~---~~~~~---~i~~-~~~-----~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          214 PPFTAFSQ---KELAG---KIRE-GKF-----RRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CSSCCSSH---HHHHH---HHHH-TCC-----CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             CCCcccCH---HHHHH---HHhh-ccc-----ccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            99865432   11111   1111 111     011   1122234778888899999999999999987553

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=272.72  Aligned_cols=208  Identities=25%  Similarity=0.315  Sum_probs=157.0

Q ss_pred             cccCCCccceeeEEEeCC-----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            5 NVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +++||||++++++|....     ..++||||+. |+|.+++...  ....+++..+..++.|++.||+|||+.   +++|
T Consensus        70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH  143 (308)
T 3g33_A           70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVH  143 (308)
T ss_dssp             HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            346999999999998765     5799999996 5999999542  233499999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||||+||+++.++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          144 RDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             SCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             CCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999998664332  23445789999999999999999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccc----------cccCCC----CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLE----------LVDPEL----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....+...........          ...+..    ....+.....+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          222 NSEA---DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SSHH---HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHH---HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            4322   11222222111110000          000000    0001122345778899999999999999999865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-40  Score=269.42  Aligned_cols=200  Identities=19%  Similarity=0.261  Sum_probs=158.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++.    .+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  131 (277)
T 3f3z_A           59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRD  131 (277)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCC
Confidence            4678999999999999999999999999999999999984    344689999999999999999999999   999999


Q ss_pred             CCCCcEEe---CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||++   +.++.+||+|||++.......  ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.
T Consensus       132 lkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  208 (277)
T 3f3z_A          132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS  208 (277)
T ss_dssp             CSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCC
Confidence            99999999   788899999999998765432  2334568999999998765 48999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ...   ...........  ......    ....+.+++.+||+.||.+||++.++++
T Consensus       209 ~~~~~---~~~---~~~~~~~~~~~--~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          209 APTDS---EVM---LKIREGTFTFP--EKDWLN----VSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CSSHH---HHH---HHHHHCCCCCC--HHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCHH---HHH---HHHHhCCCCCC--chhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            54321   111   11111111100  000011    1234778889999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-39  Score=275.54  Aligned_cols=146  Identities=27%  Similarity=0.393  Sum_probs=129.7

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      ++||||+++++++...+..++||||+ +++|.+++...  ....+++..+..++.||+.||+|||+.   +|+||||||+
T Consensus        93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~  166 (360)
T 3llt_A           93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPE  166 (360)
T ss_dssp             TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcc
Confidence            35999999999999999999999999 88999999643  233589999999999999999999999   9999999999


Q ss_pred             cEEeCC-------------------------CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccce
Q 023808           86 NILLDQ-------------------------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        86 Nill~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      |||++.                         ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||
T Consensus       167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccch
Confidence            999975                         788999999999865432    234568999999999999999999999


Q ss_pred             EehhHHHHHHHhCCCCCCccc
Q 023808          141 YSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus       141 ~slG~vl~elltg~~p~~~~~  161 (277)
                      |||||++|||++|+.||....
T Consensus       243 wslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHHHHCCCCCCCCc
Confidence            999999999999999986543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.6e-40  Score=271.30  Aligned_cols=209  Identities=25%  Similarity=0.415  Sum_probs=157.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccC----CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++++||||+++++++..++..++||||+++|+|.+++...    ......+++..++.++.|++.||+|||+.   ++
T Consensus        66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i  142 (303)
T 2vwi_A           66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQ  142 (303)
T ss_dssp             CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CC
Confidence            577889999999999999999999999999999999998531    12345689999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCc----ceeeeecccccccCcccccc-CccccccceEehhHHHHHHHh
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ellt  152 (277)
                      +|+||||+||+++.++.+||+|||++........    .......||..|+|||++.+ ..++.++||||||+++|||++
T Consensus       143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  222 (303)
T 2vwi_A          143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT  222 (303)
T ss_dssp             CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999986643221    11234568999999998876 468899999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCc---cccccCCC-CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKP---LELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |..||........   ..   ........   ....++.. ...+    ..+.+++.+||+.||.+||++.++++
T Consensus       223 g~~pf~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          223 GAAPYHKYPPMKV---LM---LTLQNDPPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCTTTTSCGGGH---HH---HHHTSSCCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCchhhH---HH---HHhccCCCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence            9999865433221   11   11111111   11111111 2222    34778888899999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-40  Score=272.29  Aligned_cols=205  Identities=25%  Similarity=0.358  Sum_probs=156.8

Q ss_pred             ccccccCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||+++++++.+. +..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +++|+
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~  141 (278)
T 1byg_A           67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR  141 (278)
T ss_dssp             HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             HHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            47789999999999997655 4789999999999999999432  122388999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      ||||+||+++.++.+||+|||+++.....    .....++..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       142 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          142 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             CCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998854432    223357889999999998889999999999999999998 9988865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .....   ...   .. .....     ...   +......+.+++.+||+.||.+||++.++++.|+++..
T Consensus       218 ~~~~~---~~~---~~-~~~~~-----~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          218 IPLKD---VVP---RV-EKGYK-----MDA---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             SCGGG---HHH---HH-TTTCC-----CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHH---HHH---HH-hcCCC-----CCC---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            43221   111   11 11110     111   11222347788888999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.6e-40  Score=276.99  Aligned_cols=204  Identities=13%  Similarity=0.116  Sum_probs=162.6

Q ss_pred             cccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            5 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      ...|+||+++++++..++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiK  199 (365)
T 3e7e_A          123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIK  199 (365)
T ss_dssp             GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCS
T ss_pred             hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCC
Confidence            34599999999999999999999999999999999954222 345699999999999999999999999   99999999


Q ss_pred             CCcEEeCC-----------CCceEEeecccccccCC-CCcceeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           84 ASNILLDQ-----------EFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        84 p~Nill~~-----------~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                      |+|||++.           ++.+||+|||+++.+.. ..........||..|+|||++.+..++.++|||||||++|||+
T Consensus       200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  279 (365)
T 3e7e_A          200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML  279 (365)
T ss_dssp             GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred             HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence            99999998           89999999999976532 2223344567999999999999999999999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCC-CCHHHHHHHHhhccc
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR-PQMNQVIKMLTKNIR  230 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~  230 (277)
                      ||+.||........                  .+...+...+  ....+.+++..|++.+|.+| |++.++.+.|++.+.
T Consensus       280 tg~~pf~~~~~~~~------------------~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          280 FGTYMKVKNEGGEC------------------KPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             HSSCCCEEEETTEE------------------EECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hCCCccccCCCCce------------------eechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            99999754322110                  0111111111  12235566777999999998 678888888888765


Q ss_pred             c
Q 023808          231 L  231 (277)
Q Consensus       231 ~  231 (277)
                      .
T Consensus       340 ~  340 (365)
T 3e7e_A          340 Q  340 (365)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-40  Score=300.11  Aligned_cols=207  Identities=25%  Similarity=0.381  Sum_probs=161.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++. ++..++||||+++|+|.+++..   .+..+++..++.++.|++.||+|||+.   +|+|||
T Consensus       444 ~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrD  516 (656)
T 2j0j_A          444 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRD  516 (656)
T ss_dssp             HHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            467889999999999985 4568999999999999999953   334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++..............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       517 ikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  596 (656)
T 2j0j_A          517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  596 (656)
T ss_dssp             CSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999998765543333344557789999999998899999999999999999997 88888653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ..   .....   ........      ..   ++.....+.+++.+||+.||.+||++.+|++.|++++.
T Consensus       597 ~~---~~~~~---~i~~~~~~------~~---~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          597 KN---NDVIG---RIENGERL------PM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             CH---HHHHH---HHHHTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CH---HHHHH---HHHcCCCC------CC---CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            32   11211   11111111      11   12223347788889999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-39  Score=266.02  Aligned_cols=198  Identities=26%  Similarity=0.394  Sum_probs=156.0

Q ss_pred             ccccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-
Q 023808            2 TLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-   76 (277)
                      +|++++||||+++++++..    +...++||||+++|+|.+++.    ....+++..++.++.|++.||+|||+.   + 
T Consensus        78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~  150 (290)
T 1t4h_A           78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TP  150 (290)
T ss_dssp             HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SS
T ss_pred             HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CC
Confidence            4788999999999999875    456899999999999999994    335689999999999999999999999   8 


Q ss_pred             -eEeccCCCCcEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           77 -IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        77 -iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                       ++|+||||+||+++ .++.+||+|||++.......   .....||..|+|||.+. +.++.++||||||+++|+|++|+
T Consensus       151 ~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~  226 (290)
T 1t4h_A          151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSE  226 (290)
T ss_dssp             CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCC
Confidence             99999999999997 78899999999997654332   33456899999999876 45899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .||.......     ............ ...+.   ..    ...+.+++.+||+.||.+||++.++++
T Consensus       227 ~pf~~~~~~~-----~~~~~~~~~~~~-~~~~~---~~----~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          227 YPYSECQNAA-----QIYRRVTSGVKP-ASFDK---VA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CTTTTCSSHH-----HHHHHHTTTCCC-GGGGG---CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCcCcHH-----HHHHHHhccCCc-cccCC---CC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            9986543221     111111111111 11111   11    134778888999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-40  Score=283.06  Aligned_cols=193  Identities=15%  Similarity=0.104  Sum_probs=149.1

Q ss_pred             ccccccCCCcccee-------eEEEeCC-----------------eeEEEEeecCCCCHHHHhccCC---CCCccCCHHH
Q 023808            2 TLSNVRHPNLVELI-------GCCVQGT-----------------RRILVYEYVENNSLDRVLLGAT---KANIKLNWEK   54 (277)
Q Consensus         2 ~L~~l~h~niv~~~-------~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~   54 (277)
                      +|++++||||++++       +++...+                 ..|+||||+ +|+|.+++....   .....+++..
T Consensus       129 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~  207 (377)
T 3byv_A          129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHA  207 (377)
T ss_dssp             GSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHH
T ss_pred             hccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHH
Confidence            46778999999998       6666553                 278999999 679999995321   1122345688


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC--
Q 023808           55 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--  132 (277)
Q Consensus        55 ~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--  132 (277)
                      ++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....    ......| ..|+|||++.+.  
T Consensus       208 ~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~  279 (377)
T 3byv_A          208 RLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRAT  279 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhccccc
Confidence            999999999999999999   999999999999999999999999999986332    2344567 999999999887  


Q ss_pred             ---------ccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHH
Q 023808          133 ---------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV  203 (277)
Q Consensus       133 ---------~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  203 (277)
                               .++.++|||||||++|||+||+.||.......                ....+.......+    ..+.++
T Consensus       280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~~~~~~~----~~~~~l  339 (377)
T 3byv_A          280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG----------------GSEWIFRSCKNIP----QPVRAL  339 (377)
T ss_dssp             THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------C----------------CSGGGGSSCCCCC----HHHHHH
T ss_pred             ccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccccc----------------chhhhhhhccCCC----HHHHHH
Confidence                     89999999999999999999999985432211                1111111112223    347788


Q ss_pred             HHhhhhhhhcCCCCHHHHHH
Q 023808          204 AFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       204 ~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +.+||+.||.+||++.++++
T Consensus       340 i~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          340 LEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHcCCCchhCCCHHHHhh
Confidence            88999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-40  Score=270.58  Aligned_cols=208  Identities=25%  Similarity=0.373  Sum_probs=163.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+. .++||||+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        74 ~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  146 (291)
T 1u46_A           74 AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRD  146 (291)
T ss_dssp             HHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            467889999999999998765 7899999999999999953   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++........  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       147 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  226 (291)
T 1u46_A          147 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  226 (291)
T ss_dssp             CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999999999999999876544322  1234457788999999998889999999999999999999 999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .....   ..   ...........    + .   +......+.+++.+||+.||.+||++.++++.|+++..
T Consensus       227 ~~~~~---~~---~~~~~~~~~~~----~-~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          227 GLNGS---QI---LHKIDKEGERL----P-R---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             TCCHH---HH---HHHHHTSCCCC----C-C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCHH---HH---HHHHHccCCCC----C-C---CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            54321   11   11221111110    1 1   11223347788889999999999999999999988664

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1e-39  Score=269.98  Aligned_cols=198  Identities=27%  Similarity=0.410  Sum_probs=160.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++||||+++++|.+++.     ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        73 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  144 (303)
T 3a7i_A           73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRD  144 (303)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCC
Confidence            4678899999999999999999999999999999999993     24689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       145 l~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  223 (303)
T 3a7i_A          145 IKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH  223 (303)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CChheEEECCCCCEEEeecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence            999999999999999999999987644321 2334568999999999999899999999999999999999999986533


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ....   .......      +.+..   .....+.+++.+||+.||.+||++.++++
T Consensus       224 ~~---~~~~---~~~~~~~------~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          224 PM---KVLF---LIPKNNP------PTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             HH---HHHH---HHHHSCC------CCCCS---SCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH---HHHH---HhhcCCC------CCCcc---ccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            21   1111   1111111      11111   11234778888899999999999999976

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.2e-40  Score=270.14  Aligned_cols=198  Identities=21%  Similarity=0.318  Sum_probs=161.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++++|.+++.    ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d  140 (294)
T 2rku_A           68 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRD  140 (294)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4678899999999999999999999999999999999984    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       141 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  219 (294)
T 2rku_A          141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  219 (294)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CChHhEEEcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999987643322 2334568999999999998889999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...      ..........       .+..   .....+.+++.+||+.||.+||++.++++
T Consensus       220 ~~~------~~~~~~~~~~-------~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          220 LKE------TYLRIKKNEY-------SIPK---HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHH------HHHHHHTTCC-------CCCT---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHH------HHHHHhhccC-------CCcc---ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            211      1111111110       1111   11234778888899999999999999876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5e-40  Score=273.33  Aligned_cols=209  Identities=26%  Similarity=0.281  Sum_probs=152.9

Q ss_pred             ccc-ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSN-VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.+ ++||||+++++++.+++..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++|||
T Consensus        64 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  136 (316)
T 2ac3_A           64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRD  136 (316)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCC
Confidence            445 4799999999999999999999999999999999943    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc---eEEeecccccccCCCCc------ceeeeecccccccCcccccc-----CccccccceEehhHHH
Q 023808           82 IKASNILLDQEFN---PKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLV  147 (277)
Q Consensus        82 ikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl  147 (277)
                      |||+||+++.++.   +||+|||+++.......      .......||..|+|||++.+     ..++.++||||||+++
T Consensus       137 lkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il  216 (316)
T 2ac3_A          137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL  216 (316)
T ss_dssp             CCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred             CCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence            9999999988776   99999999986542211      11223458999999999875     4688999999999999


Q ss_pred             HHHHhCCCCCCcccCcchh--------hHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          148 LEIISGRNSGKAMWGQMNK--------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      |||++|+.||.........        ............... ..........    ...+.+++.+||+.||.+||++.
T Consensus       217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~  291 (316)
T 2ac3_A          217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHI----SCAAKDLISKLLVRDAKQRLSAA  291 (316)
T ss_dssp             HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-ccCchhcccC----CHHHHHHHHHHhhCChhhCCCHH
Confidence            9999999998754332100        000001111111111 0000000111    23477888999999999999999


Q ss_pred             HHHH
Q 023808          220 QVIK  223 (277)
Q Consensus       220 ~v~~  223 (277)
                      |+++
T Consensus       292 e~l~  295 (316)
T 2ac3_A          292 QVLQ  295 (316)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            9976

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=270.44  Aligned_cols=191  Identities=24%  Similarity=0.258  Sum_probs=150.3

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      .+||||++++++|.+++..++||||+ +++|.+++..   .+..+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus       114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~  186 (311)
T 3p1a_A          114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA  186 (311)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred             cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHH
Confidence            38999999999999999999999999 6699988853   234699999999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcch
Q 023808           86 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  165 (277)
Q Consensus        86 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~  165 (277)
                      |||++.++.+||+|||+++......  ......||+.|+|||++.+ .++.++||||||+++|||++|..++.....   
T Consensus       187 NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---  260 (311)
T 3p1a_A          187 NIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---  260 (311)
T ss_dssp             GEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---
T ss_pred             HEEECCCCCEEEccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---
Confidence            9999999999999999998764432  2334568999999998875 789999999999999999999765432110   


Q ss_pred             hhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          166 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                             +.............       ......+.+++.+||+.||++||++.|+++
T Consensus       261 -------~~~~~~~~~~~~~~-------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          261 -------WQQLRQGYLPPEFT-------AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -------HHHHTTTCCCHHHH-------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------HHHHhccCCCcccc-------cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                   11111111111011       112234788888999999999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.2e-40  Score=276.13  Aligned_cols=196  Identities=31%  Similarity=0.487  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+. |+|.+++..   ....+++..+..++.|++.||+|||+.   +++|||
T Consensus       107 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  179 (348)
T 1u5q_A          107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRD  179 (348)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCC
Confidence            4678899999999999999999999999997 588888742   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++.++.+||+|||+++.....     ....||+.|+|||++.   ...++.++||||||+++|||++|+.||.
T Consensus       180 lkp~NIll~~~~~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  254 (348)
T 1u5q_A          180 VKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  254 (348)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCHHHEEECCCCCEEEeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999865432     3456899999999985   4678999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....      ............. ..   ....+    ..+.+++.+||+.||.+||++.++++
T Consensus       255 ~~~~~------~~~~~~~~~~~~~-~~---~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          255 NMNAM------SALYHIAQNESPA-LQ---SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TSCHH------HHHHHHHHSCCCC-CC---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCChH------HHHHHHHhcCCCC-CC---CCCCC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence            53221      1111222221110 00   01122    34678888899999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-40  Score=278.02  Aligned_cols=151  Identities=27%  Similarity=0.479  Sum_probs=132.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+..  +++|||
T Consensus        84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~d  157 (360)
T 3eqc_A           84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRD  157 (360)
T ss_dssp             GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSC
T ss_pred             HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCC
Confidence            57889999999999999999999999999999999999943    346899999999999999999999831  799999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++......   ......||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       158 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          158 VKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             CSGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             ccHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999754221   2234568999999999999999999999999999999999999986543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=279.12  Aligned_cols=200  Identities=20%  Similarity=0.327  Sum_probs=151.0

Q ss_pred             ccccccC--CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++|  |||+++++++..++..++|||+ .+|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|
T Consensus        60 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiH  131 (343)
T 3dbq_A           60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVH  131 (343)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             HHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            3567766  9999999999999999999995 5789999994    345689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCcccccc-----------CccccccceEehhHHH
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-----------GQLTMKADVYSFGVLV  147 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl  147 (277)
                      |||||+|||++ ++.+||+|||+++........ ......||+.|+|||++.+           ..++.++||||||+++
T Consensus       132 rDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il  210 (343)
T 3dbq_A          132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  210 (343)
T ss_dssp             CCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred             CCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence            99999999997 578999999999876543322 2345679999999999865           6788999999999999


Q ss_pred             HHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          148 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |||++|+.||........     ...........     ...+...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       211 ~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          211 YYMTYGKTPFQQIINQIS-----KLHAIIDPNHE-----IEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHSSCTTTTCCSHHH-----HHHHHHCTTSC-----CCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhCCCcchhhhhHHH-----HHHHHhcCCcc-----cCCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            999999999865433211     11111111111     11122222   34678888899999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-39  Score=280.82  Aligned_cols=201  Identities=22%  Similarity=0.313  Sum_probs=149.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.. +..++||||+.+|+|.+++    ..+..+++..+..++.|++.||+|||+.   +|+|||
T Consensus       193 ~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrD  264 (419)
T 3i6u_A          193 ILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRD  264 (419)
T ss_dssp             HHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            4678999999999999854 5678999999999999988    3455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC---ceEEeecccccccCCCCcceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+|||++.++   .+||+|||+++.....  .......||+.|+|||++.+   ..++.++||||||+++|+|++|..
T Consensus       265 lkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~  342 (419)
T 3i6u_A          265 LKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP  342 (419)
T ss_dssp             CCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            999999997544   5999999999876543  22344679999999999854   568899999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||........  .....    ...... ........    ....+.+++.+||+.||.+||++.|+++
T Consensus       343 pf~~~~~~~~--~~~~i----~~~~~~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          343 PFSEHRTQVS--LKDQI----TSGKYN-FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SSCCCSSSCC--HHHHH----HTTCCC-CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCcchHH--HHHHH----hcCCCC-CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            9865433221  11111    111100 00000011    2234788899999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.9e-40  Score=274.05  Aligned_cols=210  Identities=22%  Similarity=0.262  Sum_probs=151.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..++||||+++ +|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~D  157 (329)
T 3gbz_A           86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRD  157 (329)
T ss_dssp             HGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCC
Confidence            57889999999999999999999999999975 9999984    334589999999999999999999999   999999


Q ss_pred             CCCCcEEe-----CCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILL-----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill-----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+|||+     +.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|||++|..
T Consensus       158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  236 (329)
T 3gbz_A          158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP  236 (329)
T ss_dssp             CCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            99999999     4555699999999987653322 23345679999999999875 48999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccc---c--------ccCCCCCCCH------HHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLE---L--------VDPELGEYPP------NEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~~~------~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      ||.......   ................   .        ..+.......      .....+.+++.+||+.||.+|||+
T Consensus       237 pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  313 (329)
T 3gbz_A          237 LFPGDSEID---QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA  313 (329)
T ss_dssp             SSCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CcCCCCHHH---HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence            986543211   1111111111000000   0        0000000000      022457788999999999999999


Q ss_pred             HHHHH
Q 023808          219 NQVIK  223 (277)
Q Consensus       219 ~~v~~  223 (277)
                      .|+++
T Consensus       314 ~e~l~  318 (329)
T 3gbz_A          314 KNALE  318 (329)
T ss_dssp             HHHHT
T ss_pred             HHHhC
Confidence            99865

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-39  Score=266.89  Aligned_cols=206  Identities=25%  Similarity=0.304  Sum_probs=159.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++++|.+++.    .+..+++..++.++.|++.||+|||+.   +++|+|
T Consensus        61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  133 (283)
T 3bhy_A           61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFD  133 (283)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence            4678899999999999999999999999999999999994    344689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC----ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++    .+||+|||++........  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus       134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  211 (283)
T 3bhy_A          134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  211 (283)
T ss_dssp             CSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CChHHEEEecCCCCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence            999999998877    799999999987644321  23456899999999999889999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH--HHhhc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK--MLTKN  228 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~--~L~~~  228 (277)
                      .......   ..   .........   .....   .......+.+++.+||+.||.+||++.++++  .++..
T Consensus       212 ~~~~~~~---~~---~~~~~~~~~---~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          212 LGETKQE---TL---TNISAVNYD---FDEEY---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             CCSSHHH---HH---HHHHTTCCC---CCHHH---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CCcchHH---HH---HHhHhcccC---Ccchh---cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            6543211   11   111111100   00000   0111234778889999999999999999986  44443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.1e-40  Score=281.37  Aligned_cols=200  Identities=19%  Similarity=0.321  Sum_probs=151.9

Q ss_pred             cccccc--CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++|+  ||||+++++++..++..++||| +.+++|.+++..    ...+++..+..++.||+.||+|||+.   +|+|
T Consensus       107 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH  178 (390)
T 2zmd_A          107 YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVH  178 (390)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCC
T ss_pred             HHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence            356675  5999999999999999999999 568899999953    34688999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCcccccc-----------CccccccceEehhHHH
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-----------GQLTMKADVYSFGVLV  147 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl  147 (277)
                      |||||+|||++ ++.+||+|||+++.+...... ......||+.|+|||++.+           ..++.++|||||||++
T Consensus       179 rDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil  257 (390)
T 2zmd_A          179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  257 (390)
T ss_dssp             CCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred             cCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence            99999999996 578999999999876543222 2345679999999999865           3688999999999999


Q ss_pred             HHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          148 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |||++|+.||........     ...........     ...+...+   ..+.+++.+||+.||.+||++.|+++
T Consensus       258 ~ell~G~~Pf~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~---~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          258 YYMTYGKTPFQQIINQIS-----KLHAIIDPNHE-----IEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHHSSCTTTTCCCHHH-----HHHHHHCTTSC-----CCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHCCCcchhhhHHHH-----HHHHHhCcccc-----CCCCccch---HHHHHHHHHHcccChhhCCCHHHHhh
Confidence            999999999865432111     11111111111     11122222   34778888899999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9e-40  Score=273.90  Aligned_cols=207  Identities=17%  Similarity=0.223  Sum_probs=144.3

Q ss_pred             ccccc-CCCccceeeEEE--------eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            3 LSNVR-HPNLVELIGCCV--------QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         3 L~~l~-h~niv~~~~~~~--------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      |.++. ||||+++++++.        .....++||||+. |+|.+++.... ....+++..++.++.|++.||+|||+. 
T Consensus        79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-  155 (337)
T 3ll6_A           79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ-  155 (337)
T ss_dssp             HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS-
T ss_pred             HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            55674 999999999995        3345799999996 69999885422 234699999999999999999999999 


Q ss_pred             CCC--eEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-----------eeeeecccccccCcccc---ccCccccc
Q 023808           74 VPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-----------ITTRIAGTTGYLAPEYV---LGGQLTMK  137 (277)
Q Consensus        74 ~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~  137 (277)
                        +  ++||||||+|||++.++.+||+|||+++........           ......||..|+|||++   .+..++.+
T Consensus       156 --~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~  233 (337)
T 3ll6_A          156 --KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK  233 (337)
T ss_dssp             --SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHH
T ss_pred             --CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH
Confidence              8  999999999999999999999999999876543221           11244589999999988   55678999


Q ss_pred             cceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      +||||||+++|||++|..||.......          .......    .+......    ..+.+++.+||+.||.+||+
T Consensus       234 ~Dv~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~----~~~~~~~~----~~~~~li~~~l~~~p~~Rps  295 (337)
T 3ll6_A          234 QDIWALGCILYLLCFRQHPFEDGAKLR----------IVNGKYS----IPPHDTQY----TVFHSLIRAMLQVNPEERLS  295 (337)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC----------------------CC----CCTTCCSS----GGGHHHHHHHSCSSGGGSCC
T ss_pred             HhHHHHHHHHHHHHhCCCCCcchhHHH----------hhcCccc----CCcccccc----hHHHHHHHHHccCChhhCcC
Confidence            999999999999999999985432110          0000000    00011111    22677888899999999999


Q ss_pred             HHHHHHHHhhccccC
Q 023808          218 MNQVIKMLTKNIRLN  232 (277)
Q Consensus       218 ~~~v~~~L~~~~~~~  232 (277)
                      +.++++.|+.+....
T Consensus       296 ~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          296 IAEVVHQLQEIAAAR  310 (337)
T ss_dssp             HHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcc
Confidence            999999999887654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-39  Score=285.59  Aligned_cols=200  Identities=26%  Similarity=0.368  Sum_probs=158.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++++|.+....++|||||.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~D  161 (494)
T 3lij_A           89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRD  161 (494)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---Cceecc
Confidence            4788999999999999999999999999999999999884    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC---CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++.+   +.+||+|||+++.+....  ......||+.|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus       162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~  238 (494)
T 3lij_A          162 LKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG  238 (494)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChhhEEEeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999764   459999999998765432  233456999999999876 568999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ....   ........  ...+.....+    ..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~---~~~~---~i~~~~~~--~~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          239 GQTDQ---EILR---KVEKGKYT--FDSPEWKNVS----EGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CSSHH---HHHH---HHHHTCCC--CCSGGGTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHH---HHHH---HHHhCCCC--CCchhcccCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence            54321   1111   11111111  0011111222    34778888999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-39  Score=276.37  Aligned_cols=150  Identities=31%  Similarity=0.490  Sum_probs=126.9

Q ss_pred             cccccc-CCCccceeeEEEeCC--eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVR-HPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|+++. ||||+++++++...+  ..|+||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+
T Consensus        61 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~iv  131 (388)
T 3oz6_A           61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLL  131 (388)
T ss_dssp             HHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEE
Confidence            456776 999999999998654  6899999997 599999843     3689999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCC--------------------cceeeeecccccccCcccccc-Cccccc
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--------------------THITTRIAGTTGYLAPEYVLG-GQLTMK  137 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~  137 (277)
                      ||||||+|||++.++.+||+|||+++.+....                    ........||+.|+|||++.+ ..++.+
T Consensus       132 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  211 (388)
T 3oz6_A          132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG  211 (388)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH
T ss_pred             eCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh
Confidence            99999999999999999999999998653211                    111234579999999999887 578999


Q ss_pred             cceEehhHHHHHHHhCCCCCCcc
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      +|||||||++|||++|+.||...
T Consensus       212 ~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          212 IDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999998654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.6e-40  Score=276.03  Aligned_cols=212  Identities=28%  Similarity=0.410  Sum_probs=155.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|||
T Consensus        77 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~d  149 (331)
T 4aaa_A           77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRD  149 (331)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccC
Confidence            4678899999999999999999999999999999998873    344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          150 IKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             CCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cChheEEEcCCCcEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999986544322 22345689999999998875 6899999999999999999999998654


Q ss_pred             cCcchhhHHHHHH----------HHhccCCc-cccccCCCCC------CCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAW----------QLHQEEKP-LELVDPELGE------YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~----------~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....  ......          ........ .....+....      ..+.....+.+++.+||+.||.+||++.|+++
T Consensus       229 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          229 SDIDQ--LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             SHHHH--HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CcHHH--HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            32211  111100          00000000 0000011100      01122345888899999999999999998875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-39  Score=269.61  Aligned_cols=200  Identities=24%  Similarity=0.324  Sum_probs=159.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  131 (304)
T 2jam_A           59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRD  131 (304)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCS
T ss_pred             HHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            46788999999999999999999999999999999999843    34689999999999999999999999   999999


Q ss_pred             CCCCcEEe---CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||++   +.++.+||+|||+++.....   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus       132 ikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  208 (304)
T 2jam_A          132 LKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY  208 (304)
T ss_dssp             CCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999   77889999999999754332   1233468999999999999899999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....   .......  ....+.....    ...+.+++.+||+.||.+||++.++++
T Consensus       209 ~~~~---~~~~~---~i~~~~~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          209 EETE---SKLFE---KIKEGYY--EFESPFWDDI----SESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TSCH---HHHHH---HHHHCCC--CCCTTTTTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCH---HHHHH---HHHcCCC--CCCccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            5322   11111   1111111  0001111122    234778888999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=265.75  Aligned_cols=204  Identities=25%  Similarity=0.372  Sum_probs=157.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+|
T Consensus        72 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  147 (295)
T 2clq_A           72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRD  147 (295)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccC
Confidence            4678899999999999999999999999999999999996432 233567899999999999999999999   999999


Q ss_pred             CCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccCc--cccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++. ++.+||+|||+++...... .......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||.
T Consensus       148 l~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          148 IKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             CSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             CChhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            9999999987 8899999999998764322 1233456899999999987653  7899999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ........ .  .......       ..+.+.   ......+.+++.+||+.||++||++.++++
T Consensus       227 ~~~~~~~~-~--~~~~~~~-------~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          227 ELGEPQAA-M--FKVGMFK-------VHPEIP---ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             GGSSHHHH-H--HHHHHHC-------CCCCCC---TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             CCCchhHH-H--Hhhcccc-------cccccc---ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            43322111 0  0001110       111121   122234778888899999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.6e-39  Score=271.37  Aligned_cols=212  Identities=22%  Similarity=0.298  Sum_probs=156.7

Q ss_pred             ccccccCCCccceeeEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++..        .+..++||||+++ +|.+.+.   .....+++..+..++.|++.||+|||+. 
T Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~-  143 (351)
T 3mi9_A           69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN-  143 (351)
T ss_dssp             HHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678899999999999987        4468999999976 7777764   3344699999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc---ceeeeecccccccCcccccc-CccccccceEehhHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLE  149 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~e  149 (277)
                        +|+||||||+||+++.++.+||+|||+++.+.....   .......||+.|+|||++.+ ..++.++||||||+++||
T Consensus       144 --~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e  221 (351)
T 3mi9_A          144 --KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE  221 (351)
T ss_dssp             --TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHH
T ss_pred             --CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHH
Confidence              999999999999999999999999999987653221   22334568999999998876 457999999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCcc---cc-----ccC-----CCCCCCHHH------HHHHHHHHHhhhhh
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---EL-----VDP-----ELGEYPPNE------IIRYMKVAFFCTQA  210 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~-----~~~~~~~~~------~~~~~~l~~~c~~~  210 (277)
                      |++|..||.......   ....+..........   ..     .+.     .........      ...+.+++.+||+.
T Consensus       222 ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  298 (351)
T 3mi9_A          222 MWTRSPIMQGNTEQH---QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL  298 (351)
T ss_dssp             HHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred             HHhCCCCCCCCChHH---HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence            999999987543221   222222221111100   00     000     000000111      12377899999999


Q ss_pred             hhcCCCCHHHHHH
Q 023808          211 AASRRPQMNQVIK  223 (277)
Q Consensus       211 ~p~~RPs~~~v~~  223 (277)
                      ||++|||+.|+++
T Consensus       299 dP~~R~t~~e~l~  311 (351)
T 3mi9_A          299 DPAQRIDSDDALN  311 (351)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhC
Confidence            9999999998875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-39  Score=264.75  Aligned_cols=197  Identities=23%  Similarity=0.375  Sum_probs=151.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++++|.+++..    ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        64 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d  136 (276)
T 2h6d_A           64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRD  136 (276)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCC
T ss_pred             HHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCC
Confidence            46788999999999999999999999999999999999943    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||++.......  ......|+..|+|||.+.+..+ +.++||||||+++|+|++|..||...
T Consensus       137 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          137 LKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             CCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CChhhEEECCCCCEEEeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998764432  2234568899999999987765 68999999999999999999998653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   .....   .... ...      .++..   ....+.+++.+||+.||.+||++.++++
T Consensus       215 ~~---~~~~~---~~~~-~~~------~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          215 HV---PTLFK---KIRG-GVF------YIPEY---LNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             SH---HHHHH---HHHH-CCC------CCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cH---HHHHH---Hhhc-Ccc------cCchh---cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            21   11111   1111 110      11111   1234778888899999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=268.60  Aligned_cols=202  Identities=24%  Similarity=0.384  Sum_probs=162.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++|+|.+++..   .+..+++..++.++.|++.||.|||+.   +++|+|
T Consensus        77 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  150 (314)
T 3com_A           77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRD  150 (314)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCC
Confidence            46788999999999999999999999999999999999842   345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       151 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          151 IKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999986644322 2334568999999999999899999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...      ........... .     + ..+......+.+++.+||+.||.+||++.++++
T Consensus       230 ~~~------~~~~~~~~~~~-~-----~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          230 PMR------AIFMIPTNPPP-T-----F-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHH------HHHHHHHSCCC-C-----C-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hHH------HHHHHhcCCCc-c-----c-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            211      11111111110 0     0 011112335778888999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-39  Score=286.30  Aligned_cols=200  Identities=24%  Similarity=0.328  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+....++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~D  151 (484)
T 3nyv_A           79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRD  151 (484)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCC
Confidence            4788999999999999999999999999999999999984    345699999999999999999999999   999999


Q ss_pred             CCCCcEEe---CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||++   +.++.+||+|||+++.+.....  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus       152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  228 (484)
T 3nyv_A          152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN  228 (484)
T ss_dssp             CCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEEecCCCCCcEEEEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence            99999999   5678899999999987654322  234569999999998866 68999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....   ..........  .+..    ......+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~---~~~~~---~i~~~~~~~~--~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          229 GANE---YDILK---KVEKGKYTFE--LPQW----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CSSH---HHHHH---HHHHCCCCCC--SGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCH---HHHHH---HHHcCCCCCC--Cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            5432   11111   1111111100  0111    122334778889999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-39  Score=281.26  Aligned_cols=144  Identities=24%  Similarity=0.397  Sum_probs=120.6

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++...     ...|+||||+ +|+|.+++.    ....+++..+..++.||+.||+|||+.   +
T Consensus       105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~  176 (458)
T 3rp9_A          105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---G  176 (458)
T ss_dssp             HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            57789999999999999543     5789999998 569999983    445699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCc--------------------------ceeeeecccccccCcccc-
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--------------------------HITTRIAGTTGYLAPEYV-  129 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-  129 (277)
                      |+||||||+|||++.++.+||+|||+++.......                          .......||+.|+|||++ 
T Consensus       177 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  256 (458)
T 3rp9_A          177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL  256 (458)
T ss_dssp             CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred             cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence            99999999999999999999999999987643211                          112345689999999976 


Q ss_pred             ccCccccccceEehhHHHHHHHhC
Q 023808          130 LGGQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus       130 ~~~~~~~~~Dv~slG~vl~elltg  153 (277)
                      ....++.++|||||||++|||++|
T Consensus       257 ~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          257 LQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCCcHhHHHHHHHHHHHHHHh
Confidence            456799999999999999999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-39  Score=271.01  Aligned_cols=211  Identities=22%  Similarity=0.297  Sum_probs=159.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+++ +|.+++.   .....+++..+..++.|++.||+|||+.   +++|||
T Consensus        65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  137 (346)
T 1ua2_A           65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRD  137 (346)
T ss_dssp             HHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCC
Confidence            46788999999999999999999999999976 8999884   3345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++....... ......||..|+|||++.+. .++.++||||||+++|||++|..||...
T Consensus       138 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          138 LKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             CCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCHHHEEEcCCCCEEEEecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999999987644322 23345689999999998764 4889999999999999999999887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccc------c----CCCCCCC-----HHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELV------D----PELGEYP-----PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~------~----~~~~~~~-----~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ......+.............      +    ......+     ......+.+++.+||+.||.+|||+.|+++
T Consensus       217 ~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          217 SD---LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SH---HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CH---HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            32   11122222221111100000      0    0001111     112245788899999999999999999876

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-39  Score=283.93  Aligned_cols=200  Identities=25%  Similarity=0.340  Sum_probs=157.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+....++||||+.+|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+|||
T Consensus        74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~D  146 (486)
T 3mwu_A           74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRD  146 (486)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecc
Confidence            47789999999999999999999999999999999998843    34699999999999999999999999   999999


Q ss_pred             CCCCcEEeC---CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++   .++.+||+|||+++.+....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus       147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  223 (486)
T 3mwu_A          147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (486)
T ss_dssp             CSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CchHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999995   45679999999998765432  2334569999999998875 58999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....   ..........  .+..    ......+.+++.+||+.||.+|||+.++++
T Consensus       224 ~~~~---~~~~~---~i~~~~~~~~--~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          224 GKNE---YDILK---RVETGKYAFD--LPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CSSH---HHHHH---HHHHTCCCSC--SGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCH---HHHHH---HHHhCCCCCC--Cccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            5332   11111   1111111100  0111    122234778889999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-38  Score=268.42  Aligned_cols=209  Identities=18%  Similarity=0.264  Sum_probs=160.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHH------hccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV------LLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~   74 (277)
                      +|++++||||+++++++.+.+..++||||+++|+|.++      +..  .....+++..++.++.|++.||+|||+ .  
T Consensus        96 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--  171 (348)
T 2pml_X           96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK--  171 (348)
T ss_dssp             HHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS--
T ss_pred             HHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC--
Confidence            46789999999999999999999999999999999998      522  225679999999999999999999999 8  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-cccc-ccceEehhHHHHHHHh
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTM-KADVYSFGVLVLEIIS  152 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~vl~ellt  152 (277)
                       +++|+||||+||+++.++.+||+|||.+......   ......|+..|+|||.+.+. .++. ++||||||+++|||++
T Consensus       172 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~  247 (348)
T 2pml_X          172 -NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY  247 (348)
T ss_dssp             -CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred             -CEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence             9999999999999999999999999999875433   33445689999999999887 6666 9999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHHhccCCcccc-----ccCC----CCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL-----VDPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |..||.......  ...   ............     ..+.    ...........+.+++.+||+.||.+||++.++++
T Consensus       248 g~~pf~~~~~~~--~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          248 NVVPFSLKISLV--ELF---NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SSCSSCCSSCSH--HHH---HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCcHH--HHH---HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            999987543311  111   111111110000     0000    00000222345778888999999999999999976

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-39  Score=274.25  Aligned_cols=200  Identities=24%  Similarity=0.392  Sum_probs=157.9

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |+++ +||||+++++++......++||||++|++|.+++.    .+..+++..+..++.|++.||.|||+.   +++|+|
T Consensus       153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~D  225 (365)
T 2y7j_A          153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRD  225 (365)
T ss_dssp             HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            4566 79999999999999999999999999999999994    334689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc------CccccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+||+++.++.+||+|||++..+....  ......||+.|+|||++.+      ..++.++||||||+++|||++|..
T Consensus       226 lkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~  303 (365)
T 2y7j_A          226 LKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP  303 (365)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence            99999999999999999999998765432  2334678999999998864      358889999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||.....   ......+   ........  .+.....    ...+.+++.+||+.||.+||++.++++
T Consensus       304 pf~~~~~---~~~~~~i---~~~~~~~~--~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          304 PFWHRRQ---ILMLRMI---MEGQYQFS--SPEWDDR----SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SSCCSSH---HHHHHHH---HHTCCCCC--HHHHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCH---HHHHHHH---HhCCCCCC--CcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            9865321   1111111   11110000  0000111    234778888999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-39  Score=266.27  Aligned_cols=203  Identities=24%  Similarity=0.382  Sum_probs=149.1

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      ++.++||||+++++++.+++..++||||+++ +|.+++......+..+++..++.++.|++.||+|||+..  +++||||
T Consensus        60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dl  136 (290)
T 3fme_A           60 MRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDV  136 (290)
T ss_dssp             HTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCC
T ss_pred             HHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCC
Confidence            5678999999999999999999999999975 888887543345667999999999999999999999842  8999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccc----ccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||+||+++.++.+||+|||+++.......  .....||..|+|||.+    .+..++.++||||||+++|+|++|..||.
T Consensus       137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  214 (290)
T 3fme_A          137 KPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD  214 (290)
T ss_dssp             SGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             CHHHEEECCCCCEEEeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            99999999999999999999986644322  2334689999999996    45678999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....... ..    ..........      ..  .......+.+++.+||+.||.+|||+.|+++
T Consensus       215 ~~~~~~~-~~----~~~~~~~~~~------~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          215 SWGTPFQ-QL----KQVVEEPSPQ------LP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCSCHHH-HH----HHHHHSCCCC------CC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCchHH-HH----HHHhccCCCC------cc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            5322211 11    1111111110      00  0112234778888999999999999999976

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-39  Score=284.93  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=158.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.++...++|||||++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+|||
T Consensus        99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~D  171 (504)
T 3q5i_A           99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRD  171 (504)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCC
Confidence            47789999999999999999999999999999999998843    34699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC---ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.++   .+||+|||+++.+....  ......||+.|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus       172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~  248 (504)
T 3q5i_A          172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFG  248 (504)
T ss_dssp             CSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence            999999998776   69999999998765432  233456999999999876 468999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ....   ...........  +.....    ...+.+++.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~---~~~~---~i~~~~~~~~~--~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          249 GQNDQ---DIIK---KVEKGKYYFDF--NDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CSSHH---HHHH---HHHHCCCCCCH--HHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHH---HHHH---HHHcCCCCCCc--cccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            54321   1111   11111110000  000111    234778888999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.4e-39  Score=292.50  Aligned_cols=192  Identities=25%  Similarity=0.298  Sum_probs=156.7

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      |.++ +||||+++++++.+.+..|+||||++||+|.+++..    ...+++..+..++.||+.||+|||+.   +|+|||
T Consensus       395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrD  467 (674)
T 3pfq_A          395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRD  467 (674)
T ss_dssp             HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCC
T ss_pred             HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecc
Confidence            4455 799999999999999999999999999999999943    34699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus       468 LKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  546 (674)
T 3pfq_A          468 LKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  546 (674)
T ss_dssp             CCSTTEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CChhhEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999998643322 22445679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      .   ....   ........       .+   +......+.+++.+||+.||.+||++
T Consensus       547 ~---~~~~---~~i~~~~~-------~~---p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          547 E---DELF---QSIMEHNV-------AY---PKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             H---HHHH---HHHHSSCC-------CC---CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             H---HHHH---HHHHhCCC-------CC---CccCCHHHHHHHHHHccCCHHHCCCC
Confidence            2   1111   12222111       11   12223347788888999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.3e-39  Score=278.61  Aligned_cols=148  Identities=28%  Similarity=0.413  Sum_probs=124.0

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++...     ...|+||||++ |+|.+++.    .+..+++..+..++.||+.||+|||+.   +
T Consensus        78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---g  149 (432)
T 3n9x_A           78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---G  149 (432)
T ss_dssp             HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            47789999999999999876     57899999996 59999993    445699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCc---------------------ceeeeecccccccCcccc-ccCcc
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---------------------HITTRIAGTTGYLAPEYV-LGGQL  134 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~  134 (277)
                      |+||||||+|||++.++.+||+|||+++.......                     .......||..|+|||++ ....+
T Consensus       150 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~  229 (432)
T 3n9x_A          150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY  229 (432)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCC
T ss_pred             CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCC
Confidence            99999999999999999999999999987654321                     112456789999999986 45569


Q ss_pred             ccccceEehhHHHHHHHhCCCCC
Q 023808          135 TMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus       135 ~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +.++|||||||++|||++|..|+
T Consensus       230 ~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          230 TKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CcccccchHHHHHHHHHhccccc
Confidence            99999999999999999865544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.7e-39  Score=268.83  Aligned_cols=201  Identities=22%  Similarity=0.317  Sum_probs=155.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..+. .++||||+.+|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++|||
T Consensus        68 ~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~d  139 (322)
T 2ycf_A           68 ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRD  139 (322)
T ss_dssp             HHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            467889999999999987665 799999999999999983    455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCc---eEEeecccccccCCCCcceeeeecccccccCccccc---cCccccccceEehhHHHHHHHhCCC
Q 023808           82 IKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        82 ikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |||+||+++.++.   +||+|||+++......  ......||..|+|||++.   ...++.++||||||+++|+|++|..
T Consensus       140 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  217 (322)
T 2ycf_A          140 LKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP  217 (322)
T ss_dssp             CSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999987654   9999999998764432  123456899999999874   4568899999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||........  +......    .... . .+..   .......+.+++.+||+.||.+||++.++++
T Consensus       218 pf~~~~~~~~--~~~~~~~----~~~~-~-~~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          218 PFSEHRTQVS--LKDQITS----GKYN-F-IPEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SSCSTTCSSC--HHHHHHH----TCCC-C-CHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccchHHH--HHHHHHh----Cccc-c-Cchh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            9865433211  1111111    1100 0 0000   0112234778889999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=270.69  Aligned_cols=206  Identities=23%  Similarity=0.311  Sum_probs=157.2

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++....      ..|+||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.   
T Consensus        77 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---  147 (367)
T 1cm8_A           77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---  147 (367)
T ss_dssp             HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            467889999999999998663      459999999 7899999843     3589999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +|+||||||+||+++.++.+||+|||+++.....    .....||..|+|||++.+ ..++.++|||||||++|||++|+
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  223 (367)
T 1cm8_A          148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK  223 (367)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CccccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999875432    234568999999999887 67899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCC------------------ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEK------------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .||.......   ....+........                  ........+....+.....+.+++.+||+.||.+||
T Consensus       224 ~pf~~~~~~~---~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~  300 (367)
T 1cm8_A          224 TLFKGSDHLD---QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV  300 (367)
T ss_dssp             CSSCCSSHHH---HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC
Confidence            9986543211   1111111100000                  000000111111122234578888999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      |+.++++
T Consensus       301 t~~e~l~  307 (367)
T 1cm8_A          301 TAGEALA  307 (367)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.2e-40  Score=277.66  Aligned_cols=201  Identities=9%  Similarity=-0.002  Sum_probs=140.5

Q ss_pred             cccccCCCcccee-------eEEEeC-----------------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHH---
Q 023808            3 LSNVRHPNLVELI-------GCCVQG-----------------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKR---   55 (277)
Q Consensus         3 L~~l~h~niv~~~-------~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~---   55 (277)
                      |++ +||||++++       +++...                 ...++||||++ |+|.+++...   +..+++..+   
T Consensus       119 l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~  193 (371)
T 3q60_A          119 LLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGI  193 (371)
T ss_dssp             HHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHH
T ss_pred             hcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhh
Confidence            344 799988755       555433                 23799999998 7999999542   234455556   


Q ss_pred             ---HHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-
Q 023808           56 ---SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-  131 (277)
Q Consensus        56 ---~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  131 (277)
                         +.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+ 
T Consensus       194 ~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~  266 (371)
T 3q60_A          194 LALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNAS  266 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCS
T ss_pred             hhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCC
Confidence               78889999999999999   9999999999999999999999999999865432    224557799999999987 


Q ss_pred             -CccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCC-CCCCHHHHHHHHHHHHhhhh
Q 023808          132 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQ  209 (277)
Q Consensus       132 -~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~  209 (277)
                       ..++.++|||||||++|||+||+.||..........        .............. ....+.....+.+++.+||+
T Consensus       267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  338 (371)
T 3q60_A          267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN  338 (371)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTC
T ss_pred             CCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcC
Confidence             678999999999999999999999987654322110        00000000000000 01111223457788889999


Q ss_pred             hhhcCCCCHHHHHH
Q 023808          210 AAASRRPQMNQVIK  223 (277)
Q Consensus       210 ~~p~~RPs~~~v~~  223 (277)
                      .||++||++.++++
T Consensus       339 ~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          339 FDRRRRLLPLEAME  352 (371)
T ss_dssp             SSTTTCCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-39  Score=275.99  Aligned_cols=213  Identities=22%  Similarity=0.265  Sum_probs=157.7

Q ss_pred             ccccccCCCccceeeEEEe--------------------------------------CCeeEEEEeecCCCCHHHHhccC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--------------------------------------GTRRILVYEYVENNSLDRVLLGA   43 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--------------------------------------~~~~~lv~e~~~~gsL~~~l~~~   43 (277)
                      +|++++||||+++++++..                                      ..+.++||||++ |+|.+.+...
T Consensus        53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~  131 (383)
T 3eb0_A           53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF  131 (383)
T ss_dssp             HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHH
T ss_pred             HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH
Confidence            5788999999999999954                                      335889999997 4888877544


Q ss_pred             CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeC-CCCceEEeecccccccCCCCcceeeeeccccc
Q 023808           44 TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG  122 (277)
Q Consensus        44 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~  122 (277)
                      ...+..+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+++.......  .....||..
T Consensus       132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~  206 (383)
T 3eb0_A          132 IRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRF  206 (383)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSS
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCC
Confidence            34566799999999999999999999999   999999999999997 688999999999987644322  234568999


Q ss_pred             ccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCC----------ccccccCCCCC
Q 023808          123 YLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK----------PLELVDPELGE  191 (277)
Q Consensus       123 y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  191 (277)
                      |+|||.+.+. .++.++|||||||++|||++|+.||.......  .+.. +........          .....-+....
T Consensus       207 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  283 (383)
T 3eb0_A          207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID--QLVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKA  283 (383)
T ss_dssp             CCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCC
T ss_pred             ccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCCCHHHHHHhCcccccccCCccCc
Confidence            9999998775 48999999999999999999999987543221  1111 111111000          00000000000


Q ss_pred             ------CCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          192 ------YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       192 ------~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                            .+......+.+++.+||+.||.+|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  11122334788889999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-39  Score=276.38  Aligned_cols=213  Identities=23%  Similarity=0.286  Sum_probs=155.2

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++....      ..++||||+.++ +.+.+.........+++..+..++.|++.||+|||+.   
T Consensus        85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---  160 (394)
T 4e7w_A           85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---  160 (394)
T ss_dssp             HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            577899999999999997543      378999999774 4444332223455799999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhC
Q 023808           76 HIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg  153 (277)
                      +|+||||||+|||++ .++.+||+|||+++.......  .....||..|+|||++.+. .++.++|||||||++|||++|
T Consensus       161 ~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  238 (394)
T 4e7w_A          161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG  238 (394)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999998 789999999999987644322  2345689999999998765 589999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCc-------ccccc---CCCCC------CCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKP-------LELVD---PELGE------YPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~------~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      +.||.......  .+.... ........       .....   +....      +.+.....+.+++.+||+.||.+||+
T Consensus       239 ~~pf~~~~~~~--~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (394)
T 4e7w_A          239 QPLFPGESGID--QLVEII-KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT  315 (394)
T ss_dssp             SCSSCCSSHHH--HHHHHH-HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             CCCCCCCCHHH--HHHHHH-HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence            99987543221  111111 11000000       00000   00000      11112335888999999999999999


Q ss_pred             HHHHHH
Q 023808          218 MNQVIK  223 (277)
Q Consensus       218 ~~~v~~  223 (277)
                      +.|+++
T Consensus       316 ~~e~l~  321 (394)
T 4e7w_A          316 AIEALC  321 (394)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-38  Score=273.87  Aligned_cols=214  Identities=24%  Similarity=0.261  Sum_probs=156.2

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++|+||||++++++|...      .+.++||||+.+ +|.+++......+..+++..+..++.||+.||+|||+.   
T Consensus       100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---  175 (420)
T 1j1b_A          100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---  175 (420)
T ss_dssp             HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             HHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            57889999999999998642      246799999976 77776643334456799999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCC-CceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhC
Q 023808           76 HIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg  153 (277)
                      +|+||||||+|||++.+ +.+||+|||+++.+.....  .....||..|+|||++.+. .++.++|||||||++|||++|
T Consensus       176 ~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G  253 (420)
T 1j1b_A          176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG  253 (420)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence            99999999999999855 5689999999987644322  2345689999999998765 789999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhc---------cCCccccccCCCCC------CCHHHHHHHHHHHHhhhhhhhcCCCCH
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQ---------EEKPLELVDPELGE------YPPNEIIRYMKVAFFCTQAAASRRPQM  218 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~RPs~  218 (277)
                      +.||......  ..+.........         ........-+.+..      +.+.....+.+++.+||+.||.+||++
T Consensus       254 ~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~  331 (420)
T 1j1b_A          254 QPIFPGDSGV--DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  331 (420)
T ss_dssp             SCSSCCSSHH--HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence            9998754321  111111111000         00000000111111      111223457889999999999999999


Q ss_pred             HHHHH
Q 023808          219 NQVIK  223 (277)
Q Consensus       219 ~~v~~  223 (277)
                      .|+++
T Consensus       332 ~e~l~  336 (420)
T 1j1b_A          332 LEACA  336 (420)
T ss_dssp             HHHHT
T ss_pred             HHHhC
Confidence            99975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.2e-39  Score=264.15  Aligned_cols=201  Identities=23%  Similarity=0.331  Sum_probs=158.5

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++ ||||+++++++..+...++||||+++++|.+++..    +..+++..++.++.|++.||+|||+.   +++|+
T Consensus        76 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~  148 (298)
T 1phk_A           76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHR  148 (298)
T ss_dssp             HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccC
Confidence            356674 99999999999999999999999999999999943    34689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc------cCccccccceEehhHHHHHHHhCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL------GGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      ||||+||+++.++.+||+|||++.......  ......|+..|+|||++.      ...++.++||||||+++|+|++|.
T Consensus       149 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  226 (298)
T 1phk_A          149 DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS  226 (298)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence            999999999999999999999998765432  223456899999999885      346788999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .||.....   .....   ........  ...+.    .......+.+++.+||+.||.+||++.++++
T Consensus       227 ~p~~~~~~---~~~~~---~~~~~~~~--~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          227 PPFWHRKQ---MLMLR---MIMSGNYQ--FGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CSSCCSSH---HHHHH---HHHHTCCC--CCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCcCccH---HHHHH---HHhcCCcc--cCccc----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            99865322   11111   11111110  00111    1222345788889999999999999999865

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.9e-39  Score=269.13  Aligned_cols=205  Identities=20%  Similarity=0.255  Sum_probs=136.9

Q ss_pred             cccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            3 LSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      ++.++||||+++++++..    +...++||||+++|+|.+++...  .+..+++..++.++.|++.||+|||+.   +++
T Consensus        76 ~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~iv  150 (336)
T 3fhr_A           76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIA  150 (336)
T ss_dssp             HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            355789999999999986    45689999999999999999542  234699999999999999999999999   999


Q ss_pred             eccCCCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           79 HRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        79 H~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      ||||||+||+++.   ++.+||+|||+++......   .....||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  227 (336)
T 3fhr_A          151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP  227 (336)
T ss_dssp             CSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCHHHEEEEecCCCceEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence            9999999999976   4459999999998654322   234568999999999988899999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||...........   ........ ......+.....    ...+.+++.+||+.||.+|||+.++++
T Consensus       228 pf~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          228 PFYSNTGQAISPG---MKRRIRLG-QYGFPNPEWSEV----SEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CC-------------------------CCCTTTSTTC----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCccchhhhhh---HHHhhhcc-ccccCchhhccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9865433211000   00000000 000001111122    334778888999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8e-39  Score=278.87  Aligned_cols=207  Identities=22%  Similarity=0.270  Sum_probs=150.7

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...|+||||+++ +|.+.+.    .  .+++..+..++.|++.||+|||+.   
T Consensus       114 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----~--~l~~~~~~~~~~qil~aL~~lH~~---  183 (464)
T 3ttj_A          114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----M--ELDHERMSYLLYQMLCGIKHLHSA---  183 (464)
T ss_dssp             HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT----S--CCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            46788999999999999754      357999999976 5777762    1  388999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +|+||||||+|||++.++.+||+|||+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       184 ~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  261 (464)
T 3ttj_A          184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI  261 (464)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999865432  22344678999999999999999999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCcc----------ccc--cCCCCC-----------------CCHHHHHHHHHHHHh
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPL----------ELV--DPELGE-----------------YPPNEIIRYMKVAFF  206 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~--~~~~~~-----------------~~~~~~~~~~~l~~~  206 (277)
                      ||.......   ....+..........          ..+  .+....                 ........+.+++.+
T Consensus       262 pF~g~~~~~---~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~  338 (464)
T 3ttj_A          262 LFPGRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK  338 (464)
T ss_dssp             SSCCSSHHH---HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHH---HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHH
Confidence            986543211   111111111000000          000  000000                 001124568899999


Q ss_pred             hhhhhhcCCCCHHHHHH
Q 023808          207 CTQAAASRRPQMNQVIK  223 (277)
Q Consensus       207 c~~~~p~~RPs~~~v~~  223 (277)
                      ||+.||++|||+.|+++
T Consensus       339 mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          339 MLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HcCCChhhCCCHHHHhc
Confidence            99999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.7e-38  Score=263.60  Aligned_cols=209  Identities=18%  Similarity=0.238  Sum_probs=156.3

Q ss_pred             cccccc-CCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVR-HPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++ ||||+++++++.+  ....++||||+.+++|.+++.       .+++..+..++.|++.||+|||+.   +++
T Consensus        83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~iv  152 (330)
T 3nsz_A           83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIM  152 (330)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            466776 9999999999998  667899999999999999983       388999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCC
Q 023808           79 HRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        79 H~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||||||+|||++.++ .+||+|||+++.......  .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.|
T Consensus       153 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  230 (330)
T 3nsz_A          153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  230 (330)
T ss_dssp             CCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             eCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999998776 899999999987654322  234568899999999877 5689999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHH--------HHhccCC--------------ccccccCCC-CCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          157 GKAMWGQMNKFLLEWAW--------QLHQEEK--------------PLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~--------~~~~~~~--------------~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      |......... +.....        .......              ......... ..........+.+++.+||+.||.
T Consensus       231 ~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  309 (330)
T 3nsz_A          231 FFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ  309 (330)
T ss_dssp             SSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred             cccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence            8543322111 110000        0000000              000000000 011111234588899999999999


Q ss_pred             CCCCHHHHHH
Q 023808          214 RRPQMNQVIK  223 (277)
Q Consensus       214 ~RPs~~~v~~  223 (277)
                      +|||+.|+++
T Consensus       310 ~Rpta~e~l~  319 (330)
T 3nsz_A          310 SRLTAREAME  319 (330)
T ss_dssp             GSCCHHHHHT
T ss_pred             cCCCHHHHhc
Confidence            9999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=275.00  Aligned_cols=155  Identities=26%  Similarity=0.453  Sum_probs=122.3

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCC-----CCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGAT-----KANIKLNWEKRSDICVGIAKGLAFLHEELV   74 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~   74 (277)
                      +|++|+||||+++++++..  +...++||||+.+ +|.+++....     .....+++..+..++.||+.||+|||+.  
T Consensus        71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--  147 (405)
T 3rgf_A           71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--  147 (405)
T ss_dssp             HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5778999999999999965  6689999999965 8888774211     1223589999999999999999999999  


Q ss_pred             CCeEeccCCCCcEEe----CCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccC-ccccccceEehhHHH
Q 023808           75 PHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLV  147 (277)
Q Consensus        75 ~~iiH~dikp~Nill----~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl  147 (277)
                       +|+||||||+|||+    +.++.+||+|||+++.+.....  .......||+.|+|||++.+. .++.++|||||||++
T Consensus       148 -~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  226 (405)
T 3rgf_A          148 -WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  226 (405)
T ss_dssp             -TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred             -CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence             99999999999999    6778999999999987654322  223446789999999999874 589999999999999


Q ss_pred             HHHHhCCCCCCcc
Q 023808          148 LEIISGRNSGKAM  160 (277)
Q Consensus       148 ~elltg~~p~~~~  160 (277)
                      |||++|..||...
T Consensus       227 ~ell~g~~pf~~~  239 (405)
T 3rgf_A          227 AELLTSEPIFHCR  239 (405)
T ss_dssp             HHHHHSSCTTCCC
T ss_pred             HHHHhCCCCCCCc
Confidence            9999999998644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=260.05  Aligned_cols=200  Identities=20%  Similarity=0.251  Sum_probs=154.1

Q ss_pred             ccccccCCCccceeeEEE--eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            2 TLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +|++++||||+++++++.  +....++||||+.++ |.+++...  ....+++..++.++.|++.||+|||+.   +++|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H  132 (305)
T 2wtk_C           59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVH  132 (305)
T ss_dssp             HHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence            477899999999999995  455789999999876 77777542  345699999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCc--cccccceEehhHHHHHHHhCCCC
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||||+||+++.++.+||+|||++....... ........|+..|+|||++.+..  .+.++||||||+++|||++|..|
T Consensus       133 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  212 (305)
T 2wtk_C          133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP  212 (305)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998765322 22234556899999999987643  47899999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.....   ...   ...... ...      .+.   ......+.+++.+||+.||.+||++.++++
T Consensus       213 ~~~~~~---~~~---~~~i~~-~~~------~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          213 FEGDNI---YKL---FENIGK-GSY------AIP---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CCCSSH---HHH---HHHHHH-CCC------CCC---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCchH---HHH---HHHHhc-CCC------CCC---CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            865321   111   111111 111      111   112234778888899999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.2e-39  Score=277.30  Aligned_cols=206  Identities=22%  Similarity=0.302  Sum_probs=148.5

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCcc---CCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      |+++ +||||+++++++.+++..++||||+. |+|.+++.........   .++..++.++.||+.||+|||+.   +|+
T Consensus        62 l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv  137 (434)
T 2rio_A           62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KII  137 (434)
T ss_dssp             HHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---Ccc
Confidence            4454 89999999999999999999999995 5999999643322211   13345678999999999999999   999


Q ss_pred             eccCCCCcEEeCCC-------------CceEEeecccccccCCCCcc---eeeeecccccccCcccccc-------Cccc
Q 023808           79 HRDIKASNILLDQE-------------FNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLG-------GQLT  135 (277)
Q Consensus        79 H~dikp~Nill~~~-------------~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~  135 (277)
                      ||||||+|||++.+             +.+||+|||+++........   ......||+.|+|||++.+       ..++
T Consensus       138 HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  217 (434)
T 2rio_A          138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT  217 (434)
T ss_dssp             CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred             ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc
Confidence            99999999999653             47999999999976553322   1234579999999999876       5689


Q ss_pred             cccceEehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC
Q 023808          136 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       136 ~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      .++|||||||++|||+| |..||........        ..........   .............+.+++.+||+.||.+
T Consensus       218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------~i~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~  286 (434)
T 2rio_A          218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRES--------NIIRGIFSLD---EMKCLHDRSLIAEATDLISQMIDHDPLK  286 (434)
T ss_dssp             THHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--------HHHHTCCCCC---CCTTCCCHHHHHHHHHHHHHHTCSSGGG
T ss_pred             hhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--------HHhcCCCCcc---cccccccccchHHHHHHHHHHhhCChhh
Confidence            99999999999999999 8889865433211        1111111100   0011123455677889999999999999


Q ss_pred             CCCHHHHHH
Q 023808          215 RPQMNQVIK  223 (277)
Q Consensus       215 RPs~~~v~~  223 (277)
                      ||++.+|++
T Consensus       287 Rps~~eil~  295 (434)
T 2rio_A          287 RPTAMKVLR  295 (434)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHHh
Confidence            999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-38  Score=272.06  Aligned_cols=208  Identities=21%  Similarity=0.275  Sum_probs=155.8

Q ss_pred             cCCCccceeeEEE----eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            7 RHPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         7 ~h~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      +|+||+++++++.    ++...++||||+ +++|.+++..  .....+++..+..++.||+.||+|||+++  +|+||||
T Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDi  173 (397)
T 1wak_A           99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDI  173 (397)
T ss_dssp             GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCC
T ss_pred             CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCC
Confidence            3889999999998    456889999999 5566666533  22346999999999999999999999853  7999999


Q ss_pred             CCCcEEeCCCC-------------------------------------------------ceEEeecccccccCCCCcce
Q 023808           83 KASNILLDQEF-------------------------------------------------NPKIGDFGLAKLFPDNITHI  113 (277)
Q Consensus        83 kp~Nill~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~  113 (277)
                      ||+|||++.++                                                 .+||+|||+++.....    
T Consensus       174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----  249 (397)
T 1wak_A          174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----  249 (397)
T ss_dssp             SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----
T ss_pred             CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----
Confidence            99999998775                                                 7999999999876433    


Q ss_pred             eeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCcch---hhHHHHHHHHhccCC---------c
Q 023808          114 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---KFLLEWAWQLHQEEK---------P  181 (277)
Q Consensus       114 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~---------~  181 (277)
                      .....||..|+|||++.+..++.++|||||||++|||+||+.||........   ...............         .
T Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  329 (397)
T 1wak_A          250 FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS  329 (397)
T ss_dssp             SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG
T ss_pred             CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc
Confidence            2334689999999999999999999999999999999999999875543221   111111111111100         0


Q ss_pred             cccccC--------------------CCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          182 LELVDP--------------------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       182 ~~~~~~--------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......                    .....+......+.+++.+||+.||++|||+.|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000                    001235666778899999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=265.07  Aligned_cols=201  Identities=24%  Similarity=0.428  Sum_probs=150.6

Q ss_pred             cccc-cCCCccceeeEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            3 LSNV-RHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      |+++ +||||+++++++..      ....++||||+++|+|.+++...  .+..+++..++.++.|++.||+|||+.   
T Consensus        74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---  148 (326)
T 2x7f_A           74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---  148 (326)
T ss_dssp             HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            5566 79999999999987      46889999999999999999543  235689999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHH
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el  150 (277)
                      +++|+||||+||+++.++.+||+|||++....... .......|+..|+|||++.     +..++.++||||||+++|+|
T Consensus       149 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l  227 (326)
T 2x7f_A          149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM  227 (326)
T ss_dssp             TCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHH
T ss_pred             CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHH
Confidence            99999999999999999999999999998654322 1223456899999999987     45688999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ++|..||.......   .   .......... ...   ....+    ..+.+++.+||+.||.+||++.++++
T Consensus       228 ~~g~~p~~~~~~~~---~---~~~~~~~~~~-~~~---~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          228 AEGAPPLCDMHPMR---A---LFLIPRNPAP-RLK---SKKWS----KKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHSSCTTTTSCHHH---H---HHHHHHSCCC-CCS---CSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhCCCCCCCCcHHH---H---HHHhhcCccc-cCC---ccccC----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence            99999986543211   1   1111111111 000   01122    34778888899999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.3e-38  Score=266.97  Aligned_cols=212  Identities=20%  Similarity=0.247  Sum_probs=155.8

Q ss_pred             cccccCCCccceeeEEEeCCe-------eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh--cCC
Q 023808            3 LSNVRHPNLVELIGCCVQGTR-------RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH--EEL   73 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~   73 (277)
                      |++++||||+++++++.....       .++||||+.+ +|.+.+.........+++..+..++.|++.||.|||  +. 
T Consensus        73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-  150 (360)
T 3e3p_A           73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-  150 (360)
T ss_dssp             HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-
T ss_pred             HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-
Confidence            466799999999999976433       7899999976 565554333345667899999999999999999999  88 


Q ss_pred             CCCeEeccCCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII  151 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~ell  151 (277)
                        +|+||||||+|||++. ++.+||+|||+++.......  .....||..|+|||++.+.. ++.++||||||+++|||+
T Consensus       151 --~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell  226 (360)
T 3e3p_A          151 --NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM  226 (360)
T ss_dssp             --CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             --CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence              9999999999999986 88999999999987654322  23456899999999987654 899999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhcc------------CCccccccC-------CCCCCCHHHHHHHHHHHHhhhhhhh
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQE------------EKPLELVDP-------ELGEYPPNEIIRYMKVAFFCTQAAA  212 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~c~~~~p  212 (277)
                      +|+.||.......   ...........            .......+.       .+..........+.+++.+||+.||
T Consensus       227 ~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  303 (360)
T 3e3p_A          227 LGEPIFRGDNSAG---QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP  303 (360)
T ss_dssp             HSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred             hCCCCcCCCChHH---HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence            9999986543221   11111111100            000000000       0111122234568889999999999


Q ss_pred             cCCCCHHHHHH
Q 023808          213 SRRPQMNQVIK  223 (277)
Q Consensus       213 ~~RPs~~~v~~  223 (277)
                      .+|||+.|+++
T Consensus       304 ~~Rpt~~e~l~  314 (360)
T 3e3p_A          304 EERMKPYEALC  314 (360)
T ss_dssp             GGSCCHHHHTT
T ss_pred             cccCCHHHHhc
Confidence            99999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.9e-39  Score=267.03  Aligned_cols=202  Identities=22%  Similarity=0.400  Sum_probs=154.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++..++..++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+|
T Consensus        69 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~d  142 (302)
T 2j7t_A           69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD  142 (302)
T ss_dssp             HHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCC
Confidence            46788999999999999999999999999999999999843   234689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+||+++.++.+||+|||++...... ........|+..|+|||.+.     +..++.++||||||+++|+|++|..|
T Consensus       143 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  221 (302)
T 2j7t_A          143 LKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  221 (302)
T ss_dssp             CSGGGEEECTTSCEEECCCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCHHHEEECCCCCEEEEECCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999987642211 11123356899999999883     56788999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +.......      .............       ..+......+.+++.+||+.||.+||++.++++
T Consensus       222 ~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          222 HHELNPMR------VLLKIAKSDPPTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             TTTSCHHH------HHHHHHHSCCCCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CccCCHHH------HHHHHhccCCccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            86543211      1111111111100       011222334778888999999999999998864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.7e-38  Score=260.98  Aligned_cols=202  Identities=25%  Similarity=0.400  Sum_probs=148.8

Q ss_pred             ccccccCCCccceeeEEEe-------------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQ-------------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|++++||||+++++++.+             ....++||||+++|+|.+++..   .+..+++..++.++.|++.||+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~  131 (303)
T 1zy4_A           55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSY  131 (303)
T ss_dssp             HHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHH
Confidence            4778999999999999875             3567999999999999999953   34568889999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCC-------------cceeeeecccccccCccccccC-cc
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-------------THITTRIAGTTGYLAPEYVLGG-QL  134 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~  134 (277)
                      ||+.   +++|+||||+||+++.++.+||+|||+++......             ........|+..|+|||++.+. .+
T Consensus       132 LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  208 (303)
T 1zy4_A          132 IHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY  208 (303)
T ss_dssp             HHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCC
T ss_pred             HHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCC
Confidence            9999   99999999999999999999999999998654321             1122345689999999998764 68


Q ss_pred             ccccceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcC
Q 023808          135 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR  214 (277)
Q Consensus       135 ~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~  214 (277)
                      +.++||||||+++|||++   |+.....     .......... ..  ....+.   ........+.+++.+||+.||.+
T Consensus       209 ~~~~Di~slG~il~~l~~---p~~~~~~-----~~~~~~~~~~-~~--~~~~~~---~~~~~~~~~~~li~~~l~~dp~~  274 (303)
T 1zy4_A          209 NEKIDMYSLGIIFFEMIY---PFSTGME-----RVNILKKLRS-VS--IEFPPD---FDDNKMKVEKKIIRLLIDHDPNK  274 (303)
T ss_dssp             CTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHHHHHHS-TT--CCCCTT---CCTTTSHHHHHHHHHHTCSSGGG
T ss_pred             cchhhHHHHHHHHHHHHh---ccCCchh-----HHHHHHhccc-cc--cccCcc---ccccchHHHHHHHHHHHhcCccc
Confidence            999999999999999998   3322111     1111111111 11  011111   22233344778888899999999


Q ss_pred             CCCHHHHHH
Q 023808          215 RPQMNQVIK  223 (277)
Q Consensus       215 RPs~~~v~~  223 (277)
                      ||++.++++
T Consensus       275 Rps~~~ll~  283 (303)
T 1zy4_A          275 RPGARTLLN  283 (303)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHhC
Confidence            999999976

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-38  Score=267.05  Aligned_cols=207  Identities=24%  Similarity=0.298  Sum_probs=148.1

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++....      ..++||||+++ +|.+++.      ..+++..+..++.|++.||+|||+.   
T Consensus        77 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---  146 (371)
T 2xrw_A           77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---  146 (371)
T ss_dssp             HHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---
Confidence            467889999999999998665      78999999975 7888883      2488999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +|+||||||+||+++.++.+||+|||+++......  ......||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus       147 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  224 (371)
T 2xrw_A          147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV  224 (371)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CeecccCCHHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998654321  2234568999999999999899999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHh-------------------ccCCcc------cccc----CCCCCCCHHHHHHHHHHHHh
Q 023808          156 SGKAMWGQMNKFLLEWAWQLH-------------------QEEKPL------ELVD----PELGEYPPNEIIRYMKVAFF  206 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~------~~~~----~~~~~~~~~~~~~~~~l~~~  206 (277)
                      ||.......   ....+....                   ......      ....    +............+.+++.+
T Consensus       225 pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  301 (371)
T 2xrw_A          225 LFPGTDHID---QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK  301 (371)
T ss_dssp             SSCCSSHHH---HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHH
Confidence            986543211   000000000                   000000      0000    00000011224568899999


Q ss_pred             hhhhhhcCCCCHHHHHH
Q 023808          207 CTQAAASRRPQMNQVIK  223 (277)
Q Consensus       207 c~~~~p~~RPs~~~v~~  223 (277)
                      ||+.||.+|||+.|+++
T Consensus       302 mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          302 MLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HCcCChhhCCCHHHHhC
Confidence            99999999999999976

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.3e-38  Score=267.44  Aligned_cols=210  Identities=23%  Similarity=0.320  Sum_probs=156.2

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++...     ...++||||+. |+|.+++..     ..+++..+..++.|++.||+|||+.   +
T Consensus        78 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~  148 (364)
T 3qyz_A           78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---N  148 (364)
T ss_dssp             HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            46789999999999999765     36899999997 599999842     3589999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccC-ccccccceEehhHHHHHHHhC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg  153 (277)
                      |+||||||+||+++.++.+||+|||+++.........  .....||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus       149 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  228 (364)
T 3qyz_A          149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN  228 (364)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence            9999999999999999999999999998765432211  2345789999999987654 589999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHHHHhccCCccc---------------cccC-CC--CCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLE---------------LVDP-EL--GEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-~~--~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      +.||........   ...+...........               .... ..  ....+.....+.+++.+||+.||.+|
T Consensus       229 ~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  305 (364)
T 3qyz_A          229 RPIFPGKHYLDQ---LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR  305 (364)
T ss_dssp             SCSSCCSSGGGH---HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred             CCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence            999865433221   111111111000000               0000 00  00001122347888999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.|+++
T Consensus       306 ~t~~e~l~  313 (364)
T 3qyz_A          306 IEVEQALA  313 (364)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-38  Score=269.35  Aligned_cols=205  Identities=23%  Similarity=0.312  Sum_probs=143.0

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...      ...++|||++ +++|.+++.     ...+++..+..++.||+.||+|||+.   
T Consensus        81 ~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---  151 (367)
T 2fst_X           81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---  151 (367)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            46788999999999999754      5679999999 679999883     24699999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +|+||||||+||+++.++.+||+|||+++.....    .....||..|+|||++.+ ..++.++|||||||++|||++|+
T Consensus       152 givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  227 (367)
T 2fst_X          152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR  227 (367)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CeeeCCCCHhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865432    234568999999999887 67899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCcccccc--------------CCCCCC-----CHHHHHHHHHHHHhhhhhhhcCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD--------------PELGEY-----PPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~-----~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      .||.......   ....+....... ..+.+.              +.....     .+.....+.+++.+||+.||.+|
T Consensus       228 ~pf~~~~~~~---~l~~i~~~~g~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R  303 (367)
T 2fst_X          228 TLFPGTDHID---QLKLILRLVGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR  303 (367)
T ss_dssp             CSCCCSSHHH---HHHHHHHHHCSC-CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred             CCCCCCCHHH---HHHHHHHHhCCC-CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence            9986543211   111111111100 000000              000000     01112347788999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.++++
T Consensus       304 ~t~~e~L~  311 (367)
T 2fst_X          304 ITAAQALA  311 (367)
T ss_dssp             CCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=273.57  Aligned_cols=202  Identities=22%  Similarity=0.296  Sum_probs=148.5

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ +||||+++++++.++...++||||+. |+|.+++...   ....++..++.++.||+.||+|||+.   +|+||
T Consensus        70 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHr  142 (432)
T 3p23_A           70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHR  142 (432)
T ss_dssp             HHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred             HHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeC
Confidence            35667 89999999999999999999999996 5999999543   23355556788999999999999999   99999


Q ss_pred             cCCCCcEEeCC-----CCceEEeecccccccCCCCc--ceeeeecccccccCcccccc---CccccccceEehhHHHHHH
Q 023808           81 DIKASNILLDQ-----EFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        81 dikp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el  150 (277)
                      ||||+|||++.     ...+||+|||+++.......  .......||+.|+|||++.+   ..++.++|||||||++|||
T Consensus       143 DlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~el  222 (432)
T 3p23_A          143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV  222 (432)
T ss_dssp             CCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence            99999999953     33588999999987654321  22344679999999999873   5678899999999999999


Q ss_pred             Hh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          151 IS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +| |..||........        ...........     ..........+.+++.+||+.||.+||++.+|++
T Consensus       223 lt~g~~pf~~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          223 ISEGSHPFGKSLQRQA--------NILLGACSLDC-----LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HTTSCBTTBSTTTHHH--------HHHTTCCCCTT-----SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCCcchhhHHHH--------HHHhccCCccc-----cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            99 8888754322111        11111111111     1112233445778999999999999999999983

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-38  Score=266.10  Aligned_cols=203  Identities=19%  Similarity=0.232  Sum_probs=155.9

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI   87 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Ni   87 (277)
                      |++|+++++++...+..++||||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        76 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  149 (339)
T 1z57_A           76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENI  149 (339)
T ss_dssp             TTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             ceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            446999999999999999999999 88999998542  233689999999999999999999999   999999999999


Q ss_pred             EeCC-------------------CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           88 LLDQ-------------------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        88 ll~~-------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      +++.                   ++.+||+|||+++.....    .....||..|+|||++.+..++.++||||||+++|
T Consensus       150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  225 (339)
T 1z57_A          150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI  225 (339)
T ss_dssp             EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred             EEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence            9987                   667999999999865432    23456899999999999989999999999999999


Q ss_pred             HHHhCCCCCCcccCcchhhHHHHHHHHhccCC--------ccccc---------------------c--CCCCCCCHHHH
Q 023808          149 EIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--------PLELV---------------------D--PELGEYPPNEI  197 (277)
Q Consensus       149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---------------------~--~~~~~~~~~~~  197 (277)
                      ||++|..||........   ............        .....                     .  ...........
T Consensus       226 el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (339)
T 1z57_A          226 EYYLGFTVFPTHDSKEH---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH  302 (339)
T ss_dssp             HHHHSSCSCCCSCHHHH---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred             HHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhH
Confidence            99999999865432211   111111111000        00000                     0  00011233456


Q ss_pred             HHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          198 IRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       198 ~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..+.+++.+||+.||.+|||+.|+++
T Consensus       303 ~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          303 ERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHhCcCcccccCHHHHhc
Confidence            67889999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-38  Score=264.97  Aligned_cols=208  Identities=23%  Similarity=0.334  Sum_probs=156.5

Q ss_pred             cccCCCccceeeEEE-----eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            5 NVRHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         5 ~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +++||||+++++++.     .....++||||+. |+|.+++...  ....+++..++.++.|++.||+|||+.   +++|
T Consensus        70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H  143 (326)
T 1blx_A           70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVH  143 (326)
T ss_dssp             HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---Ccee
Confidence            448999999999998     4567899999997 5999998543  233589999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           80 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        80 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      +||||+||+++.++.+||+|||+++......  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          144 RDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             CCCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCCHHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999998654322  23345689999999999998999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCcc----------cccc----CCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPL----------ELVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   .....+..........          ....    ..+..........+.+++.+||+.||.+||++.++++
T Consensus       222 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          222 SSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SSHH---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHH---HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            4321   1111111111100000          0000    0001111222334778888999999999999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.3e-38  Score=271.40  Aligned_cols=145  Identities=22%  Similarity=0.296  Sum_probs=128.5

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      .+|+||+++++++...+..++||||+. ++|.+++...  ....+++..+..++.||+.||+|||+.   +|+||||||+
T Consensus       156 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~  229 (429)
T 3kvw_A          156 DNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPE  229 (429)
T ss_dssp             TSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGG
T ss_pred             cCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHH
Confidence            378899999999999999999999996 5999998543  233589999999999999999999999   9999999999


Q ss_pred             cEEeCCCCc--eEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           86 NILLDQEFN--PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        86 Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||++.++.  +||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||+||..||...
T Consensus       230 NILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          230 NILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HeEEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999887  999999999865432    23456899999999999999999999999999999999999998654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-38  Score=269.85  Aligned_cols=210  Identities=23%  Similarity=0.241  Sum_probs=148.8

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++...     ...++||||+. |+|.+++.   ..+..+++..+..++.|++.||+|||+.   +
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~  154 (362)
T 3pg1_A           82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---G  154 (362)
T ss_dssp             HHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence            46788999999999999643     36799999997 58888874   3445699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      ++||||||+||+++.++.+||+|||+++......  ......||..|+|||++.+ ..++.++||||||+++|+|++|+.
T Consensus       155 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  232 (362)
T 3pg1_A          155 VVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA  232 (362)
T ss_dssp             CCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence            9999999999999999999999999998543322  2334568899999999877 678999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCC-------------------ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEK-------------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      ||.......   .............                   .............+.....+.+++.+||+.||.+||
T Consensus       233 pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  309 (362)
T 3pg1_A          233 LFRGSTFYN---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI  309 (362)
T ss_dssp             SCCCSSHHH---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCHHH---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC
Confidence            986543211   1111111111000                   000000000001111223477889999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      |+.|+++
T Consensus       310 t~~ell~  316 (362)
T 3pg1_A          310 STEQALR  316 (362)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHHc
Confidence            9999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.6e-38  Score=258.08  Aligned_cols=200  Identities=25%  Similarity=0.346  Sum_probs=156.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++..    ...+++..++.++.|++.||+|||+.   +++|+|
T Consensus        74 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~d  146 (287)
T 2wei_A           74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRD  146 (287)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            46789999999999999999999999999999999998843    34689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC---CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||+++.+   +.+||+|||++........  .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||.
T Consensus       147 l~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  223 (287)
T 2wei_A          147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (287)
T ss_dssp             CCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChhhEEEecCCCcccEEEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence            99999999754   4699999999986654322  223458899999998765 48899999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ....   ..........  .+.....+    ..+.+++.+||+.||.+||++.++++
T Consensus       224 ~~~~~---~~~~---~~~~~~~~~~--~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          224 GKNEY---DILK---RVETGKYAFD--LPQWRTIS----DDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CSSHH---HHHH---HHHHCCCCCC--SGGGTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHH---HHHH---HHHcCCCCCC--chhhhhcC----HHHHHHHHHHcccChhhCcCHHHHhc
Confidence            54321   1111   1111111100  01111222    34778888999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.7e-38  Score=266.16  Aligned_cols=204  Identities=22%  Similarity=0.330  Sum_probs=151.3

Q ss_pred             ccccccCCCccceeeEEEeCCee------EEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++...+..      ++||||+. ++|.+++.      ..+++..+..++.|++.||+|||+.   
T Consensus        94 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---  163 (371)
T 4exu_A           94 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---  163 (371)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            46788999999999999877654      99999997 58988872      2489999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +|+||||||+||+++.++.+||+|||+++.....    .....||..|+|||++.+ ..++.++||||||+++|+|++|+
T Consensus       164 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  239 (371)
T 4exu_A          164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK  239 (371)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCcCCCcCHHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865432    234568999999999887 67899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccc-------------------cCCCCCCCHHHHHHHHHHHHhhhhhhhcCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-------------------DPELGEYPPNEIIRYMKVAFFCTQAAASRR  215 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R  215 (277)
                      .||.......   ....+....... ..+..                   ...+....+.....+.+++.+||+.||.+|
T Consensus       240 ~pf~~~~~~~---~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  315 (371)
T 4exu_A          240 TLFKGKDYLD---QLTQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR  315 (371)
T ss_dssp             CSCCCSSHHH---HHHHHHHHHCCC-CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred             CCCCCCChHH---HHHHHHHHhCCC-cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence            9986543211   111111110000 00000                   000000011123457888999999999999


Q ss_pred             CCHHHHHH
Q 023808          216 PQMNQVIK  223 (277)
Q Consensus       216 Ps~~~v~~  223 (277)
                      ||+.|+++
T Consensus       316 pt~~ell~  323 (371)
T 4exu_A          316 LTAAQALT  323 (371)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-38  Score=268.78  Aligned_cols=210  Identities=19%  Similarity=0.263  Sum_probs=154.6

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||+++++++..+     ...++||||+. |+|.+++..     ..+++..+..++.|++.||+|||+.   +
T Consensus        62 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~  132 (353)
T 2b9h_A           62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---N  132 (353)
T ss_dssp             HHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            46788999999999998764     67899999997 599999843     3689999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---------eeeeecccccccCcccccc-CccccccceEehhHH
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---------ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVL  146 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~v  146 (277)
                      ++||||||+||+++.++.+||+|||+++........         ......||..|+|||++.+ ..++.++||||||++
T Consensus       133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i  212 (353)
T 2b9h_A          133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI  212 (353)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHH
T ss_pred             eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHH
Confidence            999999999999999999999999999876532211         1123468999999998765 678999999999999


Q ss_pred             HHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccc-------------------cCCCCCCCHHHHHHHHHHHHhh
Q 023808          147 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-------------------DPELGEYPPNEIIRYMKVAFFC  207 (277)
Q Consensus       147 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~~c  207 (277)
                      +|+|++|+.||.......   ..................                   ...+....+.....+.+++.+|
T Consensus       213 l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (353)
T 2b9h_A          213 LAELFLRRPIFPGRDYRH---QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM  289 (353)
T ss_dssp             HHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence            999999999986543211   111111111100000000                   0000000112233477889999


Q ss_pred             hhhhhcCCCCHHHHHH
Q 023808          208 TQAAASRRPQMNQVIK  223 (277)
Q Consensus       208 ~~~~p~~RPs~~~v~~  223 (277)
                      |+.||.+||++.++++
T Consensus       290 L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          290 LVFDPAKRITAKEALE  305 (353)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             cCcCcccCCCHHHHhc
Confidence            9999999999999876

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-37  Score=265.12  Aligned_cols=208  Identities=20%  Similarity=0.268  Sum_probs=154.3

Q ss_pred             cCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            7 RHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      .||||+++++++...+    ..++||||+ +++|.+++...  ....+++..++.++.||+.||+|||++.  +|+||||
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Di  158 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDI  158 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCC
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCC
Confidence            4999999999998654    789999999 88999999643  2345899999999999999999999953  8999999


Q ss_pred             CCCcEEeC------CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           83 KASNILLD------QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        83 kp~Nill~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||+|||++      ..+.+||+|||+++.....    .....||..|+|||++.+..++.++||||||+++|||+||..|
T Consensus       159 kp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             ChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            99999994      4457999999999876433    2334689999999999998999999999999999999999999


Q ss_pred             CCcccCcch---hhHHHHHHHHhccC------------------Ccccccc-----------CCCCCCCHHHHHHHHHHH
Q 023808          157 GKAMWGQMN---KFLLEWAWQLHQEE------------------KPLELVD-----------PELGEYPPNEIIRYMKVA  204 (277)
Q Consensus       157 ~~~~~~~~~---~~~~~~~~~~~~~~------------------~~~~~~~-----------~~~~~~~~~~~~~~~~l~  204 (277)
                      |........   ..............                  .....+.           ......+......+.+++
T Consensus       235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  314 (373)
T 1q8y_A          235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL  314 (373)
T ss_dssp             C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred             CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence            875442211   11111111111000                  0000000           001134566777899999


Q ss_pred             HhhhhhhhcCCCCHHHHHH
Q 023808          205 FFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       205 ~~c~~~~p~~RPs~~~v~~  223 (277)
                      .+||+.||.+|||+.|+++
T Consensus       315 ~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          315 SPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhccCccccCCHHHHhh
Confidence            9999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=258.37  Aligned_cols=210  Identities=20%  Similarity=0.319  Sum_probs=152.4

Q ss_pred             ccccccCCCccceeeEEE--------------eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCV--------------QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA   67 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~--------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~   67 (277)
                      +|++++||||+++++++.              +....++||||+. |+|.+++.     ...+++..+..++.|++.||+
T Consensus        61 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~  134 (320)
T 2i6l_A           61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLK  134 (320)
T ss_dssp             HHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHH
Confidence            467899999999999874              4467899999997 59999993     246899999999999999999


Q ss_pred             HhhcCCCCCeEeccCCCCcEEeC-CCCceEEeecccccccCCCCc--ceeeeecccccccCcccccc-CccccccceEeh
Q 023808           68 FLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSF  143 (277)
Q Consensus        68 ~LH~~~~~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~sl  143 (277)
                      |||+.   +++||||||+||+++ +++.+||+|||+++.......  .......++..|+|||.+.+ ..++.++|||||
T Consensus       135 ~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  211 (320)
T 2i6l_A          135 YIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  211 (320)
T ss_dssp             HHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred             HHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence            99999   999999999999997 567899999999987643221  11233457889999998866 678999999999


Q ss_pred             hHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhcc-----------CCcc----ccccCC--CCCCCHHHHHHHHHHHHh
Q 023808          144 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE-----------EKPL----ELVDPE--LGEYPPNEIIRYMKVAFF  206 (277)
Q Consensus       144 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~----~~~~~~--~~~~~~~~~~~~~~l~~~  206 (277)
                      |+++|||++|+.||.......   ...........           ....    ....+.  +....+.....+.+++.+
T Consensus       212 G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  288 (320)
T 2i6l_A          212 GCIFAEMLTGKTLFAGAHELE---QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ  288 (320)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHH---HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH
Confidence            999999999999987543211   11111110000           0000    000000  000011123457888999


Q ss_pred             hhhhhhcCCCCHHHHHH
Q 023808          207 CTQAAASRRPQMNQVIK  223 (277)
Q Consensus       207 c~~~~p~~RPs~~~v~~  223 (277)
                      ||+.||.+||++.++++
T Consensus       289 ~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          289 ILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             TSCSSGGGSCCHHHHHT
T ss_pred             HcCCCccccCCHHHHhC
Confidence            99999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.3e-38  Score=262.91  Aligned_cols=189  Identities=22%  Similarity=0.310  Sum_probs=153.7

Q ss_pred             ccccc--CCCccceeeEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            3 LSNVR--HPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         3 L~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      |++++  ||||+++++++..++..++|||++.+ ++|.+++..    ...+++..++.++.|++.||+|||+.   +++|
T Consensus       100 l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH  172 (320)
T 3a99_A          100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLH  172 (320)
T ss_dssp             HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEe
Confidence            45564  69999999999999999999999986 899999843    44689999999999999999999999   9999


Q ss_pred             ccCCCCcEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCC
Q 023808           80 RDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        80 ~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||||+||+++ +++.+||+|||+++......   .....||..|+|||++.+..+ +.++||||||+++|||++|+.||
T Consensus       173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  249 (320)
T 3a99_A          173 RDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF  249 (320)
T ss_dssp             CCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence            99999999998 77899999999998765432   234568999999999887665 78899999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....            .......   ..   ...+    ..+.+++.+||+.||.+||++.+|++
T Consensus       250 ~~~~~------------~~~~~~~---~~---~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          250 EHDEE------------IIRGQVF---FR---QRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CSHHH------------HHHCCCC---CS---SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CChhh------------hhccccc---cc---ccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            54210            1111100   00   1122    34778888899999999999999976

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-38  Score=261.98  Aligned_cols=206  Identities=26%  Similarity=0.399  Sum_probs=138.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccC-CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA-TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +++.++||||+++++++..++..++||||+.+ +|.+++... ......+++..+..++.|++.||.|||+..  +++||
T Consensus        74 ~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~  150 (327)
T 3aln_A           74 VMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHR  150 (327)
T ss_dssp             HHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCS
T ss_pred             HHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeEC
Confidence            45678999999999999999999999999975 888877421 112456899999999999999999999852  79999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccc----ccCccccccceEehhHHHHHHHhCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||||+||+++.++.+||+|||+++.......  .....||..|+|||++    .+..++.++||||||+++|+|++|..|
T Consensus       151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (327)
T 3aln_A          151 DIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP  228 (327)
T ss_dssp             CCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred             CCCHHHEEEcCCCCEEEccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999986644321  2234689999999998    455689999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCC-CCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |........         ....  ......+.+. .........+.+++.+||+.||.+||++.+|++
T Consensus       229 f~~~~~~~~---------~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          229 YPKWNSVFD---------QLTQ--VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SSCC----------------CC--CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcchHHH---------HHHH--HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            865322110         0000  0000011111 011112234778888999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-36  Score=258.65  Aligned_cols=143  Identities=23%  Similarity=0.298  Sum_probs=124.5

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc--CCCCCeEeccCCCC
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE--ELVPHIVHRDIKAS   85 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~~iiH~dikp~   85 (277)
                      |+||+++++++...+..++||||+. |+|.+++...  ....+++..+..++.|++.||.|||.  .   +|+||||||+
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~  188 (382)
T 2vx3_A          115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPE  188 (382)
T ss_dssp             GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGG
T ss_pred             ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcc
Confidence            3459999999999999999999996 5999998643  22458999999999999999999995  5   8999999999


Q ss_pred             cEEeC--CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           86 NILLD--QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        86 Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||++  .++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       189 NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          189 NILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99994  5778999999999876443    23456899999999999999999999999999999999999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.9e-38  Score=264.84  Aligned_cols=205  Identities=21%  Similarity=0.311  Sum_probs=152.5

Q ss_pred             ccccccCCCccceeeEEEeCCe------eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTR------RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++.....      .++||||+. |+|.+++.      ..+++..+..++.|++.||+|||+.   
T Consensus        76 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---  145 (353)
T 3coi_A           76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---  145 (353)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            4678899999999999987654      499999997 58888772      2489999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +++||||||+||+++.++.+||+|||+++.....    .....||..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus       146 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~  221 (353)
T 3coi_A          146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK  221 (353)
T ss_dssp             TCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CcccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865432    234568999999999877 67899999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccC------------------CccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEE------------------KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .||.......   ....+.......                  .........+....+.....+.+++.+||+.||.+||
T Consensus       222 ~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp  298 (353)
T 3coi_A          222 TLFKGKDYLD---QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL  298 (353)
T ss_dssp             CSSBSSCHHH---HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred             CCCCCCCHHH---HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC
Confidence            9986543211   111111110000                  0000001112222223344588889999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      ++.++++
T Consensus       299 t~~e~l~  305 (353)
T 3coi_A          299 TAAQALT  305 (353)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.4e-38  Score=261.34  Aligned_cols=199  Identities=20%  Similarity=0.326  Sum_probs=149.0

Q ss_pred             ccccc--CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            3 LSNVR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         3 L~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      |++++  ||||+++++++..++..++||| +.+++|.+++..    ...+++..++.++.|++.||+|||+.   +++||
T Consensus        80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~  151 (313)
T 3cek_A           80 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHS  151 (313)
T ss_dssp             HHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred             HHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---Cceec
Confidence            55665  5999999999999999999999 557899999943    34689999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCcccccc-----------CccccccceEehhHHHH
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-----------GQLTMKADVYSFGVLVL  148 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~  148 (277)
                      ||||+||++++ +.+||+|||+++........ ......|+..|+|||.+.+           ..++.++||||||+++|
T Consensus       152 dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~  230 (313)
T 3cek_A          152 DLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  230 (313)
T ss_dssp             CCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred             CCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence            99999999964 78999999999876543222 2234568999999999875           46788999999999999


Q ss_pred             HHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          149 EIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||++|..||........     ...........     ..+....+   ..+.+++.+||+.||.+||++.++++
T Consensus       231 el~~g~~pf~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          231 YMTYGKTPFQQIINQIS-----KLHAIIDPNHE-----IEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHSSCTTTTCCSHHH-----HHHHHHCTTSC-----CCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCchhhHHHHHH-----HHHHHHhcccc-----cCCcccch---HHHHHHHHHHccCCcccCcCHHHHhc
Confidence            99999999865433211     11111111111     11112222   34777888899999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=258.63  Aligned_cols=201  Identities=26%  Similarity=0.409  Sum_probs=146.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +++.++||||+++++++.+++..++||||+ ++.+..+...   ....+++..++.++.|++.||+|||+ .   +++|+
T Consensus        77 ~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~  149 (318)
T 2dyl_A           77 VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHR  149 (318)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCC
T ss_pred             HHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeC
Confidence            356789999999999999999999999999 5577666632   23468999999999999999999998 6   89999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      ||||+||+++.++.+||+|||++.......  ......|+..|+|||++.     ...++.++||||||+++|||++|+.
T Consensus       150 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  227 (318)
T 2dyl_A          150 DVKPSNILLDERGQIKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF  227 (318)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCHHHEEECCCCCEEEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence            999999999999999999999997654432  223456899999999984     4567889999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ||.......  ..   ...........   .+.....+    ..+.+++.+||+.||.+||++.++++
T Consensus       228 pf~~~~~~~--~~---~~~~~~~~~~~---~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          228 PYKNCKTDF--EV---LTKVLQEEPPL---LPGHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             TTTTCCSHH--HH---HHHHHHSCCCC---CCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccH--HH---HHHHhccCCCC---CCccCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence            986532211  11   11112211110   01111122    34778888899999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-37  Score=262.34  Aligned_cols=207  Identities=17%  Similarity=0.225  Sum_probs=155.3

Q ss_pred             cccccCCC------ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            3 LSNVRHPN------LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         3 L~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      |++++|+|      ++.+++++...+..++||||+ +++|.+++..  .....+++..++.++.||+.||+|||+.   +
T Consensus        70 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~  143 (355)
T 2eu9_A           70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---Q  143 (355)
T ss_dssp             HHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred             HHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            44555554      999999999999999999999 5577777643  2234689999999999999999999999   9


Q ss_pred             eEeccCCCCcEEe-------------------CCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccc
Q 023808           77 IVHRDIKASNILL-------------------DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK  137 (277)
Q Consensus        77 iiH~dikp~Nill-------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  137 (277)
                      |+||||||+|||+                   +.++.+||+|||+++.....    .....||..|+|||++.+..++.+
T Consensus       144 ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~  219 (355)
T 2eu9_A          144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQP  219 (355)
T ss_dssp             EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred             cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCc
Confidence            9999999999999                   56788999999999865432    234568999999999999899999


Q ss_pred             cceEehhHHHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCcccc----------ccC--------------------
Q 023808          138 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL----------VDP--------------------  187 (277)
Q Consensus       138 ~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~--------------------  187 (277)
                      +||||||+++|||++|..||........   .......... .+...          ...                    
T Consensus       220 ~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (355)
T 2eu9_A          220 CDVWSIGCILFEYYRGFTLFQTHENREH---LVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP  295 (355)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC
T ss_pred             cchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCc
Confidence            9999999999999999999875433211   1111111110 00000          000                    


Q ss_pred             --CCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          188 --ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       188 --~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                        ............+.+++.+||+.||.+|||+.|+++
T Consensus       296 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              000112334556889999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=260.66  Aligned_cols=185  Identities=24%  Similarity=0.348  Sum_probs=147.5

Q ss_pred             cCCCccceeeEEEeCCeeEEEEee-cCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEY-VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      +||||+++++++...+..++|||+ +.+++|.+++..    ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  168 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE  168 (312)
T ss_dssp             CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred             CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence            899999999999999999999999 789999999943    34689999999999999999999999   9999999999


Q ss_pred             cEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCcccCc
Q 023808           86 NILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQ  163 (277)
Q Consensus        86 Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~  163 (277)
                      ||+++ .++.+||+|||+++......   .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||..... 
T Consensus       169 Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-  244 (312)
T 2iwi_A          169 NILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-  244 (312)
T ss_dssp             GEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-
T ss_pred             hEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-
Confidence            99998 88899999999998765432   234568999999999887665 4589999999999999999999854210 


Q ss_pred             chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                                 .....       ..+   +......+.+++.+||+.||++||++.++++
T Consensus       245 -----------~~~~~-------~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 -----------ILEAE-------LHF---PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -----------HHHTC-------CCC---CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------Hhhhc-------cCC---cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       01110       011   1112234778888999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.5e-37  Score=276.20  Aligned_cols=218  Identities=24%  Similarity=0.311  Sum_probs=162.2

Q ss_pred             ccccccCCCccceeeEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||+++++++..      ++..++||||++||+|.+++.... ....+++..++.++.|++.||+|||+.   
T Consensus        65 iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---  140 (676)
T 3qa8_A           65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---  140 (676)
T ss_dssp             HHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            4678899999999999865      667899999999999999996532 233689999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCc---eEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh
Q 023808           76 HIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  152 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  152 (277)
                      +++||||||+||+++.++.   +||+|||+++......  ......||..|+|||.+.+..++.++||||||+++|+|++
T Consensus       141 gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt  218 (676)
T 3qa8_A          141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT  218 (676)
T ss_dssp             TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred             CCccCCCCHHHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            9999999999999987664   8999999998765432  2334578999999999999999999999999999999999


Q ss_pred             CCCCCCcccCcchhhHHHHHHHH--------hccCCc--ccccc---CCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          153 GRNSGKAMWGQMNKFLLEWAWQL--------HQEEKP--LELVD---PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       153 g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~--~~~~~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      |..||.......     .|....        ......  .....   +............+.+++.+||+.||++||++.
T Consensus       219 G~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~  293 (676)
T 3qa8_A          219 GFRPFLPNWQPV-----QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP  293 (676)
T ss_dssp             SCSSCCSSCHHH-----HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred             CCCCCCcccchh-----hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence            999986532110     000000        000000  00000   111223445667788999999999999999997


Q ss_pred             H-----HHHHHhhccc
Q 023808          220 Q-----VIKMLTKNIR  230 (277)
Q Consensus       220 ~-----v~~~L~~~~~  230 (277)
                      +     +.+.+++++.
T Consensus       294 elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          294 QNPNVGCFQALDSILS  309 (676)
T ss_dssp             TCCCCTTHHHHHHHHC
T ss_pred             HHhcCHHHHHHHHHHh
Confidence            7     4556666554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-36  Score=277.35  Aligned_cols=191  Identities=25%  Similarity=0.330  Sum_probs=151.2

Q ss_pred             ccccccCCCccceeeEEEeCCe-----eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTR-----RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++++||||++++++|...+.     .|+||||++|++|.+++.    .  .+++..++.++.||+.||+|||++   +
T Consensus       132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~----~--~l~~~~~~~~~~qi~~aL~~lH~~---g  202 (681)
T 2pzi_A          132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----Q--KLPVAEAIAYLLEILPALSYLHSI---G  202 (681)
T ss_dssp             GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC--------C--CCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh----C--CCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            5788999999999999997665     799999999999998872    2  699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |+||||||+||+++.+ .+||+|||+++.....     ....||+.|+|||++.+.. +.++||||||+++|+|++|..|
T Consensus       203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~  275 (681)
T 2pzi_A          203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPT  275 (681)
T ss_dssp             EECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCE
T ss_pred             CeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCC
Confidence            9999999999999985 8999999999876543     3456899999999887654 8899999999999999999877


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-HHHHHHHHhhccc
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIKMLTKNIR  230 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-~~~v~~~L~~~~~  230 (277)
                      +........               .     .  ..........+.+++.+||+.||.+||+ ++++...|...++
T Consensus       276 ~~~~~~~~~---------------~-----~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          276 RNGRYVDGL---------------P-----E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ETTEECSSC---------------C-----T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             Ccccccccc---------------c-----c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            653221100               0     0  0000112345788999999999999995 6777777766543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-35  Score=243.49  Aligned_cols=180  Identities=18%  Similarity=0.285  Sum_probs=138.8

Q ss_pred             ccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 023808            4 SNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH   79 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH   79 (277)
                      +.++||||+++++++..    +...++||||+++|+|.+++...  .+..+++..++.++.|++.||+|||+.   +++|
T Consensus        66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H  140 (299)
T 3m2w_A           66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAH  140 (299)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            45689999999999987    67889999999999999999642  234699999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           80 RDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        80 ~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||||+||+++.   ++.+||+|||++....                       +..++.++||||||+++|||++|..|
T Consensus       141 ~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~p  197 (299)
T 3m2w_A          141 RDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPP  197 (299)
T ss_dssp             CCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHEEEecCCCCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCC
Confidence            999999999988   7889999999987432                       23577899999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCC----HHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP----PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |........           ..... ..+.......+    ......+.+++.+||+.||.+||++.|+++
T Consensus       198 f~~~~~~~~-----------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          198 FYSNHGLAI-----------SPGMK-TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CCC------------------CCSC-CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCcchhh-----------hHHHH-HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            865332110           00000 00000001111    112345788889999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5e-36  Score=245.72  Aligned_cols=184  Identities=10%  Similarity=0.079  Sum_probs=139.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+||||++|++|.+++..    +  .....+.+++.|++.||+|||+.   +|+|||
T Consensus        84 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~--~~~~~~~~i~~ql~~aL~~lH~~---givH~D  154 (286)
T 3uqc_A           84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S--PSPVGAIRAMQSLAAAADAAHRA---GVALSI  154 (286)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C--CChHHHHHHHHHHHHHHHHHHHC---CCccCC
Confidence            46789999999999999999999999999999999999932    2  35567899999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||+++.++.+||++++                     |++       .++.++||||||+++|||+||+.||....
T Consensus       155 ikp~NIll~~~g~~kl~~~~---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          155 DHPSRVRVSIDGDVVLAYPA---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             CSGGGEEEETTSCEEECSCC---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             CCcccEEEcCCCCEEEEecc---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence            99999999999999998543                     233       26789999999999999999999987543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      .......       .........  +......+.....+.+++.+||+.||.+| |+.++++.|+++....
T Consensus       207 ~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          207 VRSGLAP-------AERDTAGQP--IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             BCCCSEE-------CCBCTTSCB--CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cchhhHH-------HHHHhccCC--CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            3210000       000000000  00000011122347788889999999999 9999999999877543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.7e-35  Score=251.33  Aligned_cols=171  Identities=16%  Similarity=0.128  Sum_probs=133.1

Q ss_pred             eeEEEEeecCCCCHHHHhccC---CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEee
Q 023808           23 RRILVYEYVENNSLDRVLLGA---TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD   99 (277)
Q Consensus        23 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~D   99 (277)
                      ..+++|+++ +++|.+++...   ...+..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~D  254 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTG  254 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEe
Confidence            467788877 67999988421   23455688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcceeeeecccccccCcccc----------ccCccccccceEehhHHHHHHHhCCCCCCcccCcchhhHH
Q 023808          100 FGLAKLFPDNITHITTRIAGTTGYLAPEYV----------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  169 (277)
Q Consensus       100 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~  169 (277)
                      ||+++.....    .....| ..|+|||++          .+..++.++|||||||++|||+||+.||........    
T Consensus       255 FG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~----  325 (413)
T 3dzo_A          255 FEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG----  325 (413)
T ss_dssp             GGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC----
T ss_pred             ccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh----
Confidence            9999864332    344567 999999999          555688999999999999999999999865432110    


Q ss_pred             HHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          170 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                                 ....+. .....+    ..+.+++.+||+.||++||++.+++
T Consensus       326 -----------~~~~~~-~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          326 -----------SEWIFR-SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             -----------SGGGGS-SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             -----------HHHHHh-hcccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence                       001111 111222    3477888899999999999977764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.3e-34  Score=253.59  Aligned_cols=141  Identities=17%  Similarity=0.167  Sum_probs=105.9

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|+++ .|+||+++++++++++..||||||++|++|.+++.    .+..++..   +|+.||+.||+|+|++   |||||
T Consensus       294 ~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHR  363 (569)
T 4azs_A          294 FLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHD  363 (569)
T ss_dssp             HHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEES
T ss_pred             HHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---Cceec
Confidence            47788 79999999999999999999999999999999994    34456654   4789999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      ||||+|||++.++++||+|||+++...... ....+..||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus       364 DIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          364 DVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             cCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            999999999999999999999998765432 22345679999999998865 5677899999999988776554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=5.3e-34  Score=239.04  Aligned_cols=174  Identities=11%  Similarity=0.040  Sum_probs=128.0

Q ss_pred             CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCcEEeCCCC------
Q 023808           21 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELVPHIVHRDIKASNILLDQEF------   93 (277)
Q Consensus        21 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~iiH~dikp~Nill~~~~------   93 (277)
                      .+..++||||+.+|++.+.+.     ...+++..+..++.||+.||+||| +.   +|+||||||+|||++.++      
T Consensus       134 ~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~  205 (336)
T 2vuw_A          134 DDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHY  205 (336)
T ss_dssp             TTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEE
T ss_pred             cCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceee
Confidence            678999999999997666552     245899999999999999999999 88   999999999999998886      


Q ss_pred             --------------ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHH-HHHHHhCCCCCC
Q 023808           94 --------------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL-VLEIISGRNSGK  158 (277)
Q Consensus        94 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~v-l~elltg~~p~~  158 (277)
                                    .+||+|||+++.....      ...||..|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus       206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          206 TLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             EETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             eccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence                          8999999999876432      346999999999998766 889999998777 777888887763


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  222 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~  222 (277)
                      ...     ................   ........+.....+.+++.+||+.|     |+.|++
T Consensus       279 ~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          279 NVL-----WLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHH-----HHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             chh-----hhhHHHHhhhhhhccC---cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            210     0000011111111000   00111123456677899999999965     888886

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.9e-26  Score=204.02  Aligned_cols=139  Identities=18%  Similarity=0.186  Sum_probs=118.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++..++...+..++||||++|++|.+++..            +..++.|++.||+|||++   +|+|||
T Consensus       392 il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrD  456 (540)
T 3en9_A          392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHND  456 (540)
T ss_dssp             HHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTT
T ss_pred             HHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCC
Confidence            47789999999777777788888999999999999999932            568999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce------eeeecccccccCcccccc--CccccccceEehhHHHHHHHhC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI------TTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg  153 (277)
                      |||+|||++.  .+||+|||+++.........      .....||+.|+|||++..  ..|+..+|+|+..+-..+-+.+
T Consensus       457 iKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~  534 (540)
T 3en9_A          457 LTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER  534 (540)
T ss_dssp             CCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred             CCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence            9999999998  99999999999875532211      235679999999999987  5688899999999988888776


Q ss_pred             CCCC
Q 023808          154 RNSG  157 (277)
Q Consensus       154 ~~p~  157 (277)
                      +.++
T Consensus       535 r~rY  538 (540)
T 3en9_A          535 RARY  538 (540)
T ss_dssp             CSCC
T ss_pred             cccc
Confidence            6543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.76  E-value=6e-20  Score=149.63  Aligned_cols=95  Identities=19%  Similarity=0.164  Sum_probs=76.7

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |++++  | +++++++.. +..++||||++||+|.+ +.    .      .....++.|++.||+|||+.   +|+||||
T Consensus       158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~---giiHrDl  219 (282)
T 1zar_A          158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHR---GIVHGDL  219 (282)
T ss_dssp             HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHC---CCEeCCC
Confidence            45666  5 666665544 45699999999999988 41    1      12446999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL  130 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  130 (277)
                      ||+|||++ ++.+||+|||+++.              +..+.|||++.
T Consensus       220 kp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          220 SQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             STTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             CHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            99999999 99999999999973              34568888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.57  E-value=1.2e-15  Score=122.63  Aligned_cols=88  Identities=18%  Similarity=0.245  Sum_probs=69.2

Q ss_pred             cccccCCCc--cceeeEEEeCCeeEEEEeecCC-C----CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhh-cCCC
Q 023808            3 LSNVRHPNL--VELIGCCVQGTRRILVYEYVEN-N----SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELV   74 (277)
Q Consensus         3 L~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~   74 (277)
                      |.+|+|++|  +.++++    ...++||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.  
T Consensus       124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~--  190 (258)
T 1zth_A          124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA--  190 (258)
T ss_dssp             HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS--
T ss_pred             HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC--
Confidence            566777754  444443    256899999942 3    78777521       234567889999999999999 88  


Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  106 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  106 (277)
                       +|+||||||+|||++.  .++|+|||++...
T Consensus       191 -givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 -ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             -CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             -CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence             9999999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.25  E-value=2e-12  Score=108.53  Aligned_cols=70  Identities=19%  Similarity=0.261  Sum_probs=57.6

Q ss_pred             eEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCC----------
Q 023808           24 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----------   93 (277)
Q Consensus        24 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~----------   93 (277)
                      .+|||||++|++|.++..        .  .....++.|++.+|.+||+.   |+|||||||.|||+++++          
T Consensus       186 ~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~  252 (397)
T 4gyi_A          186 HTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITL  252 (397)
T ss_dssp             TEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred             ceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccccccccc
Confidence            369999999988876541        1  13456889999999999999   999999999999998766          


Q ss_pred             ceEEeeccccccc
Q 023808           94 NPKIGDFGLAKLF  106 (277)
Q Consensus        94 ~~kl~Dfg~~~~~  106 (277)
                      .+.|+||+.+...
T Consensus       253 ~~~iID~~Q~V~~  265 (397)
T 4gyi_A          253 TPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEECCCTTCEET
T ss_pred             ceEEEEeCCcccC
Confidence            3889999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.05  E-value=1.9e-10  Score=92.33  Aligned_cols=88  Identities=13%  Similarity=0.047  Sum_probs=70.9

Q ss_pred             CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--------------
Q 023808            8 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--------------   73 (277)
Q Consensus         8 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------   73 (277)
                      +.++.++++++...+..|+||||++|.+|.+.+.         +......++.+++.+|+.||+..              
T Consensus        69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~  139 (263)
T 3tm0_A           69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRL  139 (263)
T ss_dssp             TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHH
T ss_pred             CCCCCeEEEEEecCCceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHH
Confidence            6778899999999999999999999999988641         11223467889999999999821              


Q ss_pred             ------------------------------------------CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 ------------------------------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ------------------------------------------~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                                                                ...++|+|++|.||+++++..+.|.||+.+.
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          140 AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                                      1358999999999999876566799999775

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.82  E-value=5.1e-09  Score=87.95  Aligned_cols=92  Identities=18%  Similarity=0.259  Sum_probs=73.2

Q ss_pred             CCCccceeeEEEeC---CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----------
Q 023808            8 HPNLVELIGCCVQG---TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----------   73 (277)
Q Consensus         8 h~niv~~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----------   73 (277)
                      +..++++++++.+.   +..|+||||++|..+.+..      -..++...+..++.+++.+|+.||+..           
T Consensus        97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~  170 (359)
T 3dxp_A           97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK  170 (359)
T ss_dssp             SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred             CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence            45688999998876   3589999999998774321      123678888899999999999999731           


Q ss_pred             --------------------------------------------CCCeEeccCCCCcEEeCCCCc--eEEeecccccc
Q 023808           74 --------------------------------------------VPHIVHRDIKASNILLDQEFN--PKIGDFGLAKL  105 (277)
Q Consensus        74 --------------------------------------------~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~  105 (277)
                                                                  ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                                        237999999999999987653  68999998874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.82  E-value=3.2e-09  Score=84.86  Aligned_cols=90  Identities=18%  Similarity=0.124  Sum_probs=66.4

Q ss_pred             cccccCCC--ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-------
Q 023808            3 LSNVRHPN--LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-------   73 (277)
Q Consensus         3 L~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------   73 (277)
                      |+.+.+.+  +.++++++..++..++||||++|.+|.  ..   .    ..   ...++.+++..|..||+..       
T Consensus        67 l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~  134 (264)
T 1nd4_A           67 LSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---H----LA---PAEKVSIMADAMRRLHTLDPATCPFD  134 (264)
T ss_dssp             HHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCB
T ss_pred             HHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            34443333  567999988888899999999998884  21   1    11   2256778888888888752       


Q ss_pred             ------------------------------------------------CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 ------------------------------------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ------------------------------------------------~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                                                                      ...++|+|++|.||+++++..+.|.||+.+.
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          135 HQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                                            1139999999999999877667799999876

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.66  E-value=2.6e-09  Score=87.60  Aligned_cols=137  Identities=20%  Similarity=0.249  Sum_probs=87.1

Q ss_pred             ccceeeEEEeCC---eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--------------
Q 023808           11 LVELIGCCVQGT---RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--------------   73 (277)
Q Consensus        11 iv~~~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------   73 (277)
                      +.+++.++....   ..|+||++++|.+|.+...      ..++..++..++.+++..|+.||+..              
T Consensus        75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~  148 (304)
T 3sg8_A           75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFRE  148 (304)
T ss_dssp             CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHH
T ss_pred             CCceEeecCCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHH
Confidence            455665554433   4589999999988865431      23667777888888888888888621              


Q ss_pred             -----------------------------------------CCCeEeccCCCCcEEeCC--CCceEEeecccccccCCCC
Q 023808           74 -----------------------------------------VPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPDNI  110 (277)
Q Consensus        74 -----------------------------------------~~~iiH~dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~  110 (277)
                                                               .+.++|+|++|.||++++  +..+.|.||+.+..-... 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-  227 (304)
T 3sg8_A          149 KINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-  227 (304)
T ss_dssp             HHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-
T ss_pred             HHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-
Confidence                                                     135899999999999987  456789999988643211 


Q ss_pred             cceee--------------eecccccccC-ccccccCccccccceEehhHHHHHHHhCCCC
Q 023808          111 THITT--------------RIAGTTGYLA-PEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus       111 ~~~~~--------------~~~gt~~y~a-PE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      .....              ......+... |+...  ......+.|++|.++|.+.+|..+
T Consensus       228 ~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          228 NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHH
Confidence            00000              0000111122 22211  112235789999999999999754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=2.6e-06  Score=68.31  Aligned_cols=87  Identities=17%  Similarity=0.080  Sum_probs=63.7

Q ss_pred             CccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC----------------
Q 023808           10 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL----------------   73 (277)
Q Consensus        10 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------   73 (277)
                      -|.++++++.+++..++|||+++|.++.+....        .......++.+++..|..||+..                
T Consensus        81 PVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~  152 (272)
T 4gkh_A           81 PLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQ  152 (272)
T ss_dssp             CCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHH
T ss_pred             CcCeEEEEEEECCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhh
Confidence            367899999999999999999999888776521        11223345556666666666321                


Q ss_pred             ---------------------------------------CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 ---------------------------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ---------------------------------------~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                                                             .+.++|+|+.+.||++++++.+-|.||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          153 AQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                                   1237899999999999987767799999775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.99  E-value=1.8e-05  Score=64.76  Aligned_cols=90  Identities=18%  Similarity=0.240  Sum_probs=61.0

Q ss_pred             CccceeeEEE-eCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcC----------------
Q 023808           10 NLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE----------------   72 (277)
Q Consensus        10 niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------------   72 (277)
                      .|.+++.++. ..+..++|||+++|..|.+....      .++......++.+++..|+.||+.                
T Consensus        73 ~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~  146 (306)
T 3tdw_A           73 NIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLK  146 (306)
T ss_dssp             BCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHH
T ss_pred             CCCCeEeecccCCCceEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHH
Confidence            3677777775 44567899999999888763210      134445555555555555555542                


Q ss_pred             -----------------------------------------CCCCeEeccCCCCcEEeCC---CCc-eEEeecccccc
Q 023808           73 -----------------------------------------LVPHIVHRDIKASNILLDQ---EFN-PKIGDFGLAKL  105 (277)
Q Consensus        73 -----------------------------------------~~~~iiH~dikp~Nill~~---~~~-~kl~Dfg~~~~  105 (277)
                                                               ..+.++|+|+++.||+++.   ++. +.|.||+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          147 NKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                                     1235799999999999987   345 58999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.80  E-value=2.8e-05  Score=64.90  Aligned_cols=30  Identities=17%  Similarity=0.292  Sum_probs=25.7

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.++|+|+.+.||+++++..+.|.||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            379999999999999964457899999876

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.74  E-value=0.00014  Score=55.55  Aligned_cols=101  Identities=18%  Similarity=0.147  Sum_probs=65.0

Q ss_pred             CHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCccee
Q 023808           35 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT  114 (277)
Q Consensus        35 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  114 (277)
                      ||.++|.   ..+.++++.++|.++.|.+.+|.-+-...  .-..+=+.|..|+|..+|.|.+.+ +.+.          
T Consensus        34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            7899985   45668999999999999999988762110  111233457899999998887764 1111          


Q ss_pred             eeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808          115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus       115 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                         .....+.+||... ...+.+.=|||||+++|.-+--..
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence               1223456888653 344677889999999999985443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.84  E-value=0.0024  Score=52.59  Aligned_cols=31  Identities=42%  Similarity=0.419  Sum_probs=27.0

Q ss_pred             CCeEeccCCCCcEEeCCC----CceEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQE----FNPKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~----~~~kl~Dfg~~~~  105 (277)
                      ..++|+|+.+.||+++.+    +.+.|.||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            489999999999999874    6789999998874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.51  E-value=0.0044  Score=50.61  Aligned_cols=92  Identities=15%  Similarity=0.114  Sum_probs=55.9

Q ss_pred             CCccceeeEEEeCCeeEEEEeecCCCCHH--------HH---hccCCC-CCc-----------------cCCHHHHH---
Q 023808            9 PNLVELIGCCVQGTRRILVYEYVENNSLD--------RV---LLGATK-ANI-----------------KLNWEKRS---   56 (277)
Q Consensus         9 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~--------~~---l~~~~~-~~~-----------------~~~~~~~~---   56 (277)
                      ..++++++++...+..++||||++|..+.        ..   |+.... ...                 .-+|....   
T Consensus        91 v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~  170 (312)
T 3jr1_A           91 INVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSEN  170 (312)
T ss_dssp             SBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHH
T ss_pred             CCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHH
Confidence            56889999998888999999999987642        11   222111 000                 11354321   


Q ss_pred             HHH----------------HHHHHHH-HHhhc-CCCCCeEeccCCCCcEEeCCCCceEEeecc
Q 023808           57 DIC----------------VGIAKGL-AFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFG  101 (277)
Q Consensus        57 ~i~----------------~qi~~~l-~~LH~-~~~~~iiH~dikp~Nill~~~~~~kl~Dfg  101 (277)
                      ++.                .+++..+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       171 Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          171 RIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             THHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111                1122222 23432 2346899999999999998877 7888873

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.41  E-value=0.0041  Score=51.12  Aligned_cols=30  Identities=23%  Similarity=0.356  Sum_probs=27.3

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      ..++|+|+++.||+++.++.+.|.||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            389999999999999888889999999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.71  E-value=0.028  Score=45.37  Aligned_cols=30  Identities=23%  Similarity=0.166  Sum_probs=25.0

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ..++|+|+.+.||+ ..++.+.+.||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            36899999999999 5566789999998763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.64  E-value=0.014  Score=49.66  Aligned_cols=29  Identities=14%  Similarity=0.352  Sum_probs=26.5

Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      .++|+|+++.||+++.++ +.+.||+.+..
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            899999999999998776 99999998874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=95.23  E-value=0.059  Score=41.06  Aligned_cols=86  Identities=7%  Similarity=0.029  Sum_probs=62.6

Q ss_pred             ccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 023808            6 VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS   85 (277)
Q Consensus         6 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dikp~   85 (277)
                      ..||+++.. ..-.+++...+.++.-+  +...+-     .-+.++...+++++.+|+....+++..     +|--+.|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            368888877 56566666555555443  222222     122577899999999999888666654     88899999


Q ss_pred             cEEeCCCCceEEeeccccc
Q 023808           86 NILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        86 Nill~~~~~~kl~Dfg~~~  104 (277)
                      |++++.++.+++.-.|+-.
T Consensus       109 NL~f~~~~~p~i~~RGik~  127 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQN  127 (215)
T ss_dssp             GEEECTTSCEEESCCEETT
T ss_pred             eEEEcCCCCEEEEEccCcc
Confidence            9999999999999877654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.71  E-value=0.23  Score=37.94  Aligned_cols=83  Identities=10%  Similarity=0.122  Sum_probs=60.2

Q ss_pred             cCCCccceeeEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEeccCCC
Q 023808            7 RHPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA-FLHEELVPHIVHRDIKA   84 (277)
Q Consensus         7 ~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~iiH~dikp   84 (277)
                      .||++  =...-.+++...+.++.-++ -++..+.        .++...+++++.+|+.... +++..     +|--+.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeC
Confidence            57777  22333566676666665533 3444432        4778999999999988777 56544     8889999


Q ss_pred             CcEEeCCCCceEEeeccccc
Q 023808           85 SNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        85 ~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +|++++.++.+++.-.|+-.
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             GGEEECTTCCEEESCCEETT
T ss_pred             ceEEEeCCCcEEEEEcCCcc
Confidence            99999999999999888654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=94.21  E-value=0.062  Score=43.81  Aligned_cols=29  Identities=31%  Similarity=0.351  Sum_probs=25.1

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ..++|+|+++.||+++ + .+.+.||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3789999999999999 4 889999988763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.13  E-value=0.014  Score=47.65  Aligned_cols=30  Identities=20%  Similarity=0.264  Sum_probs=26.0

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      .+++|+|+++.||+++++..+.+.||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            479999999999999877656899999775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=93.20  E-value=0.11  Score=44.71  Aligned_cols=16  Identities=31%  Similarity=0.382  Sum_probs=14.7

Q ss_pred             CCeEeccCCCCcEEeC
Q 023808           75 PHIVHRDIKASNILLD   90 (277)
Q Consensus        75 ~~iiH~dikp~Nill~   90 (277)
                      ..++|+|+.+.||+++
T Consensus       290 ~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          290 IVLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEEECSCCCGGGEEEC
T ss_pred             eeEEecCCCCCcEEee
Confidence            3689999999999998

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.03  E-value=0.09  Score=43.26  Aligned_cols=31  Identities=32%  Similarity=0.356  Sum_probs=27.5

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ..++|+|+.+.||+++.++.+.+.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3799999999999999888899999987764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.45  E-value=0.053  Score=45.16  Aligned_cols=29  Identities=21%  Similarity=0.356  Sum_probs=24.5

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      ..++|+|+.+.||+++++. +.+.||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            3689999999999998655 8999998876

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=91.60  E-value=0.25  Score=41.47  Aligned_cols=29  Identities=21%  Similarity=0.369  Sum_probs=25.3

Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      .++|||+.+.||+++.+ .+++.||..+..
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            89999999999999876 489999987763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.89  E-value=0.086  Score=44.98  Aligned_cols=30  Identities=30%  Similarity=0.394  Sum_probs=24.1

Q ss_pred             CCeEeccCCCCcEEeCCC----------------------------CceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQE----------------------------FNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~----------------------------~~~kl~Dfg~~~  104 (277)
                      ..++|+|+.+.||+++++                            +.+.+.||..+.
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            368999999999999875                            568888888775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.68  E-value=0.15  Score=42.66  Aligned_cols=30  Identities=33%  Similarity=0.379  Sum_probs=26.4

Q ss_pred             CCeEeccCCCCcEEeCCC----CceEEeeccccc
Q 023808           75 PHIVHRDIKASNILLDQE----FNPKIGDFGLAK  104 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~----~~~kl~Dfg~~~  104 (277)
                      ..++|+|+.+.||+++.+    +.+.+.||..+.
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            368999999999999876    689999999886

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.96  E-value=0.27  Score=41.40  Aligned_cols=29  Identities=28%  Similarity=0.402  Sum_probs=24.6

Q ss_pred             CeEeccCCCCcEEe------CCCCceEEeeccccc
Q 023808           76 HIVHRDIKASNILL------DQEFNPKIGDFGLAK  104 (277)
Q Consensus        76 ~iiH~dikp~Nill------~~~~~~kl~Dfg~~~  104 (277)
                      .++|+|+.+.||++      +++..+.+.||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            35799999999999      456679999999886

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=86.49  E-value=0.6  Score=37.14  Aligned_cols=25  Identities=24%  Similarity=0.343  Sum_probs=20.3

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEee
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGD   99 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~D   99 (277)
                      .+.++|+|+.+.||+++.++. .+.|
T Consensus       187 ~p~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          187 PPARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             CCEEECSCCSGGGEEEETTEE-EECS
T ss_pred             CCeeeecCCCCCcEEEcCCCe-EEEe
Confidence            468999999999999998864 3444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.93  E-value=0.44  Score=40.47  Aligned_cols=30  Identities=20%  Similarity=0.418  Sum_probs=26.1

Q ss_pred             CCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           75 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        75 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      ..++|+|+.+.||+ +.++.+.+.||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            36899999999999 7778899999998863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	277
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-49
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-43
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-29
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-55
 Identities = 54/230 (23%), Positives = 104/230 (45%), Gaps = 21/230 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L   RH N++  +G      +  +V ++ E +SL   L        K    K  DI   
Sbjct: 57  VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQ 112

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGT 120
            A+G+ +LH      I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169

Query: 121 TGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
             ++APE +        + ++DVY+FG+++ E+++G+          N+  + +      
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIFMVG--- 223

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
                  + P+L +   N      ++   C +     RP   Q++  +  
Sbjct: 224 ----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-51
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 20/223 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +  ++H  LV L     Q     ++ EY+EN SL   L   T + IKL   K  D+   I
Sbjct: 62  MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQI 118

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
           A+G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             
Sbjct: 119 AEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 182
           + APE +  G  T+K+DV+SFG+L+ EI++    G+  +  M          +   E+  
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTH---GRIPYPGMT-----NPEVIQNLERGY 227

Query: 183 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            +V P   +  P E+ + M++   C +     RP  + +  +L
Sbjct: 228 RMVRP---DNCPEELYQLMRL---CWKERPEDRPTFDYLRSVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 2e-49
 Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 32/259 (12%)

Query: 1   MTLSNVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 56
                +RH N++  I    +     T+  LV +Y E+ SL   L         +  E   
Sbjct: 49  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMI 103

Query: 57  DICVGIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP---D 108
            + +  A GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA       D
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163

Query: 109 NITHITTRIAGTTGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAM-- 160
            I        GT  Y+APE +         +   +AD+Y+ G++  EI    + G     
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223

Query: 161 --WGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYM-KVAFFCTQAAASRRP 216
                 +    + + +  ++    + + P +   +   E +R M K+   C  A  + R 
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 217 QMNQVIKMLTKNIRLNEEE 235
              ++ K L+   +L+++E
Sbjct: 284 TALRIKKTLS---QLSQQE 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-49
 Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 22/262 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L     P +V   G         +  E+++  SLD+VL    K   ++  +    + + 
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA 112

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL +L E+    I+HRD+K SNIL++     K+ DFG++    D    +     GT 
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTR 167

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            Y++PE + G   ++++D++S G+ ++E+  GR        +  + +     +    E P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ-----------VIKMLTKN-- 228
                P           R     F       +  P               V K L KN  
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 229 IRLNEEELTAPGLFQDSESSSV 250
            R + ++L      + S++  V
Sbjct: 288 ERADLKQLMVHAFIKRSDAEEV 309

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-48
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 20/226 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + HP LV+L G C++     LV+E++E+  L   L            E    +C+ 
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLD 109

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + +G+A+L E     ++HRD+ A N L+ +    K+ DFG+ +   D+    +T      
Sbjct: 110 VCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            + +PE     + + K+DV+SFGVL+ E+ S    GK  +   +      +  +      
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE---GKIPYENRS-----NSEVVEDISTG 218

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
             L  P L       + + M     C +     RP  +++++ L +
Sbjct: 219 FRLYKPRL---ASTHVYQIMN---HCWKERPEDRPAFSRLLRQLAE 258

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-47
 Identities = 47/224 (20%), Positives = 94/224 (41%), Gaps = 20/224 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + N+ H  LV+L G C +     ++ EY+ N  L   L        +   ++  ++C  
Sbjct: 52  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKD 108

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + + + +L        +HRD+ A N L++ +   K+ DFGL++   D+    +       
Sbjct: 109 VCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            +  PE ++  + + K+D+++FGVL+ EI S    GK  + +        +       + 
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---GKMPYERFTN-----SETAEHIAQG 217

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           L L  P L      ++     + + C    A  RP    ++  +
Sbjct: 218 LRLYRPHL---ASEKVY---TIMYSCWHEKADERPTFKILLSNI 255

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-45
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 31/238 (13%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--------------LGATKANIKLNW 52
            H N+V L+G C  G   +++ EY     L   L                     + L+ 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 53  EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 112
           E        +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 113 -ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW 171
            +         ++APE +     T ++DV+S+G+ + E+ S    G + +  M   +   
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL---GSSPYPGMP--VDSK 256

Query: 172 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
            +++ +E   +          P +       +   C  A   +RP   Q+++++ K I
Sbjct: 257 FYKMIKEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (386), Expect = 2e-45
 Identities = 58/241 (24%), Positives = 108/241 (44%), Gaps = 25/241 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +    HPN++ L G   + T  +++ E++EN SLD       + + +    +   +  G
Sbjct: 80  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQNDGQFTVIQLVGMLRG 136

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----I 117
           IA G+ +L +    + VHRD+ A NIL++     K+ DFGL++   D+ +  T       
Sbjct: 137 IAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                + APE +   + T  +DV+S+G+++ E++S    G+  +  M     +    + Q
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY---GERPYWDMTN--QDVINAIEQ 248

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELT 237
           + +            P +      ++   C Q   + RP+  Q++  L K IR N   L 
Sbjct: 249 DYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR-NPNSLK 298

Query: 238 A 238
           A
Sbjct: 299 A 299

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (386), Expect = 2e-45
 Identities = 52/247 (21%), Positives = 101/247 (40%), Gaps = 38/247 (15%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI------------- 48
            ++   +PN+V+L+G C  G    L++EY+    L+  L   +   +             
Sbjct: 69  LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 49  -------KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 101
                   L+  ++  I   +A G+A+L E      VHRD+   N L+ +    KI DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 185

Query: 102 LAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 160
           L++ ++  +        A    ++ PE +   + T ++DV+++GV++ EI S        
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG------ 239

Query: 161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ 220
                   L+  + +  EE    + D  +   P N  +    +   C     + RP    
Sbjct: 240 --------LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291

Query: 221 VIKMLTK 227
           + ++L +
Sbjct: 292 IHRILQR 298

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-45
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 20/226 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 59
            L  ++HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    + 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 60  VGIAKGLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 117
             +   L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++   + T      
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAF 174

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
            GT  Y++PE +       K+D++S G L+ E+ +        +   ++  L    +  +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP----PFTAFSQKELAGKIREGK 230

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
             +       EL     NEII                RP + ++++
Sbjct: 231 FRRIPYRYSDEL-----NEIITR------MLNLKDYHRPSVEEILE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-45
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 20/235 (8%)

Query: 1   MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
             +  +RH  LV+L     +     +V EY+   SL   L G  +    L   +  D+  
Sbjct: 64  QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAA 120

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            IA G+A++      + VHRD++A+NIL+ +    K+ DFGLA+L  DN           
Sbjct: 121 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             + APE  L G+ T+K+DV+SFG+L+ E+ +    G+  +  M     E   Q+ +  +
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK---GRVPYPGMV--NREVLDQVERGYR 232

Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 235
                       PP        +   C +     RP    +   L       E +
Sbjct: 233 M---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-45
 Identities = 55/235 (23%), Positives = 106/235 (45%), Gaps = 22/235 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +    H N++ L G   +    +++ EY+EN +LD+      + + + +  +   +  G
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRG 118

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAG 119
           IA G+ +L      + VHRD+ A NIL++     K+ DFGL+++  D+   T+ T+    
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 179
              + APE +   + T  +DV+SFG+++ E+++                    W+L   E
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHE 221

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
               + D      P +      ++   C Q   +RRP+   ++ +L K IR  + 
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-45
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 23/226 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V LIG C Q    +LV E      L + L+G  +   ++     +++   
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQ 117

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAG 119
           ++ G+ +L E    + VHRD+ A N+LL      KI DFGL+K    + ++ T R     
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 179
              + APE +   + + ++DV+S+GV + E +S    G+  + +M     E    + Q +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY---GQKPYKKMK--GPEVMAFIEQGK 229

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +          E PP        +   C       RP    V + +
Sbjct: 230 RM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-45
 Identities = 55/233 (23%), Positives = 104/233 (44%), Gaps = 25/233 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            ++ +RH NLV+L+G  V+    + +V EY+   SL   L   ++    L  +      +
Sbjct: 53  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSL 110

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            + + + +L      + VHRD+ A N+L+ ++   K+ DFGL K                
Sbjct: 111 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLP 163

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             + APE +   + + K+DV+SFG+L+ EI S    G+  + ++   L +   ++ +  K
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSF---GRVPYPRIP--LKDVVPRVEKGYK 218

Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 233
                     + P        +V   C    A+ RP   Q+ + L ++I+ +E
Sbjct: 219 M---------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL-EHIKTHE 261

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-45
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 24/226 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  + +P +V +IG C   +  +LV E  E   L++ L    + N  +  +   ++   
Sbjct: 61  VMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQ 115

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAG 119
           ++ G+ +L E    + VHRD+ A N+LL  +   KI DFGL+K    +  +   +     
Sbjct: 116 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 179
              + APE +   + + K+DV+SFGVL+ E  S    G+  +  M     E    L + E
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY---GQKPYRGMK--GSEVTAMLEKGE 227

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
           +            P         +   C       RP    V   L
Sbjct: 228 RM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-44
 Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 22/267 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +++V +P++  L+G C+  T +++         LD V     +    +  +   + CV 
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQ 119

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGT 120
           IAKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +        
Sbjct: 120 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 180
             ++A E +L    T ++DV+S+GV V E+++    G   +  +     E +  L + E+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTF---GSKPYDGIP--ASEISSILEKGER 231

Query: 181 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 240
                       PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 232 L---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 241 LFQDSESSSVGTSDKKSSDSTLQMSSV 267
             +    S   ++  ++      M  V
Sbjct: 283 DERMHLPSPTDSNFYRALMDEEDMDDV 309

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (378), Expect = 2e-44
 Identities = 47/226 (20%), Positives = 102/226 (45%), Gaps = 19/226 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +  ++HPNLV+L+G C +     ++ E++   +L   L    +   +++      +   
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQ 123

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I+  + +L +    + +HRD+ A N L+ +    K+ DFGL++L   +            
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            + APE +   + ++K+DV++FGVL+ EI +    G + +  ++   L   ++L +++  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATY---GMSPYPGID---LSQVYELLEKDYR 234

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           +        E P     +  ++   C Q   S RP   ++ +    
Sbjct: 235 M--------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-44
 Identities = 55/239 (23%), Positives = 90/239 (37%), Gaps = 36/239 (15%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-------------------LGATKAN 47
            H N+V L+G C       L++EY     L   L                   L   +  
Sbjct: 99  SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 48  IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 107
             L +E        +AKG+ FL        VHRD+ A N+L+      KI DFGLA+   
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 108 DNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK 166
            +  ++          ++APE +  G  T+K+DV+S+G+L+ EI S    G   +  +  
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL---GVNPYPGIP- 271

Query: 167 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
            +    ++L Q    +        + P         +   C    + +RP    +   L
Sbjct: 272 -VDANFYKLIQNGFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 8e-44
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 24/230 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 60
            + +  HPN++ L+G C++     ++V  Y+++  L                +      +
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGL 137

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRI 117
            +AKG+ FL        VHRD+ A N +LD++F  K+ DFGLA+   D      H  T  
Sbjct: 138 QVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
                ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N    +    L Q
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR---GAPPYPDVN--TFDITVYLLQ 249

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
             + L        EY P+ +   M     C    A  RP  ++++  ++ 
Sbjct: 250 GRRLL------QPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISA 290

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-43
 Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 27/226 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRR----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 58
           L  ++HPN+V          +     +LV E + + +L   L    K    +  +     
Sbjct: 62  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSW 117

Query: 59  CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRI 117
           C  I KGL FLH    P I+HRD+K  NI +     + KIGD GLA L           +
Sbjct: 118 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAV 173

Query: 118 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 177
            GT  ++APE +   +     DVY+FG+ +LE+ +               +        +
Sbjct: 174 IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVK 230

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
                ++  PE+      EII        C +     R  +  ++ 
Sbjct: 231 PASFDKVAIPEV-----KEIIEG------CIRQNKDERYSIKDLLN 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 7e-43
 Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 22/228 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            + ++ H NL+ L G  +    ++ V E     SL        K          S   V 
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQ 119

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 119
           +A+G+ +L        +HRD+ A N+LL      KIGDFGL +  P N  H  +      
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 179
              + APE +     +  +D + FGV + E+ +    G+  W  +N    +   ++ +E 
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY---GQEPWIGLN--GSQILHKIDKEG 231

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           + L          P +       V   C       RP    +   L +
Sbjct: 232 ERLPR--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 8e-43
 Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 32/259 (12%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG------------ATKANIKLNWEK 54
            HPN++ L+G C       L  EY  + +L   L              A      L+ ++
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L +      +HRD+ A NIL+ + +  KI DFGL++     +    
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
            R      ++A E +     T  +DV+S+GVL+ EI+S    G   +  M     E   +
Sbjct: 186 GR--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL---GGTPYCGMT--CAELYEK 238

Query: 175 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 234
           L Q  +          E P N       +   C +     RP   Q++  L   +    +
Sbjct: 239 LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL-NRMLEERK 288

Query: 235 ELTAPGLFQDSESSSVGTS 253
                 L++    + +  S
Sbjct: 289 TYVNTTLYEKFTYAGIDCS 307

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 9e-43
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 29/225 (12%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L  +RHPN ++  GC ++     LV EY   ++ D +          L   + + +  G
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHG 123

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
             +GLA+LH     +++HRD+KA NILL +    K+GDFG A +             GT 
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTP 175

Query: 122 GYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
            ++APE +L    GQ   K DV+S G+  +E+   +         MN   +   + + Q 
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK----PPLFNMNA--MSALYHIAQN 229

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
           E P          +       ++     C Q     RP    ++K
Sbjct: 230 ESP-----ALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-42
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 28/229 (12%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
             S++RHPN++ L G     TR  L+ EY    ++ R L    +   K + ++ +     
Sbjct: 59  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE 114

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           +A  L++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT 
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTL 168

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            YL PE + G     K D++S GVL  E + G+           +   +       E   
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRI--SRVEFTF 223

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM--LTKN 228
            + V          ++I          +   S+RP + +V++   +T N
Sbjct: 224 PDFVTEGA-----RDLISR------LLKHNPSQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-42
 Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 24/225 (10%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
               + H N+V+  G   +G  + L  EY     L   +    + +I +           
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQ 111

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGT 120
           +  G+ +LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT
Sbjct: 112 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

Query: 121 TGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE- 178
             Y+APE +   +      DV+S G+++  +++G           +       W+  +  
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE---LPWDQPSDSCQEYSDWKEKKTY 225

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
             P + +D          ++              S R  +  + K
Sbjct: 226 LNPWKKIDSAP-----LALLHK------ILVENPSARITIPDIKK 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-42
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 33/230 (14%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L++  HPN+V+L+          ++ E+    ++D V+    +    L   +   +C   
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQT 119

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L +LH+     I+HRD+KA NIL   + + K+ DFG++      I    + I GT  
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175

Query: 123 YLAPEYVLGGQL-----TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQL 175
           ++APE V+           KADV+S G+ ++E+               + K         
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK--------- 226

Query: 176 HQEEKPLELVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIK 223
             + +P  L  P    +  N  + ++       C +     R   +Q+++
Sbjct: 227 IAKSEPPTLAQPS--RWSSNFKDFLKK------CLEKNVDARWTTSQLLQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-41
 Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 21/226 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+    HP++V+LIG   +    I + E      L             L+          
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSF---LQVRKYSLDLASLILYAYQ 116

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           ++  LA+L        VHRDI A N+L+      K+GDFGL++   D+  +  ++     
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 181
            ++APE +   + T  +DV+ FGV + EI+     G   +  +     +   ++   E+ 
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMH---GVKPFQGVKNN--DVIGRIENGERL 228

Query: 182 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
                      PPN       +   C     SRRP+  ++   L+ 
Sbjct: 229 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-39
 Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 26/236 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------LGATKANIKLNWEKR 55
            +      ++V L+G   QG   +++ E +    L   L      +         +  K 
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHIT 114
             +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +   + +     
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 174
            +      +++PE +  G  T  +DV+SFGV++ EI +                 E  +Q
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQ 237

Query: 175 LHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 229
               E+ L  V +  L + P N      ++   C Q     RP   ++I  + + +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-38
 Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 26/224 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            +   ++PN+V  +   + G    +V EY+   SL  V+         ++  + + +C  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRE 124

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
             + L FLH      ++HRDIK+ NILL  + + K+ DFG         +  +T + GT 
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 180

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEE 179
            ++APE V       K D++S G++ +E+I G      +     +         +L   E
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
           K    +          + +        C      +R    ++++
Sbjct: 241 K----LSAIF-----RDFLNR------CLDMDVEKRGSAKELLQ 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-38
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 30/234 (12%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWEK 54
           +H N++ L+G C Q     ++ EY    +L   L              +     +L+ + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
                  +A+G+ +L        +HRD+ A N+L+ ++   KI DFGLA+       +  
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 115 T-RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 173
           T        ++APE +     T ++DV+SFGVL+ EI +    G + +  +    +E  +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---GGSPYPGVP---VEELF 247

Query: 174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
           +L +E   +        + P N       +   C  A  S+RP   Q+++ L +
Sbjct: 248 KLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-38
 Identities = 58/244 (23%), Positives = 103/244 (42%), Gaps = 30/244 (12%)

Query: 3   LSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVL------------LGATKANIK 49
           +    H N+V L+G C + G   +++ E+ +  +L   L                     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 50  LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 109
           L  E        +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+    +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 110 ITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 168
             ++          ++APE +     T+++DV+SFGVL+ EI S      + +  +   +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG---ASPYPGVK--I 242

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            E   +  +E   +   D     Y   E+ + M     C     S+RP  +++++ L   
Sbjct: 243 DEEFCRRLKEGTRMRAPD-----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 294

Query: 229 IRLN 232
           ++ N
Sbjct: 295 LQAN 298

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-37
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 8/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S + HP  V+L        +      Y +N  L + +    +     +          I
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEI 117

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTT 121
              L +LH      I+HRD+K  NILL+++ + +I DFG AK+  P++         GT 
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            Y++PE +        +D+++ G ++ ++++G 
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  130 bits (329), Expect = 2e-36
 Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 26/226 (11%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           T+S +RHP LV L          +++YE++    L   +      + K++ ++  +    
Sbjct: 76  TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQ 132

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAG 119
           + KGL  +HE    + VH D+K  NI+   + +   K+ DFGL        +   T   G
Sbjct: 133 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--G 187

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQ 177
           T  + APE   G  +    D++S GVL   ++SG +   G+     +       +   + 
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK---SCDWNM 244

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
           ++     +  +       + IR          A  + R  ++Q ++
Sbjct: 245 DDSAFSGISEDG-----KDFIRK------LLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  127 bits (319), Expect = 5e-35
 Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 10/154 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           ++ + HP L+ L          +L+ E++    L   +      + K++  +  +     
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQA 136

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGT 120
            +GL  +HE     IVH DIK  NI+ + +     KI DFGLA     +   I      T
Sbjct: 137 CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTAT 191

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             + APE V    +    D+++ GVL   ++SG 
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (307), Expect = 6e-34
 Identities = 45/226 (19%), Positives = 86/226 (38%), Gaps = 35/226 (15%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
           HPN+++L       T   LV++ ++   L   L       + L+ ++   I   + + + 
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 124

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 127
            LH+    +IVHRD+K  NILLD + N K+ DFG +             + GT  YLAPE
Sbjct: 125 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPE 179

Query: 128 YVLGGQL------TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEE 179
            +             + D++S GV++  +++G      +     +   +           
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM----------S 229

Query: 180 KPLELVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIK 223
              +   PE  +Y     +++               +R    + + 
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEALA 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 6e-34
 Identities = 43/233 (18%), Positives = 86/233 (36%), Gaps = 25/233 (10%)

Query: 3   LSNVRHPNLVELIG-CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
              ++    +  I  C  +G   ++V E +  +  D         + K + +    +   
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQ 111

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHI----- 113
           +   + ++H +   + +HRD+K  N L     +     I DFGLAK + D  TH      
Sbjct: 112 MISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 114 -TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 172
               + GT  Y +    LG + + + D+ S G +++    G    + +     +   E  
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228

Query: 173 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 225
                 EK +      L +  P+E   Y+    FC       +P  + + ++ 
Sbjct: 229 S-----EKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 6e-33
 Identities = 35/155 (22%), Positives = 63/155 (40%), Gaps = 10/155 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L+  RH N++ L          ++++E++    +   +     +  +LN  +       +
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQV 111

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGT 120
            + L FLH     +I H DI+  NI+     +   KI +FG A+                
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TA 166

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 155
             Y APE      ++   D++S G LV  ++SG N
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  121 bits (304), Expect = 7e-33
 Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 11/154 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           +S    P +V +        +   + + +    L   L      +   +          I
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 116

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             GL  +H      +V+RD+K +NILLD+  + +I D GLA  F     H +    GT G
Sbjct: 117 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHG 170

Query: 123 YLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN 155
           Y+APE +  G      AD +S G ++ +++ G +
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-32
 Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 8/148 (5%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
            HP L  +            V EY+    L   +    ++  K +  + +     I  GL
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGL 116

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 126
            FLH      IV+RD+K  NILLD++ + KI DFG+ K          T   GT  Y+AP
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 172

Query: 127 EYVLGGQLTMKADVYSFGVLVLEIISGR 154
           E +LG +     D +SFGVL+ E++ G+
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 39/232 (16%), Positives = 87/232 (37%), Gaps = 26/232 (11%)

Query: 7   RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 66
               +  +     +G   +LV + +  +  D +         K + +  +     +   +
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARV 114

Query: 67  AFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHI------TT 115
             +HE     +V+RDIK  N L+ +  +       + DFG+ K + D +T          
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 175
            ++GT  Y++    LG + + + D+ + G + +  + G        G       +   ++
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERI 228

Query: 176 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 227
            ++++   L   EL    P E  +YM    +    A    P  + +  + +K
Sbjct: 229 GEKKQSTPL--RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (296), Expect = 4e-32
 Identities = 41/225 (18%), Positives = 78/225 (34%), Gaps = 26/225 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN+V L      G    L+ + V    L   +               S +   +
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQV 116

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              + +LH+  + H   +        LD++    I DFGL+K+       + +   GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPG 174

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEK 180
           Y+APE +     +   D +S GV+   ++ G      +       + L          + 
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL----------KA 224

Query: 181 PLELVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIK 223
             E   P   +   +  + IR+        +    +R    Q ++
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRH------LMEKDPEKRFTCEQALQ 263

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-31
 Identities = 49/280 (17%), Positives = 111/280 (39%), Gaps = 29/280 (10%)

Query: 7   RHPNLVELIGCC----VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           + P++V ++             ++V E ++   L   +    + +      + S+I   I
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSI 120

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAG 119
            + + +LH     +I HRD+K  N+L   +      K+ DFG AK    + +  T     
Sbjct: 121 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-- 175

Query: 120 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 179
           T  Y+APE +   +     D++S GV++  ++ G       +   +   +    +     
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP----PFYSNHGLAISPGMKTRIRM 231

Query: 180 KPLELVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIKM--LTKNIRLNEEE 235
              E  +PE  E       +IR         +   ++R  + + +    + ++ ++ +  
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 236 L-TAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQV 274
           L T+  L +D E       +  S+ +T+++    + I ++
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKI 325

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (292), Expect = 2e-31
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           LS V HP ++ + G      +  ++ +Y+E   L  +     + + +            +
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFYAAEV 113

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L +LH      I++RD+K  NILLD+  + KI DFG AK  PD    +     GT  
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPD 166

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           Y+APE V         D +SFG+L+ E+++G 
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  114 bits (285), Expect = 8e-31
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 13/159 (8%)

Query: 2   TLSNVRHPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 57
             + + HP +V +          G    +V EYV+  +L  ++         +  ++  +
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIE 115

Query: 58  ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TT 115
           +     + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +  T 
Sbjct: 116 VIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            + GT  YL+PE   G  +  ++DVYS G ++ E+++G 
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 9e-31
 Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 7/154 (4%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYV--ENNSLDRVLLGATKANIKLNWEKRSDICV 60
           L    HPN+V L   C            +  E+   D            +  E   D+  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 61  GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 120
            + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++   +    T +  T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 121 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
             Y APE +L        D++S G +  E+   +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-29
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 18/229 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  + HPN++ L+      +   LV++++E +    +       ++ L         +  
Sbjct: 54  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMT 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GL +LH+     I+HRD+K +N+LLD+    K+ DFGLAK F       T ++  T  
Sbjct: 110 LQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRW 165

Query: 123 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEE 179
           Y APE + G ++  +  D+++ G ++ E++       G +   Q+ +             
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-------FETLG 218

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            P E   P++   P     +           +A+    ++ +  +   N
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-29
 Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 11/152 (7%)

Query: 5   NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 64
           +     ++ L+    +    +L+ E  E        +        L  E        + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLE 121

Query: 65  GLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGY 123
            +   H      ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 175

Query: 124 LAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 154
             PE++   +     A V+S G+L+ +++ G 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-29
 Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 22/240 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L   RH N++ +       T   +   Y+  + +   L    K    L+ +        
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQ 117

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAG 119
           I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++   +  H    T    
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 120 TTGYLAPEYVLGGQLTM-KADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL-------- 168
           T  Y APE +L  +      D++S G ++ E++S R    GK    Q+N  L        
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 169 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF-----CTQAAASRRPQMNQVIK 223
            +    ++ + +   L  P   + P N +                     +R ++ Q + 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-28
 Identities = 41/235 (17%), Positives = 85/235 (36%), Gaps = 19/235 (8%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L  + HPN+V+L+       +  LV+E++  +    +   A      +           
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQ 110

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + +GLAF H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +    
Sbjct: 111 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167

Query: 122 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL------LEWAW 173
                  +     +   D++S G +  E+++ R    G +   Q+ +         E  W
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 174 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF-----CTQAAASRRPQMNQVIK 223
                    +   P+      ++++  +                ++R      + 
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-28
 Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 29/292 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKR 55
            +  + H N+V L         +       LV +YV      RV    ++A   L     
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYV 124

Query: 56  SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHIT 114
                 + + LA++H      I HRDIK  N+LLD +    K+ DFG AK       +++
Sbjct: 125 KLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 115 TRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEW 171
                +  Y APE + G    T   DV+S G ++ E++ G+    G +   Q+ + +++ 
Sbjct: 182 YIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE-IIKV 238

Query: 172 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI-- 229
                +E+      +    ++P  +   + KV    T   A     +    ++L      
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA-----IALCSRLLEYTPTA 293

Query: 230 RLNEEELTAPGLFQDSESSSVGTSDKKSSD-----STLQMSSVPVTITQVTP 276
           RL   E  A   F +    +V   + + +      +T ++SS P   T + P
Sbjct: 294 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 4e-28
 Identities = 51/225 (22%), Positives = 82/225 (36%), Gaps = 25/225 (11%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++HPN++ L       T  IL+ E V    L             L  E+ ++    I
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQI 122

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIA 118
             G+ +LH      I H D+K  NI+L     P    KI DFGLA        +    I 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIF 177

Query: 119 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 178
           GT  ++APE V    L ++AD++S GV+   ++SG +       Q           L   
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANV 228

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 223
                  + E           +++           +R  +   ++
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIRR---LLVKDPKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  105 bits (262), Expect = 2e-27
 Identities = 45/234 (19%), Positives = 90/234 (38%), Gaps = 20/234 (8%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V+L        R +LV+E+++ +    +          L         + +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQL 109

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
             G+A+ H+     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  I     
Sbjct: 110 LNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQ 177
                 +   + +   D++S G +  E+++G       S      ++ + L     +   
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 178 EEKPLELVDPELGEYPPNEIIRYMKVAFF--------CTQAAASRRPQMNQVIK 223
               L   DP    Y P     ++K              +   ++R    Q ++
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 2e-26
 Identities = 51/245 (20%), Positives = 99/245 (40%), Gaps = 32/245 (13%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRI--------LVYEYVENNSLDRVLLGATKANIKLNWE 53
            L  ++H N+V LI  C               LV+++ E++    +        +K    
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLS 117

Query: 54  KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNI 110
           +   +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F    ++ 
Sbjct: 118 EIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174

Query: 111 THITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR-----NSGKAMWGQM 164
            +  T    T  Y  PE +LG +      D++  G ++ E+ +       N+ +     +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234

Query: 165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI-K 223
           ++       ++       EL       Y   E+++  K        A  R P    +I K
Sbjct: 235 SQLCGSITPEVWPNVDNYEL-------YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287

Query: 224 MLTKN 228
           +L  +
Sbjct: 288 LLVLD 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 4e-26
 Identities = 46/152 (30%), Positives = 62/152 (40%), Gaps = 8/152 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L N RHP L  L        R   V EY     L   L            E+       I
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
              L +LH      +V+RDIK  N++LD++ + KI DFGL K    +         GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPE 170

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           YLAPE +         D +  GV++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.7 bits (242), Expect = 2e-24
 Identities = 42/229 (18%), Positives = 83/229 (36%), Gaps = 16/229 (6%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  ++H N+V L        +  LV+E+ + +            N  L+ E        +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQL 110

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            KGL F H     +++HRD+K  N+L+++    K+ +FGLA+ F   +   +  +     
Sbjct: 111 LKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN---SGKAMWGQMNKFLLEWAWQLHQEE 179
                       +   D++S G +  E+ +       G  +  Q+ + +        +E+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQ 226

Query: 180 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
            P     P+   YP       +        A        + +  +L  N
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG-----RDLLQNLLKCN 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 2e-24
 Identities = 51/263 (19%), Positives = 98/263 (37%), Gaps = 24/263 (9%)

Query: 2   TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
            L ++RH N++ L+             ++          LG    + KL  ++   +   
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +T        T 
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----VTR 182

Query: 122 GYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQL 175
            Y APE +L     T   D++S G ++ E+I+G+     +       ++ K       + 
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 176 HQEEKPLELVD-----PELGEYPPNEIIRYMKVAFF-----CTQAAASRRPQMNQVIKM- 224
            Q  +  E  +     PEL +     I+                  A +R    + +   
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302

Query: 225 LTKNIRLNEEELTAPGLFQDSES 247
             +++   E+E          + 
Sbjct: 303 YFESLHDTEDEPQVQKYDDSFDD 325

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 96.4 bits (239), Expect = 1e-23
 Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 11/152 (7%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L  V  P LV+L       +   +V EYV    +   L    +   + +          I
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQI 150

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
                +LH      +++RD+K  N+L+DQ+   ++ DFG AK        +     GT  
Sbjct: 151 VLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPE 203

Query: 123 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
            LAPE +L        D ++ GVL+ E+ +G 
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 91.8 bits (227), Expect = 4e-22
 Identities = 41/230 (17%), Positives = 84/230 (36%), Gaps = 21/230 (9%)

Query: 8   HPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 65
            PN++ L         R   LV+E+V N    ++          L           I K 
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKA 141

Query: 66  LAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYL 124
           L + H      I+HRD+K  N+++D E    ++ D+GLA+ +     +       +  + 
Sbjct: 142 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFK 196

Query: 125 APEYVLGGQL-TMKADVYSFGVLVLEIISGRN---SGKAMWGQMNKF--LLEWAWQLHQE 178
            PE ++  Q+     D++S G ++  +I  +     G   + Q+ +   +L         
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256

Query: 179 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 228
           +K    +DP   +       +  +               ++ + K+L  +
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 1e-21
 Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 10/155 (6%)

Query: 3   LSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 61
           L ++R  P LV L       T+  L+ +Y+    L   L        +    +       
Sbjct: 82  LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGE 137

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 121
           I   L  LH+     I++RDIK  NILLD   +  + DFGL+K F  + T       GT 
Sbjct: 138 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 122 GYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGR 154
            Y+AP+ V GG        D +S GVL+ E+++G 
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.8 bits (211), Expect = 7e-20
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 18/160 (11%)

Query: 1   MTLSNVRHPNLVELIGCCV------QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 54
           + +  V H N++ L+          +     LV E ++ N    +        ++L+ E+
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHER 120

Query: 55  RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 114
            S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+    +   + 
Sbjct: 121 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 175

Query: 115 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 154
           T    T  Y APE +LG       D++S G ++ E++  +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.1 bits (199), Expect = 3e-18
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 8/153 (5%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 62
           L +++H N++ L+             +      L    L       KL  +    +   I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 63  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 122
            +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T        T  
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRW 183

Query: 123 YLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 154
           Y APE +L         D++S G ++ E+++GR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 74.7 bits (182), Expect = 5e-16
 Identities = 47/261 (18%), Positives = 94/261 (36%), Gaps = 25/261 (9%)

Query: 3   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVG 61
             ++   ++++L+          +    V     + +L    K   +         I   
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 62  IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNITHITT 115
           +  GL ++H      I+H DIK  N+L++   +P      KI D G A  + ++ T+   
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI- 190

Query: 116 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-----------NSGKAMWGQM 164
               T  Y +PE +LG      AD++S   L+ E+I+G                    Q+
Sbjct: 191 ---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 165 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 224
            + L E    L +  K         G       +++  +    T+     + +  ++   
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 225 LTKNIRLNEEE-LTAPGLFQD 244
           L+  ++L+  +   A GL   
Sbjct: 308 LSPMLQLDPRKRADAGGLVNH 328

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 55.9 bits (134), Expect = 3e-10
 Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 19/144 (13%)

Query: 8   HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 67
              L +L G  V       VY +  N  L  ++       +++       +   I + +A
Sbjct: 65  FRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117

Query: 68  FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--PDNITHITTRIAGTTGYLA 125
             +      IVH D+   N+L+  E    I DF  +           +   +     Y +
Sbjct: 118 KFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 126 PEYVLGGQLTMKADVYSFGVLVLE 149
             Y        + D+ S    +L+
Sbjct: 174 RTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	277
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.73
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.08
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.53
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	93.74
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	84.46

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=333.59  Aligned_cols=213  Identities=25%  Similarity=0.421  Sum_probs=163.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|++.+ +..++|||||++|+|.+++..   .+..+++..++.++.||+.||+|||++   +|+|||
T Consensus        57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrD  129 (276)
T d1uwha_          57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRD  129 (276)
T ss_dssp             HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccc
Confidence            5789999999999999865 467899999999999999943   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+|||++.++.+||+|||+++....... .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||
T Consensus       130 lKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf  209 (276)
T d1uwha_         130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY  209 (276)
T ss_dssp             CCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence            999999999999999999999987654322 23345679999999999864   35789999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      .......  ....    .......    .+.+..........+.+++.+||+.||.+|||+.||++.|+.+.+.
T Consensus       210 ~~~~~~~--~~~~----~~~~~~~----~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         210 SNINNRD--QIIF----MVGRGYL----SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             TTCCCHH--HHHH----HHHHTSC----CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCChHH--HHHH----HHhcCCC----CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            7543321  1111    1111111    1111111222233577888899999999999999999999987653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-52  Score=339.00  Aligned_cols=209  Identities=26%  Similarity=0.439  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++|+|.+++..++|||||++|+|.+++.   .....+++..++.++.||+.||+|||++   +++|||
T Consensus        80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrD  153 (299)
T d1jpaa_          80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRD  153 (299)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCc
Confidence            5789999999999999999999999999999999999884   3345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce----eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI----TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p  156 (277)
                      |||+||||+.++.+||+|||+++.+.......    .....||+.|+|||.+.+..++.++|||||||++|||+| |..|
T Consensus       154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P  233 (299)
T d1jpaa_         154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP  233 (299)
T ss_dssp             CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence            99999999999999999999999765433221    223457899999999999999999999999999999998 7888


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      |.....   ..+..   ........         ..+......+.+++.+||+.||++|||+.||++.|+++++.
T Consensus       234 f~~~~~---~~~~~---~i~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         234 YWDMTN---QDVIN---AIEQDYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             TTTCCH---HHHHH---HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCH---HHHHH---HHHcCCCC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            865432   11221   12221111         11222334577888899999999999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=330.66  Aligned_cols=209  Identities=23%  Similarity=0.393  Sum_probs=157.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++|+|.+++..++||||+++|+|.+++.   .....+++..++.++.|++.||+|||+.   +|+|||
T Consensus        53 ~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrD  126 (263)
T d1sm2a_          53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRD  126 (263)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTT
T ss_pred             HHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecc
Confidence            4778999999999999999999999999999999999984   3445689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||+++++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||+|+..|+....
T Consensus       127 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~  206 (263)
T d1sm2a_         127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  206 (263)
T ss_dssp             CSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred             cchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999999998776554444455678999999999999999999999999999999999655543222


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      .  .......+   ......      ..+...   ...+.+++.+||+.||++|||++||++.|+++..
T Consensus       207 ~--~~~~~~~i---~~~~~~------~~p~~~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         207 S--NSEVVEDI---STGFRL------YKPRLA---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             C--HHHHHHHH---HHTCCC------CCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C--HHHHHHHH---HhcCCC------CCcccc---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1  11222221   111111      111112   2347788888999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-51  Score=333.90  Aligned_cols=210  Identities=22%  Similarity=0.343  Sum_probs=172.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|+|.+++..++|||||++|+|.+++..  .....+++..++.++.|++.||+|||++   +|+|||
T Consensus        66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrD  140 (287)
T d1opja_          66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD  140 (287)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCc
Confidence            57889999999999999999999999999999999999854  2345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||+++++.+||+|||+++..............|+..|+|||++.+..++.++|||||||++|||++|..|+....
T Consensus       141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~  220 (287)
T d1opja_         141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  220 (287)
T ss_dssp             CSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence            99999999999999999999999876655555555678999999999999999999999999999999999877754332


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ..  ....    .....+..     +..+.   .....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       221 ~~--~~~~----~~i~~~~~-----~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         221 DL--SQVY----ELLEKDYR-----MERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CH--HHHH----HHHHTTCC-----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             hH--HHHH----HHHhcCCC-----CCCCc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            21  1111    11222111     11212   223347788889999999999999999999987754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=327.47  Aligned_cols=202  Identities=24%  Similarity=0.333  Sum_probs=162.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||+||+|.+++.    .+..+++..+..++.|++.||+|||++   +|+|||
T Consensus        56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrD  128 (271)
T d1nvra_          56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRD  128 (271)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCc
Confidence            5789999999999999999999999999999999999983    455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCC-cceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||+++++.+||+|||+++...... ........||+.|+|||++.+..+ +.++|||||||++|||+||+.||..
T Consensus       129 iKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~  208 (271)
T d1nvra_         129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  208 (271)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998764332 223445679999999999988776 6789999999999999999999976


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ........ .    .........        .........+.+++.+||+.||++|||+.|+++
T Consensus       209 ~~~~~~~~-~----~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         209 PSDSCQEY-S----DWKEKKTYL--------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             SSTTSHHH-H----HHHTTCTTS--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CChHHHHH-H----HHhcCCCCC--------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            54322111 1    111111110        001122234778888999999999999998854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=331.06  Aligned_cols=209  Identities=29%  Similarity=0.427  Sum_probs=166.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|++.+ +..++||||+++|+|.+++..  ..+..+++..+++++.||+.||+|||+.   +|+|||
T Consensus        61 ~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrD  134 (272)
T d1qpca_          61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRD  134 (272)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCc
Confidence            5788999999999998865 456899999999999998742  2233599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||||++++.+||+|||+++..............||+.|+|||++.++.++.++|||||||++|||+||..|+....
T Consensus       135 iKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~  214 (272)
T d1qpca_         135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (272)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999876554444455678999999999999999999999999999999999766654322


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ..  .....   .......      +..+.   .....+.+++.+||+.||++|||+.+|++.|++...
T Consensus       215 ~~--~~~~~---~i~~~~~------~~~p~---~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         215 TN--PEVIQ---NLERGYR------MVRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CH--HHHHH---HHHTTCC------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CH--HHHHH---HHHhcCC------CCCcc---cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            21  11111   1111111      11111   222347788889999999999999999999998654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=328.52  Aligned_cols=206  Identities=25%  Similarity=0.382  Sum_probs=166.9

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|+|.+ +..++|||||++|+|.+++.   ..+..+++..+++++.|++.||+|||++   +|+|||
T Consensus        62 il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrD  134 (285)
T d1u59a_          62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRD  134 (285)
T ss_dssp             HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCc
Confidence            5788999999999999875 46789999999999999983   3445799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++.+.......  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~  214 (285)
T d1u59a_         135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  214 (285)
T ss_dssp             CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence            99999999999999999999999776543322  234568899999999999999999999999999999998 899987


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      .....   .+..   ... .+..     +..   ++.....+.+++.+||+.||++|||+.+|++.|+...
T Consensus       215 ~~~~~---~~~~---~i~-~~~~-----~~~---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         215 KMKGP---EVMA---FIE-QGKR-----MEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TCCTH---HHHH---HHH-TTCC-----CCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHH---HHHH---HHH-cCCC-----CCC---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            64332   1211   111 1111     111   1222334778888999999999999999999998754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=325.49  Aligned_cols=196  Identities=28%  Similarity=0.410  Sum_probs=162.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||++|+|.+++.    ....+++..+..++.||+.||+|||++   +|+|||
T Consensus        59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrD  131 (263)
T d2j4za1          59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRD  131 (263)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeeee
Confidence            5788999999999999999999999999999999999994    344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++......   .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       132 iKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  208 (263)
T d2j4za1         132 IKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  208 (263)
T ss_dssp             CCGGGEEECTTSCEEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eccccceecCCCCEeecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999998665432   345679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .   ....   .......       ..++..   ....+.+++.+||+.||++|||+.|+++
T Consensus       209 ~---~~~~---~~i~~~~-------~~~p~~---~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         209 Y---QETY---KRISRVE-------FTFPDF---VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             H---HHHH---HHHHTTC-------CCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHHH---HHHHcCC-------CCCCcc---CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            2   1111   1111111       111122   2234778888899999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=328.23  Aligned_cols=205  Identities=27%  Similarity=0.402  Sum_probs=164.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|+|..+ ..++|||||++|+|.+++.    ....+++..+++++.||+.||+|||+.   +|+|||
T Consensus        61 il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrD  132 (277)
T d1xbba_          61 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRD  132 (277)
T ss_dssp             HHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCC
Confidence            57899999999999999654 5689999999999999994    345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcce--eeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+|||++.++.+||+|||+++.+.......  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~  212 (277)
T d1xbba_         133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  212 (277)
T ss_dssp             CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence            99999999999999999999999765543322  234568999999999999999999999999999999998 898986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ....   ..+..   ......+      +..   +......+.+++.+||+.||++|||+.+|.+.|+...
T Consensus       213 ~~~~---~~~~~---~i~~~~~------~~~---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         213 GMKG---SEVTA---MLEKGER------MGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             TCCH---HHHHH---HHHTTCC------CCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCH---HHHHH---HHHcCCC------CCC---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            5432   11211   1112111      111   1222334778888899999999999999999888754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=330.36  Aligned_cols=206  Identities=25%  Similarity=0.360  Sum_probs=152.1

Q ss_pred             ccccccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--CCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--VPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i   77 (277)
                      +|++++||||+++++++.+  ++..|+|||||++|+|.+++......+..+++..++.++.|++.||+|||+..  ..+|
T Consensus        56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I  135 (269)
T d2java1          56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV  135 (269)
T ss_dssp             HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred             HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence            5789999999999999975  45689999999999999998654445567999999999999999999999861  0139


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      +||||||+|||++.++.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf  214 (269)
T d2java1         136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF  214 (269)
T ss_dssp             ----CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EeCcCchhhcCcCCCCcEEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence            999999999999999999999999999865432 2234567999999999999999999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ..+..   ..... ...     .+   +......+.+++.+||+.||.+|||+.|+++
T Consensus       215 ~~~~~---~~~~~---~i~~~-~~~-----~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         215 TAFSQ---KELAG---KIREG-KFR-----RI---PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCSSH---HHHHH---HHHHT-CCC-----CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCH---HHHHH---HHHcC-CCC-----CC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            65322   11211   11111 111     11   1122234778888999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=323.90  Aligned_cols=200  Identities=23%  Similarity=0.404  Sum_probs=163.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||+||+|.+++..     ..+++..+..++.||+.||+|||++   +|+|||
T Consensus        70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrD  141 (293)
T d1yhwa1          70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD  141 (293)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccC
Confidence            57889999999999999999999999999999999998842     3599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       142 iKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CcHHHeEECCCCcEeeccchhheeecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999999765432 22345679999999999999999999999999999999999999986433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ..   ...........      + ..+......+.+++.+||+.||.+|||+.|+++
T Consensus       221 ~~---~~---~~~~~~~~~~~------~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         221 PL---RA---LYLIATNGTPE------L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HH---HH---HHHHHHHCSCC------C-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HH---HH---HHHHHhCCCCC------C-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            21   11   11111111110      0 111222345778889999999999999999854

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=326.69  Aligned_cols=211  Identities=24%  Similarity=0.395  Sum_probs=162.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|+|.+.+..++||||+.+|++.+++..   ....+++..+++++.|++.||+|||+.   +|+|||
T Consensus        62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrD  135 (283)
T d1mqba_          62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRD  135 (283)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCc
Confidence            57889999999999999999999999999999999998743   345699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++.++.+||+|||+++........  ......||+.|+|||++.+..++.++|||||||++|||+||..|+..
T Consensus       136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence            9999999999999999999999876543222  23345689999999999999999999999999999999997766543


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ....  ..+..   ......+      +.   .+......+.+++.+||+.||++||++.||++.|+++.+.+
T Consensus       216 ~~~~--~~~~~---~i~~~~~------~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         216 ELSN--HEVMK---AINDGFR------LP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             TCCH--HHHHH---HHHTTCC------CC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             cCCH--HHHHH---HHhccCC------CC---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            3221  11221   1111111      11   12223345778888999999999999999999999887653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-50  Score=330.43  Aligned_cols=208  Identities=26%  Similarity=0.368  Sum_probs=165.9

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC-------------------CCccCCHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------------------ANIKLNWEKRSDICVG   61 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~i~~q   61 (277)
                      +|+++ +|||||+++++|.+.+..++|||||++|+|.+++.....                   ....+++..++.++.|
T Consensus        93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  172 (325)
T d1rjba_          93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ  172 (325)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred             HHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHH
Confidence            35677 899999999999999999999999999999999964322                   1235899999999999


Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccce
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      ++.||+|||++   +|+||||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++||
T Consensus       173 i~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di  249 (325)
T d1rjba_         173 VAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV  249 (325)
T ss_dssp             HHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceec
Confidence            99999999999   9999999999999999999999999999876543332 3345668999999999999999999999


Q ss_pred             EehhHHHHHHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          141 YSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       141 ~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      |||||++|||+| |..||.......  .+.    .....+..     +..+   ......+.+++.+||+.||++|||++
T Consensus       250 wS~Gvil~emlt~g~~Pf~~~~~~~--~~~----~~~~~~~~-----~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         250 WSYGILLWEIFSLGVNPYPGIPVDA--NFY----KLIQNGFK-----MDQP---FYATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             HHHHHHHHHHTTTSCCSSTTCCCSH--HHH----HHHHTTCC-----CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cchhHHHHHHHhCCCCCCCCCCHHH--HHH----HHHhcCCC-----CCCC---CcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            999999999998 888886543321  111    11122111     1111   22233577888899999999999999


Q ss_pred             HHHHHHh
Q 023808          220 QVIKMLT  226 (277)
Q Consensus       220 ~v~~~L~  226 (277)
                      ||++.|.
T Consensus       316 ei~~~L~  322 (325)
T d1rjba_         316 NLTSFLG  322 (325)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=318.06  Aligned_cols=206  Identities=21%  Similarity=0.384  Sum_probs=169.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      ++++++||||++++|+|.+++..++||||+++|+|.+++.   .....+++..+++++.|++.||+|||+.   +|+|||
T Consensus        52 ~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~d  125 (258)
T d1k2pa_          52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRD  125 (258)
T ss_dssp             HHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSC
T ss_pred             HHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---Cccccc
Confidence            4778999999999999999999999999999999999973   3445689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||++++++.+||+|||+++.+............||..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       126 lk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~  205 (258)
T d1k2pa_         126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  205 (258)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             ccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence            99999999999999999999998766554444445678999999999999999999999999999999998 78888655


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      ...   .+..   ......+.      ..+.   .....+.+++.+||+.||.+|||+.+|++.|.++
T Consensus       206 ~~~---~~~~---~i~~~~~~------~~p~---~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         206 TNS---ETAE---HIAQGLRL------YRPH---LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CHH---HHHH---HHHTTCCC------CCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CHH---HHHH---HHHhCCCC------CCcc---cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            322   1221   22221111      1111   2223577888899999999999999999988653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=315.45  Aligned_cols=198  Identities=25%  Similarity=0.386  Sum_probs=156.4

Q ss_pred             ccccccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC-
Q 023808            2 TLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-   76 (277)
                      +|++++||||+++++++.+    +...++||||+++|+|.+++.    ....+++..+..++.||+.||+|||++   + 
T Consensus        61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~  133 (270)
T d1t4ha_          61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TP  133 (270)
T ss_dssp             HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SS
T ss_pred             HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            5789999999999999975    346799999999999999994    345799999999999999999999998   6 


Q ss_pred             -eEeccCCCCcEEeC-CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           77 -IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        77 -iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                       |+||||||+|||++ +++.+||+|||+++.....   ......||+.|+|||++.+ .++.++|||||||++|||+||+
T Consensus       134 ~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~  209 (270)
T d1t4ha_         134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE  209 (270)
T ss_dssp             CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCC
Confidence             99999999999996 5789999999999865433   2345679999999998865 6999999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .||.......  ..   ............ .+.   ...    ..+.+++.+||+.||++|||+.|+++
T Consensus       210 ~Pf~~~~~~~--~~---~~~i~~~~~~~~-~~~---~~~----~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         210 YPYSECQNAA--QI---YRRVTSGVKPAS-FDK---VAI----PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CTTTTCSSHH--HH---HHHHTTTCCCGG-GGG---CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCcccHH--HH---HHHHHcCCCCcc-cCc---cCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            9986433211  11   112222111111 111   112    23778888999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=320.03  Aligned_cols=211  Identities=27%  Similarity=0.415  Sum_probs=161.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|+|.+ +..++||||+.+|+|..++..  .....++|..++.++.||+.||+|||+.   +|+|||
T Consensus        65 ~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~D  138 (285)
T d1fmka3          65 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD  138 (285)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heeccc
Confidence            4788999999999999965 457899999999999999843  2234599999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+||||++++.+||+|||+++..............||+.|+|||++.++.++.++||||||+++|||+||..|+....
T Consensus       139 lKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~  218 (285)
T d1fmka3         139 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  218 (285)
T ss_dssp             CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999998775544444455678999999999999999999999999999999999877654433


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccccC
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  232 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~  232 (277)
                      ..  .....   .......      ...   ++.....+.+++.+||+.||++||++++|++.|++.....
T Consensus       219 ~~--~~~~~---~i~~~~~------~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         219 VN--REVLD---QVERGYR------MPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CH--HHHHH---HHHTTCC------CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CH--HHHHH---HHHhcCC------CCC---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            21  11222   1111111      111   1222335778888999999999999999999999877543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=328.33  Aligned_cols=150  Identities=27%  Similarity=0.486  Sum_probs=134.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~   80 (277)
                      +|++++|||||+++++|.+++..++||||++||+|.+++.    ....+++..+..++.|++.||+|||+ +   +|+||
T Consensus        57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHR  129 (322)
T d1s9ja_          57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHR  129 (322)
T ss_dssp             GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCS
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcc
Confidence            6889999999999999999999999999999999999994    33469999999999999999999996 5   89999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      ||||+|||++.++++||+|||+|+.+...   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       130 DiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             ccCHHHeeECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999999865332   234567999999999999999999999999999999999999998654


Q ss_pred             c
Q 023808          161 W  161 (277)
Q Consensus       161 ~  161 (277)
                      .
T Consensus       207 ~  207 (322)
T d1s9ja_         207 D  207 (322)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=322.54  Aligned_cols=202  Identities=24%  Similarity=0.393  Sum_probs=161.0

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||++++++.+++..++|||||++|+|.+++..   .+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrD  135 (288)
T d2jfla1          62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRD  135 (288)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEee
Confidence            57889999999999999999999999999999999999742   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccc-----cCccccccceEehhHHHHHHHhCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      |||+|||++.++.+||+|||+++..... ........||+.|+|||++.     +..++.++|||||||++|||+||+.|
T Consensus       136 iKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P  214 (288)
T d2jfla1         136 LKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP  214 (288)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cChhheeECCCCCEEEEechhhhccCCC-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence            9999999999999999999999754322 11233467999999999984     34578999999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |.......   ...   ........      . ...+......+.+++.+||+.||.+|||+.|+++
T Consensus       215 f~~~~~~~---~~~---~i~~~~~~------~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         215 HHELNPMR---VLL---KIAKSEPP------T-LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             TTTSCGGG---HHH---HHHHSCCC------C-CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCHHH---HHH---HHHcCCCC------C-CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            86543322   111   11221111      0 0111223345778889999999999999999854

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=323.20  Aligned_cols=199  Identities=19%  Similarity=0.298  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||+||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrD  133 (288)
T d1uu3a_          61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRD  133 (288)
T ss_dssp             HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCc
Confidence            5788999999999999999999999999999999999984    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||+++++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||+||..||...
T Consensus       134 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence            999999999999999999999997754332 2334567999999999999999999999999999999999999998653


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   .....   ..... ..      .++   ......+.+++.+||+.||.+|||++|++.
T Consensus       214 ~~---~~~~~---~i~~~-~~------~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         214 NE---YLIFQ---KIIKL-EY------DFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             SH---HHHHH---HHHTT-CC------CCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CH---HHHHH---HHHcC-CC------CCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            22   11111   11111 11      111   122234778899999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=319.80  Aligned_cols=207  Identities=25%  Similarity=0.375  Sum_probs=156.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++|++. ++..++||||+++|+|.+++..   ....+++..++.++.||+.||+|||+.   +++|||
T Consensus        61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrD  133 (273)
T d1mp8a_          61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRD  133 (273)
T ss_dssp             HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---Ceeccc
Confidence            478899999999999996 4578999999999999998743   345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~  160 (277)
                      |||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus       134 lKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~  213 (273)
T d1mp8a_         134 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  213 (273)
T ss_dssp             CSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999999766544444556678999999999999999999999999999999998 78887654


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      ....   +...   .......      ..   ++.....+.+++.+||+.||++|||+.||++.|+.++.
T Consensus       214 ~~~~---~~~~---i~~~~~~------~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         214 KNND---VIGR---IENGERL------PM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             CGGG---HHHH---HHTTCCC------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHH---HHHH---HHcCCCC------CC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            4322   2221   1111111      11   22223457788889999999999999999999988764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-48  Score=320.01  Aligned_cols=201  Identities=22%  Similarity=0.316  Sum_probs=151.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||+||+|.+++.    ....+++..+..++.||+.||+|||++   +|+|||
T Consensus        60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrD  132 (307)
T d1a06a_          60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRD  132 (307)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEE
Confidence            5789999999999999999999999999999999999994    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeC---CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+||++.   +++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  210 (307)
T d1a06a_         133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY  210 (307)
T ss_dssp             CCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ecccceeecccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence            999999994   57889999999998654332  2344679999999999999999999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   ...   .........  ...+.....+    ..+.+++.+||+.||++|||+.|+++
T Consensus       211 ~~~~~---~~~---~~i~~~~~~--~~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         211 DENDA---KLF---EQILKAEYE--FDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CSSHH---HHH---HHHHTTCCC--CCTTTTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHH---HHH---HHHhccCCC--CCCccccCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            53321   111   122221111  1111112222    34788889999999999999999976

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-48  Score=318.39  Aligned_cols=196  Identities=30%  Similarity=0.499  Sum_probs=159.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||++++++.+++..|+|||||.+|+|..++.    .+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrD  140 (309)
T d1u5ra_          68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRD  140 (309)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccC
Confidence            5789999999999999999999999999999999987763    345799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc---CccccccceEehhHHHHHHHhCCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      |||+|||++.++.+||+|||+++....     .....||+.|+|||++.+   +.++.++|||||||++|||++|..||.
T Consensus       141 iKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         141 VKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999986543     234569999999999864   458999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....      ............. ...   ...+    ..+.+++.+||+.||.+|||+.|+++
T Consensus       216 ~~~~~------~~~~~i~~~~~~~-~~~---~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         216 NMNAM------SALYHIAQNESPA-LQS---GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TSCHH------HHHHHHHHSCCCC-CSC---TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCHH------HHHHHHHhCCCCC-CCC---CCCC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            53221      1111222222111 101   1122    34778888899999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.9e-48  Score=320.71  Aligned_cols=202  Identities=21%  Similarity=0.279  Sum_probs=163.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||+++++|.+++..|+|||||+||+|.+++.   ..+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRD  152 (352)
T d1koba_          79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLD  152 (352)
T ss_dssp             HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            5789999999999999999999999999999999998873   3455699999999999999999999999   999999


Q ss_pred             CCCCcEEeC--CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLD--QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++  .++.+||+|||+++.+....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         153 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             CCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             cccccccccccCCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            999999997  57899999999999875532  34456799999999999999999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ....   ........   .....   .+.....+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~~~~---~~~~---~i~~~~~~---~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         231 EDDL---ETLQ---NVKRCDWE---FDEDA---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SSHH---HHHH---HHHHCCCC---CCSST---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCHH---HHHH---HHHhCCCC---CCccc---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3321   1111   11111111   01111   1122234778899999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-47  Score=318.01  Aligned_cols=202  Identities=23%  Similarity=0.307  Sum_probs=163.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||++++++.+++..|+|||||+||+|.+++.   .....+++..+..++.||+.||+|||++   +|+|||
T Consensus        76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrD  149 (350)
T d1koaa2          76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD  149 (350)
T ss_dssp             HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeee
Confidence            5788999999999999999999999999999999999983   3345699999999999999999999999   999999


Q ss_pred             CCCCcEEeC--CCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLD--QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++  .++.+||+|||+++.+....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             CCGGGEEESSTTSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             echhHeeeccCCCCeEEEeecchheeccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence            999999995  46789999999999765432  23456799999999999999999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .....   .........   ...   ..+.....+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~---~~~~~---~i~~~~~~~---~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         228 END---DETLR---NVKSCDWNM---DDS---AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             SSH---HHHHH---HHHHTCCCS---CCG---GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCH---HHHHH---HHHhCCCCC---Ccc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            422   11111   111111100   000   01122234778889999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=315.87  Aligned_cols=210  Identities=25%  Similarity=0.396  Sum_probs=166.7

Q ss_pred             ccccccCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||++++|++.+. ...++|||||++|+|.+++.   .....+++..+++++.|++.||.|||+.   +|+||
T Consensus        81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHr  154 (311)
T d1r0pa_          81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHR  154 (311)
T ss_dssp             HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccC
Confidence            57899999999999999864 58899999999999999985   3444678899999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||||+|||+++++.+||+|||+++........   ......||..|+|||.+.+..++.++||||||+++|||+||..|+
T Consensus       155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~  234 (311)
T d1r0pa_         155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  234 (311)
T ss_dssp             CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence            99999999999999999999999876543222   223456899999999999999999999999999999999988876


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      .......  ....   ........      ..+...   ...+.+++.+||+.||++||++.||++.|+++...
T Consensus       235 ~~~~~~~--~~~~---~i~~g~~~------~~p~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         235 YPDVNTF--DITV---YLLQGRRL------LQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CC--------CHH---HHHTTCCC------CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCHH--HHHH---HHHcCCCC------CCcccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            5432211  1111   11121111      111222   23477888899999999999999999999998764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=313.61  Aligned_cols=211  Identities=26%  Similarity=0.354  Sum_probs=167.4

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccC------------CCCCccCCHHHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA------------TKANIKLNWEKRSDICVGIAKGLAF   68 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~   68 (277)
                      +|+++ +||||++++|+|.+++..++||||+++|+|.+++...            ......+++..++.++.||+.||.|
T Consensus        63 ~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~  142 (309)
T d1fvra_          63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  142 (309)
T ss_dssp             HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence            47788 7999999999999999999999999999999999543            1234579999999999999999999


Q ss_pred             hhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           69 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        69 LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||+.   +++||||||+|||++.++.+||+|||+++......  ......||..|+|||.+.+..++.++|||||||++|
T Consensus       143 lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~  217 (309)
T d1fvra_         143 LSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  217 (309)
T ss_dssp             HHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             hhcC---CccccccccceEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence            9999   99999999999999999999999999998644322  123456899999999999999999999999999999


Q ss_pred             HHHhCCC-CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIISGRN-SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||++|.. ||.....   ..+   ........+      +..   +......+.+++.+||+.||++|||+.||++.|++
T Consensus       218 ell~~~~~p~~~~~~---~~~---~~~i~~~~~------~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         218 EIVSLGGTPYCGMTC---AEL---YEKLPQGYR------LEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             HHHTTSCCTTTTCCH---HHH---HHHGGGTCC------CCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCH---HHH---HHHHHhcCC------CCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            9999765 5543221   111   112222111      111   12223457788889999999999999999999999


Q ss_pred             ccccC
Q 023808          228 NIRLN  232 (277)
Q Consensus       228 ~~~~~  232 (277)
                      ++...
T Consensus       283 i~~~~  287 (309)
T d1fvra_         283 MLEER  287 (309)
T ss_dssp             HHHSS
T ss_pred             HHhcC
Confidence            87543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=310.56  Aligned_cols=204  Identities=25%  Similarity=0.342  Sum_probs=157.1

Q ss_pred             ccccccCCCccceeeEEEeC-CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++||||++++|+|.++ +..++||||+++|+|.+++...  ....+++..+++++.||+.||+|||+.   +++||
T Consensus        53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~  127 (262)
T d1byga_          53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR  127 (262)
T ss_dssp             HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceecc
Confidence            57899999999999999754 5679999999999999999532  233589999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      ||||+||+++.++.+|++|||+++.....    .....++..|+|||++.+..++.++||||||+++|||+| |+.|+..
T Consensus       128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~  203 (262)
T d1byga_         128 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  203 (262)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             ccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999999865432    233457889999999999999999999999999999998 5666654


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  229 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~  229 (277)
                      ....   .....   .....      .+.+..   .....+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       204 ~~~~---~~~~~---i~~~~------~~~~~~---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         204 IPLK---DVVPR---VEKGY------KMDAPD---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             SCGG---GHHHH---HTTTC------CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHH---HHHHH---HHcCC------CCCCCc---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3222   22221   11111      112222   22234778888999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=309.19  Aligned_cols=206  Identities=24%  Similarity=0.376  Sum_probs=162.8

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||++++|+|.++ ..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||++   +|+|||
T Consensus        64 ~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrD  136 (273)
T d1u46a_          64 AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRD  136 (273)
T ss_dssp             HHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeee
Confidence            47889999999999999764 66899999999999988743   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCC
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  158 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~  158 (277)
                      |||+||+++.++.+||+|||+++........  ......|+..|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~  216 (273)
T d1u46a_         137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  216 (273)
T ss_dssp             CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987554332  2334567889999999999999999999999999999998 888886


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhc
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  228 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~  228 (277)
                      .....   ..   ............    .....+    ..+.+++.+||+.||++|||+.+|.+.|+++
T Consensus       217 ~~~~~---~~---~~~i~~~~~~~~----~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         217 GLNGS---QI---LHKIDKEGERLP----RPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TCCHH---HH---HHHHHTSCCCCC----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcCHH---HH---HHHHHhCCCCCC----Cccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            54321   11   122222221111    111222    3477888899999999999999999999764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=316.52  Aligned_cols=208  Identities=25%  Similarity=0.386  Sum_probs=163.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||+++|+|.++ ..+++|||+.+|+|.+++.   .....+++..+++++.||+.||+|||++   +|+|||
T Consensus        64 ~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrD  136 (317)
T d1xkka_          64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRD  136 (317)
T ss_dssp             HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCc
Confidence            57889999999999999876 4567889999999998884   3455799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHHHHHh-CCCCCCc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~  159 (277)
                      |||+|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||..
T Consensus       137 lKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~  216 (317)
T d1xkka_         137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  216 (317)
T ss_dssp             CCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             chhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999999999977554332 2334568999999999999999999999999999999999 6777765


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      .....   +......   ..+.         ..++.....+.+++.+||+.||.+|||+.||++.|..+.+.
T Consensus       217 ~~~~~---~~~~i~~---~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         217 IPASE---ISSILEK---GERL---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             SCGGG---HHHHHHH---TCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCHHH---HHHHHHc---CCCC---------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            43221   2221111   1111         11222334577888899999999999999999999887653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-48  Score=315.76  Aligned_cols=210  Identities=24%  Similarity=0.408  Sum_probs=166.1

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC--------------------CCCccCCHHHHHHHHHH
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT--------------------KANIKLNWEKRSDICVG   61 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~~~i~~q   61 (277)
                      +|++++||||++++++|...+..++||||+.+|+|.+++....                    .....+++..++.++.|
T Consensus        69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  148 (301)
T d1lufa_          69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ  148 (301)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred             HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence            5789999999999999999999999999999999999985322                    12234899999999999


Q ss_pred             HHHHHHHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc-ceeeeecccccccCccccccCccccccce
Q 023808           62 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADV  140 (277)
Q Consensus        62 i~~~l~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  140 (277)
                      ++.||+|||+.   +++||||||+|||++.++.+||+|||+++....... .......|++.|+|||++.+..++.++||
T Consensus       149 i~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV  225 (301)
T d1lufa_         149 VAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV  225 (301)
T ss_dssp             HHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence            99999999999   999999999999999999999999999986644322 23345678899999999999999999999


Q ss_pred             EehhHHHHHHHhCCC-CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH
Q 023808          141 YSFGVLVLEIISGRN-SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  219 (277)
Q Consensus       141 ~slG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~  219 (277)
                      |||||++|||++|.. |+.....   ....   ..+... ...     ..   +.....++.+++.+||+.+|++|||+.
T Consensus       226 wS~Gvvl~ell~~~~~p~~~~~~---~e~~---~~v~~~-~~~-----~~---p~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         226 WAYGVVLWEIFSYGLQPYYGMAH---EEVI---YYVRDG-NIL-----AC---PENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             HHHHHHHHHHHTTTCCTTTTSCH---HHHH---HHHHTT-CCC-----CC---CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ccchhhHHHHHccCCCCCCCCCH---HHHH---HHHHcC-CCC-----CC---CccchHHHHHHHHHHcCCChhHCcCHH
Confidence            999999999999964 5544322   1111   122222 111     11   122223577889999999999999999


Q ss_pred             HHHHHHhhcc
Q 023808          220 QVIKMLTKNI  229 (277)
Q Consensus       220 ~v~~~L~~~~  229 (277)
                      ||++.|+++.
T Consensus       291 ev~~~L~~i~  300 (301)
T d1lufa_         291 SIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHhc
Confidence            9999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=312.56  Aligned_cols=211  Identities=27%  Similarity=0.418  Sum_probs=168.9

Q ss_pred             cccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            3 LSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         3 L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      +.++ +|||||+++++|.+++..++||||+++|+|.+++.....            ....+++..++.++.||+.||+||
T Consensus        72 l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl  151 (299)
T d1fgka_          72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  151 (299)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh
Confidence            4455 899999999999999999999999999999999965432            234689999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |+.   +++||||||+|||++.++.+||+|||+++........ ......|++.|+|||.+.++.++.++||||||+++|
T Consensus       152 H~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~  228 (299)
T d1fgka_         152 ASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW  228 (299)
T ss_dssp             HHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             hhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHH
Confidence            999   9999999999999999999999999999876543322 234456889999999999999999999999999999


Q ss_pred             HHHh-CCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||+| |..||.....   ..+    ......+...     ..   +......+.+++.+||+.||.+|||+.||++.|++
T Consensus       229 ell~~g~~p~~~~~~---~~~----~~~i~~~~~~-----~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         229 EIFTLGGSPYPGVPV---EEL----FKLLKEGHRM-----DK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HHHTTSCCSSTTCCH---HHH----HHHHHTTCCC-----CC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCH---HHH----HHHHHcCCCC-----CC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            9998 5777654322   111    1222222111     11   11223357888999999999999999999999998


Q ss_pred             cccc
Q 023808          228 NIRL  231 (277)
Q Consensus       228 ~~~~  231 (277)
                      +++.
T Consensus       294 i~a~  297 (299)
T d1fgka_         294 IVAL  297 (299)
T ss_dssp             HHHH
T ss_pred             Hhhc
Confidence            8753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=313.97  Aligned_cols=198  Identities=26%  Similarity=0.295  Sum_probs=162.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||+||+|.+++.    .+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRD  130 (337)
T d1o6la_          58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRD  130 (337)
T ss_dssp             HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCC
T ss_pred             HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---Cccccc
Confidence            5788999999999999999999999999999999999984    445789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       131 lKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         131 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCHHHeEecCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            99999999999999999999998654332 23445679999999999999999999999999999999999999986543


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      .   ..+..   .... ...      .+   +......+.+++.+||+.||.+||+     +.|+++
T Consensus       210 ~---~~~~~---~i~~-~~~------~~---p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         210 H---ERLFE---LILM-EEI------RF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             H---HHHHH---HHHH-CCC------CC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             H---HHHHH---HHhc-CCC------CC---CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            2   11111   1111 111      11   1122234778888999999999995     777764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-47  Score=310.83  Aligned_cols=200  Identities=25%  Similarity=0.265  Sum_probs=161.3

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++|+|||||++++++.+++..|+|||||+||+|.+++.    ....+++..+..++.|++.||+|||+.   +|+|||
T Consensus        66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrD  138 (293)
T d1jksa_          66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFD  138 (293)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecc
Confidence            4778999999999999999999999999999999999994    334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCC----ceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           82 IKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        82 ikp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      |||+||+++.++    .+|++|||+++......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf  216 (293)
T d1jksa_         139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  216 (293)
T ss_dssp             CSGGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCC
Confidence            999999998776    49999999998765432  234456899999999999989999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCc-cccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKP-LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ......   ...   ......... .....   ..    ....+.+++.+||+.||.+|||+.|+++
T Consensus       217 ~~~~~~---~~~---~~i~~~~~~~~~~~~---~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         217 LGDTKQ---ETL---ANVSAVNYEFEDEYF---SN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCSSHH---HHH---HHHHTTCCCCCHHHH---TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCHH---HHH---HHHHhcCCCCCchhc---CC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            653321   111   111111110 00000   11    2234778899999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.2e-47  Score=311.03  Aligned_cols=195  Identities=27%  Similarity=0.360  Sum_probs=161.5

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||.||+|..++.    .+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrD  129 (316)
T d1fota_          57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRD  129 (316)
T ss_dssp             HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCC
T ss_pred             HHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccc
Confidence            5788999999999999999999999999999999999983    455688999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       130 iKp~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         130 LKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             CCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cCchheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence            9999999999999999999999976543    335679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .   ...   .........       .+   ++.....+.+++.+||+.||.+|+     +++++++
T Consensus       206 ~---~~~---~~~i~~~~~-------~~---p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         206 T---MKT---YEKILNAEL-------RF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             H---HHH---HHHHHHCCC-------CC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             H---HHH---HHHHHcCCC-------CC---CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            2   111   112222111       11   111223477888889999999996     8888875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=309.04  Aligned_cols=219  Identities=25%  Similarity=0.312  Sum_probs=164.9

Q ss_pred             ccccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC----
Q 023808            2 TLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL----   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----   73 (277)
                      .+++++||||++++|+|.+++    ..++||||+++|+|.+++..     ..++|..+++++.|++.||+|||+..    
T Consensus        50 ~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~  124 (303)
T d1vjya_          50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQ  124 (303)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred             HHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence            456789999999999998654    57899999999999999943     25899999999999999999999631    


Q ss_pred             -CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc---eeeeecccccccCccccccC------ccccccceEeh
Q 023808           74 -VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG------QLTMKADVYSF  143 (277)
Q Consensus        74 -~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~sl  143 (277)
                       ..+|+||||||+|||++.++.+||+|||+++........   ......||+.|+|||++.+.      .++.++|||||
T Consensus       125 ~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~  204 (303)
T d1vjya_         125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             cCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence             128999999999999999999999999999876543322   23456799999999998754      36889999999


Q ss_pred             hHHHHHHHhCCCCCCcccCcc---------hhhHHHHHHHHhccCCccccccCCCCCC--CHHHHHHHHHHHHhhhhhhh
Q 023808          144 GVLVLEIISGRNSGKAMWGQM---------NKFLLEWAWQLHQEEKPLELVDPELGEY--PPNEIIRYMKVAFFCTQAAA  212 (277)
Q Consensus       144 G~vl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~c~~~~p  212 (277)
                      ||++|||+||..|+.......         ...... ........    ..++.++..  .......+.+++.+||+.||
T Consensus       205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp  279 (303)
T d1vjya_         205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANG  279 (303)
T ss_dssp             HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred             HHHHHHHhhCCCCCCcccccccchhhcccccchHHH-HHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence            999999999987764322111         011111 11111111    112222111  23455668899999999999


Q ss_pred             cCCCCHHHHHHHHhhccc
Q 023808          213 SRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       213 ~~RPs~~~v~~~L~~~~~  230 (277)
                      ++|||+.||++.|+++..
T Consensus       280 ~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         280 AARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             GGSCCHHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHHHHH
Confidence            999999999999988764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-47  Score=310.85  Aligned_cols=210  Identities=24%  Similarity=0.344  Sum_probs=157.7

Q ss_pred             ccc-cCCCccceeeEEEeCC-eeEEEEeecCCCCHHHHhccCCC------------CCccCCHHHHHHHHHHHHHHHHHh
Q 023808            4 SNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFL   69 (277)
Q Consensus         4 ~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L   69 (277)
                      .++ +|+||+.+++++.+++ ..++|||||++|+|.+++.....            ....+++..++.++.||+.||+||
T Consensus        71 ~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl  150 (299)
T d1ywna1          71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  150 (299)
T ss_dssp             HHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH
Confidence            344 7999999999987654 68999999999999999964321            233589999999999999999999


Q ss_pred             hcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           70 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        70 H~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      |++   +|+||||||+|||+++++++||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|
T Consensus       151 H~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~  227 (299)
T d1ywna1         151 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW  227 (299)
T ss_dssp             HHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHH
Confidence            999   9999999999999999999999999999876543332 234567999999999999999999999999999999


Q ss_pred             HHHhCCC-CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhh
Q 023808          149 EIISGRN-SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  227 (277)
Q Consensus       149 elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~  227 (277)
                      ||+||.. ||......  ..+...    ...+..     +..++   .....+.+++.+||+.||++|||+.||++.|++
T Consensus       228 ellt~~~~p~~~~~~~--~~~~~~----~~~~~~-----~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         228 EIFSLGASPYPGVKID--EEFCRR----LKEGTR-----MRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             HHHTTSCCSSTTCCCS--HHHHHH----HHHTCC-----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHH--HHHHHH----HhcCCC-----CCCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            9999754 55433221  111111    111111     11111   122347788889999999999999999999998


Q ss_pred             ccc
Q 023808          228 NIR  230 (277)
Q Consensus       228 ~~~  230 (277)
                      +++
T Consensus       294 ilq  296 (299)
T d1ywna1         294 LLQ  296 (299)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-46  Score=315.27  Aligned_cols=199  Identities=21%  Similarity=0.248  Sum_probs=160.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|+.++|||||++++++.+++..|+|||||+||+|.+++.    .+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        60 ~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrD  132 (364)
T d1omwa3          60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRD  132 (364)
T ss_dssp             HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---Ccccee
Confidence            3567899999999999999999999999999999999994    345689999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++.+....   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus       133 lKP~NILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         133 LKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             CSGGGEEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             eccceeEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999765432   344579999999999875 46899999999999999999999999765


Q ss_pred             cCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      ........   . .......      ..++.   .....+.+++.+||+.||.+||+     ++|+++
T Consensus       210 ~~~~~~~~---~-~~~~~~~------~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         210 KTKDKHEI---D-RMTLTMA------VELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CSSCHHHH---H-HHSSSCC------CCCCS---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CHHHHHHH---H-HhcccCC------CCCCC---CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            43322111   1 1111111      11111   12234778888999999999999     677764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-46  Score=301.87  Aligned_cols=201  Identities=23%  Similarity=0.339  Sum_probs=160.9

Q ss_pred             cccccc-CCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++ ||||+++++++.+++..|+|||||++|+|.+++.    .+..+++..+..++.||+.||+|||++   +|+||
T Consensus        62 ~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHr  134 (277)
T d1phka_          62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHR  134 (277)
T ss_dssp             HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCccc
Confidence            466776 9999999999999999999999999999999994    344799999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCcccccc------CccccccceEehhHHHHHHHhCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      ||||+||+++.++.+||+|||+++.+....  ......||..|+|||.+.+      ..++.++||||+||++|||+||+
T Consensus       135 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~  212 (277)
T d1phka_         135 DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS  212 (277)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence            999999999999999999999999775432  2344679999999999864      24678999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .||.....   .....   ........  ...+..    +.....+.+++.+||+.||++||++.||++
T Consensus       213 ~Pf~~~~~---~~~~~---~i~~~~~~--~~~~~~----~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         213 PPFWHRKQ---MLMLR---MIMSGNYQ--FGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CSSCCSSH---HHHHH---HHHHTCCC--CCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCH---HHHHH---HHHhCCCC--CCCccc----ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            99875432   11111   11221111  011111    122335788899999999999999998854

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=308.10  Aligned_cols=213  Identities=26%  Similarity=0.399  Sum_probs=167.6

Q ss_pred             ccccc-cCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCC--------------CCccCCHHHHHHHHHHHHHHH
Q 023808            2 TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------------ANIKLNWEKRSDICVGIAKGL   66 (277)
Q Consensus         2 ~L~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~l   66 (277)
                      +++++ +|||||+++|+|.+++..++|||||++|+|.+++.....              ....+++..+..++.||+.||
T Consensus        79 ~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl  158 (311)
T d1t46a_          79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM  158 (311)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence            35566 799999999999999999999999999999999864331              223589999999999999999


Q ss_pred             HHhhcCCCCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCcc-eeeeecccccccCccccccCccccccceEehhH
Q 023808           67 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV  145 (277)
Q Consensus        67 ~~LH~~~~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  145 (277)
                      +|||++   +++||||||+||+++.++.+|++|||+++........ ......||+.|+|||.+.+..++.++||||||+
T Consensus       159 ~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~  235 (311)
T d1t46a_         159 AFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI  235 (311)
T ss_dssp             HHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence            999999   9999999999999999999999999999977654332 334567899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHH
Q 023808          146 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  225 (277)
Q Consensus       146 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L  225 (277)
                      ++|||+|+..|+....... ..+....    ..+..     +..+.   .....+.+++.+||+.||++|||+.+|+++|
T Consensus       236 ~l~ellt~g~p~~~~~~~~-~~~~~~i----~~~~~-----~~~~~---~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L  302 (311)
T d1t46a_         236 FLWELFSLGSSPYPGMPVD-SKFYKMI----KEGFR-----MLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (311)
T ss_dssp             HHHHHHTTTCCSSTTCCSS-HHHHHHH----HHTCC-----CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHH-HHHHHHH----hcCCC-----CCCcc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            9999999655543222221 1111111    11111     11111   1223478888999999999999999999999


Q ss_pred             hhccc
Q 023808          226 TKNIR  230 (277)
Q Consensus       226 ~~~~~  230 (277)
                      ++.+.
T Consensus       303 ~~~i~  307 (311)
T d1t46a_         303 EKQIS  307 (311)
T ss_dssp             HHHHH
T ss_pred             HHhhc
Confidence            98765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-45  Score=299.94  Aligned_cols=209  Identities=22%  Similarity=0.334  Sum_probs=158.6

Q ss_pred             ccccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++++||||+++++++...+    ..|+||||++||+|.+++.    ....+++.+++.++.||+.||+|||+.   +|
T Consensus        60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~i  132 (277)
T d1o6ya_          60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GI  132 (277)
T ss_dssp             HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            478899999999999998654    4789999999999999883    345799999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCc--ceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      +||||||+|||++.++..+++|||.+........  .......||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus       133 iHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~  212 (277)
T d1o6ya_         133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP  212 (277)
T ss_dssp             ECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence            9999999999999999999999999876543222  23445679999999999999999999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-CHHHHHHHHhhcc
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNI  229 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~  229 (277)
                      ||......      ...............  ......+    ..+.+++.+||+.||.+|| |+++++..|.++.
T Consensus       213 Pf~~~~~~------~~~~~~~~~~~~~~~--~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         213 PFTGDSPV------SVAYQHVREDPIPPS--ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             SCCCSSHH------HHHHHHHHCCCCCGG--GTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCCcCHH------HHHHHHHhcCCCCCc--hhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            98653221      112222222221110  0011222    3477888899999999999 8999988887653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-46  Score=309.83  Aligned_cols=195  Identities=24%  Similarity=0.276  Sum_probs=161.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+....++||||+.+|+|.+++.    ....+++..+..++.||+.||.|||++   +|+|||
T Consensus        94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRD  166 (350)
T d1rdqe_          94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRD  166 (350)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHHcCCCcEeecccccccccccccccccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCc
Confidence            5789999999999999999999999999999999999984    334699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCccc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  161 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~  161 (277)
                      |||+|||++.++.+||+|||+++.+...    .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       167 IKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  242 (350)
T d1rdqe_         167 LKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCHHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence            9999999999999999999999976543    234679999999999999999999999999999999999999986532


Q ss_pred             CcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC-----CHHHHHH
Q 023808          162 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  223 (277)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP-----s~~~v~~  223 (277)
                      .   .....   .......       ..   +......+.+++.+||+.||.+|+     ++.++++
T Consensus       243 ~---~~~~~---~i~~~~~-------~~---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         243 P---IQIYE---KIVSGKV-------RF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             H---HHHHH---HHHHCCC-------CC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             H---HHHHH---HHhcCCC-------CC---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1   11111   1111111       11   111223477888899999999994     8999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=307.60  Aligned_cols=203  Identities=18%  Similarity=0.222  Sum_probs=157.6

Q ss_pred             cccCCCccceeeEEEe----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            5 NVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         5 ~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      .++||||++++++|.+    +...|+|||||+||+|.+++..  .....+++..+..++.||+.||+|||+.   +|+||
T Consensus        61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHR  135 (335)
T d2ozaa1          61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHR  135 (335)
T ss_dssp             HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccc
Confidence            3489999999999975    4578999999999999999953  2234699999999999999999999999   99999


Q ss_pred             cCCCCcEEeCC---CCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCC
Q 023808           81 DIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  157 (277)
Q Consensus        81 dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~  157 (277)
                      ||||+|||++.   .+.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||
T Consensus       136 DiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf  213 (335)
T d2ozaa1         136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF  213 (335)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred             cccccccccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence            99999999975   4579999999998765432  234567999999999999999999999999999999999999998


Q ss_pred             CcccCcchhhHHHHHHHHhccCCccccccCCCCC-CCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          158 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .........   ..........      ...++. ........+.+++.+||+.||++|||+.|+++
T Consensus       214 ~~~~~~~~~---~~~~~~i~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         214 YSNHGLAIS---PGMKTRIRMG------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             EETTCC-----------CCCSC------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHH---HHHHHHHhcC------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            654332110   0000000000      001110 11223345888999999999999999999976

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=305.67  Aligned_cols=211  Identities=22%  Similarity=0.349  Sum_probs=167.7

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCC------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------KANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||++++|+|..++..++||||+.+|+|.+++....      .....+++..+++++.|++.||.|||+.   
T Consensus        76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---  152 (308)
T d1p4oa_          76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---  152 (308)
T ss_dssp             HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---
Confidence            5789999999999999999999999999999999999985321      1223478999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcce-eeeecccccccCccccccCccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +|+||||||+|||+++++++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||.
T Consensus       153 ~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~  232 (308)
T d1p4oa_         153 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA  232 (308)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence            99999999999999999999999999998765433322 33446899999999999999999999999999999999996


Q ss_pred             -CCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          155 -NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       155 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                       .|+.....   ....   .........         ..+......+.+++.+||+.+|.+|||+.+|++.|++.+.
T Consensus       233 ~~p~~~~~~---~~~~---~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         233 EQPYQGLSN---EQVL---RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCTTTTSCH---HHHH---HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCCCCCCH---HHHH---HHHHhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             55543221   1111   122221111         1112222357888889999999999999999999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=304.10  Aligned_cols=202  Identities=21%  Similarity=0.278  Sum_probs=162.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+|||||+||+|.+++.   ..+..+++.++..++.||+.||+|||++   +|+|||
T Consensus        54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrD  127 (321)
T d1tkia_          54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD  127 (321)
T ss_dssp             HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCccc
Confidence            5788999999999999999999999999999999999993   2344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCC--CceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCc
Q 023808           82 IKASNILLDQE--FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  159 (277)
Q Consensus        82 ikp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~  159 (277)
                      |||+|||++.+  ..+||+|||+++.....  .......||+.|+|||...+..++.++|||||||++|+|++|..||..
T Consensus       128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~  205 (321)
T d1tkia_         128 IRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             CCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccccceeecCCCceEEEEcccchhhccccC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence            99999999754  47999999999876443  234456789999999999999999999999999999999999999865


Q ss_pred             ccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          160 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....   ...   ...........  .......    ...+.+++.+||+.||.+|||+.|+++
T Consensus       206 ~~~~---~~~---~~i~~~~~~~~--~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         206 ETNQ---QII---ENIMNAEYTFD--EEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SSHH---HHH---HHHHHTCCCCC--HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHH---HHH---HHHHhCCCCCC--hhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4321   111   12222111100  0000111    234778899999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=307.67  Aligned_cols=195  Identities=26%  Similarity=0.344  Sum_probs=159.8

Q ss_pred             ccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 023808            4 SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK   83 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dik   83 (277)
                      ..++||||+++++++.+++..|+||||+++|+|.+++.    .+..+++..+..++.||+.||+|||++   +++|||||
T Consensus        58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDik  130 (320)
T d1xjda_          58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLK  130 (320)
T ss_dssp             HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCC
T ss_pred             HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence            36899999999999999999999999999999999994    445689999999999999999999999   99999999


Q ss_pred             CCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCCcccCc
Q 023808           84 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  163 (277)
Q Consensus        84 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~  163 (277)
                      |+|||+++++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... 
T Consensus       131 p~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-  208 (320)
T d1xjda_         131 LDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-  208 (320)
T ss_dssp             GGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred             ccceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-
Confidence            999999999999999999998654332 223446799999999999999999999999999999999999999865432 


Q ss_pred             chhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHH-HHH
Q 023808          164 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVI  222 (277)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~-~v~  222 (277)
                        ..+..   .... ..      +.++..   ....+.+++.+||+.||.+||++. +++
T Consensus       209 --~~~~~---~i~~-~~------~~~p~~---~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         209 --EELFH---SIRM-DN------PFYPRW---LEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             --HHHHH---HHHH-CC------CCCCTT---SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --HHHHH---HHHc-CC------CCCCcc---CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence              11211   1111 11      111111   223477888899999999999985 664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-46  Score=303.62  Aligned_cols=211  Identities=21%  Similarity=0.260  Sum_probs=161.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++|||||++++++.+++..|+||||+.++++..+.    ..+..+++..+..++.||+.||+|||++   +|+|||
T Consensus        53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrD  125 (299)
T d1ua2a_          53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRD  125 (299)
T ss_dssp             HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceeccc
Confidence            578899999999999999999999999999988777766    4456799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++....... ......||+.|+|||++... .++.++|||||||++|||+||..||...
T Consensus       126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         126 LKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcceEEecCCCccccccCccccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            999999999999999999999987654322 23345789999999998754 5799999999999999999999888654


Q ss_pred             cCcchhhHHHHHHHHhccCCcccc----------ccCCCCCCC-----HHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPLEL----------VDPELGEYP-----PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ..   ......+............          ........+     +.....+.+++.+||+.||++|||+.|+++
T Consensus       205 ~~---~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         205 SD---LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SH---HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CH---HHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            32   1222222222111100000          000001111     112245888999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-45  Score=293.75  Aligned_cols=190  Identities=22%  Similarity=0.309  Sum_probs=153.3

Q ss_pred             cccccc--CCCccceeeEEEeCCeeEEEEeecCC-CCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVR--HPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++  ||||+++++++.+++..++||||+.+ +++.+++.    .+..+++..+..++.|++.||+|||+.   +|+
T Consensus        60 il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ii  132 (273)
T d1xwsa_          60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVL  132 (273)
T ss_dssp             HHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence            355665  89999999999999999999999976 67888873    345799999999999999999999999   999


Q ss_pred             eccCCCCcEEeCC-CCceEEeecccccccCCCCcceeeeecccccccCccccccCcc-ccccceEehhHHHHHHHhCCCC
Q 023808           79 HRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        79 H~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||||||+|||++. ++.+||+|||+++.....   ......||+.|+|||++.+..+ +.++|||||||++|||+||+.|
T Consensus       133 HrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P  209 (273)
T d1xwsa_         133 HRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP  209 (273)
T ss_dssp             CSCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCcccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence            9999999999985 478999999999875433   2345679999999999987765 6779999999999999999999


Q ss_pred             CCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          157 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      |....            ........   +.+   ..+    ..+.+++.+||+.||++|||+.|+++
T Consensus       210 f~~~~------------~i~~~~~~---~~~---~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         210 FEHDE------------EIIRGQVF---FRQ---RVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCSHH------------HHHHCCCC---CSS---CCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCch------------HHhhcccC---CCC---CCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            86421            11111110   111   122    34778888999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-44  Score=293.33  Aligned_cols=212  Identities=22%  Similarity=0.317  Sum_probs=158.4

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..|+||||+.++ +.+++..  .....+++..+..++.|++.||+|||++   +|+|||
T Consensus        54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrD  127 (298)
T d1gz8a_          54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRD  127 (298)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCcEEEeccccccccceeEEEeecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccc
Confidence            578999999999999999999999999999765 4444422  3445699999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||+++...... .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...
T Consensus       128 iKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         128 LKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             CCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence            99999999999999999999998765432 2234457999999999877765 578999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCC--cc-cc--c---cCCC---CC-----CCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEK--PL-EL--V---DPEL---GE-----YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~--~~-~~--~---~~~~---~~-----~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .....+........  .. ..  .   ....   ..     ..+.....+.+++.+||+.||.+|||+.|+++
T Consensus       207 ~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         207 SEI---DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             SHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHH---HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            321   11111111111100  00 00  0   0000   00     00112245778899999999999999999975

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-43  Score=286.65  Aligned_cols=225  Identities=18%  Similarity=0.251  Sum_probs=171.8

Q ss_pred             cccccC-CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            3 LSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         3 L~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +++|+| +||+.+++++..+...++||||+ +|+|.+++..   .+..+++..+..++.|++.||+|||+.   +|+|||
T Consensus        54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrD  126 (293)
T d1csna_          54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD  126 (293)
T ss_dssp             HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCC
T ss_pred             HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---Cceecc
Confidence            456655 99999999999999999999999 6799998843   344699999999999999999999999   999999


Q ss_pred             CCCCcEEeCC-----CCceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHH
Q 023808           82 IKASNILLDQ-----EFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI  150 (277)
Q Consensus        82 ikp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~el  150 (277)
                      |||+||+++.     ++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||
T Consensus       127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el  206 (293)
T d1csna_         127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF  206 (293)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence            9999999964     567999999999976543221      23346799999999999999999999999999999999


Q ss_pred             HhCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhccc
Q 023808          151 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  230 (277)
Q Consensus       151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~  230 (277)
                      +||..||.........................++    ....+    ..+.+++..|++.+|.+||+++.+.+.|++++.
T Consensus       207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HhCCCcCCCccchhHHHHHHHHHhccCCCChHHh----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            9999999765544333222222221111111111    11222    236667777999999999999999999998876


Q ss_pred             cCccccCCCCcc
Q 023808          231 LNEEELTAPGLF  242 (277)
Q Consensus       231 ~~~~~~~~~~~~  242 (277)
                      ........+..|
T Consensus       279 ~~~~~~~~~~Dw  290 (293)
T d1csna_         279 RLNTTEDENFDW  290 (293)
T ss_dssp             HTTCCSCSCCGG
T ss_pred             HcCCCCCCCCCC
Confidence            554443444444

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=289.02  Aligned_cols=209  Identities=22%  Similarity=0.304  Sum_probs=156.3

Q ss_pred             ccccCCCccceeeEEEe-----CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            4 SNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         4 ~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +.++||||++++++|..     ....+++|||+.+|++.....   .....+++..+..++.|++.||+|||++   +|+
T Consensus        65 ~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~iv  138 (305)
T d1blxa_          65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVV  138 (305)
T ss_dssp             HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             hhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEE
Confidence            34589999999999963     346799999999877765542   3455689999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCCCC
Q 023808           79 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        79 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||||||+|||++.++.+||+|||+++.....  .......||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus       139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             CCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence            9999999999999999999999998864332  23445679999999999999999999999999999999999999986


Q ss_pred             cccCcchhhHHHHHHHHhccCCcc----------cccc----CCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPL----------ELVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      .....   .....+..........          ....    .............+.+++.+||+.||++|||+.|+++
T Consensus       217 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         217 GSSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CSSHH---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHH---HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            54321   1111111111110000          0000    0001111122234678888999999999999999865

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.5e-43  Score=287.23  Aligned_cols=211  Identities=21%  Similarity=0.320  Sum_probs=157.6

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+++..+++||++.++.+..+.    .....+++..+..++.||+.||+|||+.   +|+|||
T Consensus        53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrD  125 (286)
T d1ob3a_          53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD  125 (286)
T ss_dssp             GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecC
Confidence            578999999999999999999999999999887777776    4456799999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+|++|||.+....... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       126 iKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         126 LKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             CCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCceeeEcCCCCEEecccccceecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            99999999999999999999998765432 223345688999999998765 5689999999999999999999998654


Q ss_pred             cCcchhhHHHHHHHHhccCCcc------c--cccCCC--------CCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPL------E--LVDPEL--------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~------~--~~~~~~--------~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ...   .....+..........      .  ......        ....+.....+.+++.+||+.||++|||+.|+++
T Consensus       205 ~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         205 SEA---DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             SHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHH---HHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            321   1111111111110000      0  000000        0111222345778899999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-43  Score=286.35  Aligned_cols=226  Identities=18%  Similarity=0.243  Sum_probs=162.3

Q ss_pred             ccccccCCCc-cceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      ++++++|+|+ +.+.+++.+++..++||||+ +|+|.+.+.   ..+..+++..+..++.|++.||+|||++   +|+||
T Consensus        55 i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHr  127 (299)
T d1ckia_          55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR  127 (299)
T ss_dssp             HHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---Ceeec
Confidence            4667876664 55566667888999999999 557766653   3445799999999999999999999999   99999


Q ss_pred             cCCCCcEEeCC---CCceEEeecccccccCCCCcc------eeeeecccccccCccccccCccccccceEehhHHHHHHH
Q 023808           81 DIKASNILLDQ---EFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  151 (277)
Q Consensus        81 dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  151 (277)
                      ||||+|||++.   +..+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||+
T Consensus       128 DiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~  207 (299)
T d1ckia_         128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN  207 (299)
T ss_dssp             CCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence            99999999854   457999999999976543221      234567999999999999999999999999999999999


Q ss_pred             hCCCCCCcccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHHHHhhcccc
Q 023808          152 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  231 (277)
Q Consensus       152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~  231 (277)
                      ||..||........................ ...   ....+    ..+.+++..||+.+|.+||++.++.+.|++....
T Consensus       208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         208 LGSLPWQGLKAATKRQKYERISEKKMSTPI-EVL---CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HSSCTTCCCC-------HHHHHHHHHHSCH-HHH---TTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCcccccchHHHHHHHHHhhcccCCCCh-hHh---ccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            999999765443322211111111100000 000   01122    3367778889999999999999999999987654


Q ss_pred             CccccCCCCcc
Q 023808          232 NEEELTAPGLF  242 (277)
Q Consensus       232 ~~~~~~~~~~~  242 (277)
                      .......+..|
T Consensus       280 ~~~~~~~~~Dw  290 (299)
T d1ckia_         280 QGFSYDYVFDW  290 (299)
T ss_dssp             HTCCCSCCCHH
T ss_pred             cCCCCCCCcCc
Confidence            43333334333

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=286.46  Aligned_cols=203  Identities=25%  Similarity=0.323  Sum_probs=161.5

Q ss_pred             ccccccC-CCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 023808            2 TLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR   80 (277)
Q Consensus         2 ~L~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~   80 (277)
                      +|++++| |||+++++++.+....++||||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||
T Consensus        81 il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHr  153 (322)
T d1vzoa_          81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYR  153 (322)
T ss_dssp             HHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred             HHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEec
Confidence            4678877 899999999999999999999999999999984    444678899999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC--ccccccceEehhHHHHHHHhCCCCCC
Q 023808           81 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGK  158 (277)
Q Consensus        81 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~  158 (277)
                      ||||+||+++.++.+||+|||+++.+............|++.|++||.+.+.  .++.++|||||||++|||+||+.||.
T Consensus       154 DiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~  233 (322)
T d1vzoa_         154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT  233 (322)
T ss_dssp             CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             cCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987765555555567899999999999764  46789999999999999999999997


Q ss_pred             cccCcchhhHHHHHHHHhccCCccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCC-----HHHHHH
Q 023808          159 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  223 (277)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-----~~~v~~  223 (277)
                      ...........  ........       +.+   +......+.+++.+||+.||.+||+     ++|+++
T Consensus       234 ~~~~~~~~~~i--~~~~~~~~-------~~~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         234 VDGEKNSQAEI--SRRILKSE-------PPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CTTSCCCHHHH--HHHHHHCC-------CCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCHHHHHHHH--HHhcccCC-------CCC---cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            65443322111  11111111       111   1122344778888999999999995     777764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=288.35  Aligned_cols=213  Identities=23%  Similarity=0.241  Sum_probs=154.3

Q ss_pred             ccccccCCCccceeeEEEeC------CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||++++++|...      .+.++|||||++|.+. .+.........+++..+..++.||+.||+|||++   
T Consensus        66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---  141 (350)
T d1q5ka_          66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---  141 (350)
T ss_dssp             HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---
Confidence            57889999999999999643      3578999999775433 3322224555799999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCcccccc-CccccccceEehhHHHHHHHhC
Q 023808           76 HIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISG  153 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg  153 (277)
                      +|+||||||+|||++.++ .+||+|||+++......  ......||..|+|||.+.+ ..++.++||||+||++|||++|
T Consensus       142 ~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g  219 (350)
T d1q5ka_         142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG  219 (350)
T ss_dssp             TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCCcceEEEecCCCceeEecccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhC
Confidence            999999999999999775 89999999998765432  2334579999999998875 4689999999999999999999


Q ss_pred             CCCCCcccCcchhhHHHHHH----------HHhccCCccccccCCC------CCCCHHHHHHHHHHHHhhhhhhhcCCCC
Q 023808          154 RNSGKAMWGQMNKFLLEWAW----------QLHQEEKPLELVDPEL------GEYPPNEIIRYMKVAFFCTQAAASRRPQ  217 (277)
Q Consensus       154 ~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~c~~~~p~~RPs  217 (277)
                      +.||........  +.....          ........ ...-+..      ....+.....+.+++.+||+.||++|||
T Consensus       220 ~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t  296 (350)
T d1q5ka_         220 QPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYT-EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT  296 (350)
T ss_dssp             SCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCCCCCCCHHHH--HHHHHHHhCCChHHhhhhhccchh-hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence            999865432211  111100          00000000 0000000      0011122334778899999999999999


Q ss_pred             HHHHHH
Q 023808          218 MNQVIK  223 (277)
Q Consensus       218 ~~~v~~  223 (277)
                      +.|+++
T Consensus       297 a~e~L~  302 (350)
T d1q5ka_         297 PLEACA  302 (350)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=282.66  Aligned_cols=206  Identities=23%  Similarity=0.318  Sum_probs=155.6

Q ss_pred             ccccccCCCccceeeEEEeCC------eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++|||||+++++|...+      ..|+||||+ +++|..+..     ...+++..+..++.||+.||+|||++   
T Consensus        70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---  140 (346)
T d1cm8a_          70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---  140 (346)
T ss_dssp             HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---
Confidence            578899999999999998654      569999999 668888873     33699999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +|+||||||+|||++.++.+|++|||+++.....    .....||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus       141 ~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~  216 (346)
T d1cm8a_         141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK  216 (346)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCcccccCcchhhcccccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCc
Confidence            9999999999999999999999999999876543    2345689999999998764 5689999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCC------------------ccccccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEK------------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .||........   ............                  ........+..........+.+++.+||..||.+||
T Consensus       217 ~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  293 (346)
T d1cm8a_         217 TLFKGSDHLDQ---LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV  293 (346)
T ss_dssp             CSSCCSSHHHH---HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCCCCCChHHH---HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence            99865432111   111100000000                  000000001111111223467888999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      |+.|+++
T Consensus       294 ta~eiL~  300 (346)
T d1cm8a_         294 TAGEALA  300 (346)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=280.24  Aligned_cols=212  Identities=22%  Similarity=0.281  Sum_probs=155.2

Q ss_pred             ccccccCCCccceeeEEEe--------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL   73 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~   73 (277)
                      +|++++||||+++++++..        ++..++||||+.++.+..+.    .....+++..+..++.|++.||.|||+. 
T Consensus        62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~-  136 (318)
T d3blha1          62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN-  136 (318)
T ss_dssp             HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC-
Confidence            5789999999999999865        34678999999887666554    4455789999999999999999999999 


Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccccCCCCc---ceeeeecccccccCccccccC-ccccccceEehhHHHHH
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLE  149 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~e  149 (277)
                        +|+||||||+|||++.++.+||+|||+++.+.....   .......||+.|+|||++.+. .++.++|||||||++||
T Consensus       137 --~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~e  214 (318)
T d3blha1         137 --KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE  214 (318)
T ss_dssp             --TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             --CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeee
Confidence              999999999999999999999999999987654321   122345689999999998765 68999999999999999


Q ss_pred             HHhCCCCCCcccCcchhhHHHHHHHHhccCCcc--cccc----------CCCCCC-CHHH------HHHHHHHHHhhhhh
Q 023808          150 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL--ELVD----------PELGEY-PPNE------IIRYMKVAFFCTQA  210 (277)
Q Consensus       150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~-~~~~------~~~~~~l~~~c~~~  210 (277)
                      |++|+.||.....   ......+..........  ...+          ...... ....      ...+.+++.+||+.
T Consensus       215 l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~  291 (318)
T d3blha1         215 MWTRSPIMQGNTE---QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL  291 (318)
T ss_dssp             HHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred             HhhCCCCCCCCCH---HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence            9999999865332   11222222221111000  0000          000000 0111      22456789999999


Q ss_pred             hhcCCCCHHHHHH
Q 023808          211 AASRRPQMNQVIK  223 (277)
Q Consensus       211 ~p~~RPs~~~v~~  223 (277)
                      ||++|||+.|+++
T Consensus       292 dP~~R~sa~elL~  304 (318)
T d3blha1         292 DPAQRIDSDDALN  304 (318)
T ss_dssp             STTTSCCHHHHHH
T ss_pred             ChhHCcCHHHHHc
Confidence            9999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-41  Score=281.09  Aligned_cols=211  Identities=23%  Similarity=0.302  Sum_probs=153.7

Q ss_pred             ccccccCCCccceeeEEEeCC----eeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 023808            2 TLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI   77 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i   77 (277)
                      +|++|+||||+++++++....    ..+++++|+.+|+|.+++..     ..+++..+..++.|++.||+|||++   +|
T Consensus        59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~i  130 (345)
T d1pmea_          59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NV  130 (345)
T ss_dssp             HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            578899999999999997653    23445556779999999942     3599999999999999999999999   99


Q ss_pred             EeccCCCCcEEeCCCCceEEeecccccccCCCCcc--eeeeecccccccCcccccc-CccccccceEehhHHHHHHHhCC
Q 023808           78 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR  154 (277)
Q Consensus        78 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~  154 (277)
                      +||||||+|||++.++.+||+|||+++........  ......||+.|+|||++.. ..++.++||||+||++|||++|+
T Consensus       131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~  210 (345)
T d1pmea_         131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR  210 (345)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence            99999999999999999999999999865443221  2344668999999999855 45788999999999999999999


Q ss_pred             CCCCcccCcchhhHHHHHHHHhccCCccc-------------cccCCCCCC-----CHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          155 NSGKAMWGQMNKFLLEWAWQLHQEEKPLE-------------LVDPELGEY-----PPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~-----~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      .||.........   ..............             ...+.....     .+....++.+++.+||+.||.+||
T Consensus       211 ~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  287 (345)
T d1pmea_         211 PIFPGKHYLDQL---NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI  287 (345)
T ss_dssp             CSCCCSSHHHHH---HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCCCCCCHHHHH---HHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence            998654321111   11111110000000             000000000     011112477899999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      |+.|+++
T Consensus       288 ta~e~L~  294 (345)
T d1pmea_         288 EVEQALA  294 (345)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=272.22  Aligned_cols=212  Identities=19%  Similarity=0.250  Sum_probs=161.2

Q ss_pred             ccccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 023808            2 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD   81 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d   81 (277)
                      +|++++||||+++++++.+....++|++++.+++|..++.    ..+.+++..+..++.|++.||+|||++   +|+|||
T Consensus        54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrD  126 (292)
T d1unla_          54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRD  126 (292)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HHHhcCcCCEEeeccccccccceeEEeeeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeec
Confidence            5789999999999999999999999999999999988873    455789999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCc-cccccceEehhHHHHHHHhCCCCCCcc
Q 023808           82 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAM  160 (277)
Q Consensus        82 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~  160 (277)
                      |||+|||++.++.+||+|||.++....... ......++..|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus       127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  205 (292)
T d1unla_         127 LKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred             ccCcccccccCCceeeeecchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence            999999999999999999999997654332 233345778899999887765 689999999999999999999987543


Q ss_pred             cCcchhhHHHHHHHHhccCCcc--------------c--cccCCCCCCCHHHHHHHHHHHHhhhhhhhcCCCCHHHHHH
Q 023808          161 WGQMNKFLLEWAWQLHQEEKPL--------------E--LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~--------------~--~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~  223 (277)
                      ....  .....+..........              .  ..........+.....+.+++.+||+.||.+|||++|+++
T Consensus       206 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         206 NDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             SSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCHH--HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3221  1111111111110000              0  0001111122233345778889999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-39  Score=270.00  Aligned_cols=209  Identities=18%  Similarity=0.232  Sum_probs=153.8

Q ss_pred             cccccc-CCCccceeeEEEeC--CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 023808            2 TLSNVR-HPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV   78 (277)
Q Consensus         2 ~L~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii   78 (277)
                      +|++++ ||||+++++++...  ...++|||||.+|+|.++.       +.+++..+..++.||+.||+|||++   +|+
T Consensus        82 il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIv  151 (328)
T d3bqca1          82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIM  151 (328)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccc
Confidence            467785 99999999999844  4689999999999987654       2589999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCC-ceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCCC
Q 023808           79 HRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        79 H~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||||||+|||++.++ .+||+|||+++......  ......||..|+|||.+.+. .++.++||||+||++|||++|+.|
T Consensus       152 HrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p  229 (328)
T d3bqca1         152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  229 (328)
T ss_dssp             CCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             cccccccceEEcCCCCeeeecccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence            999999999998655 69999999998765432  23445689999999998775 479999999999999999999999


Q ss_pred             CCcccCcchhhHH-----------HHHHHHhccCCccc---ccc--------CCC-CCCCHHHHHHHHHHHHhhhhhhhc
Q 023808          157 GKAMWGQMNKFLL-----------EWAWQLHQEEKPLE---LVD--------PEL-GEYPPNEIIRYMKVAFFCTQAAAS  213 (277)
Q Consensus       157 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~---~~~--------~~~-~~~~~~~~~~~~~l~~~c~~~~p~  213 (277)
                      |............           .+... ........   ...        ... ..........+.+++.+||+.||+
T Consensus       230 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  308 (328)
T d3bqca1         230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ  308 (328)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHH-TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGG
T ss_pred             CCCCchhHHHHHHHHHHHCCchhhhhhhh-cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChh
Confidence            8654432211100           00000 00000000   000        000 001111234577889999999999


Q ss_pred             CCCCHHHHHH
Q 023808          214 RRPQMNQVIK  223 (277)
Q Consensus       214 ~RPs~~~v~~  223 (277)
                      +|||++|+++
T Consensus       309 ~R~ta~e~L~  318 (328)
T d3bqca1         309 SRLTAREAME  318 (328)
T ss_dssp             GSCCHHHHHT
T ss_pred             HCcCHHHHhc
Confidence            9999999865

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-40  Score=274.66  Aligned_cols=207  Identities=22%  Similarity=0.260  Sum_probs=148.2

Q ss_pred             ccccccCCCccceeeEEEe------CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP   75 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~   75 (277)
                      +|++++||||++++++|..      ....|+|||||.++.+. .+      ...+++..+..++.|++.||+|||+.   
T Consensus        69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~------~~~~~~~~i~~~~~qil~gl~~LH~~---  138 (355)
T d2b1pa1          69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VI------QMELDHERMSYLLYQMLCGIKHLHSA---  138 (355)
T ss_dssp             HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HH------TSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hh------hcCCCHHHHHHHHHHHHHHHHHhhhc---
Confidence            5788999999999999964      36889999999775544 44      12589999999999999999999999   


Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCC
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      ||+||||||+|||++.++.+|++|||+++.....  .......||..|+|||++.+..++.++||||+||++|||++|+.
T Consensus       139 giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~  216 (355)
T d2b1pa1         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI  216 (355)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccCCccccccccccceeeechhhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCC
Confidence            9999999999999999999999999998865432  23345568999999999999999999999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHH-------------------hccCCcc----------ccccCCCCCCCHHHHHHHHHHHHh
Q 023808          156 SGKAMWGQMNKFLLEWAWQL-------------------HQEEKPL----------ELVDPELGEYPPNEIIRYMKVAFF  206 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~~  206 (277)
                      ||.......   ....+...                   .......          ....+............+.+++.+
T Consensus       217 pF~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~  293 (355)
T d2b1pa1         217 LFPGRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK  293 (355)
T ss_dssp             SSCCSSHHH---HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHH---HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHH
Confidence            986443211   11111000                   0000000          000000011122345668899999


Q ss_pred             hhhhhhcCCCCHHHHHH
Q 023808          207 CTQAAASRRPQMNQVIK  223 (277)
Q Consensus       207 c~~~~p~~RPs~~~v~~  223 (277)
                      ||+.||++|||++|+++
T Consensus       294 mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         294 MLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HCcCChhHCcCHHHHhc
Confidence            99999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-39  Score=271.51  Aligned_cols=206  Identities=22%  Similarity=0.293  Sum_probs=149.7

Q ss_pred             ccccccCCCccceeeEEEeC-----CeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 023808            2 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH   76 (277)
Q Consensus         2 ~L~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~   76 (277)
                      +|++|+||||+++++++...     ...++||+|+.+|+|.+++.     ...+++..+..++.||+.||+|||++   +
T Consensus        70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---g  141 (348)
T d2gfsa1          70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---D  141 (348)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            57899999999999999733     34466777888999999993     23699999999999999999999999   9


Q ss_pred             eEeccCCCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccC-ccccccceEehhHHHHHHHhCCC
Q 023808           77 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN  155 (277)
Q Consensus        77 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~  155 (277)
                      |+||||||+|||++.++.+|++|||++.....    ......|+..|+|||...+. .++.++|||||||++|+|++|+.
T Consensus       142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~  217 (348)
T d2gfsa1         142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT  217 (348)
T ss_dssp             CCCCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CcccccCCccccccccccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCC
Confidence            99999999999999999999999999975432    23445689999999987765 46889999999999999999999


Q ss_pred             CCCcccCcchhhHHHHHHHHhccCCccccc------------c--CCCCCC-----CHHHHHHHHHHHHhhhhhhhcCCC
Q 023808          156 SGKAMWGQMNKFLLEWAWQLHQEEKPLELV------------D--PELGEY-----PPNEIIRYMKVAFFCTQAAASRRP  216 (277)
Q Consensus       156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~--~~~~~~-----~~~~~~~~~~l~~~c~~~~p~~RP  216 (277)
                      ||.......   ....+....... .....            .  ......     .......+.+++.+||+.||.+||
T Consensus       218 pF~~~~~~~---~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  293 (348)
T d2gfsa1         218 LFPGTDHID---QLKLILRLVGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI  293 (348)
T ss_dssp             SCCCSSHHH---HHHHHHHHHCCC-CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCCCCCHHH---HHHHHHHhcCCC-ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence            986543211   111111111000 00000            0  000000     011123477889999999999999


Q ss_pred             CHHHHHH
Q 023808          217 QMNQVIK  223 (277)
Q Consensus       217 s~~~v~~  223 (277)
                      |+.|+++
T Consensus       294 ta~elL~  300 (348)
T d2gfsa1         294 TAAQALA  300 (348)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999976

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-34  Score=241.97  Aligned_cols=209  Identities=20%  Similarity=0.224  Sum_probs=146.7

Q ss_pred             ccCCCccceeeEEEe--CCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccC
Q 023808            6 VRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDI   82 (277)
Q Consensus         6 l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~di   82 (277)
                      +.|+||+++++++..  ....+++++++..+........ ......+++..+..++.|++.||+|||+ .   +|+||||
T Consensus        77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDl  152 (362)
T d1q8ya_          77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDI  152 (362)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCC
T ss_pred             cCcCceEEEEEEeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccC
Confidence            457999999999874  3456667776655443222211 2345568899999999999999999998 6   8999999


Q ss_pred             CCCcEEeCCCCc------eEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHHHHHhCCCC
Q 023808           83 KASNILLDQEFN------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  156 (277)
Q Consensus        83 kp~Nill~~~~~------~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p  156 (277)
                      ||+|||++.++.      ++++|||.+......    .....||+.|+|||++.+..++.++||||+||++++|++|+.|
T Consensus       153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p  228 (362)
T d1q8ya_         153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  228 (362)
T ss_dssp             SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             ChhHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence            999999976543      899999999865432    2445699999999999999999999999999999999999999


Q ss_pred             CCcccCcchh----hHHHHHHHHhcc------------------CCcccccc-----------CCCCCCCHHHHHHHHHH
Q 023808          157 GKAMWGQMNK----FLLEWAWQLHQE------------------EKPLELVD-----------PELGEYPPNEIIRYMKV  203 (277)
Q Consensus       157 ~~~~~~~~~~----~~~~~~~~~~~~------------------~~~~~~~~-----------~~~~~~~~~~~~~~~~l  203 (277)
                      |.........    ....... ....                  ......+.           +............+.++
T Consensus       229 F~~~~~~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  307 (362)
T d1q8ya_         229 FEPDEGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  307 (362)
T ss_dssp             C---------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCccccccchhHHHHHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence            8654332111    1111110 0000                  00000000           00123345677789999


Q ss_pred             HHhhhhhhhcCCCCHHHHHH
Q 023808          204 AFFCTQAAASRRPQMNQVIK  223 (277)
Q Consensus       204 ~~~c~~~~p~~RPs~~~v~~  223 (277)
                      +.+||+.||.+|||++|+++
T Consensus       308 l~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         308 LSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.73  E-value=3.9e-19  Score=134.77  Aligned_cols=123  Identities=16%  Similarity=0.130  Sum_probs=85.8

Q ss_pred             cccccCCCccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 023808            3 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI   82 (277)
Q Consensus         3 L~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~di   82 (277)
                      |.++.|.+++..+++.    ..+++|||++++.+.+           ++......++.|++.||+|||+.   +|+||||
T Consensus        68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDi  129 (191)
T d1zara2          68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDL  129 (191)
T ss_dssp             HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             HHHccCCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccC
Confidence            5678899999988663    2379999998865433           33445667999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeecccccccCCCCcceeeeecccccccCccccccCccccccceEehhHHHH
Q 023808           83 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  148 (277)
Q Consensus        83 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~  148 (277)
                      ||+|||++++ .++|+|||++.....+....-...  .... -.+ +....|+.++|+||..--++
T Consensus       130 KP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~r--d~~~-~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         130 SQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILER--DVRN-IIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             STTSEEEETT-EEEECCCTTCEETTSTTHHHHHHH--HHHH-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             ChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHH--HHHH-HHH-HHcCCCCCcccHHHHHHHHh
Confidence            9999999865 489999999986543321100000  0000 001 12356788999999865543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.08  E-value=4.6e-06  Score=64.59  Aligned_cols=85  Identities=13%  Similarity=0.071  Sum_probs=59.7

Q ss_pred             ccceeeEEEeCCeeEEEEeecCCCCHHHHhccCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----------------
Q 023808           11 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----------------   73 (277)
Q Consensus        11 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----------------   73 (277)
                      +.++++++.+++..++||++++|.++.+....    .     .....++.+++..++.||+..                 
T Consensus        72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~----~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~  142 (263)
T d1j7la_          72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYED----E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL  142 (263)
T ss_dssp             CCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred             CCcEEEEEecCCceEEEEEecccccccccccc----c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence            67889999999999999999999888665411    0     011223444455555555321                 


Q ss_pred             ---------------------------------------CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 ---------------------------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ---------------------------------------~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                                                             ...++|+|+.|.||++++++.+-|.||+.+.
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                                   1237899999999999977666799999776

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.57  E-value=2.2e-05  Score=60.27  Aligned_cols=29  Identities=21%  Similarity=0.196  Sum_probs=25.4

Q ss_pred             CeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      .++|+|+.|.||+++++..+-|.||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            48999999999999987667899999775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.53  E-value=0.0014  Score=53.30  Aligned_cols=29  Identities=21%  Similarity=0.314  Sum_probs=25.3

Q ss_pred             CeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           76 HIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        76 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      .++|||+.+.||+++++. ++|.||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            689999999999998764 89999988763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.16  E-value=0.0073  Score=47.25  Aligned_cols=31  Identities=19%  Similarity=0.236  Sum_probs=27.3

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeeccccc
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  104 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  104 (277)
                      +.++||+|+.+.||+++++...-+.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4489999999999999988777899999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=93.74  E-value=0.036  Score=43.37  Aligned_cols=30  Identities=30%  Similarity=0.306  Sum_probs=24.5

Q ss_pred             CCCeEeccCCCCcEEeCCCCceEEeecccccc
Q 023808           74 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  105 (277)
Q Consensus        74 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  105 (277)
                      +.+++|+|+.+.|||++++  ..+.||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4589999999999999754  45789998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=84.46  E-value=0.19  Score=40.18  Aligned_cols=15  Identities=40%  Similarity=0.740  Sum_probs=13.2

Q ss_pred             eEeccCCCCcEEeCC
Q 023808           77 IVHRDIKASNILLDQ   91 (277)
Q Consensus        77 iiH~dikp~Nill~~   91 (277)
                      ++|+|+.+.||++.+
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            579999999999854